data_2rqe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rqe _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 121.62 0.724 . . . . 64.11 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.26 24.92 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 73.1 112.333 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.404 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 53.6 Cg_endo -69.79 134.19 27.32 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.686 2.257 . . . . 74.45 112.342 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.444 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . . . -81.55 136.02 35.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 71.22 111.112 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.4 m -95.6 77.57 3.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 74.01 111.107 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.42 110.17 14.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 71.22 110.912 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.423 ' CB ' HG23 ' A' ' 99' ' ' VAL . 12.9 mm-40 -79.8 -165.61 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 64.42 110.903 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -134.95 80.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 73.0 111.103 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.6 mm -70.81 172.5 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 74.15 111.127 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.571 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -53.79 172.37 0.23 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.573 0.702 . . . . 74.13 110.853 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.571 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.79 20.02 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.614 2.209 . . . . 65.24 112.378 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' HIS . 3.8 ptpt -126.78 24.04 6.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 70.02 110.885 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.91 -178.48 30.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 62.12 112.498 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.451 ' C ' HG13 ' A' ' 11' ' ' ILE . 29.1 tp -150.52 164.11 36.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.857 0.361 . . . . 74.33 110.892 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -127.61 137.61 52.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 71.13 110.863 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.8 t -145.6 108.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 72.42 111.11 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.5 t -122.3 156.45 33.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 73.34 110.919 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.572 HG23 ' CZ ' ' A' ' 28' ' ' PHE . 10.4 m -141.36 150.86 59.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.633 0.73 . . . . 73.04 111.117 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 122.27 8.95 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.725 2.283 . . . . 73.25 112.348 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.54 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 15.0 t70 -83.81 128.74 34.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.1 110.844 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -117.97 2.21 12.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.916 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.27 31.08 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 62.53 112.452 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.495 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 63.3 m-85 -82.27 160.9 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 74.35 110.897 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.7 t -126.48 -13.52 6.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 70.24 110.856 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.556 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -153.64 140.17 18.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 75.02 110.959 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.572 ' CZ ' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -133.75 143.72 48.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.52 110.861 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.03 129.35 43.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 74.51 111.171 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -115.24 120.62 40.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.941 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.487 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 11.4 m-70 -151.58 91.07 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 74.45 110.864 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.482 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -145.96 -177.6 20.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.777 -0.725 . . . . 73.52 112.484 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -135.3 -166.44 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 74.44 110.847 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' ASN . 9.5 tp -128.07 147.35 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 64.15 110.886 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 34' ' ' LEU . 1.7 m-80 36.47 34.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 74.25 110.929 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 34' ' ' LEU . 1.2 tp10 -163.43 129.16 3.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 65.13 110.922 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -102.74 150.21 23.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 72.04 110.87 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 64.35 110.898 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.435 -0.266 . . . . 74.21 112.435 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -103.27 -53.32 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 74.21 110.861 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.9 m-90 -73.25 147.47 44.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.219 -0.446 . . . . 70.12 110.881 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.487 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 87.2 p -151.27 119.01 6.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 72.14 110.88 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.92 163.12 4.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 71.34 110.889 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -142.82 119.37 11.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 55.23 110.88 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 28' ' ' PHE . 5.5 mm -86.17 109.98 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 75.34 111.138 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 p -94.79 28.01 2.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 72.4 111.174 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt 171.22 135.66 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.562 0.696 . . . . 73.44 110.908 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -175.57 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.679 2.253 . . . . 74.34 112.399 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 1.2 ttmm -157.16 109.57 2.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 62.15 110.867 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 3.6 t-20 82.68 15.14 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 75.41 110.855 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.67 -17.5 49.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 73.11 112.444 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.86 160.4 37.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 74.23 110.865 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.54 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 20.1 m95 -84.69 94.17 8.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 73.05 110.946 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.72 143.12 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 74.44 111.102 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -138.55 153.52 48.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 75.44 110.864 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.99 137.41 26.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 75.14 110.873 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.433 ' OD2' ' CG ' ' A' ' 64' ' ' ASN . 1.1 t70 -112.19 -177.67 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.894 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -143.49 10.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 74.3 110.85 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.433 ' CG ' ' OD2' ' A' ' 62' ' ' ASP . 22.1 p30 -127.28 9.87 6.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 73.22 110.844 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.24 101.06 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.35 111.085 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.85 88.74 3.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 64.54 111.162 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.417 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -136.33 171.22 14.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 74.53 110.951 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.475 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -155.29 154.48 32.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 70.44 110.906 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.616 ' CG1' ' CE2' ' A' ' 98' ' ' PHE . 16.2 mm -32.14 115.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 75.2 111.106 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.8 -20.53 6.4 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.686 -0.769 . . . . 63.3 112.455 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.69 -173.75 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.881 0.372 . . . . 75.32 110.849 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.5 mttt -149.56 159.68 44.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.45 110.894 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.4 mt -134.26 148.1 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 74.4 111.113 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -147.75 105.55 3.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.938 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.482 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 2.3 p90 -163.68 -159.44 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 74.23 110.855 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.431 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.9 p-90 -145.44 168.58 20.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 74.32 110.92 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -139.92 147.59 40.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 73.32 111.152 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -112.92 141.01 47.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 75.53 110.884 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.69 171.2 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.14 111.112 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.4 mt -150.24 96.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 74.51 111.111 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.51 135.85 53.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.89 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 48.43 33.37 3.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 64.35 110.897 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.69 31.0 63.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 71.42 112.524 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.19 -56.54 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.882 0.372 . . . . 75.54 110.921 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.14 113.93 2.92 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 52.2 112.462 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -133.4 170.67 15.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 75.03 110.9 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -170.86 137.82 1.29 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 73.51 110.919 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.41 ' N ' ' HG2' ' A' ' 87' ' ' ARG . 1.5 tp60 -85.75 152.22 23.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 72.34 110.898 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -134.35 -166.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.828 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 82.92 -36.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.86 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 43.47 80.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 65.3 112.469 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -168.74 113.43 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 74.1 110.91 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -151.09 121.56 7.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.187 -0.46 . . . . 72.3 110.9 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.4 m -92.96 134.56 34.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 64.42 111.143 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.472 ' CG1' ' HB3' ' A' ' 10' ' ' ALA . 21.4 t -63.61 121.24 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 63.35 111.145 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.1 34.05 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.891 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -162.9 125.52 1.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.7 -0.762 . . . . 74.4 112.509 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.616 ' CE2' ' CG1' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -94.92 163.89 13.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 75.2 110.886 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.423 HG23 ' CB ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -164.48 167.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 74.13 111.13 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.34 130.31 50.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 64.43 110.876 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.36 57.07 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.51 110.862 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 72.22 111.121 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.541 0.686 . . . . 74.24 111.156 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.443 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.7 Cg_endo -69.75 166.01 29.03 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.65 2.233 . . . . 75.25 112.37 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 134.25 27.39 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.667 2.245 . . . . 75.0 112.327 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.01 140.41 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 61.54 111.086 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -97.1 78.7 2.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 75.52 111.146 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mp -76.15 110.79 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 73.52 110.938 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 98' ' ' PHE . 4.8 mm-40 -84.5 -168.54 2.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 75.32 110.848 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -134.57 80.54 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 71.54 111.05 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.49 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -72.16 172.2 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.24 111.136 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.579 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.07 172.53 0.23 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 75.02 110.825 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.3 Cg_endo -69.8 19.91 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.705 2.27 . . . . 63.1 112.335 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 12' ' ' HIS . 8.1 pttt -127.18 25.14 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 73.31 110.862 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.58 -179.23 30.06 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.775 -0.726 . . . . 72.4 112.482 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.454 ' C ' HG13 ' A' ' 11' ' ' ILE . 17.7 tp -150.35 164.49 35.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 74.35 110.931 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.1 ttt-85 -126.19 141.89 51.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 75.33 110.9 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -152.11 102.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 64.21 111.113 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -115.22 157.08 24.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 73.22 110.83 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.5 m -139.94 151.64 65.86 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 71.31 111.148 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 53.9 Cg_endo -69.74 125.26 11.95 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.719 2.279 . . . . 74.52 112.366 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 20.1 t0 -87.33 83.72 7.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 50.04 110.868 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -70.96 -0.27 8.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 73.41 110.899 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.5 28.7 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 75.12 112.489 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -77.18 166.87 22.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.868 0.365 . . . . 75.22 110.906 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.5 t -124.64 -15.26 6.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 73.33 110.836 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -157.0 136.9 12.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 75.4 110.965 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.629 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 7.6 t80 -131.06 148.09 52.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 75.32 110.881 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.25 157.7 45.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 74.24 111.091 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.629 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.5 m-85 -130.96 127.28 38.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 75.14 110.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -153.27 85.76 1.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 75.02 110.877 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.513 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.15 173.84 26.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 61.51 112.488 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.32 -164.57 1.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 73.11 110.942 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 tp -134.01 145.3 49.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 75.21 110.916 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 47.57 28.88 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 62.32 110.914 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -168.32 134.64 1.94 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.31 110.922 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -108.49 160.18 16.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 72.14 110.852 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.462 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 75.31 110.843 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.459 ' CA ' ' HE3' ' A' ' 38' ' ' MET . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.505 -0.238 . . . . 70.41 112.505 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.68 -65.27 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.742 0.305 . . . . 64.0 110.861 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -60.64 139.37 57.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 71.2 110.954 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.5 p -139.64 115.55 10.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.811 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.457 ' CD ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -155.76 154.75 31.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.487 . . . . 65.15 110.87 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.34 109.63 5.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.01 110.859 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.457 HD13 ' CD ' ' A' ' 48' ' ' ARG . 12.8 mm -92.64 125.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 72.51 111.094 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 55.6 p -111.06 33.85 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 65.12 111.141 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 51' ' ' THR . 3.2 tttt 163.45 131.78 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 74.14 110.906 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -176.0 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.698 2.266 . . . . 63.31 112.363 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.04 -35.98 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 72.51 110.881 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' NH1' ' A' ' 57' ' ' ARG . 1.9 m120 -128.0 38.24 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 75.45 110.899 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.42 -27.86 8.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.685 -0.769 . . . . 74.42 112.548 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -125.2 173.51 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.348 . . . . 74.44 110.877 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.414 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 12.6 m95 -92.28 94.46 9.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 75.21 110.898 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.2 mt -98.24 141.31 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 63.44 111.141 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 19.6 t80 -136.52 153.08 51.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.15 110.895 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -143.96 137.28 27.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 75.33 110.883 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.17 178.41 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 71.24 110.9 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.89 10.83 2.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 73.02 110.83 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -125.47 7.38 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 62.42 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.409 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -94.82 103.03 14.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.23 111.097 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.42 85.21 2.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 72.12 111.105 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.525 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -138.56 170.96 15.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.904 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -156.84 164.56 37.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.885 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 68' ' ' LYS . 26.4 mm -33.01 122.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.31 111.11 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.4 -29.41 6.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.719 -0.753 . . . . 63.24 112.509 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.36 -176.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.903 0.382 . . . . 73.23 110.86 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -143.6 169.36 17.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 72.14 110.91 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.3 mt -147.84 145.22 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 72.42 111.092 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.2 m-85 -148.38 105.25 3.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.938 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 2.4 p90 -164.6 -160.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 74.45 110.905 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.462 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -149.05 155.58 40.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.937 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.45 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 5.6 p -124.0 147.37 47.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 71.43 111.163 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.99 151.07 25.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.879 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -145.48 169.41 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 71.45 111.125 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.9 mt -150.26 95.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.44 111.151 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -112.15 136.6 51.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 71.21 110.899 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.35 38.79 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.871 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.9 35.74 59.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 71.34 112.459 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 mt -97.72 -59.19 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 73.41 110.951 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.53 105.87 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 54.22 112.526 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.417 ' C ' HG22 ' A' ' 79' ' ' VAL . 94.5 m-85 -124.21 178.35 5.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.824 0.345 . . . . 75.03 110.957 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -178.42 130.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 75.44 110.903 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -65.29 -171.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 75.43 110.92 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.0 t70 -170.37 -169.8 0.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 62.52 110.841 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.3 t-20 83.01 -36.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 64.12 110.864 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.33 75.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 34.54 112.513 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -168.18 117.49 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.889 0.375 . . . . 73.42 110.9 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -157.06 118.53 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 71.4 110.93 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 95' ' ' VAL . 36.5 m -90.82 142.12 28.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 54.44 111.153 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.415 ' N ' HG23 ' A' ' 94' ' ' THR . 28.2 t -76.35 112.47 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 71.45 111.154 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -131.52 4.7 4.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.24 110.923 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -116.6 -176.53 17.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.777 -0.725 . . . . 62.31 112.492 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.5 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -156.66 159.89 38.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.371 . . . . 74.44 110.896 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.79 -174.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.33 111.101 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.05 137.68 22.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 45.41 110.877 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.27 46.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 74.35 110.892 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.072 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.597 0.713 . . . . 74.02 111.06 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.09 25.41 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.666 2.244 . . . . 74.01 112.33 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 133.47 25.69 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.235 . . . . 65.12 112.34 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.03 136.6 35.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 70.33 111.122 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -92.95 77.72 4.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 64.31 111.141 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mp -78.48 108.68 12.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 63.4 110.927 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 0.7 OUTLIER -82.55 -173.47 4.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 71.45 110.928 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.466 ' HB3' ' CG1' ' A' ' 95' ' ' VAL . . . -129.49 80.75 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 73.32 111.096 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 2.5 mm -71.72 172.68 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 73.14 111.134 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.561 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -53.92 171.63 0.26 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 74.22 110.823 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.561 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.2 Cg_endo -69.79 19.7 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.628 2.219 . . . . 63.44 112.361 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 12' ' ' HIS . 12.6 pttt -125.82 22.1 7.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.861 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.67 -178.98 31.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.757 -0.735 . . . . 73.13 112.506 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.472 ' C ' HG13 ' A' ' 11' ' ' ILE . 19.4 tp -150.46 164.42 35.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 75.24 110.938 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -128.95 136.77 50.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 71.35 110.839 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -146.34 106.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 73.03 111.157 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.0 t -119.68 157.84 27.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 63.31 110.83 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.86 151.53 63.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.735 . . . . 73.13 111.125 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 122.16 8.84 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 61.1 112.325 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -80.51 97.91 7.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.838 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.32 12.42 10.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.931 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.26 15.68 3.7 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.703 -0.761 . . . . 63.11 112.46 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.514 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 87.5 m-85 -66.49 165.56 14.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 74.32 110.865 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 t -125.03 -17.24 5.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 73.0 110.839 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.572 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -153.45 139.67 18.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 75.13 110.903 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.644 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 8.0 t80 -132.0 148.63 52.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 64.54 110.873 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.53 155.12 50.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 73.02 111.152 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.644 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.6 m-85 -127.94 125.51 39.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 72.11 110.871 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -149.03 83.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 74.31 110.83 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.527 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.14 173.61 26.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 70.11 112.496 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.6 -164.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 73.44 110.925 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 36' ' ' GLU . 21.9 tp -126.49 147.61 49.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 71.53 110.962 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 34' ' ' LEU . 1.6 m-80 37.04 32.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.86 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 34' ' ' LEU . 64.5 tt0 -161.96 134.36 5.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.925 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -106.51 160.43 15.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.2 110.88 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 70.2 110.888 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.482 -0.247 . . . . 55.4 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.67 -68.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.322 . . . . 74.24 110.827 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.594 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 6.0 m0 -58.02 97.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 72.15 110.925 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.8 p -109.17 105.09 14.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 72.33 110.874 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.89 162.8 37.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 75.41 110.868 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -144.6 117.22 8.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.833 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 18.4 mm -97.42 113.04 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 73.44 111.163 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.6 p -95.9 30.46 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 75.43 111.17 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.429 ' O ' ' CG2' ' A' ' 50' ' ' ILE . 2.8 tttt 173.99 138.62 0.15 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.721 . . . . 75.52 110.937 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -175.47 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.707 2.271 . . . . 73.43 112.323 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -118.47 -71.56 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 72.14 110.872 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.07 46.57 2.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.2 110.87 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.67 -35.05 4.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 63.12 112.497 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.78 177.2 6.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 74.23 110.879 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -93.32 98.65 11.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.879 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.9 mt -103.09 141.0 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 73.42 111.147 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -135.64 147.1 48.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.914 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 126.83 29.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.872 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.594 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -104.06 169.81 8.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 74.54 110.916 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.2 mtt180 -136.93 20.3 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.0 110.837 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -133.19 14.55 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 74.51 110.887 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.54 101.86 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 75.1 111.109 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.96 84.23 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 71.23 111.11 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.484 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -135.89 171.17 14.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 75.52 110.879 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -157.71 158.07 34.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 74.35 110.959 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.6 mm -31.44 116.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 73.01 111.11 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.24 -26.1 5.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 74.21 112.512 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -72.79 -175.62 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 62.25 110.856 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.0 mptt -144.88 163.02 35.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 73.24 110.902 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.466 HG21 ' N ' ' A' ' 74' ' ' TYR . 37.3 mt -138.63 143.59 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.169 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.466 ' N ' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -145.48 105.27 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.931 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.527 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 3.9 p90 -165.44 -161.38 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 74.13 110.853 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.86 174.06 11.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 73.32 110.877 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 p -141.5 156.45 45.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 72.11 111.137 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.2 137.79 52.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 70.43 110.903 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.514 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -134.19 166.62 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 73.34 111.149 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.7 mt -142.44 95.9 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 70.24 111.138 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -116.44 147.51 41.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 74.25 110.919 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.05 27.8 1.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 62.1 110.884 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.77 30.94 70.27 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.734 -0.746 . . . . 63.31 112.464 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.17 -73.14 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.803 0.335 . . . . 73.21 110.93 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.94 117.21 2.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 73.12 112.505 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -128.08 170.76 12.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.95 0.405 . . . . 72.43 110.911 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -159.05 139.0 11.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 75.51 110.884 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -80.78 160.93 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 75.33 110.908 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 6.1 m-20 -145.49 -173.45 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 75.23 110.876 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 85.11 -32.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 64.45 110.894 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 33.47 81.91 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 72.32 112.512 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -172.48 110.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 74.33 110.909 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -153.22 105.89 2.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 74.13 110.943 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.414 HG23 ' N ' ' A' ' 95' ' ' VAL . 89.3 m -76.3 136.39 39.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 74.33 111.122 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' ' 10' ' ' ALA . 45.6 t -64.82 109.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 75.33 111.128 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -128.6 5.2 5.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.89 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -115.64 -178.64 18.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 74.02 112.498 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.443 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -155.96 155.87 33.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 75.31 110.881 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.58 -177.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 74.23 111.142 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -139.45 132.0 28.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.865 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -76.06 54.98 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 72.23 110.913 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 70.13 111.083 179.928 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.596 0.713 . . . . 75.34 111.063 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 169.68 18.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 72.55 112.354 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.417 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 53.7 Cg_endo -69.78 134.79 28.79 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.256 . . . . 72.22 112.362 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.32 137.46 33.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 74.02 111.148 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -96.5 77.43 2.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 74.1 111.141 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.432 HD11 ' CG ' ' A' ' 93' ' ' TRP . 1.9 mp -76.81 110.13 11.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.437 . . . . 75.01 110.953 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.427 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 28.9 mp0 -83.01 -173.24 4.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 73.1 110.857 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -131.12 80.29 1.93 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 71.01 111.115 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 2.9 mm -70.23 172.42 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.126 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -53.92 172.04 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.581 0.705 . . . . 75.01 110.841 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.5 Cg_endo -69.77 20.12 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.674 2.249 . . . . 64.31 112.368 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' A' ' 12' ' ' HIS . 39.9 pttt -125.76 21.71 7.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 72.12 110.895 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.4 -178.11 32.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.784 -0.722 . . . . 74.12 112.518 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.465 ' C ' HG13 ' A' ' 11' ' ' ILE . 23.1 tp -150.08 164.57 35.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 71.3 110.862 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -130.2 140.59 50.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 70.12 110.901 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.0 t -148.58 111.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.13 111.084 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 t -122.57 156.17 34.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.85 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.06 152.17 66.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.671 0.748 . . . . 65.44 111.102 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 121.39 8.08 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.672 2.248 . . . . 74.22 112.355 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -76.3 105.89 7.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 61.34 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.47 34.67 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 62.53 110.855 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.66 1.48 52.87 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.731 -0.747 . . . . 71.4 112.494 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.481 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 74.3 m-85 -54.05 164.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 75.12 110.881 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 t -127.08 -11.8 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 75.45 110.885 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.566 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -158.73 138.49 11.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 74.34 110.914 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.668 ' CD2' ' CE1' ' A' ' 30' ' ' PHE . 7.3 t80 -130.89 146.01 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.88 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.421 ' C ' ' CD1' ' A' ' 30' ' ' PHE . . . -129.53 158.39 39.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 72.11 111.071 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.668 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 1.8 m-85 -132.81 127.85 35.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 71.14 110.902 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -157.35 86.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.854 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -144.8 175.02 24.69 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 71.55 112.523 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.29 -166.68 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 63.33 110.919 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.506 ' CD1' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -129.93 124.64 33.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 72.35 110.912 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.506 ' ND2' ' CD1' ' A' ' 34' ' ' LEU . 67.9 m-80 62.05 23.54 13.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 64.24 110.875 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -155.93 144.13 19.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 74.33 110.893 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -112.73 169.05 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 63.51 110.853 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.527 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 74.23 110.853 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.514 -0.234 . . . . 53.31 112.514 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.49 -63.09 1.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.343 . . . . 72.5 110.836 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.459 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.4 m-90 -61.15 155.33 20.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 72.2 110.9 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.2 p -158.45 109.53 2.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 75.54 110.867 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.37 160.3 38.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.861 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.09 107.22 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 72.32 110.913 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.1 mm -86.75 106.66 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 74.32 111.137 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.0 p -96.01 29.93 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 74.44 111.145 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.85 113.66 0.25 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.628 0.727 . . . . 73.22 110.871 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 53.9 Cg_endo -69.76 -178.23 2.24 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.677 2.252 . . . . 74.43 112.321 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -174.33 136.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.893 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 2.6 t30 82.48 7.88 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 71.31 110.937 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' CD ' ' A' ' 57' ' ' ARG . . . 100.0 -6.73 58.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 74.01 112.51 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.418 ' CD ' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -153.27 174.2 14.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 73.12 110.883 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.516 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 14.6 m95 -90.35 106.24 18.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.935 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.5 146.63 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 74.32 111.13 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -143.43 149.06 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 71.15 110.913 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 133.1 28.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.35 110.883 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.72 -178.49 3.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 64.22 110.855 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.56 20.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.867 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -134.89 14.56 3.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 74.42 110.908 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.36 107.25 18.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 51.52 111.112 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.47 79.7 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 75.23 111.069 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -126.65 171.6 11.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 74.44 110.944 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.501 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -158.09 154.43 27.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.14 110.893 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.501 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.7 mm -29.61 123.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 73.53 111.096 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.54 7.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 62.41 112.499 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.444 ' CB ' HG22 ' A' ' 95' ' ' VAL . 2.5 m-20 -70.73 -176.89 1.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.927 0.394 . . . . 74.0 110.808 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -142.2 166.6 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 75.4 110.919 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 87.4 mt -142.96 145.27 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 74.11 111.125 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -147.5 103.32 3.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 75.33 110.937 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.436 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 1.4 p90 -162.29 -162.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 74.15 110.927 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.527 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -150.64 149.77 30.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.896 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.532 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 7.0 p -119.76 145.87 46.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 72.24 111.132 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -103.84 150.5 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 75.42 110.896 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.481 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -143.28 166.92 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 65.04 111.112 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 85.7 mt -145.61 96.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 73.13 111.143 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -115.14 137.31 52.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 71.14 110.854 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 42.92 41.16 2.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 65.33 110.897 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.08 37.27 36.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.746 -0.74 . . . . 74.14 112.535 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 mt -98.18 -55.79 2.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 54.15 110.913 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.79 105.23 1.63 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 63.51 112.447 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.427 ' C ' HG21 ' A' ' 79' ' ' VAL . 99.0 m-85 -130.1 176.16 8.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 75.15 110.929 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -176.77 136.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.907 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.417 ' NE2' ' HA ' ' A' ' 5' ' ' PRO . 1.4 tp60 -73.42 163.53 27.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 71.52 110.878 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -145.94 -169.92 3.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.52 110.849 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.6 t-20 83.46 -33.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 73.15 110.884 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.73 84.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 74.12 112.468 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -170.13 116.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.822 0.344 . . . . 53.34 110.888 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.432 ' CG ' HD11 ' A' ' 8' ' ' LEU . 22.8 m-90 -157.84 109.57 2.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.938 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.6 m -81.59 138.91 35.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 73.35 111.138 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 22.4 t -70.11 110.58 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.43 111.083 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -131.76 4.32 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 71.02 110.887 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.95 -176.39 19.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 61.21 112.51 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.36 155.2 28.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.888 0.375 . . . . 73.33 110.895 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.438 ' CG2' ' CD1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.51 175.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 61.34 111.136 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -139.1 127.64 23.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 75.12 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -80.22 54.6 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 73.44 110.898 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 74.51 111.081 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 121.571 0.7 . . . . 61.35 111.069 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 167.61 23.97 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.644 2.229 . . . . 73.22 112.315 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 136.35 32.78 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.685 2.256 . . . . 72.13 112.32 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.65 137.27 32.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 71.42 111.132 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m -95.94 77.07 3.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 72.44 111.153 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 mp -75.71 108.39 8.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 73.53 110.913 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.48 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 10.3 mm-40 -79.93 -172.54 3.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 73.11 110.835 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -129.63 80.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.03 111.104 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.483 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.2 mm -71.01 172.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 72.03 111.152 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -54.2 172.32 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.574 0.702 . . . . 73.42 110.898 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.74 20.39 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.664 2.243 . . . . 75.25 112.347 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 12' ' ' HIS . 1.8 pttt -125.58 22.26 7.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 72.42 110.864 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.49 -177.42 31.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.697 -0.763 . . . . 65.14 112.464 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.475 ' C ' HG13 ' A' ' 11' ' ' ILE . 20.7 tp -149.47 161.73 41.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 74.44 110.93 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.436 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 18.0 ttm180 -125.51 137.8 53.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 73.43 110.862 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -147.69 110.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 73.41 111.122 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.0 t -120.32 154.28 35.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 75.01 110.882 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.572 HG23 ' CZ ' ' A' ' 28' ' ' PHE . 34.1 m -141.64 152.65 63.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.639 0.733 . . . . 74.32 111.116 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 122.09 8.77 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.664 2.243 . . . . 65.24 112.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 1.1 t70 -76.99 107.56 9.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 73.35 110.874 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -95.21 30.01 2.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.9 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.6 20.9 27.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 75.41 112.495 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 94.9 m-85 -68.13 167.56 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 74.14 110.888 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.8 t -128.95 -8.5 4.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.35 110.851 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.57 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -156.02 143.07 19.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 75.24 110.967 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.572 ' CZ ' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -139.68 148.4 42.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.1 110.878 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.0 136.64 35.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.34 111.102 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -118.52 120.54 37.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.907 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -148.85 92.05 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 73.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.466 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.11 172.06 26.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 73.34 112.46 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.34 -164.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 74.35 110.885 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tp -136.21 142.49 44.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 73.01 110.925 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 54.22 25.38 5.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.866 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -167.53 141.22 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.932 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -113.63 160.52 18.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 70.13 110.887 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.559 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 73.33 110.901 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.487 -0.245 . . . . 73.22 112.487 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.32 -63.31 1.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 72.04 110.873 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.7 m0 -66.51 146.95 53.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.904 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.3 p -146.51 112.27 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 73.43 110.862 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.14 162.14 41.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.23 110.877 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.48 117.35 8.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.24 110.889 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -98.97 107.12 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 75.4 111.127 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 60.7 p -101.01 32.4 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 75.34 111.136 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 51' ' ' THR . 14.6 mttt 164.32 135.83 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 73.23 110.919 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -175.65 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.732 2.288 . . . . 60.12 112.34 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.06 14.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.14 110.896 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -179.35 33.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 75.14 110.895 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' HG3' ' A' ' 57' ' ' ARG . . . 87.94 -17.13 48.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 70.24 112.468 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.418 ' HG3' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -136.57 167.62 21.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 74.14 110.893 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.493 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 11.2 m95 -92.61 92.82 8.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 71.22 110.856 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.0 mt -95.76 138.48 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 75.54 111.14 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -126.77 148.68 49.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.881 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 135.07 27.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.873 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -113.76 177.22 4.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 65.13 110.853 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.84 12.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.835 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.62 5.73 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 71.2 110.936 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.81 101.95 14.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 54.4 111.1 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.96 86.67 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 63.21 111.124 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -137.42 170.79 15.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 64.12 110.912 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.526 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -154.82 158.35 39.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.852 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.475 ' C ' ' O ' ' A' ' 68' ' ' LYS . 10.3 mm -30.93 124.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 75.32 111.137 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.14 -30.04 6.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.744 -0.741 . . . . 53.2 112.515 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.29 -171.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 52.45 110.87 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.8 mptt -150.03 159.27 44.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.03 110.926 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 97.5 mt -133.15 147.39 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 75.41 111.133 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -148.98 103.09 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 75.45 110.905 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.424 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 1.1 p90 -162.35 -161.46 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.497 . . . . 75.32 110.874 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.559 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -150.72 144.89 25.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.926 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.498 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 3.3 p -112.83 151.85 29.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.14 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.12 144.89 46.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 71.45 110.897 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.557 HG11 ' CE2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -144.52 172.68 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 64.41 111.133 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 84.1 mt -148.14 96.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 61.33 111.14 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -113.44 138.33 50.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 73.45 110.86 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 43.01 38.9 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 72.12 110.906 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.91 37.88 45.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.723 -0.751 . . . . 54.33 112.463 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.64 -53.13 3.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 73.15 110.942 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 104.68 1.68 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 71.41 112.494 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -124.8 166.03 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.382 . . . . 75.32 110.926 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.498 ' CG ' ' O ' ' A' ' 77' ' ' THR . 7.1 ttp180 -174.15 136.56 0.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 75.34 110.85 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -75.65 168.78 19.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.906 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.7 t0 -152.94 -176.3 5.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.896 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 83.82 -26.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.34 110.886 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 34.74 87.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 71.43 112.493 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -172.01 110.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.845 0.355 . . . . 72.31 110.91 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -150.63 115.91 5.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 72.14 110.896 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 92.6 m -87.04 136.19 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 64.5 111.138 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.409 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 45.4 t -67.58 118.36 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 75.24 111.099 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -134.16 0.89 3.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.54 110.884 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -117.75 -177.74 17.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 71.41 112.468 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.457 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -154.78 155.69 34.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 71.14 110.891 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.48 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.79 169.81 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 72.45 111.155 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -132.42 139.77 48.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 65.2 110.889 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.53 45.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 65.22 110.907 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.502 ' N ' ' OD1' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 71.32 111.111 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.566 0.698 . . . . 73.54 111.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 164.36 34.81 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.743 2.295 . . . . 73.24 112.314 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 134.34 27.62 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.674 2.249 . . . . 73.41 112.313 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.38 139.6 32.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 71.02 111.105 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.6 m -92.72 77.44 4.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 75.41 111.165 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.34 111.76 14.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 72.05 110.92 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.417 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 4.3 mm-40 -86.7 -158.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.23 110.903 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -143.08 81.2 1.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 71.21 111.096 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 6.6 mm -71.0 172.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 75.31 111.143 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.581 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.08 172.2 0.24 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.595 0.712 . . . . 64.34 110.832 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.4 Cg_endo -69.76 20.31 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.681 2.254 . . . . 73.4 112.339 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 12' ' ' HIS . 42.3 pttt -130.08 27.8 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 71.35 110.908 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.66 -178.84 30.4 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 73.4 112.442 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.436 ' C ' HG13 ' A' ' 11' ' ' ILE . 19.3 tp -152.83 166.22 32.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 74.44 110.896 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -130.31 141.39 50.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.875 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.3 t -153.12 103.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.33 111.138 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.4 t -114.93 159.82 20.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.1 110.858 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.55 151.63 66.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.604 0.716 . . . . 71.33 111.17 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 121.99 8.69 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.671 2.247 . . . . 72.15 112.338 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -80.19 101.33 8.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 73.42 110.871 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -96.01 28.13 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 71.31 110.864 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.27 16.51 13.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.762 -0.732 . . . . 73.23 112.533 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.508 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 92.1 m-85 -67.08 164.82 17.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 71.52 110.929 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.6 t -127.98 -9.55 5.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.87 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.546 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -158.97 139.97 12.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 74.13 110.894 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.544 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 19.3 t80 -134.16 152.49 51.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.32 110.881 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.35 163.29 30.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 74.22 111.104 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.5 t80 -148.22 113.28 5.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.22 110.856 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -147.28 95.15 2.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 73.54 110.859 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.46 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.09 -174.14 17.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.729 -0.748 . . . . 63.1 112.509 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.408 ' O ' ' CZ3' ' A' ' 46' ' ' TRP . 3.0 mtpp -134.74 -164.27 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 73.22 110.911 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.503 ' HG ' ' ND2' ' A' ' 35' ' ' ASN . 1.7 tp -140.24 140.18 35.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 72.52 110.889 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.503 ' ND2' ' HG ' ' A' ' 34' ' ' LEU . 3.1 m120 51.26 21.59 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.21 110.848 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -156.39 123.51 5.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 74.23 110.877 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -94.86 140.66 29.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 73.23 110.884 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.2 ptp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 75.34 110.879 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.493 -0.243 . . . . 73.31 112.493 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -104.24 -62.72 1.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.733 0.302 . . . . 71.33 110.885 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.514 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 9.1 m0 -60.87 155.09 20.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 74.44 110.926 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 53.1 p -160.99 114.43 2.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 74.41 110.879 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -156.76 149.24 23.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 63.51 110.842 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -139.5 102.32 4.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.887 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.7 mm -90.26 117.77 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.41 111.098 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.415 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 17.2 p -103.34 34.34 2.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 74.42 111.163 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 51' ' ' THR . 3.3 mtpt 167.07 137.46 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.55 0.691 . . . . 72.01 110.865 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -175.6 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.66 2.24 . . . . 74.52 112.358 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -139.39 -35.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.859 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.418 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 1.4 t30 -137.25 51.76 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.43 110.906 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.18 -29.43 4.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 52.42 112.513 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.92 171.23 11.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 74.23 110.846 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.416 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 6.0 m95 -90.12 89.73 7.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 75.43 110.957 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.3 mt -92.47 138.14 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 72.52 111.117 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -132.35 146.61 52.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.41 110.892 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.84 127.55 23.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.903 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -99.78 -178.46 3.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.92 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.38 26.4 1.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 74.01 110.9 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -149.44 28.24 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 72.23 110.865 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.52 84.92 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 43.25 111.137 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.09 93.76 7.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 74.42 111.092 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -148.33 169.33 20.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.03 110.948 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.04 164.55 38.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.939 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.558 HG12 ' CD2' ' A' ' 98' ' ' PHE . 9.4 mm -34.78 118.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 75.34 111.147 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.22 -28.92 5.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.769 -0.729 . . . . 61.41 112.485 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.96 -178.16 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 73.01 110.865 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.2 mttt -141.22 167.66 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.2 110.885 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 74' ' ' TYR . 67.3 mt -144.85 149.37 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 72.42 111.116 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.474 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -151.96 108.54 3.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 75.43 110.902 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.46 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -165.72 -168.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 75.34 110.88 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.6 p-90 -135.28 162.75 31.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 72.43 110.94 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.6 p -134.89 146.4 49.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 74.32 111.126 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.46 149.01 28.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.872 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.411 HG21 ' C ' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -148.94 165.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 75.42 111.157 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.1 mt -148.38 96.24 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.33 111.151 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.508 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 23.5 tttt -113.18 138.43 49.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 73.02 110.857 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.82 28.89 3.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 75.33 110.866 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.71 27.5 66.53 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 72.12 112.491 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.65 -50.97 4.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 74.42 110.906 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.56 125.85 3.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 74.21 112.492 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.411 ' C ' HG21 ' A' ' 79' ' ' VAL . 95.6 m-85 -143.07 -179.67 6.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 75.32 110.923 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 77' ' ' THR . 1.2 ttp180 -177.46 136.48 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.911 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -78.21 166.02 23.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 74.03 110.925 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.1 t0 -147.22 -165.86 2.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 74.22 110.852 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 2.5 t-20 83.59 -33.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 53.13 110.895 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 39.04 74.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.746 . . . . 41.53 112.484 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -167.7 112.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 61.33 110.867 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -152.33 122.57 7.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 73.01 110.945 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.1 m -94.08 145.23 24.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 74.44 111.16 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.467 HG13 ' CB ' ' A' ' 10' ' ' ALA . 62.7 t -75.24 129.7 36.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 75.02 111.124 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -154.79 23.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.05 110.888 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -155.62 111.28 0.48 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.786 -0.721 . . . . 73.42 112.499 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -82.34 170.39 15.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 75.44 110.871 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.45 HG23 ' C ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -167.34 -178.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.33 111.137 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.26 139.1 37.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.472 . . . . 74.41 110.857 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -87.2 44.71 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 72.42 110.845 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.089 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.574 0.702 . . . . 75.4 111.109 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 161.01 47.58 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.733 2.288 . . . . 74.2 112.313 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 134.84 28.95 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.709 2.273 . . . . 74.32 112.342 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.401 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . . . -90.52 139.68 30.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 72.33 111.061 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.5 m -93.16 77.3 4.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.51 111.113 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.11 107.38 10.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 73.24 110.913 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -80.92 -156.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 71.15 110.935 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -143.1 80.21 1.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.52 111.082 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.491 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 4.1 mm -70.64 172.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.32 111.079 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -54.19 172.0 0.25 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 73.4 110.835 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.9 Cg_endo -69.77 21.05 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.661 2.241 . . . . 73.43 112.336 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 12' ' ' HIS . 10.6 ptmt -126.79 20.71 7.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.907 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.64 -176.81 33.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 75.34 112.514 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.461 ' C ' HG13 ' A' ' 11' ' ' ILE . 22.2 tp -151.13 163.57 38.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 74.24 110.924 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -126.77 137.32 53.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.23 110.861 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -148.26 102.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 70.33 111.091 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 t -114.49 157.07 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 74.31 110.902 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.575 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 17.8 m -140.81 151.51 63.11 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.616 0.722 . . . . 75.24 111.077 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 123.37 10.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.639 2.226 . . . . 73.5 112.327 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.565 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 4.7 t70 -79.94 133.38 36.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 72.35 110.885 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -123.88 12.86 9.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.838 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.68 4.94 8.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 74.44 112.42 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 68.5 m-85 -54.28 163.02 0.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 70.23 110.878 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.9 t -130.01 -7.67 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.869 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.582 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -157.3 143.71 18.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 70.12 110.966 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -139.59 143.65 37.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 64.21 110.889 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.91 123.03 22.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 71.02 111.12 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -109.84 113.98 27.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 74.02 110.863 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.473 ' CE1' ' HB2' ' A' ' 47' ' ' SER . 0.2 OUTLIER -142.27 95.29 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 74.44 110.879 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.507 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -146.31 -178.55 21.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 73.12 112.477 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.0 -168.27 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.341 . . . . 74.24 110.881 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.449 ' HG ' ' CG ' ' A' ' 35' ' ' ASN . 4.4 tp -134.85 146.73 49.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 62.11 110.906 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.449 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 2.4 m120 42.73 27.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.883 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -159.46 130.39 5.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 55.14 110.857 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -97.23 144.13 27.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 72.34 110.886 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.1 ptp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 71.05 110.918 179.934 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.498 -0.241 . . . . 30.3 112.498 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.38 -60.95 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 74.23 110.86 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.462 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 7.4 m0 -60.28 165.91 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 73.43 110.91 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.473 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 6.9 t -164.38 122.34 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 72.54 110.863 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.476 ' HG3' ' N ' ' A' ' 49' ' ' ASP . 3.2 tpm_? -159.67 145.02 15.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 75.51 110.877 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' N ' ' HG3' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -130.75 82.41 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 71.34 110.831 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 28' ' ' PHE . 2.7 mm -71.92 110.72 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 74.45 111.162 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.458 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 82.4 p -104.69 34.05 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 71.32 111.136 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 51' ' ' THR . 37.7 tttt 163.97 137.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.546 0.688 . . . . 74.41 110.925 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -175.87 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.715 2.277 . . . . 73.44 112.324 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HZ3' ' NE ' ' A' ' 61' ' ' ARG . 0.9 OUTLIER -134.25 -34.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.9 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -139.85 51.66 1.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 63.11 110.895 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.07 -27.78 4.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.75 -0.738 . . . . 63.34 112.482 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 169.27 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.331 . . . . 75.14 110.867 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.565 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 10.7 m95 -92.09 90.79 7.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 74.11 110.919 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.0 mt -96.17 138.2 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 75.15 111.178 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -130.34 151.98 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 72.53 110.873 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.448 ' NE ' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -142.27 135.44 28.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.55 110.891 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.6 OUTLIER -108.53 -179.41 3.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 63.4 110.895 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -145.26 11.67 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 70.4 110.866 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -129.84 12.31 5.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 62.33 110.874 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.32 94.84 6.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.23 111.072 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -94.35 75.33 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 72.14 111.089 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -123.81 171.36 9.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 75.12 110.91 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -158.16 156.7 31.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.55 110.873 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 68' ' ' LYS . 18.0 mm -30.34 121.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 64.01 111.135 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.33 -29.46 6.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 74.33 112.48 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.41 -179.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 74.31 110.856 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 1.1 mtmt -144.85 153.71 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 75.52 110.923 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.476 HG21 ' N ' ' A' ' 74' ' ' TYR . 9.1 mt -128.43 141.25 47.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 74.53 111.145 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -140.96 99.08 3.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 74.51 110.968 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.507 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -159.85 -160.07 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 74.1 110.822 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -148.29 177.7 9.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 73.03 110.911 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -144.45 153.95 42.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 64.51 111.149 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -118.23 136.44 53.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 54.44 110.899 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.77 167.58 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 74.3 111.101 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.4 mt -146.01 96.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 75.44 111.116 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 18.6 tttt -114.27 141.43 47.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.35 110.898 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 2.5 m-20 44.91 38.23 2.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 73.3 110.874 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.52 35.35 44.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 74.21 112.481 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.9 mt -100.51 -71.25 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.876 0.369 . . . . 74.32 110.947 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.49 106.41 2.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 74.32 112.487 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -120.57 171.84 8.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 75.23 110.909 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.4 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 9.5 ttm180 -174.38 138.47 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 73.15 110.86 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' A' ' 87' ' ' ARG . 6.3 tp60 -85.98 153.71 21.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 74.3 110.885 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -136.82 -163.18 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 65.34 110.903 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.2 t-20 82.23 -39.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 74.31 110.89 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.57 76.44 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 75.14 112.454 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -172.8 113.22 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 74.4 110.862 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -152.43 110.88 3.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.103 -0.499 . . . . 64.23 110.922 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 97.1 m -82.37 136.16 35.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 70.3 111.149 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 39.3 t -67.27 110.32 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 70.13 111.135 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -128.94 17.82 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.04 110.911 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -133.92 -178.26 15.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 71.34 112.475 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.424 ' C ' HG22 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -152.8 157.57 40.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.362 . . . . 73.54 110.894 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.424 HG22 ' C ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -165.81 164.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 75.2 111.143 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -129.81 131.08 46.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 75.13 110.858 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -85.68 51.43 2.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 65.5 111.116 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.589 0.709 . . . . 63.23 111.085 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 167.39 24.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.715 2.277 . . . . 73.32 112.312 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 133.99 27.02 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.645 2.23 . . . . 75.34 112.361 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.51 137.83 32.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 74.03 111.105 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -93.99 77.15 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 74.31 111.159 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.4 107.98 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.44 110.906 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.475 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 43.9 mm-40 -80.34 -173.28 3.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 74.23 110.892 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -129.76 81.49 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 65.44 111.094 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.2 mm -72.01 172.49 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 74.21 111.146 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.569 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.16 172.03 0.25 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.584 0.707 . . . . 74.2 110.897 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.3 Cg_endo -69.72 20.15 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.639 2.226 . . . . 73.42 112.35 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.0 OUTLIER -125.92 21.71 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 74.54 110.943 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.38 -178.02 32.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 71.43 112.481 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.475 ' C ' HG13 ' A' ' 11' ' ' ILE . 21.9 tp -150.24 167.74 26.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 62.11 110.961 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -132.83 139.24 47.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 75.23 110.857 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.4 t -148.52 108.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 74.41 111.125 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.402 ' C ' HG13 ' A' ' 20' ' ' VAL . 26.2 t -119.85 157.94 27.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 63.12 110.857 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.402 HG13 ' C ' ' A' ' 19' ' ' SER . 17.2 m -139.99 149.35 58.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 74.41 111.149 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 122.19 8.87 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.707 2.271 . . . . 72.42 112.354 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 22.8 t70 -88.45 97.26 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.86 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.75 0.21 40.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 73.11 110.879 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 138.41 30.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 74.01 112.47 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 82.2 m-85 -82.28 167.96 18.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.804 0.335 . . . . 75.41 110.936 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.5 t -127.19 -10.89 5.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.846 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -153.32 142.72 21.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.916 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.541 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 18.3 t80 -139.13 144.32 38.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 75.51 110.93 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.69 163.68 23.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 72.54 111.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.4 t80 -151.04 114.42 4.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.89 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -147.57 95.26 2.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 73.43 110.859 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.426 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.07 -174.27 18.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 75.42 112.466 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.447 ' CE ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -135.92 -165.45 1.71 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.792 0.33 . . . . 74.31 110.863 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.478 ' CD1' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -132.36 127.24 35.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 74.51 110.935 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.478 ' ND2' ' CD1' ' A' ' 34' ' ' LEU . 67.2 m-80 56.45 34.13 23.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.866 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' HG2' ' CE ' ' A' ' 33' ' ' LYS . 5.6 tp10 -155.56 131.52 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 73.24 110.903 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -98.59 140.65 32.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 74.41 110.856 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 1.3 mtt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 75.11 110.873 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.454 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.501 -0.24 . . . . 61.15 112.501 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.9 -55.3 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.831 0.348 . . . . 72.34 110.89 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.542 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 6.5 m0 -68.4 173.16 5.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 75.23 110.91 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.518 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 95.3 p -176.84 118.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 73.54 110.851 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.456 ' CD ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -164.39 162.2 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.4 110.848 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.46 106.55 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 75.41 110.883 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.482 ' N ' ' O ' ' A' ' 28' ' ' PHE . 36.5 mm -90.27 105.13 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 72.32 111.121 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.3 p -102.42 34.42 2.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 45.3 111.156 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.5 124.53 0.11 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.593 0.711 . . . . 74.21 110.857 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 165.6 30.46 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.267 . . . . 75.44 112.346 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.93 -17.7 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 73.45 110.882 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -149.75 43.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 75.33 110.903 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.42 -16.64 12.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.712 -0.756 . . . . 72.55 112.555 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -133.57 164.66 26.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.826 0.346 . . . . 75.05 110.88 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.483 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 12.2 m95 -88.18 96.16 10.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 75.1 110.931 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.0 mt -99.47 142.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 73.05 111.121 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -133.56 144.91 49.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 70.41 110.926 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.59 127.74 27.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 75.55 110.847 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.42 -178.62 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.891 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -148.85 17.42 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 74.52 110.889 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -135.89 14.44 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.886 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.62 109.54 21.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 71.22 111.136 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.94 87.91 2.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 70.14 111.069 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -139.87 170.95 14.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 74.22 110.904 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -157.55 161.79 38.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 71.42 110.871 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.565 HG13 ' CE2' ' A' ' 98' ' ' PHE . 11.8 mm -33.28 120.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 73.11 111.138 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.84 -29.89 5.46 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.734 -0.746 . . . . 72.44 112.464 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.98 177.96 2.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 74.44 110.86 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.55 162.02 35.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 74.43 110.907 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.411 HG12 ' CD2' ' A' ' 34' ' ' LEU . 62.6 mt -137.96 152.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 62.43 111.116 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -151.15 107.56 3.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.45 110.861 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.426 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -165.32 -163.66 0.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 73.23 110.883 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.48 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.2 p-90 -145.14 166.06 26.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 73.05 110.887 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.478 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 5.0 p -136.52 162.37 33.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 74.15 111.151 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.95 142.94 51.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 65.25 110.837 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.45 176.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.517 . . . . 75.01 111.133 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.7 mt -150.91 98.67 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 73.53 111.149 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -117.8 141.32 48.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 74.14 110.904 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.454 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 46.07 36.74 3.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.13 110.885 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.23 33.85 39.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 75.34 112.441 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 mt -100.33 -54.84 2.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.865 0.364 . . . . 74.22 110.934 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.22 116.49 1.76 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.726 -0.75 . . . . 75.51 112.45 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -132.72 -175.09 3.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 74.33 110.955 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.478 ' CG ' ' O ' ' A' ' 77' ' ' THR . 7.5 ttp180 -177.61 138.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.874 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.405 ' N ' ' HG2' ' A' ' 87' ' ' ARG . 2.7 tp60 -81.94 155.17 25.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 73.14 110.857 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -140.0 -166.86 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 65.04 110.899 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.8 OUTLIER 83.06 -38.88 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.4 110.918 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.47 81.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 75.21 112.514 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -171.77 114.4 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 75.22 110.887 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -154.87 112.97 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 74.2 110.942 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.2 m -85.11 132.96 34.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 71.14 111.104 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.46 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 37.6 t -63.76 117.72 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.34 111.112 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -136.39 14.37 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.41 110.927 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -124.95 -178.02 15.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 62.04 112.492 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.565 ' CE2' HG13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -154.69 151.49 28.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 73.31 110.863 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.12 -178.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 74.41 111.119 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -146.51 129.86 16.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 72.11 110.843 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.13 40.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 72.04 110.909 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.31 111.11 179.918 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.577 0.703 . . . . 73.12 111.111 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.99 22.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.657 2.238 . . . . 74.22 112.366 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 133.39 25.57 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.684 2.256 . . . . 72.21 112.356 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.19 139.55 36.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 72.11 111.1 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 m -99.76 77.6 2.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 72.53 111.166 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.65 109.69 11.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 74.2 110.936 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.469 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 3.0 mm-40 -80.08 -168.56 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 72.11 110.866 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -133.81 81.58 1.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.3 111.139 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.483 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 7.6 mm -71.66 172.84 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.44 111.125 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.581 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -54.17 172.37 0.24 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.583 0.706 . . . . 64.12 110.825 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.78 20.2 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.613 2.209 . . . . 74.31 112.326 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -129.1 26.28 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 74.54 110.86 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.25 -177.71 31.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 61.14 112.467 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.459 ' CD1' HD21 ' A' ' 67' ' ' LEU . 22.2 tp -152.29 166.98 30.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.812 0.339 . . . . 75.42 110.89 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -132.59 136.57 46.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 73.41 110.833 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.0 109.36 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 74.22 111.152 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 t -121.53 159.54 26.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.41 110.843 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.556 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 10.2 m -142.73 151.61 57.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 74.11 111.109 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 121.69 8.38 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.628 2.219 . . . . 75.12 112.32 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.16 140.19 52.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 61.12 110.863 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -132.51 18.88 4.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.883 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.72 8.17 30.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.733 -0.746 . . . . 62.2 112.45 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.528 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 39.5 m-85 -58.41 164.63 2.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 74.5 110.908 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -126.37 -13.01 6.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.886 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.56 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -153.82 140.68 19.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 63.14 110.935 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.556 ' CZ ' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -134.61 145.77 48.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.32 110.924 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.79 142.69 49.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 73.15 111.117 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.28 120.95 31.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.855 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.445 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -152.67 93.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 75.13 110.88 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.463 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.9 176.73 24.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 74.24 112.5 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.66 -164.94 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 72.3 110.839 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 tp -134.23 145.79 49.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 73.22 110.934 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.498 ' ND2' ' OD1' ' A' ' 71' ' ' ASP . 22.0 m-80 49.15 24.04 0.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 74.44 110.858 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -163.43 139.34 6.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 75.13 110.861 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -110.1 164.94 12.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 74.43 110.892 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.65 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.44 110.855 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.485 -0.246 . . . . 71.55 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -102.44 -68.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 74.24 110.881 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.489 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 5.2 m-90 -62.37 154.19 28.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 73.15 110.863 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.445 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 95.1 p -158.39 123.84 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 64.31 110.887 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.66 160.73 10.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 73.42 110.861 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -138.9 103.14 4.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 72.43 110.853 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' PHE . 5.6 mm -77.98 108.9 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 75.23 111.165 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 81.1 p -96.37 30.58 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 70.42 111.133 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.9 OUTLIER 163.29 138.82 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.569 0.7 . . . . 71.42 110.903 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 176.2 7.07 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.705 2.27 . . . . 71.32 112.349 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -109.19 -77.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 75.45 110.91 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -113.24 60.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 72.3 110.929 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.17 -19.2 32.23 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.713 -0.756 . . . . 61.01 112.485 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.45 164.91 25.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 73.02 110.861 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.528 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 16.3 m95 -89.83 94.15 9.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.3 149.7 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 75.04 111.156 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.455 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 42.1 t80 -144.31 159.87 41.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 75.34 110.874 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -147.68 140.01 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.853 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -114.39 -178.16 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 74.31 110.887 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.29 17.99 1.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.879 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -137.07 20.42 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 75.42 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -107.39 95.76 5.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.43 111.106 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -94.11 84.55 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.54 111.073 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -120.03 171.61 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 64.52 110.881 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -153.24 134.29 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.889 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.552 ' C ' ' O ' ' A' ' 68' ' ' LYS . 9.2 mm -23.6 118.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 72.31 111.098 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.6 -19.09 9.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.787 -0.72 . . . . 64.54 112.495 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.498 ' OD1' ' ND2' ' A' ' 35' ' ' ASN . 0.4 OUTLIER -67.23 -166.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 63.51 110.837 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 1.5 mtmt -152.45 165.15 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.52 110.873 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 99.2 mt -142.53 149.15 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 73.22 111.194 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -149.62 104.1 3.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 73.54 110.885 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.509 ' CE2' HG22 ' A' ' 77' ' ' THR . 1.0 OUTLIER -160.3 -164.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 73.51 110.903 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.65 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -146.98 142.73 27.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.893 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.509 HG22 ' CE2' ' A' ' 75' ' ' PHE . 4.4 p -112.37 147.75 35.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 73.32 111.113 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CD1' ' HG3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -112.68 143.51 43.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 72.21 110.855 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.01 168.69 13.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 74.4 111.118 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -146.69 96.17 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 75.33 111.121 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.408 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 7.4 tttt -114.51 143.73 44.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 72.25 110.961 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.03 20.71 1.8 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 72.02 110.892 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.09 27.54 73.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 52.12 112.481 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mt -97.86 -72.31 0.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 72.41 110.907 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.48 109.86 2.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 70.44 112.484 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -122.31 161.68 22.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 74.54 110.921 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.407 ' HG3' ' CD1' ' A' ' 78' ' ' PHE . 6.2 ttp180 -163.45 129.13 3.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 72.33 110.866 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -80.64 150.35 29.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.917 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -132.02 -159.92 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 75.35 110.866 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 82.86 -37.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 64.23 110.923 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.51 78.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.783 -0.722 . . . . 64.44 112.481 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -171.41 111.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 64.42 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -148.98 119.42 7.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 64.14 110.898 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.6 m -89.84 141.15 28.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 72.14 111.152 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.457 HG21 ' CD1' ' A' ' 67' ' ' LEU . 40.2 t -75.81 124.92 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 74.23 111.093 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -147.19 21.97 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 72.11 110.936 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -154.67 114.35 0.61 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 74.44 112.482 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.447 ' C ' HG21 ' A' ' 99' ' ' VAL . 0.6 OUTLIER -87.81 172.16 9.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 71.14 110.882 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.469 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -167.53 156.64 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 75.52 111.109 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.55 130.25 56.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -100.11 38.59 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 74.23 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 75.4 111.082 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.6 0.714 . . . . 73.12 111.061 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.82 33.09 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.254 . . . . 72.51 112.385 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 134.37 27.89 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.735 2.29 . . . . 72.42 112.371 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.43 140.71 33.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 75.4 111.121 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 m -97.19 79.14 2.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 74.4 111.145 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mp -83.1 113.06 20.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 73.34 110.884 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.94 -158.34 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.147 -0.478 . . . . 73.15 110.893 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.495 ' CB ' ' CG1' ' A' ' 95' ' ' VAL . . . -141.12 80.37 1.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.31 111.102 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.482 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 2.7 mm -71.3 172.55 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 65.43 111.131 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.568 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -54.22 172.16 0.25 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.561 0.695 . . . . 74.34 110.842 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.8 Cg_endo -69.76 19.47 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.66 2.24 . . . . 73.32 112.384 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -124.58 19.79 8.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 75.13 110.868 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.24 -177.93 33.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 63.34 112.521 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.448 ' C ' HG13 ' A' ' 11' ' ' ILE . 26.3 tp -151.27 166.38 31.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 75.41 110.94 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -128.23 139.13 52.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 74.24 110.867 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.3 t -151.26 105.26 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.415 ' CB ' ' HA ' ' A' ' 59' ' ' ILE . 18.7 t -122.46 162.25 22.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.55 110.876 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.414 HG12 ' C ' ' A' ' 19' ' ' SER . 5.4 m -140.4 151.17 63.38 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.664 0.745 . . . . 73.42 111.084 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 122.2 8.87 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.673 2.249 . . . . 74.44 112.327 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 14.9 t70 -83.44 140.0 32.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.913 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -137.2 12.61 3.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 74.54 110.91 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.01 2.93 2.64 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.748 . . . . 74.2 112.491 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.498 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 91.5 m-85 -58.33 160.18 5.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 73.24 110.899 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -129.72 -7.04 4.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 73.02 110.859 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.565 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -157.75 140.75 15.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 72.53 110.898 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.521 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 19.8 t80 -137.61 146.2 43.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.841 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.98 163.06 28.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 74.2 111.134 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.4 t80 -147.59 111.7 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.876 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -144.29 92.58 2.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 73.53 110.836 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.517 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -145.99 -179.48 22.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 71.54 112.484 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.69 -164.15 1.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 75.41 110.929 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.47 ' HG ' ' ND2' ' A' ' 35' ' ' ASN . 1.1 tp -143.48 144.91 32.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 70.12 110.931 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.47 ' ND2' ' HG ' ' A' ' 34' ' ' LEU . 2.3 m120 57.73 12.02 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 73.04 110.867 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -156.77 130.58 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.4 110.877 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -102.4 143.92 31.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 50.11 110.905 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 75.5 110.92 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.539 -0.224 . . . . 73.14 112.539 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.46 -65.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.771 0.32 . . . . 74.33 110.89 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.418 ' O ' ' ND1' ' A' ' 31' ' ' HIS . 8.2 m0 -58.03 161.43 4.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.851 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.567 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 97.0 p -167.39 122.51 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 61.43 110.887 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.77 155.36 8.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 74.22 110.872 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.24 103.2 4.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 75.14 110.873 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.0 mm -80.84 117.14 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.34 111.121 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.5 p -99.36 32.24 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 73.11 111.17 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 172.99 135.67 0.11 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.61 0.719 . . . . 74.14 110.909 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 168.18 22.22 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.26 . . . . 73.33 112.322 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -141.95 112.78 7.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.54 110.905 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER 78.27 27.72 0.51 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 73.45 110.883 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.81 -25.88 19.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 73.53 112.507 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 161.76 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 75.51 110.825 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.421 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 13.2 m95 -82.15 101.19 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 73.22 110.953 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.415 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 28.0 mt -105.65 139.13 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 75.44 111.119 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -135.32 141.91 45.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.12 110.852 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.04 130.44 37.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.44 110.859 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.57 -178.9 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.864 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -144.82 15.56 1.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 75.41 110.887 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -131.45 3.58 4.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 74.24 110.874 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.2 101.01 13.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 70.14 111.093 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.58 84.53 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 71.21 111.061 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.454 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.38 171.29 12.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 72.31 110.899 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -152.8 147.47 26.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 75.43 110.894 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.5 mm -30.89 115.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.01 111.145 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.44 -19.37 7.15 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 70.25 112.505 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.16 -162.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 75.21 110.865 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.1 mttt -155.0 167.24 31.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 73.53 110.901 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 80.0 mt -146.4 146.35 19.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 73.01 111.138 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -148.9 102.19 3.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.34 110.956 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.517 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 0.8 OUTLIER -160.68 -161.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 70.34 110.896 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.543 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.5 OUTLIER -145.97 161.34 40.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.908 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 p -131.05 159.69 36.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 71.44 111.151 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.62 146.06 48.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 75.24 110.859 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.08 170.87 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 73.35 111.16 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.1 mt -149.36 96.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 73.41 111.171 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.498 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 1.7 tttt -113.05 137.72 51.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 75.15 110.916 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.401 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 47.31 33.11 2.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.853 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.33 33.39 61.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.738 . . . . 71.15 112.478 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.7 mt -97.47 -54.25 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 75.3 110.878 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 119.32 2.83 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.784 -0.722 . . . . 54.43 112.492 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -143.47 156.81 44.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 73.54 110.916 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -152.56 133.68 14.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 73.51 110.854 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -80.11 154.98 27.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.894 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.542 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -138.52 -160.79 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 65.45 110.854 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.542 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 3.1 t-20 82.7 -38.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 70.02 110.861 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.03 78.87 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 62.02 112.536 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -171.74 110.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.35 . . . . 73.42 110.895 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 17.1 m-90 -151.72 120.09 6.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.134 -0.485 . . . . 73.22 110.963 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.4 m -91.24 130.43 37.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.34 111.186 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.495 ' CG1' ' CB ' ' A' ' 10' ' ' ALA . 48.3 t -61.41 110.5 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 75.35 111.117 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.0 7.5 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 74.22 110.895 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -120.23 179.13 16.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 74.23 112.476 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.48 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -151.75 153.2 33.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 73.52 110.895 -179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.451 ' CG2' ' CD1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -159.96 177.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 64.53 111.109 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -146.03 126.87 14.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 70.24 110.843 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -80.43 55.31 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 75.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.03 111.093 179.919 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.543 0.687 . . . . 75.24 111.097 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 165.46 30.88 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 74.41 112.34 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 133.6 25.92 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 75.24 112.301 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.64 144.15 31.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.25 111.111 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.5 m -99.83 77.13 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 75.22 111.138 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mp -73.04 109.89 6.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.961 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.462 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 7.9 mm-40 -85.99 -172.92 4.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.43 110.863 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.56 80.25 1.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 71.12 111.084 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.501 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.2 mm -70.27 172.34 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 74.31 111.159 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.563 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.07 171.83 0.26 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.622 0.725 . . . . 74.45 110.818 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.563 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.1 Cg_endo -69.72 20.54 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 65.34 112.37 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' HIS . 20.7 pttt -126.64 23.06 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.884 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.1 -178.13 31.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 45.44 112.501 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.471 ' C ' HG13 ' A' ' 11' ' ' ILE . 20.0 tp -149.65 160.83 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 73.44 110.924 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -125.95 138.95 53.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.888 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -148.79 103.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 75.01 111.098 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.3 t -114.21 160.69 18.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 64.23 110.89 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -141.51 151.73 61.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 64.24 111.146 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 122.14 8.82 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.719 2.279 . . . . 75.23 112.343 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.558 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 17.1 t0 -89.12 107.91 19.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 71.13 110.868 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -95.79 -3.55 45.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 63.41 110.894 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.94 31.02 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 64.41 112.513 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 81.4 m-85 -80.14 165.1 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 75.34 110.87 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -126.05 -11.55 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.878 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.56 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -155.66 141.13 17.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 73.4 110.898 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.541 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 16.9 t80 -133.38 146.42 51.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.33 110.909 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.67 155.8 49.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.04 111.119 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.511 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 3.2 t80 -141.0 123.78 16.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 75.33 110.895 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.511 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 8.4 m-70 -153.47 93.31 1.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 72.31 110.884 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.506 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -145.94 -177.1 20.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.75 . . . . 55.43 112.506 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.43 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 2.6 mtpp -135.73 -169.64 2.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 72.14 110.912 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 35' ' ' ASN . 2.3 tp -131.77 143.78 50.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 75.02 110.897 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 34' ' ' LEU . 67.2 m-80 37.48 37.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.901 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -159.17 139.84 12.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.11 110.913 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -90.36 145.28 25.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 75.13 110.913 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.5 ptp . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 64.31 110.904 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.504 -0.239 . . . . 54.34 112.504 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.428 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -106.25 -62.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.75 0.31 . . . . 71.44 110.825 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -65.41 150.93 47.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 71.13 110.91 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.461 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 58.5 p -158.33 119.02 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 63.21 110.822 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.461 ' CD ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -163.22 158.56 21.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 73.34 110.897 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -144.34 115.26 7.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 73.11 110.866 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.461 HD12 ' CD ' ' A' ' 48' ' ' ARG . 7.6 mm -96.27 120.49 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 72.42 111.148 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 81.4 p -107.89 36.92 2.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.22 111.126 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.8 OUTLIER 163.08 130.81 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.616 0.722 . . . . 74.44 110.901 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -176.33 1.46 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.682 2.255 . . . . 63.25 112.318 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.14 19.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.51 110.842 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 178.85 34.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 73.24 110.858 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.42 -19.53 13.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 63.51 112.445 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.04 164.32 27.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.806 0.336 . . . . 74.45 110.861 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.558 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 18.3 m95 -87.5 93.27 9.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.918 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.1 mt -96.47 136.37 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 74.11 111.146 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -129.95 150.63 51.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.01 110.883 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.89 138.68 28.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 62.12 110.878 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.5 -176.53 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.826 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.45 17.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 73.22 110.842 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -131.77 12.09 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.31 110.879 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.22 103.82 13.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 71.3 111.077 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.57 73.8 1.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 60.32 111.111 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -117.52 171.41 8.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 73.5 110.932 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.53 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.53 151.05 27.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 71.42 110.914 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.2 mm -28.04 116.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 73.03 111.13 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.31 -24.72 6.85 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 75.42 112.515 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.93 -175.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 74.2 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -141.75 166.73 23.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 72.13 110.898 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.6 mt -144.52 143.21 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.23 111.142 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.38 103.88 3.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.954 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.506 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -168.71 -162.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 74.31 110.908 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.7 p-90 -146.91 174.61 11.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 73.11 110.927 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 p -139.23 159.05 43.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 74.55 111.11 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.54 150.21 42.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 73.54 110.882 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -147.81 174.55 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.483 . . . . 72.14 111.171 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.4 mt -150.48 96.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 71.0 111.148 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 17.1 tttm -113.01 121.55 44.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 75.32 110.907 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.79 32.41 18.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.895 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.75 33.33 72.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 72.23 112.471 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -99.67 -55.95 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 72.25 110.921 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.05 112.19 2.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 72.23 112.499 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB2' ' CG2' ' A' ' 79' ' ' VAL . 29.0 m-85 -126.27 164.77 20.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.889 0.376 . . . . 75.52 110.902 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -152.88 137.63 17.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 74.52 110.862 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.73 141.86 28.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.91 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -132.39 143.44 49.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 72.44 110.854 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.53 -37.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 63.24 110.873 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 40.55 44.53 3.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.726 -0.75 . . . . 63.24 112.533 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -168.08 105.4 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.348 . . . . 72.44 110.854 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -146.48 106.3 3.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 75.34 110.929 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.4 m -80.87 131.12 35.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 74.14 111.18 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.41 121.35 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.52 111.142 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -137.9 8.51 2.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 72.2 110.881 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.54 -175.54 15.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 55.31 112.466 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.421 ' C ' HG23 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -157.17 153.55 27.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.96 0.409 . . . . 75.12 110.875 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.67 172.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 73.33 111.132 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -141.54 132.86 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 62.13 110.867 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.93 45.62 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 72.3 110.882 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 64.31 111.121 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.569 0.7 . . . . 75.32 111.115 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 167.66 23.87 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.642 2.228 . . . . 65.22 112.331 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 134.98 29.31 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 72.31 112.339 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.54 136.85 33.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.51 111.098 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 m -94.66 77.27 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 64.44 111.169 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.461 ' CD2' HG21 ' A' ' 18' ' ' VAL . 2.0 mp -80.08 106.25 11.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 74.13 110.934 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -78.38 -165.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 75.23 110.847 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.473 ' CB ' ' CG1' ' A' ' 95' ' ' VAL . . . -135.88 79.45 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.43 111.07 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.499 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.6 mm -68.6 172.42 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.41 111.098 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.565 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -53.34 172.05 0.22 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.581 0.705 . . . . 74.32 110.841 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.565 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.72 21.48 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 73.54 112.34 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 12' ' ' HIS . 6.9 ptpt -129.06 26.14 5.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 70.54 110.953 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.99 -178.63 29.14 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 70.52 112.486 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.466 ' C ' HG13 ' A' ' 11' ' ' ILE . 35.6 tp -149.87 163.67 37.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 64.45 110.901 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -131.24 135.23 47.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 75.41 110.863 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 8' ' ' LEU . 41.9 t -143.26 110.6 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 54.23 111.113 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 t -118.2 157.41 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 71.22 110.888 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 m -139.94 151.94 66.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.654 0.74 . . . . 74.23 111.123 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 121.36 8.04 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.655 2.237 . . . . 75.54 112.335 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.436 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 22.8 t0 -82.81 93.6 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.53 110.862 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.7 30.59 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 73.31 110.933 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.14 23.46 7.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 73.43 112.464 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 64.3 m-85 -72.24 166.23 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 73.21 110.871 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 t -129.86 -6.49 4.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.854 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.552 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -163.05 140.56 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 75.23 110.912 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.542 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 14.0 t80 -135.59 149.97 49.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.3 110.898 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.62 152.73 42.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 63.13 111.139 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.551 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 1.9 t80 -132.68 132.47 42.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 74.34 110.922 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 16.3 m-70 -157.79 89.05 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 74.31 110.875 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.12 -175.32 19.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 74.11 112.481 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.424 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -135.48 -164.17 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 74.35 110.928 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.569 ' CD1' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -130.27 138.83 50.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 74.2 110.897 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.569 ' ND2' ' CD1' ' A' ' 34' ' ' LEU . 68.4 m-80 46.52 26.69 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.905 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -154.11 144.22 22.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 71.44 110.914 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.32 152.77 29.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.855 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 71.31 110.899 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.456 -0.257 . . . . 51.02 112.456 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.44 -54.28 2.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.82 0.343 . . . . 74.3 110.854 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -71.39 171.11 11.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.11 110.9 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -173.31 115.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 74.04 110.854 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.435 ' CD ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -163.46 158.24 20.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.34 110.884 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.46 122.88 13.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.861 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.435 HD11 ' CD ' ' A' ' 48' ' ' ARG . 19.2 mm -103.66 118.35 50.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 72.24 111.115 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 51.7 p -104.6 35.07 2.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 74.32 111.152 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' A' ' 51' ' ' THR . 16.7 mttt 164.93 137.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.571 0.701 . . . . 74.14 110.91 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 174.77 9.04 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 2.263 . . . . 73.01 112.318 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HZ3' ' NE ' ' A' ' 61' ' ' ARG . 1.5 ptpt -136.94 11.57 3.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.919 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.77 44.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 73.43 110.917 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.78 -24.62 5.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.807 -0.711 . . . . 72.43 112.477 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.23 163.36 27.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 75.33 110.909 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 8.1 m95 -85.1 96.2 9.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 73.2 110.918 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.2 mt -102.41 140.83 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.127 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 41.9 t80 -134.64 158.01 45.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 75.34 110.865 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.407 ' NE ' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -148.37 139.0 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 75.1 110.843 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.68 -179.38 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 65.32 110.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.75 28.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.895 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -144.47 18.59 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 63.23 110.945 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.41 102.71 11.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 72.22 111.128 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.59 83.11 2.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.34 111.066 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.66 171.63 8.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.91 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -155.51 141.75 18.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.873 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.538 ' C ' ' O ' ' A' ' 68' ' ' LYS . 25.6 mm -25.41 119.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.12 111.153 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.56 -18.08 8.78 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.743 -0.742 . . . . 74.11 112.469 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.29 -176.58 2.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 74.04 110.85 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 6.7 mttt -143.32 160.58 40.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 75.44 110.86 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.46 HG12 ' CD2' ' A' ' 34' ' ' LEU . 49.1 mt -137.82 146.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 73.24 111.126 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.9 m-85 -146.98 104.97 3.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.951 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.9 p90 -165.96 -168.26 1.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.906 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.3 p-90 -135.61 171.59 14.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.474 . . . . 73.11 110.908 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.2 p -142.11 149.01 39.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 71.44 111.182 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.07 144.17 39.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.04 110.868 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.513 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -143.72 167.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 74.33 111.152 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 88.9 mt -149.0 96.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 73.52 111.116 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 1.3 tttt -112.28 133.66 54.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.884 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 48.88 37.85 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 74.21 110.882 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.65 29.71 49.52 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 64.3 112.472 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 mt -93.0 -58.33 2.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.858 0.361 . . . . 75.31 110.924 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.21 120.66 3.79 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.776 -0.726 . . . . 73.42 112.497 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -143.59 163.74 32.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.947 0.403 . . . . 73.53 110.9 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -159.04 134.7 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 74.02 110.874 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -80.77 154.8 27.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.496 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -138.84 -164.73 1.7 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.895 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.496 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.2 t-20 82.08 -40.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.891 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.16 84.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.671 -0.776 . . . . 74.55 112.493 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -172.26 110.68 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.823 0.344 . . . . 74.42 110.89 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -149.75 114.77 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.915 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.5 m -87.98 136.04 33.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 73.32 111.111 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.473 ' CG1' ' CB ' ' A' ' 10' ' ' ALA . 35.5 t -71.85 115.09 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 71.41 111.134 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -133.21 12.46 4.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.904 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -130.78 177.7 18.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 72.11 112.44 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.433 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -145.02 160.41 41.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 73.2 110.902 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.447 ' CG2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.13 167.57 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.32 111.133 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.43 137.28 50.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 74.25 110.896 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -89.49 42.22 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.876 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 74.22 111.096 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.564 0.697 . . . . 52.13 111.118 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 167.05 25.61 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 2.238 . . . . 75.41 112.318 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 135.76 31.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.64 2.226 . . . . 74.32 112.392 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.65 141.43 28.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 73.22 111.078 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.2 m -100.47 76.83 1.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 73.52 111.156 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -73.81 106.73 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 75.41 110.943 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 7.3 mm-40 -78.41 -170.28 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 71.52 110.881 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.477 ' HB3' ' CG1' ' A' ' 95' ' ' VAL . . . -133.59 80.83 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 74.24 111.125 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.485 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -72.14 172.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 75.53 111.174 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.565 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.0 171.82 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.603 0.715 . . . . 72.14 110.854 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.565 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.2 Cg_endo -69.71 20.85 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.693 2.262 . . . . 73.53 112.356 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 12' ' ' HIS . 9.5 pttt -125.67 19.76 7.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 62.12 110.901 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.21 -177.39 33.27 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.782 -0.723 . . . . 73.15 112.508 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.474 ' C ' HG13 ' A' ' 11' ' ' ILE . 24.0 tp -149.8 166.71 28.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 71.34 110.902 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -133.25 138.93 46.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.86 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -147.19 107.49 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 74.24 111.151 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.435 ' C ' HG13 ' A' ' 20' ' ' VAL . 12.4 t -112.24 156.45 22.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 72.24 110.872 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.435 HG13 ' C ' ' A' ' 19' ' ' SER . 30.3 m -141.73 151.84 61.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.653 0.74 . . . . 75.44 111.132 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 122.44 9.11 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.733 2.289 . . . . 74.23 112.311 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 12.1 t0 -83.64 92.77 7.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 72.22 110.853 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.35 40.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.897 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.0 24.5 24.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 52.52 112.511 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 95.7 m-85 -74.71 165.02 25.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.866 0.365 . . . . 73.2 110.854 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.1 t -129.41 -7.61 4.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 61.45 110.861 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.568 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -155.02 142.1 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 71.05 110.951 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.537 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 17.9 t80 -137.55 147.9 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.44 110.903 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.7 156.76 46.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.31 111.098 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -139.4 125.42 19.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.901 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.445 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 25.8 m-70 -152.58 92.58 1.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 73.42 110.869 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.47 ' CA ' ' CB ' ' A' ' 75' ' ' PHE . . . -144.67 -174.47 16.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 61.23 112.448 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -163.98 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 73.11 110.918 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.438 ' CD1' ' OD2' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.86 123.46 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 74.3 110.899 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 61.4 27.23 16.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 75.4 110.878 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -156.89 146.68 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.915 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -113.92 159.33 20.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 64.12 110.893 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.562 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 73.01 110.887 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.459 -0.256 . . . . 34.43 112.459 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 -56.33 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 74.43 110.837 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -69.85 177.07 3.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 72.11 110.931 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.445 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 66.0 p -179.92 109.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 71.45 110.837 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.422 ' NE ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -161.06 156.7 24.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 73.22 110.863 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -140.22 120.02 13.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 63.23 110.859 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.422 HD11 ' NE ' ' A' ' 48' ' ' ARG . 8.6 mm -95.18 117.16 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 74.43 111.154 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.6 p -98.96 32.55 2.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 72.4 111.149 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.422 ' O ' ' CG2' ' A' ' 50' ' ' ILE . 0.8 OUTLIER 170.24 139.83 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.555 0.693 . . . . 74.42 110.923 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -178.95 2.58 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.66 2.24 . . . . 70.42 112.363 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -119.63 -61.7 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 75.34 110.89 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -131.43 58.47 1.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.891 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.38 -28.74 6.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 40.44 112.461 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.5 160.7 29.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.322 . . . . 74.5 110.887 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.519 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 44.1 m95 -82.59 89.1 6.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 75.13 110.949 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -94.46 135.91 27.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 75.25 111.159 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.478 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 56.1 t80 -135.56 162.37 32.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 75.31 110.847 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.478 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -158.24 152.71 24.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 75.43 110.892 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.39 -176.41 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 65.4 110.855 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.1 mtt180 -142.76 16.47 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 73.34 110.877 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -132.8 8.72 4.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.892 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.85 95.96 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 74.51 111.108 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.67 77.46 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.12 111.104 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -125.07 171.47 10.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 71.32 110.9 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.506 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.71 154.88 28.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 74.33 110.913 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.7 mm -29.98 121.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 73.41 111.118 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.52 -28.45 5.98 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.729 -0.748 . . . . 74.4 112.452 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.438 ' OD2' ' CD1' ' A' ' 34' ' ' LEU . 1.4 m-20 -66.53 -171.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 71.43 110.861 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.7 mttt -148.78 168.71 22.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 72.5 110.898 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.401 HG21 ' N ' ' A' ' 74' ' ' TYR . 78.6 mt -146.67 145.28 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 73.52 111.153 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -148.36 103.29 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.914 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.47 ' CB ' ' CA ' ' A' ' 32' ' ' GLY . 1.3 p90 -160.97 -168.99 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 75.14 110.903 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.562 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -139.99 146.12 38.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 74.53 110.912 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.402 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 1.9 p -111.63 161.76 15.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 74.12 111.142 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 138.1 51.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 75.15 110.893 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.566 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 2.3 m -141.86 177.2 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 74.34 111.141 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.3 mt -152.95 98.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 73.42 111.122 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.573 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -112.7 141.02 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 72.53 110.866 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER 44.92 32.51 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.879 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.38 36.98 91.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 54.21 112.472 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.7 -50.59 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.836 0.35 . . . . 60.12 110.899 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.48 105.01 0.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.758 . . . . 73.04 112.501 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -123.72 -175.02 3.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 75.21 110.906 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.446 ' HB3' ' NH1' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -178.44 135.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 74.43 110.854 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -79.1 153.28 30.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.918 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.482 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -136.28 -165.5 1.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 73.31 110.841 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.482 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 81.34 -40.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 73.2 110.861 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.27 83.05 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 62.25 112.504 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -170.69 112.91 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 72.13 110.894 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.6 m-90 -155.04 113.05 3.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 74.33 110.923 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 96.1 m -88.48 135.34 33.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 60.54 111.151 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 10' ' ' ALA . 15.8 t -64.75 114.94 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 73.4 111.14 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.62 -2.34 3.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 70.12 110.894 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -113.51 -174.89 19.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 74.33 112.48 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -155.49 156.73 35.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 75.04 110.896 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.64 167.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 74.24 111.128 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -127.46 129.44 47.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 65.02 110.889 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -78.69 48.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 74.01 110.844 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.04 111.091 179.947 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.583 0.706 . . . . 75.1 111.067 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 165.07 32.22 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.664 2.243 . . . . 64.52 112.35 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 134.79 28.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.635 2.223 . . . . 72.03 112.375 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.34 135.0 36.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 75.12 111.115 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.7 m -93.95 77.7 4.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 72.15 111.105 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mp -85.84 111.45 20.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 73.34 110.898 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.58 -155.14 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.131 -0.486 . . . . 75.52 110.906 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.62 80.44 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 63.43 111.065 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.487 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 2.6 mm -69.51 172.27 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 61.22 111.123 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.581 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -54.18 172.74 0.23 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.627 0.727 . . . . 61.4 110.834 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.1 Cg_endo -69.77 19.82 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.239 . . . . 75.5 112.36 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.0 OUTLIER -124.54 21.72 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.15 110.923 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.55 -177.47 31.07 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 62.3 112.434 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.468 ' HB2' ' CB ' ' A' ' 65' ' ' ALA . 36.0 tp -149.47 162.05 40.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 73.13 110.92 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 37.3 ttt180 -123.16 138.3 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 72.24 110.886 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.1 t -148.61 110.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 72.5 111.092 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -123.31 156.12 35.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 61.03 110.828 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.9 m -141.45 151.66 61.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.649 0.738 . . . . 75.44 111.125 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 126.26 13.1 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.709 2.273 . . . . 70.44 112.31 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.523 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 34.3 t0 -97.21 86.23 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.32 110.871 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -20.57 63.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.895 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.84 30.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 73.52 112.523 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 83.4 m-85 -81.36 167.75 19.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 75.23 110.866 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 t -127.22 -10.48 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.845 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.559 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -151.96 141.44 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 75.3 110.949 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.54 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 14.5 t80 -137.34 140.89 41.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 71.33 110.924 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.17 144.66 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 74.11 111.092 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.442 ' CE1' ' CZ ' ' A' ' 75' ' ' PHE . 1.6 t80 -130.78 109.7 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 74.52 110.852 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -135.84 93.69 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 73.24 110.841 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' A' ' 75' ' ' PHE . . . -142.28 -177.26 17.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.679 -0.772 . . . . 54.22 112.467 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -131.3 -164.27 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 75.41 110.882 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.503 ' CD1' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -133.9 129.07 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 72.42 110.903 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.503 ' ND2' ' CD1' ' A' ' 34' ' ' LEU . 61.0 m-80 60.29 17.11 6.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.897 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -153.23 142.01 21.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 71.45 110.888 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.441 ' CB ' ' HB2' ' A' ' 74' ' ' TYR . 4.3 pt-20 -117.59 154.41 31.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 62.11 110.914 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 7.2 ptt? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 71.25 110.919 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.477 -0.249 . . . . 53.34 112.477 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.31 -71.42 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.319 . . . . 71.21 110.871 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.589 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 5.9 m-90 -58.09 155.41 11.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.2 110.931 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.511 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 87.3 p -153.15 108.2 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 61.31 110.833 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.79 160.76 39.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 65.55 110.861 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.96 108.41 4.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.876 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 28' ' ' PHE . 4.6 mm -85.85 101.0 9.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.444 . . . . 72.24 111.111 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 p -87.81 26.48 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 65.43 111.154 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 mttt 178.84 135.38 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 75.21 110.889 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 168.12 22.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.684 2.256 . . . . 74.41 112.329 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -105.77 -60.35 1.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 75.0 110.933 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -132.11 53.94 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 65.51 110.863 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.91 -20.01 48.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 44.32 112.472 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -133.84 162.4 32.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 74.34 110.922 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.523 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 15.8 m95 -85.07 91.85 8.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 75.12 110.956 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.3 mt -100.38 146.08 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 65.14 111.123 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -142.69 155.06 44.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.33 110.902 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.0 119.95 11.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.875 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD2' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -93.24 -178.24 4.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.855 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -145.25 10.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 75.34 110.878 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.486 ' ND2' ' OD2' ' A' ' 62' ' ' ASP . 15.1 p30 -124.08 -1.39 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 73.3 110.883 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -84.41 98.93 10.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 63.11 111.082 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.19 78.98 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 73.4 111.124 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.514 ' CD2' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -127.75 170.24 12.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.14 110.924 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.514 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.31 151.99 23.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 74.53 110.865 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.578 HG12 ' CE2' ' A' ' 98' ' ' PHE . 2.8 mm -27.45 122.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 74.02 111.116 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.03 -25.46 7.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 53.24 112.513 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.11 -168.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 74.22 110.841 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.9 mttt -151.18 171.96 16.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 72.33 110.908 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 74' ' ' TYR . 83.9 mt -147.96 149.23 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 75.42 111.09 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.1 m-85 -152.76 115.3 4.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 75.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.442 ' CZ ' ' CE1' ' A' ' 30' ' ' PHE . 8.3 p90 -171.55 -159.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.426 ' N ' ' CD2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -151.79 133.29 14.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 75.25 110.935 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.456 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 1.7 p -93.78 166.84 12.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 63.31 111.182 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.58 132.22 28.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 70.41 110.857 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.404 ' HB ' ' CD2' ' A' ' 25' ' ' PHE . 2.1 m -135.6 177.12 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 71.21 111.103 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.0 mt -150.13 99.65 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 65.02 111.155 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -115.92 140.86 48.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.907 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.87 33.13 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 62.31 110.848 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.94 36.96 83.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 62.54 112.5 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.43 -52.22 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.906 0.384 . . . . 73.33 110.908 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.02 102.9 0.73 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 74.1 112.486 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -122.88 179.19 4.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 74.34 110.948 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.456 ' CG ' ' O ' ' A' ' 77' ' ' THR . 1.7 tmm_? -177.38 136.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 75.44 110.899 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -75.28 160.87 29.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 73.23 110.942 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -139.34 -167.77 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 75.12 110.88 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.7 OUTLIER 82.47 -40.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 65.31 110.822 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.09 79.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 74.22 112.502 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -167.49 109.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 73.4 110.888 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 -149.17 111.29 4.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 74.3 110.899 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 84.8 m -91.98 135.17 34.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 74.34 111.156 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.433 ' O ' ' CG ' ' A' ' 96' ' ' GLU . 9.9 t -60.45 156.03 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 73.35 111.154 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 69' ' ' ILE . 13.7 mt-10 -163.05 -33.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.916 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.02 -170.91 26.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 74.25 112.486 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.578 ' CE2' HG12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -150.3 168.5 23.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.924 0.392 . . . . 61.05 110.879 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -167.52 175.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 72.52 111.138 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -137.73 142.26 40.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 75.13 110.888 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -88.48 51.29 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 70.33 110.836 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 64.12 111.085 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.6 0.714 . . . . 71.21 111.114 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.427 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.8 Cg_endo -69.79 167.79 23.45 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.7 2.267 . . . . 75.42 112.37 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 133.13 24.84 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 72.44 112.34 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.412 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . . . -85.3 142.52 29.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 72.31 111.098 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m -99.01 77.36 2.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 71.31 111.174 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.499 HD11 ' CG ' ' A' ' 93' ' ' TRP . 1.8 mp -76.05 105.72 7.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 72.25 110.929 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 5.1 mm-40 -78.53 -170.88 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 75.02 110.863 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB1' ' CG1' ' A' ' 95' ' ' VAL . . . -133.78 80.27 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 72.5 111.098 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.49 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -71.94 172.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 71.24 111.135 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.25 172.09 0.25 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.596 0.712 . . . . 74.04 110.855 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.82 20.06 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 53.41 112.301 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 12' ' ' HIS . 2.7 pttt -125.95 21.87 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 73.33 110.918 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 62' ' ' ASP . . . 155.58 -178.49 32.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 74.54 112.485 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' C ' HG13 ' A' ' 11' ' ' ILE . 19.9 tp -149.83 168.23 24.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 75.23 110.931 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -135.56 134.91 39.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 73.44 110.87 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -144.62 106.65 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 75.42 111.114 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.1 t -116.08 156.47 26.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 75.51 110.822 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.567 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 33.0 m -141.25 152.66 64.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.672 0.749 . . . . 62.04 111.088 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 120.91 7.61 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.628 2.218 . . . . 70.25 112.312 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 3.6 t70 -75.9 99.71 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 70.52 110.855 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -88.98 35.44 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 61.12 110.873 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.12 25.01 25.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 60.12 112.485 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 98.8 m-85 -73.05 168.1 19.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.913 0.387 . . . . 73.23 110.857 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.2 t -129.34 -8.15 4.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 62.44 110.839 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.561 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -159.62 142.06 13.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.95 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -137.19 150.97 48.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 71.32 110.876 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.17 143.81 40.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 64.54 111.133 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -126.52 119.76 27.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 75.44 110.884 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 5.8 m-70 -152.08 92.32 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.504 . . . . 72.54 110.846 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 75' ' ' PHE . . . -146.22 178.55 23.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 71.14 112.498 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.449 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -133.18 -164.81 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 61.44 110.907 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 36' ' ' GLU . 1.4 tp -132.56 152.33 51.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 72.42 110.921 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 41.27 25.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 61.34 110.916 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -164.01 136.86 5.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 71.04 110.915 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.42 163.81 12.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 73.25 110.839 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.556 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 73.24 110.867 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.449 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.523 -0.231 . . . . 71.3 112.523 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.03 -71.82 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 72.31 110.907 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -53.73 148.35 10.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.975 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.543 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 52.4 p -155.45 119.74 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 61.23 110.889 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.57 160.97 11.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 74.03 110.89 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.02 114.7 9.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 75.14 110.87 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' PHE . 10.2 mm -94.57 97.51 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 70.3 111.124 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.2 p -95.38 29.7 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.04 111.158 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.92 133.06 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 74.41 110.902 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -178.14 2.18 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.675 2.25 . . . . 72.23 112.387 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -135.73 -34.39 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 74.24 110.924 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -138.77 49.2 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 72.33 110.909 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.87 -26.12 4.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 73.25 112.415 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.64 168.22 14.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.775 0.322 . . . . 74.04 110.897 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.481 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 13.9 m95 -90.25 87.96 7.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.908 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.9 mt -91.91 141.52 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.5 111.075 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.524 ' CE2' ' OD1' ' A' ' 62' ' ' ASP . 18.8 t80 -138.24 147.06 43.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 64.12 110.869 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 139.38 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 71.54 110.928 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -120.29 140.59 51.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 72.05 110.867 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.03 31.03 6.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.34 110.877 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.36 19.89 2.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 73.34 110.867 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.4 112.4 23.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 70.54 111.091 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.39 83.72 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 74.04 111.107 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.511 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -135.61 171.22 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.884 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -156.85 158.46 36.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.9 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.563 HG13 ' CE2' ' A' ' 98' ' ' PHE . 26.9 mm -32.16 115.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 72.15 111.136 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.24 -26.66 4.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.709 -0.757 . . . . 71.13 112.474 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.37 -172.5 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.914 0.388 . . . . 71.22 110.834 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -143.17 168.23 20.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.917 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.7 mt -145.24 143.18 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.145 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -147.43 108.69 4.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 73.11 110.948 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.43 ' CE2' HG22 ' A' ' 77' ' ' THR . 0.2 OUTLIER -164.07 -163.87 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 75.02 110.833 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.556 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -149.13 144.1 26.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 74.12 110.925 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.1 p -113.15 149.62 33.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 73.44 111.17 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.59 142.96 46.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.873 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.424 ' CG1' ' CD2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -141.8 170.83 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 74.42 111.14 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.1 mt -147.63 96.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 70.44 111.138 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 9.2 tttt -112.68 140.74 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.921 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 40.97 38.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 52.5 110.893 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.01 40.86 51.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 73.14 112.501 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 mt -105.09 -48.24 3.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 74.3 110.946 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.21 105.27 1.08 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.704 -0.76 . . . . 73.41 112.499 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -123.97 168.96 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.38 . . . . 75.52 110.9 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 77' ' ' THR . 3.7 ttp-105 -175.05 140.03 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 71.33 110.848 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.433 ' N ' ' HG2' ' A' ' 87' ' ' ARG . 3.2 tp-100 -84.19 155.47 22.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 74.35 110.869 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -137.97 -169.47 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 70.4 110.884 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 83.78 -33.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 71.41 110.884 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 41.13 83.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.8 -0.714 . . . . 71.42 112.429 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -169.66 112.98 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 75.45 110.9 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.499 ' CG ' HD11 ' A' ' 8' ' ' LEU . 16.7 m-90 -155.32 110.97 3.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 75.23 110.931 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 95.9 m -83.82 139.27 32.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 73.22 111.137 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.475 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 39.2 t -69.67 116.67 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 72.23 111.083 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -138.64 10.3 2.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.849 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -117.88 -178.11 17.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.771 -0.728 . . . . 73.42 112.512 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CE2' HG13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -153.41 152.01 30.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 74.22 110.872 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -165.61 170.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 73.44 111.166 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.61 129.03 25.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 74.23 110.865 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -87.66 45.94 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 73.4 110.906 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 61.11 111.096 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.46 ' CB ' ' OE1' ' A' ' 88' ' ' GLN . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.605 0.717 . . . . 73.25 111.109 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 161.03 47.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.719 2.279 . . . . 74.15 112.323 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 134.58 28.27 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.694 2.263 . . . . 64.31 112.327 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.53 139.06 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.095 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -89.48 77.7 7.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 73.52 111.145 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -79.63 111.47 15.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 73.32 110.919 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.18 -155.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 72.02 110.848 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -144.21 80.96 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 65.02 111.074 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.495 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 4.0 mm -69.62 172.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 75.32 111.134 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.577 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -53.69 172.41 0.23 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.597 0.713 . . . . 64.13 110.861 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.2 Cg_endo -69.75 20.38 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.671 2.247 . . . . 74.21 112.356 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' HIS . 1.2 ptmt -128.33 26.44 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.23 110.933 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.34 -178.81 29.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.749 . . . . 63.33 112.454 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' CD1' HD23 ' A' ' 67' ' ' LEU . 35.1 tp -150.78 167.07 28.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 71.21 110.896 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -129.33 141.1 51.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.1 110.871 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.4 t -153.17 105.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 75.43 111.1 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 t -116.31 164.28 14.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.23 110.874 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.7 m -143.15 151.65 56.02 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.668 0.747 . . . . 73.11 111.117 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 122.12 8.81 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 74.33 112.344 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -81.84 94.89 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 72.25 110.898 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -91.88 24.97 2.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 74.53 110.871 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.98 28.15 4.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.729 -0.748 . . . . 71.11 112.534 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 77.7 m-85 -78.41 165.83 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 73.52 110.839 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.0 t -128.79 -8.25 5.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 65.13 110.844 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.552 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -161.19 140.63 10.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 73.55 110.926 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.534 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 16.6 t80 -134.57 145.68 48.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 71.14 110.846 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.64 164.6 23.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 65.14 111.088 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.2 t80 -150.16 113.75 4.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 72.53 110.877 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -149.23 95.17 2.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 53.4 110.864 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.545 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -146.19 -175.36 19.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 74.44 112.474 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.414 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 mtpp -131.84 -165.12 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.324 . . . . 73.44 110.882 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.64 148.14 40.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.901 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.402 ' N ' HD21 ' A' ' 35' ' ' ASN . 1.0 OUTLIER 49.29 22.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.844 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.7 143.17 2.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 64.4 110.879 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -108.82 154.17 22.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 71.13 110.902 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.907 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.414 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.485 -0.246 . . . . 71.45 112.485 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.88 -69.17 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 74.42 110.845 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.543 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 8.0 m0 -54.98 170.96 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 75.14 110.931 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.418 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 59.9 p -176.13 127.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 74.41 110.927 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.06 155.58 3.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 71.03 110.875 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.26 99.98 3.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.855 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.96 122.53 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.117 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.5 p -110.14 37.92 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 65.22 111.134 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 174.35 116.91 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.594 0.711 . . . . 70.13 110.871 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.543 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 54.0 Cg_endo -69.74 159.35 53.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.24 . . . . 73.43 112.375 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -142.12 131.88 24.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 72.03 110.909 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 1.9 t30 78.45 16.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 74.24 110.869 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.33 -23.87 33.74 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 74.32 112.454 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.52 171.79 13.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 71.31 110.856 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.543 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 9.4 m95 -86.87 101.06 13.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 75.54 110.919 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 mt -101.06 137.04 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 75.44 111.144 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -132.23 145.11 51.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.12 110.895 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.36 134.01 31.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.42 110.914 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.94 179.32 4.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 63.11 110.906 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 19.84 2.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.2 110.883 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -137.84 30.28 2.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 74.42 110.908 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -118.71 83.35 2.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.21 111.074 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.09 86.06 5.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 71.31 111.057 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.47 HD23 ' CD1' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -125.71 171.68 10.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.1 110.925 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -160.28 140.57 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 65.44 110.91 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.544 ' C ' ' O ' ' A' ' 68' ' ' LYS . 11.5 mm -24.26 118.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 72.22 111.093 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.27 -18.68 7.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.775 -0.726 . . . . 73.32 112.468 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.12 -176.76 4.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.339 . . . . 55.04 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -143.99 161.81 37.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 70.43 110.857 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.8 mt -138.93 145.66 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 75.43 111.108 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -146.15 103.01 3.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 74.02 110.89 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.545 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -162.14 -157.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 74.45 110.889 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.423 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.1 p-90 -150.93 173.74 13.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.932 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 p -143.05 158.74 43.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 73.14 111.172 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.16 144.48 45.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 73.41 110.829 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.498 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -143.69 169.52 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 72.42 111.111 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.9 mt -147.71 96.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 74.35 111.172 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -114.63 140.64 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.43 110.942 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 50.63 27.12 2.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 75.32 110.845 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.37 29.13 68.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 63.21 112.5 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.98 -49.53 4.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 74.23 110.908 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.6 131.48 4.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 74.1 112.496 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -145.17 -179.24 6.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 74.41 110.935 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -172.24 133.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 75.34 110.897 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.46 ' OE1' ' CB ' ' A' ' 3' ' ' ALA . 4.3 tp60 -78.74 155.15 29.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 75.32 110.92 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.509 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -141.6 -163.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 75.31 110.87 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.509 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.7 t-20 83.05 -36.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 75.14 110.893 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.19 78.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 75.41 112.471 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -170.47 109.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.358 . . . . 74.42 110.925 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -151.14 112.89 4.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 74.53 110.928 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.9 m -86.85 130.92 34.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.43 111.066 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.85 116.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.12 111.128 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.0 15.2 3.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 74.22 110.895 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -130.44 -177.82 15.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 62.41 112.507 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.427 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -153.86 155.52 35.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.372 . . . . 71.35 110.872 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.424 HG22 ' C ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -166.71 168.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 75.43 111.151 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.34 133.92 39.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.876 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.17 39.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 74.04 110.851 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 73.12 111.099 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.612 0.72 . . . . 64.14 111.062 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.483 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.8 Cg_endo -69.74 166.95 25.83 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.653 2.235 . . . . 72.24 112.365 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 132.65 23.77 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.683 2.255 . . . . 72.52 112.379 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.538 ' N ' HE22 ' A' ' 88' ' ' GLN . . . -83.12 138.24 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 61.4 111.103 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.5 m -95.59 78.03 3.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 74.15 111.138 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 mp -79.32 109.31 13.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 64.33 110.969 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 6.7 mm-40 -79.99 -171.79 3.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.924 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HB1' ' CG1' ' A' ' 95' ' ' VAL . . . -130.46 81.26 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 72.13 111.119 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.477 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 2.9 mm -72.66 172.52 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 73.45 111.12 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.568 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.34 172.01 0.26 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.605 0.717 . . . . 65.23 110.849 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.73 19.86 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 74.03 112.373 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 12' ' ' HIS . 11.1 ptmt -124.66 19.94 8.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.887 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.21 -177.44 33.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.796 -0.716 . . . . 60.33 112.486 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.46 ' C ' HG13 ' A' ' 11' ' ' ILE . 19.8 tp -150.89 168.98 22.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 74.35 110.888 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -132.92 139.44 47.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.54 110.86 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -147.83 108.28 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.137 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.8 t -119.5 157.41 28.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.859 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -141.6 151.58 60.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.644 0.735 . . . . 63.44 111.138 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 122.21 8.89 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.713 2.275 . . . . 72.52 112.326 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.464 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 28.4 t0 -84.55 86.12 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 75.04 110.86 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -73.08 2.52 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.852 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.33 24.24 0.86 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.737 . . . . 74.31 112.511 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.53 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 81.4 m-85 -70.45 168.34 16.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 74.05 110.866 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t -125.39 -16.03 6.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 63.53 110.893 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.567 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -158.34 140.14 13.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 74.1 110.944 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.645 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 8.3 t80 -132.77 151.5 51.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 74.32 110.883 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.74 155.39 48.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 71.34 111.082 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.645 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.4 m-85 -128.88 131.28 47.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 64.41 110.849 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.436 ' O ' ' CE ' ' A' ' 38' ' ' MET . 14.0 m-70 -157.63 84.97 0.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 71.43 110.868 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -144.55 177.47 23.08 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 74.41 112.491 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -136.21 -166.23 1.84 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 75.24 110.905 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 36' ' ' GLU . 13.7 tp -127.38 148.12 50.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 73.2 110.889 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 43.14 23.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.886 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 34' ' ' LEU . 2.0 tp10 -157.67 145.54 18.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.907 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.448 ' CB ' ' HB2' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -125.09 150.42 46.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 62.51 110.849 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.436 ' CE ' ' O ' ' A' ' 31' ' ' HIS . 2.3 ptt? . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 72.11 110.88 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.522 -0.231 . . . . 74.42 112.522 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.55 -65.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 72.23 110.857 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -60.01 154.83 18.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 73.01 110.941 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.432 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 99.3 p -158.01 109.22 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 71.31 110.836 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.73 162.92 40.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 74.2 110.871 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.65 113.73 7.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 74.35 110.893 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.2 mm -99.85 103.9 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 64.51 111.177 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.6 p -96.06 30.47 2.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.169 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 175.46 132.8 0.15 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 74.41 110.945 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 178.68 4.35 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.634 2.222 . . . . 64.24 112.363 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 -30.41 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 74.53 110.878 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -146.27 47.66 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 73.24 110.863 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.13 -26.26 7.04 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 53.02 112.459 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.88 164.42 21.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.827 0.346 . . . . 74.33 110.845 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.464 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 5.9 m95 -87.16 96.2 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 75.31 110.946 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.0 mt -102.75 142.04 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 70.42 111.155 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -134.98 154.28 51.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 74.43 110.91 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.76 135.4 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.869 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD2' ' ND2' ' A' ' 64' ' ' ASN . 6.0 t70 -112.22 174.97 5.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 74.43 110.839 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -139.42 15.46 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.844 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.492 ' ND2' ' OD2' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -129.44 4.94 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.888 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.16 98.13 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 73.21 111.102 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.45 87.53 4.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 75.52 111.086 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.464 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -138.79 171.17 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 64.33 110.911 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.464 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -157.73 156.57 31.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 72.24 110.943 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.4 mm -32.01 118.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 75.42 111.189 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.26 -23.56 6.43 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 62.41 112.516 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.9 -170.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 73.05 110.88 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -147.91 162.05 40.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 63.43 110.924 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 74' ' ' TYR . 96.4 mt -136.87 145.9 29.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 74.24 111.114 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -148.4 111.42 4.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.959 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.6 p90 -171.98 -163.45 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 75.14 110.913 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.18 145.6 24.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 71.1 110.895 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.483 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 11.2 p -113.45 161.11 17.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 74.2 111.153 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -119.17 144.77 46.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.884 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.53 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -139.24 166.14 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.35 111.178 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 90.7 mt -143.26 96.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 71.22 111.15 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.454 ' HG2' ' N ' ' A' ' 82' ' ' ASP . 4.9 tttt -118.66 146.36 44.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 75.2 110.918 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.454 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 52.15 22.26 1.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 64.53 110.858 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.15 27.67 71.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.754 . . . . 64.23 112.499 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mt -100.05 -65.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 73.25 110.917 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.39 124.85 4.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.688 -0.768 . . . . 31.32 112.464 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -136.71 178.0 7.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.394 . . . . 74.0 110.89 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.55 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -164.2 123.97 2.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 74.32 110.886 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.538 HE22 ' N ' ' A' ' 6' ' ' ALA . 1.9 tt0 -52.85 -173.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.897 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -170.49 -166.25 0.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 62.3 110.885 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER 83.53 -32.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 74.45 110.873 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 33.9 61.76 0.48 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.71 -0.757 . . . . 74.12 112.495 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -167.88 106.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 74.01 110.91 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 25.7 m-90 -145.42 115.51 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 71.01 110.889 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 60.5 m -87.31 133.16 33.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 65.54 111.149 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.47 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 21.6 t -63.38 107.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 72.0 111.143 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.75 5.21 7.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 75.2 110.892 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -117.53 179.76 17.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 75.1 112.464 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.421 ' C ' HG21 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -152.96 155.52 37.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.904 0.383 . . . . 74.42 110.872 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -164.51 -176.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 72.43 111.14 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -141.88 129.6 21.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 63.5 110.893 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -80.23 58.71 3.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.33 110.897 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 74.4 111.109 179.927 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.576 0.703 . . . . 61.35 111.125 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 154.62 67.62 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.71 2.273 . . . . 74.53 112.315 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 134.47 28.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.672 2.248 . . . . 73.31 112.336 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.24 137.92 32.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 72.31 111.11 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 m -93.18 77.19 4.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 74.22 111.122 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.458 HD13 ' CG ' ' A' ' 93' ' ' TRP . 1.9 mp -77.94 110.87 13.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 74.52 110.911 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -87.26 -167.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 75.52 110.858 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.542 ' CB ' ' CG1' ' A' ' 95' ' ' VAL . . . -134.32 80.51 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 71.2 111.131 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.495 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 4.5 mm -69.38 172.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 72.45 111.122 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -53.85 172.03 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 73.25 110.817 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.9 Cg_endo -69.77 21.43 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 75.41 112.347 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.524 ' H ' ' C ' ' A' ' 12' ' ' HIS . 7.5 pttt -128.82 25.07 5.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 75.33 110.884 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.29 -177.9 30.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 51.11 112.488 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.47 ' CD1' HD23 ' A' ' 67' ' ' LEU . 24.6 tp -150.71 157.97 43.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.347 . . . . 75.11 110.919 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 74.8 ttt180 -122.75 135.25 54.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 72.52 110.889 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -147.06 108.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 75.53 111.095 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.4 t -120.56 162.2 20.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.897 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.04 152.03 63.87 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.646 0.736 . . . . 74.41 111.102 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 123.98 10.65 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.646 2.231 . . . . 72.34 112.364 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 17.0 t0 -87.82 107.05 18.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 74.43 110.889 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -96.09 6.81 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 74.24 110.893 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.48 8.97 2.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 73.24 112.462 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.509 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 63.5 m-85 -60.27 168.5 1.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.328 . . . . 71.41 110.887 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -128.95 -7.39 4.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.33 110.854 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.562 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -156.32 143.06 18.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 75.23 110.915 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.539 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 16.3 t80 -139.73 139.32 36.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 75.5 110.882 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.44 158.86 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 73.24 111.141 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.1 t80 -145.75 114.65 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 65.51 110.891 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.549 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -147.35 94.87 2.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 73.35 110.846 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.62 177.61 23.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 75.03 112.456 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.55 -164.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 75.21 110.905 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.0 tp -136.31 148.53 47.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 74.44 110.954 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 48.96 19.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 71.42 110.894 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -161.24 142.7 11.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 73.02 110.888 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.03 156.69 22.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 73.43 110.897 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.599 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 64.35 110.821 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.483 -0.247 . . . . 71.43 112.483 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -103.41 -51.75 3.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 75.01 110.877 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.567 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 8.3 m0 -70.19 165.42 22.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.922 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.549 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 96.0 p -164.65 124.25 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 73.5 110.847 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.493 ' HG2' ' CD1' ' A' ' 60' ' ' PHE . 17.0 tpp180 -165.44 144.26 6.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 73.21 110.872 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.39 99.31 3.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.868 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mm -87.87 115.42 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 64.41 111.115 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.401 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 63.8 p -103.78 33.47 3.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 64.45 111.134 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.6 OUTLIER 167.84 127.38 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.605 0.717 . . . . 74.01 110.903 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 171.17 15.01 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.687 2.258 . . . . 73.1 112.32 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.82 19.45 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 60.21 110.907 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -177.56 38.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 75.41 110.917 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.47 -13.62 15.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 75.33 112.452 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.05 160.54 40.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.805 0.336 . . . . 75.21 110.873 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.451 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 3.9 m95 -85.79 101.39 12.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 75.22 110.949 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 mt -104.32 143.78 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 73.2 111.121 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.493 ' CD1' ' HG2' ' A' ' 48' ' ' ARG . 13.1 t80 -132.27 147.89 52.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 75.44 110.939 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.439 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -140.93 127.45 20.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 74.01 110.886 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.567 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 2.5 t0 -104.47 -179.53 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 65.42 110.853 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -148.95 28.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 75.44 110.865 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -144.88 13.58 1.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 65.01 110.876 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.03 100.09 9.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 73.2 111.142 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.54 86.55 4.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 62.45 111.094 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.47 HD23 ' CD1' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -125.62 171.55 10.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 74.15 110.895 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.501 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -152.79 140.49 19.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 75.32 110.931 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.53 HG12 ' CD1' ' A' ' 98' ' ' PHE . 17.1 mm -28.23 118.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 71.34 111.096 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.67 -22.04 5.56 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.749 -0.739 . . . . 71.1 112.474 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.84 -166.87 0.32 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 65.24 110.898 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -147.33 172.16 14.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 73.33 110.871 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.2 mt -144.72 144.69 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 75.11 111.129 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.3 100.75 3.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 74.3 110.87 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.452 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -159.5 -156.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 72.41 110.826 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.599 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -152.46 156.68 39.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.51 110.918 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 p -118.82 175.38 5.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 74.45 111.176 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -146.95 130.46 16.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 70.24 110.905 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 86' ' ' TYR . 3.3 m -134.13 -179.03 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.34 111.138 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.419 HG13 ' C ' ' A' ' 79' ' ' VAL . 83.1 mt -153.37 97.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 74.1 111.108 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.509 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 16.1 tttm -113.1 135.19 54.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 75.32 110.9 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.3 t0 50.51 25.1 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.25 110.851 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.98 30.04 73.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 54.21 112.511 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -92.53 -66.87 0.89 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.359 . . . . 75.4 110.915 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.59 116.09 4.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.755 . . . . 60.13 112.495 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.555 ' CD1' ' N ' ' A' ' 86' ' ' TYR . 0.5 OUTLIER -127.33 166.46 17.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.879 0.371 . . . . 74.03 110.902 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.426 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -160.33 110.67 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 74.52 110.904 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.74 157.9 13.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 74.45 110.924 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -146.72 -169.11 3.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.3 110.849 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.6 m120 83.93 -28.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 73.43 110.862 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 34.41 78.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 73.34 112.492 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -165.96 104.14 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 75.41 110.887 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.458 ' CG ' HD13 ' A' ' 8' ' ' LEU . 19.4 m-90 -145.95 113.28 6.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 74.31 110.939 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 95' ' ' VAL . 93.1 m -82.07 140.07 34.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 75.1 111.138 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.542 ' CG1' ' CB ' ' A' ' 10' ' ' ALA . 21.2 t -78.64 111.61 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 74.3 111.133 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -138.66 16.32 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 74.53 110.861 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -139.38 121.7 2.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.78 -0.724 . . . . 62.24 112.527 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.53 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -91.02 170.08 10.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.91 0.386 . . . . 74.03 110.895 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.442 HG21 ' C ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -168.03 155.16 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 71.32 111.127 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -115.18 127.35 55.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 65.12 110.864 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -89.81 39.5 0.96 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.45 110.924 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 73.02 111.132 179.927 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.58 0.705 . . . . 71.4 111.075 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.472 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 54.2 Cg_endo -69.66 168.3 21.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.267 . . . . 73.33 112.358 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 132.72 23.96 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 73.24 112.356 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.01 134.92 35.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 51.25 111.085 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -93.12 77.16 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 75.55 111.117 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 mp -79.34 107.18 11.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 64.34 110.928 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 6.6 mm-40 -79.92 -173.58 3.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -129.68 79.65 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 71.11 111.047 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.499 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.2 mm -70.6 172.61 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 74.14 111.139 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.559 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -53.05 171.54 0.22 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 73.32 110.839 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.559 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.5 Cg_endo -69.79 19.77 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.686 2.257 . . . . 72.13 112.307 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 12' ' ' HIS . 25.5 pttt -127.91 25.43 5.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 72.42 110.921 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.55 -179.98 30.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.754 -0.736 . . . . 71.55 112.498 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.469 ' CD1' HD22 ' A' ' 67' ' ' LEU . 20.5 tp -149.97 158.3 44.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 74.1 110.902 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.41 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 11.4 ttt180 -126.37 132.55 51.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.88 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -141.29 114.03 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.32 111.129 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.8 t -119.96 156.56 30.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.22 110.85 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -139.01 152.67 70.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.589 0.709 . . . . 74.25 111.168 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 121.36 8.05 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.727 2.285 . . . . 72.01 112.313 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.598 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.1 t70 -55.69 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 70.23 110.881 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' A' ' 22' ' ' ASP . 0.9 OUTLIER 83.46 -13.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 75.44 110.874 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.83 6.47 2.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 74.33 112.516 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CD2' ' O ' ' A' ' 22' ' ' ASP . 36.1 m-85 -53.8 166.74 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 74.12 110.865 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 80' ' ' ILE . 11.4 t -133.08 -2.25 3.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 73.41 110.822 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.557 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -171.45 139.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.892 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.548 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 13.3 t80 -133.77 152.5 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.5 110.871 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.79 158.87 43.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 75.53 111.113 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 1.5 t80 -139.2 127.27 22.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 71.13 110.871 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.529 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 7.3 m-70 -152.89 88.04 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.2 110.859 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.505 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.27 -176.67 20.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 64.44 112.47 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -134.8 -164.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 74.11 110.863 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.1 tp -131.94 147.02 52.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 74.55 110.875 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 39.92 30.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 74.42 110.859 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.03 127.6 4.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.45 110.893 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -99.96 146.81 26.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.864 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.0 ptp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 72.2 110.881 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.503 -0.239 . . . . 74.1 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.74 -58.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.752 0.31 . . . . 63.5 110.837 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -69.66 146.96 51.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 74.54 110.936 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.529 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 77.7 p -155.12 120.18 4.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 75.24 110.812 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.46 ' CD ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -162.14 158.85 25.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 75.22 110.92 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.56 116.19 8.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 71.14 110.835 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.46 HD13 ' CD ' ' A' ' 48' ' ' ARG . 21.5 mm -98.76 108.17 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 73.33 111.144 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -98.23 31.84 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 75.25 111.106 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.23 115.59 0.27 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.656 0.741 . . . . 74.44 110.858 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 53.7 Cg_endo -69.71 178.16 4.82 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.66 2.24 . . . . 74.13 112.377 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -169.88 133.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 75.3 110.902 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 7.1 t-20 81.62 8.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 71.42 110.92 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.88 -16.84 42.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 74.21 112.542 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.1 176.01 9.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 72.14 110.911 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.551 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 6.9 m95 -93.41 107.91 19.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 71.54 110.893 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.1 mt -106.21 146.62 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 72.24 111.111 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -136.38 144.53 44.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 73.51 110.85 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.51 133.43 40.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 73.13 110.859 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.78 155.1 31.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 70.31 110.864 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -123.31 41.9 3.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 63.32 110.862 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.87 24.02 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 64.24 110.854 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.3 93.1 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.45 111.129 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.38 81.1 6.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 70.24 111.11 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.469 HD22 ' CD1' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -121.91 171.52 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.948 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.569 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -157.74 138.45 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.935 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.569 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.8 mm -22.65 118.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 75.41 111.181 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.94 -18.12 7.09 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 65.03 112.472 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.97 -169.19 1.47 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.866 0.365 . . . . 73.43 110.908 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.9 mttt -150.34 161.67 42.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 73.13 110.937 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.46 HG23 ' N ' ' A' ' 74' ' ' TYR . 82.3 mt -135.63 146.65 29.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 74.15 111.145 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.9 m-85 -147.59 107.01 3.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 75.21 110.903 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.505 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.4 p90 -167.67 -167.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 71.34 110.883 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.9 p-90 -135.97 163.11 31.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 73.01 110.943 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 p -131.35 164.4 25.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 64.24 111.133 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.67 141.64 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 75.31 110.912 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.505 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -141.03 167.3 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.25 111.137 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' SER . 94.1 mt -149.89 95.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 75.03 111.094 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.566 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -109.84 137.49 47.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 73.21 110.891 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 43.4 34.95 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 72.01 110.909 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.69 37.73 92.77 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 73.24 112.461 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.81 -55.11 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 64.32 110.94 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.11 113.22 1.13 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 73.22 112.482 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.23 -178.72 5.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 75.44 110.918 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -174.09 135.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 73.01 110.849 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 4' ' ' PRO . 1.4 tp-100 -86.1 153.19 22.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 75.45 110.881 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -135.19 -163.91 1.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 73.02 110.884 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.4 t-20 83.73 -37.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 73.45 110.896 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.51 79.12 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.77 -0.728 . . . . 75.24 112.479 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -170.14 110.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 75.23 110.886 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -151.52 115.4 4.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.33 110.921 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.5 m -87.06 131.18 34.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 73.22 111.185 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.403 HG21 ' CD1' ' A' ' 67' ' ' LEU . 28.8 t -63.21 116.33 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 74.1 111.123 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.04 6.1 3.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 75.41 110.875 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -115.82 -178.55 18.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 71.1 112.461 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.406 ' C ' HG21 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.7 155.7 33.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 71.22 110.89 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.76 178.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 64.54 111.119 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.38 133.61 27.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.905 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -85.24 44.89 1.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 75.12 110.882 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.4 111.074 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.563 0.697 . . . . 75.55 111.126 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 169.11 19.6 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.281 . . . . 62.45 112.369 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 133.37 25.28 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 72.04 112.35 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.68 140.54 32.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 73.11 111.063 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m -100.77 78.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 71.13 111.175 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mp -78.27 110.18 13.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 75.4 110.925 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.19 -160.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 75.2 110.891 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -139.92 80.34 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 71.21 111.118 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.484 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.3 mm -72.19 172.69 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 73.43 111.179 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.18 172.09 0.25 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.712 . . . . 71.23 110.858 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.2 Cg_endo -69.82 20.07 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.665 2.243 . . . . 75.35 112.3 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 12' ' ' HIS . 3.0 pttt -125.1 19.8 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 75.23 110.902 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.78 -177.3 33.77 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 71.33 112.492 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.452 ' C ' HG13 ' A' ' 11' ' ' ILE . 27.8 tp -150.98 167.93 26.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.804 0.335 . . . . 75.3 110.922 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -130.78 141.08 50.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.879 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -149.59 107.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 74.11 111.121 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.7 t -120.18 156.3 31.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 72.14 110.871 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.575 HG23 ' CZ ' ' A' ' 28' ' ' PHE . 3.1 m -145.08 151.76 49.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 73.04 111.139 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 121.2 7.9 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.677 2.251 . . . . 74.13 112.339 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.538 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 1.2 t70 -75.7 130.84 39.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.872 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.7 23.93 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 73.41 110.836 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 112.8 5.91 23.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.736 . . . . 74.52 112.468 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 66.7 m-85 -55.62 162.54 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 74.13 110.897 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.3 t -129.84 -8.9 4.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.03 110.879 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.558 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -158.64 141.85 14.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 74.24 110.936 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CZ ' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -135.65 150.39 49.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.841 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.422 ' CB ' ' OD1' ' A' ' 49' ' ' ASP . . . -141.0 136.75 32.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 74.45 111.083 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.62 118.28 30.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.84 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.488 ' NE2' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -146.0 90.58 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 72.41 110.881 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' A' ' 75' ' ' PHE . . . -146.24 -178.31 21.56 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 73.41 112.494 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -132.76 -164.3 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 72.24 110.909 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HG ' ' ND2' ' A' ' 35' ' ' ASN . 14.0 tp -133.18 147.94 52.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 65.42 110.965 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.467 ' ND2' ' HG ' ' A' ' 34' ' ' LEU . 2.2 m120 43.39 24.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.881 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -166.49 143.09 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 70.52 110.938 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -105.51 -170.55 1.76 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 74.01 110.907 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.508 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 2.1 ptt? . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 71.02 110.866 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.508 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.483 -0.247 . . . . 73.1 112.483 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.43 -69.87 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 72.14 110.897 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.446 ' O ' ' ND1' ' A' ' 31' ' ' HIS . 6.1 m-90 -47.47 164.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 73.32 110.915 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.488 ' CB ' ' NE2' ' A' ' 31' ' ' HIS . 97.0 p -166.31 117.39 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 74.23 110.878 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.56 162.43 21.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 74.3 110.874 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.422 ' OD1' ' CB ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -139.44 108.38 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 74.34 110.915 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 28' ' ' PHE . 3.4 mm -82.94 104.2 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 65.02 111.095 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.1 p -91.94 28.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 72.11 111.136 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.34 140.78 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.555 0.693 . . . . 75.02 110.885 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 178.25 4.74 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.739 2.293 . . . . 73.54 112.298 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -109.9 -55.53 2.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 71.2 110.926 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.02 75.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 73.3 110.906 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.61 -22.22 6.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 74.43 112.481 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -137.98 171.89 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 75.45 110.906 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . 0.56 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 18.9 m95 -93.58 98.44 11.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.922 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -99.97 150.67 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.05 111.132 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -146.1 147.41 31.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 63.34 110.935 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.29 127.46 22.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 74.11 110.869 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -98.6 -179.55 4.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 73.21 110.871 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.59 16.17 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 73.35 110.879 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -133.43 6.93 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 75.43 110.871 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.68 103.28 15.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 75.02 111.09 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.61 83.01 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 75.12 111.057 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.465 ' CD1' HG23 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -122.38 171.6 8.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 75.41 110.917 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -158.45 141.62 14.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 72.23 110.888 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.537 ' C ' ' O ' ' A' ' 68' ' ' LYS . 5.2 mm -26.0 117.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 74.12 111.168 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.31 -17.15 10.54 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.803 -0.713 . . . . 63.04 112.507 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.83 -167.98 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 73.43 110.892 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -151.52 165.56 33.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.34 110.918 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.8 mt -141.26 151.12 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 74.01 111.143 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.28 101.1 2.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.25 110.87 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CB ' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -160.1 -166.35 1.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.872 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.4 148.64 32.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 74.13 110.902 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 p -115.07 155.61 26.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.431 . . . . 75.42 111.173 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.02 142.97 49.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 74.11 110.877 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.486 HG12 ' CE2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -142.68 170.72 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 72.53 111.098 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.5 mt -146.5 96.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 74.4 111.151 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.422 ' HG3' ' C ' ' A' ' 24' ' ' GLY . 1.6 tttt -114.15 141.58 47.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.41 110.947 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 49.14 32.44 4.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 72.15 110.852 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.08 30.11 60.27 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 75.24 112.476 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -96.85 -63.6 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 65.05 110.923 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.09 106.11 3.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 72.22 112.452 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -119.47 171.72 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 75.33 110.875 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 6.8 ttp-105 -171.33 131.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 75.01 110.895 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -74.08 158.93 33.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 72.13 110.923 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.4 OUTLIER -140.83 -164.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.869 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.2 t-20 83.75 -42.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.23 110.907 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.52 70.48 0.75 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 64.51 112.473 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -170.02 117.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 73.34 110.895 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -155.23 118.65 4.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 74.14 110.942 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.8 m -87.6 132.04 34.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 72.53 111.147 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.465 HG23 ' CD1' ' A' ' 67' ' ' LEU . 32.8 t -67.29 112.3 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 74.52 111.159 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -129.42 10.92 5.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 73.2 110.897 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -122.65 -177.0 15.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 72.22 112.473 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.445 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -154.04 155.76 36.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.372 . . . . 72.43 110.861 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.48 -176.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 72.23 111.153 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -151.95 132.57 13.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 60.53 110.829 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -102.93 46.14 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 73.25 110.897 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 64.24 111.078 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.879 0.371 . . . . 72.34 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -141.78 85.86 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.081 -0.509 . . . . 74.22 110.898 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.67 141.06 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 64.11 111.07 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.26 24.92 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 73.1 112.333 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.404 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 53.6 Cg_endo -69.79 134.19 27.32 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.686 2.257 . . . . 74.45 112.342 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.444 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . . . -81.55 136.02 35.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 71.22 111.112 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.4 m -95.6 77.57 3.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 74.01 111.107 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -79.42 110.17 14.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 71.22 110.912 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.423 ' CB ' HG23 ' A' ' 99' ' ' VAL . 12.9 mm-40 -79.8 -165.61 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 64.42 110.903 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -134.95 80.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 73.0 111.103 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.6 mm -70.81 172.5 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 74.15 111.127 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.571 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -53.79 172.37 0.23 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.573 0.702 . . . . 74.13 110.853 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.571 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.79 20.02 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.614 2.209 . . . . 65.24 112.378 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' HIS . 3.8 ptpt -126.78 24.04 6.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 70.02 110.885 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.91 -178.48 30.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 62.12 112.498 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.451 ' C ' HG13 ' A' ' 11' ' ' ILE . 29.1 tp -150.52 164.11 36.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.857 0.361 . . . . 74.33 110.892 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -127.61 137.61 52.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 71.13 110.863 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.8 t -145.6 108.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 72.42 111.11 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.5 t -122.3 156.45 33.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 73.34 110.919 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.572 HG23 ' CZ ' ' A' ' 28' ' ' PHE . 10.4 m -141.36 150.86 59.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.633 0.73 . . . . 73.04 111.117 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 122.27 8.95 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.725 2.283 . . . . 73.25 112.348 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.54 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 15.0 t70 -83.81 128.74 34.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.1 110.844 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -117.97 2.21 12.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 72.43 110.916 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.27 31.08 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 62.53 112.452 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.495 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 63.3 m-85 -82.27 160.9 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 74.35 110.897 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.7 t -126.48 -13.52 6.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 70.24 110.856 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.556 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -153.64 140.17 18.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 75.02 110.959 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.572 ' CZ ' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -133.75 143.72 48.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 73.52 110.861 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.03 129.35 43.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 74.51 111.171 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -115.24 120.62 40.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.941 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.487 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 11.4 m-70 -151.58 91.07 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 74.45 110.864 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.482 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -145.96 -177.6 20.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.777 -0.725 . . . . 73.52 112.484 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.417 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.3 OUTLIER -135.3 -166.44 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 74.44 110.847 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' ASN . 9.5 tp -128.07 147.35 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 64.15 110.886 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 34' ' ' LEU . 1.7 m-80 36.47 34.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 74.25 110.929 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 34' ' ' LEU . 1.2 tp10 -163.43 129.16 3.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 65.13 110.922 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -102.74 150.21 23.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 72.04 110.87 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.35 -174.47 2.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 64.35 110.898 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -146.04 146.65 31.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 64.52 110.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 65.14 36.48 92.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.736 . . . . 54.54 112.476 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.508 HD23 ' CD2' ' A' ' 76' ' ' TRP . 5.6 mt 36.88 81.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 74.3 110.958 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -123.32 171.68 9.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 72.24 110.818 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.31 98.63 6.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 70.24 111.127 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.83 -115.16 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.721 -0.752 . . . . 74.21 112.435 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -103.27 -53.32 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 74.21 110.861 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.9 m-90 -73.25 147.47 44.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.219 -0.446 . . . . 70.12 110.881 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.487 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 87.2 p -151.27 119.01 6.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 72.14 110.88 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.92 163.12 4.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 71.34 110.889 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -142.82 119.37 11.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 55.23 110.88 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 28' ' ' PHE . 5.5 mm -86.17 109.98 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 75.34 111.138 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 p -94.79 28.01 2.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 72.4 111.174 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt 171.22 135.66 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.562 0.696 . . . . 73.44 110.908 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -175.57 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.679 2.253 . . . . 74.34 112.399 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 1.2 ttmm -157.16 109.57 2.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 62.15 110.867 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 3.6 t-20 82.68 15.14 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 75.41 110.855 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.67 -17.5 49.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 73.11 112.444 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.86 160.4 37.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 74.23 110.865 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.54 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 20.1 m95 -84.69 94.17 8.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 73.05 110.946 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 21.7 mt -97.72 143.12 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 74.44 111.102 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -138.55 153.52 48.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 75.44 110.864 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.99 137.41 26.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 75.14 110.873 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.433 ' OD2' ' CG ' ' A' ' 64' ' ' ASN . 1.1 t70 -112.19 -177.67 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.894 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -143.49 10.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 74.3 110.85 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.433 ' CG ' ' OD2' ' A' ' 62' ' ' ASP . 22.1 p30 -127.28 9.87 6.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 73.22 110.844 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.24 101.06 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.35 111.085 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.85 88.74 3.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 64.54 111.162 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.417 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -136.33 171.22 14.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 74.53 110.951 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.475 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -155.29 154.48 32.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 70.44 110.906 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.616 ' CG1' ' CE2' ' A' ' 98' ' ' PHE . 16.2 mm -32.14 115.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 75.2 111.106 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.8 -20.53 6.4 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.686 -0.769 . . . . 63.3 112.455 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.69 -173.75 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.881 0.372 . . . . 75.32 110.849 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.5 mttt -149.56 159.68 44.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.45 110.894 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.4 mt -134.26 148.1 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 74.4 111.113 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -147.75 105.55 3.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 74.34 110.938 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.482 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 2.3 p90 -163.68 -159.44 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 74.23 110.855 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.508 ' CD2' HD23 ' A' ' 41' ' ' LEU . 1.9 p-90 -145.44 168.58 20.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 74.32 110.92 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -139.92 147.59 40.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 73.32 111.152 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -112.92 141.01 47.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 75.53 110.884 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.69 171.2 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.14 111.112 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 97.4 mt -150.24 96.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 74.51 111.111 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.51 135.85 53.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.89 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 48.43 33.37 3.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 64.35 110.897 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.69 31.0 63.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 71.42 112.524 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.7 mt -95.19 -56.54 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.882 0.372 . . . . 75.54 110.921 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.14 113.93 2.92 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 52.2 112.462 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -133.4 170.67 15.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 75.03 110.9 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -170.86 137.82 1.29 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 73.51 110.919 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.41 ' N ' ' HG2' ' A' ' 87' ' ' ARG . 1.5 tp60 -85.75 152.22 23.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 72.34 110.898 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -134.35 -166.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.828 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 82.92 -36.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.86 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 43.47 80.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 65.3 112.469 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -168.74 113.43 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 74.1 110.91 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -151.09 121.56 7.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.187 -0.46 . . . . 72.3 110.9 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.4 m -92.96 134.56 34.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 64.42 111.143 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.472 ' CG1' ' HB3' ' A' ' 10' ' ' ALA . 21.4 t -63.61 121.24 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 63.35 111.145 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.1 34.05 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 74.52 110.891 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -162.9 125.52 1.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.7 -0.762 . . . . 74.4 112.509 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.616 ' CE2' ' CG1' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -94.92 163.89 13.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 75.2 110.886 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.423 HG23 ' CB ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -164.48 167.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 74.13 111.13 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.34 130.31 50.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 64.43 110.876 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.36 57.07 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.51 110.862 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 72.22 111.121 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.851 0.358 . . . . 73.11 110.921 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -143.01 76.51 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 73.41 110.899 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.06 147.25 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.541 0.686 . . . . 74.24 111.156 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.7 Cg_endo -69.75 166.01 29.03 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.65 2.233 . . . . 75.25 112.37 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 134.25 27.39 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.667 2.245 . . . . 75.0 112.327 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.01 140.41 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 61.54 111.086 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -97.1 78.7 2.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 75.52 111.146 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mp -76.15 110.79 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 73.52 110.938 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 98' ' ' PHE . 4.8 mm-40 -84.5 -168.54 2.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 75.32 110.848 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -134.57 80.54 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 71.54 111.05 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.49 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -72.16 172.2 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 74.24 111.136 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.579 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.07 172.53 0.23 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 75.02 110.825 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.3 Cg_endo -69.8 19.91 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.705 2.27 . . . . 63.1 112.335 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 12' ' ' HIS . 8.1 pttt -127.18 25.14 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 73.31 110.862 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.58 -179.23 30.06 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.775 -0.726 . . . . 72.4 112.482 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.454 ' C ' HG13 ' A' ' 11' ' ' ILE . 17.7 tp -150.35 164.49 35.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 74.35 110.931 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.1 ttt-85 -126.19 141.89 51.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 75.33 110.9 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -152.11 102.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 64.21 111.113 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -115.22 157.08 24.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 73.22 110.83 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.5 m -139.94 151.64 65.86 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 71.31 111.148 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 53.9 Cg_endo -69.74 125.26 11.95 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.719 2.279 . . . . 74.52 112.366 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.414 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 20.1 t0 -87.33 83.72 7.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 50.04 110.868 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -70.96 -0.27 8.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 73.41 110.899 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.5 28.7 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 75.12 112.489 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -77.18 166.87 22.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.868 0.365 . . . . 75.22 110.906 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.5 t -124.64 -15.26 6.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 73.33 110.836 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.548 ' CD2' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -157.0 136.9 12.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 75.4 110.965 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.629 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 7.6 t80 -131.06 148.09 52.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 75.32 110.881 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.25 157.7 45.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 74.24 111.091 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.629 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.5 m-85 -130.96 127.28 38.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 75.14 110.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -153.27 85.76 1.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 75.02 110.877 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.513 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.15 173.84 26.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 61.51 112.488 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.32 -164.57 1.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 73.11 110.942 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 tp -134.01 145.3 49.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 75.21 110.916 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 47.57 28.88 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 62.32 110.914 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -168.32 134.64 1.94 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.31 110.922 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -108.49 160.18 16.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 72.14 110.852 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.462 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -103.03 -173.77 2.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 75.31 110.843 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -146.11 145.87 30.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 65.52 110.925 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.39 21.9 74.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.748 . . . . 73.32 112.487 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.477 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.2 OUTLIER 50.81 86.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.794 0.33 . . . . 70.2 110.958 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -129.37 -171.47 2.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.02 110.867 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -92.31 105.19 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 71.22 111.096 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.459 ' CA ' ' HE3' ' A' ' 38' ' ' MET . . . -60.19 -121.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.702 -0.761 . . . . 70.41 112.505 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.68 -65.27 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.742 0.305 . . . . 64.0 110.861 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -60.64 139.37 57.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 71.2 110.954 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.5 p -139.64 115.55 10.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.811 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.457 ' CD ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -155.76 154.75 31.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.487 . . . . 65.15 110.87 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.34 109.63 5.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.01 110.859 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.457 HD13 ' CD ' ' A' ' 48' ' ' ARG . 12.8 mm -92.64 125.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 72.51 111.094 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 55.6 p -111.06 33.85 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 65.12 111.141 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 51' ' ' THR . 3.2 tttt 163.45 131.78 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 74.14 110.906 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -176.0 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.698 2.266 . . . . 63.31 112.363 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.04 -35.98 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 72.51 110.881 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' NH1' ' A' ' 57' ' ' ARG . 1.9 m120 -128.0 38.24 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 75.45 110.899 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.42 -27.86 8.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.685 -0.769 . . . . 74.42 112.548 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -125.2 173.51 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.348 . . . . 74.44 110.877 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.414 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 12.6 m95 -92.28 94.46 9.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 75.21 110.898 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 56.2 mt -98.24 141.31 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 63.44 111.141 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 19.6 t80 -136.52 153.08 51.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 74.15 110.895 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -143.96 137.28 27.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 75.33 110.883 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.17 178.41 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 71.24 110.9 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.89 10.83 2.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 73.02 110.83 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -125.47 7.38 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 62.42 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.409 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -94.82 103.03 14.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 74.23 111.097 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -102.42 85.21 2.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 72.12 111.105 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.525 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -138.56 170.96 15.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.904 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -156.84 164.56 37.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.885 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.455 ' C ' ' O ' ' A' ' 68' ' ' LYS . 26.4 mm -33.01 122.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.31 111.11 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.4 -29.41 6.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.719 -0.753 . . . . 63.24 112.509 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.36 -176.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.903 0.382 . . . . 73.23 110.86 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -143.6 169.36 17.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 72.14 110.91 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.3 mt -147.84 145.22 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 72.42 111.092 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.462 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.2 m-85 -148.38 105.25 3.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.938 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 2.4 p90 -164.6 -160.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 74.45 110.905 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.477 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -149.05 155.58 40.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.937 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.45 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 5.6 p -124.0 147.37 47.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 71.43 111.163 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.99 151.07 25.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.22 110.879 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -145.48 169.41 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 71.45 111.125 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 69.9 mt -150.26 95.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.44 111.151 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -112.15 136.6 51.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 71.21 110.899 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.35 38.79 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 73.2 110.871 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.9 35.74 59.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 71.34 112.459 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 mt -97.72 -59.19 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 73.41 110.951 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.53 105.87 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 54.22 112.526 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.417 ' C ' HG22 ' A' ' 79' ' ' VAL . 94.5 m-85 -124.21 178.35 5.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.824 0.345 . . . . 75.03 110.957 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -178.42 130.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 75.44 110.903 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -65.29 -171.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 75.43 110.92 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.0 t70 -170.37 -169.8 0.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 62.52 110.841 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.3 t-20 83.01 -36.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 64.12 110.864 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.33 75.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 34.54 112.513 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -168.18 117.49 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.889 0.375 . . . . 73.42 110.9 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -157.06 118.53 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 71.4 110.93 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.415 HG23 ' N ' ' A' ' 95' ' ' VAL . 36.5 m -90.82 142.12 28.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 54.44 111.153 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.415 ' N ' HG23 ' A' ' 94' ' ' THR . 28.2 t -76.35 112.47 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 71.45 111.154 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -131.52 4.7 4.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.24 110.923 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -116.6 -176.53 17.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.777 -0.725 . . . . 62.31 112.492 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.5 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -156.66 159.89 38.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.371 . . . . 74.44 110.896 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.79 -174.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.33 111.101 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.05 137.68 22.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 45.41 110.877 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.27 46.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 74.35 110.892 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 74.34 111.072 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.878 0.37 . . . . 75.41 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -135.86 72.9 1.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 75.41 110.913 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.38 147.32 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 74.02 111.06 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.09 25.41 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.666 2.244 . . . . 74.01 112.33 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 133.47 25.69 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.235 . . . . 65.12 112.34 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.03 136.6 35.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 70.33 111.122 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -92.95 77.72 4.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 64.31 111.141 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mp -78.48 108.68 12.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 63.4 110.927 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 0.7 OUTLIER -82.55 -173.47 4.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 71.45 110.928 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.466 ' HB3' ' CG1' ' A' ' 95' ' ' VAL . . . -129.49 80.75 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 73.32 111.096 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 2.5 mm -71.72 172.68 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 73.14 111.134 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.561 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -53.92 171.63 0.26 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 74.22 110.823 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.561 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.2 Cg_endo -69.79 19.7 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.628 2.219 . . . . 63.44 112.361 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 12' ' ' HIS . 12.6 pttt -125.82 22.1 7.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.861 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.67 -178.98 31.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.757 -0.735 . . . . 73.13 112.506 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.472 ' C ' HG13 ' A' ' 11' ' ' ILE . 19.4 tp -150.46 164.42 35.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 75.24 110.938 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -128.95 136.77 50.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 71.35 110.839 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -146.34 106.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 73.03 111.157 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.0 t -119.68 157.84 27.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 63.31 110.83 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.6 m -140.86 151.53 63.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.735 . . . . 73.13 111.125 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 122.16 8.84 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 61.1 112.325 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -80.51 97.91 7.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.838 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.32 12.42 10.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.931 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.26 15.68 3.7 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.703 -0.761 . . . . 63.11 112.46 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.514 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 87.5 m-85 -66.49 165.56 14.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 74.32 110.865 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 t -125.03 -17.24 5.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 73.0 110.839 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.572 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -153.45 139.67 18.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 75.13 110.903 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.644 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 8.0 t80 -132.0 148.63 52.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 64.54 110.873 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.53 155.12 50.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 73.02 111.152 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.644 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.6 m-85 -127.94 125.51 39.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 72.11 110.871 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.636 ' CE1' ' CB ' ' A' ' 43' ' ' ALA . 4.1 m-70 -149.03 83.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 74.31 110.83 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.527 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.14 173.61 26.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 70.11 112.496 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.6 -164.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 73.44 110.925 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 36' ' ' GLU . 21.9 tp -126.49 147.61 49.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 71.53 110.962 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 34' ' ' LEU . 1.6 m-80 37.04 32.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.86 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 34' ' ' LEU . 64.5 tt0 -161.96 134.36 5.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.925 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -106.51 160.43 15.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.2 110.88 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.43 178.45 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 70.2 110.888 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.46 153.94 48.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 73.14 110.933 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.45 27.06 68.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 73.13 112.502 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.483 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 2.0 mt 45.58 78.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.354 . . . . 71.14 110.91 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -119.0 174.16 6.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 72.34 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.636 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . . . -84.09 103.9 13.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 65.03 111.097 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.45 -121.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.74 . . . . 55.4 112.482 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.67 -68.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.322 . . . . 74.24 110.827 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.594 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 6.0 m0 -58.02 97.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 72.15 110.925 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.8 p -109.17 105.09 14.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 72.33 110.874 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.89 162.8 37.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 75.41 110.868 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -144.6 117.22 8.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.833 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 52' ' ' LYS . 18.4 mm -97.42 113.04 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 73.44 111.163 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.6 p -95.9 30.46 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 75.43 111.17 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.429 ' O ' ' CG2' ' A' ' 50' ' ' ILE . 2.8 tttt 173.99 138.62 0.15 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.721 . . . . 75.52 110.937 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -175.47 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.707 2.271 . . . . 73.43 112.323 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.7 ttmm -118.47 -71.56 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 72.14 110.872 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.07 46.57 2.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.2 110.87 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.67 -35.05 4.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 63.12 112.497 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.78 177.2 6.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 74.23 110.879 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -93.32 98.65 11.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.879 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.9 mt -103.09 141.0 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 73.42 111.147 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -135.64 147.1 48.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.914 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 126.83 29.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.872 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.594 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -104.06 169.81 8.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 74.54 110.916 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.2 mtt180 -136.93 20.3 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.0 110.837 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -133.19 14.55 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 74.51 110.887 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.54 101.86 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 75.1 111.109 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.96 84.23 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 71.23 111.11 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.484 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -135.89 171.17 14.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 75.52 110.879 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.478 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -157.71 158.07 34.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 74.35 110.959 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.6 mm -31.44 116.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 73.01 111.11 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.24 -26.1 5.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 74.21 112.512 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -72.79 -175.62 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 62.25 110.856 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.0 mptt -144.88 163.02 35.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 73.24 110.902 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.466 HG21 ' N ' ' A' ' 74' ' ' TYR . 37.3 mt -138.63 143.59 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.169 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.466 ' N ' HG21 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -145.48 105.27 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.931 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.527 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 3.9 p90 -165.44 -161.38 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 74.13 110.853 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.483 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -145.86 174.06 11.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 73.32 110.877 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 p -141.5 156.45 45.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 72.11 111.137 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.2 137.79 52.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 70.43 110.903 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.514 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -134.19 166.62 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 73.34 111.149 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 91.7 mt -142.44 95.9 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 70.24 111.138 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -116.44 147.51 41.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 74.25 110.919 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.05 27.8 1.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 62.1 110.884 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.77 30.94 70.27 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.734 -0.746 . . . . 63.31 112.464 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.17 -73.14 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.803 0.335 . . . . 73.21 110.93 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.94 117.21 2.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 73.12 112.505 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -128.08 170.76 12.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.95 0.405 . . . . 72.43 110.911 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -159.05 139.0 11.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 75.51 110.884 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -80.78 160.93 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 75.33 110.908 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 6.1 m-20 -145.49 -173.45 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 75.23 110.876 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 85.11 -32.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 64.45 110.894 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 33.47 81.91 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 72.32 112.512 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -172.48 110.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 74.33 110.909 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -153.22 105.89 2.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 74.13 110.943 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.414 HG23 ' N ' ' A' ' 95' ' ' VAL . 89.3 m -76.3 136.39 39.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 74.33 111.122 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' ' 10' ' ' ALA . 45.6 t -64.82 109.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 75.33 111.128 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -128.6 5.2 5.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.89 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -115.64 -178.64 18.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 74.02 112.498 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.443 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -155.96 155.87 33.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 75.31 110.881 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.58 -177.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 74.23 111.142 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -139.45 132.0 28.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 75.44 110.865 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -76.06 54.98 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 72.23 110.913 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 70.13 111.083 179.928 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.846 0.355 . . . . 74.22 110.924 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -142.57 73.84 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.884 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.05 148.43 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.713 . . . . 75.34 111.063 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 169.68 18.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 72.55 112.354 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.417 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 53.7 Cg_endo -69.78 134.79 28.79 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.256 . . . . 72.22 112.362 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.32 137.46 33.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 74.02 111.148 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -96.5 77.43 2.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 74.1 111.141 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.432 HD11 ' CG ' ' A' ' 93' ' ' TRP . 1.9 mp -76.81 110.13 11.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.437 . . . . 75.01 110.953 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 28.9 mp0 -83.01 -173.24 4.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 73.1 110.857 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -131.12 80.29 1.93 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 71.01 111.115 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 2.9 mm -70.23 172.42 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 74.32 111.126 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -53.92 172.04 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.581 0.705 . . . . 75.01 110.841 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.5 Cg_endo -69.77 20.12 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.674 2.249 . . . . 64.31 112.368 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' A' ' 12' ' ' HIS . 39.9 pttt -125.76 21.71 7.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 72.12 110.895 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.4 -178.11 32.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.784 -0.722 . . . . 74.12 112.518 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.465 ' C ' HG13 ' A' ' 11' ' ' ILE . 23.1 tp -150.08 164.57 35.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 71.3 110.862 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.7 ttt180 -130.2 140.59 50.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 70.12 110.901 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 45.0 t -148.58 111.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 74.13 111.084 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 t -122.57 156.17 34.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.85 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.06 152.17 66.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.671 0.748 . . . . 65.44 111.102 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 121.39 8.08 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.672 2.248 . . . . 74.22 112.355 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -76.3 105.89 7.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 61.34 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.47 34.67 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 62.53 110.855 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.66 1.48 52.87 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.731 -0.747 . . . . 71.4 112.494 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.481 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 74.3 m-85 -54.05 164.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 75.12 110.881 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 t -127.08 -11.8 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 75.45 110.885 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.566 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -158.73 138.49 11.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 74.34 110.914 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.668 ' CD2' ' CE1' ' A' ' 30' ' ' PHE . 7.3 t80 -130.89 146.01 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 74.33 110.88 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.421 ' C ' ' CD1' ' A' ' 30' ' ' PHE . . . -129.53 158.39 39.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 72.11 111.071 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.668 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 1.8 m-85 -132.81 127.85 35.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 71.14 110.902 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -157.35 86.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.854 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -144.8 175.02 24.69 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 71.55 112.523 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.29 -166.68 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 63.33 110.919 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.506 ' CD1' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -129.93 124.64 33.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 72.35 110.912 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.506 ' ND2' ' CD1' ' A' ' 34' ' ' LEU . 67.9 m-80 62.05 23.54 13.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 64.24 110.875 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -155.93 144.13 19.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 74.33 110.893 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -112.73 169.05 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 63.51 110.853 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.527 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -116.68 -174.4 2.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 74.23 110.853 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -144.1 147.0 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 73.4 110.905 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.53 31.69 81.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 72.4 112.502 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.431 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 1.9 mt 42.93 86.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 74.32 110.901 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -131.47 175.07 9.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.852 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.46 104.28 14.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 72.01 111.125 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.6 -120.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 53.31 112.514 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.49 -63.09 1.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.343 . . . . 72.5 110.836 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.459 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.4 m-90 -61.15 155.33 20.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 72.2 110.9 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.2 p -158.45 109.53 2.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 75.54 110.867 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.37 160.3 38.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 74.34 110.861 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.09 107.22 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 72.32 110.913 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.1 mm -86.75 106.66 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 74.32 111.137 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.0 p -96.01 29.93 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 74.44 111.145 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -176.85 113.66 0.25 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.628 0.727 . . . . 73.22 110.871 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.516 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 53.9 Cg_endo -69.76 -178.23 2.24 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.677 2.252 . . . . 74.43 112.321 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -174.33 136.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.893 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 2.6 t30 82.48 7.88 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 71.31 110.937 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' CD ' ' A' ' 57' ' ' ARG . . . 100.0 -6.73 58.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 74.01 112.51 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' CD ' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -153.27 174.2 14.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 73.12 110.883 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.516 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 14.6 m95 -90.35 106.24 18.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.935 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.5 146.63 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 74.32 111.13 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -143.43 149.06 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 71.15 110.913 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 133.1 28.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.35 110.883 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.72 -178.49 3.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 64.22 110.855 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.56 20.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.867 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -134.89 14.56 3.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 74.42 110.908 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.36 107.25 18.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 51.52 111.112 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -103.47 79.7 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 75.23 111.069 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.429 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -126.65 171.6 11.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 74.44 110.944 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.501 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -158.09 154.43 27.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 74.14 110.893 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.501 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.7 mm -29.61 123.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 73.53 111.096 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.54 7.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 62.41 112.499 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.444 ' CB ' HG22 ' A' ' 95' ' ' VAL . 2.5 m-20 -70.73 -176.89 1.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.927 0.394 . . . . 74.0 110.808 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -142.2 166.6 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 75.4 110.919 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 87.4 mt -142.96 145.27 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 74.11 111.125 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -147.5 103.32 3.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 75.33 110.937 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.436 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 1.4 p90 -162.29 -162.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 74.15 110.927 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.527 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -150.64 149.77 30.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 75.11 110.896 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.532 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 7.0 p -119.76 145.87 46.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 72.24 111.132 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.448 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -103.84 150.5 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 75.42 110.896 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.481 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -143.28 166.92 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 65.04 111.112 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 85.7 mt -145.61 96.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 73.13 111.143 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.441 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -115.14 137.31 52.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 71.14 110.854 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 42.92 41.16 2.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 65.33 110.897 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.08 37.27 36.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.746 -0.74 . . . . 74.14 112.535 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 mt -98.18 -55.79 2.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 54.15 110.913 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.79 105.23 1.63 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 63.51 112.447 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.427 ' C ' HG21 ' A' ' 79' ' ' VAL . 99.0 m-85 -130.1 176.16 8.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 75.15 110.929 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -176.77 136.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.907 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.417 ' NE2' ' HA ' ' A' ' 5' ' ' PRO . 1.4 tp60 -73.42 163.53 27.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 71.52 110.878 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -145.94 -169.92 3.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.52 110.849 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.6 t-20 83.46 -33.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 73.15 110.884 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.73 84.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 74.12 112.468 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -170.13 116.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.822 0.344 . . . . 53.34 110.888 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.432 ' CG ' HD11 ' A' ' 8' ' ' LEU . 22.8 m-90 -157.84 109.57 2.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.938 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.6 m -81.59 138.91 35.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 73.35 111.138 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.474 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 22.4 t -70.11 110.58 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.43 111.083 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -131.76 4.32 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 71.02 110.887 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.95 -176.39 19.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 61.21 112.51 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.36 155.2 28.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.888 0.375 . . . . 73.33 110.895 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.438 ' CG2' ' CD1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.51 175.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 61.34 111.136 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -139.1 127.64 23.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 75.12 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -80.22 54.6 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 73.44 110.898 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 74.51 111.081 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 4.8 t80 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.859 0.362 . . . . 74.33 110.897 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -140.94 72.57 1.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 70.33 110.899 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.86 144.88 0.11 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.571 0.7 . . . . 61.35 111.069 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 167.61 23.97 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.644 2.229 . . . . 73.22 112.315 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 136.35 32.78 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.685 2.256 . . . . 72.13 112.32 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.65 137.27 32.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 71.42 111.132 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m -95.94 77.07 3.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 72.44 111.153 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 mp -75.71 108.39 8.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 73.53 110.913 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.48 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 10.3 mm-40 -79.93 -172.54 3.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 73.11 110.835 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -129.63 80.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.03 111.104 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.483 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.2 mm -71.01 172.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 72.03 111.152 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.2 OUTLIER -54.2 172.32 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.574 0.702 . . . . 73.42 110.898 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.74 20.39 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.664 2.243 . . . . 75.25 112.347 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 12' ' ' HIS . 1.8 pttt -125.58 22.26 7.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 72.42 110.864 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.49 -177.42 31.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.697 -0.763 . . . . 65.14 112.464 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.475 ' C ' HG13 ' A' ' 11' ' ' ILE . 20.7 tp -149.47 161.73 41.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 74.44 110.93 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.436 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 18.0 ttm180 -125.51 137.8 53.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 73.43 110.862 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.0 t -147.69 110.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 73.41 111.122 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.0 t -120.32 154.28 35.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 75.01 110.882 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.572 HG23 ' CZ ' ' A' ' 28' ' ' PHE . 34.1 m -141.64 152.65 63.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.639 0.733 . . . . 74.32 111.116 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 122.09 8.77 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.664 2.243 . . . . 65.24 112.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 1.1 t70 -76.99 107.56 9.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 73.35 110.874 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.44 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -95.21 30.01 2.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.9 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.6 20.9 27.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 75.41 112.495 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 94.9 m-85 -68.13 167.56 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 74.14 110.888 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.8 t -128.95 -8.5 4.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.35 110.851 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.57 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -156.02 143.07 19.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 75.24 110.967 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.572 ' CZ ' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -139.68 148.4 42.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.1 110.878 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.0 136.64 35.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.34 111.102 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -118.52 120.54 37.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.907 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -148.85 92.05 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 73.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.11 172.06 26.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 73.34 112.46 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.34 -164.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 74.35 110.885 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 tp -136.21 142.49 44.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 73.01 110.925 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 54.22 25.38 5.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.866 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -167.53 141.22 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.932 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -113.63 160.52 18.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 70.13 110.887 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.559 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -108.2 -173.87 2.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 73.33 110.901 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.79 146.2 43.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 74.53 110.878 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.511 ' O ' ' CH2' ' A' ' 76' ' ' TRP . . . 51.65 -96.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 64.21 112.482 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.52 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.7 OUTLIER -161.9 88.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.346 . . . . 73.42 110.887 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -126.15 174.3 8.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 75.12 110.909 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.95 103.44 15.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 75.3 111.101 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.74 -111.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 73.22 112.487 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.32 -63.31 1.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 72.04 110.873 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.7 m0 -66.51 146.95 53.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 75.21 110.904 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.3 p -146.51 112.27 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 73.43 110.862 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.14 162.14 41.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.23 110.877 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.48 117.35 8.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.24 110.889 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -98.97 107.12 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 75.4 111.127 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 60.7 p -101.01 32.4 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 75.34 111.136 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 51' ' ' THR . 14.6 mttt 164.32 135.83 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 73.23 110.919 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -175.65 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.732 2.288 . . . . 60.12 112.34 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.06 14.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.14 110.896 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -179.35 33.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 75.14 110.895 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' HG3' ' A' ' 57' ' ' ARG . . . 87.94 -17.13 48.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 70.24 112.468 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' HG3' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -136.57 167.62 21.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 74.14 110.893 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.493 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 11.2 m95 -92.61 92.82 8.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 71.22 110.856 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.0 mt -95.76 138.48 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 75.54 111.14 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -126.77 148.68 49.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.881 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 135.07 27.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.873 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -113.76 177.22 4.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 65.13 110.853 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.84 12.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.835 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.62 5.73 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 71.2 110.936 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.81 101.95 14.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 54.4 111.1 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.96 86.67 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 63.21 111.124 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -137.42 170.79 15.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 64.12 110.912 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.526 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -154.82 158.35 39.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.852 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.475 ' C ' ' O ' ' A' ' 68' ' ' LYS . 10.3 mm -30.93 124.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 75.32 111.137 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.14 -30.04 6.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.744 -0.741 . . . . 53.2 112.515 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.29 -171.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 52.45 110.87 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.8 mptt -150.03 159.27 44.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.03 110.926 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 97.5 mt -133.15 147.39 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 75.41 111.133 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -148.98 103.09 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 75.45 110.905 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.424 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 1.1 p90 -162.35 -161.46 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.497 . . . . 75.32 110.874 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.559 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -150.72 144.89 25.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.926 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.498 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 3.3 p -112.83 151.85 29.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 73.33 111.14 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.12 144.89 46.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 71.45 110.897 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.557 HG11 ' CE2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -144.52 172.68 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 64.41 111.133 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 84.1 mt -148.14 96.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 61.33 111.14 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.565 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -113.44 138.33 50.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 73.45 110.86 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 43.01 38.9 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 72.12 110.906 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.91 37.88 45.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.723 -0.751 . . . . 54.33 112.463 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.64 -53.13 3.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 73.15 110.942 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 104.68 1.68 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 71.41 112.494 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -124.8 166.03 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.382 . . . . 75.32 110.926 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.498 ' CG ' ' O ' ' A' ' 77' ' ' THR . 7.1 ttp180 -174.15 136.56 0.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 75.34 110.85 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -75.65 168.78 19.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.906 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.7 t0 -152.94 -176.3 5.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.896 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 83.82 -26.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.34 110.886 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 34.74 87.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 71.43 112.493 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -172.01 110.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.845 0.355 . . . . 72.31 110.91 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -150.63 115.91 5.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 72.14 110.896 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 92.6 m -87.04 136.19 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 64.5 111.138 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.409 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 45.4 t -67.58 118.36 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 75.24 111.099 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -134.16 0.89 3.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 74.54 110.884 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -117.75 -177.74 17.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 71.41 112.468 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.457 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -154.78 155.69 34.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 71.14 110.891 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.48 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.79 169.81 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 72.45 111.155 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.502 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -132.42 139.77 48.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 65.2 110.889 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.53 45.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 65.22 110.907 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.502 ' N ' ' OD1' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 71.32 111.111 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.835 0.35 . . . . 74.24 110.956 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -140.54 91.75 2.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 71.53 110.883 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.7 145.63 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.566 0.698 . . . . 73.54 111.097 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 164.36 34.81 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.743 2.295 . . . . 73.24 112.314 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 134.34 27.62 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.674 2.249 . . . . 73.41 112.313 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -84.38 139.6 32.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 71.02 111.105 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.6 m -92.72 77.44 4.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 75.41 111.165 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 mp -78.34 111.76 14.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 72.05 110.92 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.417 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 4.3 mm-40 -86.7 -158.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.23 110.903 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -143.08 81.2 1.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 71.21 111.096 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 6.6 mm -71.0 172.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 75.31 111.143 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.581 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.08 172.2 0.24 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.595 0.712 . . . . 64.34 110.832 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.4 Cg_endo -69.76 20.31 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.681 2.254 . . . . 73.4 112.339 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 12' ' ' HIS . 42.3 pttt -130.08 27.8 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 71.35 110.908 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.66 -178.84 30.4 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 73.4 112.442 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.436 ' C ' HG13 ' A' ' 11' ' ' ILE . 19.3 tp -152.83 166.22 32.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 74.44 110.896 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -130.31 141.39 50.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.875 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.3 t -153.12 103.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.33 111.138 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.4 t -114.93 159.82 20.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.1 110.858 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m -139.55 151.63 66.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.604 0.716 . . . . 71.33 111.17 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 121.99 8.69 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.671 2.247 . . . . 72.15 112.338 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -80.19 101.33 8.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 73.42 110.871 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -96.01 28.13 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 71.31 110.864 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.27 16.51 13.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.762 -0.732 . . . . 73.23 112.533 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.508 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 92.1 m-85 -67.08 164.82 17.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 71.52 110.929 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.6 t -127.98 -9.55 5.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.87 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.546 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -158.97 139.97 12.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 74.13 110.894 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.544 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 19.3 t80 -134.16 152.49 51.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.32 110.881 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.35 163.29 30.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 74.22 111.104 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.5 t80 -148.22 113.28 5.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 74.22 110.856 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.571 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -147.28 95.15 2.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 73.54 110.859 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.46 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.09 -174.14 17.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.729 -0.748 . . . . 63.1 112.509 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.408 ' O ' ' CZ3' ' A' ' 46' ' ' TRP . 3.0 mtpp -134.74 -164.27 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 73.22 110.911 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.503 ' HG ' ' ND2' ' A' ' 35' ' ' ASN . 1.7 tp -140.24 140.18 35.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 72.52 110.889 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.503 ' ND2' ' HG ' ' A' ' 34' ' ' LEU . 3.1 m120 51.26 21.59 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.21 110.848 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -156.39 123.51 5.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 74.23 110.877 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -94.86 140.66 29.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 73.23 110.884 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.2 ptp -96.46 -174.49 3.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 75.34 110.879 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -149.67 157.33 43.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.15 110.848 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 57.23 35.91 72.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.716 . . . . 55.13 112.518 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 40' ' ' GLY . 4.0 mt 35.85 83.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.762 0.315 . . . . 70.03 110.889 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -124.92 169.69 11.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 75.01 110.861 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . . . -79.1 98.23 6.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 72.51 111.082 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.95 -115.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.776 -0.726 . . . . 73.31 112.493 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -104.24 -62.72 1.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.733 0.302 . . . . 71.33 110.885 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.514 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 9.1 m0 -60.87 155.09 20.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 74.44 110.926 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.571 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 53.1 p -160.99 114.43 2.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 74.41 110.879 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -156.76 149.24 23.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 63.51 110.842 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -139.5 102.32 4.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.887 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.7 mm -90.26 117.77 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.41 111.098 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.415 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 17.2 p -103.34 34.34 2.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 74.42 111.163 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' CB ' ' O ' ' A' ' 51' ' ' THR . 3.3 mtpt 167.07 137.46 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.55 0.691 . . . . 72.01 110.865 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -175.6 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.66 2.24 . . . . 74.52 112.358 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -139.39 -35.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.859 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.418 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 1.4 t30 -137.25 51.76 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.43 110.906 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.18 -29.43 4.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 52.42 112.513 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.92 171.23 11.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 74.23 110.846 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.416 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 6.0 m95 -90.12 89.73 7.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 75.43 110.957 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.3 mt -92.47 138.14 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 72.52 111.117 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -132.35 146.61 52.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.41 110.892 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.84 127.55 23.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.903 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -99.78 -178.46 3.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.92 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.38 26.4 1.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 74.01 110.9 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -149.44 28.24 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 72.23 110.865 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.52 84.92 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 43.25 111.137 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.09 93.76 7.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 74.42 111.092 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -148.33 169.33 20.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.03 110.948 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.04 164.55 38.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.939 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.558 HG12 ' CD2' ' A' ' 98' ' ' PHE . 9.4 mm -34.78 118.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 75.34 111.147 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.22 -28.92 5.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.769 -0.729 . . . . 61.41 112.485 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.96 -178.16 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 73.01 110.865 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.2 mttt -141.22 167.66 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.2 110.885 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 74' ' ' TYR . 67.3 mt -144.85 149.37 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 72.42 111.116 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.474 ' N ' HG23 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -151.96 108.54 3.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 75.43 110.902 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.46 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -165.72 -168.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 75.34 110.88 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.6 p-90 -135.28 162.75 31.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 72.43 110.94 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.6 p -134.89 146.4 49.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 74.32 111.126 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.46 149.01 28.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.872 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.411 HG21 ' C ' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -148.94 165.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 75.42 111.157 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.1 mt -148.38 96.24 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.33 111.151 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.508 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 23.5 tttt -113.18 138.43 49.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 73.02 110.857 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.82 28.89 3.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 75.33 110.866 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.71 27.5 66.53 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 72.12 112.491 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.65 -50.97 4.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 74.42 110.906 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.56 125.85 3.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 74.21 112.492 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.411 ' C ' HG21 ' A' ' 79' ' ' VAL . 95.6 m-85 -143.07 -179.67 6.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 75.32 110.923 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 77' ' ' THR . 1.2 ttp180 -177.46 136.48 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 72.13 110.911 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -78.21 166.02 23.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 74.03 110.925 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.1 t0 -147.22 -165.86 2.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 74.22 110.852 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 2.5 t-20 83.59 -33.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 53.13 110.895 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 39.04 74.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.746 . . . . 41.53 112.484 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -167.7 112.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 61.33 110.867 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -152.33 122.57 7.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 73.01 110.945 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.1 m -94.08 145.23 24.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 74.44 111.16 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.467 HG13 ' CB ' ' A' ' 10' ' ' ALA . 62.7 t -75.24 129.7 36.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 75.02 111.124 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -154.79 23.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.05 110.888 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -155.62 111.28 0.48 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.786 -0.721 . . . . 73.42 112.499 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -82.34 170.39 15.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 75.44 110.871 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.45 HG23 ' C ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -167.34 -178.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.33 111.137 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.26 139.1 37.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.472 . . . . 74.41 110.857 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -87.2 44.71 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 72.42 110.845 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.089 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 18.7 t80 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.817 0.341 . . . . 65.43 110.955 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -158.9 85.2 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 74.41 110.903 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.66 142.42 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.574 0.702 . . . . 75.4 111.109 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 161.01 47.58 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.733 2.288 . . . . 74.2 112.313 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 134.84 28.95 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.709 2.273 . . . . 74.32 112.342 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.401 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . . . -90.52 139.68 30.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 72.33 111.061 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.5 m -93.16 77.3 4.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 73.51 111.113 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.11 107.38 10.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 73.24 110.913 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -80.92 -156.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 71.15 110.935 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -143.1 80.21 1.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 72.52 111.082 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.491 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 4.1 mm -70.64 172.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.32 111.079 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -54.19 172.0 0.25 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 73.4 110.835 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.9 Cg_endo -69.77 21.05 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.661 2.241 . . . . 73.43 112.336 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.521 ' H ' ' C ' ' A' ' 12' ' ' HIS . 10.6 ptmt -126.79 20.71 7.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.907 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.64 -176.81 33.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 75.34 112.514 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' C ' HG13 ' A' ' 11' ' ' ILE . 22.2 tp -151.13 163.57 38.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 74.24 110.924 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -126.77 137.32 53.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.23 110.861 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 69.7 t -148.26 102.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 70.33 111.091 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 t -114.49 157.07 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 74.31 110.902 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.575 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 17.8 m -140.81 151.51 63.11 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.616 0.722 . . . . 75.24 111.077 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 123.37 10.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.639 2.226 . . . . 73.5 112.327 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.565 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 4.7 t70 -79.94 133.38 36.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 72.35 110.885 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -123.88 12.86 9.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.838 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.68 4.94 8.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 74.44 112.42 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 68.5 m-85 -54.28 163.02 0.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 70.23 110.878 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.9 t -130.01 -7.67 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.869 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.582 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -157.3 143.71 18.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 70.12 110.966 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -139.59 143.65 37.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 64.21 110.889 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.91 123.03 22.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 71.02 111.12 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -109.84 113.98 27.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 74.02 110.863 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.512 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -142.27 95.29 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 74.44 110.879 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.507 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -146.31 -178.55 21.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 73.12 112.477 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.0 -168.27 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.341 . . . . 74.24 110.881 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.449 ' HG ' ' CG ' ' A' ' 35' ' ' ASN . 4.4 tp -134.85 146.73 49.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 62.11 110.906 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.449 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 2.4 m120 42.73 27.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.883 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -159.46 130.39 5.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 55.14 110.857 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -97.23 144.13 27.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 72.34 110.886 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.1 ptp -94.24 -174.89 3.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 71.05 110.918 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 41' ' ' LEU . 1.2 tt0 -98.32 126.69 43.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 73.41 110.91 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.05 -91.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 75.41 112.546 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 39' ' ' GLU . 0.8 OUTLIER -154.84 89.68 1.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.779 0.323 . . . . 74.42 110.94 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -130.32 -175.73 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 74.35 110.852 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.512 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -85.83 100.45 12.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 72.53 111.112 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 -118.18 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 30.3 112.498 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.38 -60.95 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 74.23 110.86 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.462 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 7.4 m0 -60.28 165.91 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 73.43 110.91 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.473 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 6.9 t -164.38 122.34 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 72.54 110.863 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.476 ' HG3' ' N ' ' A' ' 49' ' ' ASP . 3.2 tpm_? -159.67 145.02 15.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 75.51 110.877 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' N ' ' HG3' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -130.75 82.41 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 71.34 110.831 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 28' ' ' PHE . 2.7 mm -71.92 110.72 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 74.45 111.162 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.458 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 82.4 p -104.69 34.05 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 71.32 111.136 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 51' ' ' THR . 37.7 tttt 163.97 137.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.546 0.688 . . . . 74.41 110.925 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -175.87 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.715 2.277 . . . . 73.44 112.324 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HZ3' ' NE ' ' A' ' 61' ' ' ARG . 0.9 OUTLIER -134.25 -34.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.31 110.9 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -139.85 51.66 1.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 63.11 110.895 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.07 -27.78 4.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.75 -0.738 . . . . 63.34 112.482 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 169.27 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.331 . . . . 75.14 110.867 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.565 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 10.7 m95 -92.09 90.79 7.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 74.11 110.919 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.0 mt -96.17 138.2 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 75.15 111.178 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -130.34 151.98 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 72.53 110.873 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.448 ' NE ' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -142.27 135.44 28.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.55 110.891 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.6 OUTLIER -108.53 -179.41 3.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 63.4 110.895 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -145.26 11.67 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 70.4 110.866 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -129.84 12.31 5.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 62.33 110.874 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.32 94.84 6.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.23 111.072 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -94.35 75.33 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 72.14 111.089 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -123.81 171.36 9.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 75.12 110.91 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.486 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -158.16 156.7 31.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 73.55 110.873 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.486 ' C ' ' O ' ' A' ' 68' ' ' LYS . 18.0 mm -30.34 121.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 64.01 111.135 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.33 -29.46 6.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 74.33 112.48 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.41 -179.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 74.31 110.856 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 1.1 mtmt -144.85 153.71 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 75.52 110.923 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.476 HG21 ' N ' ' A' ' 74' ' ' TYR . 9.1 mt -128.43 141.25 47.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 74.53 111.145 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -140.96 99.08 3.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 74.51 110.968 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.507 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -159.85 -160.07 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 74.1 110.822 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -148.29 177.7 9.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 73.03 110.911 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -144.45 153.95 42.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 64.51 111.149 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -118.23 136.44 53.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 54.44 110.899 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.77 167.58 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 74.3 111.101 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.4 mt -146.01 96.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 75.44 111.116 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 18.6 tttt -114.27 141.43 47.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.35 110.898 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 2.5 m-20 44.91 38.23 2.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 73.3 110.874 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.52 35.35 44.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 74.21 112.481 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.9 mt -100.51 -71.25 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.876 0.369 . . . . 74.32 110.947 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.49 106.41 2.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 74.32 112.487 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -120.57 171.84 8.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 75.23 110.909 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.4 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 9.5 ttm180 -174.38 138.47 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 73.15 110.86 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.4 ' N ' ' HG2' ' A' ' 87' ' ' ARG . 6.3 tp60 -85.98 153.71 21.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 74.3 110.885 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -136.82 -163.18 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 65.34 110.903 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.2 t-20 82.23 -39.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 74.31 110.89 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.57 76.44 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 75.14 112.454 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -172.8 113.22 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 74.4 110.862 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -152.43 110.88 3.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.103 -0.499 . . . . 64.23 110.922 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 97.1 m -82.37 136.16 35.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 70.3 111.149 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 39.3 t -67.27 110.32 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 70.13 111.135 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -128.94 17.82 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.04 110.911 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -133.92 -178.26 15.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 71.34 112.475 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.424 ' C ' HG22 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -152.8 157.57 40.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.362 . . . . 73.54 110.894 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.424 HG22 ' C ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -165.81 164.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 75.2 111.143 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -129.81 131.08 46.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 75.13 110.858 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -85.68 51.43 2.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 65.5 111.116 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.885 0.374 . . . . 74.55 110.907 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -128.96 76.61 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 72.13 110.84 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.2 140.53 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.589 0.709 . . . . 63.23 111.085 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 167.39 24.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.715 2.277 . . . . 73.32 112.312 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 133.99 27.02 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.645 2.23 . . . . 75.34 112.361 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.51 137.83 32.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 74.03 111.105 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -93.99 77.15 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 74.31 111.159 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.4 107.98 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 73.44 110.906 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.475 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 43.9 mm-40 -80.34 -173.28 3.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 74.23 110.892 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -129.76 81.49 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 65.44 111.094 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.2 mm -72.01 172.49 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 74.21 111.146 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.569 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.16 172.03 0.25 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.584 0.707 . . . . 74.2 110.897 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.3 Cg_endo -69.72 20.15 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.639 2.226 . . . . 73.42 112.35 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.0 OUTLIER -125.92 21.71 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 74.54 110.943 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.38 -178.02 32.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 71.43 112.481 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.475 ' C ' HG13 ' A' ' 11' ' ' ILE . 21.9 tp -150.24 167.74 26.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 62.11 110.961 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -132.83 139.24 47.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 75.23 110.857 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.4 t -148.52 108.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 74.41 111.125 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.402 ' C ' HG13 ' A' ' 20' ' ' VAL . 26.2 t -119.85 157.94 27.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 63.12 110.857 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.402 HG13 ' C ' ' A' ' 19' ' ' SER . 17.2 m -139.99 149.35 58.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 74.41 111.149 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 122.19 8.87 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.707 2.271 . . . . 72.42 112.354 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 22.8 t70 -88.45 97.26 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.86 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.75 0.21 40.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 73.11 110.879 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 138.41 30.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 74.01 112.47 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.566 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 82.2 m-85 -82.28 167.96 18.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.804 0.335 . . . . 75.41 110.936 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.5 t -127.19 -10.89 5.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 74.13 110.846 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -153.32 142.72 21.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.44 110.916 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.541 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 18.3 t80 -139.13 144.32 38.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 75.51 110.93 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.69 163.68 23.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 72.54 111.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.4 t80 -151.04 114.42 4.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.89 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.542 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -147.57 95.26 2.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 73.43 110.859 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.426 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.07 -174.27 18.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 75.42 112.466 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.447 ' CE ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -135.92 -165.45 1.71 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.792 0.33 . . . . 74.31 110.863 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' CD1' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -132.36 127.24 35.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 74.51 110.935 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.478 ' ND2' ' CD1' ' A' ' 34' ' ' LEU . 67.2 m-80 56.45 34.13 23.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.866 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.447 ' HG2' ' CE ' ' A' ' 33' ' ' LYS . 5.6 tp10 -155.56 131.52 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 73.24 110.903 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -98.59 140.65 32.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 74.41 110.856 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 1.3 mtt -83.49 -178.4 7.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 75.11 110.873 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.2 124.51 13.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 74.24 110.854 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.32 40.63 96.64 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 74.24 112.498 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mt 41.38 88.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 75.45 110.918 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.7 -177.84 4.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.452 . . . . 71.45 110.887 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.416 ' HB1' ' NE2' ' A' ' 31' ' ' HIS . . . -87.2 102.14 14.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 71.24 111.112 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.454 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . -60.4 -120.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.7 -0.762 . . . . 61.15 112.501 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.9 -55.3 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.831 0.348 . . . . 72.34 110.89 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.542 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 6.5 m0 -68.4 173.16 5.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 75.23 110.91 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.518 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 95.3 p -176.84 118.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 73.54 110.851 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.456 ' CD ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -164.39 162.2 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.4 110.848 -179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -144.46 106.55 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 75.41 110.883 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.482 ' N ' ' O ' ' A' ' 28' ' ' PHE . 36.5 mm -90.27 105.13 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 72.32 111.121 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.3 p -102.42 34.42 2.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 45.3 111.156 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.5 124.53 0.11 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.593 0.711 . . . . 74.21 110.857 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 165.6 30.46 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.267 . . . . 75.44 112.346 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.93 -17.7 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 73.45 110.882 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -149.75 43.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 75.33 110.903 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.42 -16.64 12.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.712 -0.756 . . . . 72.55 112.555 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -133.57 164.66 26.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.826 0.346 . . . . 75.05 110.88 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.483 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 12.2 m95 -88.18 96.16 10.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 75.1 110.931 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.0 mt -99.47 142.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 73.05 111.121 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -133.56 144.91 49.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 70.41 110.926 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.59 127.74 27.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 75.55 110.847 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.42 -178.62 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.891 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -148.85 17.42 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 74.52 110.889 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -135.89 14.44 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.886 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.62 109.54 21.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 71.22 111.136 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.94 87.91 2.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 70.14 111.069 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.477 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -139.87 170.95 14.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 74.22 110.904 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.457 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -157.55 161.79 38.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 71.42 110.871 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.565 HG13 ' CE2' ' A' ' 98' ' ' PHE . 11.8 mm -33.28 120.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 73.11 111.138 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.84 -29.89 5.46 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.734 -0.746 . . . . 72.44 112.464 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.98 177.96 2.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 74.44 110.86 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -138.55 162.02 35.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 74.43 110.907 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.411 HG12 ' CD2' ' A' ' 34' ' ' LEU . 62.6 mt -137.96 152.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 62.43 111.116 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -151.15 107.56 3.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.45 110.861 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.426 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -165.32 -163.66 0.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 73.23 110.883 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.48 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.2 p-90 -145.14 166.06 26.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 73.05 110.887 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.478 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 5.0 p -136.52 162.37 33.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 74.15 111.151 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.95 142.94 51.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 65.25 110.837 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.45 176.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.517 . . . . 75.01 111.133 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.7 mt -150.91 98.67 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 73.53 111.149 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.566 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -117.8 141.32 48.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 74.14 110.904 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.454 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 46.07 36.74 3.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 74.13 110.885 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.23 33.85 39.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 75.34 112.441 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 mt -100.33 -54.84 2.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.865 0.364 . . . . 74.22 110.934 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.22 116.49 1.76 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.726 -0.75 . . . . 75.51 112.45 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -132.72 -175.09 3.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 74.33 110.955 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.478 ' CG ' ' O ' ' A' ' 77' ' ' THR . 7.5 ttp180 -177.61 138.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.874 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.405 ' N ' ' HG2' ' A' ' 87' ' ' ARG . 2.7 tp60 -81.94 155.17 25.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 73.14 110.857 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -140.0 -166.86 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 65.04 110.899 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.8 OUTLIER 83.06 -38.88 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.4 110.918 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.47 81.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 75.21 112.514 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -171.77 114.4 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 75.22 110.887 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -154.87 112.97 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 74.2 110.942 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.2 m -85.11 132.96 34.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 71.14 111.104 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.46 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 37.6 t -63.76 117.72 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.34 111.112 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -136.39 14.37 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.41 110.927 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -124.95 -178.02 15.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 62.04 112.492 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.565 ' CE2' HG13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -154.69 151.49 28.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 73.31 110.863 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.12 -178.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 74.41 111.119 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -146.51 129.86 16.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 72.11 110.843 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.13 40.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 72.04 110.909 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.31 111.11 179.918 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.858 0.361 . . . . 73.51 110.925 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -140.93 75.91 1.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 61.0 110.875 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.63 142.5 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.577 0.703 . . . . 73.12 111.111 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.99 22.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.657 2.238 . . . . 74.22 112.366 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 133.39 25.57 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.684 2.256 . . . . 72.21 112.356 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.19 139.55 36.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 72.11 111.1 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 m -99.76 77.6 2.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 72.53 111.166 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 mp -77.65 109.69 11.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 74.2 110.936 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.469 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 3.0 mm-40 -80.08 -168.56 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 72.11 110.866 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.506 ' N ' ' O ' ' A' ' 97' ' ' GLY . . . -133.81 81.58 1.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.3 111.139 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.483 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 7.6 mm -71.66 172.84 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.44 111.125 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.581 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -54.17 172.37 0.24 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.583 0.706 . . . . 64.12 110.825 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.78 20.2 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.613 2.209 . . . . 74.31 112.326 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -129.1 26.28 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 74.54 110.86 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.25 -177.71 31.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 61.14 112.467 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.459 ' CD1' HD21 ' A' ' 67' ' ' LEU . 22.2 tp -152.29 166.98 30.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.812 0.339 . . . . 75.42 110.89 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -132.59 136.57 46.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 73.41 110.833 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.0 109.36 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 74.22 111.152 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 t -121.53 159.54 26.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.41 110.843 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.556 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 10.2 m -142.73 151.61 57.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 74.11 111.109 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 121.69 8.38 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.628 2.219 . . . . 75.12 112.32 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.16 140.19 52.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 61.12 110.863 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -132.51 18.88 4.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.883 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.72 8.17 30.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.733 -0.746 . . . . 62.2 112.45 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.528 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 39.5 m-85 -58.41 164.63 2.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 74.5 110.908 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -126.37 -13.01 6.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.886 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.56 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -153.82 140.68 19.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 63.14 110.935 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.556 ' CZ ' HG22 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -134.61 145.77 48.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 73.32 110.924 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.79 142.69 49.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 73.15 111.117 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.28 120.95 31.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.855 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.487 ' CE1' ' HB3' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -152.67 93.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 75.13 110.88 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.9 176.73 24.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 74.24 112.5 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.66 -164.94 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 72.3 110.839 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 tp -134.23 145.79 49.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 73.22 110.934 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.498 ' ND2' ' OD1' ' A' ' 71' ' ' ASP . 22.0 m-80 49.15 24.04 0.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 74.44 110.858 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -163.43 139.34 6.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 75.13 110.861 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -110.1 164.94 12.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 74.43 110.892 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.65 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -111.42 178.19 4.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.44 110.855 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -141.18 130.56 23.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 63.53 110.862 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 76.95 42.99 18.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.709 -0.758 . . . . 74.33 112.445 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.498 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.3 OUTLIER 32.9 80.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.764 0.316 . . . . 65.51 110.926 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -119.54 -169.74 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 72.14 110.855 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.487 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . . . -98.83 103.4 15.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 63.31 111.122 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.75 -111.54 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.76 . . . . 71.55 112.485 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -102.44 -68.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 74.24 110.881 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.489 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 5.2 m-90 -62.37 154.19 28.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 73.15 110.863 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.445 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 95.1 p -158.39 123.84 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 64.31 110.887 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.66 160.73 10.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 73.42 110.861 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -138.9 103.14 4.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 72.43 110.853 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' PHE . 5.6 mm -77.98 108.9 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 75.23 111.165 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 81.1 p -96.37 30.58 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 70.42 111.133 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.9 OUTLIER 163.29 138.82 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.569 0.7 . . . . 71.42 110.903 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 176.2 7.07 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.705 2.27 . . . . 71.32 112.349 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -109.19 -77.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 75.45 110.91 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -113.24 60.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 72.3 110.929 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.17 -19.2 32.23 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.713 -0.756 . . . . 61.01 112.485 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.45 164.91 25.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 73.02 110.861 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.528 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 16.3 m95 -89.83 94.15 9.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.3 149.7 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 75.04 111.156 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.455 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 42.1 t80 -144.31 159.87 41.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 75.34 110.874 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -147.68 140.01 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.853 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -114.39 -178.16 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 74.31 110.887 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.29 17.99 1.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.879 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -137.07 20.42 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 75.42 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -107.39 95.76 5.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.43 111.106 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -94.11 84.55 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 73.54 111.073 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.459 HD21 ' CD1' ' A' ' 16' ' ' LEU . 1.0 OUTLIER -120.03 171.61 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 64.52 110.881 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -153.24 134.29 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.889 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.552 ' C ' ' O ' ' A' ' 68' ' ' LYS . 9.2 mm -23.6 118.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 72.31 111.098 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.6 -19.09 9.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.787 -0.72 . . . . 64.54 112.495 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.498 ' OD1' ' ND2' ' A' ' 35' ' ' ASN . 0.4 OUTLIER -67.23 -166.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 63.51 110.837 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 1.5 mtmt -152.45 165.15 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.52 110.873 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 99.2 mt -142.53 149.15 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 73.22 111.194 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -149.62 104.1 3.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 73.54 110.885 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.509 ' CE2' HG22 ' A' ' 77' ' ' THR . 1.0 OUTLIER -160.3 -164.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 73.51 110.903 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.65 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -146.98 142.73 27.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.893 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.509 HG22 ' CE2' ' A' ' 75' ' ' PHE . 4.4 p -112.37 147.75 35.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 73.32 111.113 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.407 ' CD1' ' HG3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -112.68 143.51 43.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 72.21 110.855 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.01 168.69 13.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 74.4 111.118 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 95.4 mt -146.69 96.17 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 75.33 111.121 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.408 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 7.4 tttt -114.51 143.73 44.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 72.25 110.961 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 53.03 20.71 1.8 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 72.02 110.892 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.09 27.54 73.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 52.12 112.481 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.0 mt -97.86 -72.31 0.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 72.41 110.907 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.48 109.86 2.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 70.44 112.484 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -122.31 161.68 22.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 74.54 110.921 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.407 ' HG3' ' CD1' ' A' ' 78' ' ' PHE . 6.2 ttp180 -163.45 129.13 3.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 72.33 110.866 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -80.64 150.35 29.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.917 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -132.02 -159.92 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 75.35 110.866 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 82.86 -37.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 64.23 110.923 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.51 78.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.783 -0.722 . . . . 64.44 112.481 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -171.41 111.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 64.42 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -148.98 119.42 7.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 64.14 110.898 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.6 m -89.84 141.15 28.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 72.14 111.152 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.457 HG21 ' CD1' ' A' ' 67' ' ' LEU . 40.2 t -75.81 124.92 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 74.23 111.093 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -147.19 21.97 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 72.11 110.936 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -154.67 114.35 0.61 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 74.44 112.482 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.447 ' C ' HG21 ' A' ' 99' ' ' VAL . 0.6 OUTLIER -87.81 172.16 9.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 71.14 110.882 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.469 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -167.53 156.64 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 75.52 111.109 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.55 130.25 56.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -100.11 38.59 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 74.23 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 75.4 111.082 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.816 0.341 . . . . 74.13 110.933 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -143.9 70.13 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 73.51 110.868 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.42 145.49 0.11 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 73.12 111.061 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.82 33.09 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.254 . . . . 72.51 112.385 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 134.37 27.89 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.735 2.29 . . . . 72.42 112.371 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.43 140.71 33.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 75.4 111.121 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 m -97.19 79.14 2.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 74.4 111.145 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 mp -83.1 113.06 20.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 73.34 110.884 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.94 -158.34 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.147 -0.478 . . . . 73.15 110.893 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.495 ' CB ' ' CG1' ' A' ' 95' ' ' VAL . . . -141.12 80.37 1.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.31 111.102 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.482 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 2.7 mm -71.3 172.55 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 65.43 111.131 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.568 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -54.22 172.16 0.25 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.561 0.695 . . . . 74.34 110.842 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.8 Cg_endo -69.76 19.47 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.66 2.24 . . . . 73.32 112.384 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.517 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -124.58 19.79 8.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 75.13 110.868 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.24 -177.93 33.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 63.34 112.521 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.448 ' C ' HG13 ' A' ' 11' ' ' ILE . 26.3 tp -151.27 166.38 31.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 75.41 110.94 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -128.23 139.13 52.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 74.24 110.867 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.3 t -151.26 105.26 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 74.0 111.131 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.415 ' CB ' ' HA ' ' A' ' 59' ' ' ILE . 18.7 t -122.46 162.25 22.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.55 110.876 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.414 HG12 ' C ' ' A' ' 19' ' ' SER . 5.4 m -140.4 151.17 63.38 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.664 0.745 . . . . 73.42 111.084 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 122.2 8.87 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.673 2.249 . . . . 74.44 112.327 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 14.9 t70 -83.44 140.0 32.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 74.44 110.913 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -137.2 12.61 3.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 74.54 110.91 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.01 2.93 2.64 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.748 . . . . 74.2 112.491 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.498 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 91.5 m-85 -58.33 160.18 5.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 73.24 110.899 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -129.72 -7.04 4.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 73.02 110.859 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.565 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -157.75 140.75 15.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 72.53 110.898 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.521 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 19.8 t80 -137.61 146.2 43.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.841 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.98 163.06 28.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 74.2 111.134 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.4 t80 -147.59 111.7 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.876 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.567 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -144.29 92.58 2.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 73.53 110.836 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.517 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -145.99 -179.48 22.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 71.54 112.484 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.69 -164.15 1.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 75.41 110.929 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.47 ' HG ' ' ND2' ' A' ' 35' ' ' ASN . 1.1 tp -143.48 144.91 32.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 70.12 110.931 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.47 ' ND2' ' HG ' ' A' ' 34' ' ' LEU . 2.3 m120 57.73 12.02 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 73.04 110.867 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -156.77 130.58 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.4 110.877 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -102.4 143.92 31.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 50.11 110.905 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.07 172.7 8.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 75.5 110.92 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.85 157.83 41.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 75.22 110.912 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.56 35.32 44.84 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 72.15 112.475 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.477 ' C ' ' CZ2' ' A' ' 76' ' ' TRP . 1.1 mt 39.24 84.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.763 0.316 . . . . 74.53 110.914 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -126.22 174.19 8.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.908 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.41 98.9 6.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 74.34 111.107 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.84 -116.05 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 73.14 112.539 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.46 -65.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.771 0.32 . . . . 74.33 110.89 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.418 ' O ' ' ND1' ' A' ' 31' ' ' HIS . 8.2 m0 -58.03 161.43 4.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.194 -0.457 . . . . 73.12 110.851 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.567 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 97.0 p -167.39 122.51 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 61.43 110.887 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.77 155.36 8.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 74.22 110.872 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.24 103.2 4.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 75.14 110.873 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 28.0 mm -80.84 117.14 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.34 111.121 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.5 p -99.36 32.24 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 73.11 111.17 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 172.99 135.67 0.11 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.61 0.719 . . . . 74.14 110.909 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 168.18 22.22 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.26 . . . . 73.33 112.322 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.3 OUTLIER -141.95 112.78 7.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.54 110.905 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER 78.27 27.72 0.51 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 73.45 110.883 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.81 -25.88 19.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 73.53 112.507 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 161.76 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 75.51 110.825 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.421 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 13.2 m95 -82.15 101.19 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 73.22 110.953 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.415 ' HA ' ' CB ' ' A' ' 19' ' ' SER . 28.0 mt -105.65 139.13 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 75.44 111.119 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -135.32 141.91 45.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.12 110.852 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.04 130.44 37.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.44 110.859 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.57 -178.9 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 72.33 110.864 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -144.82 15.56 1.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 75.41 110.887 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -131.45 3.58 4.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 74.24 110.874 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.2 101.01 13.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 70.14 111.093 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.58 84.53 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 71.21 111.061 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.454 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.38 171.29 12.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 72.31 110.899 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.488 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -152.8 147.47 26.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 75.43 110.894 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.488 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.5 mm -30.89 115.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 75.01 111.145 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.44 -19.37 7.15 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 70.25 112.505 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.16 -162.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 75.21 110.865 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.1 mttt -155.0 167.24 31.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 73.53 110.901 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 80.0 mt -146.4 146.35 19.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 73.01 111.138 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -148.9 102.19 3.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.34 110.956 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.517 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 0.8 OUTLIER -160.68 -161.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 70.34 110.896 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.543 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.5 OUTLIER -145.97 161.34 40.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.908 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 p -131.05 159.69 36.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 71.44 111.151 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.62 146.06 48.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 75.24 110.859 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.08 170.87 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 73.35 111.16 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 81.1 mt -149.36 96.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 73.41 111.171 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.498 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 1.7 tttt -113.05 137.72 51.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 75.15 110.916 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.401 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 47.31 33.11 2.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 72.21 110.853 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.33 33.39 61.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.738 . . . . 71.15 112.478 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.7 mt -97.47 -54.25 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 75.3 110.878 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 119.32 2.83 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.784 -0.722 . . . . 54.43 112.492 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -143.47 156.81 44.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 73.54 110.916 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -152.56 133.68 14.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 73.51 110.854 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -80.11 154.98 27.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 72.24 110.894 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.542 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -138.52 -160.79 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 65.45 110.854 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.542 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 3.1 t-20 82.7 -38.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 70.02 110.861 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.03 78.87 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 62.02 112.536 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -171.74 110.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.35 . . . . 73.42 110.895 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 17.1 m-90 -151.72 120.09 6.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.134 -0.485 . . . . 73.22 110.963 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.4 m -91.24 130.43 37.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.34 111.186 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.495 ' CG1' ' CB ' ' A' ' 10' ' ' ALA . 48.3 t -61.41 110.5 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 75.35 111.117 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.0 7.5 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 74.22 110.895 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -120.23 179.13 16.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 74.23 112.476 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.48 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -151.75 153.2 33.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 73.52 110.895 -179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.451 ' CG2' ' CD1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -159.96 177.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 64.53 111.109 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -146.03 126.87 14.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 70.24 110.843 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -80.43 55.31 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 75.0 110.87 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 74.03 111.093 179.919 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 17.2 t80 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.847 0.356 . . . . 71.02 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -141.53 76.45 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 60.3 110.921 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.03 141.78 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.543 0.687 . . . . 75.24 111.097 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 165.46 30.88 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 74.41 112.34 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 133.6 25.92 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 75.24 112.301 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.64 144.15 31.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.25 111.111 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.5 m -99.83 77.13 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 75.22 111.138 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mp -73.04 109.89 6.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.961 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.462 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 7.9 mm-40 -85.99 -172.92 4.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.43 110.863 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -130.56 80.25 1.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 71.12 111.084 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.501 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.2 mm -70.27 172.34 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 74.31 111.159 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.563 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.07 171.83 0.26 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.622 0.725 . . . . 74.45 110.818 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.563 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.1 Cg_endo -69.72 20.54 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 65.34 112.37 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' HIS . 20.7 pttt -126.64 23.06 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.884 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.1 -178.13 31.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 45.44 112.501 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.471 ' C ' HG13 ' A' ' 11' ' ' ILE . 20.0 tp -149.65 160.83 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 73.44 110.924 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -125.95 138.95 53.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.888 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -148.79 103.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 75.01 111.098 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.3 t -114.21 160.69 18.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 64.23 110.89 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.3 m -141.51 151.73 61.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 64.24 111.146 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 122.14 8.82 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.719 2.279 . . . . 75.23 112.343 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.558 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 17.1 t0 -89.12 107.91 19.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 71.13 110.868 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -95.79 -3.55 45.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 63.41 110.894 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.94 31.02 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 64.41 112.513 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.439 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 81.4 m-85 -80.14 165.1 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 75.34 110.87 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -126.05 -11.55 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.878 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.56 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -155.66 141.13 17.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 73.4 110.898 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.541 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 16.9 t80 -133.38 146.42 51.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.33 110.909 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.67 155.8 49.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.04 111.119 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.511 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 3.2 t80 -141.0 123.78 16.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 75.33 110.895 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.511 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 8.4 m-70 -153.47 93.31 1.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 72.31 110.884 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.506 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -145.94 -177.1 20.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.75 . . . . 55.43 112.506 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.43 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 2.6 mtpp -135.73 -169.64 2.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 72.14 110.912 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 35' ' ' ASN . 2.3 tp -131.77 143.78 50.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 75.02 110.897 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 34' ' ' LEU . 67.2 m-80 37.48 37.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.901 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -159.17 139.84 12.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.11 110.913 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -90.36 145.28 25.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 75.13 110.913 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.5 ptp -104.03 177.78 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 64.31 110.904 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -83.31 169.92 15.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 74.31 110.911 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -46.12 90.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 72.24 112.455 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 39' ' ' GLU . 1.0 OUTLIER 49.95 83.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.803 0.335 . . . . 73.32 110.899 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -143.83 -176.98 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 73.35 110.878 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.5 99.85 12.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.038 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . -68.3 -106.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.77 -0.728 . . . . 54.34 112.504 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.428 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -106.25 -62.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.75 0.31 . . . . 71.44 110.825 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -65.41 150.93 47.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 71.13 110.91 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.461 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 58.5 p -158.33 119.02 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 63.21 110.822 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.461 ' CD ' HD12 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -163.22 158.56 21.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 73.34 110.897 -179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -144.34 115.26 7.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 73.11 110.866 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.461 HD12 ' CD ' ' A' ' 48' ' ' ARG . 7.6 mm -96.27 120.49 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 72.42 111.148 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 81.4 p -107.89 36.92 2.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.22 111.126 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.8 OUTLIER 163.08 130.81 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.616 0.722 . . . . 74.44 110.901 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -176.33 1.46 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.682 2.255 . . . . 63.25 112.318 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.14 19.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 74.51 110.842 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 178.85 34.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 73.24 110.858 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.42 -19.53 13.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 63.51 112.445 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.04 164.32 27.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.806 0.336 . . . . 74.45 110.861 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.558 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 18.3 m95 -87.5 93.27 9.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.918 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.1 mt -96.47 136.37 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 74.11 111.146 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -129.95 150.63 51.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.01 110.883 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.89 138.68 28.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 62.12 110.878 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.5 -176.53 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.826 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.45 17.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 73.22 110.842 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -131.77 12.09 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 75.31 110.879 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.22 103.82 13.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 71.3 111.077 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -101.57 73.8 1.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 60.32 111.111 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -117.52 171.41 8.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 73.5 110.932 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.53 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.53 151.05 27.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 71.42 110.914 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.2 mm -28.04 116.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 73.03 111.13 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.31 -24.72 6.85 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 75.42 112.515 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.93 -175.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 74.2 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -141.75 166.73 23.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 72.13 110.898 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.6 mt -144.52 143.21 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.23 111.142 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -145.38 103.88 3.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.954 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.506 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -168.71 -162.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 74.31 110.908 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.464 ' NE1' ' HA ' ' A' ' 41' ' ' LEU . 2.7 p-90 -146.91 174.61 11.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 73.11 110.927 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 p -139.23 159.05 43.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 74.55 111.11 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.54 150.21 42.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 73.54 110.882 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -147.81 174.55 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.483 . . . . 72.14 111.171 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 78.4 mt -150.48 96.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 71.0 111.148 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 17.1 tttm -113.01 121.55 44.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 75.32 110.907 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.79 32.41 18.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.895 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.75 33.33 72.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 72.23 112.471 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -99.67 -55.95 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 72.25 110.921 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.05 112.19 2.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 72.23 112.499 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB2' ' CG2' ' A' ' 79' ' ' VAL . 29.0 m-85 -126.27 164.77 20.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.889 0.376 . . . . 75.52 110.902 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -152.88 137.63 17.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 74.52 110.862 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.73 141.86 28.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 75.23 110.91 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -132.39 143.44 49.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 72.44 110.854 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 167.53 -37.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 63.24 110.873 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 40.55 44.53 3.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.726 -0.75 . . . . 63.24 112.533 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -168.08 105.4 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.348 . . . . 72.44 110.854 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -146.48 106.3 3.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 75.34 110.929 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.4 m -80.87 131.12 35.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 74.14 111.18 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.41 121.35 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.52 111.142 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -137.9 8.51 2.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 72.2 110.881 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -119.54 -175.54 15.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 55.31 112.466 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.421 ' C ' HG23 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -157.17 153.55 27.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.96 0.409 . . . . 75.12 110.875 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.462 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.67 172.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 73.33 111.132 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -141.54 132.86 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 62.13 110.867 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.93 45.62 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 72.3 110.882 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 64.31 111.121 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 3.0 t80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.84 0.352 . . . . 71.03 110.943 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -140.95 67.47 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 73.35 110.921 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.86 143.85 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.569 0.7 . . . . 75.32 111.115 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 167.66 23.87 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.642 2.228 . . . . 65.22 112.331 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 134.98 29.31 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 72.31 112.339 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.54 136.85 33.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 74.51 111.098 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 m -94.66 77.27 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 64.44 111.169 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.461 ' CD2' HG21 ' A' ' 18' ' ' VAL . 2.0 mp -80.08 106.25 11.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 74.13 110.934 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -78.38 -165.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 75.23 110.847 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.473 ' CB ' ' CG1' ' A' ' 95' ' ' VAL . . . -135.88 79.45 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 73.43 111.07 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.499 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.6 mm -68.6 172.42 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.41 111.098 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.565 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -53.34 172.05 0.22 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.581 0.705 . . . . 74.32 110.841 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.565 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.72 21.48 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 73.54 112.34 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 12' ' ' HIS . 6.9 ptpt -129.06 26.14 5.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 70.54 110.953 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.99 -178.63 29.14 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 70.52 112.486 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.466 ' C ' HG13 ' A' ' 11' ' ' ILE . 35.6 tp -149.87 163.67 37.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 64.45 110.901 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -131.24 135.23 47.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 75.41 110.863 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.461 HG21 ' CD2' ' A' ' 8' ' ' LEU . 41.9 t -143.26 110.6 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 54.23 111.113 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 t -118.2 157.41 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 71.22 110.888 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 25.4 m -139.94 151.94 66.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.654 0.74 . . . . 74.23 111.123 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 121.36 8.04 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.655 2.237 . . . . 75.54 112.335 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 22.8 t0 -82.81 93.6 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.53 110.862 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.7 30.59 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 73.31 110.933 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.14 23.46 7.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 73.43 112.464 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 64.3 m-85 -72.24 166.23 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 73.21 110.871 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 t -129.86 -6.49 4.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.854 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.552 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -163.05 140.56 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 75.23 110.912 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.542 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 14.0 t80 -135.59 149.97 49.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.3 110.898 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.62 152.73 42.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 63.13 111.139 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.551 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 1.9 t80 -132.68 132.47 42.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 74.34 110.922 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 16.3 m-70 -157.79 89.05 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 74.31 110.875 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.12 -175.32 19.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 74.11 112.481 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.424 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -135.48 -164.17 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 74.35 110.928 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.569 ' CD1' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -130.27 138.83 50.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 74.2 110.897 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.569 ' ND2' ' CD1' ' A' ' 34' ' ' LEU . 68.4 m-80 46.52 26.69 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.905 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -154.11 144.22 22.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 71.44 110.914 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.32 152.77 29.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.855 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.77 178.54 4.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 71.31 110.899 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.28 145.0 50.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 54.12 110.923 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 57.9 40.0 92.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.761 -0.733 . . . . 62.31 112.506 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.471 ' HB3' ' CE2' ' A' ' 76' ' ' TRP . 7.5 mt 35.38 84.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.765 0.317 . . . . 73.32 110.921 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -124.3 -179.76 4.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.899 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.58 99.69 8.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 73.24 111.134 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.91 -118.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.781 -0.723 . . . . 51.02 112.456 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.44 -54.28 2.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.82 0.343 . . . . 74.3 110.854 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -71.39 171.11 11.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.11 110.9 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -173.31 115.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 74.04 110.854 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.435 ' CD ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -163.46 158.24 20.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.34 110.884 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.46 122.88 13.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.861 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.435 HD11 ' CD ' ' A' ' 48' ' ' ARG . 19.2 mm -103.66 118.35 50.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 72.24 111.115 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 51.7 p -104.6 35.07 2.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 74.32 111.152 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.439 ' CB ' ' O ' ' A' ' 51' ' ' THR . 16.7 mttt 164.93 137.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.571 0.701 . . . . 74.14 110.91 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 174.77 9.04 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 2.263 . . . . 73.01 112.318 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' HZ3' ' NE ' ' A' ' 61' ' ' ARG . 1.5 ptpt -136.94 11.57 3.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 75.11 110.919 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.77 44.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 73.43 110.917 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.78 -24.62 5.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.807 -0.711 . . . . 72.43 112.477 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.23 163.36 27.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 75.33 110.909 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 8.1 m95 -85.1 96.2 9.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 73.2 110.918 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.2 mt -102.41 140.83 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.127 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 41.9 t80 -134.64 158.01 45.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 75.34 110.865 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.407 ' NE ' ' HZ3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -148.37 139.0 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 75.1 110.843 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.68 -179.38 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 65.32 110.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.75 28.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 73.31 110.895 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -144.47 18.59 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 63.23 110.945 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.41 102.71 11.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 72.22 111.128 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.59 83.11 2.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 74.34 111.066 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.66 171.63 8.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.91 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -155.51 141.75 18.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.873 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.538 ' C ' ' O ' ' A' ' 68' ' ' LYS . 25.6 mm -25.41 119.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.12 111.153 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.56 -18.08 8.78 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.743 -0.742 . . . . 74.11 112.469 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.29 -176.58 2.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 74.04 110.85 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.467 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 6.7 mttt -143.32 160.58 40.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 75.44 110.86 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.46 HG12 ' CD2' ' A' ' 34' ' ' LEU . 49.1 mt -137.82 146.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 73.24 111.126 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.9 m-85 -146.98 104.97 3.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.951 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.9 p90 -165.96 -168.26 1.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.906 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.471 ' CE2' ' HB3' ' A' ' 41' ' ' LEU . 1.3 p-90 -135.61 171.59 14.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.474 . . . . 73.11 110.908 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.2 p -142.11 149.01 39.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 71.44 111.182 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.07 144.17 39.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.04 110.868 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.513 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -143.72 167.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 74.33 111.152 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 88.9 mt -149.0 96.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 73.52 111.116 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 1.3 tttt -112.28 133.66 54.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.884 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 48.88 37.85 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 74.21 110.882 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.65 29.71 49.52 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 64.3 112.472 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 mt -93.0 -58.33 2.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.858 0.361 . . . . 75.31 110.924 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.21 120.66 3.79 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.776 -0.726 . . . . 73.42 112.497 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -143.59 163.74 32.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.947 0.403 . . . . 73.53 110.9 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -159.04 134.7 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 74.02 110.874 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -80.77 154.8 27.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.496 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -138.84 -164.73 1.7 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.895 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.496 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.2 t-20 82.08 -40.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.891 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.16 84.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.671 -0.776 . . . . 74.55 112.493 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -172.26 110.68 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.823 0.344 . . . . 74.42 110.89 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -149.75 114.77 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.915 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.5 m -87.98 136.04 33.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 73.32 111.111 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.473 ' CG1' ' CB ' ' A' ' 10' ' ' ALA . 35.5 t -71.85 115.09 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 71.41 111.134 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -133.21 12.46 4.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.904 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -130.78 177.7 18.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 72.11 112.44 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.433 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -145.02 160.41 41.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 73.2 110.902 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.447 ' CG2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.13 167.57 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.32 111.133 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.43 137.28 50.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 74.25 110.896 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -89.49 42.22 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.876 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 74.22 111.096 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 3.4 t80 . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.806 0.336 . . . . 75.24 110.924 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -140.5 77.36 1.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 74.44 110.867 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.6 142.92 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.564 0.697 . . . . 52.13 111.118 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 167.05 25.61 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 2.238 . . . . 75.41 112.318 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 135.76 31.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.64 2.226 . . . . 74.32 112.392 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.65 141.43 28.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 73.22 111.078 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.2 m -100.47 76.83 1.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 73.52 111.156 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -73.81 106.73 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 75.41 110.943 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 7.3 mm-40 -78.41 -170.28 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 71.52 110.881 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.477 ' HB3' ' CG1' ' A' ' 95' ' ' VAL . . . -133.59 80.83 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 74.24 111.125 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.485 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -72.14 172.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 75.53 111.174 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.565 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.0 171.82 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.603 0.715 . . . . 72.14 110.854 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.565 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.2 Cg_endo -69.71 20.85 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.693 2.262 . . . . 73.53 112.356 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 12' ' ' HIS . 9.5 pttt -125.67 19.76 7.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 62.12 110.901 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.21 -177.39 33.27 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.782 -0.723 . . . . 73.15 112.508 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.474 ' C ' HG13 ' A' ' 11' ' ' ILE . 24.0 tp -149.8 166.71 28.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 71.34 110.902 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -133.25 138.93 46.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.86 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.0 t -147.19 107.49 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 74.24 111.151 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.435 ' C ' HG13 ' A' ' 20' ' ' VAL . 12.4 t -112.24 156.45 22.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 72.24 110.872 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.435 HG13 ' C ' ' A' ' 19' ' ' SER . 30.3 m -141.73 151.84 61.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.653 0.74 . . . . 75.44 111.132 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 122.44 9.11 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.733 2.289 . . . . 74.23 112.311 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 12.1 t0 -83.64 92.77 7.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 72.22 110.853 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.35 40.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.897 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.0 24.5 24.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 52.52 112.511 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 95.7 m-85 -74.71 165.02 25.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.866 0.365 . . . . 73.2 110.854 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.1 t -129.41 -7.61 4.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 61.45 110.861 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.568 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -155.02 142.1 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 71.05 110.951 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.537 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 17.9 t80 -137.55 147.9 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.44 110.903 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.7 156.76 46.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.31 111.098 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -139.4 125.42 19.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 74.5 110.901 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.445 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 25.8 m-70 -152.58 92.58 1.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 73.42 110.869 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.47 ' CA ' ' CB ' ' A' ' 75' ' ' PHE . . . -144.67 -174.47 16.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 61.23 112.448 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -163.98 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 73.11 110.918 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.438 ' CD1' ' OD2' ' A' ' 71' ' ' ASP . 0.2 OUTLIER -131.86 123.46 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 74.3 110.899 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 61.4 27.23 16.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 75.4 110.878 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -156.89 146.68 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.915 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -113.92 159.33 20.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 64.12 110.893 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.562 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -110.89 -174.52 2.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 73.01 110.887 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -152.15 138.32 18.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 72.14 110.879 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.28 31.09 57.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 73.44 112.513 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.449 ' HA ' ' NE1' ' A' ' 76' ' ' TRP . 5.1 mt 43.96 83.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.794 0.331 . . . . 75.02 110.926 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -129.25 169.07 15.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 75.34 110.91 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.31 101.5 9.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 75.43 111.078 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.54 -111.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 34.43 112.459 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 -56.33 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 74.43 110.837 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -69.85 177.07 3.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 72.11 110.931 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.445 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 66.0 p -179.92 109.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 71.45 110.837 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.422 ' NE ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -161.06 156.7 24.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 73.22 110.863 -179.954 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -140.22 120.02 13.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 63.23 110.859 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.422 HD11 ' NE ' ' A' ' 48' ' ' ARG . 8.6 mm -95.18 117.16 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 74.43 111.154 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.6 p -98.96 32.55 2.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 72.4 111.149 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' O ' ' CG2' ' A' ' 50' ' ' ILE . 0.8 OUTLIER 170.24 139.83 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.555 0.693 . . . . 74.42 110.923 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -178.95 2.58 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.66 2.24 . . . . 70.42 112.363 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.8 ttmt -119.63 -61.7 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 75.34 110.89 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -131.43 58.47 1.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.891 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.38 -28.74 6.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 40.44 112.461 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.5 160.7 29.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.322 . . . . 74.5 110.887 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.519 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 44.1 m95 -82.59 89.1 6.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 75.13 110.949 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -94.46 135.91 27.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 75.25 111.159 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.478 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 56.1 t80 -135.56 162.37 32.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 75.31 110.847 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.478 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -158.24 152.71 24.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 75.43 110.892 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.39 -176.41 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 65.4 110.855 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.1 mtt180 -142.76 16.47 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 73.34 110.877 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -132.8 8.72 4.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 73.33 110.892 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.85 95.96 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 74.51 111.108 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.67 77.46 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 74.12 111.104 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -125.07 171.47 10.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 71.32 110.9 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.506 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.71 154.88 28.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 74.33 110.913 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.7 mm -29.98 121.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 73.41 111.118 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.52 -28.45 5.98 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.729 -0.748 . . . . 74.4 112.452 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.438 ' OD2' ' CD1' ' A' ' 34' ' ' LEU . 1.4 m-20 -66.53 -171.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 71.43 110.861 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.493 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.7 mttt -148.78 168.71 22.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 72.5 110.898 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.401 HG21 ' N ' ' A' ' 74' ' ' TYR . 78.6 mt -146.67 145.28 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 73.52 111.153 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.493 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -148.36 103.29 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 74.43 110.914 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.47 ' CB ' ' CA ' ' A' ' 32' ' ' GLY . 1.3 p90 -160.97 -168.99 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 75.14 110.903 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.562 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -139.99 146.12 38.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 74.53 110.912 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.402 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 1.9 p -111.63 161.76 15.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 74.12 111.142 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 138.1 51.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 75.15 110.893 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.566 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 2.3 m -141.86 177.2 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 74.34 111.141 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.3 mt -152.95 98.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 73.42 111.122 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.573 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -112.7 141.02 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 72.53 110.866 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.433 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER 44.92 32.51 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.879 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.38 36.98 91.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 54.21 112.472 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.7 -50.59 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.836 0.35 . . . . 60.12 110.899 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.48 105.01 0.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.758 . . . . 73.04 112.501 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -123.72 -175.02 3.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 75.21 110.906 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.446 ' HB3' ' NH1' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -178.44 135.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 74.43 110.854 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -79.1 153.28 30.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.918 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.482 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -136.28 -165.5 1.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 73.31 110.841 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.482 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 81.34 -40.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 73.2 110.861 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.27 83.05 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 62.25 112.504 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -170.69 112.91 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 72.13 110.894 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.6 m-90 -155.04 113.05 3.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 74.33 110.923 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 96.1 m -88.48 135.34 33.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 60.54 111.151 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 10' ' ' ALA . 15.8 t -64.75 114.94 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 73.4 111.14 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.62 -2.34 3.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 70.12 110.894 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -113.51 -174.89 19.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 74.33 112.48 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.425 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -155.49 156.73 35.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 75.04 110.896 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.433 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.64 167.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 74.24 111.128 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -127.46 129.44 47.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 65.02 110.889 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -78.69 48.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 74.01 110.844 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 74.04 111.091 179.947 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.857 0.361 . . . . 70.25 110.901 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -143.99 67.29 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.31 110.931 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.54 139.57 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.583 0.706 . . . . 75.1 111.067 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 165.07 32.22 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.664 2.243 . . . . 64.52 112.35 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 134.79 28.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.635 2.223 . . . . 72.03 112.375 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.34 135.0 36.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 75.12 111.115 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.7 m -93.95 77.7 4.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 72.15 111.105 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mp -85.84 111.45 20.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 73.34 110.898 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -84.58 -155.14 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.131 -0.486 . . . . 75.52 110.906 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.62 80.44 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 63.43 111.065 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.487 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 2.6 mm -69.51 172.27 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 61.22 111.123 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.581 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -54.18 172.74 0.23 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.627 0.727 . . . . 61.4 110.834 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.1 Cg_endo -69.77 19.82 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.239 . . . . 75.5 112.36 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.514 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.0 OUTLIER -124.54 21.72 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.15 110.923 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.55 -177.47 31.07 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 62.3 112.434 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.468 ' HB2' ' CB ' ' A' ' 65' ' ' ALA . 36.0 tp -149.47 162.05 40.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 73.13 110.92 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.448 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 37.3 ttt180 -123.16 138.3 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 72.24 110.886 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.1 t -148.61 110.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 72.5 111.092 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.5 t -123.31 156.12 35.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 61.03 110.828 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 23.9 m -141.45 151.66 61.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.649 0.738 . . . . 75.44 111.125 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 126.26 13.1 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.709 2.273 . . . . 70.44 112.31 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.523 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 34.3 t0 -97.21 86.23 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.32 110.871 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -20.57 63.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.895 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.84 30.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 73.52 112.523 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 83.4 m-85 -81.36 167.75 19.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 75.23 110.866 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 t -127.22 -10.48 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.845 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.559 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -151.96 141.44 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 75.3 110.949 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.54 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 14.5 t80 -137.34 140.89 41.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 71.33 110.924 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.17 144.66 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 74.11 111.092 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.442 ' CE1' ' CZ ' ' A' ' 75' ' ' PHE . 1.6 t80 -130.78 109.7 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 74.52 110.852 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -135.84 93.69 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 73.24 110.841 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' CB ' ' A' ' 75' ' ' PHE . . . -142.28 -177.26 17.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.679 -0.772 . . . . 54.22 112.467 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -131.3 -164.27 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 75.41 110.882 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.503 ' CD1' ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -133.9 129.07 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 72.42 110.903 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.503 ' ND2' ' CD1' ' A' ' 34' ' ' LEU . 61.0 m-80 60.29 17.11 6.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.897 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -153.23 142.01 21.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 71.45 110.888 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.441 ' CB ' ' HB2' ' A' ' 74' ' ' TYR . 4.3 pt-20 -117.59 154.41 31.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 62.11 110.914 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 7.2 ptt? -109.83 178.88 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 71.25 110.919 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.07 173.49 10.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 71.13 110.866 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 46.41 39.48 10.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 60.33 112.521 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.3 OUTLIER 32.49 76.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.753 0.311 . . . . 74.3 110.912 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -113.66 -164.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 70.31 110.892 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' CB ' ' NE2' ' A' ' 31' ' ' HIS . . . -97.9 101.23 12.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 74.24 111.111 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . -57.85 -114.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.732 -0.747 . . . . 53.34 112.477 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.31 -71.42 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.319 . . . . 71.21 110.871 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.589 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 5.9 m-90 -58.09 155.41 11.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.2 110.931 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.511 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 87.3 p -153.15 108.2 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 61.31 110.833 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.79 160.76 39.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 65.55 110.861 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.96 108.41 4.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.876 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 28' ' ' PHE . 4.6 mm -85.85 101.0 9.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.444 . . . . 72.24 111.111 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 p -87.81 26.48 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 65.43 111.154 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.8 mttt 178.84 135.38 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 75.21 110.889 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 168.12 22.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.684 2.256 . . . . 74.41 112.329 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -105.77 -60.35 1.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 75.0 110.933 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -132.11 53.94 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 65.51 110.863 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.91 -20.01 48.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 44.32 112.472 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -133.84 162.4 32.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 74.34 110.922 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.523 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 15.8 m95 -85.07 91.85 8.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 75.12 110.956 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 17.3 mt -100.38 146.08 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 65.14 111.123 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -142.69 155.06 44.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.33 110.902 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.0 119.95 11.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 74.34 110.875 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD2' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -93.24 -178.24 4.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 74.3 110.855 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -145.25 10.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 75.34 110.878 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.486 ' ND2' ' OD2' ' A' ' 62' ' ' ASP . 15.1 p30 -124.08 -1.39 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 73.3 110.883 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -84.41 98.93 10.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 63.11 111.082 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.19 78.98 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 73.4 111.124 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.514 ' CD2' ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -127.75 170.24 12.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.14 110.924 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.514 ' N ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.31 151.99 23.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 74.53 110.865 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.578 HG12 ' CE2' ' A' ' 98' ' ' PHE . 2.8 mm -27.45 122.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 74.02 111.116 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.03 -25.46 7.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 53.24 112.513 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.11 -168.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 74.22 110.841 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.9 mttt -151.18 171.96 16.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 72.33 110.908 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.471 HG23 ' N ' ' A' ' 74' ' ' TYR . 83.9 mt -147.96 149.23 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 75.42 111.09 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.1 m-85 -152.76 115.3 4.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 75.0 110.935 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.442 ' CZ ' ' CE1' ' A' ' 30' ' ' PHE . 8.3 p90 -171.55 -159.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.521 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -151.79 133.29 14.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 75.25 110.935 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.456 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 1.7 p -93.78 166.84 12.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 63.31 111.182 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.58 132.22 28.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 70.41 110.857 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.404 ' HB ' ' CD2' ' A' ' 25' ' ' PHE . 2.1 m -135.6 177.12 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 71.21 111.103 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 79.0 mt -150.13 99.65 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 65.02 111.155 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -115.92 140.86 48.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 75.43 110.907 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.87 33.13 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 62.31 110.848 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.94 36.96 83.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 62.54 112.5 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.43 -52.22 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.906 0.384 . . . . 73.33 110.908 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.02 102.9 0.73 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 74.1 112.486 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -122.88 179.19 4.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 74.34 110.948 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.456 ' CG ' ' O ' ' A' ' 77' ' ' THR . 1.7 tmm_? -177.38 136.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 75.44 110.899 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -75.28 160.87 29.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 73.23 110.942 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -139.34 -167.77 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 75.12 110.88 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.7 OUTLIER 82.47 -40.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 65.31 110.822 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.09 79.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 74.22 112.502 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -167.49 109.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 73.4 110.888 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 -149.17 111.29 4.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 74.3 110.899 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 84.8 m -91.98 135.17 34.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 74.34 111.156 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.433 ' O ' ' CG ' ' A' ' 96' ' ' GLU . 9.9 t -60.45 156.03 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 73.35 111.154 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 69' ' ' ILE . 13.7 mt-10 -163.05 -33.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.916 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -103.02 -170.91 26.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 74.25 112.486 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.578 ' CE2' HG12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -150.3 168.5 23.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.924 0.392 . . . . 61.05 110.879 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -167.52 175.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 72.52 111.138 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -137.73 142.26 40.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 75.13 110.888 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -88.48 51.29 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 70.33 110.836 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 64.12 111.085 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 9.6 t80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.817 0.341 . . . . 72.21 110.962 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.96 76.74 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 64.32 110.89 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.38 143.33 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.6 0.714 . . . . 71.21 111.114 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.8 Cg_endo -69.79 167.79 23.45 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.7 2.267 . . . . 75.42 112.37 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 133.13 24.84 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 72.44 112.34 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.412 ' HA ' ' CG1' ' A' ' 20' ' ' VAL . . . -85.3 142.52 29.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 72.31 111.098 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m -99.01 77.36 2.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 71.31 111.174 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.499 HD11 ' CG ' ' A' ' 93' ' ' TRP . 1.8 mp -76.05 105.72 7.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 72.25 110.929 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 5.1 mm-40 -78.53 -170.88 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 75.02 110.863 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.475 ' HB1' ' CG1' ' A' ' 95' ' ' VAL . . . -133.78 80.27 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 72.5 111.098 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.49 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -71.94 172.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 71.24 111.135 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.25 172.09 0.25 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.596 0.712 . . . . 74.04 110.855 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.82 20.06 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 53.41 112.301 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 12' ' ' HIS . 2.7 pttt -125.95 21.87 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 73.33 110.918 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 62' ' ' ASP . . . 155.58 -178.49 32.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 74.54 112.485 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' C ' HG13 ' A' ' 11' ' ' ILE . 19.9 tp -149.83 168.23 24.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 75.23 110.931 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 -135.56 134.91 39.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 73.44 110.87 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.6 t -144.62 106.65 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 75.42 111.114 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.1 t -116.08 156.47 26.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 75.51 110.822 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.567 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 33.0 m -141.25 152.66 64.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.672 0.749 . . . . 62.04 111.088 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 120.91 7.61 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.628 2.218 . . . . 70.25 112.312 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 3.6 t70 -75.9 99.71 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 70.52 110.855 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -88.98 35.44 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 61.12 110.873 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.12 25.01 25.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 60.12 112.485 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 98.8 m-85 -73.05 168.1 19.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.913 0.387 . . . . 73.23 110.857 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.2 t -129.34 -8.15 4.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 62.44 110.839 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.561 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -159.62 142.06 13.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.95 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.567 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -137.19 150.97 48.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 71.32 110.876 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.17 143.81 40.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 64.54 111.133 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -126.52 119.76 27.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 75.44 110.884 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 5.8 m-70 -152.08 92.32 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.504 . . . . 72.54 110.846 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 75' ' ' PHE . . . -146.22 178.55 23.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 71.14 112.498 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.449 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -133.18 -164.81 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 61.44 110.907 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 36' ' ' GLU . 1.4 tp -132.56 152.33 51.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 72.42 110.921 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 41.27 25.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 61.34 110.916 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -164.01 136.86 5.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 71.04 110.915 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.42 163.81 12.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 73.25 110.839 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.556 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -112.42 -177.47 3.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 73.24 110.867 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -146.53 146.24 30.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 73.32 110.907 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.42 26.86 74.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 75.44 112.499 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.463 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 1.6 mt 47.46 84.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.313 . . . . 73.2 110.88 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.32 170.69 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 74.34 110.886 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -87.35 100.83 13.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 71.33 111.078 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.449 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . -66.93 -107.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 71.3 112.523 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.03 -71.82 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 72.31 110.907 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -53.73 148.35 10.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.975 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.543 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 52.4 p -155.45 119.74 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 61.23 110.889 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.57 160.97 11.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 74.03 110.89 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.02 114.7 9.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 75.14 110.87 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' PHE . 10.2 mm -94.57 97.51 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 70.3 111.124 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 46.2 p -95.38 29.7 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 74.04 111.158 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.92 133.06 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 74.41 110.902 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -178.14 2.18 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.675 2.25 . . . . 72.23 112.387 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -135.73 -34.39 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 74.24 110.924 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -138.77 49.2 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 72.33 110.909 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.87 -26.12 4.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 73.25 112.415 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.64 168.22 14.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.775 0.322 . . . . 74.04 110.897 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.481 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 13.9 m95 -90.25 87.96 7.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 73.32 110.908 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.9 mt -91.91 141.52 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.5 111.075 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.524 ' CE2' ' OD1' ' A' ' 62' ' ' ASP . 18.8 t80 -138.24 147.06 43.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 64.12 110.869 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 139.38 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 71.54 110.928 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -120.29 140.59 51.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 72.05 110.867 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.03 31.03 6.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 74.34 110.877 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.36 19.89 2.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 73.34 110.867 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.4 112.4 23.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 70.54 111.091 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -108.39 83.72 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 74.04 111.107 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.511 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -135.61 171.22 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.884 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.463 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -156.85 158.46 36.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.9 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.563 HG13 ' CE2' ' A' ' 98' ' ' PHE . 26.9 mm -32.16 115.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 72.15 111.136 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.24 -26.66 4.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.709 -0.757 . . . . 71.13 112.474 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.37 -172.5 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.914 0.388 . . . . 71.22 110.834 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.511 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -143.17 168.23 20.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.917 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.7 mt -145.24 143.18 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.145 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -147.43 108.69 4.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 73.11 110.948 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.43 ' CE2' HG22 ' A' ' 77' ' ' THR . 0.2 OUTLIER -164.07 -163.87 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 75.02 110.833 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.556 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -149.13 144.1 26.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 74.12 110.925 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.1 p -113.15 149.62 33.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 73.44 111.17 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.59 142.96 46.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.873 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.424 ' CG1' ' CD2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -141.8 170.83 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 74.42 111.14 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 80.1 mt -147.63 96.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 70.44 111.138 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 9.2 tttt -112.68 140.74 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.52 110.921 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 40.97 38.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 52.5 110.893 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.01 40.86 51.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 73.14 112.501 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 mt -105.09 -48.24 3.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 74.3 110.946 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.21 105.27 1.08 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.704 -0.76 . . . . 73.41 112.499 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -123.97 168.96 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.38 . . . . 75.52 110.9 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 77' ' ' THR . 3.7 ttp-105 -175.05 140.03 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 71.33 110.848 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.433 ' N ' ' HG2' ' A' ' 87' ' ' ARG . 3.2 tp-100 -84.19 155.47 22.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 74.35 110.869 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -137.97 -169.47 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 70.4 110.884 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 83.78 -33.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 71.41 110.884 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 41.13 83.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.8 -0.714 . . . . 71.42 112.429 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -169.66 112.98 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 75.45 110.9 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.499 ' CG ' HD11 ' A' ' 8' ' ' LEU . 16.7 m-90 -155.32 110.97 3.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 75.23 110.931 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 95.9 m -83.82 139.27 32.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 73.22 111.137 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.475 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 39.2 t -69.67 116.67 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 72.23 111.083 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -138.64 10.3 2.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.849 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -117.88 -178.11 17.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.771 -0.728 . . . . 73.42 112.512 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.563 ' CE2' HG13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -153.41 152.01 30.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 74.22 110.872 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -165.61 170.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 73.44 111.166 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.61 129.03 25.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 74.23 110.865 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -87.66 45.94 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 73.4 110.906 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 61.11 111.096 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 13.8 t80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.84 0.353 . . . . 75.23 110.954 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -149.74 87.71 1.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 74.22 110.882 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.46 ' CB ' ' OE1' ' A' ' 88' ' ' GLN . . . 61.0 143.61 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.605 0.717 . . . . 73.25 111.109 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 161.03 47.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.719 2.279 . . . . 74.15 112.323 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 134.58 28.27 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.694 2.263 . . . . 64.31 112.327 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.53 139.06 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 74.24 111.095 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -89.48 77.7 7.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 73.52 111.145 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mp -79.63 111.47 15.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 73.32 110.919 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -86.18 -155.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 72.02 110.848 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -144.21 80.96 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 65.02 111.074 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.495 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 4.0 mm -69.62 172.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 75.32 111.134 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.577 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -53.69 172.41 0.23 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.597 0.713 . . . . 64.13 110.861 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.2 Cg_endo -69.75 20.38 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.671 2.247 . . . . 74.21 112.356 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.519 ' H ' ' C ' ' A' ' 12' ' ' HIS . 1.2 ptmt -128.33 26.44 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.23 110.933 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.34 -178.81 29.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.749 . . . . 63.33 112.454 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' CD1' HD23 ' A' ' 67' ' ' LEU . 35.1 tp -150.78 167.07 28.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 71.21 110.896 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.404 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -129.33 141.1 51.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 72.1 110.871 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 62.4 t -153.17 105.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 75.43 111.1 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 t -116.31 164.28 14.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.23 110.874 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.7 m -143.15 151.65 56.02 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.668 0.747 . . . . 73.11 111.117 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 122.12 8.81 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 74.33 112.344 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -81.84 94.89 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 72.25 110.898 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -91.88 24.97 2.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 74.53 110.871 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.98 28.15 4.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.729 -0.748 . . . . 71.11 112.534 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 77.7 m-85 -78.41 165.83 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 73.52 110.839 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.0 t -128.79 -8.25 5.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 65.13 110.844 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.552 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -161.19 140.63 10.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 73.55 110.926 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.534 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 16.6 t80 -134.57 145.68 48.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 71.14 110.846 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.64 164.6 23.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 65.14 111.088 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.2 t80 -150.16 113.75 4.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 72.53 110.877 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -149.23 95.17 2.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 53.4 110.864 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.545 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -146.19 -175.36 19.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 74.44 112.474 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.414 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 mtpp -131.84 -165.12 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.324 . . . . 73.44 110.882 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.64 148.14 40.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.901 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.402 ' N ' HD21 ' A' ' 35' ' ' ASN . 1.0 OUTLIER 49.29 22.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.844 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.7 143.17 2.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 64.4 110.879 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -108.82 154.17 22.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 71.13 110.902 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -177.88 4.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.907 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -96.12 133.2 40.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 65.12 110.91 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.88 -92.49 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.735 . . . . 73.44 112.475 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 39' ' ' GLU . 1.0 OUTLIER -157.25 83.83 0.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 75.11 110.897 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 43' ' ' ALA . 7.9 pt-20 -124.31 -168.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 75.5 110.893 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.409 ' N ' ' HG3' ' A' ' 42' ' ' GLU . . . -94.01 106.6 18.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 73.42 111.095 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.414 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . -72.9 -109.15 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 71.45 112.485 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.88 -69.17 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 74.42 110.845 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.543 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 8.0 m0 -54.98 170.96 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 75.14 110.931 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.418 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 59.9 p -176.13 127.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 74.41 110.927 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.06 155.58 3.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 71.03 110.875 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.26 99.98 3.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.855 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.96 122.53 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.117 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.5 p -110.14 37.92 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 65.22 111.134 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 174.35 116.91 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.594 0.711 . . . . 70.13 110.871 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.543 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 54.0 Cg_endo -69.74 159.35 53.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.24 . . . . 73.43 112.375 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -142.12 131.88 24.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 72.03 110.909 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 1.9 t30 78.45 16.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 74.24 110.869 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.33 -23.87 33.74 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 74.32 112.454 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.52 171.79 13.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 71.31 110.856 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.543 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 9.4 m95 -86.87 101.06 13.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 75.54 110.919 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 mt -101.06 137.04 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 75.44 111.144 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -132.23 145.11 51.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.12 110.895 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.36 134.01 31.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.42 110.914 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.94 179.32 4.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 63.11 110.906 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 19.84 2.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.2 110.883 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -137.84 30.28 2.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 74.42 110.908 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -118.71 83.35 2.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.21 111.074 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.09 86.06 5.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 71.31 111.057 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.47 HD23 ' CD1' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -125.71 171.68 10.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.1 110.925 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -160.28 140.57 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 65.44 110.91 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.544 ' C ' ' O ' ' A' ' 68' ' ' LYS . 11.5 mm -24.26 118.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 72.22 111.093 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.27 -18.68 7.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.775 -0.726 . . . . 73.32 112.468 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.12 -176.76 4.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.339 . . . . 55.04 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -143.99 161.81 37.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 70.43 110.857 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.8 mt -138.93 145.66 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 75.43 111.108 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -146.15 103.01 3.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 74.02 110.89 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.545 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -162.14 -157.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 74.45 110.889 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.423 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.1 p-90 -150.93 173.74 13.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.932 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 p -143.05 158.74 43.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 73.14 111.172 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.16 144.48 45.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 73.41 110.829 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.498 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -143.69 169.52 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 72.42 111.111 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 66.9 mt -147.71 96.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 74.35 111.172 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -114.63 140.64 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.43 110.942 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.43 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 50.63 27.12 2.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 75.32 110.845 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.37 29.13 68.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 63.21 112.5 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.4 mt -98.98 -49.53 4.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 74.23 110.908 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.6 131.48 4.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 74.1 112.496 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -145.17 -179.24 6.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 74.41 110.935 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -172.24 133.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 75.34 110.897 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.46 ' OE1' ' CB ' ' A' ' 3' ' ' ALA . 4.3 tp60 -78.74 155.15 29.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 75.32 110.92 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.509 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -141.6 -163.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 75.31 110.87 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.509 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.7 t-20 83.05 -36.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 75.14 110.893 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.19 78.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 75.41 112.471 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -170.47 109.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.358 . . . . 74.42 110.925 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -151.14 112.89 4.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 74.53 110.928 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.9 m -86.85 130.92 34.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.43 111.066 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.85 116.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 74.12 111.128 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.0 15.2 3.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 74.22 110.895 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -130.44 -177.82 15.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 62.41 112.507 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.427 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -153.86 155.52 35.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.372 . . . . 71.35 110.872 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.424 HG22 ' C ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -166.71 168.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 75.43 111.151 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.34 133.92 39.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 74.33 110.876 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.17 39.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 74.04 110.851 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 73.12 111.099 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.814 0.34 . . . . 75.04 110.936 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -126.18 71.64 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 74.44 110.855 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.12 143.54 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.612 0.72 . . . . 64.14 111.062 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.483 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.8 Cg_endo -69.74 166.95 25.83 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.653 2.235 . . . . 72.24 112.365 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 132.65 23.77 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.683 2.255 . . . . 72.52 112.379 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.538 ' N ' HE22 ' A' ' 88' ' ' GLN . . . -83.12 138.24 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 61.4 111.103 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.5 m -95.59 78.03 3.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 74.15 111.138 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 mp -79.32 109.31 13.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 64.33 110.969 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 6.7 mm-40 -79.99 -171.79 3.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 73.42 110.924 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HB1' ' CG1' ' A' ' 95' ' ' VAL . . . -130.46 81.26 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 72.13 111.119 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.477 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 2.9 mm -72.66 172.52 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 73.45 111.12 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.568 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.34 172.01 0.26 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.605 0.717 . . . . 65.23 110.849 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.73 19.86 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 74.03 112.373 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 12' ' ' HIS . 11.1 ptmt -124.66 19.94 8.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.887 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.21 -177.44 33.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.796 -0.716 . . . . 60.33 112.486 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.46 ' C ' HG13 ' A' ' 11' ' ' ILE . 19.8 tp -150.89 168.98 22.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 74.35 110.888 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -132.92 139.44 47.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.54 110.86 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -147.83 108.28 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.137 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.8 t -119.5 157.41 28.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 71.13 110.859 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 m -141.6 151.58 60.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.644 0.735 . . . . 63.44 111.138 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 122.21 8.89 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.713 2.275 . . . . 72.52 112.326 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.464 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 28.4 t0 -84.55 86.12 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 75.04 110.86 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -73.08 2.52 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.852 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.33 24.24 0.86 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.737 . . . . 74.31 112.511 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.53 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 81.4 m-85 -70.45 168.34 16.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 74.05 110.866 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t -125.39 -16.03 6.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 63.53 110.893 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.567 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -158.34 140.14 13.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 74.1 110.944 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.645 ' CE2' ' CZ ' ' A' ' 30' ' ' PHE . 8.3 t80 -132.77 151.5 51.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 74.32 110.883 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.74 155.39 48.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 71.34 111.082 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.645 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.4 m-85 -128.88 131.28 47.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 64.41 110.849 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.478 ' CE1' ' HB3' ' A' ' 43' ' ' ALA . 14.0 m-70 -157.63 84.97 0.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 71.43 110.868 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -144.55 177.47 23.08 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 74.41 112.491 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.428 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -136.21 -166.23 1.84 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 75.24 110.905 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 36' ' ' GLU . 13.7 tp -127.38 148.12 50.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 73.2 110.889 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 43.14 23.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.886 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 34' ' ' LEU . 2.0 tp10 -157.67 145.54 18.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.907 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.448 ' CB ' ' HB2' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -125.09 150.42 46.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 62.51 110.849 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.436 ' CE ' ' O ' ' A' ' 31' ' ' HIS . 2.3 ptt? -102.73 -172.53 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 72.11 110.88 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.95 172.52 12.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 62.2 110.892 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 48.25 37.03 17.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 55.11 112.483 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.53 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.2 OUTLIER 35.05 83.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 73.24 110.864 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -124.79 -164.34 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 72.04 110.882 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.478 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . . . -102.61 99.98 10.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 70.2 111.083 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 43' ' ' ALA . . . -56.74 -114.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.759 . . . . 74.42 112.522 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.55 -65.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 72.23 110.857 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -60.01 154.83 18.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 73.01 110.941 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.432 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 99.3 p -158.01 109.22 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 71.31 110.836 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.73 162.92 40.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 74.2 110.871 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -143.65 113.73 7.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 74.35 110.893 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.2 mm -99.85 103.9 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 64.51 111.177 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 76.6 p -96.06 30.47 2.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.169 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 175.46 132.8 0.15 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 74.41 110.945 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 178.68 4.35 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.634 2.222 . . . . 64.24 112.363 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.53 -30.41 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 74.53 110.878 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -146.27 47.66 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 73.24 110.863 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.13 -26.26 7.04 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 53.02 112.459 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.88 164.42 21.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.827 0.346 . . . . 74.33 110.845 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.464 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 5.9 m95 -87.16 96.2 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 75.31 110.946 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.0 mt -102.75 142.04 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 70.42 111.155 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -134.98 154.28 51.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 74.43 110.91 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.76 135.4 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.869 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD2' ' ND2' ' A' ' 64' ' ' ASN . 6.0 t70 -112.22 174.97 5.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 74.43 110.839 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -139.42 15.46 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 74.32 110.844 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.492 ' ND2' ' OD2' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -129.44 4.94 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.888 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.16 98.13 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 73.21 111.102 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.45 87.53 4.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 75.52 111.086 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.464 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -138.79 171.17 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 64.33 110.911 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.464 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -157.73 156.57 31.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 72.24 110.943 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.4 mm -32.01 118.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 75.42 111.189 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.26 -23.56 6.43 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 62.41 112.516 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.9 -170.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 73.05 110.88 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.8 OUTLIER -147.91 162.05 40.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 63.43 110.924 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 74' ' ' TYR . 96.4 mt -136.87 145.9 29.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 74.24 111.114 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -148.4 111.42 4.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.959 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.6 p90 -171.98 -163.45 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 75.14 110.913 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.53 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -152.18 145.6 24.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 71.1 110.895 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.483 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 11.2 p -113.45 161.11 17.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 74.2 111.153 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.55 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -119.17 144.77 46.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 74.21 110.884 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.53 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -139.24 166.14 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.35 111.178 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 90.7 mt -143.26 96.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 71.22 111.15 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.454 ' HG2' ' N ' ' A' ' 82' ' ' ASP . 4.9 tttt -118.66 146.36 44.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 75.2 110.918 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.454 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 52.15 22.26 1.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 64.53 110.858 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.15 27.67 71.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.754 . . . . 64.23 112.499 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mt -100.05 -65.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 73.25 110.917 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.39 124.85 4.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.688 -0.768 . . . . 31.32 112.464 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -136.71 178.0 7.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.394 . . . . 74.0 110.89 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.55 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -164.2 123.97 2.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 74.32 110.886 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.538 HE22 ' N ' ' A' ' 6' ' ' ALA . 1.9 tt0 -52.85 -173.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.897 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -170.49 -166.25 0.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 62.3 110.885 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER 83.53 -32.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 74.45 110.873 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 33.9 61.76 0.48 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.71 -0.757 . . . . 74.12 112.495 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -167.88 106.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 74.01 110.91 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 25.7 m-90 -145.42 115.51 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 71.01 110.889 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 60.5 m -87.31 133.16 33.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 65.54 111.149 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.47 ' CG1' ' HB1' ' A' ' 10' ' ' ALA . 21.6 t -63.38 107.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 72.0 111.143 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.75 5.21 7.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 75.2 110.892 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.462 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -117.53 179.76 17.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 75.1 112.464 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.421 ' C ' HG21 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -152.96 155.52 37.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.904 0.383 . . . . 74.42 110.872 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -164.51 -176.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 72.43 111.14 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -141.88 129.6 21.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 63.5 110.893 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -80.23 58.71 3.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.33 110.897 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 74.4 111.109 179.927 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.563 ' CD1' ' C ' ' A' ' 1' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.819 0.343 . . . . 75.05 110.91 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 1' ' ' TYR . 39.6 mt-10 -162.53 68.68 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 73.15 110.9 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 2' ' ' GLU . . . -33.22 142.07 0.2 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.576 0.703 . . . . 61.35 111.125 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 154.62 67.62 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.71 2.273 . . . . 74.53 112.315 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 134.47 28.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.672 2.248 . . . . 73.31 112.336 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -86.24 137.92 32.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 72.31 111.11 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 m -93.18 77.19 4.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 74.22 111.122 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.458 HD13 ' CG ' ' A' ' 93' ' ' TRP . 1.9 mp -77.94 110.87 13.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 74.52 110.911 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -87.26 -167.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 75.52 110.858 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.542 ' CB ' ' CG1' ' A' ' 95' ' ' VAL . . . -134.32 80.51 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 71.2 111.131 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.495 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 4.5 mm -69.38 172.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 72.45 111.122 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -53.85 172.03 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 73.25 110.817 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.9 Cg_endo -69.77 21.43 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 75.41 112.347 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.524 ' H ' ' C ' ' A' ' 12' ' ' HIS . 7.5 pttt -128.82 25.07 5.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 75.33 110.884 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.29 -177.9 30.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 51.11 112.488 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.47 ' CD1' HD23 ' A' ' 67' ' ' LEU . 24.6 tp -150.71 157.97 43.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.347 . . . . 75.11 110.919 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 74.8 ttt180 -122.75 135.25 54.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 72.52 110.889 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.7 t -147.06 108.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 75.53 111.095 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.4 t -120.56 162.2 20.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.897 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -141.04 152.03 63.87 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.646 0.736 . . . . 74.41 111.102 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 123.98 10.65 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.646 2.231 . . . . 72.34 112.364 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 17.0 t0 -87.82 107.05 18.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 74.43 110.889 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -96.09 6.81 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 74.24 110.893 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.48 8.97 2.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 73.24 112.462 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.509 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 63.5 m-85 -60.27 168.5 1.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.328 . . . . 71.41 110.887 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -128.95 -7.39 4.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.33 110.854 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.562 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -156.32 143.06 18.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 75.23 110.915 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.539 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 16.3 t80 -139.73 139.32 36.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 75.5 110.882 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.44 158.86 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 73.24 111.141 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.46 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.1 t80 -145.75 114.65 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 65.51 110.891 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.549 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -147.35 94.87 2.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 73.35 110.846 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.62 177.61 23.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 75.03 112.456 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.55 -164.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 75.21 110.905 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 15.0 tp -136.31 148.53 47.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 74.44 110.954 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 48.96 19.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 71.42 110.894 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -161.24 142.7 11.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 73.02 110.888 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.03 156.69 22.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 73.43 110.897 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.599 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -100.75 -178.98 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 64.35 110.821 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.26 136.51 51.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 71.52 110.87 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.21 -91.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 74.12 112.498 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.8 OUTLIER -164.56 91.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.751 0.31 . . . . 63.43 110.916 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -129.28 173.88 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 75.53 110.843 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -85.66 101.67 12.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 71.42 111.069 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.23 -119.58 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 71.43 112.483 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -103.41 -51.75 3.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 75.01 110.877 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.567 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 8.3 m0 -70.19 165.42 22.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.922 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.549 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 96.0 p -164.65 124.25 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 73.5 110.847 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.493 ' HG2' ' CD1' ' A' ' 60' ' ' PHE . 17.0 tpp180 -165.44 144.26 6.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 73.21 110.872 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.39 99.31 3.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.868 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mm -87.87 115.42 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 64.41 111.115 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.401 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 63.8 p -103.78 33.47 3.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 64.45 111.134 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.6 OUTLIER 167.84 127.38 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.605 0.717 . . . . 74.01 110.903 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 171.17 15.01 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.687 2.258 . . . . 73.1 112.32 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.82 19.45 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 60.21 110.907 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -177.56 38.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 75.41 110.917 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.47 -13.62 15.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 75.33 112.452 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.05 160.54 40.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.805 0.336 . . . . 75.21 110.873 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.451 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 3.9 m95 -85.79 101.39 12.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 75.22 110.949 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 7.7 mt -104.32 143.78 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 73.2 111.121 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.493 ' CD1' ' HG2' ' A' ' 48' ' ' ARG . 13.1 t80 -132.27 147.89 52.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 75.44 110.939 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.439 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -140.93 127.45 20.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 74.01 110.886 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.567 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 2.5 t0 -104.47 -179.53 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 65.42 110.853 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -148.95 28.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 75.44 110.865 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -144.88 13.58 1.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 65.01 110.876 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.03 100.09 9.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 73.2 111.142 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.54 86.55 4.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 62.45 111.094 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.47 HD23 ' CD1' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -125.62 171.55 10.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 74.15 110.895 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.501 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -152.79 140.49 19.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 75.32 110.931 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.53 HG12 ' CD1' ' A' ' 98' ' ' PHE . 17.1 mm -28.23 118.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 71.34 111.096 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.67 -22.04 5.56 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.749 -0.739 . . . . 71.1 112.474 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.84 -166.87 0.32 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 65.24 110.898 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -147.33 172.16 14.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 73.33 110.871 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.2 mt -144.72 144.69 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 75.11 111.129 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.3 100.75 3.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 74.3 110.87 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.452 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -159.5 -156.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 72.41 110.826 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.599 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -152.46 156.68 39.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.51 110.918 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 p -118.82 175.38 5.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 74.45 111.176 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.426 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -146.95 130.46 16.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 70.24 110.905 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.462 ' CG2' ' HB2' ' A' ' 86' ' ' TYR . 3.3 m -134.13 -179.03 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 74.34 111.138 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.419 HG13 ' C ' ' A' ' 79' ' ' VAL . 83.1 mt -153.37 97.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 74.1 111.108 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.509 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 16.1 tttm -113.1 135.19 54.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 75.32 110.9 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.3 t0 50.51 25.1 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.25 110.851 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.98 30.04 73.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 54.21 112.511 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.0 mt -92.53 -66.87 0.89 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.359 . . . . 75.4 110.915 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.59 116.09 4.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.755 . . . . 60.13 112.495 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.555 ' CD1' ' N ' ' A' ' 86' ' ' TYR . 0.5 OUTLIER -127.33 166.46 17.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.879 0.371 . . . . 74.03 110.902 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.426 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -160.33 110.67 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 74.52 110.904 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.74 157.9 13.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 74.45 110.924 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -146.72 -169.11 3.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.3 110.849 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.6 m120 83.93 -28.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 73.43 110.862 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 34.41 78.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 73.34 112.492 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -165.96 104.14 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 75.41 110.887 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.458 ' CG ' HD13 ' A' ' 8' ' ' LEU . 19.4 m-90 -145.95 113.28 6.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 74.31 110.939 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.415 HG21 ' N ' ' A' ' 95' ' ' VAL . 93.1 m -82.07 140.07 34.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 75.1 111.138 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.542 ' CG1' ' CB ' ' A' ' 10' ' ' ALA . 21.2 t -78.64 111.61 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 74.3 111.133 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -138.66 16.32 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 74.53 110.861 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -139.38 121.7 2.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.78 -0.724 . . . . 62.24 112.527 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.53 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -91.02 170.08 10.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.91 0.386 . . . . 74.03 110.895 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.442 HG21 ' C ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -168.03 155.16 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 71.32 111.127 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -115.18 127.35 55.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 65.12 110.864 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -89.81 39.5 0.96 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 75.45 110.924 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 73.02 111.132 179.927 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.864 0.364 . . . . 73.33 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -142.57 73.13 1.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 71.0 110.911 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.71 145.03 0.11 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 71.4 111.075 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 54.2 Cg_endo -69.66 168.3 21.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.267 . . . . 73.33 112.358 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 132.72 23.96 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 73.24 112.356 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.01 134.92 35.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 51.25 111.085 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -93.12 77.16 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 75.55 111.117 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 mp -79.34 107.18 11.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 64.34 110.928 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 99' ' ' VAL . 6.6 mm-40 -79.92 -173.58 3.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -129.68 79.65 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 71.11 111.047 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.499 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.2 mm -70.6 172.61 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 74.14 111.139 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.559 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.0 OUTLIER -53.05 171.54 0.22 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 73.32 110.839 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.559 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.5 Cg_endo -69.79 19.77 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.686 2.257 . . . . 72.13 112.307 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 12' ' ' HIS . 25.5 pttt -127.91 25.43 5.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 72.42 110.921 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.55 -179.98 30.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.754 -0.736 . . . . 71.55 112.498 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.469 ' CD1' HD22 ' A' ' 67' ' ' LEU . 20.5 tp -149.97 158.3 44.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 74.1 110.902 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.41 ' HB2' ' CD1' ' A' ' 11' ' ' ILE . 11.4 ttt180 -126.37 132.55 51.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.88 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 54.2 t -141.29 114.03 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 73.32 111.129 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.8 t -119.96 156.56 30.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 72.22 110.85 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.4 m -139.01 152.67 70.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.589 0.709 . . . . 74.25 111.168 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 121.36 8.05 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.727 2.285 . . . . 72.01 112.313 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.598 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.1 t70 -55.69 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 70.23 110.881 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' A' ' 22' ' ' ASP . 0.9 OUTLIER 83.46 -13.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 75.44 110.874 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.83 6.47 2.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 74.33 112.516 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CD2' ' O ' ' A' ' 22' ' ' ASP . 36.1 m-85 -53.8 166.74 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 74.12 110.865 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 80' ' ' ILE . 11.4 t -133.08 -2.25 3.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 73.41 110.822 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.557 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -171.45 139.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 75.43 110.892 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.548 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 13.3 t80 -133.77 152.5 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 75.5 110.871 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.79 158.87 43.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 75.53 111.113 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.478 ' CE1' ' CE2' ' A' ' 75' ' ' PHE . 1.5 t80 -139.2 127.27 22.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 71.13 110.871 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.529 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 7.3 m-70 -152.89 88.04 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.2 110.859 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.505 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.27 -176.67 20.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 64.44 112.47 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.416 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -134.8 -164.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 74.11 110.863 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.1 tp -131.94 147.02 52.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 74.55 110.875 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 39.92 30.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 74.42 110.859 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.03 127.6 4.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.45 110.893 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -99.96 146.81 26.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 74.33 110.864 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.0 ptp -101.98 -174.92 2.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 72.2 110.881 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.37 154.65 42.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 75.22 110.909 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 56.52 36.29 70.09 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 53.34 112.508 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 40' ' ' GLY . 4.1 mt 35.72 84.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 74.53 110.937 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -124.61 178.41 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 74.52 110.877 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.83 98.26 10.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 73.12 111.137 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.96 -116.35 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.694 -0.765 . . . . 74.1 112.503 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.74 -58.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.752 0.31 . . . . 63.5 110.837 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -69.66 146.96 51.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 74.54 110.936 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.529 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 77.7 p -155.12 120.18 4.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 75.24 110.812 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.46 ' CD ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -162.14 158.85 25.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 75.22 110.92 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.56 116.19 8.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 71.14 110.835 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.46 HD13 ' CD ' ' A' ' 48' ' ' ARG . 21.5 mm -98.76 108.17 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 73.33 111.144 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -98.23 31.84 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 75.25 111.106 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.23 115.59 0.27 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.656 0.741 . . . . 74.44 110.858 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 53.7 Cg_endo -69.71 178.16 4.82 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.66 2.24 . . . . 74.13 112.377 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -169.88 133.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 75.3 110.902 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 7.1 t-20 81.62 8.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 71.42 110.92 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.88 -16.84 42.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 74.21 112.542 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.1 176.01 9.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 72.14 110.911 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.551 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 6.9 m95 -93.41 107.91 19.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 71.54 110.893 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 11.1 mt -106.21 146.62 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 72.24 111.111 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -136.38 144.53 44.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 73.51 110.85 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.51 133.43 40.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 73.13 110.859 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.78 155.1 31.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 70.31 110.864 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -123.31 41.9 3.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 63.32 110.862 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.87 24.02 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 64.24 110.854 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.3 93.1 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.45 111.129 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.38 81.1 6.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 70.24 111.11 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.469 HD22 ' CD1' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -121.91 171.52 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 73.14 110.948 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.569 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -157.74 138.45 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.935 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.569 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.8 mm -22.65 118.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 75.41 111.181 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.94 -18.12 7.09 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 65.03 112.472 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.97 -169.19 1.47 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.866 0.365 . . . . 73.43 110.908 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.9 mttt -150.34 161.67 42.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 73.13 110.937 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.46 HG23 ' N ' ' A' ' 74' ' ' TYR . 82.3 mt -135.63 146.65 29.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 74.15 111.145 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.9 m-85 -147.59 107.01 3.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 75.21 110.903 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.505 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.4 p90 -167.67 -167.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 71.34 110.883 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.9 p-90 -135.97 163.11 31.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 73.01 110.943 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 p -131.35 164.4 25.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 64.24 111.133 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.67 141.64 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 75.31 110.912 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.505 ' HB ' ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -141.03 167.3 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.25 111.137 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 26' ' ' SER . 94.1 mt -149.89 95.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 75.03 111.094 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.566 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -109.84 137.49 47.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 73.21 110.891 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 43.4 34.95 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 72.01 110.909 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.69 37.73 92.77 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 73.24 112.461 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.81 -55.11 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 64.32 110.94 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.11 113.22 1.13 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 73.22 112.482 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -132.23 -178.72 5.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 75.44 110.918 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -174.09 135.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 73.01 110.849 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 4' ' ' PRO . 1.4 tp-100 -86.1 153.19 22.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 75.45 110.881 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -135.19 -163.91 1.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 73.02 110.884 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.4 t-20 83.73 -37.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 73.45 110.896 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.51 79.12 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.77 -0.728 . . . . 75.24 112.479 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -170.14 110.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 75.23 110.886 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -151.52 115.4 4.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.33 110.921 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.5 m -87.06 131.18 34.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 73.22 111.185 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.403 HG21 ' CD1' ' A' ' 67' ' ' LEU . 28.8 t -63.21 116.33 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 74.1 111.123 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.04 6.1 3.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 75.41 110.875 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -115.82 -178.55 18.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 71.1 112.461 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.406 ' C ' HG21 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.7 155.7 33.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 71.22 110.89 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -167.76 178.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 64.54 111.119 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.38 133.61 27.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 72.23 110.905 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -85.24 44.89 1.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 75.12 110.882 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.4 111.074 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.865 0.364 . . . . 73.03 110.928 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -145.95 86.32 1.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 62.41 110.889 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.93 148.5 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 75.55 111.126 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 169.11 19.6 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.281 . . . . 62.45 112.369 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 133.37 25.28 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 72.04 112.35 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.68 140.54 32.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 73.11 111.063 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m -100.77 78.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 71.13 111.175 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 mp -78.27 110.18 13.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 75.4 110.925 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.19 -160.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 75.2 110.891 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 97' ' ' GLY . . . -139.92 80.34 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 71.21 111.118 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.484 ' CG2' ' H ' ' A' ' 12' ' ' HIS . 3.3 mm -72.19 172.69 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 73.43 111.179 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' A' ' 13' ' ' PRO . 0.1 OUTLIER -54.18 172.09 0.25 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.712 . . . . 71.23 110.858 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.2 Cg_endo -69.82 20.07 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.665 2.243 . . . . 75.35 112.3 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 12' ' ' HIS . 3.0 pttt -125.1 19.8 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 75.23 110.902 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.78 -177.3 33.77 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 71.33 112.492 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' C ' HG13 ' A' ' 11' ' ' ILE . 27.8 tp -150.98 167.93 26.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.804 0.335 . . . . 75.3 110.922 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.2 ttm180 -130.78 141.08 50.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.879 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -149.59 107.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 74.11 111.121 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.7 t -120.18 156.3 31.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 72.14 110.871 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.575 HG23 ' CZ ' ' A' ' 28' ' ' PHE . 3.1 m -145.08 151.76 49.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 73.04 111.139 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 121.2 7.9 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.677 2.251 . . . . 74.13 112.339 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.538 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 1.2 t70 -75.7 130.84 39.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.872 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.7 23.93 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 73.41 110.836 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 112.8 5.91 23.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.736 . . . . 74.52 112.468 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.56 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 66.7 m-85 -55.62 162.54 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 74.13 110.897 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.3 t -129.84 -8.9 4.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 73.03 110.879 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.558 ' CD1' ' C ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -158.64 141.85 14.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 74.24 110.936 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CZ ' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -135.65 150.39 49.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.24 110.841 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.422 ' CB ' ' OD1' ' A' ' 49' ' ' ASP . . . -141.0 136.75 32.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 74.45 111.083 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.62 118.28 30.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.84 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.488 ' NE2' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -146.0 90.58 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 72.41 110.881 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' A' ' 75' ' ' PHE . . . -146.24 -178.31 21.56 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 73.41 112.494 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -132.76 -164.3 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 72.24 110.909 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HG ' ' ND2' ' A' ' 35' ' ' ASN . 14.0 tp -133.18 147.94 52.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 65.42 110.965 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.467 ' ND2' ' HG ' ' A' ' 34' ' ' LEU . 2.2 m120 43.39 24.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.881 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -166.49 143.09 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 70.52 110.938 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -105.51 -170.55 1.76 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 74.01 110.907 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.508 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 2.1 ptt? -137.96 178.84 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 71.02 110.866 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' A' ' 40' ' ' GLY . 1.4 mt-10 -45.16 171.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.895 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.5 ' C ' ' O ' ' A' ' 39' ' ' GLU . . . -30.04 -49.21 0.15 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.754 -0.736 . . . . 71.13 112.442 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.46 ' HA ' ' NE1' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -170.03 84.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.778 0.323 . . . . 74.1 110.944 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 43' ' ' ALA . 3.9 pt-20 -127.9 -152.95 0.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 70.14 110.937 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.481 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . . . -104.62 107.15 17.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 73.54 111.11 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.508 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . -61.09 -121.6 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 73.1 112.483 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.43 -69.87 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 72.14 110.897 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.446 ' O ' ' ND1' ' A' ' 31' ' ' HIS . 6.1 m-90 -47.47 164.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 73.32 110.915 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.488 ' CB ' ' NE2' ' A' ' 31' ' ' HIS . 97.0 p -166.31 117.39 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 74.23 110.878 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.56 162.43 21.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 74.3 110.874 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.422 ' OD1' ' CB ' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -139.44 108.38 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 74.34 110.915 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 28' ' ' PHE . 3.4 mm -82.94 104.2 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 65.02 111.095 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.1 p -91.94 28.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 72.11 111.136 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.34 140.78 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.555 0.693 . . . . 75.02 110.885 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 178.25 4.74 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.739 2.293 . . . . 73.54 112.298 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -109.9 -55.53 2.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 71.2 110.926 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.02 75.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 73.3 110.906 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.61 -22.22 6.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 74.43 112.481 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -137.98 171.89 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 75.45 110.906 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . 0.56 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 18.9 m95 -93.58 98.44 11.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.922 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -99.97 150.67 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 74.05 111.132 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -146.1 147.41 31.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 63.34 110.935 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.29 127.46 22.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 74.11 110.869 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -98.6 -179.55 4.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 73.21 110.871 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.59 16.17 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 73.35 110.879 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -133.43 6.93 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 75.43 110.871 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.68 103.28 15.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 75.02 111.09 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.61 83.01 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 75.12 111.057 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.465 ' CD1' HG23 ' A' ' 95' ' ' VAL . 0.5 OUTLIER -122.38 171.6 8.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 75.41 110.917 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -158.45 141.62 14.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 72.23 110.888 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.537 ' C ' ' O ' ' A' ' 68' ' ' LYS . 5.2 mm -26.0 117.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 74.12 111.168 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.31 -17.15 10.54 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.803 -0.713 . . . . 63.04 112.507 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.83 -167.98 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 73.43 110.892 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -151.52 165.56 33.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.34 110.918 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.8 mt -141.26 151.12 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 74.01 111.143 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.28 101.1 2.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.25 110.87 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CB ' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -160.1 -166.35 1.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.872 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.46 ' NE1' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.4 148.64 32.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 74.13 110.902 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 p -115.07 155.61 26.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.431 . . . . 75.42 111.173 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.02 142.97 49.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 74.11 110.877 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.486 HG12 ' CE2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -142.68 170.72 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 72.53 111.098 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 77.5 mt -146.5 96.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 74.4 111.151 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.422 ' HG3' ' C ' ' A' ' 24' ' ' GLY . 1.6 tttt -114.15 141.58 47.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.41 110.947 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 49.14 32.44 4.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 72.15 110.852 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.08 30.11 60.27 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 75.24 112.476 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.5 mt -96.85 -63.6 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 65.05 110.923 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.09 106.11 3.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 72.22 112.452 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -119.47 171.72 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 75.33 110.875 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 6.8 ttp-105 -171.33 131.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 75.01 110.895 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -74.08 158.93 33.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 72.13 110.923 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.4 OUTLIER -140.83 -164.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 74.5 110.869 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.2 t-20 83.75 -42.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.23 110.907 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.52 70.48 0.75 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 64.51 112.473 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -170.02 117.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 73.34 110.895 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -155.23 118.65 4.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 74.14 110.942 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.8 m -87.6 132.04 34.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 72.53 111.147 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.465 HG23 ' CD1' ' A' ' 67' ' ' LEU . 32.8 t -67.29 112.3 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 74.52 111.159 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -129.42 10.92 5.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 73.2 110.897 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 10' ' ' ALA . . . -122.65 -177.0 15.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 72.22 112.473 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.445 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -154.04 155.76 36.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.372 . . . . 72.43 110.861 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.48 -176.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 72.23 111.153 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -151.95 132.57 13.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 60.53 110.829 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -102.93 46.14 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 73.25 110.897 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 64.24 111.078 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 121.62 0.724 . . . . 54.43 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.26 24.92 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 73.1 112.333 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 134.19 27.32 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.686 2.257 . . . . 74.45 112.342 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.921 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.55 136.02 35.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 71.22 111.112 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.4 m -95.6 77.57 3.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 74.01 111.107 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -79.42 110.17 14.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 71.22 110.912 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.789 ' O ' HD11 ' A' ' 16' ' ' LEU . 12.9 mm-40 -79.8 -165.61 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 64.42 110.903 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.823 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -134.95 80.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 60.3 111.103 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.702 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.6 mm -70.81 172.5 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 74.15 111.127 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.702 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.79 172.37 0.23 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.573 0.702 . . . . 60.12 110.853 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.79 20.02 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.614 2.209 . . . . 63.03 112.378 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 12' ' ' HIS . 3.8 ptpt -126.78 24.04 6.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 70.02 110.885 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.91 -178.48 30.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 42.41 112.498 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.789 HD11 ' O ' ' A' ' 9' ' ' GLU . 29.1 tp -150.52 164.11 36.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.857 0.361 . . . . 64.31 110.892 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.618 ' HB2' HD11 ' A' ' 11' ' ' ILE . 49.6 ttt180 -127.61 137.61 52.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 71.13 110.863 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.8 t -145.6 108.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 72.42 111.11 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.5 t -122.3 156.45 33.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 73.34 110.919 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 6' ' ' ALA . 10.4 m -141.36 150.86 59.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.633 0.73 . . . . 72.35 111.117 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 122.27 8.95 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.725 2.283 . . . . 71.14 112.348 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 15.0 t70 -83.81 128.74 34.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.1 110.844 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -117.97 2.21 12.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 51.01 110.916 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.27 31.08 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 62.53 112.452 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.518 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 63.3 m-85 -82.27 160.9 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 53.21 110.897 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.7 t -126.48 -13.52 6.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 53.42 110.856 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.035 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -153.64 140.17 18.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 70.11 110.959 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.035 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -133.75 143.72 48.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 64.03 110.861 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.03 129.35 43.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 74.51 111.171 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -115.24 120.62 40.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.941 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -151.58 91.07 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 55.05 110.864 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -145.96 -177.6 20.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.777 -0.725 . . . . 62.03 112.484 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -135.3 -166.44 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 73.25 110.847 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' ASN . 9.5 tp -128.07 147.35 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 62.3 110.886 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 34' ' ' LEU . 3.0 m120 36.47 34.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 65.3 110.929 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 34' ' ' LEU . 1.2 tp10 -163.43 129.16 3.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 65.13 110.922 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -102.74 150.21 23.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 64.3 110.87 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 64.35 110.898 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.435 -0.266 . . . . 74.21 112.435 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -103.27 -53.32 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 74.21 110.861 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.9 m-90 -73.25 147.47 44.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.219 -0.446 . . . . 70.12 110.881 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.2 p -151.27 119.01 6.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 60.22 110.88 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.92 163.12 4.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 71.34 110.889 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -142.82 119.37 11.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 45.43 110.88 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 28' ' ' PHE . 5.5 mm -86.17 109.98 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 63.53 111.138 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 p -94.79 28.01 2.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 71.12 111.174 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt 171.22 135.66 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.562 0.696 . . . . 62.35 110.908 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -175.57 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.679 2.253 . . . . 74.34 112.399 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.619 ' HD2' HD12 ' A' ' 59' ' ' ILE . 1.2 ttmm -157.16 109.57 2.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 60.34 110.867 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER 82.68 15.14 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 54.23 110.855 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.67 -17.5 49.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 62.21 112.444 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.86 160.4 37.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 71.31 110.865 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.539 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 20.1 m95 -84.69 94.17 8.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 73.05 110.946 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.619 HD12 ' HD2' ' A' ' 54' ' ' LYS . 21.7 mt -97.72 143.12 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 71.23 111.102 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -138.55 153.52 48.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 62.01 110.864 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.99 137.41 26.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 73.3 110.873 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.433 ' OD2' ' CG ' ' A' ' 64' ' ' ASN . 1.1 t70 -112.19 -177.67 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.894 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -143.49 10.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 73.43 110.85 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.433 ' CG ' ' OD2' ' A' ' 62' ' ' ASP . 22.1 p30 -127.28 9.87 6.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 73.22 110.844 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.24 101.06 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.35 111.085 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -100.85 88.74 3.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 64.54 111.162 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.743 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -136.33 171.22 14.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 63.24 110.951 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.669 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.29 154.48 32.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 63.23 110.906 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.616 ' CG1' ' CE2' ' A' ' 98' ' ' PHE . 16.2 mm -32.14 115.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 75.2 111.106 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.8 -20.53 6.4 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.686 -0.769 . . . . 55.32 112.455 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.69 -173.75 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.881 0.372 . . . . 75.32 110.849 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.5 mttt -149.56 159.68 44.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.45 110.894 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 33' ' ' LYS . 10.4 mt -134.26 148.1 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 74.4 111.113 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -147.75 105.55 3.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 64.53 110.938 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 2.3 p90 -163.68 -159.44 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 74.23 110.855 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.431 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.9 p-90 -145.44 168.58 20.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 70.42 110.92 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.403 HG23 ' CE2' ' A' ' 75' ' ' PHE . 1.7 p -139.92 147.59 40.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 73.32 111.152 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -112.92 141.01 47.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 75.53 110.884 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.405 ' C ' HG13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -139.69 171.2 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.14 111.112 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.624 HG13 HD12 ' A' ' 27' ' ' LEU . 97.4 mt -150.24 96.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 61.43 111.111 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.51 135.85 53.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.89 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 48.43 33.37 3.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 64.35 110.897 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.69 31.0 63.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 71.42 112.524 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.536 HD13 ' OH ' ' A' ' 86' ' ' TYR . 29.7 mt -95.19 -56.54 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.882 0.372 . . . . 64.11 110.921 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.14 113.93 2.92 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 52.2 112.462 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.536 ' OH ' HD13 ' A' ' 84' ' ' LEU . 97.4 m-85 -133.4 170.67 15.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 75.03 110.9 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -170.86 137.82 1.29 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 72.41 110.919 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.405 ' N ' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -85.75 152.22 23.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 72.34 110.898 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -134.35 -166.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.828 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 82.92 -36.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.86 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 43.47 80.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 65.3 112.469 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -168.74 113.43 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 74.1 110.91 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -151.09 121.56 7.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.187 -0.46 . . . . 71.54 110.9 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.4 m -92.96 134.56 34.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 64.42 111.143 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.823 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 21.4 t -63.61 121.24 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 63.34 111.145 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.1 34.05 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 63.42 110.891 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -162.9 125.52 1.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.7 -0.762 . . . . 50.54 112.509 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.616 ' CE2' ' CG1' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -94.92 163.89 13.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 75.12 110.886 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.649 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.48 167.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 74.13 111.13 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.34 130.31 50.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 62.01 110.876 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.36 57.07 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.51 110.862 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 71.44 111.121 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.541 0.686 . . . . 63.4 111.156 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.443 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.7 Cg_endo -69.75 166.01 29.03 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.65 2.233 . . . . 44.24 112.37 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 134.25 27.39 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.667 2.245 . . . . 75.0 112.327 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.752 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.01 140.41 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 61.54 111.086 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -97.1 78.7 2.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 75.52 111.146 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.5 HD21 ' CE1' ' A' ' 75' ' ' PHE . 1.7 mp -76.15 110.79 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 73.14 110.938 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.708 ' O ' HD11 ' A' ' 16' ' ' LEU . 4.8 mm-40 -84.5 -168.54 2.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 75.32 110.848 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -134.57 80.54 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 71.54 111.05 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.689 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -72.16 172.2 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 65.04 111.136 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.689 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.07 172.53 0.23 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 75.02 110.825 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.604 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.3 Cg_endo -69.8 19.91 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.705 2.27 . . . . 55.25 112.335 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 12' ' ' HIS . 8.1 pttt -127.18 25.14 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 72.24 110.862 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.58 -179.23 30.06 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.775 -0.726 . . . . 61.55 112.482 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.975 HD13 HD11 ' A' ' 67' ' ' LEU . 17.7 tp -150.35 164.49 35.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 71.22 110.931 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.626 ' HB2' HD11 ' A' ' 11' ' ' ILE . 25.1 ttt-85 -126.19 141.89 51.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 73.02 110.9 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -152.11 102.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 63.24 111.113 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -115.22 157.08 24.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 73.22 110.83 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 6' ' ' ALA . 20.5 m -139.94 151.64 65.86 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 71.31 111.148 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.429 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 53.9 Cg_endo -69.74 125.26 11.95 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.719 2.279 . . . . 74.04 112.366 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 20.1 t0 -87.33 83.72 7.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 31.23 110.868 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -70.96 -0.27 8.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 73.41 110.899 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.5 28.7 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 75.12 112.489 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -77.18 166.87 22.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.868 0.365 . . . . 74.23 110.906 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.5 t -124.64 -15.26 6.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 73.33 110.836 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.05 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -157.0 136.9 12.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 75.4 110.965 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.05 ' N ' HD22 ' A' ' 27' ' ' LEU . 7.6 t80 -131.06 148.09 52.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 74.0 110.881 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.25 157.7 45.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 64.41 111.091 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.629 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.5 m-85 -130.96 127.28 38.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 73.14 110.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -153.27 85.76 1.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 71.44 110.877 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.533 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.15 173.84 26.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 61.51 112.488 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.32 -164.57 1.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 73.11 110.942 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 tp -134.01 145.3 49.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 72.32 110.916 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.6 m120 47.57 28.88 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 53.42 110.914 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -168.32 134.64 1.94 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.31 110.922 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -108.49 160.18 16.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 63.14 110.852 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 61.22 110.843 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.505 -0.238 . . . . 64.41 112.505 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.68 -65.27 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.742 0.305 . . . . 64.0 110.861 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -60.64 139.37 57.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 71.2 110.954 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.5 p -139.64 115.55 10.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 43.22 110.811 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.76 154.75 31.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.487 . . . . 65.15 110.87 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.668 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -144.34 109.63 5.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.01 110.859 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 52' ' ' LYS . 12.8 mm -92.64 125.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 60.33 111.094 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 55.6 p -111.06 33.85 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 43.15 111.141 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.506 ' H ' HG22 ' A' ' 50' ' ' ILE . 3.2 tttt 163.45 131.78 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 60.13 110.906 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -176.0 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.698 2.266 . . . . 63.31 112.363 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.409 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -139.04 -35.98 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 72.22 110.881 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' NH1' ' A' ' 57' ' ' ARG . 1.9 m120 -128.0 38.24 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.899 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.42 -27.86 8.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.685 -0.769 . . . . 74.42 112.548 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -125.2 173.51 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.348 . . . . 74.21 110.877 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.412 ' HB2' HG22 ' A' ' 20' ' ' VAL . 12.6 m95 -92.28 94.46 9.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 72.51 110.898 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.409 HD12 ' HD2' ' A' ' 54' ' ' LYS . 56.2 mt -98.24 141.31 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 63.44 111.141 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 19.6 t80 -136.52 153.08 51.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 62.25 110.895 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -143.96 137.28 27.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 74.33 110.883 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.17 178.41 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 64.43 110.9 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.89 10.83 2.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 61.23 110.83 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -125.47 7.38 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 62.42 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -94.82 103.03 14.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 54.15 111.097 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -102.42 85.21 2.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 70.22 111.105 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.975 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -138.56 170.96 15.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.904 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.663 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.84 164.56 37.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.885 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.537 HD11 ' O ' ' A' ' 97' ' ' GLY . 26.4 mm -33.01 122.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.31 111.11 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.4 -29.41 6.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.719 -0.753 . . . . 63.24 112.509 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.36 -176.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.903 0.382 . . . . 72.23 110.86 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -143.6 169.36 17.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 72.14 110.91 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.3 mt -147.84 145.22 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 64.4 111.092 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.2 m-85 -148.38 105.25 3.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.938 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 2.4 p90 -164.6 -160.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 72.4 110.905 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.486 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -149.05 155.58 40.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.937 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.455 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 5.6 p -124.0 147.37 47.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 61.23 111.163 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.99 151.07 25.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 60.42 110.879 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.596 HG13 ' HD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -145.48 169.41 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 71.45 111.125 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.715 HG13 HD12 ' A' ' 27' ' ' LEU . 69.9 mt -150.26 95.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.44 111.151 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -112.15 136.6 51.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 71.21 110.899 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.35 38.79 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 72.15 110.871 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.9 35.74 59.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 63.41 112.459 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 mt -97.72 -59.19 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 64.42 110.951 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.53 105.87 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 54.22 112.526 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.517 ' HB2' HG23 ' A' ' 79' ' ' VAL . 94.5 m-85 -124.21 178.35 5.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.824 0.345 . . . . 75.03 110.957 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -178.42 130.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 64.31 110.903 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -65.29 -171.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.92 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.0 t70 -170.37 -169.8 0.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 62.52 110.841 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.3 t-20 83.01 -36.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 64.12 110.864 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.33 75.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 34.54 112.513 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -168.18 117.49 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.889 0.375 . . . . 73.42 110.9 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -157.06 118.53 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 71.4 110.93 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 36.5 m -90.82 142.12 28.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 54.44 111.153 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.687 HG13 ' HB2' ' A' ' 10' ' ' ALA . 28.2 t -76.35 112.47 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 71.4 111.154 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -131.52 4.7 4.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.24 110.923 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.813 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -116.6 -176.53 17.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.777 -0.725 . . . . 43.24 112.492 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.5 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -156.66 159.89 38.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.371 . . . . 74.44 110.896 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.64 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.79 -174.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.33 111.101 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.05 137.68 22.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 43.24 110.877 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.27 46.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 74.35 110.892 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 50.13 111.072 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.541 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.597 0.713 . . . . 74.02 111.06 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.09 25.41 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.666 2.244 . . . . 74.01 112.33 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 133.47 25.69 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.235 . . . . 65.12 112.34 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.867 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -82.03 136.6 35.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 70.33 111.122 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -92.95 77.72 4.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 64.31 111.141 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.436 HD21 ' CE1' ' A' ' 75' ' ' PHE . 2.0 mp -78.48 108.68 12.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 54.41 110.927 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.845 ' O ' HD11 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -82.55 -173.47 4.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 71.45 110.928 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.49 80.75 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 73.32 111.096 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 12' ' ' HIS . 2.5 mm -71.72 172.68 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 72.43 111.134 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.71 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.92 171.63 0.26 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 74.22 110.823 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.585 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.2 Cg_endo -69.79 19.7 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.628 2.219 . . . . 63.44 112.361 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 12' ' ' HIS . 12.6 pttt -125.82 22.1 7.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.861 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 155.67 -178.98 31.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.757 -0.735 . . . . 34.03 112.506 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.845 HD11 ' O ' ' A' ' 9' ' ' GLU . 19.4 tp -150.46 164.42 35.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 72.11 110.938 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HB2' HD11 ' A' ' 11' ' ' ILE . 8.5 ttm180 -128.95 136.77 50.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 55.51 110.839 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -146.34 106.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 72.35 111.157 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.531 ' HB2' HG23 ' A' ' 59' ' ' ILE . 13.0 t -119.68 157.84 27.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 63.13 110.83 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.867 HG12 ' HA ' ' A' ' 6' ' ' ALA . 20.6 m -140.86 151.53 63.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.735 . . . . 73.13 111.125 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 122.16 8.84 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 32.11 112.325 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -80.51 97.91 7.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.838 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.32 12.42 10.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.931 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.26 15.68 3.7 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.703 -0.761 . . . . 63.11 112.46 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 87.5 m-85 -66.49 165.56 14.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 74.31 110.865 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 t -125.03 -17.24 5.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 71.03 110.839 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.046 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -153.45 139.67 18.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 73.34 110.903 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.046 ' N ' HD22 ' A' ' 27' ' ' LEU . 8.0 t80 -132.0 148.63 52.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 63.02 110.873 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.53 155.12 50.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 65.43 111.152 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.644 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.6 m-85 -127.94 125.51 39.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 72.11 110.871 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -149.03 83.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 73.12 110.83 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.14 173.61 26.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 70.11 112.496 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.6 -164.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 73.44 110.925 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 36' ' ' GLU . 21.9 tp -126.49 147.61 49.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 64.31 110.962 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 34' ' ' LEU . 3.0 m120 37.04 32.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.86 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 34' ' ' LEU . 64.5 tt0 -161.96 134.36 5.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 74.14 110.925 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -106.51 160.43 15.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.2 110.88 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.411 ' HE1' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 62.14 110.888 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.482 -0.247 . . . . 55.4 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.67 -68.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.322 . . . . 74.24 110.827 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.594 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 6.0 m0 -58.02 97.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 72.15 110.925 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.8 p -109.17 105.09 14.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 62.42 110.874 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.89 162.8 37.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.868 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -144.6 117.22 8.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.833 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 52' ' ' LYS . 18.4 mm -97.42 113.04 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 72.42 111.163 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.6 p -95.9 30.46 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 74.14 111.17 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.552 ' H ' HG22 ' A' ' 50' ' ' ILE . 2.8 tttt 173.99 138.62 0.15 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.721 . . . . 61.5 110.937 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -175.47 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.707 2.271 . . . . 73.43 112.323 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.719 ' HD2' HD12 ' A' ' 59' ' ' ILE . 21.7 ttmm -118.47 -71.56 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 72.14 110.872 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.07 46.57 2.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 60.31 110.87 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.67 -35.05 4.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 30.02 112.497 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.78 177.2 6.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 72.34 110.879 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -93.32 98.65 11.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.879 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.719 HD12 ' HD2' ' A' ' 54' ' ' LYS . 20.9 mt -103.09 141.0 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 73.42 111.147 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -135.64 147.1 48.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.914 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 126.83 29.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.872 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.594 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -104.06 169.81 8.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 61.13 110.916 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.2 mtt180 -136.93 20.3 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.0 110.837 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -133.19 14.55 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 74.51 110.887 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.54 101.86 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 64.13 111.109 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -98.96 84.23 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 54.15 111.11 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.764 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -135.89 171.17 14.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 75.52 110.879 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.757 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.71 158.07 34.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 43.44 110.959 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.6 mm -31.44 116.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 73.01 111.11 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.24 -26.1 5.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 74.21 112.512 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -72.79 -175.62 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 62.25 110.856 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.0 mptt -144.88 163.02 35.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 70.03 110.902 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 37.3 mt -138.63 143.59 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 62.34 111.169 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -145.48 105.27 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.931 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.546 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 3.9 p90 -165.44 -161.38 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 74.13 110.853 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.86 174.06 11.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 73.15 110.877 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 p -141.5 156.45 45.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 72.11 111.137 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.2 137.79 52.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 70.43 110.903 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -134.19 166.62 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 73.34 111.149 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.66 HG13 HD12 ' A' ' 27' ' ' LEU . 91.7 mt -142.44 95.9 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 63.23 111.138 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -116.44 147.51 41.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 71.33 110.919 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.05 27.8 1.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 62.1 110.884 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.77 30.94 70.27 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.734 -0.746 . . . . 53.41 112.464 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.17 -73.14 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.803 0.335 . . . . 61.22 110.93 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.94 117.21 2.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 73.12 112.505 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.656 ' HB2' HG23 ' A' ' 79' ' ' VAL . 76.7 m-85 -128.08 170.76 12.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.95 0.405 . . . . 72.43 110.911 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -159.05 139.0 11.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 71.3 110.884 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.541 ' OE1' ' HB3' ' A' ' 3' ' ' ALA . 2.9 tp60 -80.78 160.93 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 75.33 110.908 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 6.1 m-20 -145.49 -173.45 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 75.23 110.876 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 10.5 t-20 85.11 -32.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 63.15 110.894 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 33.47 81.91 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 72.32 112.512 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -172.48 110.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 72.24 110.909 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -153.22 105.89 2.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 74.13 110.943 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.3 m -76.3 136.39 39.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 74.33 111.122 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.757 HG13 ' HB2' ' A' ' 10' ' ' ALA . 45.6 t -64.82 109.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 75.33 111.128 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -128.6 5.2 5.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.89 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.825 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -115.64 -178.64 18.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 74.02 112.498 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.497 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.96 155.87 33.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 75.31 110.881 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.684 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.58 -177.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 72.25 111.142 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -139.45 132.0 28.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 70.1 110.865 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -76.06 54.98 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 63.31 110.913 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 70.13 111.083 179.928 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 79' ' ' VAL . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.596 0.713 . . . . 65.21 111.063 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 169.68 18.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 72.2 112.354 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.444 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 53.7 Cg_endo -69.78 134.79 28.79 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.256 . . . . 72.22 112.362 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.883 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -83.32 137.46 33.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 74.02 111.148 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -96.5 77.43 2.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 74.1 111.141 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.568 HD21 ' CE1' ' A' ' 75' ' ' PHE . 1.9 mp -76.81 110.13 11.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.437 . . . . 75.01 110.953 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.846 ' O ' HD11 ' A' ' 16' ' ' LEU . 28.9 mp0 -83.01 -173.24 4.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.23 110.857 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.664 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -131.12 80.29 1.93 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 71.01 111.115 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.753 HD13 ' CG2' ' A' ' 99' ' ' VAL . 2.9 mm -70.23 172.42 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 73.24 111.126 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.698 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.92 172.04 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.581 0.705 . . . . 75.01 110.841 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.5 Cg_endo -69.77 20.12 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.674 2.249 . . . . 64.31 112.368 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' HIS . 39.9 pttt -125.76 21.71 7.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 44.22 110.895 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.4 -178.11 32.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.784 -0.722 . . . . 74.12 112.518 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.846 HD11 ' O ' ' A' ' 9' ' ' GLU . 23.1 tp -150.08 164.57 35.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 71.3 110.862 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.664 ' HB2' HD11 ' A' ' 11' ' ' ILE . 51.7 ttt180 -130.2 140.59 50.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 70.12 110.901 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 8' ' ' LEU . 45.0 t -148.58 111.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 52.53 111.084 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 t -122.57 156.17 34.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.85 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.883 HG12 ' HA ' ' A' ' 6' ' ' ALA . 29.9 m -140.06 152.17 66.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.671 0.748 . . . . 65.44 111.102 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 121.39 8.08 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.672 2.248 . . . . 74.22 112.355 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -76.3 105.89 7.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 61.34 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.47 34.67 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 62.53 110.855 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.66 1.48 52.87 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.731 -0.747 . . . . 55.04 112.494 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.491 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 74.3 m-85 -54.05 164.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 75.12 110.881 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 t -127.08 -11.8 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 73.33 110.885 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.05 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -158.73 138.49 11.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 73.23 110.914 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.05 ' N ' HD22 ' A' ' 27' ' ' LEU . 7.3 t80 -130.89 146.01 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 63.04 110.88 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.445 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . . . -129.53 158.39 39.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 72.11 111.071 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.668 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 1.8 m-85 -132.81 127.85 35.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 71.03 110.902 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -157.35 86.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.854 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -144.8 175.02 24.69 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 53.41 112.523 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.29 -166.68 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 61.52 110.919 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.708 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -129.93 124.64 33.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 70.31 110.912 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.442 ' OD1' HD12 ' A' ' 34' ' ' LEU . 27.3 m120 62.05 23.54 13.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 64.24 110.875 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -155.93 144.13 19.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 71.14 110.893 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -112.73 169.05 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 63.51 110.853 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.551 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 74.23 110.853 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.514 -0.234 . . . . 15.11 112.514 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.49 -63.09 1.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.343 . . . . 72.5 110.836 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.708 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.4 m-90 -61.15 155.33 20.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 71.31 110.9 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.2 p -158.45 109.53 2.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 75.54 110.867 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.37 160.3 38.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 61.34 110.861 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.531 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -144.09 107.22 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 72.32 110.913 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.1 mm -86.75 106.66 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 74.01 111.137 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.0 p -96.01 29.93 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 74.44 111.145 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -176.85 113.66 0.25 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.628 0.727 . . . . 73.22 110.871 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.514 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 53.9 Cg_endo -69.76 -178.23 2.24 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.677 2.252 . . . . 73.24 112.321 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -174.33 136.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.893 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 2.6 t30 82.48 7.88 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 71.31 110.937 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' CD ' ' A' ' 57' ' ' ARG . . . 100.0 -6.73 58.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 74.01 112.51 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.418 ' CD ' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -153.27 174.2 14.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 73.12 110.883 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.514 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 14.6 m95 -90.35 106.24 18.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.935 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.5 146.63 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 74.32 111.13 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -143.43 149.06 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 65.52 110.913 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 133.1 28.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.35 110.883 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.72 -178.49 3.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 64.04 110.855 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.56 20.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.867 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -134.89 14.56 3.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 74.32 110.908 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.36 107.25 18.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 51.52 111.112 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -103.47 79.7 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 75.23 111.069 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.734 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -126.65 171.6 11.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 74.44 110.944 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.707 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.09 154.43 27.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 71.24 110.893 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.501 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.7 mm -29.61 123.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 73.53 111.096 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.54 7.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 61.43 112.499 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.73 -176.89 1.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.927 0.394 . . . . 63.14 110.808 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -142.2 166.6 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 75.4 110.919 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.501 HG12 HD22 ' A' ' 34' ' ' LEU . 87.4 mt -142.96 145.27 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 63.14 111.125 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -147.5 103.32 3.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 75.33 110.937 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.568 ' CE1' HD21 ' A' ' 8' ' ' LEU . 1.4 p90 -162.29 -162.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 74.15 110.927 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.551 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -150.64 149.77 30.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 73.04 110.896 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.537 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 7.0 p -119.76 145.87 46.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 62.32 111.132 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -103.84 150.5 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 75.42 110.896 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -143.28 166.92 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 65.04 111.112 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.629 HG13 HD12 ' A' ' 27' ' ' LEU . 85.7 mt -145.61 96.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 50.34 111.143 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -115.14 137.31 52.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 63.15 110.854 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 42.92 41.16 2.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 65.33 110.897 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.08 37.27 36.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.746 -0.74 . . . . 74.14 112.535 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 mt -98.18 -55.79 2.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 53.21 110.913 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.79 105.23 1.63 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 60.31 112.447 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.538 ' HB2' HG23 ' A' ' 79' ' ' VAL . 99.0 m-85 -130.1 176.16 8.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 75.15 110.929 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.451 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -176.77 136.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 64.05 110.907 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' A' ' 5' ' ' PRO . 1.4 tp60 -73.42 163.53 27.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 71.52 110.878 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -145.94 -169.92 3.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.52 110.849 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.6 t-20 83.46 -33.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 73.15 110.884 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.73 84.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 73.54 112.468 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -170.13 116.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.822 0.344 . . . . 53.34 110.888 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.8 m-90 -157.84 109.57 2.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.938 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.6 m -81.59 138.91 35.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 65.34 111.138 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.664 HG13 ' HB2' ' A' ' 10' ' ' ALA . 22.4 t -70.11 110.58 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.43 111.083 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -131.76 4.32 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 63.22 110.887 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -113.95 -176.39 19.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 60.42 112.51 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.473 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -158.36 155.2 28.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.888 0.375 . . . . 73.33 110.895 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.753 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.51 175.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 53.41 111.136 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -139.1 127.64 23.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 75.12 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -80.22 54.6 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 73.44 110.898 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 74.51 111.081 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 121.571 0.7 . . . . 61.33 111.069 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 167.61 23.97 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.644 2.229 . . . . 73.22 112.315 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 136.35 32.78 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.685 2.256 . . . . 61.11 112.32 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.889 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -89.65 137.27 32.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 63.2 111.132 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m -95.94 77.07 3.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 42.01 111.153 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.506 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.5 mp -75.71 108.39 8.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 61.21 110.913 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.842 ' O ' HD11 ' A' ' 16' ' ' LEU . 10.3 mm-40 -79.93 -172.54 3.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 62.34 110.835 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.63 80.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.03 111.104 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 17' ' ' ARG . 3.2 mm -71.01 172.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 65.51 111.152 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.687 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -54.2 172.32 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.574 0.702 . . . . 62.24 110.898 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.74 20.39 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.664 2.243 . . . . 75.25 112.347 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' HIS . 1.8 pttt -125.58 22.26 7.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 72.42 110.864 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.49 -177.42 31.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.697 -0.763 . . . . 44.02 112.464 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.842 HD11 ' O ' ' A' ' 9' ' ' GLU . 20.7 tp -149.47 161.73 41.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 74.44 110.93 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.76 ' HB2' HD11 ' A' ' 11' ' ' ILE . 18.0 ttm180 -125.51 137.8 53.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 73.43 110.862 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 8' ' ' LEU . 77.0 t -147.69 110.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 61.34 111.122 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 59' ' ' ILE . 11.0 t -120.32 154.28 35.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 71.43 110.882 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.899 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 34.1 m -141.64 152.65 63.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.639 0.733 . . . . 74.32 111.116 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 122.09 8.77 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.664 2.243 . . . . 65.24 112.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 1.1 t70 -76.99 107.56 9.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 72.31 110.874 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.451 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -95.21 30.01 2.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.9 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.6 20.9 27.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 75.41 112.495 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 94.9 m-85 -68.13 167.56 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 74.14 110.888 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.8 t -128.95 -8.5 4.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.35 110.851 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.998 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -156.02 143.07 19.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 65.11 110.967 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.998 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -139.68 148.4 42.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 55.05 110.878 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.0 136.64 35.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.34 111.102 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -118.52 120.54 37.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.907 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -148.85 92.05 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 73.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.466 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.11 172.06 26.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 73.34 112.46 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.34 -164.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 70.11 110.885 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.632 HD21 ' OD2' ' A' ' 71' ' ' ASP . 7.9 tp -136.21 142.49 44.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 73.01 110.925 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 54.22 25.38 5.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.866 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -167.53 141.22 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.932 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -113.63 160.52 18.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 63.12 110.887 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.573 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.901 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.487 -0.245 . . . . 34.12 112.487 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.32 -63.31 1.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 64.43 110.873 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.7 m0 -66.51 146.95 53.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 74.32 110.904 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.3 p -146.51 112.27 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 73.13 110.862 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.14 162.14 41.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.23 110.877 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.48 117.35 8.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.24 110.889 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -98.97 107.12 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 65.31 111.127 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 60.7 p -101.01 32.4 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 53.11 111.136 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 51' ' ' THR . 14.6 mttt 164.32 135.83 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 73.23 110.919 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -175.65 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.732 2.288 . . . . 42.02 112.34 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.06 14.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.14 110.896 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -179.35 33.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 75.14 110.895 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 57' ' ' ARG . . . 87.94 -17.13 48.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 70.24 112.468 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -136.57 167.62 21.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 74.14 110.893 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.515 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 11.2 m95 -92.61 92.82 8.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 71.22 110.856 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.585 HG23 ' HB2' ' A' ' 19' ' ' SER . 12.0 mt -95.76 138.48 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 75.54 111.14 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -126.77 148.68 49.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.881 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 135.07 27.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 72.24 110.873 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -113.76 177.22 4.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 63.14 110.853 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.84 12.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.835 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.62 5.73 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 71.2 110.936 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.81 101.95 14.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 54.4 111.1 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -99.96 86.67 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 63.21 111.124 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.858 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -137.42 170.79 15.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 64.12 110.912 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.858 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -154.82 158.35 39.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 65.41 110.852 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.577 HD11 ' O ' ' A' ' 97' ' ' GLY . 10.3 mm -30.93 124.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 64.25 111.137 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.14 -30.04 6.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.744 -0.741 . . . . 53.2 112.515 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.632 ' OD2' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -63.29 -171.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 52.45 110.87 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.8 mptt -150.03 159.27 44.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.03 110.926 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 97.5 mt -133.15 147.39 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 70.33 111.133 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -148.98 103.09 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 75.45 110.905 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 1.1 p90 -162.35 -161.46 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.497 . . . . 74.32 110.874 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.573 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -150.72 144.89 25.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.926 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.498 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 3.3 p -112.83 151.85 29.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 71.45 111.14 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.12 144.89 46.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 60.32 110.897 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.507 ' CG1' ' CD2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -144.52 172.68 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 33.15 111.133 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.754 HG13 HD12 ' A' ' 27' ' ' LEU . 84.1 mt -148.14 96.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 45.25 111.14 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.585 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -113.44 138.33 50.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 72.33 110.86 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 43.01 38.9 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 72.12 110.906 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.91 37.88 45.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.723 -0.751 . . . . 52.33 112.463 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.64 -53.13 3.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 61.51 110.942 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 104.68 1.68 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 70.34 112.494 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -124.8 166.03 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.382 . . . . 75.32 110.926 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.498 ' CG ' ' O ' ' A' ' 77' ' ' THR . 7.1 ttp180 -174.15 136.56 0.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 72.23 110.85 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -75.65 168.78 19.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.906 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.7 t0 -152.94 -176.3 5.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.896 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 83.82 -26.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.34 110.886 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 34.74 87.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 71.43 112.493 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -172.01 110.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.845 0.355 . . . . 63.14 110.91 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -150.63 115.91 5.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 71.32 110.896 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 92.6 m -87.04 136.19 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 64.44 111.138 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.826 HG13 ' HB2' ' A' ' 10' ' ' ALA . 45.4 t -67.58 118.36 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 73.2 111.099 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -134.16 0.89 3.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 73.34 110.884 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.832 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -117.75 -177.74 17.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 71.11 112.468 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.52 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -154.78 155.69 34.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 65.51 110.891 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.714 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.79 169.81 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 72.45 111.155 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -132.42 139.77 48.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 60.31 110.889 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.53 45.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 63.42 110.907 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.486 ' N ' ' OD1' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 44.44 111.111 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.566 0.698 . . . . 73.54 111.097 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 164.36 34.81 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.743 2.295 . . . . 73.24 112.314 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 134.34 27.62 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.674 2.249 . . . . 71.15 112.313 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.669 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -84.38 139.6 32.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 71.02 111.105 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.6 m -92.72 77.44 4.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 75.41 111.165 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.456 HD23 HG21 ' A' ' 18' ' ' VAL . 1.5 mp -78.34 111.76 14.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 62.24 110.92 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.475 ' CB ' HG21 ' A' ' 99' ' ' VAL . 4.3 mm-40 -86.7 -158.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.23 110.903 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.838 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -143.08 81.2 1.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 61.45 111.096 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 12' ' ' HIS . 6.6 mm -71.0 172.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 63.15 111.143 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.71 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.08 172.2 0.24 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.595 0.712 . . . . 64.34 110.832 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.4 Cg_endo -69.76 20.31 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.681 2.254 . . . . 73.33 112.339 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 42.3 pttt -130.08 27.8 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 64.41 110.908 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.66 -178.84 30.4 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 73.4 112.442 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.824 HD13 HD11 ' A' ' 67' ' ' LEU . 19.3 tp -152.83 166.22 32.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 74.44 110.896 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.696 ' HB2' HD11 ' A' ' 11' ' ' ILE . 35.1 ttt180 -130.31 141.39 50.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.875 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.456 HG21 HD23 ' A' ' 8' ' ' LEU . 77.3 t -153.12 103.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.33 111.138 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.4 t -114.93 159.82 20.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.1 110.858 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 6' ' ' ALA . 26.7 m -139.55 151.63 66.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.604 0.716 . . . . 53.32 111.17 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 121.99 8.69 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.671 2.247 . . . . 72.15 112.338 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -80.19 101.33 8.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 62.33 110.871 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -96.01 28.13 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 65.3 110.864 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.27 16.51 13.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.762 -0.732 . . . . 73.23 112.533 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 92.1 m-85 -67.08 164.82 17.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 63.32 110.929 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.6 t -127.98 -9.55 5.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.87 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.028 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -158.97 139.97 12.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 73.43 110.894 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.028 ' N ' HD22 ' A' ' 27' ' ' LEU . 19.3 t80 -134.16 152.49 51.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.32 110.881 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.35 163.29 30.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 74.22 111.104 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.5 t80 -148.22 113.28 5.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 55.35 110.856 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.59 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -147.28 95.15 2.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 73.54 110.859 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.09 -174.14 17.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.729 -0.748 . . . . 63.1 112.509 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.408 ' O ' ' CZ3' ' A' ' 46' ' ' TRP . 3.0 mtpp -134.74 -164.27 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 73.22 110.911 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.523 HD11 ' OD2' ' A' ' 71' ' ' ASP . 1.7 tp -140.24 140.18 35.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 72.31 110.889 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 51.26 21.59 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.21 110.848 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -156.39 123.51 5.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 74.23 110.877 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -94.86 140.66 29.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 73.23 110.884 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.2 ptp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 75.34 110.879 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.493 -0.243 . . . . 70.24 112.493 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -104.24 -62.72 1.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.733 0.302 . . . . 71.21 110.885 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.514 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 9.1 m0 -60.87 155.09 20.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 73.24 110.926 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.59 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 53.1 p -160.99 114.43 2.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 74.41 110.879 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -156.76 149.24 23.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 63.51 110.842 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -139.5 102.32 4.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.887 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 52' ' ' LYS . 8.7 mm -90.26 117.77 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 62.35 111.098 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.415 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 17.2 p -103.34 34.34 2.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 74.42 111.163 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 50' ' ' ILE . 3.3 mtpt 167.07 137.46 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.55 0.691 . . . . 72.01 110.865 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -175.6 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.66 2.24 . . . . 73.0 112.358 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HG3' ' N ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -139.39 -35.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 72.12 110.859 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.429 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 1.4 t30 -137.25 51.76 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.43 110.906 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.18 -29.43 4.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 52.42 112.513 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.92 171.23 11.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 74.23 110.846 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.442 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 6.0 m95 -90.12 89.73 7.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 75.43 110.957 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.3 mt -92.47 138.14 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 64.05 111.117 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -132.35 146.61 52.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.41 110.892 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.84 127.55 23.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.903 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -99.78 -178.46 3.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.92 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.38 26.4 1.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 74.01 110.9 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -149.44 28.24 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 72.23 110.865 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . . . -113.52 84.92 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 43.25 111.137 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -82.09 93.76 7.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 63.1 111.092 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.892 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -148.33 169.33 20.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.03 110.948 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.892 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.04 164.55 38.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.939 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 98' ' ' PHE . 9.4 mm -34.78 118.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.02 111.147 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.22 -28.92 5.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.769 -0.729 . . . . 61.41 112.485 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.523 ' OD2' HD11 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -67.96 -178.16 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 73.01 110.865 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.2 mttt -141.22 167.66 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.2 110.885 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.3 mt -144.85 149.37 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 54.34 111.116 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -151.96 108.54 3.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 74.31 110.902 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.48 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -165.72 -168.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 75.34 110.88 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.6 p-90 -135.28 162.75 31.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 71.04 110.94 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.6 p -134.89 146.4 49.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 64.45 111.126 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.46 149.01 28.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.872 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.55 HG13 ' HD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -148.94 165.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 74.31 111.157 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.715 HG13 HD12 ' A' ' 27' ' ' LEU . 41.1 mt -148.38 96.24 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.33 111.151 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 23.5 tttt -113.18 138.43 49.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 71.23 110.857 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.82 28.89 3.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 75.33 110.866 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.71 27.5 66.53 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 64.41 112.491 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.65 -50.97 4.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 63.45 110.906 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.56 125.85 3.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 72.14 112.492 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -143.07 -179.67 6.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 75.32 110.923 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 77' ' ' THR . 1.2 ttp180 -177.46 136.48 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 70.44 110.911 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -78.21 166.02 23.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 74.03 110.925 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.1 t0 -147.22 -165.86 2.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 65.04 110.852 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 2.5 t-20 83.59 -33.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 44.4 110.895 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 39.04 74.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.746 . . . . 41.53 112.484 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -167.7 112.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 54.15 110.867 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -152.33 122.57 7.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 73.01 110.945 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.1 m -94.08 145.23 24.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 74.44 111.16 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.838 HG13 ' HB2' ' A' ' 10' ' ' ALA . 62.7 t -75.24 129.7 36.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 63.35 111.124 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -154.79 23.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.05 110.888 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -155.62 111.28 0.48 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.786 -0.721 . . . . 54.24 112.499 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.578 ' CD2' HG12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -82.34 170.39 15.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 72.41 110.871 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.556 HG22 ' C ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -167.34 -178.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.33 111.137 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.26 139.1 37.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.472 . . . . 74.41 110.857 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -87.2 44.71 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 53.34 110.845 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.089 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.574 0.702 . . . . 72.15 111.109 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 161.01 47.58 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.733 2.288 . . . . 74.2 112.313 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 134.84 28.95 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.709 2.273 . . . . 63.32 112.342 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.937 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -90.52 139.68 30.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 61.24 111.061 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.5 m -93.16 77.3 4.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 52.11 111.113 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.11 107.38 10.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 64.15 110.913 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.527 ' O ' HD11 ' A' ' 16' ' ' LEU . 1.2 mm-40 -80.92 -156.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 71.15 110.935 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.814 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -143.1 80.21 1.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 53.12 111.082 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.703 HG22 ' H ' ' A' ' 12' ' ' HIS . 4.1 mm -70.64 172.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.32 111.079 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.703 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -54.19 172.0 0.25 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 73.4 110.835 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.9 Cg_endo -69.77 21.05 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.661 2.241 . . . . 52.12 112.336 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 12' ' ' HIS . 10.6 ptmt -126.79 20.71 7.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.907 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.64 -176.81 33.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 75.34 112.514 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.787 HD13 HD11 ' A' ' 67' ' ' LEU . 22.2 tp -151.13 163.57 38.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 74.24 110.924 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.656 ' HB2' HD11 ' A' ' 11' ' ' ILE . 69.0 ttt180 -126.77 137.32 53.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.23 110.861 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.44 HG12 ' HE2' ' A' ' 30' ' ' PHE . 69.7 t -148.26 102.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 70.33 111.091 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.547 ' HB2' HG23 ' A' ' 59' ' ' ILE . 19.6 t -114.49 157.07 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 73.11 110.902 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 6' ' ' ALA . 17.8 m -140.81 151.51 63.11 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.616 0.722 . . . . 75.24 111.077 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 123.37 10.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.639 2.226 . . . . 73.5 112.327 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 4.7 t70 -79.94 133.38 36.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 64.01 110.885 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -123.88 12.86 9.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.838 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.68 4.94 8.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 74.44 112.42 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 68.5 m-85 -54.28 163.02 0.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 65.11 110.878 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.9 t -130.01 -7.67 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.869 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.994 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -157.3 143.71 18.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 54.41 110.966 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.994 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -139.59 143.65 37.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 54.05 110.889 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.91 123.03 22.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 61.12 111.12 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.44 ' HE2' HG12 ' A' ' 18' ' ' VAL . 3.0 m-85 -109.84 113.98 27.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 74.02 110.863 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 47' ' ' SER . 0.2 OUTLIER -142.27 95.29 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 74.33 110.879 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -146.31 -178.55 21.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 73.12 112.477 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.0 -168.27 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.341 . . . . 62.41 110.881 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' CG ' ' A' ' 35' ' ' ASN . 4.4 tp -134.85 146.73 49.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 55.35 110.906 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.451 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 7.1 m-20 42.73 27.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.883 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -159.46 130.39 5.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 54.43 110.857 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -97.23 144.13 27.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 64.51 110.886 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.1 ptp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 63.34 110.918 179.934 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.498 -0.241 . . . . 30.3 112.498 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.38 -60.95 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 74.23 110.86 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.462 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 7.4 m0 -60.28 165.91 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 73.43 110.91 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 6.9 t -164.38 122.34 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 72.54 110.863 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 49' ' ' ASP . 3.2 tpm_? -159.67 145.02 15.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 64.21 110.877 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.464 ' N ' ' HG3' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -130.75 82.41 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 71.34 110.831 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 28' ' ' PHE . 2.7 mm -71.92 110.72 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 64.0 111.162 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.458 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 82.4 p -104.69 34.05 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 71.21 111.136 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 51' ' ' THR . 37.7 tttt 163.97 137.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.546 0.688 . . . . 41.33 110.925 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -175.87 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.715 2.277 . . . . 64.24 112.324 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.727 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -134.25 -34.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 60.21 110.9 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -139.85 51.66 1.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 54.15 110.895 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.07 -27.78 4.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.75 -0.738 . . . . 53.02 112.482 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 169.27 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.331 . . . . 75.14 110.867 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 10.7 m95 -92.09 90.79 7.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.919 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.727 HD12 ' HD2' ' A' ' 54' ' ' LYS . 27.0 mt -96.17 138.2 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 75.15 111.178 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -130.34 151.98 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 72.53 110.873 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.27 135.44 28.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.55 110.891 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.6 OUTLIER -108.53 -179.41 3.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 63.4 110.895 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -145.26 11.67 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 42.12 110.866 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -129.84 12.31 5.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 62.33 110.874 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.32 94.84 6.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.23 111.072 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -94.35 75.33 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 64.34 111.089 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.787 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -123.81 171.36 9.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 61.32 110.91 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.693 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.16 156.7 31.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 64.13 110.873 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.72 HD13 HG12 ' A' ' 95' ' ' VAL . 18.0 mm -30.34 121.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 64.01 111.135 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.33 -29.46 6.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 22.13 112.48 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.41 -179.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 74.31 110.856 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 1.1 mtmt -144.85 153.71 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 75.52 110.923 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.1 mt -128.43 141.25 47.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 72.11 111.145 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -140.96 99.08 3.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 74.51 110.968 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.519 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -159.85 -160.07 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 74.1 110.822 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -148.29 177.7 9.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 71.0 110.911 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -144.45 153.95 42.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 64.51 111.149 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -118.23 136.44 53.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 54.44 110.899 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.77 167.58 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 73.32 111.101 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.641 HG13 HD12 ' A' ' 27' ' ' LEU . 78.4 mt -146.01 96.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 74.33 111.116 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 18.6 tttt -114.27 141.43 47.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 55.53 110.898 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.441 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 2.5 m-20 44.91 38.23 2.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 73.24 110.874 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.52 35.35 44.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 74.21 112.481 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.44 HD13 ' OH ' ' A' ' 86' ' ' TYR . 14.9 mt -100.51 -71.25 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.876 0.369 . . . . 74.32 110.947 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.49 106.41 2.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 74.32 112.487 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.44 ' OH ' HD13 ' A' ' 84' ' ' LEU . 44.7 m-85 -120.57 171.84 8.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 75.23 110.909 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -174.38 138.47 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 73.15 110.86 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -85.98 153.71 21.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 74.3 110.885 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -136.82 -163.18 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 65.34 110.903 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.2 t-20 82.23 -39.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 74.31 110.89 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.57 76.44 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 52.2 112.454 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -172.8 113.22 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 74.4 110.862 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -152.43 110.88 3.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.103 -0.499 . . . . 64.23 110.922 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 97.1 m -82.37 136.16 35.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 54.31 111.149 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.793 HG13 ' HB2' ' A' ' 10' ' ' ALA . 39.3 t -67.27 110.32 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 70.13 111.135 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -128.94 17.82 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.04 110.911 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.814 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -133.92 -178.26 15.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 71.34 112.475 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.429 ' C ' HG22 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -152.8 157.57 40.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.362 . . . . 73.54 110.894 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.69 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.81 164.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 73.54 111.143 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -129.81 131.08 46.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 61.1 110.858 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -85.68 51.43 2.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 43.2 111.116 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.576 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.589 0.709 . . . . 63.23 111.085 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 167.39 24.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.715 2.277 . . . . 73.12 112.312 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 133.99 27.02 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.645 2.23 . . . . 62.01 112.361 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.737 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -86.51 137.83 32.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 74.03 111.105 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -93.99 77.15 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 63.14 111.159 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.401 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.8 mp -77.4 107.98 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 65.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.845 ' O ' HD11 ' A' ' 16' ' ' LEU . 43.9 mm-40 -80.34 -173.28 3.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 63.33 110.892 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.859 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.76 81.49 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 65.44 111.094 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.753 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.2 mm -72.01 172.49 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 62.23 111.146 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.697 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.16 172.03 0.25 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.584 0.707 . . . . 74.2 110.897 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.3 Cg_endo -69.72 20.15 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.639 2.226 . . . . 61.33 112.35 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.0 OUTLIER -125.92 21.71 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 60.54 110.943 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 155.38 -178.02 32.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 71.43 112.481 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.899 HD13 HD11 ' A' ' 67' ' ' LEU . 21.9 tp -150.24 167.74 26.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 60.02 110.961 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.593 ' HB2' HD11 ' A' ' 11' ' ' ILE . 2.1 ttt180 -132.83 139.24 47.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.3 110.857 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.413 HG21 ' HE2' ' A' ' 30' ' ' PHE . 70.4 t -148.52 108.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 54.1 111.125 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -119.85 157.94 27.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 63.12 110.857 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.737 HG12 ' HA ' ' A' ' 6' ' ' ALA . 17.2 m -139.99 149.35 58.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 71.14 111.149 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 122.19 8.87 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.707 2.271 . . . . 72.23 112.354 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 22.8 t70 -88.45 97.26 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.86 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.75 0.21 40.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 54.13 110.879 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 138.41 30.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 61.52 112.47 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 82.2 m-85 -82.28 167.96 18.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.804 0.335 . . . . 75.41 110.936 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.5 t -127.19 -10.89 5.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 65.43 110.846 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.999 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -153.32 142.72 21.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.916 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.999 ' N ' HD22 ' A' ' 27' ' ' LEU . 18.3 t80 -139.13 144.32 38.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 75.51 110.93 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.69 163.68 23.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 72.54 111.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.4 t80 -151.04 114.42 4.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.89 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.531 ' CE1' ' O ' ' A' ' 46' ' ' TRP . 2.0 t-80 -147.57 95.26 2.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 73.43 110.859 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.07 -174.27 18.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 65.32 112.466 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.464 ' CE ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -135.92 -165.45 1.71 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.792 0.33 . . . . 70.23 110.863 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.744 HD22 HG12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -132.36 127.24 35.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 74.51 110.935 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.605 ' OD1' HD12 ' A' ' 34' ' ' LEU . 25.4 m120 56.45 34.13 23.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.866 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG2' ' CE ' ' A' ' 33' ' ' LYS . 5.6 tp10 -155.56 131.52 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 73.24 110.903 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -98.59 140.65 32.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 73.02 110.856 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 1.3 mtt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 74.25 110.873 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.454 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.501 -0.24 . . . . 50.55 112.501 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.9 -55.3 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.831 0.348 . . . . 71.53 110.89 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.706 ' HH2' HD23 ' A' ' 34' ' ' LEU . 6.5 m0 -68.4 173.16 5.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 75.23 110.91 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.3 p -176.84 118.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 73.54 110.851 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.39 162.2 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.23 110.848 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.682 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -144.46 106.55 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 75.41 110.883 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.482 ' N ' ' O ' ' A' ' 28' ' ' PHE . 36.5 mm -90.27 105.13 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 71.24 111.121 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.754 HG22 HD23 ' A' ' 27' ' ' LEU . 32.3 p -102.42 34.42 2.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 45.3 111.156 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.5 124.53 0.11 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.593 0.711 . . . . 74.21 110.857 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 165.6 30.46 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.267 . . . . 75.44 112.346 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.93 -17.7 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.882 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -149.75 43.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 73.42 110.903 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.42 -16.64 12.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.712 -0.756 . . . . 61.51 112.555 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -133.57 164.66 26.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.826 0.346 . . . . 75.05 110.88 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.481 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 12.2 m95 -88.18 96.16 10.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 75.1 110.931 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.415 HG22 ' HD2' ' A' ' 61' ' ' ARG . 16.0 mt -99.47 142.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 72.23 111.121 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -133.56 144.91 49.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 70.41 110.926 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HD2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -136.59 127.74 27.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 74.45 110.847 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.42 -178.62 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.891 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -148.85 17.42 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 74.52 110.889 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -135.89 14.44 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.886 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.62 109.54 21.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 71.22 111.136 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -105.94 87.91 2.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 62.32 111.069 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.899 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -139.87 170.95 14.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 53.3 110.904 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.67 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.55 161.79 38.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 70.55 110.871 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.592 HG13 ' CE2' ' A' ' 98' ' ' PHE . 11.8 mm -33.28 120.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 73.11 111.138 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.84 -29.89 5.46 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.734 -0.746 . . . . 63.23 112.464 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.98 177.96 2.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 74.44 110.86 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -138.55 162.02 35.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 71.33 110.907 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.744 HG12 HD22 ' A' ' 34' ' ' LEU . 62.6 mt -137.96 152.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 54.21 111.116 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -151.15 107.56 3.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.45 110.861 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.445 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -165.32 -163.66 0.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 73.23 110.883 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.48 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.2 p-90 -145.14 166.06 26.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 73.05 110.887 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.478 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 5.0 p -136.52 162.37 33.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 64.4 111.151 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.95 142.94 51.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 65.25 110.837 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.45 176.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.517 . . . . 75.01 111.133 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.786 HG13 HD12 ' A' ' 27' ' ' LEU . 68.7 mt -150.91 98.67 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 73.33 111.149 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -117.8 141.32 48.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 64.23 110.904 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.453 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 46.07 36.74 3.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 64.21 110.885 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.23 33.85 39.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 52.33 112.441 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.413 HD13 ' OH ' ' A' ' 86' ' ' TYR . 2.3 mt -100.33 -54.84 2.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.865 0.364 . . . . 74.1 110.934 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.22 116.49 1.76 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.726 -0.75 . . . . 75.51 112.45 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.413 ' OH ' HD13 ' A' ' 84' ' ' LEU . 98.8 m-85 -132.72 -175.09 3.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 74.33 110.955 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.478 ' CG ' ' O ' ' A' ' 77' ' ' THR . 7.5 ttp180 -177.61 138.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.874 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.576 ' OE1' ' HB3' ' A' ' 3' ' ' ALA . 2.7 tp60 -81.94 155.17 25.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 73.14 110.857 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -140.0 -166.86 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 65.04 110.899 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.8 OUTLIER 83.06 -38.88 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.4 110.918 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.47 81.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 70.23 112.514 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -171.77 114.4 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 75.22 110.887 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -154.87 112.97 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 71.33 110.942 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.2 m -85.11 132.96 34.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 71.13 111.104 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.744 HG21 HD23 ' A' ' 67' ' ' LEU . 37.6 t -63.76 117.72 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.34 111.112 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -136.39 14.37 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.12 110.927 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.859 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -124.95 -178.02 15.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 62.04 112.492 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -154.69 151.49 28.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 73.31 110.863 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.753 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.12 -178.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 61.2 111.119 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -146.51 129.86 16.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 72.11 110.843 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.13 40.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 71.54 110.909 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.31 111.11 179.918 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.577 0.703 . . . . 73.12 111.111 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.99 22.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.657 2.238 . . . . 73.11 112.366 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 133.39 25.57 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.684 2.256 . . . . 72.21 112.356 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.772 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -80.19 139.55 36.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 72.11 111.1 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 m -99.76 77.6 2.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 51.25 111.166 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.592 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.8 mp -77.65 109.69 11.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 74.2 110.936 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.761 ' O ' HD11 ' A' ' 16' ' ' LEU . 3.0 mm-40 -80.08 -168.56 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 64.34 110.866 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.831 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -133.81 81.58 1.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.3 111.139 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 12' ' ' HIS . 7.6 mm -71.66 172.84 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.34 111.125 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.718 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.17 172.37 0.24 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.583 0.706 . . . . 64.12 110.825 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.78 20.2 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.613 2.209 . . . . 74.31 112.326 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -129.1 26.28 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 74.54 110.86 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.25 -177.71 31.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 34.34 112.467 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.039 HD13 HD21 ' A' ' 67' ' ' LEU . 22.2 tp -152.29 166.98 30.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.812 0.339 . . . . 73.32 110.89 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HB2' HD11 ' A' ' 11' ' ' ILE . 61.7 ttt180 -132.59 136.57 46.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 73.12 110.833 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 8' ' ' LEU . 51.1 t -145.0 109.36 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 54.41 111.152 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.79 ' HB2' HG23 ' A' ' 59' ' ' ILE . 11.2 t -121.53 159.54 26.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.41 110.843 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.883 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 10.2 m -142.73 151.61 57.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 74.11 111.109 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 121.69 8.38 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.628 2.219 . . . . 74.11 112.32 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.16 140.19 52.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 61.12 110.863 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -132.51 18.88 4.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.883 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.72 8.17 30.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.733 -0.746 . . . . 62.2 112.45 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.546 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 39.5 m-85 -58.41 164.63 2.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 64.25 110.908 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -126.37 -13.01 6.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.886 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.027 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -153.82 140.68 19.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 55.54 110.935 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.027 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -134.61 145.77 48.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 72.21 110.924 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.79 142.69 49.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 73.15 111.117 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.28 120.95 31.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 53.24 110.855 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.465 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -152.67 93.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 75.13 110.88 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.463 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.9 176.73 24.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 74.24 112.5 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.66 -164.94 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 65.44 110.839 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 tp -134.23 145.79 49.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 73.22 110.934 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 49.15 24.04 0.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 74.44 110.858 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -163.43 139.34 6.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.34 110.861 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -110.1 164.94 12.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 74.43 110.892 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.65 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.44 110.855 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.485 -0.246 . . . . 71.55 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -102.44 -68.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 72.4 110.881 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.489 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 5.2 m-90 -62.37 154.19 28.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 73.15 110.863 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.465 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 95.1 p -158.39 123.84 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 54.21 110.887 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.66 160.73 10.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 73.42 110.861 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.708 ' OD1' HD21 ' A' ' 27' ' ' LEU . 14.4 t0 -138.9 103.14 4.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 71.33 110.853 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' PHE . 5.6 mm -77.98 108.9 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 75.23 111.165 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 81.1 p -96.37 30.58 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 70.42 111.133 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.9 OUTLIER 163.29 138.82 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.569 0.7 . . . . 70.35 110.903 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.406 ' N ' ' HG3' ' A' ' 52' ' ' LYS . 53.9 Cg_endo -69.74 176.2 7.07 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.705 2.27 . . . . 71.32 112.349 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HD2' HD12 ' A' ' 59' ' ' ILE . 4.4 ttmt -109.19 -77.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 70.42 110.91 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -113.24 60.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 71.34 110.929 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.17 -19.2 32.23 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.713 -0.756 . . . . 61.01 112.485 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.45 164.91 25.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 73.02 110.861 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.546 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 16.3 m95 -89.83 94.15 9.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.79 HG23 ' HB2' ' A' ' 19' ' ' SER . 6.4 mt -102.3 149.7 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 75.04 111.156 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.455 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 42.1 t80 -144.31 159.87 41.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 55.32 110.874 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -147.68 140.01 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.853 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -114.39 -178.16 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 74.31 110.887 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.29 17.99 1.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.879 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -137.07 20.42 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . . . -107.39 95.76 5.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.43 111.106 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -94.11 84.55 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 54.3 111.073 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.039 HD21 HD13 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -120.03 171.61 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 63.23 110.881 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -153.24 134.29 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.889 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.552 ' C ' ' O ' ' A' ' 68' ' ' LYS . 9.2 mm -23.6 118.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.45 111.098 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.6 -19.09 9.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.787 -0.72 . . . . 64.54 112.495 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.23 -166.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 55.53 110.837 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 1.5 mtmt -152.45 165.15 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.52 110.873 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 99.2 mt -142.53 149.15 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 54.34 111.194 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -149.62 104.1 3.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 73.54 110.885 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.495 ' CE2' HG23 ' A' ' 77' ' ' THR . 1.0 OUTLIER -160.3 -164.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 73.51 110.903 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.65 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -146.98 142.73 27.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.893 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.495 HG23 ' CE2' ' A' ' 75' ' ' PHE . 4.4 p -112.37 147.75 35.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 73.32 111.113 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.401 ' CD1' ' HG3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -112.68 143.51 43.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 72.21 110.855 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.01 168.69 13.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 74.4 111.118 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.671 HG13 HD12 ' A' ' 27' ' ' LEU . 95.4 mt -146.69 96.17 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 75.33 111.121 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 7.4 tttt -114.51 143.73 44.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 72.25 110.961 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.405 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER 53.03 20.71 1.8 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 62.21 110.892 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.09 27.54 73.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 50.02 112.481 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 84' ' ' LEU . 8.0 mt -97.86 -72.31 0.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 61.44 110.907 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.48 109.86 2.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 70.44 112.484 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -122.31 161.68 22.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 74.54 110.921 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.401 ' HG3' ' CD1' ' A' ' 78' ' ' PHE . 6.2 ttp180 -163.45 129.13 3.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 72.33 110.866 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.64 150.35 29.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.917 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -132.02 -159.92 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.14 110.866 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 82.86 -37.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 64.23 110.923 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.51 78.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.783 -0.722 . . . . 64.44 112.481 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -171.41 111.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 64.42 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -148.98 119.42 7.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 52.13 110.898 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.6 m -89.84 141.15 28.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 52.45 111.152 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.86 HG21 HD12 ' A' ' 67' ' ' LEU . 40.2 t -75.81 124.92 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 63.31 111.093 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -147.19 21.97 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 61.45 110.936 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -154.67 114.35 0.61 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 74.44 112.482 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.542 ' C ' HG22 ' A' ' 99' ' ' VAL . 0.6 OUTLIER -87.81 172.16 9.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 71.14 110.882 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.702 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -167.53 156.64 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 75.52 111.109 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.55 130.25 56.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -100.11 38.59 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 72.54 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.34 111.082 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.6 0.714 . . . . 73.12 111.061 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.82 33.09 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.254 . . . . 63.3 112.385 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 134.37 27.89 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.735 2.29 . . . . 72.31 112.371 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -82.43 140.71 33.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 60.21 111.121 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 m -97.19 79.14 2.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 74.4 111.145 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.3 mp -83.1 113.06 20.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 73.34 110.884 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.584 ' O ' HD11 ' A' ' 16' ' ' LEU . 2.6 mm-40 -83.94 -158.34 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.147 -0.478 . . . . 73.03 110.893 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.88 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -141.12 80.37 1.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.31 111.102 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.722 HD13 ' CG2' ' A' ' 99' ' ' VAL . 2.7 mm -71.3 172.55 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 65.43 111.131 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.707 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -54.22 172.16 0.25 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.561 0.695 . . . . 54.04 110.842 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.8 Cg_endo -69.76 19.47 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.66 2.24 . . . . 73.32 112.384 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -124.58 19.79 8.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 73.42 110.868 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.24 -177.93 33.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 63.34 112.521 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.689 HD13 HD11 ' A' ' 67' ' ' LEU . 26.3 tp -151.27 166.38 31.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 75.41 110.94 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.529 ' HB2' HD11 ' A' ' 11' ' ' ILE . 50.6 ttt180 -128.23 139.13 52.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 74.24 110.867 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.3 t -151.26 105.26 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 61.12 111.131 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' A' ' 59' ' ' ILE . 18.7 t -122.46 162.25 22.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.55 110.876 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 6' ' ' ALA . 5.4 m -140.4 151.17 63.38 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.664 0.745 . . . . 73.42 111.084 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 122.2 8.87 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.673 2.249 . . . . 74.44 112.327 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 14.9 t70 -83.44 140.0 32.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 72.14 110.913 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -137.2 12.61 3.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 74.54 110.91 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.01 2.93 2.64 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.748 . . . . 51.23 112.491 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 91.5 m-85 -58.33 160.18 5.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 64.51 110.899 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -129.72 -7.04 4.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 73.02 110.859 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.992 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -157.75 140.75 15.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 72.53 110.898 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.992 ' N ' HD22 ' A' ' 27' ' ' LEU . 19.8 t80 -137.61 146.2 43.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.841 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.98 163.06 28.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 74.2 111.134 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.4 t80 -147.59 111.7 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.876 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.588 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -144.29 92.58 2.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 73.53 110.836 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -145.99 -179.48 22.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 71.54 112.484 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.69 -164.15 1.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 75.05 110.929 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 tp -143.48 144.91 32.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 70.12 110.931 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 57.73 12.02 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 73.04 110.867 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -156.77 130.58 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.4 110.877 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -102.4 143.92 31.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 42.55 110.905 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.43 ' HE1' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 54.32 110.92 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.539 -0.224 . . . . 73.14 112.539 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.46 -65.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.771 0.32 . . . . 74.33 110.89 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.418 ' O ' ' ND1' ' A' ' 31' ' ' HIS . 8.2 m0 -58.03 161.43 4.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.194 -0.457 . . . . 73.05 110.851 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.588 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 97.0 p -167.39 122.51 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 60.2 110.887 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.77 155.36 8.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 61.42 110.872 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.24 103.2 4.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 72.45 110.873 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 52' ' ' LYS . 28.0 mm -80.84 117.14 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.34 111.121 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.5 p -99.36 32.24 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 73.11 111.17 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.539 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER 172.99 135.67 0.11 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.61 0.719 . . . . 73.41 110.909 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 168.18 22.22 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.26 . . . . 54.23 112.322 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -141.95 112.78 7.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.04 110.905 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER 78.27 27.72 0.51 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 72.13 110.883 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.81 -25.88 19.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 73.53 112.507 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 161.76 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 75.51 110.825 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 13.2 m95 -82.15 101.19 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 73.22 110.953 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.484 HD12 ' HD2' ' A' ' 54' ' ' LYS . 28.0 mt -105.65 139.13 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 61.21 111.119 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -135.32 141.91 45.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.12 110.852 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.454 ' HD2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -134.04 130.44 37.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.859 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.57 -178.9 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 43.52 110.864 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -144.82 15.56 1.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 75.41 110.887 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -131.45 3.58 4.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 74.24 110.874 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.2 101.01 13.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 55.13 111.093 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -99.58 84.53 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 64.14 111.061 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.737 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -129.38 171.29 12.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 51.41 110.899 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.737 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -152.8 147.47 26.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 75.43 110.894 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.499 HG12 ' CE1' ' A' ' 98' ' ' PHE . 2.5 mm -30.89 115.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 73.31 111.145 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.44 -19.37 7.15 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 70.25 112.505 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.16 -162.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 74.1 110.865 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.1 mttt -155.0 167.24 31.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 73.53 110.901 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 80.0 mt -146.4 146.35 19.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 65.31 111.138 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -148.9 102.19 3.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.34 110.956 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.535 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 0.8 OUTLIER -160.68 -161.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 70.34 110.896 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.543 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.5 OUTLIER -145.97 161.34 40.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.908 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 p -131.05 159.69 36.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 63.22 111.151 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.62 146.06 48.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 75.24 110.859 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -146.08 170.87 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 62.54 111.16 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.696 HG13 HD12 ' A' ' 27' ' ' LEU . 81.1 mt -149.36 96.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 62.22 111.171 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 1.7 tttt -113.05 137.72 51.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 65.51 110.916 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 47.31 33.11 2.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 71.1 110.853 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.33 33.39 61.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.738 . . . . 70.42 112.478 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.412 HD13 ' OH ' ' A' ' 86' ' ' TYR . 1.7 mt -97.47 -54.25 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 52.35 110.878 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 119.32 2.83 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.784 -0.722 . . . . 54.43 112.492 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB2' HG23 ' A' ' 79' ' ' VAL . 96.0 m-85 -143.47 156.81 44.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 73.54 110.916 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -152.56 133.68 14.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 71.31 110.854 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -80.11 154.98 27.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 54.13 110.894 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.542 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -138.52 -160.79 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 65.45 110.854 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.542 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 3.1 t-20 82.7 -38.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 65.4 110.861 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.03 78.87 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 25.23 112.536 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -171.74 110.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.35 . . . . 73.42 110.895 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 17.1 m-90 -151.72 120.09 6.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.134 -0.485 . . . . 73.22 110.963 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.4 m -91.24 130.43 37.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.01 111.186 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.88 HG13 ' HB2' ' A' ' 10' ' ' ALA . 48.3 t -61.41 110.5 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 71.05 111.117 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.0 7.5 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 55.34 110.895 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.814 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -120.23 179.13 16.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 62.31 112.476 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -151.75 153.2 33.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 64.11 110.895 -179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.722 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -159.96 177.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 64.53 111.109 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -146.03 126.87 14.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 60.3 110.843 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -80.43 55.31 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 74.23 110.87 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 52.51 111.093 179.919 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.543 0.687 . . . . 75.24 111.097 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 165.46 30.88 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 74.41 112.34 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 133.6 25.92 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 75.24 112.301 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.778 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.64 144.15 31.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 32.23 111.111 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.5 m -99.83 77.13 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 73.32 111.138 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.465 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.7 mp -73.04 109.89 6.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.961 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.834 ' O ' HD11 ' A' ' 16' ' ' LEU . 7.9 mm-40 -85.99 -172.92 4.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.32 110.863 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -130.56 80.25 1.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 71.12 111.084 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.682 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.2 mm -70.27 172.34 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 62.13 111.159 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.682 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.07 171.83 0.26 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.622 0.725 . . . . 74.45 110.818 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.1 Cg_endo -69.72 20.54 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 64.1 112.37 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 12' ' ' HIS . 20.7 pttt -126.64 23.06 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 62.44 110.884 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.1 -178.13 31.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 45.44 112.501 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.834 HD11 ' O ' ' A' ' 9' ' ' GLU . 20.0 tp -149.65 160.83 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 73.44 110.924 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.661 ' HB2' HD11 ' A' ' 11' ' ' ILE . 1.3 ttt85 -125.95 138.95 53.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 61.31 110.888 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 8' ' ' LEU . 54.2 t -148.79 103.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 72.3 111.098 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.529 ' HB2' HG23 ' A' ' 59' ' ' ILE . 41.3 t -114.21 160.69 18.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 64.23 110.89 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 6' ' ' ALA . 24.3 m -141.51 151.73 61.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 64.24 111.146 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 122.14 8.82 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.719 2.279 . . . . 75.23 112.343 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 17.1 t0 -89.12 107.91 19.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 65.14 110.868 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -95.79 -3.55 45.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 63.41 110.894 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.94 31.02 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 53.23 112.513 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.464 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 81.4 m-85 -80.14 165.1 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 74.31 110.87 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -126.05 -11.55 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.878 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.012 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -155.66 141.13 17.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 73.4 110.898 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.012 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.9 t80 -133.38 146.42 51.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.33 110.909 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.67 155.8 49.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.04 111.119 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.408 ' HE2' HG11 ' A' ' 18' ' ' VAL . 3.2 t80 -141.0 123.78 16.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 75.33 110.895 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -153.47 93.31 1.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 72.31 110.884 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -145.94 -177.1 20.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.75 . . . . 55.43 112.506 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 45' ' ' HIS . 2.6 mtpp -135.73 -169.64 2.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 62.24 110.912 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 35' ' ' ASN . 2.3 tp -131.77 143.78 50.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 75.02 110.897 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 34' ' ' LEU . 26.0 m120 37.48 37.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.901 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -159.17 139.84 12.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.11 110.913 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -90.36 145.28 25.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 75.13 110.913 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.5 ptp . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 64.31 110.904 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.44 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.504 -0.239 . . . . 51.32 112.504 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.453 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -106.25 -62.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.75 0.31 . . . . 30.21 110.825 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -65.41 150.93 47.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 55.23 110.91 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.5 p -158.33 119.02 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 63.21 110.822 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.22 158.56 21.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 73.34 110.897 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -144.34 115.26 7.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 73.11 110.866 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 mm -96.27 120.49 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 72.42 111.148 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 81.4 p -107.89 36.92 2.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.22 111.126 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.8 OUTLIER 163.08 130.81 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.616 0.722 . . . . 74.44 110.901 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -176.33 1.46 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.682 2.255 . . . . 61.01 112.318 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.14 19.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 62.51 110.842 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 178.85 34.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 73.23 110.858 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.42 -19.53 13.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 63.51 112.445 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.04 164.32 27.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.806 0.336 . . . . 64.54 110.861 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.552 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 18.3 m95 -87.5 93.27 9.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.918 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 ' HB2' ' A' ' 19' ' ' SER . 8.1 mt -96.47 136.37 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 53.14 111.146 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -129.95 150.63 51.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.01 110.883 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.89 138.68 28.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 61.54 110.878 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.5 -176.53 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.826 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.45 17.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 70.23 110.842 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -131.77 12.09 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.879 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.22 103.82 13.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 70.41 111.077 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -101.57 73.8 1.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 60.32 111.111 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.843 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -117.52 171.41 8.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 73.5 110.932 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.843 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.53 151.05 27.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 71.42 110.914 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.2 mm -28.04 116.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 63.31 111.13 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.31 -24.72 6.85 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 75.42 112.515 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.93 -175.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 74.2 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 2.4 mttt -141.75 166.73 23.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 64.24 110.898 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.6 mt -144.52 143.21 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.23 111.142 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.4 OUTLIER -145.38 103.88 3.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.954 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.518 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -168.71 -162.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 73.43 110.908 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.7 p-90 -146.91 174.61 11.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 71.1 110.927 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 p -139.23 159.05 43.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 74.55 111.11 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.54 150.21 42.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 72.14 110.882 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -147.81 174.55 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.483 . . . . 63.11 111.171 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.776 HG13 HD12 ' A' ' 27' ' ' LEU . 78.4 mt -150.48 96.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 60.53 111.148 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 17.1 tttm -113.01 121.55 44.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 72.44 110.907 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.79 32.41 18.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.895 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.75 33.33 72.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 34.5 112.471 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -99.67 -55.95 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 64.03 110.921 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.05 112.19 2.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 72.23 112.499 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.677 ' HB2' HG23 ' A' ' 79' ' ' VAL . 29.0 m-85 -126.27 164.77 20.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.889 0.376 . . . . 75.52 110.902 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -152.88 137.63 17.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 73.25 110.862 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.73 141.86 28.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 70.54 110.91 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.403 ' O ' ' ND2' ' A' ' 90' ' ' ASN . 2.9 p30 -132.39 143.44 49.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 72.44 110.854 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER 167.53 -37.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 63.24 110.873 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 40.55 44.53 3.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.726 -0.75 . . . . 34.12 112.533 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -168.08 105.4 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.348 . . . . 70.5 110.854 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -146.48 106.3 3.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 75.34 110.929 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.4 m -80.87 131.12 35.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 74.14 111.18 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.678 HG13 ' HB2' ' A' ' 10' ' ' ALA . 69.0 t -63.41 121.35 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.52 111.142 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -137.9 8.51 2.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 71.34 110.881 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.743 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -119.54 -175.54 15.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 55.31 112.466 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.485 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -157.17 153.55 27.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.96 0.409 . . . . 75.12 110.875 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.667 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.67 172.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 61.05 111.132 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -141.54 132.86 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 62.02 110.867 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.93 45.62 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 72.3 110.882 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 45.25 111.121 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.569 0.7 . . . . 73.21 111.115 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 167.66 23.87 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.642 2.228 . . . . 65.22 112.331 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 134.98 29.31 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 64.02 112.339 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.83 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -85.54 136.85 33.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 53.41 111.098 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 m -94.66 77.27 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 64.44 111.169 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.663 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.0 mp -80.08 106.25 11.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 71.32 110.934 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.806 ' O ' HD11 ' A' ' 16' ' ' LEU . 3.6 mm-40 -78.38 -165.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.847 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.853 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -135.88 79.45 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 71.2 111.07 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.726 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.6 mm -68.6 172.42 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.41 111.098 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.684 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.34 172.05 0.22 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.581 0.705 . . . . 65.13 110.841 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.591 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.72 21.48 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 73.54 112.34 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 12' ' ' HIS . 6.9 ptpt -129.06 26.14 5.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 55.53 110.953 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.99 -178.63 29.14 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 54.13 112.486 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.035 HD13 HD21 ' A' ' 67' ' ' LEU . 35.6 tp -149.87 163.67 37.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 64.45 110.901 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.646 ' HB2' HD11 ' A' ' 11' ' ' ILE . 6.2 ttt180 -131.24 135.23 47.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 62.23 110.863 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.663 HG22 ' HA ' ' A' ' 8' ' ' LEU . 41.9 t -143.26 110.6 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 51.13 111.113 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 59' ' ' ILE . 10.8 t -118.2 157.41 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 71.22 110.888 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.83 HG12 ' HA ' ' A' ' 6' ' ' ALA . 25.4 m -139.94 151.94 66.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.654 0.74 . . . . 74.23 111.123 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 121.36 8.04 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.655 2.237 . . . . 75.54 112.335 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 22.8 t0 -82.81 93.6 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.53 110.862 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.7 30.59 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 73.31 110.933 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.414 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 105.14 23.46 7.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 73.32 112.464 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 64.3 m-85 -72.24 166.23 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 73.21 110.871 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 t -129.86 -6.49 4.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.854 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.029 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -163.05 140.56 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 72.42 110.912 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.029 ' N ' HD22 ' A' ' 27' ' ' LEU . 14.0 t80 -135.59 149.97 49.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.3 110.898 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.62 152.73 42.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 63.13 111.139 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' HE2' HG11 ' A' ' 18' ' ' VAL . 1.9 t80 -132.68 132.47 42.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 72.52 110.922 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -157.79 89.05 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 72.53 110.875 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.547 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.12 -175.32 19.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 62.21 112.481 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -135.48 -164.17 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 72.24 110.928 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.717 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -130.27 138.83 50.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 64.11 110.897 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.509 ' OD1' HD12 ' A' ' 34' ' ' LEU . 27.8 m120 46.52 26.69 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.905 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -154.11 144.22 22.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 63.23 110.914 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.32 152.77 29.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.855 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 63.01 110.899 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.456 -0.257 . . . . 51.02 112.456 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.44 -54.28 2.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.82 0.343 . . . . 74.3 110.854 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.717 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.4 m-90 -71.39 171.11 11.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.11 110.9 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -173.31 115.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 63.11 110.854 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.46 158.24 20.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.34 110.884 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.46 122.88 13.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.861 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.449 HG22 ' H ' ' A' ' 52' ' ' LYS . 19.2 mm -103.66 118.35 50.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 63.41 111.115 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 51.7 p -104.6 35.07 2.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 55.43 111.152 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.449 ' H ' HG22 ' A' ' 50' ' ' ILE . 16.7 mttt 164.93 137.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.571 0.701 . . . . 73.53 110.91 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 174.77 9.04 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 2.263 . . . . 73.01 112.318 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -136.94 11.57 3.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.919 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.77 44.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 73.43 110.917 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.78 -24.62 5.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.807 -0.711 . . . . 72.43 112.477 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.23 163.36 27.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 75.33 110.909 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.426 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 8.1 m95 -85.1 96.2 9.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 73.2 110.918 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 19' ' ' SER . 28.2 mt -102.41 140.83 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.127 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 41.9 t80 -134.64 158.01 45.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 73.34 110.865 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -148.37 139.0 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 75.1 110.843 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.68 -179.38 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 65.32 110.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.75 28.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 71.04 110.895 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -144.47 18.59 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 63.23 110.945 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.41 102.71 11.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 72.22 111.128 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -98.59 83.11 2.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 63.55 111.066 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.035 HD21 HD13 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -121.66 171.63 8.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.91 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -155.51 141.75 18.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 72.23 110.873 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.707 HD11 ' O ' ' A' ' 97' ' ' GLY . 25.6 mm -25.41 119.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 63.13 111.153 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.56 -18.08 8.78 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.743 -0.742 . . . . 60.55 112.469 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.29 -176.58 2.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 74.04 110.85 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 6.7 mttt -143.32 160.58 40.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 71.43 110.86 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.479 HG12 ' CD2' ' A' ' 34' ' ' LEU . 49.1 mt -137.82 146.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 73.24 111.126 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.9 m-85 -146.98 104.97 3.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.951 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.547 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.9 p90 -165.96 -168.26 1.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.906 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.3 p-90 -135.61 171.59 14.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.474 . . . . 64.1 110.908 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.2 p -142.11 149.01 39.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 71.44 111.182 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.07 144.17 39.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.03 110.868 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.54 HG13 ' HD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -143.72 167.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 72.11 111.152 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.66 HG13 HD12 ' A' ' 27' ' ' LEU . 88.9 mt -149.0 96.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 72.22 111.116 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.548 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 1.3 tttt -112.28 133.66 54.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.884 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 48.88 37.85 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 74.21 110.882 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.65 29.71 49.52 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 64.3 112.472 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 mt -93.0 -58.33 2.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.858 0.361 . . . . 63.34 110.924 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.21 120.66 3.79 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.776 -0.726 . . . . 73.42 112.497 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.41 ' HB2' HG23 ' A' ' 79' ' ' VAL . 98.2 m-85 -143.59 163.74 32.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.947 0.403 . . . . 64.22 110.9 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -159.04 134.7 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 74.02 110.874 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -80.77 154.8 27.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.496 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -138.84 -164.73 1.7 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.895 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.496 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.2 t-20 82.08 -40.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.891 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.16 84.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.671 -0.776 . . . . 74.55 112.493 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -172.26 110.68 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.823 0.344 . . . . 71.43 110.89 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -149.75 114.77 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.915 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.5 m -87.98 136.04 33.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 64.31 111.111 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.853 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 35.5 t -71.85 115.09 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 71.41 111.134 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -133.21 12.46 4.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.904 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.844 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -130.78 177.7 18.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 72.11 112.44 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -145.02 160.41 41.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 71.42 110.902 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.726 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.13 167.57 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.32 111.133 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.43 137.28 50.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 74.25 110.896 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -89.49 42.22 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 63.45 110.876 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 63.23 111.096 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.564 0.697 . . . . 21.02 111.118 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 167.05 25.61 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 2.238 . . . . 63.35 112.318 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 135.76 31.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.64 2.226 . . . . 73.34 112.392 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.627 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -89.65 141.43 28.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 64.14 111.078 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.2 m -100.47 76.83 1.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 70.21 111.156 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.505 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.9 mp -73.81 106.73 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 65.22 110.943 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.797 ' O ' HD11 ' A' ' 16' ' ' LEU . 7.3 mm-40 -78.41 -170.28 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 71.52 110.881 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -133.59 80.83 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 64.54 111.125 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.697 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -72.14 172.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 75.53 111.174 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.697 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.0 171.82 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.603 0.715 . . . . 72.14 110.854 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.2 Cg_endo -69.71 20.85 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.693 2.262 . . . . 54.25 112.356 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 9.5 pttt -125.67 19.76 7.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 62.12 110.901 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 156.21 -177.39 33.27 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.782 -0.723 . . . . 73.15 112.508 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.797 HD11 ' O ' ' A' ' 9' ' ' GLU . 24.0 tp -149.8 166.71 28.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 50.21 110.902 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.584 ' HB2' HD11 ' A' ' 11' ' ' ILE . 65.6 ttt180 -133.25 138.93 46.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.86 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 8' ' ' LEU . 73.0 t -147.19 107.49 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 74.24 111.151 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.48 ' HB2' HG23 ' A' ' 59' ' ' ILE . 12.4 t -112.24 156.45 22.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 63.12 110.872 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 6' ' ' ALA . 30.3 m -141.73 151.84 61.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.653 0.74 . . . . 75.44 111.132 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 122.44 9.11 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.733 2.289 . . . . 74.23 112.311 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.512 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 12.1 t0 -83.64 92.77 7.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 72.22 110.853 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.35 40.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.897 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.405 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 92.0 24.5 24.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 52.52 112.511 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.592 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 95.7 m-85 -74.71 165.02 25.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.866 0.365 . . . . 72.22 110.854 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.1 t -129.41 -7.61 4.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 53.23 110.861 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.008 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -155.02 142.1 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 71.05 110.951 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.008 ' N ' HD22 ' A' ' 27' ' ' LEU . 17.9 t80 -137.55 147.9 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.44 110.903 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.7 156.76 46.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.35 111.098 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.448 ' HE2' HG11 ' A' ' 18' ' ' VAL . 1.8 t80 -139.4 125.42 19.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 73.32 110.901 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -152.58 92.58 1.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 73.42 110.869 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.486 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -144.67 -174.47 16.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 61.23 112.448 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -163.98 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 72.43 110.918 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.756 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -131.86 123.46 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 53.24 110.899 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.0 m120 61.4 27.23 16.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.12 110.878 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -156.89 146.68 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.915 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -113.92 159.33 20.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 61.35 110.893 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.562 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 73.01 110.887 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.459 -0.256 . . . . 30.44 112.459 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 -56.33 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 74.43 110.837 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.756 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.3 m-90 -69.85 177.07 3.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 70.44 110.931 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.0 p -179.92 109.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 70.14 110.837 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.06 156.7 24.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 73.22 110.863 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -140.22 120.02 13.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 63.23 110.859 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 52' ' ' LYS . 8.6 mm -95.18 117.16 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 74.43 111.154 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.403 HG23 ' OD1' ' A' ' 49' ' ' ASP . 30.6 p -98.96 32.55 2.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 72.4 111.149 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.582 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.8 OUTLIER 170.24 139.83 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.555 0.693 . . . . 63.32 110.923 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -178.95 2.58 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.66 2.24 . . . . 70.42 112.363 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HD2' HD12 ' A' ' 59' ' ' ILE . 15.8 ttmt -119.63 -61.7 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 74.13 110.89 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -131.43 58.47 1.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 64.34 110.891 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.38 -28.74 6.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 40.44 112.461 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.5 160.7 29.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.322 . . . . 64.41 110.887 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.512 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 44.1 m95 -82.59 89.1 6.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 75.13 110.949 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.48 HG23 ' HB2' ' A' ' 19' ' ' SER . 25.8 mt -94.46 135.91 27.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 75.25 111.159 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.478 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 56.1 t80 -135.56 162.37 32.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 71.31 110.847 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.478 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -158.24 152.71 24.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 75.43 110.892 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.39 -176.41 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 65.4 110.855 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.1 mtt180 -142.76 16.47 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 72.15 110.877 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -132.8 8.72 4.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 54.25 110.892 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.85 95.96 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 53.13 111.108 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -93.67 77.46 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 60.11 111.104 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.82 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -125.07 171.47 10.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 71.23 110.9 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.82 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.71 154.88 28.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 55.32 110.913 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.7 mm -29.98 121.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 73.41 111.118 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.52 -28.45 5.98 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.729 -0.748 . . . . 74.4 112.452 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.469 ' OD2' HD11 ' A' ' 34' ' ' LEU . 1.4 m-20 -66.53 -171.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 71.43 110.861 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.7 mttt -148.78 168.71 22.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 72.5 110.898 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.454 HG12 HD22 ' A' ' 34' ' ' LEU . 78.6 mt -146.67 145.28 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 63.14 111.153 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -148.36 103.29 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 72.11 110.914 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.486 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.3 p90 -160.97 -168.99 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 75.14 110.903 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.562 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -139.99 146.12 38.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 74.43 110.912 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.402 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 1.9 p -111.63 161.76 15.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 73.33 111.142 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 138.1 51.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 74.43 110.893 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.577 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 2.3 m -141.86 177.2 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 74.34 111.141 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.772 HG13 HD12 ' A' ' 27' ' ' LEU . 68.3 mt -152.95 98.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 70.05 111.122 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -112.7 141.02 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 72.15 110.866 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.427 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER 44.92 32.51 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.879 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.38 36.98 91.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 54.21 112.472 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.7 -50.59 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.836 0.35 . . . . 52.51 110.899 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.48 105.01 0.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.758 . . . . 63.31 112.501 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -123.72 -175.02 3.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 74.32 110.906 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.449 ' HB3' ' NH1' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -178.44 135.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 64.41 110.854 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -79.1 153.28 30.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.918 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.482 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -136.28 -165.5 1.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 71.1 110.841 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.482 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 81.34 -40.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 73.2 110.861 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.27 83.05 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 54.23 112.504 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -170.69 112.91 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 72.13 110.894 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.6 m-90 -155.04 113.05 3.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 72.35 110.923 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 96.1 m -88.48 135.34 33.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 51.24 111.151 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 10' ' ' ALA . 15.8 t -64.75 114.94 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 73.4 111.14 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.62 -2.34 3.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 61.12 110.894 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.773 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -113.51 -174.89 19.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 74.33 112.48 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.493 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.49 156.73 35.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 75.04 110.896 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.67 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.64 167.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 61.33 111.128 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -127.46 129.44 47.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 52.2 110.889 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -78.69 48.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 74.01 110.844 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 65.14 111.091 179.947 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.583 0.706 . . . . 74.22 111.067 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 165.07 32.22 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.664 2.243 . . . . 64.52 112.35 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 134.79 28.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.635 2.223 . . . . 72.03 112.375 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -80.34 135.0 36.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 75.12 111.115 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.7 m -93.95 77.7 4.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 64.51 111.105 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 8' ' ' LEU . 2.3 mp -85.84 111.45 20.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 63.52 110.898 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.543 ' O ' HD11 ' A' ' 16' ' ' LEU . 2.5 mm-40 -84.58 -155.14 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.131 -0.486 . . . . 75.52 110.906 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -143.62 80.44 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 63.43 111.065 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 17' ' ' ARG . 2.6 mm -69.51 172.27 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 61.22 111.123 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.692 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.18 172.74 0.23 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.627 0.727 . . . . 60.25 110.834 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.1 Cg_endo -69.77 19.82 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.239 . . . . 65.12 112.36 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.0 OUTLIER -124.54 21.72 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 64.21 110.923 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.55 -177.47 31.07 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 61.11 112.434 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.726 HD13 HD11 ' A' ' 67' ' ' LEU . 36.0 tp -149.47 162.05 40.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 73.13 110.92 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.756 ' HB2' HD11 ' A' ' 11' ' ' ILE . 37.3 ttt180 -123.16 138.3 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 63.11 110.886 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.1 t -148.61 110.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 70.22 111.092 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.407 ' HB2' HG23 ' A' ' 59' ' ' ILE . 8.5 t -123.31 156.12 35.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 54.34 110.828 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 6' ' ' ALA . 23.9 m -141.45 151.66 61.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.649 0.738 . . . . 75.44 111.125 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 126.26 13.1 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.709 2.273 . . . . 64.02 112.31 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 34.3 t0 -97.21 86.23 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.32 110.871 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -20.57 63.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.895 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.417 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 160.84 30.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 73.52 112.523 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 83.4 m-85 -81.36 167.75 19.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 75.23 110.866 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 t -127.22 -10.48 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.845 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.006 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -151.96 141.44 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 75.3 110.949 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.006 ' N ' HD22 ' A' ' 27' ' ' LEU . 14.5 t80 -137.34 140.89 41.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 70.51 110.924 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.17 144.66 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 74.11 111.092 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.442 ' CE1' ' CZ ' ' A' ' 75' ' ' PHE . 1.6 t80 -130.78 109.7 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 73.4 110.852 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -135.84 93.69 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 73.24 110.841 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 75' ' ' PHE . . . -142.28 -177.26 17.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.679 -0.772 . . . . 54.22 112.467 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -131.3 -164.27 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 75.41 110.882 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.713 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -133.9 129.07 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 72.34 110.903 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.495 ' OD1' HD12 ' A' ' 34' ' ' LEU . 21.1 m120 60.29 17.11 6.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.897 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -153.23 142.01 21.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 52.23 110.888 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HB3' ' CB ' ' A' ' 74' ' ' TYR . 4.3 pt-20 -117.59 154.41 31.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 62.11 110.914 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 7.2 ptt? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 71.14 110.919 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.477 -0.249 . . . . 53.34 112.477 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.31 -71.42 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.319 . . . . 53.13 110.871 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.713 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.9 m-90 -58.09 155.41 11.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.2 110.931 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.3 p -153.15 108.2 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 61.31 110.833 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.79 160.76 39.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 65.55 110.861 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.729 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -144.96 108.41 4.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.876 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 28' ' ' PHE . 4.6 mm -85.85 101.0 9.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.444 . . . . 72.24 111.111 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 p -87.81 26.48 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 65.43 111.154 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' H ' HG22 ' A' ' 50' ' ' ILE . 2.8 mttt 178.84 135.38 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 72.55 110.889 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 168.12 22.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.684 2.256 . . . . 61.42 112.329 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.617 ' HD2' HD12 ' A' ' 59' ' ' ILE . 17.2 ttmt -105.77 -60.35 1.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 74.23 110.933 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -132.11 53.94 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 65.41 110.863 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.91 -20.01 48.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 42.15 112.472 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -133.84 162.4 32.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 74.34 110.922 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.516 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 15.8 m95 -85.07 91.85 8.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 75.12 110.956 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.617 HD12 ' HD2' ' A' ' 54' ' ' LYS . 17.3 mt -100.38 146.08 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 64.24 111.123 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -142.69 155.06 44.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.03 110.902 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.0 119.95 11.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 72.13 110.875 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD2' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -93.24 -178.24 4.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 74.2 110.855 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -145.25 10.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 70.51 110.878 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.486 ' ND2' ' OD2' ' A' ' 62' ' ' ASP . 15.1 p30 -124.08 -1.39 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 52.14 110.883 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.492 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -84.41 98.93 10.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 62.12 111.082 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -100.19 78.98 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 73.4 111.124 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.86 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -127.75 170.24 12.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 72.32 110.924 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.86 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.31 151.99 23.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 64.45 110.865 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.603 HG12 ' CE2' ' A' ' 98' ' ' PHE . 2.8 mm -27.45 122.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.116 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.03 -25.46 7.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 53.24 112.513 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.11 -168.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 74.22 110.841 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.9 mttt -151.18 171.96 16.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 71.3 110.908 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.58 HG12 HD22 ' A' ' 34' ' ' LEU . 83.9 mt -147.96 149.23 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 75.42 111.09 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.1 m-85 -152.76 115.3 4.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 65.52 110.935 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.598 ' CE2' HG23 ' A' ' 77' ' ' THR . 8.3 p90 -171.55 -159.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.428 ' CZ2' ' HG3' ' A' ' 38' ' ' MET . 0.0 OUTLIER -151.79 133.29 14.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 75.25 110.935 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.598 HG23 ' CE2' ' A' ' 75' ' ' PHE . 1.7 p -93.78 166.84 12.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 63.31 111.182 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.58 132.22 28.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 65.33 110.857 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.414 ' C ' HG13 ' A' ' 80' ' ' ILE . 2.1 m -135.6 177.12 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 71.21 111.103 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.8 HG13 HD12 ' A' ' 27' ' ' LEU . 79.0 mt -150.13 99.65 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 60.32 111.155 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -115.92 140.86 48.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.22 110.907 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.87 33.13 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 62.31 110.848 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.94 36.96 83.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 54.34 112.5 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.43 -52.22 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.906 0.384 . . . . 54.5 110.908 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.02 102.9 0.73 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 74.1 112.486 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -122.88 179.19 4.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 74.34 110.948 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.456 ' CG ' ' O ' ' A' ' 77' ' ' THR . 1.7 tmm_? -177.38 136.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 75.44 110.899 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -75.28 160.87 29.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 73.23 110.942 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -139.34 -167.77 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 72.01 110.88 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.7 OUTLIER 82.47 -40.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 65.31 110.822 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.09 79.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 25.22 112.502 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -167.49 109.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 73.4 110.888 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 -149.17 111.29 4.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 74.02 110.899 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 84.8 m -91.98 135.17 34.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 64.43 111.156 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.715 HG13 ' HB2' ' A' ' 10' ' ' ALA . 9.9 t -60.45 156.03 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 72.11 111.154 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 69' ' ' ILE . 13.7 mt-10 -163.05 -33.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.916 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.729 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -103.02 -170.91 26.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 74.25 112.486 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.603 ' CE2' HG12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -150.3 168.5 23.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.924 0.392 . . . . 61.05 110.879 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.63 ' HB ' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.52 175.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 71.31 111.138 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -137.73 142.26 40.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.888 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -88.48 51.29 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 70.33 110.836 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 51.22 111.085 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.6 0.714 . . . . 71.21 111.114 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 167.79 23.45 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.7 2.267 . . . . 62.42 112.37 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 133.13 24.84 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 72.22 112.34 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.955 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -85.3 142.52 29.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 71.21 111.098 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m -99.01 77.36 2.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 65.12 111.174 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.593 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.8 mp -76.05 105.72 7.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 72.25 110.929 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.761 ' O ' HD11 ' A' ' 16' ' ' LEU . 5.1 mm-40 -78.53 -170.88 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 75.02 110.863 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.86 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -133.78 80.27 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 42.12 111.098 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.718 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.1 mm -71.94 172.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 71.24 111.135 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.704 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.25 172.09 0.25 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.596 0.712 . . . . 73.03 110.855 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.82 20.06 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 53.41 112.301 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 12' ' ' HIS . 2.7 pttt -125.95 21.87 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 72.32 110.918 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 62' ' ' ASP . . . 155.58 -178.49 32.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 61.43 112.485 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.808 HD13 HD11 ' A' ' 67' ' ' LEU . 19.9 tp -149.83 168.23 24.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 75.23 110.931 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HB2' HD11 ' A' ' 11' ' ' ILE . 13.9 ttm180 -135.56 134.91 39.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 64.32 110.87 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 8' ' ' LEU . 78.6 t -144.62 106.65 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 75.42 111.114 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.418 ' HB2' HG23 ' A' ' 59' ' ' ILE . 20.1 t -116.08 156.47 26.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 75.51 110.822 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.978 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 33.0 m -141.25 152.66 64.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.672 0.749 . . . . 62.04 111.088 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 120.91 7.61 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.628 2.218 . . . . 63.52 112.312 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.48 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 3.6 t70 -75.9 99.71 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 70.52 110.855 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -88.98 35.44 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 52.54 110.873 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.12 25.01 25.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 60.12 112.485 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.488 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 98.8 m-85 -73.05 168.1 19.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.913 0.387 . . . . 72.24 110.857 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.2 t -129.34 -8.15 4.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 53.24 110.839 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.014 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -159.62 142.06 13.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.95 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.014 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -137.19 150.97 48.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 64.14 110.876 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.17 143.81 40.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 64.54 111.133 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -126.52 119.76 27.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 63.22 110.884 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 5.8 m-70 -152.08 92.32 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.504 . . . . 63.3 110.846 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 75' ' ' PHE . . . -146.22 178.55 23.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 71.14 112.498 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.459 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -133.18 -164.81 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 44.11 110.907 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 36' ' ' GLU . 1.4 tp -132.56 152.33 51.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 65.31 110.921 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.5 m120 41.27 25.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 43.11 110.916 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -164.01 136.86 5.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 71.04 110.915 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.42 163.81 12.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 73.25 110.839 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.579 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 64.32 110.867 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.459 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.523 -0.231 . . . . 71.3 112.523 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.03 -71.82 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 70.24 110.907 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -53.73 148.35 10.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.975 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.543 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 52.4 p -155.45 119.74 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 52.11 110.889 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.57 160.97 11.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 64.33 110.89 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.02 114.7 9.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.3 110.87 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' PHE . 10.2 mm -94.57 97.51 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 64.1 111.124 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.561 HG22 HD23 ' A' ' 27' ' ' LEU . 46.2 p -95.38 29.7 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 73.25 111.158 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.92 133.06 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 74.41 110.902 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -178.14 2.18 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.675 2.25 . . . . 64.44 112.387 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -135.73 -34.39 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 74.24 110.924 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -138.77 49.2 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 72.33 110.909 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.87 -26.12 4.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 72.52 112.415 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.64 168.22 14.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.775 0.322 . . . . 70.34 110.897 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.488 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 13.9 m95 -90.25 87.96 7.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.908 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.418 HG23 ' HB2' ' A' ' 19' ' ' SER . 44.9 mt -91.91 141.52 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.5 111.075 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.524 ' CE2' ' OD1' ' A' ' 62' ' ' ASP . 18.8 t80 -138.24 147.06 43.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 64.12 110.869 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 139.38 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 62.15 110.928 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -120.29 140.59 51.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 70.14 110.867 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.03 31.03 6.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 70.32 110.877 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.36 19.89 2.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 73.34 110.867 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.4 112.4 23.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 62.22 111.091 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -108.39 83.72 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 51.13 111.107 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -135.61 171.22 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.884 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.661 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.85 158.46 36.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.9 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.684 HD11 ' O ' ' A' ' 97' ' ' GLY . 26.9 mm -32.16 115.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 64.24 111.136 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.24 -26.66 4.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.709 -0.757 . . . . 71.13 112.474 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.37 -172.5 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.914 0.388 . . . . 52.1 110.834 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -143.17 168.23 20.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.917 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.7 mt -145.24 143.18 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.145 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -147.43 108.69 4.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 73.11 110.948 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.422 ' CB ' ' HA3' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -164.07 -163.87 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 75.02 110.833 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.579 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -149.13 144.1 26.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 74.12 110.925 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.1 p -113.15 149.62 33.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 70.11 111.17 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.59 142.96 46.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.873 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -141.8 170.83 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 74.42 111.14 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.721 HG13 HD12 ' A' ' 27' ' ' LEU . 80.1 mt -147.63 96.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 70.44 111.138 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 9.2 tttt -112.68 140.74 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.32 110.921 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 40.97 38.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 33.35 110.893 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.01 40.86 51.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 63.04 112.501 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 mt -105.09 -48.24 3.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 74.3 110.946 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.21 105.27 1.08 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.704 -0.76 . . . . 73.41 112.499 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -123.97 168.96 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.38 . . . . 64.33 110.9 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 77' ' ' THR . 3.7 ttp-105 -175.05 140.03 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 63.41 110.848 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.435 ' N ' ' HG2' ' A' ' 87' ' ' ARG . 15.6 tp60 -84.19 155.47 22.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 74.35 110.869 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -137.97 -169.47 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 70.4 110.884 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 83.78 -33.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 63.32 110.884 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 41.13 83.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.8 -0.714 . . . . 71.42 112.429 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -169.66 112.98 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 75.45 110.9 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -155.32 110.97 3.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 75.23 110.931 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 95.9 m -83.82 139.27 32.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 73.22 111.137 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.676 HG13 ' HB2' ' A' ' 10' ' ' ALA . 39.2 t -69.67 116.67 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 65.21 111.083 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -138.64 10.3 2.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 72.54 110.849 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.86 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -117.88 -178.11 17.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.771 -0.728 . . . . 73.42 112.512 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.585 ' CE2' HG13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -153.41 152.01 30.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 55.3 110.872 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.718 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.61 170.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 73.44 111.166 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.61 129.03 25.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 64.1 110.865 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -87.66 45.94 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 54.32 110.906 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 44.32 111.096 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.716 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.605 0.717 . . . . 73.25 111.109 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 161.03 47.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.719 2.279 . . . . 71.34 112.323 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 134.58 28.27 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.694 2.263 . . . . 63.32 112.327 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.629 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -89.53 139.06 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 50.02 111.095 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -89.48 77.7 7.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 73.52 111.145 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.516 HD23 ' CG2' ' A' ' 18' ' ' VAL . 1.9 mp -79.63 111.47 15.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 44.22 110.919 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.495 ' O ' HD11 ' A' ' 16' ' ' LEU . 2.0 mm-40 -86.18 -155.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 61.34 110.848 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -144.21 80.96 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 41.11 111.074 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 17' ' ' ARG . 4.0 mm -69.62 172.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 61.51 111.134 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.7 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.69 172.41 0.23 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.597 0.713 . . . . 62.23 110.861 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.2 Cg_endo -69.75 20.38 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.671 2.247 . . . . 74.21 112.356 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 1.2 ptmt -128.33 26.44 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.23 110.933 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.34 -178.81 29.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.749 . . . . 63.33 112.454 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.074 HD13 HD21 ' A' ' 67' ' ' LEU . 35.1 tp -150.78 167.07 28.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 71.21 110.896 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.716 ' HB2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -129.33 141.1 51.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 62.13 110.871 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.516 ' CG2' HD23 ' A' ' 8' ' ' LEU . 62.4 t -153.17 105.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 31.43 111.1 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 t -116.31 164.28 14.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.23 110.874 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 6' ' ' ALA . 22.7 m -143.15 151.65 56.02 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.668 0.747 . . . . 43.24 111.117 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 122.12 8.81 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 44.51 112.344 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -81.84 94.89 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 72.25 110.898 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -91.88 24.97 2.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 71.24 110.871 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.98 28.15 4.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.729 -0.748 . . . . 63.43 112.534 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 77.7 m-85 -78.41 165.83 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 72.01 110.839 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.0 t -128.79 -8.25 5.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 65.13 110.844 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.008 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -161.19 140.63 10.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 72.34 110.926 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.008 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.6 t80 -134.57 145.68 48.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 70.02 110.846 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.64 164.6 23.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 65.14 111.088 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.2 t80 -150.16 113.75 4.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 72.53 110.877 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -149.23 95.17 2.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 43.54 110.864 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.556 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -146.19 -175.36 19.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 74.44 112.474 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 mtpp -131.84 -165.12 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.324 . . . . 64.23 110.882 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.64 148.14 40.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.901 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 49.29 22.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.844 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.7 143.17 2.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 64.4 110.879 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -108.82 154.17 22.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 41.3 110.902 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.907 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.485 -0.246 . . . . 71.45 112.485 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.88 -69.17 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 63.32 110.845 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -54.98 170.96 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 75.14 110.931 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.9 p -176.13 127.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 74.41 110.927 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.06 155.58 3.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 52.32 110.875 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.26 99.98 3.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.855 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.96 122.53 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.117 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.5 p -110.14 37.92 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 65.22 111.134 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 174.35 116.91 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.594 0.711 . . . . 70.13 110.871 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.541 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 54.0 Cg_endo -69.74 159.35 53.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.24 . . . . 73.43 112.375 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -142.12 131.88 24.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 71.33 110.909 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 1.9 t30 78.45 16.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 54.22 110.869 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.33 -23.87 33.74 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 54.51 112.454 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.52 171.79 13.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 71.31 110.856 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.541 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 9.4 m95 -86.87 101.06 13.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 75.54 110.919 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 mt -101.06 137.04 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 74.41 111.144 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -132.23 145.11 51.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.12 110.895 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.36 134.01 31.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.42 110.914 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.94 179.32 4.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 61.35 110.906 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 19.84 2.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.2 110.883 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -137.84 30.28 2.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 71.51 110.908 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.425 ' O ' HD23 ' A' ' 67' ' ' LEU . . . -118.71 83.35 2.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 54.42 111.074 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -80.09 86.06 5.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 43.32 111.057 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.074 HD21 HD13 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -125.71 171.68 10.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 74.43 110.925 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -160.28 140.57 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 65.44 110.91 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 97' ' ' GLY . 11.5 mm -24.26 118.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 72.22 111.093 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.27 -18.68 7.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.775 -0.726 . . . . 73.32 112.468 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.12 -176.76 4.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.339 . . . . 55.04 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -143.99 161.81 37.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 70.43 110.857 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.8 mt -138.93 145.66 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 71.42 111.108 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -146.15 103.01 3.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 71.54 110.89 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -162.14 -157.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 70.33 110.889 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.423 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.1 p-90 -150.93 173.74 13.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.932 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 p -143.05 158.74 43.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 54.11 111.172 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.16 144.48 45.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 73.41 110.829 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -143.69 169.52 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 62.43 111.111 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.736 HG13 HD12 ' A' ' 27' ' ' LEU . 66.9 mt -147.71 96.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.172 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -114.63 140.64 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.03 110.942 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 50.63 27.12 2.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 75.32 110.845 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.37 29.13 68.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 42.3 112.5 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.45 HD13 ' OH ' ' A' ' 86' ' ' TYR . 2.4 mt -98.98 -49.53 4.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 74.23 110.908 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.6 131.48 4.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 74.1 112.496 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.65 ' HB2' HG23 ' A' ' 79' ' ' VAL . 76.5 m-85 -145.17 -179.24 6.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 74.41 110.935 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -172.24 133.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 75.34 110.897 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.716 ' OE1' ' HB3' ' A' ' 3' ' ' ALA . 4.3 tp60 -78.74 155.15 29.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 75.32 110.92 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.509 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -141.6 -163.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.87 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.509 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.7 t-20 83.05 -36.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 75.14 110.893 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.19 78.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 41.1 112.471 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -170.47 109.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.358 . . . . 74.42 110.925 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -151.14 112.89 4.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 74.53 110.928 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.9 m -86.85 130.92 34.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.43 111.066 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.69 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 21.2 t -62.85 116.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 63.23 111.128 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.0 15.2 3.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 62.11 110.895 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -130.44 -177.82 15.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 62.41 112.507 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.448 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -153.86 155.52 35.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.372 . . . . 64.43 110.872 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.604 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -166.71 168.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 65.12 111.151 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.34 133.92 39.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 54.55 110.876 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.17 39.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 73.33 110.851 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 62.22 111.099 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.612 0.72 . . . . 64.14 111.062 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.483 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.8 Cg_endo -69.74 166.95 25.83 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.653 2.235 . . . . 72.24 112.365 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 132.65 23.77 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.683 2.255 . . . . 72.52 112.379 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.811 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -83.12 138.24 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 45.13 111.103 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.5 m -95.59 78.03 3.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.138 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.559 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.4 mp -79.32 109.31 13.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 52.34 110.969 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.846 ' O ' HD11 ' A' ' 16' ' ' LEU . 6.7 mm-40 -79.99 -171.79 3.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 53.1 110.924 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -130.46 81.26 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 52.24 111.119 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.731 HD13 ' CG2' ' A' ' 99' ' ' VAL . 2.9 mm -72.66 172.52 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 73.45 111.12 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.706 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.34 172.01 0.26 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.605 0.717 . . . . 61.41 110.849 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.73 19.86 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 74.03 112.373 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 12' ' ' HIS . 11.1 ptmt -124.66 19.94 8.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.887 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.21 -177.44 33.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.796 -0.716 . . . . 60.33 112.486 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.846 HD11 ' O ' ' A' ' 9' ' ' GLU . 19.8 tp -150.89 168.98 22.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 72.54 110.888 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HB2' HD11 ' A' ' 11' ' ' ILE . 3.2 ttt180 -132.92 139.44 47.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 73.04 110.86 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -147.83 108.28 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.137 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 59' ' ' ILE . 12.8 t -119.5 157.41 28.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 60.03 110.859 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 6' ' ' ALA . 21.6 m -141.6 151.58 60.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.644 0.735 . . . . 63.44 111.138 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 122.21 8.89 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.713 2.275 . . . . 65.44 112.326 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 28.4 t0 -84.55 86.12 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 75.04 110.86 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -73.08 2.52 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.852 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.33 24.24 0.86 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.737 . . . . 74.31 112.511 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 81.4 m-85 -70.45 168.34 16.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 74.05 110.866 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t -125.39 -16.03 6.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 54.32 110.893 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.026 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -158.34 140.14 13.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 64.24 110.944 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.026 ' N ' HD22 ' A' ' 27' ' ' LEU . 8.3 t80 -132.77 151.5 51.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 72.32 110.883 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.74 155.39 48.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 71.34 111.082 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.645 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.4 m-85 -128.88 131.28 47.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 64.41 110.849 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.436 ' O ' ' CE ' ' A' ' 38' ' ' MET . 14.0 m-70 -157.63 84.97 0.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 71.43 110.868 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -144.55 177.47 23.08 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 70.21 112.491 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -136.21 -166.23 1.84 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 75.24 110.905 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 72' ' ' LYS . 13.7 tp -127.38 148.12 50.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 73.2 110.889 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 m120 43.14 23.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.886 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 34' ' ' LEU . 2.0 tp10 -157.67 145.54 18.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.907 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.462 ' CB ' ' HB2' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -125.09 150.42 46.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 61.23 110.849 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.436 ' CE ' ' O ' ' A' ' 31' ' ' HIS . 2.3 ptt? . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 54.14 110.88 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.522 -0.231 . . . . 74.42 112.522 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.55 -65.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 72.23 110.857 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -60.01 154.83 18.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 72.55 110.941 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.432 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 99.3 p -158.01 109.22 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 61.43 110.836 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.845 ' NH1' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.73 162.92 40.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 74.2 110.871 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.509 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -143.65 113.73 7.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 74.35 110.893 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.845 HD13 ' NH1' ' A' ' 48' ' ' ARG . 11.2 mm -99.85 103.9 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 64.42 111.177 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.47 HG22 HD23 ' A' ' 27' ' ' LEU . 76.6 p -96.06 30.47 2.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.169 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 175.46 132.8 0.15 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 74.41 110.945 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 178.68 4.35 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.634 2.222 . . . . 64.24 112.363 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -129.53 -30.41 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 53.01 110.878 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -146.27 47.66 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 54.54 110.863 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.13 -26.26 7.04 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 40.42 112.459 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.88 164.42 21.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.827 0.346 . . . . 62.15 110.845 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 5.9 m95 -87.16 96.2 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 75.31 110.946 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.503 HD12 ' HD2' ' A' ' 54' ' ' LYS . 43.0 mt -102.75 142.04 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 62.34 111.155 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -134.98 154.28 51.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 74.43 110.91 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.76 135.4 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 71.33 110.869 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD2' ' ND2' ' A' ' 64' ' ' ASN . 6.0 t70 -112.22 174.97 5.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 72.54 110.839 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -139.42 15.46 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 63.34 110.844 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.492 ' ND2' ' OD2' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -129.44 4.94 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.888 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.16 98.13 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 73.21 111.102 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -96.45 87.53 4.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 71.41 111.086 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.798 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -138.79 171.17 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 61.22 110.911 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.699 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.73 156.57 31.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 72.23 110.943 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.4 mm -32.01 118.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 75.42 111.189 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.26 -23.56 6.43 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 62.11 112.516 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.9 -170.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 73.05 110.88 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.514 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -147.91 162.05 40.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 60.42 110.924 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.87 145.9 29.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 61.15 111.114 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -148.4 111.42 4.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.959 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.6 p90 -171.98 -163.45 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.913 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.18 145.6 24.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 61.35 110.895 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.484 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 11.2 p -113.45 161.11 17.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 74.2 111.153 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.551 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -119.17 144.77 46.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 71.31 110.884 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.642 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -139.24 166.14 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.35 111.178 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.643 HG13 HD12 ' A' ' 27' ' ' LEU . 90.7 mt -143.26 96.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 64.51 111.15 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.461 ' HG2' ' N ' ' A' ' 82' ' ' ASP . 4.9 tttt -118.66 146.36 44.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 72.14 110.918 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 52.15 22.26 1.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.44 110.858 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.15 27.67 71.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.754 . . . . 61.32 112.499 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mt -100.05 -65.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 73.25 110.917 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.39 124.85 4.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.688 -0.768 . . . . 31.32 112.464 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.642 ' HB2' HG23 ' A' ' 79' ' ' VAL . 8.2 m-85 -136.71 178.0 7.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.394 . . . . 74.0 110.89 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.551 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -164.2 123.97 2.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 72.22 110.886 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.579 HE22 ' N ' ' A' ' 6' ' ' ALA . 1.9 tt0 -52.85 -173.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 62.1 110.897 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -170.49 -166.25 0.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 62.3 110.885 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER 83.53 -32.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 73.21 110.873 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 33.9 61.76 0.48 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.71 -0.757 . . . . 43.43 112.495 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -167.88 106.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 74.01 110.91 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 25.7 m-90 -145.42 115.51 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 61.12 110.889 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 60.5 m -87.31 133.16 33.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 65.54 111.149 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 10' ' ' ALA . 21.6 t -63.38 107.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 51.22 111.143 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.75 5.21 7.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 60.32 110.892 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.8 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -117.53 179.76 17.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 75.1 112.464 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -152.96 155.52 37.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.904 0.383 . . . . 74.42 110.872 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.731 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.51 -176.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 72.43 111.14 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -141.88 129.6 21.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 63.5 110.893 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -80.23 58.71 3.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.33 110.897 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 74.4 111.109 179.927 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 86' ' ' TYR . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.576 0.703 . . . . 53.02 111.125 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.501 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.6 Cg_endo -69.74 154.62 67.62 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.71 2.273 . . . . 74.53 112.315 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 134.47 28.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.672 2.248 . . . . 52.52 112.336 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.888 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -86.24 137.92 32.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 64.12 111.11 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 m -93.18 77.19 4.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 74.22 111.122 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.535 HD21 ' CE1' ' A' ' 75' ' ' PHE . 1.9 mp -77.94 110.87 13.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 72.54 110.911 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.795 ' O ' HD11 ' A' ' 16' ' ' LEU . 20.4 mm-40 -87.26 -167.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 75.52 110.858 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.867 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -134.32 80.51 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 62.24 111.131 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 17' ' ' ARG . 4.5 mm -69.38 172.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 71.2 111.122 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.7 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -53.85 172.03 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 73.25 110.817 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.9 Cg_endo -69.77 21.43 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 54.51 112.347 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 12' ' ' HIS . 7.5 pttt -128.82 25.07 5.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 72.14 110.884 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.29 -177.9 30.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 51.11 112.488 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.934 HD13 HD21 ' A' ' 67' ' ' LEU . 24.6 tp -150.71 157.97 43.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.347 . . . . 61.54 110.919 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.771 ' HB2' HD11 ' A' ' 11' ' ' ILE . 74.8 ttt180 -122.75 135.25 54.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 65.4 110.889 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 8' ' ' LEU . 53.7 t -147.06 108.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.095 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.702 ' HB2' HG23 ' A' ' 59' ' ' ILE . 46.4 t -120.56 162.2 20.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.897 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.888 HG12 ' HA ' ' A' ' 6' ' ' ALA . 30.4 m -141.04 152.03 63.87 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.646 0.736 . . . . 73.42 111.102 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 123.98 10.65 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.646 2.231 . . . . 72.34 112.364 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 17.0 t0 -87.82 107.05 18.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 63.43 110.889 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -96.09 6.81 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 44.13 110.893 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.48 8.97 2.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 73.24 112.462 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 63.5 m-85 -60.27 168.5 1.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.328 . . . . 71.41 110.887 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -128.95 -7.39 4.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.33 110.854 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.994 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -156.32 143.06 18.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 62.51 110.915 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.994 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.3 t80 -139.73 139.32 36.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 75.5 110.882 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.44 158.86 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 73.24 111.141 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.484 ' HE2' HG11 ' A' ' 18' ' ' VAL . 4.1 t80 -145.75 114.65 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 65.51 110.891 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.557 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -147.35 94.87 2.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 73.35 110.846 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.62 177.61 23.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 53.34 112.456 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.55 -164.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 75.21 110.905 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.688 HD12 ' O ' ' A' ' 72' ' ' LYS . 15.0 tp -136.31 148.53 47.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 70.34 110.954 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 48.96 19.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 71.42 110.894 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -161.24 142.7 11.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 73.02 110.888 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.03 156.69 22.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 73.43 110.897 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.599 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 64.35 110.821 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.483 -0.247 . . . . 71.43 112.483 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -103.41 -51.75 3.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 75.01 110.877 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.567 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 8.3 m0 -70.19 165.42 22.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.922 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.557 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 96.0 p -164.65 124.25 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 72.0 110.847 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HG2' ' CD1' ' A' ' 60' ' ' PHE . 17.0 tpp180 -165.44 144.26 6.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 73.21 110.872 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.572 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -139.39 99.31 3.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.868 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mm -87.87 115.42 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 64.41 111.115 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.415 HG22 HD23 ' A' ' 27' ' ' LEU . 63.8 p -103.78 33.47 3.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 53.14 111.134 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.6 OUTLIER 167.84 127.38 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.605 0.717 . . . . 72.01 110.903 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 171.17 15.01 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.687 2.258 . . . . 73.1 112.32 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.82 19.45 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 44.42 110.907 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -177.56 38.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.14 110.917 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.47 -13.62 15.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 75.33 112.452 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.05 160.54 40.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.805 0.336 . . . . 75.21 110.873 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.474 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 3.9 m95 -85.79 101.39 12.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 75.22 110.949 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.702 HG23 ' HB2' ' A' ' 19' ' ' SER . 7.7 mt -104.32 143.78 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 62.4 111.121 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.494 ' CD1' ' HG2' ' A' ' 48' ' ' ARG . 13.1 t80 -132.27 147.89 52.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 73.53 110.939 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.439 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -140.93 127.45 20.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 74.01 110.886 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.567 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 2.5 t0 -104.47 -179.53 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 65.42 110.853 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -148.95 28.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 75.44 110.865 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -144.88 13.58 1.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 63.44 110.876 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.03 100.09 9.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 73.2 111.142 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -95.54 86.55 4.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 62.45 111.094 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.934 HD21 HD13 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -125.62 171.55 10.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 74.15 110.895 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.501 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -152.79 140.49 19.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 63.53 110.931 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.54 HG12 ' CD1' ' A' ' 98' ' ' PHE . 17.1 mm -28.23 118.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 60.53 111.096 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.67 -22.04 5.56 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.749 -0.739 . . . . 71.1 112.474 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.84 -166.87 0.32 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 65.24 110.898 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.688 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.1 mttt -147.33 172.16 14.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 73.33 110.871 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.2 mt -144.72 144.69 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 75.11 111.129 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.3 100.75 3.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 74.3 110.87 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.535 ' CE1' HD21 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -159.5 -156.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 72.41 110.826 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.599 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -152.46 156.68 39.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.51 110.918 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 p -118.82 175.38 5.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 74.45 111.176 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -146.95 130.46 16.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 70.24 110.905 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 86' ' ' TYR . 3.3 m -134.13 -179.03 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 64.43 111.138 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.737 HG13 HD12 ' A' ' 27' ' ' LEU . 83.1 mt -153.37 97.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 74.1 111.108 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.531 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 16.1 tttm -113.1 135.19 54.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 62.22 110.9 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.3 t0 50.51 25.1 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.25 110.851 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.98 30.04 73.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 54.21 112.511 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.733 HD13 ' OH ' ' A' ' 86' ' ' TYR . 2.0 mt -92.53 -66.87 0.89 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.359 . . . . 75.4 110.915 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.59 116.09 4.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.755 . . . . 60.13 112.495 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.733 ' OH ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -127.33 166.46 17.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.879 0.371 . . . . 70.11 110.902 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.434 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -160.33 110.67 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 74.52 110.904 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -60.74 157.9 13.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 74.45 110.924 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -146.72 -169.11 3.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.3 110.849 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.6 m120 83.93 -28.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 71.04 110.862 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 34.41 78.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 31.54 112.492 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -165.96 104.14 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 75.41 110.887 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.406 ' CG ' HD13 ' A' ' 8' ' ' LEU . 19.4 m-90 -145.95 113.28 6.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 73.1 110.939 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 93.1 m -82.07 140.07 34.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 75.1 111.138 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.867 HG13 ' HB2' ' A' ' 10' ' ' ALA . 21.2 t -78.64 111.61 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 53.51 111.133 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -138.66 16.32 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 74.53 110.861 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -139.38 121.7 2.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.78 -0.724 . . . . 61.3 112.527 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -91.02 170.08 10.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.91 0.386 . . . . 73.03 110.895 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.643 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -168.03 155.16 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 71.32 111.127 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -115.18 127.35 55.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 65.12 110.864 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -89.81 39.5 0.96 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 54.42 110.924 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 73.02 111.132 179.927 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.58 0.705 . . . . 71.4 111.075 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 168.3 21.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.267 . . . . 73.33 112.358 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 132.72 23.96 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 64.22 112.356 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.784 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.01 134.92 35.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 51.25 111.085 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -93.12 77.16 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 75.55 111.117 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.666 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.1 mp -79.34 107.18 11.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 63.35 110.928 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.903 ' O ' HD11 ' A' ' 16' ' ' LEU . 6.6 mm-40 -79.92 -173.58 3.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.68 79.65 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 64.42 111.047 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 17' ' ' ARG . 3.2 mm -70.6 172.61 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 73.24 111.139 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.694 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -53.05 171.54 0.22 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 64.03 110.839 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.5 Cg_endo -69.79 19.77 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.686 2.257 . . . . 72.13 112.307 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' HIS . 25.5 pttt -127.91 25.43 5.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 72.42 110.921 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.55 -179.98 30.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.754 -0.736 . . . . 71.55 112.498 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.019 HD13 HD21 ' A' ' 67' ' ' LEU . 20.5 tp -149.97 158.3 44.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 71.01 110.902 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.717 ' HB2' HD11 ' A' ' 11' ' ' ILE . 11.4 ttt180 -126.37 132.55 51.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.02 110.88 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.666 HG22 ' HA ' ' A' ' 8' ' ' LEU . 54.2 t -141.29 114.03 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 71.1 111.129 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.529 ' HB2' HG23 ' A' ' 59' ' ' ILE . 7.8 t -119.96 156.56 30.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 63.3 110.85 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.784 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.4 m -139.01 152.67 70.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.589 0.709 . . . . 74.25 111.168 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 121.36 8.05 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.727 2.285 . . . . 72.01 112.313 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.598 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.1 t70 -55.69 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 65.03 110.881 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' A' ' 22' ' ' ASP . 0.9 OUTLIER 83.46 -13.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 75.44 110.874 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.83 6.47 2.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 71.23 112.516 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CD2' ' O ' ' A' ' 22' ' ' ASP . 36.1 m-85 -53.8 166.74 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 74.12 110.865 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 80' ' ' ILE . 11.4 t -133.08 -2.25 3.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 73.41 110.822 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.043 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -171.45 139.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 75.31 110.892 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.043 ' N ' HD22 ' A' ' 27' ' ' LEU . 13.3 t80 -133.77 152.5 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 64.13 110.871 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.79 158.87 43.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 75.53 111.113 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.522 ' HE2' HG11 ' A' ' 18' ' ' VAL . 1.5 t80 -139.2 127.27 22.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 71.13 110.871 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -152.89 88.04 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.2 110.859 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.523 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.27 -176.67 20.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 33.55 112.47 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -134.8 -164.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 74.11 110.863 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.1 tp -131.94 147.02 52.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 73.14 110.875 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m120 39.92 30.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 74.42 110.859 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.03 127.6 4.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.45 110.893 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -99.96 146.81 26.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 71.34 110.864 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.0 ptp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 64.05 110.881 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.503 -0.239 . . . . 74.1 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.74 -58.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.752 0.31 . . . . 63.44 110.837 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -69.66 146.96 51.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 74.54 110.936 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -155.12 120.18 4.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 64.24 110.812 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.14 158.85 25.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 63.34 110.92 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.743 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -143.56 116.19 8.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 71.14 110.835 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mm -98.76 108.17 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 54.45 111.144 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -98.23 31.84 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 72.22 111.106 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.23 115.59 0.27 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.656 0.741 . . . . 74.44 110.858 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 53.7 Cg_endo -69.71 178.16 4.82 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.66 2.24 . . . . 74.13 112.377 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.693 ' HD3' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -169.88 133.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 62.33 110.902 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 7.1 t-20 81.62 8.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 52.02 110.92 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.88 -16.84 42.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 74.21 112.542 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.1 176.01 9.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 72.14 110.911 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.55 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 6.9 m95 -93.41 107.91 19.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 71.54 110.893 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.693 HD12 ' HD3' ' A' ' 54' ' ' LYS . 11.1 mt -106.21 146.62 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 72.24 111.111 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -136.38 144.53 44.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 73.51 110.85 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.51 133.43 40.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 73.13 110.859 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.78 155.1 31.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 70.31 110.864 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -123.31 41.9 3.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 54.35 110.862 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -153.87 24.02 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 64.24 110.854 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.3 93.1 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.45 111.129 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -89.38 81.1 6.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.42 111.11 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.019 HD21 HD13 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -121.91 171.52 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 70.51 110.948 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.569 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -157.74 138.45 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.935 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.569 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.8 mm -22.65 118.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 75.41 111.181 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.94 -18.12 7.09 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 24.2 112.472 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.97 -169.19 1.47 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.866 0.365 . . . . 72.33 110.908 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.9 mttt -150.34 161.67 42.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 71.44 110.937 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.3 mt -135.63 146.65 29.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 74.15 111.145 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.9 m-85 -147.59 107.01 3.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 75.21 110.903 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.4 p90 -167.67 -167.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 70.12 110.883 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.9 p-90 -135.97 163.11 31.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 73.01 110.943 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 p -131.35 164.4 25.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 55.33 111.133 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.67 141.64 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 75.31 110.912 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.598 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -141.03 167.3 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.25 111.137 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.589 ' CD1' HD12 ' A' ' 27' ' ' LEU . 94.1 mt -149.89 95.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 65.12 111.094 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -109.84 137.49 47.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 71.43 110.891 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 43.4 34.95 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 64.5 110.909 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.69 37.73 92.77 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 64.35 112.461 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.81 -55.11 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 64.32 110.94 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.11 113.22 1.13 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 73.22 112.482 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.598 ' HB2' HG23 ' A' ' 79' ' ' VAL . 96.7 m-85 -132.23 -178.72 5.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 75.44 110.918 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -174.09 135.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 70.14 110.849 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.1 153.19 22.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 74.11 110.881 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -135.19 -163.91 1.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 65.12 110.884 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.4 t-20 83.73 -37.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 73.2 110.896 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.51 79.12 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.77 -0.728 . . . . 75.24 112.479 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -170.14 110.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 62.11 110.886 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -151.52 115.4 4.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.33 110.921 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.5 m -87.06 131.18 34.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 61.45 111.185 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.688 HG21 HD12 ' A' ' 67' ' ' LEU . 28.8 t -63.21 116.33 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 73.45 111.123 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.04 6.1 3.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 75.41 110.875 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.812 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -115.82 -178.55 18.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 71.1 112.461 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.515 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.7 155.7 33.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 63.33 110.89 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.711 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.76 178.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 64.54 111.119 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.38 133.61 27.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 70.52 110.905 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -85.24 44.89 1.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 75.12 110.882 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.4 111.074 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.563 0.697 . . . . 75.55 111.126 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 169.11 19.6 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.281 . . . . 54.13 112.369 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 133.37 25.28 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 51.41 112.35 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.727 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -83.68 140.54 32.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 64.31 111.063 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m -100.77 78.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 63.34 111.175 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.529 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.7 mp -78.27 110.18 13.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 74.11 110.925 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.635 ' O ' HD11 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -78.19 -160.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 75.2 110.891 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.796 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -139.92 80.34 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 71.21 111.118 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.755 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.3 mm -72.19 172.69 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 73.43 111.179 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . 0.709 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.18 172.09 0.25 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.712 . . . . 71.23 110.858 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.598 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.2 Cg_endo -69.82 20.07 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.665 2.243 . . . . 74.5 112.3 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 12' ' ' HIS . 3.0 pttt -125.1 19.8 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 53.3 110.902 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.78 -177.3 33.77 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 71.33 112.492 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.987 HD13 HD21 ' A' ' 67' ' ' LEU . 27.8 tp -150.98 167.93 26.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.804 0.335 . . . . 75.3 110.922 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.575 ' HB2' HD11 ' A' ' 11' ' ' ILE . 5.2 ttm180 -130.78 141.08 50.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.879 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -149.59 107.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 72.43 111.121 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.553 ' HB2' HG23 ' A' ' 59' ' ' ILE . 11.7 t -120.18 156.3 31.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 65.03 110.871 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 6' ' ' ALA . 3.1 m -145.08 151.76 49.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 73.04 111.139 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 121.2 7.9 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.677 2.251 . . . . 74.13 112.339 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 1.2 t70 -75.7 130.84 39.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.872 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.7 23.93 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 73.41 110.836 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 112.8 5.91 23.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.736 . . . . 74.52 112.468 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 66.7 m-85 -55.62 162.54 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 53.13 110.897 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.3 t -129.84 -8.9 4.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 61.31 110.879 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.009 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -158.64 141.85 14.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 71.42 110.936 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 1.009 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -135.65 150.39 49.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 70.22 110.841 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.718 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . . . -141.0 136.75 32.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 74.45 111.083 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.62 118.28 30.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.84 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.488 ' NE2' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -146.0 90.58 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 71.51 110.881 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 75' ' ' PHE . . . -146.24 -178.31 21.56 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 73.41 112.494 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -132.76 -164.3 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 72.24 110.909 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.44 ' HG ' ' CG ' ' A' ' 35' ' ' ASN . 14.0 tp -133.18 147.94 52.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 62.33 110.965 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.44 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 6.9 m-20 43.39 24.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 74.02 110.881 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -166.49 143.09 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 70.52 110.938 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -105.51 -170.55 1.76 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 72.32 110.907 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.508 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 2.1 ptt? . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 63.01 110.866 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.508 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.483 -0.247 . . . . 73.1 112.483 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.43 -69.87 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 54.12 110.897 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.446 ' O ' ' ND1' ' A' ' 31' ' ' HIS . 6.1 m-90 -47.47 164.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 70.41 110.915 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.488 ' CB ' ' NE2' ' A' ' 31' ' ' HIS . 97.0 p -166.31 117.39 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 74.21 110.878 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.56 162.43 21.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 62.24 110.874 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.718 ' OD1' ' HB2' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -139.44 108.38 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 55.31 110.915 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 28' ' ' PHE . 3.4 mm -82.94 104.2 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 60.31 111.095 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.1 p -91.94 28.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 51.4 111.136 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.34 140.78 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.555 0.693 . . . . 72.34 110.885 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 178.25 4.74 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.739 2.293 . . . . 53.34 112.298 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.706 ' HD2' HD12 ' A' ' 59' ' ' ILE . 12.3 ttmt -109.9 -55.53 2.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 71.2 110.926 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.02 75.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 73.3 110.906 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.61 -22.22 6.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 74.43 112.481 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -137.98 171.89 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 73.14 110.906 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.585 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 18.9 m95 -93.58 98.44 11.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.922 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.706 HD12 ' HD2' ' A' ' 54' ' ' LYS . 27.9 mt -99.97 150.67 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 73.24 111.132 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -146.1 147.41 31.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 55.41 110.935 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.29 127.46 22.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 71.12 110.869 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -98.6 -179.55 4.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 73.21 110.871 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.59 16.17 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 72.21 110.879 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -133.43 6.93 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 75.43 110.871 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.68 103.28 15.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 73.42 111.09 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -98.61 83.01 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 75.12 111.057 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.987 HD21 HD13 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -122.38 171.6 8.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 73.22 110.917 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -158.45 141.62 14.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 71.2 110.888 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.576 HD11 ' O ' ' A' ' 97' ' ' GLY . 5.2 mm -26.0 117.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 62.25 111.168 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.31 -17.15 10.54 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.803 -0.713 . . . . 63.04 112.507 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.83 -167.98 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 73.43 110.892 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 16.4 mttt -151.52 165.56 33.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.34 110.918 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.8 mt -141.26 151.12 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 53.34 111.143 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -150.28 101.1 2.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.25 110.87 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.488 ' CB ' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -160.1 -166.35 1.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.872 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.4 148.64 32.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 74.13 110.902 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 p -115.07 155.61 26.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.431 . . . . 75.42 111.173 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.02 142.97 49.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 71.55 110.877 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.451 ' CG1' ' CD2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -142.68 170.72 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 72.53 111.098 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.675 HG13 HD12 ' A' ' 27' ' ' LEU . 77.5 mt -146.5 96.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 71.33 111.151 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.443 ' HG3' ' C ' ' A' ' 24' ' ' GLY . 1.6 tttt -114.15 141.58 47.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.41 110.947 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 49.14 32.44 4.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 72.15 110.852 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.08 30.11 60.27 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 74.31 112.476 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.535 HD13 ' OH ' ' A' ' 86' ' ' TYR . 1.5 mt -96.85 -63.6 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 65.05 110.923 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.09 106.11 3.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 72.22 112.452 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.535 ' OH ' HD13 ' A' ' 84' ' ' LEU . 80.2 m-85 -119.47 171.72 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 74.44 110.875 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 6.8 ttp-105 -171.33 131.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 71.43 110.895 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -74.08 158.93 33.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 72.13 110.923 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.4 OUTLIER -140.83 -164.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 64.14 110.869 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.2 t-20 83.75 -42.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.23 110.907 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.52 70.48 0.75 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 31.4 112.473 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -170.02 117.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 62.13 110.895 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -155.23 118.65 4.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 73.42 110.942 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.8 m -87.6 132.04 34.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 64.44 111.147 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.71 HG21 HD12 ' A' ' 67' ' ' LEU . 32.8 t -67.29 112.3 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.15 111.159 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -129.42 10.92 5.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.52 110.897 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.796 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -122.65 -177.0 15.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 61.3 112.473 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.507 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -154.04 155.76 36.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.372 . . . . 71.34 110.861 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.755 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.48 -176.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 72.23 111.153 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -151.95 132.57 13.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 60.53 110.829 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -102.93 46.14 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 63.42 110.897 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 63.3 111.078 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.879 0.371 . . . . 71.33 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.539 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 6.2 mm-40 -141.78 85.86 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.081 -0.509 . . . . 74.22 110.898 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.67 141.06 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 54.43 111.07 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.26 24.92 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 73.1 112.333 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 134.19 27.32 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.686 2.257 . . . . 74.45 112.342 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.921 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.55 136.02 35.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 71.22 111.112 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.4 m -95.6 77.57 3.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 74.01 111.107 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -79.42 110.17 14.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 71.22 110.912 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.789 ' O ' HD11 ' A' ' 16' ' ' LEU . 12.9 mm-40 -79.8 -165.61 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 64.42 110.903 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.823 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -134.95 80.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 60.3 111.103 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.702 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.6 mm -70.81 172.5 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 74.15 111.127 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.702 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.79 172.37 0.23 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.573 0.702 . . . . 60.12 110.853 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.79 20.02 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.614 2.209 . . . . 63.03 112.378 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 12' ' ' HIS . 3.8 ptpt -126.78 24.04 6.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 70.02 110.885 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.91 -178.48 30.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 42.41 112.498 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.789 HD11 ' O ' ' A' ' 9' ' ' GLU . 29.1 tp -150.52 164.11 36.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.857 0.361 . . . . 64.31 110.892 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.618 ' HB2' HD11 ' A' ' 11' ' ' ILE . 49.6 ttt180 -127.61 137.61 52.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 71.13 110.863 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.8 t -145.6 108.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 72.42 111.11 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.5 t -122.3 156.45 33.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 73.34 110.919 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 6' ' ' ALA . 10.4 m -141.36 150.86 59.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.633 0.73 . . . . 72.35 111.117 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 122.27 8.95 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.725 2.283 . . . . 71.14 112.348 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 15.0 t70 -83.81 128.74 34.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.1 110.844 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -117.97 2.21 12.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 51.01 110.916 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.27 31.08 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 62.53 112.452 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.518 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 63.3 m-85 -82.27 160.9 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 53.21 110.897 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.7 t -126.48 -13.52 6.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 53.42 110.856 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.035 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -153.64 140.17 18.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 70.11 110.959 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.035 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -133.75 143.72 48.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 64.03 110.861 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.03 129.35 43.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 74.51 111.171 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -115.24 120.62 40.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.941 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 20.2 m80 -151.58 91.07 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 55.05 110.864 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -145.96 -177.6 20.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.777 -0.725 . . . . 62.03 112.484 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -135.3 -166.44 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 73.25 110.847 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' ASN . 9.5 tp -128.07 147.35 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 62.3 110.886 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 34' ' ' LEU . 3.0 m120 36.47 34.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 65.3 110.929 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 34' ' ' LEU . 1.2 tp10 -163.43 129.16 3.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 65.13 110.922 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -102.74 150.21 23.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 64.3 110.87 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.35 -174.47 2.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 64.35 110.898 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -146.04 146.65 31.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 64.52 110.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 65.14 36.48 92.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.736 . . . . 44.14 112.476 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 40' ' ' GLY . 5.6 mt 36.88 81.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 72.3 110.958 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -123.32 171.68 9.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 64.11 110.818 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.31 98.63 6.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 70.24 111.127 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.83 -115.16 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.721 -0.752 . . . . 74.21 112.435 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -103.27 -53.32 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 74.21 110.861 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.9 m-90 -73.25 147.47 44.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.219 -0.446 . . . . 70.12 110.881 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.2 p -151.27 119.01 6.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 60.22 110.88 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.92 163.12 4.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 71.34 110.889 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -142.82 119.37 11.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 45.43 110.88 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 28' ' ' PHE . 5.5 mm -86.17 109.98 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 63.53 111.138 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 p -94.79 28.01 2.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 71.12 111.174 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt 171.22 135.66 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.562 0.696 . . . . 62.35 110.908 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -175.57 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.679 2.253 . . . . 74.34 112.399 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.619 ' HD2' HD12 ' A' ' 59' ' ' ILE . 1.2 ttmm -157.16 109.57 2.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 60.34 110.867 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER 82.68 15.14 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 54.23 110.855 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.67 -17.5 49.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 62.21 112.444 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.86 160.4 37.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 71.31 110.865 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.539 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 20.1 m95 -84.69 94.17 8.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 73.05 110.946 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.619 HD12 ' HD2' ' A' ' 54' ' ' LYS . 21.7 mt -97.72 143.12 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 71.23 111.102 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -138.55 153.52 48.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 62.01 110.864 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.99 137.41 26.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 73.3 110.873 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.433 ' OD2' ' CG ' ' A' ' 64' ' ' ASN . 1.1 t70 -112.19 -177.67 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.22 110.894 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -143.49 10.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 73.43 110.85 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.433 ' CG ' ' OD2' ' A' ' 62' ' ' ASP . 22.1 p30 -127.28 9.87 6.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 73.22 110.844 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.24 101.06 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.35 111.085 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -100.85 88.74 3.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 64.54 111.162 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.743 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -136.33 171.22 14.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 63.24 110.951 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.669 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.29 154.48 32.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 63.23 110.906 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.616 ' CG1' ' CE2' ' A' ' 98' ' ' PHE . 16.2 mm -32.14 115.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 75.2 111.106 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.8 -20.53 6.4 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.686 -0.769 . . . . 55.32 112.455 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.69 -173.75 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.881 0.372 . . . . 75.32 110.849 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.5 mttt -149.56 159.68 44.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.45 110.894 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 33' ' ' LYS . 10.4 mt -134.26 148.1 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 74.4 111.113 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -147.75 105.55 3.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 64.53 110.938 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 2.3 p90 -163.68 -159.44 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 74.23 110.855 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.431 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.9 p-90 -145.44 168.58 20.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 70.42 110.92 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.403 HG23 ' CE2' ' A' ' 75' ' ' PHE . 1.7 p -139.92 147.59 40.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 73.32 111.152 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -112.92 141.01 47.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 75.53 110.884 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.405 ' C ' HG13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -139.69 171.2 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.14 111.112 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.624 HG13 HD12 ' A' ' 27' ' ' LEU . 97.4 mt -150.24 96.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 61.43 111.111 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.51 135.85 53.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 72.24 110.89 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 48.43 33.37 3.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 64.35 110.897 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.69 31.0 63.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 71.42 112.524 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.536 HD13 ' OH ' ' A' ' 86' ' ' TYR . 29.7 mt -95.19 -56.54 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.882 0.372 . . . . 64.11 110.921 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.14 113.93 2.92 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 52.2 112.462 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.536 ' OH ' HD13 ' A' ' 84' ' ' LEU . 97.4 m-85 -133.4 170.67 15.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 75.03 110.9 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -170.86 137.82 1.29 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 72.41 110.919 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.539 ' NE2' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -85.75 152.22 23.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 72.34 110.898 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -134.35 -166.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.42 110.828 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 82.92 -36.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.86 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 43.47 80.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 65.3 112.469 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -168.74 113.43 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 74.1 110.91 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -151.09 121.56 7.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.187 -0.46 . . . . 71.54 110.9 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.4 m -92.96 134.56 34.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 64.42 111.143 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.823 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 21.4 t -63.61 121.24 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 63.34 111.145 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.1 34.05 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 63.42 110.891 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -162.9 125.52 1.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.7 -0.762 . . . . 50.54 112.509 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.616 ' CE2' ' CG1' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -94.92 163.89 13.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 75.12 110.886 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.649 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.48 167.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 74.13 111.13 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.34 130.31 50.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 62.01 110.876 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.36 57.07 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.51 110.862 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 71.44 111.121 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.851 0.358 . . . . 73.11 110.921 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -143.01 76.51 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 71.44 110.899 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.06 147.25 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.541 0.686 . . . . 63.4 111.156 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.7 Cg_endo -69.75 166.01 29.03 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.65 2.233 . . . . 44.24 112.37 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 134.25 27.39 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.667 2.245 . . . . 75.0 112.327 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.752 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.01 140.41 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 61.54 111.086 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -97.1 78.7 2.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 75.52 111.146 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.5 HD21 ' CE1' ' A' ' 75' ' ' PHE . 1.7 mp -76.15 110.79 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 73.14 110.938 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.708 ' O ' HD11 ' A' ' 16' ' ' LEU . 4.8 mm-40 -84.5 -168.54 2.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 75.32 110.848 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -134.57 80.54 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 71.54 111.05 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.689 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -72.16 172.2 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 65.04 111.136 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.689 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.07 172.53 0.23 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 75.02 110.825 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.604 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.3 Cg_endo -69.8 19.91 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.705 2.27 . . . . 55.25 112.335 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 12' ' ' HIS . 8.1 pttt -127.18 25.14 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 72.24 110.862 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.58 -179.23 30.06 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.775 -0.726 . . . . 61.55 112.482 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.975 HD13 HD11 ' A' ' 67' ' ' LEU . 17.7 tp -150.35 164.49 35.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 71.22 110.931 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.626 ' HB2' HD11 ' A' ' 11' ' ' ILE . 25.1 ttt-85 -126.19 141.89 51.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 73.02 110.9 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -152.11 102.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 63.24 111.113 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -115.22 157.08 24.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 73.22 110.83 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 6' ' ' ALA . 20.5 m -139.94 151.64 65.86 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 71.31 111.148 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.429 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 53.9 Cg_endo -69.74 125.26 11.95 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.719 2.279 . . . . 74.04 112.366 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 20.1 t0 -87.33 83.72 7.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 31.23 110.868 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -70.96 -0.27 8.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 73.41 110.899 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.5 28.7 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 75.12 112.489 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -77.18 166.87 22.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.868 0.365 . . . . 74.23 110.906 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.5 t -124.64 -15.26 6.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 73.33 110.836 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.05 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -157.0 136.9 12.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 75.4 110.965 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.05 ' N ' HD22 ' A' ' 27' ' ' LEU . 7.6 t80 -131.06 148.09 52.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 74.0 110.881 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.25 157.7 45.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 64.41 111.091 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.629 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.5 m-85 -130.96 127.28 38.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 73.14 110.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.571 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 1.7 m-70 -153.27 85.76 1.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 71.44 110.877 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.533 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.15 173.84 26.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 61.51 112.488 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.32 -164.57 1.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 73.11 110.942 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 tp -134.01 145.3 49.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 72.32 110.916 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.6 m120 47.57 28.88 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 53.42 110.914 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -168.32 134.64 1.94 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.31 110.922 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -108.49 160.18 16.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 63.14 110.852 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -103.03 -173.77 2.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 61.22 110.843 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -146.11 145.87 30.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 65.52 110.925 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.39 21.9 74.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.748 . . . . 73.32 112.487 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.549 HD13 ' NH2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER 50.81 86.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.794 0.33 . . . . 64.45 110.958 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -129.37 -171.47 2.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.02 110.867 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.571 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -92.31 105.19 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 70.32 111.096 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.19 -121.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.702 -0.761 . . . . 64.41 112.505 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.68 -65.27 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.742 0.305 . . . . 64.0 110.861 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -60.64 139.37 57.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 71.2 110.954 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.5 p -139.64 115.55 10.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 43.22 110.811 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.76 154.75 31.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.487 . . . . 65.15 110.87 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.668 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -144.34 109.63 5.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.01 110.859 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 52' ' ' LYS . 12.8 mm -92.64 125.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 60.33 111.094 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 55.6 p -111.06 33.85 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 43.15 111.141 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.506 ' H ' HG22 ' A' ' 50' ' ' ILE . 3.2 tttt 163.45 131.78 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 60.13 110.906 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -176.0 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.698 2.266 . . . . 63.31 112.363 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.409 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -139.04 -35.98 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 72.22 110.881 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' NH1' ' A' ' 57' ' ' ARG . 1.9 m120 -128.0 38.24 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.899 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.42 -27.86 8.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.685 -0.769 . . . . 74.42 112.548 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -125.2 173.51 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.348 . . . . 74.21 110.877 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.412 ' HB2' HG22 ' A' ' 20' ' ' VAL . 12.6 m95 -92.28 94.46 9.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 72.51 110.898 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.409 HD12 ' HD2' ' A' ' 54' ' ' LYS . 56.2 mt -98.24 141.31 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 63.44 111.141 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 19.6 t80 -136.52 153.08 51.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 62.25 110.895 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -143.96 137.28 27.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 74.33 110.883 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.17 178.41 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 64.43 110.9 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.89 10.83 2.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 61.23 110.83 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -125.47 7.38 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 62.42 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -94.82 103.03 14.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 54.15 111.097 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -102.42 85.21 2.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 70.22 111.105 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.975 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -138.56 170.96 15.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 74.33 110.904 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.663 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.84 164.56 37.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 74.11 110.885 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.537 HD11 ' O ' ' A' ' 97' ' ' GLY . 26.4 mm -33.01 122.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.31 111.11 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.4 -29.41 6.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.719 -0.753 . . . . 63.24 112.509 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.36 -176.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.903 0.382 . . . . 72.23 110.86 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -143.6 169.36 17.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 72.14 110.91 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.3 mt -147.84 145.22 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 64.4 111.092 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.2 m-85 -148.38 105.25 3.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.938 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 2.4 p90 -164.6 -160.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 72.4 110.905 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.486 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -149.05 155.58 40.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 75.11 110.937 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.455 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 5.6 p -124.0 147.37 47.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 61.23 111.163 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.99 151.07 25.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 60.42 110.879 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.596 HG13 ' HD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -145.48 169.41 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 71.45 111.125 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.715 HG13 HD12 ' A' ' 27' ' ' LEU . 69.9 mt -150.26 95.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.44 111.151 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -112.15 136.6 51.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 71.21 110.899 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.35 38.79 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 72.15 110.871 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.9 35.74 59.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 63.41 112.459 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 mt -97.72 -59.19 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 64.42 110.951 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.53 105.87 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 54.22 112.526 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.517 ' HB2' HG23 ' A' ' 79' ' ' VAL . 94.5 m-85 -124.21 178.35 5.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.824 0.345 . . . . 75.03 110.957 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.549 ' NH2' HD13 ' A' ' 41' ' ' LEU . 4.1 tmm_? -178.42 130.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 64.31 110.903 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -65.29 -171.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.92 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.0 t70 -170.37 -169.8 0.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 62.52 110.841 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.3 t-20 83.01 -36.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 64.12 110.864 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.33 75.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 34.54 112.513 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -168.18 117.49 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.889 0.375 . . . . 73.42 110.9 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -157.06 118.53 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 71.4 110.93 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 36.5 m -90.82 142.12 28.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 54.44 111.153 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.687 HG13 ' HB2' ' A' ' 10' ' ' ALA . 28.2 t -76.35 112.47 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 71.4 111.154 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -131.52 4.7 4.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.24 110.923 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.813 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -116.6 -176.53 17.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.777 -0.725 . . . . 43.24 112.492 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.5 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -156.66 159.89 38.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.371 . . . . 74.44 110.896 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.64 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.79 -174.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.33 111.101 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.05 137.68 22.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 43.24 110.877 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.27 46.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 74.35 110.892 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 50.13 111.072 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.878 0.37 . . . . 74.01 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -135.86 72.9 1.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 71.14 110.913 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.541 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . . . 59.38 147.32 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 74.02 111.06 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.09 25.41 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.666 2.244 . . . . 74.01 112.33 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 133.47 25.69 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.235 . . . . 65.12 112.34 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.867 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -82.03 136.6 35.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 70.33 111.122 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -92.95 77.72 4.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 64.31 111.141 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.436 HD21 ' CE1' ' A' ' 75' ' ' PHE . 2.0 mp -78.48 108.68 12.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 54.41 110.927 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.845 ' O ' HD11 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -82.55 -173.47 4.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 71.45 110.928 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.49 80.75 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 73.32 111.096 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 12' ' ' HIS . 2.5 mm -71.72 172.68 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 72.43 111.134 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.71 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.92 171.63 0.26 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 74.22 110.823 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.585 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.2 Cg_endo -69.79 19.7 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.628 2.219 . . . . 63.44 112.361 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 12' ' ' HIS . 12.6 pttt -125.82 22.1 7.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.861 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 155.67 -178.98 31.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.757 -0.735 . . . . 34.03 112.506 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.845 HD11 ' O ' ' A' ' 9' ' ' GLU . 19.4 tp -150.46 164.42 35.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 72.11 110.938 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HB2' HD11 ' A' ' 11' ' ' ILE . 8.5 ttm180 -128.95 136.77 50.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 55.51 110.839 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -146.34 106.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 72.35 111.157 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.531 ' HB2' HG23 ' A' ' 59' ' ' ILE . 13.0 t -119.68 157.84 27.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 63.13 110.83 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.867 HG12 ' HA ' ' A' ' 6' ' ' ALA . 20.6 m -140.86 151.53 63.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.735 . . . . 73.13 111.125 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 122.16 8.84 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 32.11 112.325 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -80.51 97.91 7.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.838 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.32 12.42 10.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.931 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.26 15.68 3.7 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.703 -0.761 . . . . 63.11 112.46 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 87.5 m-85 -66.49 165.56 14.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 74.31 110.865 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 t -125.03 -17.24 5.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 71.03 110.839 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.046 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -153.45 139.67 18.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 73.34 110.903 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.046 ' N ' HD22 ' A' ' 27' ' ' LEU . 8.0 t80 -132.0 148.63 52.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 63.02 110.873 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.53 155.12 50.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 65.43 111.152 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.644 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.6 m-85 -127.94 125.51 39.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 72.11 110.871 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.783 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 1.7 m80 -149.03 83.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 73.12 110.83 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.14 173.61 26.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 70.11 112.496 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.6 -164.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 73.44 110.925 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 36' ' ' GLU . 21.9 tp -126.49 147.61 49.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 64.31 110.962 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 34' ' ' LEU . 3.0 m120 37.04 32.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 74.21 110.86 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 34' ' ' LEU . 64.5 tt0 -161.96 134.36 5.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 74.14 110.925 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -106.51 160.43 15.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.2 110.88 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.439 ' HE1' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -111.43 178.45 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 62.14 110.888 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.46 153.94 48.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 64.03 110.933 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.45 27.06 68.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 73.13 112.502 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.647 HD13 ' NH1' ' A' ' 87' ' ' ARG . 2.0 mt 45.58 78.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.354 . . . . 71.14 110.91 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -119.0 174.16 6.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 64.44 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.783 ' HB1' ' CD2' ' A' ' 31' ' ' HIS . . . -84.09 103.9 13.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 65.03 111.097 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.45 -121.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.74 . . . . 55.4 112.482 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.67 -68.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.322 . . . . 74.24 110.827 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.594 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 6.0 m0 -58.02 97.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 72.15 110.925 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.8 p -109.17 105.09 14.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 62.42 110.874 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.89 162.8 37.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.868 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -144.6 117.22 8.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.833 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 52' ' ' LYS . 18.4 mm -97.42 113.04 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 72.42 111.163 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.6 p -95.9 30.46 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 74.14 111.17 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.552 ' H ' HG22 ' A' ' 50' ' ' ILE . 2.8 tttt 173.99 138.62 0.15 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.721 . . . . 61.5 110.937 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -175.47 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.707 2.271 . . . . 73.43 112.323 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.719 ' HD2' HD12 ' A' ' 59' ' ' ILE . 21.7 ttmm -118.47 -71.56 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 72.14 110.872 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.07 46.57 2.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 60.31 110.87 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.67 -35.05 4.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 30.02 112.497 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.78 177.2 6.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 72.34 110.879 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -93.32 98.65 11.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 75.32 110.879 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.719 HD12 ' HD2' ' A' ' 54' ' ' LYS . 20.9 mt -103.09 141.0 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 73.42 111.147 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -135.64 147.1 48.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.914 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 126.83 29.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.872 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.594 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -104.06 169.81 8.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 61.13 110.916 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.2 mtt180 -136.93 20.3 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.0 110.837 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -133.19 14.55 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 74.51 110.887 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.54 101.86 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 64.13 111.109 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -98.96 84.23 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 54.15 111.11 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.764 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -135.89 171.17 14.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 75.52 110.879 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.757 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.71 158.07 34.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 43.44 110.959 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.6 mm -31.44 116.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 73.01 111.11 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.24 -26.1 5.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 74.21 112.512 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -72.79 -175.62 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 62.25 110.856 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.0 mptt -144.88 163.02 35.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 70.03 110.902 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 37.3 mt -138.63 143.59 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 62.34 111.169 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -145.48 105.27 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.21 110.931 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.546 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 3.9 p90 -165.44 -161.38 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 74.13 110.853 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.494 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -145.86 174.06 11.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 73.15 110.877 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 p -141.5 156.45 45.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 72.11 111.137 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.2 137.79 52.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 70.43 110.903 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -134.19 166.62 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 73.34 111.149 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.66 HG13 HD12 ' A' ' 27' ' ' LEU . 91.7 mt -142.44 95.9 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 63.23 111.138 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -116.44 147.51 41.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 71.33 110.919 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.05 27.8 1.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 62.1 110.884 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.77 30.94 70.27 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.734 -0.746 . . . . 53.41 112.464 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.17 -73.14 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.803 0.335 . . . . 61.22 110.93 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.94 117.21 2.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 73.12 112.505 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.656 ' HB2' HG23 ' A' ' 79' ' ' VAL . 76.7 m-85 -128.08 170.76 12.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.95 0.405 . . . . 72.43 110.911 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.647 ' NH1' HD13 ' A' ' 41' ' ' LEU . 43.0 ttp180 -159.05 139.0 11.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 71.3 110.884 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.541 ' OE1' ' HB3' ' A' ' 3' ' ' ALA . 2.9 tp60 -80.78 160.93 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 75.33 110.908 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 6.1 m-20 -145.49 -173.45 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 75.23 110.876 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 10.5 t-20 85.11 -32.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 63.15 110.894 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 33.47 81.91 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 72.32 112.512 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -172.48 110.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 72.24 110.909 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -153.22 105.89 2.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 74.13 110.943 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.3 m -76.3 136.39 39.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 74.33 111.122 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.757 HG13 ' HB2' ' A' ' 10' ' ' ALA . 45.6 t -64.82 109.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 75.33 111.128 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -128.6 5.2 5.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.22 110.89 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.825 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -115.64 -178.64 18.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 74.02 112.498 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.497 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.96 155.87 33.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 75.31 110.881 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.684 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.58 -177.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 72.25 111.142 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -139.45 132.0 28.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 70.1 110.865 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -76.06 54.98 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 63.31 110.913 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 70.13 111.083 179.928 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.846 0.355 . . . . 74.22 110.924 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -142.57 73.84 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 71.13 110.884 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 79' ' ' VAL . . . 62.05 148.43 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.713 . . . . 65.21 111.063 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 169.68 18.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 72.2 112.354 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.444 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 53.7 Cg_endo -69.78 134.79 28.79 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.256 . . . . 72.22 112.362 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.883 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -83.32 137.46 33.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 74.02 111.148 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -96.5 77.43 2.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 74.1 111.141 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.568 HD21 ' CE1' ' A' ' 75' ' ' PHE . 1.9 mp -76.81 110.13 11.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.437 . . . . 75.01 110.953 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.846 ' O ' HD11 ' A' ' 16' ' ' LEU . 28.9 mp0 -83.01 -173.24 4.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.23 110.857 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.664 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -131.12 80.29 1.93 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 71.01 111.115 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.753 HD13 ' CG2' ' A' ' 99' ' ' VAL . 2.9 mm -70.23 172.42 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 73.24 111.126 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.698 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.92 172.04 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.581 0.705 . . . . 75.01 110.841 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.5 Cg_endo -69.77 20.12 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.674 2.249 . . . . 64.31 112.368 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' HIS . 39.9 pttt -125.76 21.71 7.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 44.22 110.895 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.4 -178.11 32.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.784 -0.722 . . . . 74.12 112.518 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.846 HD11 ' O ' ' A' ' 9' ' ' GLU . 23.1 tp -150.08 164.57 35.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 71.3 110.862 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.664 ' HB2' HD11 ' A' ' 11' ' ' ILE . 51.7 ttt180 -130.2 140.59 50.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 70.12 110.901 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 8' ' ' LEU . 45.0 t -148.58 111.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 52.53 111.084 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 t -122.57 156.17 34.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.85 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.883 HG12 ' HA ' ' A' ' 6' ' ' ALA . 29.9 m -140.06 152.17 66.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.671 0.748 . . . . 65.44 111.102 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 121.39 8.08 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.672 2.248 . . . . 74.22 112.355 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -76.3 105.89 7.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 61.34 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.47 34.67 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 62.53 110.855 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.66 1.48 52.87 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.731 -0.747 . . . . 55.04 112.494 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.491 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 74.3 m-85 -54.05 164.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 75.12 110.881 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 t -127.08 -11.8 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 73.33 110.885 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.05 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -158.73 138.49 11.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 73.23 110.914 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.05 ' N ' HD22 ' A' ' 27' ' ' LEU . 7.3 t80 -130.89 146.01 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 63.04 110.88 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.445 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . . . -129.53 158.39 39.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 72.11 111.071 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.668 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 1.8 m-85 -132.81 127.85 35.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 71.03 110.902 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.624 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 22.2 m-70 -157.35 86.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 73.14 110.854 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -144.8 175.02 24.69 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 53.41 112.523 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.29 -166.68 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 61.52 110.919 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.708 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -129.93 124.64 33.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 70.31 110.912 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.442 ' OD1' HD12 ' A' ' 34' ' ' LEU . 27.3 m120 62.05 23.54 13.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 64.24 110.875 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -155.93 144.13 19.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 71.14 110.893 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -112.73 169.05 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 63.51 110.853 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.551 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -116.68 -174.4 2.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 74.23 110.853 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -144.1 147.0 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 71.23 110.905 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.53 31.69 81.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 41.1 112.502 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 1.9 mt 42.93 86.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 74.32 110.901 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -131.47 175.07 9.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 62.1 110.852 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -84.46 104.28 14.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 72.01 111.125 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.6 -120.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 15.11 112.514 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.49 -63.09 1.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.343 . . . . 72.5 110.836 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.708 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.4 m-90 -61.15 155.33 20.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 71.31 110.9 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.2 p -158.45 109.53 2.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 75.54 110.867 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.37 160.3 38.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 61.34 110.861 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.531 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -144.09 107.22 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 72.32 110.913 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.1 mm -86.75 106.66 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 74.01 111.137 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.0 p -96.01 29.93 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 74.44 111.145 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -176.85 113.66 0.25 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.628 0.727 . . . . 73.22 110.871 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.514 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 53.9 Cg_endo -69.76 -178.23 2.24 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.677 2.252 . . . . 73.24 112.321 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -174.33 136.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.02 110.893 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 2.6 t30 82.48 7.88 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 71.31 110.937 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' CD ' ' A' ' 57' ' ' ARG . . . 100.0 -6.73 58.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 74.01 112.51 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' CD ' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -153.27 174.2 14.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 73.12 110.883 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.514 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 14.6 m95 -90.35 106.24 18.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.935 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.5 146.63 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 74.32 111.13 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -143.43 149.06 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 65.52 110.913 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 133.1 28.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.35 110.883 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.72 -178.49 3.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 64.04 110.855 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.56 20.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.11 110.867 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -134.89 14.56 3.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 74.32 110.908 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.36 107.25 18.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 51.52 111.112 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -103.47 79.7 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 75.23 111.069 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.734 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -126.65 171.6 11.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 74.44 110.944 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.707 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.09 154.43 27.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 71.24 110.893 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.501 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.7 mm -29.61 123.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 73.53 111.096 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.54 7.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 61.43 112.499 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.73 -176.89 1.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.927 0.394 . . . . 63.14 110.808 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -142.2 166.6 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 75.4 110.919 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.501 HG12 HD22 ' A' ' 34' ' ' LEU . 87.4 mt -142.96 145.27 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 63.14 111.125 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -147.5 103.32 3.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 75.33 110.937 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.568 ' CE1' HD21 ' A' ' 8' ' ' LEU . 1.4 p90 -162.29 -162.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 74.15 110.927 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.551 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -150.64 149.77 30.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 73.04 110.896 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.537 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 7.0 p -119.76 145.87 46.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 62.32 111.132 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -103.84 150.5 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 75.42 110.896 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -143.28 166.92 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 65.04 111.112 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.629 HG13 HD12 ' A' ' 27' ' ' LEU . 85.7 mt -145.61 96.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 50.34 111.143 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -115.14 137.31 52.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 63.15 110.854 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 42.92 41.16 2.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 65.33 110.897 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.08 37.27 36.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.746 -0.74 . . . . 74.14 112.535 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 mt -98.18 -55.79 2.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 53.21 110.913 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.79 105.23 1.63 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 60.31 112.447 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.538 ' HB2' HG23 ' A' ' 79' ' ' VAL . 99.0 m-85 -130.1 176.16 8.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 75.15 110.929 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.451 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -176.77 136.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 64.05 110.907 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' A' ' 5' ' ' PRO . 1.4 tp60 -73.42 163.53 27.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 71.52 110.878 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -145.94 -169.92 3.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.52 110.849 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.6 t-20 83.46 -33.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 73.15 110.884 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.73 84.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 73.54 112.468 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -170.13 116.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.822 0.344 . . . . 53.34 110.888 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.8 m-90 -157.84 109.57 2.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.194 -0.457 . . . . 75.42 110.938 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.6 m -81.59 138.91 35.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 65.34 111.138 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.664 HG13 ' HB2' ' A' ' 10' ' ' ALA . 22.4 t -70.11 110.58 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.43 111.083 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -131.76 4.32 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 63.22 110.887 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -113.95 -176.39 19.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 60.42 112.51 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.473 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -158.36 155.2 28.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.888 0.375 . . . . 73.33 110.895 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.753 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.51 175.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 53.41 111.136 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -139.1 127.64 23.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 75.12 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -80.22 54.6 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 73.44 110.898 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 74.51 111.081 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 4.8 t80 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.859 0.362 . . . . 73.42 110.897 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 6.5 mt-10 -140.94 72.57 1.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 64.03 110.899 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 2' ' ' GLU . . . 71.86 144.88 0.11 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.571 0.7 . . . . 61.33 111.069 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 167.61 23.97 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.644 2.229 . . . . 73.22 112.315 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 136.35 32.78 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.685 2.256 . . . . 61.11 112.32 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.889 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -89.65 137.27 32.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 63.2 111.132 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m -95.94 77.07 3.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 42.01 111.153 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.506 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.5 mp -75.71 108.39 8.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 61.21 110.913 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.842 ' O ' HD11 ' A' ' 16' ' ' LEU . 10.3 mm-40 -79.93 -172.54 3.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 62.34 110.835 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.63 80.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.03 111.104 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 17' ' ' ARG . 3.2 mm -71.01 172.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 65.51 111.152 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.687 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -54.2 172.32 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.574 0.702 . . . . 62.24 110.898 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.74 20.39 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.664 2.243 . . . . 75.25 112.347 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' HIS . 1.8 pttt -125.58 22.26 7.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 72.42 110.864 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.49 -177.42 31.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.697 -0.763 . . . . 44.02 112.464 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.842 HD11 ' O ' ' A' ' 9' ' ' GLU . 20.7 tp -149.47 161.73 41.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 74.44 110.93 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.76 ' HB2' HD11 ' A' ' 11' ' ' ILE . 18.0 ttm180 -125.51 137.8 53.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 73.43 110.862 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 8' ' ' LEU . 77.0 t -147.69 110.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 61.34 111.122 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 59' ' ' ILE . 11.0 t -120.32 154.28 35.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 71.43 110.882 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.899 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 34.1 m -141.64 152.65 63.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.639 0.733 . . . . 74.32 111.116 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 122.09 8.77 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.664 2.243 . . . . 65.24 112.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 1.1 t70 -76.99 107.56 9.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 72.31 110.874 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.451 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -95.21 30.01 2.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.9 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.6 20.9 27.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 75.41 112.495 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 94.9 m-85 -68.13 167.56 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 74.14 110.888 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.8 t -128.95 -8.5 4.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.35 110.851 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.998 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -156.02 143.07 19.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 65.11 110.967 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.998 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -139.68 148.4 42.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 55.05 110.878 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.0 136.64 35.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.34 111.102 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -118.52 120.54 37.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.907 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -148.85 92.05 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 73.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.11 172.06 26.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 73.34 112.46 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.34 -164.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 70.11 110.885 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.632 HD21 ' OD2' ' A' ' 71' ' ' ASP . 7.9 tp -136.21 142.49 44.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 73.01 110.925 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 54.22 25.38 5.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 73.32 110.866 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -167.53 141.22 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.932 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -113.63 160.52 18.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 63.12 110.887 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.573 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -108.2 -173.87 2.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.901 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.79 146.2 43.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 73.11 110.878 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.511 ' O ' ' CH2' ' A' ' 76' ' ' TRP . . . 51.65 -96.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 64.21 112.482 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.7 OUTLIER -161.9 88.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.346 . . . . 73.42 110.887 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -126.15 174.3 8.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 75.12 110.909 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.95 103.44 15.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 63.44 111.101 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.74 -111.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 34.12 112.487 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.32 -63.31 1.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 64.43 110.873 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.7 m0 -66.51 146.95 53.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 74.32 110.904 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.3 p -146.51 112.27 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 73.13 110.862 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.14 162.14 41.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.23 110.877 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.48 117.35 8.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.24 110.889 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -98.97 107.12 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 65.31 111.127 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 60.7 p -101.01 32.4 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 53.11 111.136 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 51' ' ' THR . 14.6 mttt 164.32 135.83 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 73.23 110.919 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -175.65 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.732 2.288 . . . . 42.02 112.34 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.06 14.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.14 110.896 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -179.35 33.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 75.14 110.895 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 57' ' ' ARG . . . 87.94 -17.13 48.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 70.24 112.468 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -136.57 167.62 21.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 74.14 110.893 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.515 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 11.2 m95 -92.61 92.82 8.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 71.22 110.856 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.585 HG23 ' HB2' ' A' ' 19' ' ' SER . 12.0 mt -95.76 138.48 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 75.54 111.14 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -126.77 148.68 49.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 74.33 110.881 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 135.07 27.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 72.24 110.873 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -113.76 177.22 4.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 63.14 110.853 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.84 12.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.835 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.62 5.73 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 71.2 110.936 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.81 101.95 14.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 54.4 111.1 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -99.96 86.67 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 63.21 111.124 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.858 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -137.42 170.79 15.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 64.12 110.912 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.858 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -154.82 158.35 39.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 65.41 110.852 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.577 HD11 ' O ' ' A' ' 97' ' ' GLY . 10.3 mm -30.93 124.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 64.25 111.137 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.14 -30.04 6.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.744 -0.741 . . . . 53.2 112.515 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.632 ' OD2' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -63.29 -171.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 52.45 110.87 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.8 mptt -150.03 159.27 44.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.03 110.926 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 97.5 mt -133.15 147.39 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 70.33 111.133 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -148.98 103.09 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 75.45 110.905 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 1.1 p90 -162.35 -161.46 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.497 . . . . 74.32 110.874 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.573 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -150.72 144.89 25.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.926 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.498 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 3.3 p -112.83 151.85 29.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 71.45 111.14 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.12 144.89 46.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 60.32 110.897 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.507 ' CG1' ' CD2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -144.52 172.68 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 33.15 111.133 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.754 HG13 HD12 ' A' ' 27' ' ' LEU . 84.1 mt -148.14 96.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 45.25 111.14 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.585 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -113.44 138.33 50.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 72.33 110.86 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 43.01 38.9 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 72.12 110.906 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.91 37.88 45.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.723 -0.751 . . . . 52.33 112.463 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.64 -53.13 3.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 61.51 110.942 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 104.68 1.68 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 70.34 112.494 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -124.8 166.03 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.382 . . . . 75.32 110.926 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.498 ' CG ' ' O ' ' A' ' 77' ' ' THR . 7.1 ttp180 -174.15 136.56 0.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 72.23 110.85 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -75.65 168.78 19.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.906 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.7 t0 -152.94 -176.3 5.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.896 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 83.82 -26.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.34 110.886 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 34.74 87.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 71.43 112.493 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -172.01 110.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.845 0.355 . . . . 63.14 110.91 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -150.63 115.91 5.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 71.32 110.896 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 92.6 m -87.04 136.19 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 64.44 111.138 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.826 HG13 ' HB2' ' A' ' 10' ' ' ALA . 45.4 t -67.58 118.36 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 73.2 111.099 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -134.16 0.89 3.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 73.34 110.884 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.832 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -117.75 -177.74 17.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 71.11 112.468 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.52 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -154.78 155.69 34.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 65.51 110.891 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.714 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.79 169.81 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 72.45 111.155 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -132.42 139.77 48.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 60.31 110.889 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.53 45.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 63.42 110.907 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.486 ' N ' ' OD1' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 44.44 111.111 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.835 0.35 . . . . 74.24 110.956 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -140.54 91.75 2.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 45.55 110.883 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.7 145.63 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.566 0.698 . . . . 73.54 111.097 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 164.36 34.81 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.743 2.295 . . . . 73.24 112.314 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 134.34 27.62 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.674 2.249 . . . . 71.15 112.313 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.669 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -84.38 139.6 32.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 71.02 111.105 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.6 m -92.72 77.44 4.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 75.41 111.165 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.456 HD23 HG21 ' A' ' 18' ' ' VAL . 1.5 mp -78.34 111.76 14.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 62.24 110.92 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.475 ' CB ' HG21 ' A' ' 99' ' ' VAL . 4.3 mm-40 -86.7 -158.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.23 110.903 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.838 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -143.08 81.2 1.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 61.45 111.096 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 12' ' ' HIS . 6.6 mm -71.0 172.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 63.15 111.143 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.71 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.08 172.2 0.24 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.595 0.712 . . . . 64.34 110.832 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.4 Cg_endo -69.76 20.31 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.681 2.254 . . . . 73.33 112.339 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 42.3 pttt -130.08 27.8 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 64.41 110.908 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.66 -178.84 30.4 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 73.4 112.442 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.824 HD13 HD11 ' A' ' 67' ' ' LEU . 19.3 tp -152.83 166.22 32.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 74.44 110.896 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.696 ' HB2' HD11 ' A' ' 11' ' ' ILE . 35.1 ttt180 -130.31 141.39 50.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.875 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.456 HG21 HD23 ' A' ' 8' ' ' LEU . 77.3 t -153.12 103.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.33 111.138 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.4 t -114.93 159.82 20.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.1 110.858 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 6' ' ' ALA . 26.7 m -139.55 151.63 66.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.604 0.716 . . . . 53.32 111.17 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 121.99 8.69 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.671 2.247 . . . . 72.15 112.338 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -80.19 101.33 8.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 62.33 110.871 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -96.01 28.13 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 65.3 110.864 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.27 16.51 13.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.762 -0.732 . . . . 73.23 112.533 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 92.1 m-85 -67.08 164.82 17.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 63.32 110.929 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.6 t -127.98 -9.55 5.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 73.04 110.87 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.028 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -158.97 139.97 12.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 73.43 110.894 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.028 ' N ' HD22 ' A' ' 27' ' ' LEU . 19.3 t80 -134.16 152.49 51.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.32 110.881 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.35 163.29 30.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 74.22 111.104 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.5 t80 -148.22 113.28 5.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 55.35 110.856 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.697 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -147.28 95.15 2.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 73.54 110.859 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.09 -174.14 17.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.729 -0.748 . . . . 63.1 112.509 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.408 ' O ' ' CZ3' ' A' ' 46' ' ' TRP . 3.0 mtpp -134.74 -164.27 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 73.22 110.911 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.523 HD11 ' OD2' ' A' ' 71' ' ' ASP . 1.7 tp -140.24 140.18 35.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 72.31 110.889 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 51.26 21.59 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.21 110.848 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -156.39 123.51 5.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 74.23 110.877 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -94.86 140.66 29.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 73.23 110.884 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.2 ptp -96.46 -174.49 3.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 75.34 110.879 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -149.67 157.33 43.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.15 110.848 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 57.23 35.91 72.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.716 . . . . 42.12 112.518 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 40' ' ' GLY . 4.0 mt 35.85 83.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.762 0.315 . . . . 61.25 110.889 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -124.92 169.69 11.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 63.53 110.861 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.697 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -79.1 98.23 6.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 54.35 111.082 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.95 -115.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.776 -0.726 . . . . 70.24 112.493 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -104.24 -62.72 1.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.733 0.302 . . . . 71.21 110.885 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.514 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 9.1 m0 -60.87 155.09 20.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 73.24 110.926 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.59 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 53.1 p -160.99 114.43 2.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 74.41 110.879 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -156.76 149.24 23.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 63.51 110.842 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -139.5 102.32 4.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 74.12 110.887 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 52' ' ' LYS . 8.7 mm -90.26 117.77 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 62.35 111.098 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.415 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 17.2 p -103.34 34.34 2.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 74.42 111.163 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 50' ' ' ILE . 3.3 mtpt 167.07 137.46 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.55 0.691 . . . . 72.01 110.865 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -175.6 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.66 2.24 . . . . 73.0 112.358 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HG3' ' N ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -139.39 -35.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 72.12 110.859 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.429 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 1.4 t30 -137.25 51.76 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.43 110.906 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.18 -29.43 4.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 52.42 112.513 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.92 171.23 11.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 74.23 110.846 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.442 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 6.0 m95 -90.12 89.73 7.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 75.43 110.957 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.3 mt -92.47 138.14 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 64.05 111.117 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -132.35 146.61 52.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.41 110.892 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.84 127.55 23.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.22 110.903 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -99.78 -178.46 3.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.92 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.38 26.4 1.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 74.01 110.9 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -149.44 28.24 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 72.23 110.865 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . . . -113.52 84.92 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 43.25 111.137 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -82.09 93.76 7.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 63.1 111.092 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.892 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -148.33 169.33 20.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.03 110.948 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.892 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.04 164.55 38.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 75.31 110.939 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 98' ' ' PHE . 9.4 mm -34.78 118.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.02 111.147 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.22 -28.92 5.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.769 -0.729 . . . . 61.41 112.485 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.523 ' OD2' HD11 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -67.96 -178.16 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 73.01 110.865 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.2 mttt -141.22 167.66 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.2 110.885 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.3 mt -144.85 149.37 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 54.34 111.116 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -151.96 108.54 3.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 74.31 110.902 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.48 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -165.72 -168.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 75.34 110.88 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.6 p-90 -135.28 162.75 31.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 71.04 110.94 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.6 p -134.89 146.4 49.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 64.45 111.126 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.46 149.01 28.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.32 110.872 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.55 HG13 ' HD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -148.94 165.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 74.31 111.157 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.715 HG13 HD12 ' A' ' 27' ' ' LEU . 41.1 mt -148.38 96.24 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.33 111.151 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 23.5 tttt -113.18 138.43 49.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 71.23 110.857 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.82 28.89 3.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 75.33 110.866 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.71 27.5 66.53 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 64.41 112.491 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.65 -50.97 4.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 63.45 110.906 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.56 125.85 3.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 72.14 112.492 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -143.07 -179.67 6.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 75.32 110.923 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 77' ' ' THR . 1.2 ttp180 -177.46 136.48 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 70.44 110.911 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -78.21 166.02 23.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 74.03 110.925 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.1 t0 -147.22 -165.86 2.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 65.04 110.852 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 2.5 t-20 83.59 -33.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 44.4 110.895 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 39.04 74.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.746 . . . . 41.53 112.484 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -167.7 112.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 54.15 110.867 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -152.33 122.57 7.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 73.01 110.945 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.1 m -94.08 145.23 24.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 74.44 111.16 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.838 HG13 ' HB2' ' A' ' 10' ' ' ALA . 62.7 t -75.24 129.7 36.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 63.35 111.124 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -154.79 23.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.05 110.888 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -155.62 111.28 0.48 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.786 -0.721 . . . . 54.24 112.499 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.578 ' CD2' HG12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -82.34 170.39 15.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 72.41 110.871 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.556 HG22 ' C ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -167.34 -178.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.33 111.137 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.26 139.1 37.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.472 . . . . 74.41 110.857 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -87.2 44.71 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 53.34 110.845 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.43 111.089 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 18.7 t80 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.817 0.341 . . . . 63.5 110.955 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -158.9 85.2 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 74.41 110.903 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.66 142.42 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.574 0.702 . . . . 72.15 111.109 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 161.01 47.58 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.733 2.288 . . . . 74.2 112.313 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 134.84 28.95 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.709 2.273 . . . . 63.32 112.342 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.937 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -90.52 139.68 30.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 61.24 111.061 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.5 m -93.16 77.3 4.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 52.11 111.113 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.11 107.38 10.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 64.15 110.913 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' O ' HD11 ' A' ' 16' ' ' LEU . 1.2 mm-40 -80.92 -156.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 71.15 110.935 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.814 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -143.1 80.21 1.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 53.12 111.082 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.703 HG22 ' H ' ' A' ' 12' ' ' HIS . 4.1 mm -70.64 172.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.32 111.079 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.703 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -54.19 172.0 0.25 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 73.4 110.835 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.9 Cg_endo -69.77 21.05 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.661 2.241 . . . . 52.12 112.336 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 12' ' ' HIS . 10.6 ptmt -126.79 20.71 7.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 73.11 110.907 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.64 -176.81 33.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 75.34 112.514 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.787 HD13 HD11 ' A' ' 67' ' ' LEU . 22.2 tp -151.13 163.57 38.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 74.24 110.924 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.656 ' HB2' HD11 ' A' ' 11' ' ' ILE . 69.0 ttt180 -126.77 137.32 53.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.23 110.861 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.44 HG12 ' HE2' ' A' ' 30' ' ' PHE . 69.7 t -148.26 102.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 70.33 111.091 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.547 ' HB2' HG23 ' A' ' 59' ' ' ILE . 19.6 t -114.49 157.07 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 73.11 110.902 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 6' ' ' ALA . 17.8 m -140.81 151.51 63.11 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.616 0.722 . . . . 75.24 111.077 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 123.37 10.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.639 2.226 . . . . 73.5 112.327 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 4.7 t70 -79.94 133.38 36.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 64.01 110.885 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -123.88 12.86 9.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 73.32 110.838 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.68 4.94 8.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 74.44 112.42 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 68.5 m-85 -54.28 163.02 0.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 65.11 110.878 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.9 t -130.01 -7.67 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.869 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.994 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -157.3 143.71 18.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 54.41 110.966 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.994 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -139.59 143.65 37.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 54.05 110.889 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.91 123.03 22.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 61.12 111.12 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.44 ' HE2' HG12 ' A' ' 18' ' ' VAL . 3.0 m-85 -109.84 113.98 27.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 74.02 110.863 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.789 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -142.27 95.29 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 74.33 110.879 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -146.31 -178.55 21.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 73.12 112.477 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.0 -168.27 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.341 . . . . 62.41 110.881 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' CG ' ' A' ' 35' ' ' ASN . 4.4 tp -134.85 146.73 49.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 55.35 110.906 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.451 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 7.1 m-20 42.73 27.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.883 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -159.46 130.39 5.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 54.43 110.857 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -97.23 144.13 27.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 64.51 110.886 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.1 ptp -94.24 -174.89 3.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 63.34 110.918 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 41' ' ' LEU . 1.2 tt0 -98.32 126.69 43.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 73.41 110.91 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.05 -91.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 75.41 112.546 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 39' ' ' GLU . 0.8 OUTLIER -154.84 89.68 1.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.779 0.323 . . . . 54.41 110.94 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -130.32 -175.73 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 74.35 110.852 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.789 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -85.83 100.45 12.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 72.32 111.112 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 -118.18 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 30.3 112.498 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.38 -60.95 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 74.23 110.86 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.462 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 7.4 m0 -60.28 165.91 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 73.43 110.91 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 6.9 t -164.38 122.34 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 72.54 110.863 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 49' ' ' ASP . 3.2 tpm_? -159.67 145.02 15.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 64.21 110.877 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' N ' ' HG3' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -130.75 82.41 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 71.34 110.831 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 28' ' ' PHE . 2.7 mm -71.92 110.72 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 64.0 111.162 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.458 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 82.4 p -104.69 34.05 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 71.21 111.136 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 51' ' ' THR . 37.7 tttt 163.97 137.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.546 0.688 . . . . 41.33 110.925 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -175.87 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.715 2.277 . . . . 64.24 112.324 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.727 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -134.25 -34.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 60.21 110.9 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -139.85 51.66 1.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 54.15 110.895 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.07 -27.78 4.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.75 -0.738 . . . . 53.02 112.482 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 169.27 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.331 . . . . 75.14 110.867 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 10.7 m95 -92.09 90.79 7.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.34 110.919 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.727 HD12 ' HD2' ' A' ' 54' ' ' LYS . 27.0 mt -96.17 138.2 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 75.15 111.178 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -130.34 151.98 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 72.53 110.873 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.27 135.44 28.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.55 110.891 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.6 OUTLIER -108.53 -179.41 3.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 63.4 110.895 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -145.26 11.67 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 42.12 110.866 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -129.84 12.31 5.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 62.33 110.874 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.32 94.84 6.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.23 111.072 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -94.35 75.33 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 64.34 111.089 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.787 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -123.81 171.36 9.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 61.32 110.91 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.693 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.16 156.7 31.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 64.13 110.873 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.72 HD13 HG12 ' A' ' 95' ' ' VAL . 18.0 mm -30.34 121.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 64.01 111.135 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.33 -29.46 6.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 22.13 112.48 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.41 -179.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 74.31 110.856 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 1.1 mtmt -144.85 153.71 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 75.52 110.923 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.1 mt -128.43 141.25 47.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 72.11 111.145 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -140.96 99.08 3.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 74.51 110.968 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.519 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -159.85 -160.07 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 74.1 110.822 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -148.29 177.7 9.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 71.0 110.911 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -144.45 153.95 42.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 64.51 111.149 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -118.23 136.44 53.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 54.44 110.899 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.77 167.58 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 73.32 111.101 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.641 HG13 HD12 ' A' ' 27' ' ' LEU . 78.4 mt -146.01 96.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 74.33 111.116 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 18.6 tttt -114.27 141.43 47.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 55.53 110.898 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.441 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 2.5 m-20 44.91 38.23 2.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 73.24 110.874 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.52 35.35 44.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 74.21 112.481 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.44 HD13 ' OH ' ' A' ' 86' ' ' TYR . 14.9 mt -100.51 -71.25 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.876 0.369 . . . . 74.32 110.947 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.49 106.41 2.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 74.32 112.487 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.44 ' OH ' HD13 ' A' ' 84' ' ' LEU . 44.7 m-85 -120.57 171.84 8.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 75.23 110.909 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -174.38 138.47 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 73.15 110.86 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -85.98 153.71 21.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 74.3 110.885 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -136.82 -163.18 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 65.34 110.903 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.2 t-20 82.23 -39.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 74.31 110.89 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.57 76.44 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 52.2 112.454 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -172.8 113.22 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 74.4 110.862 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -152.43 110.88 3.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.103 -0.499 . . . . 64.23 110.922 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 97.1 m -82.37 136.16 35.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 54.31 111.149 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.793 HG13 ' HB2' ' A' ' 10' ' ' ALA . 39.3 t -67.27 110.32 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 70.13 111.135 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -128.94 17.82 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.04 110.911 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.814 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -133.92 -178.26 15.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 71.34 112.475 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.429 ' C ' HG22 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -152.8 157.57 40.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.362 . . . . 73.54 110.894 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.69 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.81 164.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 73.54 111.143 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -129.81 131.08 46.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 61.1 110.858 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -85.68 51.43 2.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 43.2 111.116 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.885 0.374 . . . . 74.55 110.907 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -128.96 76.61 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 72.13 110.84 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.576 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . . . 60.2 140.53 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.589 0.709 . . . . 63.23 111.085 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 167.39 24.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.715 2.277 . . . . 73.12 112.312 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 133.99 27.02 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.645 2.23 . . . . 62.01 112.361 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.737 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -86.51 137.83 32.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 74.03 111.105 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -93.99 77.15 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 63.14 111.159 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.8 mp -77.4 107.98 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 65.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.845 ' O ' HD11 ' A' ' 16' ' ' LEU . 43.9 mm-40 -80.34 -173.28 3.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 63.33 110.892 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.859 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.76 81.49 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 65.44 111.094 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.753 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.2 mm -72.01 172.49 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 62.23 111.146 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.697 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.16 172.03 0.25 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.584 0.707 . . . . 74.2 110.897 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.3 Cg_endo -69.72 20.15 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.639 2.226 . . . . 61.33 112.35 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.0 OUTLIER -125.92 21.71 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 60.54 110.943 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 155.38 -178.02 32.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 71.43 112.481 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.899 HD13 HD11 ' A' ' 67' ' ' LEU . 21.9 tp -150.24 167.74 26.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 60.02 110.961 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.593 ' HB2' HD11 ' A' ' 11' ' ' ILE . 2.1 ttt180 -132.83 139.24 47.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.3 110.857 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.413 HG21 ' HE2' ' A' ' 30' ' ' PHE . 70.4 t -148.52 108.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 54.1 111.125 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -119.85 157.94 27.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 63.12 110.857 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.737 HG12 ' HA ' ' A' ' 6' ' ' ALA . 17.2 m -139.99 149.35 58.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 71.14 111.149 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 122.19 8.87 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.707 2.271 . . . . 72.23 112.354 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 22.8 t70 -88.45 97.26 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.86 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.75 0.21 40.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 54.13 110.879 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 138.41 30.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 61.52 112.47 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 82.2 m-85 -82.28 167.96 18.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.804 0.335 . . . . 75.41 110.936 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.5 t -127.19 -10.89 5.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 65.43 110.846 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.999 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -153.32 142.72 21.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.916 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.999 ' N ' HD22 ' A' ' 27' ' ' LEU . 18.3 t80 -139.13 144.32 38.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 75.51 110.93 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.69 163.68 23.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 72.54 111.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.4 t80 -151.04 114.42 4.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.89 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.904 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 2.0 t-80 -147.57 95.26 2.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 73.43 110.859 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.07 -174.27 18.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 65.32 112.466 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.464 ' CE ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -135.92 -165.45 1.71 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.792 0.33 . . . . 70.23 110.863 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.744 HD22 HG12 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -132.36 127.24 35.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 74.51 110.935 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.605 ' OD1' HD12 ' A' ' 34' ' ' LEU . 25.4 m120 56.45 34.13 23.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.866 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG2' ' CE ' ' A' ' 33' ' ' LYS . 5.6 tp10 -155.56 131.52 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 73.24 110.903 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -98.59 140.65 32.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 73.02 110.856 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 1.3 mtt -83.49 -178.4 7.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 74.25 110.873 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.2 124.51 13.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 71.34 110.854 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.32 40.63 96.64 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 74.24 112.498 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mt 41.38 88.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 75.45 110.918 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.7 -177.84 4.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.452 . . . . 70.22 110.887 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.904 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -87.2 102.14 14.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 71.24 111.112 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.454 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . -60.4 -120.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.7 -0.762 . . . . 50.55 112.501 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.9 -55.3 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.831 0.348 . . . . 71.53 110.89 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.706 ' HH2' HD23 ' A' ' 34' ' ' LEU . 6.5 m0 -68.4 173.16 5.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 75.23 110.91 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.3 p -176.84 118.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 73.54 110.851 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.39 162.2 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.23 110.848 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.682 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -144.46 106.55 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 75.41 110.883 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.482 ' N ' ' O ' ' A' ' 28' ' ' PHE . 36.5 mm -90.27 105.13 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 71.24 111.121 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.754 HG22 HD23 ' A' ' 27' ' ' LEU . 32.3 p -102.42 34.42 2.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 45.3 111.156 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.5 124.53 0.11 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.593 0.711 . . . . 74.21 110.857 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 165.6 30.46 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.267 . . . . 75.44 112.346 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.93 -17.7 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.882 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -149.75 43.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 73.42 110.903 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.42 -16.64 12.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.712 -0.756 . . . . 61.51 112.555 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -133.57 164.66 26.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.826 0.346 . . . . 75.05 110.88 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.481 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 12.2 m95 -88.18 96.16 10.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 75.1 110.931 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.415 HG22 ' HD2' ' A' ' 61' ' ' ARG . 16.0 mt -99.47 142.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 72.23 111.121 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -133.56 144.91 49.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 70.41 110.926 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HD2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -136.59 127.74 27.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 74.45 110.847 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.42 -178.62 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.51 110.891 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -148.85 17.42 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 74.52 110.889 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -135.89 14.44 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.43 110.886 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.62 109.54 21.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 71.22 111.136 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -105.94 87.91 2.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 62.32 111.069 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.899 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -139.87 170.95 14.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 53.3 110.904 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.67 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.55 161.79 38.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 70.55 110.871 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.592 HG13 ' CE2' ' A' ' 98' ' ' PHE . 11.8 mm -33.28 120.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 73.11 111.138 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.84 -29.89 5.46 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.734 -0.746 . . . . 63.23 112.464 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.98 177.96 2.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 74.44 110.86 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -138.55 162.02 35.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 71.33 110.907 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.744 HG12 HD22 ' A' ' 34' ' ' LEU . 62.6 mt -137.96 152.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 54.21 111.116 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -151.15 107.56 3.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.45 110.861 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.445 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -165.32 -163.66 0.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 73.23 110.883 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.48 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.2 p-90 -145.14 166.06 26.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 73.05 110.887 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.478 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 5.0 p -136.52 162.37 33.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 64.4 111.151 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.95 142.94 51.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 65.25 110.837 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.45 176.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.517 . . . . 75.01 111.133 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.786 HG13 HD12 ' A' ' 27' ' ' LEU . 68.7 mt -150.91 98.67 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 73.33 111.149 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -117.8 141.32 48.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 64.23 110.904 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.453 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 46.07 36.74 3.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 64.21 110.885 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.23 33.85 39.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 52.33 112.441 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.413 HD13 ' OH ' ' A' ' 86' ' ' TYR . 2.3 mt -100.33 -54.84 2.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.865 0.364 . . . . 74.1 110.934 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.22 116.49 1.76 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.726 -0.75 . . . . 75.51 112.45 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.413 ' OH ' HD13 ' A' ' 84' ' ' LEU . 98.8 m-85 -132.72 -175.09 3.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 74.33 110.955 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.478 ' CG ' ' O ' ' A' ' 77' ' ' THR . 7.5 ttp180 -177.61 138.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.874 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.576 ' OE1' ' HB3' ' A' ' 3' ' ' ALA . 2.7 tp60 -81.94 155.17 25.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 73.14 110.857 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -140.0 -166.86 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 65.04 110.899 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.8 OUTLIER 83.06 -38.88 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.4 110.918 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.47 81.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 70.23 112.514 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -171.77 114.4 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 75.22 110.887 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -154.87 112.97 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 71.33 110.942 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.2 m -85.11 132.96 34.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 71.13 111.104 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.744 HG21 HD23 ' A' ' 67' ' ' LEU . 37.6 t -63.76 117.72 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.34 111.112 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -136.39 14.37 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.12 110.927 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.859 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -124.95 -178.02 15.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 62.04 112.492 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -154.69 151.49 28.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 73.31 110.863 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.753 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.12 -178.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 61.2 111.119 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -146.51 129.86 16.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 72.11 110.843 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.13 40.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 71.54 110.909 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.31 111.11 179.918 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.858 0.361 . . . . 73.45 110.925 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.544 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 5.1 mt-10 -140.93 75.91 1.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 61.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 2' ' ' GLU . . . 66.63 142.5 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.577 0.703 . . . . 73.12 111.111 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.99 22.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.657 2.238 . . . . 73.11 112.366 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 133.39 25.57 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.684 2.256 . . . . 72.21 112.356 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.772 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -80.19 139.55 36.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 72.11 111.1 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 m -99.76 77.6 2.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 51.25 111.166 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.592 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.8 mp -77.65 109.69 11.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 74.2 110.936 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.761 ' O ' HD11 ' A' ' 16' ' ' LEU . 3.0 mm-40 -80.08 -168.56 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 64.34 110.866 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.831 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -133.81 81.58 1.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.3 111.139 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 12' ' ' HIS . 7.6 mm -71.66 172.84 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.34 111.125 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.718 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.17 172.37 0.24 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.583 0.706 . . . . 64.12 110.825 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.78 20.2 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.613 2.209 . . . . 74.31 112.326 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -129.1 26.28 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 74.54 110.86 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.25 -177.71 31.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 34.34 112.467 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.039 HD13 HD21 ' A' ' 67' ' ' LEU . 22.2 tp -152.29 166.98 30.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.812 0.339 . . . . 73.32 110.89 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HB2' HD11 ' A' ' 11' ' ' ILE . 61.7 ttt180 -132.59 136.57 46.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 73.12 110.833 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 8' ' ' LEU . 51.1 t -145.0 109.36 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 54.41 111.152 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.79 ' HB2' HG23 ' A' ' 59' ' ' ILE . 11.2 t -121.53 159.54 26.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.41 110.843 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.883 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 10.2 m -142.73 151.61 57.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 74.11 111.109 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 121.69 8.38 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.628 2.219 . . . . 74.11 112.32 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.16 140.19 52.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 61.12 110.863 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -132.51 18.88 4.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.883 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.72 8.17 30.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.733 -0.746 . . . . 62.2 112.45 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.546 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 39.5 m-85 -58.41 164.63 2.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 64.25 110.908 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -126.37 -13.01 6.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 75.45 110.886 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.027 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -153.82 140.68 19.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 55.54 110.935 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.027 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -134.61 145.77 48.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 72.21 110.924 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.79 142.69 49.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 73.15 111.117 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.28 120.95 31.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 53.24 110.855 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.842 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -152.67 93.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 75.13 110.88 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.9 176.73 24.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 74.24 112.5 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.66 -164.94 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 65.44 110.839 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 tp -134.23 145.79 49.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 73.22 110.934 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.8 m120 49.15 24.04 0.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 74.44 110.858 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -163.43 139.34 6.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.34 110.861 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -110.1 164.94 12.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 74.43 110.892 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.65 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -111.42 178.19 4.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.44 110.855 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -141.18 130.56 23.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 63.53 110.862 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 76.95 42.99 18.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.709 -0.758 . . . . 61.34 112.445 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.507 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.3 OUTLIER 32.9 80.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.764 0.316 . . . . 65.51 110.926 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -119.54 -169.74 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 72.14 110.855 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -98.83 103.4 15.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 62.23 111.122 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.75 -111.54 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.76 . . . . 71.55 112.485 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -102.44 -68.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 72.4 110.881 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.489 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 5.2 m-90 -62.37 154.19 28.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 73.15 110.863 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.465 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 95.1 p -158.39 123.84 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 54.21 110.887 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.66 160.73 10.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 73.42 110.861 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.708 ' OD1' HD21 ' A' ' 27' ' ' LEU . 14.4 t0 -138.9 103.14 4.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 71.33 110.853 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' PHE . 5.6 mm -77.98 108.9 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 75.23 111.165 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 81.1 p -96.37 30.58 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 70.42 111.133 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.9 OUTLIER 163.29 138.82 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.569 0.7 . . . . 70.35 110.903 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' N ' ' HG3' ' A' ' 52' ' ' LYS . 53.9 Cg_endo -69.74 176.2 7.07 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.705 2.27 . . . . 71.32 112.349 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HD2' HD12 ' A' ' 59' ' ' ILE . 4.4 ttmt -109.19 -77.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 70.42 110.91 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -113.24 60.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 71.34 110.929 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.17 -19.2 32.23 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.713 -0.756 . . . . 61.01 112.485 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.45 164.91 25.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 73.02 110.861 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.546 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 16.3 m95 -89.83 94.15 9.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 73.32 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.79 HG23 ' HB2' ' A' ' 19' ' ' SER . 6.4 mt -102.3 149.7 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 75.04 111.156 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.455 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 42.1 t80 -144.31 159.87 41.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 55.32 110.874 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -147.68 140.01 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.853 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -114.39 -178.16 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 74.31 110.887 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.29 17.99 1.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.879 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -137.07 20.42 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . . . -107.39 95.76 5.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.43 111.106 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -94.11 84.55 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 54.3 111.073 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.039 HD21 HD13 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -120.03 171.61 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 63.23 110.881 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -153.24 134.29 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.44 110.889 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.552 ' C ' ' O ' ' A' ' 68' ' ' LYS . 9.2 mm -23.6 118.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.45 111.098 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.6 -19.09 9.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.787 -0.72 . . . . 64.54 112.495 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.23 -166.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 55.53 110.837 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 1.5 mtmt -152.45 165.15 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.52 110.873 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 99.2 mt -142.53 149.15 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 54.34 111.194 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -149.62 104.1 3.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 73.54 110.885 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.495 ' CE2' HG23 ' A' ' 77' ' ' THR . 1.0 OUTLIER -160.3 -164.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 73.51 110.903 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.65 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -146.98 142.73 27.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 73.33 110.893 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.495 HG23 ' CE2' ' A' ' 75' ' ' PHE . 4.4 p -112.37 147.75 35.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 73.32 111.113 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.401 ' CD1' ' HG3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -112.68 143.51 43.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 72.21 110.855 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.01 168.69 13.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 74.4 111.118 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.671 HG13 HD12 ' A' ' 27' ' ' LEU . 95.4 mt -146.69 96.17 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 75.33 111.121 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 7.4 tttt -114.51 143.73 44.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 72.25 110.961 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.405 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER 53.03 20.71 1.8 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 62.21 110.892 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.09 27.54 73.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 50.02 112.481 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 84' ' ' LEU . 8.0 mt -97.86 -72.31 0.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 61.44 110.907 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.48 109.86 2.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 70.44 112.484 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -122.31 161.68 22.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 74.54 110.921 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.401 ' HG3' ' CD1' ' A' ' 78' ' ' PHE . 6.2 ttp180 -163.45 129.13 3.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 72.33 110.866 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.544 ' NE2' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -80.64 150.35 29.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.12 110.917 -179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -132.02 -159.92 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.14 110.866 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 82.86 -37.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 64.23 110.923 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.51 78.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.783 -0.722 . . . . 64.44 112.481 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -171.41 111.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 64.42 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -148.98 119.42 7.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 52.13 110.898 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.6 m -89.84 141.15 28.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 52.45 111.152 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.86 HG21 HD12 ' A' ' 67' ' ' LEU . 40.2 t -75.81 124.92 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 63.31 111.093 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -147.19 21.97 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 61.45 110.936 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -154.67 114.35 0.61 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 74.44 112.482 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.542 ' C ' HG22 ' A' ' 99' ' ' VAL . 0.6 OUTLIER -87.81 172.16 9.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 71.14 110.882 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.702 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -167.53 156.64 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 75.52 111.109 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.55 130.25 56.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -100.11 38.59 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 72.54 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.34 111.082 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.816 0.341 . . . . 74.13 110.933 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.538 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 90.3 mt-10 -143.9 70.13 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 73.51 110.868 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 2' ' ' GLU . . . 69.42 145.49 0.11 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 73.12 111.061 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.82 33.09 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.254 . . . . 63.3 112.385 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 134.37 27.89 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.735 2.29 . . . . 72.31 112.371 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -82.43 140.71 33.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 60.21 111.121 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 m -97.19 79.14 2.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 74.4 111.145 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.3 mp -83.1 113.06 20.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 73.34 110.884 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.584 ' O ' HD11 ' A' ' 16' ' ' LEU . 2.6 mm-40 -83.94 -158.34 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.147 -0.478 . . . . 73.03 110.893 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.88 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -141.12 80.37 1.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.31 111.102 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.722 HD13 ' CG2' ' A' ' 99' ' ' VAL . 2.7 mm -71.3 172.55 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 65.43 111.131 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.707 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -54.22 172.16 0.25 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.561 0.695 . . . . 54.04 110.842 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.8 Cg_endo -69.76 19.47 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.66 2.24 . . . . 73.32 112.384 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -124.58 19.79 8.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 73.42 110.868 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.24 -177.93 33.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 63.34 112.521 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.689 HD13 HD11 ' A' ' 67' ' ' LEU . 26.3 tp -151.27 166.38 31.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 75.41 110.94 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.529 ' HB2' HD11 ' A' ' 11' ' ' ILE . 50.6 ttt180 -128.23 139.13 52.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 74.24 110.867 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.3 t -151.26 105.26 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 61.12 111.131 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' A' ' 59' ' ' ILE . 18.7 t -122.46 162.25 22.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.55 110.876 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 6' ' ' ALA . 5.4 m -140.4 151.17 63.38 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.664 0.745 . . . . 73.42 111.084 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 122.2 8.87 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.673 2.249 . . . . 74.44 112.327 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 14.9 t70 -83.44 140.0 32.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 72.14 110.913 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -137.2 12.61 3.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 74.54 110.91 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.01 2.93 2.64 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.748 . . . . 51.23 112.491 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 91.5 m-85 -58.33 160.18 5.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 64.51 110.899 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -129.72 -7.04 4.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 73.02 110.859 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.992 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -157.75 140.75 15.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 72.53 110.898 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.992 ' N ' HD22 ' A' ' 27' ' ' LEU . 19.8 t80 -137.61 146.2 43.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.841 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.98 163.06 28.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 74.2 111.134 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.4 t80 -147.59 111.7 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 74.14 110.876 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.722 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -144.29 92.58 2.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 73.53 110.836 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -145.99 -179.48 22.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 71.54 112.484 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.69 -164.15 1.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 75.05 110.929 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 tp -143.48 144.91 32.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 70.12 110.931 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 57.73 12.02 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 73.04 110.867 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -156.77 130.58 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.4 110.877 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -102.4 143.92 31.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 42.55 110.905 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.43 ' HE1' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -93.07 172.7 8.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 54.32 110.92 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.85 157.83 41.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 61.15 110.912 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.56 35.32 44.84 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 72.15 112.475 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.477 ' C ' ' CZ2' ' A' ' 76' ' ' TRP . 1.1 mt 39.24 84.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.763 0.316 . . . . 72.34 110.914 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -126.22 174.19 8.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 75.22 110.908 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.722 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -79.41 98.9 6.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 74.34 111.107 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.84 -116.05 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 73.14 112.539 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.46 -65.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.771 0.32 . . . . 74.33 110.89 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.418 ' O ' ' ND1' ' A' ' 31' ' ' HIS . 8.2 m0 -58.03 161.43 4.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.194 -0.457 . . . . 73.05 110.851 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.588 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 97.0 p -167.39 122.51 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 60.2 110.887 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.77 155.36 8.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 61.42 110.872 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.24 103.2 4.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 72.45 110.873 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 52' ' ' LYS . 28.0 mm -80.84 117.14 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.34 111.121 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.5 p -99.36 32.24 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 73.11 111.17 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.539 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER 172.99 135.67 0.11 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.61 0.719 . . . . 73.41 110.909 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 168.18 22.22 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.26 . . . . 54.23 112.322 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -141.95 112.78 7.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.04 110.905 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER 78.27 27.72 0.51 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 72.13 110.883 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.81 -25.88 19.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 73.53 112.507 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 161.76 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 75.51 110.825 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 13.2 m95 -82.15 101.19 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 73.22 110.953 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.484 HD12 ' HD2' ' A' ' 54' ' ' LYS . 28.0 mt -105.65 139.13 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 61.21 111.119 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -135.32 141.91 45.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.12 110.852 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.454 ' HD2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -134.04 130.44 37.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.859 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.57 -178.9 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 43.52 110.864 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -144.82 15.56 1.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 75.41 110.887 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -131.45 3.58 4.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 74.24 110.874 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.2 101.01 13.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 55.13 111.093 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -99.58 84.53 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 64.14 111.061 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.737 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -129.38 171.29 12.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 51.41 110.899 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.737 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -152.8 147.47 26.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 75.43 110.894 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.499 HG12 ' CE1' ' A' ' 98' ' ' PHE . 2.5 mm -30.89 115.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 73.31 111.145 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.44 -19.37 7.15 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 70.25 112.505 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.16 -162.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 74.1 110.865 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.1 mttt -155.0 167.24 31.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 73.53 110.901 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 80.0 mt -146.4 146.35 19.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 65.31 111.138 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -148.9 102.19 3.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.34 110.956 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.535 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 0.8 OUTLIER -160.68 -161.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 70.34 110.896 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.543 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.5 OUTLIER -145.97 161.34 40.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.908 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 p -131.05 159.69 36.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 63.22 111.151 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.62 146.06 48.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 75.24 110.859 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -146.08 170.87 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 62.54 111.16 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.696 HG13 HD12 ' A' ' 27' ' ' LEU . 81.1 mt -149.36 96.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 62.22 111.171 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 1.7 tttt -113.05 137.72 51.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 65.51 110.916 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 47.31 33.11 2.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 71.1 110.853 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.33 33.39 61.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.738 . . . . 70.42 112.478 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.412 HD13 ' OH ' ' A' ' 86' ' ' TYR . 1.7 mt -97.47 -54.25 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 52.35 110.878 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 119.32 2.83 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.784 -0.722 . . . . 54.43 112.492 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB2' HG23 ' A' ' 79' ' ' VAL . 96.0 m-85 -143.47 156.81 44.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 73.54 110.916 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -152.56 133.68 14.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 71.31 110.854 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 2' ' ' GLU . 0.1 OUTLIER -80.11 154.98 27.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 54.13 110.894 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.542 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -138.52 -160.79 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 65.45 110.854 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.542 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 3.1 t-20 82.7 -38.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 65.4 110.861 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.03 78.87 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 25.23 112.536 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -171.74 110.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.35 . . . . 73.42 110.895 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 17.1 m-90 -151.72 120.09 6.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.134 -0.485 . . . . 73.22 110.963 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.4 m -91.24 130.43 37.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.01 111.186 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.88 HG13 ' HB2' ' A' ' 10' ' ' ALA . 48.3 t -61.41 110.5 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 71.05 111.117 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.0 7.5 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 55.34 110.895 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.814 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -120.23 179.13 16.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 62.31 112.476 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -151.75 153.2 33.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 64.11 110.895 -179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.722 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -159.96 177.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 64.53 111.109 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -146.03 126.87 14.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 60.3 110.843 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -80.43 55.31 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 74.23 110.87 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 52.51 111.093 179.919 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 17.2 t80 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.847 0.356 . . . . 71.02 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -141.53 76.45 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 55.2 110.921 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.03 141.78 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.543 0.687 . . . . 75.24 111.097 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 165.46 30.88 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 74.41 112.34 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 133.6 25.92 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 75.24 112.301 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.778 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.64 144.15 31.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 32.23 111.111 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.5 m -99.83 77.13 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 73.32 111.138 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.465 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.7 mp -73.04 109.89 6.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 72.34 110.961 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.834 ' O ' HD11 ' A' ' 16' ' ' LEU . 7.9 mm-40 -85.99 -172.92 4.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.32 110.863 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -130.56 80.25 1.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 71.12 111.084 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.682 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.2 mm -70.27 172.34 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 62.13 111.159 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.682 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.07 171.83 0.26 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.622 0.725 . . . . 74.45 110.818 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.1 Cg_endo -69.72 20.54 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 64.1 112.37 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 12' ' ' HIS . 20.7 pttt -126.64 23.06 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 62.44 110.884 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.1 -178.13 31.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 45.44 112.501 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.834 HD11 ' O ' ' A' ' 9' ' ' GLU . 20.0 tp -149.65 160.83 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 73.44 110.924 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.661 ' HB2' HD11 ' A' ' 11' ' ' ILE . 1.3 ttt85 -125.95 138.95 53.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 61.31 110.888 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 8' ' ' LEU . 54.2 t -148.79 103.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 72.3 111.098 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.529 ' HB2' HG23 ' A' ' 59' ' ' ILE . 41.3 t -114.21 160.69 18.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 64.23 110.89 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 6' ' ' ALA . 24.3 m -141.51 151.73 61.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 64.24 111.146 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 122.14 8.82 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.719 2.279 . . . . 75.23 112.343 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 17.1 t0 -89.12 107.91 19.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 65.14 110.868 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -95.79 -3.55 45.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 63.41 110.894 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.94 31.02 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 53.23 112.513 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.464 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 81.4 m-85 -80.14 165.1 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 74.31 110.87 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -126.05 -11.55 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.34 110.878 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.012 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -155.66 141.13 17.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 73.4 110.898 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.012 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.9 t80 -133.38 146.42 51.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.33 110.909 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.67 155.8 49.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.04 111.119 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.408 ' HE2' HG11 ' A' ' 18' ' ' VAL . 3.2 t80 -141.0 123.78 16.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 75.33 110.895 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -153.47 93.31 1.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 72.31 110.884 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -145.94 -177.1 20.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.75 . . . . 55.43 112.506 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 45' ' ' HIS . 2.6 mtpp -135.73 -169.64 2.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 62.24 110.912 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 35' ' ' ASN . 2.3 tp -131.77 143.78 50.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 75.02 110.897 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.409 ' C ' ' O ' ' A' ' 34' ' ' LEU . 26.0 m120 37.48 37.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.901 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -159.17 139.84 12.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.11 110.913 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -90.36 145.28 25.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 75.13 110.913 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.5 ptp -104.03 177.78 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 64.31 110.904 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -83.31 169.92 15.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 74.01 110.911 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -46.12 90.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 72.24 112.455 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 39' ' ' GLU . 1.0 OUTLIER 49.95 83.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.803 0.335 . . . . 55.14 110.899 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -143.83 -176.98 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 73.35 110.878 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.5 99.85 12.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 74.03 111.038 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.44 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . -68.3 -106.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.77 -0.728 . . . . 51.32 112.504 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.453 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -106.25 -62.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.75 0.31 . . . . 30.21 110.825 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -65.41 150.93 47.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 55.23 110.91 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 58.5 p -158.33 119.02 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 63.21 110.822 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.22 158.56 21.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 73.34 110.897 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -144.34 115.26 7.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 73.11 110.866 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 mm -96.27 120.49 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 72.42 111.148 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 81.4 p -107.89 36.92 2.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.22 111.126 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.8 OUTLIER 163.08 130.81 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.616 0.722 . . . . 74.44 110.901 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -176.33 1.46 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.682 2.255 . . . . 61.01 112.318 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.14 19.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 62.51 110.842 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 178.85 34.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 73.23 110.858 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.42 -19.53 13.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 63.51 112.445 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.04 164.32 27.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.806 0.336 . . . . 64.54 110.861 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.552 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 18.3 m95 -87.5 93.27 9.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.918 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 ' HB2' ' A' ' 19' ' ' SER . 8.1 mt -96.47 136.37 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 53.14 111.146 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -129.95 150.63 51.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.01 110.883 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.89 138.68 28.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 61.54 110.878 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.5 -176.53 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 74.11 110.826 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.45 17.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 70.23 110.842 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -131.77 12.09 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.33 110.879 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.22 103.82 13.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 70.41 111.077 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -101.57 73.8 1.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 60.32 111.111 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.843 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -117.52 171.41 8.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 73.5 110.932 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.843 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.53 151.05 27.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 71.42 110.914 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.2 mm -28.04 116.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 63.31 111.13 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.31 -24.72 6.85 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 75.42 112.515 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.93 -175.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 74.2 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 2.4 mttt -141.75 166.73 23.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 64.24 110.898 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.6 mt -144.52 143.21 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.23 111.142 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.4 OUTLIER -145.38 103.88 3.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.13 110.954 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -168.71 -162.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 73.43 110.908 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.477 ' NE1' ' HA ' ' A' ' 41' ' ' LEU . 2.7 p-90 -146.91 174.61 11.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 71.1 110.927 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 p -139.23 159.05 43.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 74.55 111.11 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.54 150.21 42.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 72.14 110.882 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -147.81 174.55 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.483 . . . . 63.11 111.171 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.776 HG13 HD12 ' A' ' 27' ' ' LEU . 78.4 mt -150.48 96.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 60.53 111.148 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 17.1 tttm -113.01 121.55 44.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 72.44 110.907 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.79 32.41 18.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.44 110.895 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.75 33.33 72.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 34.5 112.471 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -99.67 -55.95 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 64.03 110.921 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.05 112.19 2.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 72.23 112.499 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.677 ' HB2' HG23 ' A' ' 79' ' ' VAL . 29.0 m-85 -126.27 164.77 20.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.889 0.376 . . . . 75.52 110.902 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -152.88 137.63 17.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 73.25 110.862 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.73 141.86 28.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 70.54 110.91 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.403 ' O ' ' ND2' ' A' ' 90' ' ' ASN . 2.9 p30 -132.39 143.44 49.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 72.44 110.854 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER 167.53 -37.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 63.24 110.873 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 40.55 44.53 3.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.726 -0.75 . . . . 34.12 112.533 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -168.08 105.4 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.348 . . . . 70.5 110.854 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -146.48 106.3 3.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 75.34 110.929 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.4 m -80.87 131.12 35.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 74.14 111.18 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.678 HG13 ' HB2' ' A' ' 10' ' ' ALA . 69.0 t -63.41 121.35 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.52 111.142 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -137.9 8.51 2.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 71.34 110.881 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.743 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -119.54 -175.54 15.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 55.31 112.466 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.485 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -157.17 153.55 27.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.96 0.409 . . . . 75.12 110.875 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.667 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.67 172.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 61.05 111.132 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -141.54 132.86 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 62.02 110.867 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.93 45.62 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 72.3 110.882 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 45.25 111.121 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 3.0 t80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.84 0.352 . . . . 64.24 110.943 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -140.95 67.47 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 72.12 110.921 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.86 143.85 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.569 0.7 . . . . 73.21 111.115 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 167.66 23.87 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.642 2.228 . . . . 65.22 112.331 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 134.98 29.31 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 64.02 112.339 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.83 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -85.54 136.85 33.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 53.41 111.098 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 m -94.66 77.27 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 64.44 111.169 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.663 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.0 mp -80.08 106.25 11.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 71.32 110.934 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.806 ' O ' HD11 ' A' ' 16' ' ' LEU . 3.6 mm-40 -78.38 -165.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.847 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.853 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -135.88 79.45 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 71.2 111.07 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.726 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.6 mm -68.6 172.42 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.41 111.098 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.684 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.34 172.05 0.22 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.581 0.705 . . . . 65.13 110.841 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.591 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.72 21.48 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 73.54 112.34 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 12' ' ' HIS . 6.9 ptpt -129.06 26.14 5.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 55.53 110.953 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.99 -178.63 29.14 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 54.13 112.486 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.035 HD13 HD21 ' A' ' 67' ' ' LEU . 35.6 tp -149.87 163.67 37.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 64.45 110.901 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.646 ' HB2' HD11 ' A' ' 11' ' ' ILE . 6.2 ttt180 -131.24 135.23 47.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 62.23 110.863 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.663 HG22 ' HA ' ' A' ' 8' ' ' LEU . 41.9 t -143.26 110.6 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 51.13 111.113 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 59' ' ' ILE . 10.8 t -118.2 157.41 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 71.22 110.888 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.83 HG12 ' HA ' ' A' ' 6' ' ' ALA . 25.4 m -139.94 151.94 66.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.654 0.74 . . . . 74.23 111.123 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 121.36 8.04 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.655 2.237 . . . . 75.54 112.335 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 22.8 t0 -82.81 93.6 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.53 110.862 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.7 30.59 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 73.31 110.933 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.414 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 105.14 23.46 7.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 73.32 112.464 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 64.3 m-85 -72.24 166.23 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 73.21 110.871 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 t -129.86 -6.49 4.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 72.35 110.854 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.029 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -163.05 140.56 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 72.42 110.912 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.029 ' N ' HD22 ' A' ' 27' ' ' LEU . 14.0 t80 -135.59 149.97 49.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.3 110.898 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.62 152.73 42.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 63.13 111.139 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' HE2' HG11 ' A' ' 18' ' ' VAL . 1.9 t80 -132.68 132.47 42.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 72.52 110.922 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -157.79 89.05 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 72.53 110.875 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.547 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.12 -175.32 19.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 62.21 112.481 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -135.48 -164.17 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 72.24 110.928 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.717 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -130.27 138.83 50.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 64.11 110.897 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.509 ' OD1' HD12 ' A' ' 34' ' ' LEU . 27.8 m120 46.52 26.69 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.31 110.905 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -154.11 144.22 22.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 63.23 110.914 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.32 152.77 29.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.855 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.77 178.54 4.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 63.01 110.899 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.28 145.0 50.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 54.12 110.923 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 57.9 40.0 92.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.761 -0.733 . . . . 62.31 112.506 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.471 ' HB3' ' CE2' ' A' ' 76' ' ' TRP . 7.5 mt 35.38 84.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.765 0.317 . . . . 71.43 110.921 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -124.3 -179.76 4.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 43.52 110.899 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.58 99.69 8.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 64.44 111.134 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.91 -118.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.781 -0.723 . . . . 51.02 112.456 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.44 -54.28 2.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.82 0.343 . . . . 74.3 110.854 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.717 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.4 m-90 -71.39 171.11 11.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.11 110.9 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -173.31 115.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 63.11 110.854 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.46 158.24 20.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.34 110.884 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.46 122.88 13.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 72.22 110.861 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.449 HG22 ' H ' ' A' ' 52' ' ' LYS . 19.2 mm -103.66 118.35 50.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 63.41 111.115 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 51.7 p -104.6 35.07 2.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 55.43 111.152 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.449 ' H ' HG22 ' A' ' 50' ' ' ILE . 16.7 mttt 164.93 137.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.571 0.701 . . . . 73.53 110.91 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 174.77 9.04 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 2.263 . . . . 73.01 112.318 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -136.94 11.57 3.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 74.11 110.919 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.77 44.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 73.43 110.917 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.78 -24.62 5.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.807 -0.711 . . . . 72.43 112.477 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.23 163.36 27.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 75.33 110.909 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.426 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 8.1 m95 -85.1 96.2 9.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 73.2 110.918 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 19' ' ' SER . 28.2 mt -102.41 140.83 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.127 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 41.9 t80 -134.64 158.01 45.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 73.34 110.865 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -148.37 139.0 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 75.1 110.843 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.68 -179.38 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 65.32 110.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.75 28.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 71.04 110.895 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -144.47 18.59 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 63.23 110.945 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.41 102.71 11.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 72.22 111.128 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -98.59 83.11 2.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 63.55 111.066 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.035 HD21 HD13 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -121.66 171.63 8.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 73.34 110.91 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -155.51 141.75 18.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 72.23 110.873 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.707 HD11 ' O ' ' A' ' 97' ' ' GLY . 25.6 mm -25.41 119.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 63.13 111.153 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.56 -18.08 8.78 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.743 -0.742 . . . . 60.55 112.469 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.29 -176.58 2.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 74.04 110.85 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 6.7 mttt -143.32 160.58 40.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 71.43 110.86 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.479 HG12 ' CD2' ' A' ' 34' ' ' LEU . 49.1 mt -137.82 146.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 73.24 111.126 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.9 m-85 -146.98 104.97 3.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 73.31 110.951 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.547 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.9 p90 -165.96 -168.26 1.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 73.42 110.906 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.471 ' CE2' ' HB3' ' A' ' 41' ' ' LEU . 1.3 p-90 -135.61 171.59 14.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.474 . . . . 64.1 110.908 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.2 p -142.11 149.01 39.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 71.44 111.182 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.07 144.17 39.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.03 110.868 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.54 HG13 ' HD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -143.72 167.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 72.11 111.152 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.66 HG13 HD12 ' A' ' 27' ' ' LEU . 88.9 mt -149.0 96.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 72.22 111.116 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.548 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 1.3 tttt -112.28 133.66 54.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 74.23 110.884 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 48.88 37.85 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 74.21 110.882 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.65 29.71 49.52 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 64.3 112.472 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 mt -93.0 -58.33 2.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.858 0.361 . . . . 63.34 110.924 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.21 120.66 3.79 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.776 -0.726 . . . . 73.42 112.497 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.41 ' HB2' HG23 ' A' ' 79' ' ' VAL . 98.2 m-85 -143.59 163.74 32.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.947 0.403 . . . . 64.22 110.9 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -159.04 134.7 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 74.02 110.874 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -80.77 154.8 27.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.496 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -138.84 -164.73 1.7 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.895 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.496 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.2 t-20 82.08 -40.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.891 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.16 84.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.671 -0.776 . . . . 74.55 112.493 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -172.26 110.68 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.823 0.344 . . . . 71.43 110.89 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -149.75 114.77 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.915 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.5 m -87.98 136.04 33.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 64.31 111.111 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.853 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 35.5 t -71.85 115.09 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 71.41 111.134 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -133.21 12.46 4.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.904 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.844 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -130.78 177.7 18.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 72.11 112.44 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -145.02 160.41 41.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 71.42 110.902 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.726 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.13 167.57 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.32 111.133 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.43 137.28 50.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 74.25 110.896 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -89.49 42.22 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 63.45 110.876 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 63.23 111.096 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 3.4 t80 . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.806 0.336 . . . . 75.24 110.924 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -140.5 77.36 1.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 74.44 110.867 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.6 142.92 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.564 0.697 . . . . 21.02 111.118 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 167.05 25.61 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 2.238 . . . . 63.35 112.318 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 135.76 31.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.64 2.226 . . . . 73.34 112.392 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.627 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -89.65 141.43 28.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 64.14 111.078 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.2 m -100.47 76.83 1.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 70.21 111.156 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.505 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.9 mp -73.81 106.73 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 65.22 110.943 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.797 ' O ' HD11 ' A' ' 16' ' ' LEU . 7.3 mm-40 -78.41 -170.28 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 71.52 110.881 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -133.59 80.83 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 64.54 111.125 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.697 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -72.14 172.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 75.53 111.174 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.697 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.0 171.82 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.603 0.715 . . . . 72.14 110.854 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.2 Cg_endo -69.71 20.85 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.693 2.262 . . . . 54.25 112.356 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 9.5 pttt -125.67 19.76 7.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 62.12 110.901 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 156.21 -177.39 33.27 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.782 -0.723 . . . . 73.15 112.508 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.797 HD11 ' O ' ' A' ' 9' ' ' GLU . 24.0 tp -149.8 166.71 28.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 50.21 110.902 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.584 ' HB2' HD11 ' A' ' 11' ' ' ILE . 65.6 ttt180 -133.25 138.93 46.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 74.45 110.86 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 8' ' ' LEU . 73.0 t -147.19 107.49 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 74.24 111.151 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.48 ' HB2' HG23 ' A' ' 59' ' ' ILE . 12.4 t -112.24 156.45 22.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 63.12 110.872 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 6' ' ' ALA . 30.3 m -141.73 151.84 61.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.653 0.74 . . . . 75.44 111.132 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 122.44 9.11 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.733 2.289 . . . . 74.23 112.311 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.512 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 12.1 t0 -83.64 92.77 7.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 72.22 110.853 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.35 40.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.897 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.405 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 92.0 24.5 24.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 52.52 112.511 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.592 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 95.7 m-85 -74.71 165.02 25.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.866 0.365 . . . . 72.22 110.854 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.1 t -129.41 -7.61 4.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 53.23 110.861 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.008 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -155.02 142.1 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 71.05 110.951 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.008 ' N ' HD22 ' A' ' 27' ' ' LEU . 17.9 t80 -137.55 147.9 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.44 110.903 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.7 156.76 46.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.35 111.098 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.448 ' HE2' HG11 ' A' ' 18' ' ' VAL . 1.8 t80 -139.4 125.42 19.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 73.32 110.901 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -152.58 92.58 1.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 73.42 110.869 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.486 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -144.67 -174.47 16.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 61.23 112.448 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -163.98 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 72.43 110.918 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.756 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -131.86 123.46 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 53.24 110.899 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.0 m120 61.4 27.23 16.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.12 110.878 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -156.89 146.68 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.915 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -113.92 159.33 20.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 61.35 110.893 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.562 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -110.89 -174.52 2.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 73.01 110.887 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -152.15 138.32 18.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 72.14 110.879 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.28 31.09 57.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 73.4 112.513 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.461 ' HA ' ' NE1' ' A' ' 76' ' ' TRP . 5.1 mt 43.96 83.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.794 0.331 . . . . 51.21 110.926 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -129.25 169.07 15.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 74.2 110.91 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.31 101.5 9.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 75.43 111.078 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.54 -111.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 30.44 112.459 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 -56.33 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 74.43 110.837 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.756 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.3 m-90 -69.85 177.07 3.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 70.44 110.931 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.0 p -179.92 109.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 70.14 110.837 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.06 156.7 24.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 73.22 110.863 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -140.22 120.02 13.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 63.23 110.859 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 52' ' ' LYS . 8.6 mm -95.18 117.16 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 74.43 111.154 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.403 HG23 ' OD1' ' A' ' 49' ' ' ASP . 30.6 p -98.96 32.55 2.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 72.4 111.149 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.582 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.8 OUTLIER 170.24 139.83 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.555 0.693 . . . . 63.32 110.923 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -178.95 2.58 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.66 2.24 . . . . 70.42 112.363 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HD2' HD12 ' A' ' 59' ' ' ILE . 15.8 ttmt -119.63 -61.7 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 74.13 110.89 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -131.43 58.47 1.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 64.34 110.891 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.38 -28.74 6.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 40.44 112.461 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.5 160.7 29.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.322 . . . . 64.41 110.887 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.512 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 44.1 m95 -82.59 89.1 6.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 75.13 110.949 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.48 HG23 ' HB2' ' A' ' 19' ' ' SER . 25.8 mt -94.46 135.91 27.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 75.25 111.159 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.478 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 56.1 t80 -135.56 162.37 32.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 71.31 110.847 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.478 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -158.24 152.71 24.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 75.43 110.892 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.39 -176.41 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 65.4 110.855 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.1 mtt180 -142.76 16.47 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 72.15 110.877 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -132.8 8.72 4.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 54.25 110.892 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.85 95.96 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 53.13 111.108 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -93.67 77.46 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 60.11 111.104 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.82 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -125.07 171.47 10.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 71.23 110.9 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.82 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.71 154.88 28.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 55.32 110.913 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.7 mm -29.98 121.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 73.41 111.118 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.52 -28.45 5.98 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.729 -0.748 . . . . 74.4 112.452 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.469 ' OD2' HD11 ' A' ' 34' ' ' LEU . 1.4 m-20 -66.53 -171.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 71.43 110.861 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.7 mttt -148.78 168.71 22.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 72.5 110.898 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.454 HG12 HD22 ' A' ' 34' ' ' LEU . 78.6 mt -146.67 145.28 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 63.14 111.153 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -148.36 103.29 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 72.11 110.914 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.486 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.3 p90 -160.97 -168.99 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 75.14 110.903 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.562 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -139.99 146.12 38.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 74.43 110.912 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.402 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 1.9 p -111.63 161.76 15.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 73.33 111.142 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 138.1 51.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 74.43 110.893 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.577 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 2.3 m -141.86 177.2 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 74.34 111.141 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.772 HG13 HD12 ' A' ' 27' ' ' LEU . 68.3 mt -152.95 98.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 70.05 111.122 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -112.7 141.02 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 72.15 110.866 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.427 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER 44.92 32.51 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 74.13 110.879 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.38 36.98 91.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 54.21 112.472 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.7 -50.59 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.836 0.35 . . . . 52.51 110.899 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.48 105.01 0.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.758 . . . . 63.31 112.501 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -123.72 -175.02 3.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 74.32 110.906 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.449 ' HB3' ' NH1' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -178.44 135.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 64.41 110.854 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -79.1 153.28 30.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.918 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.482 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -136.28 -165.5 1.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 71.1 110.841 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.482 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 81.34 -40.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 73.2 110.861 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.27 83.05 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 54.23 112.504 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -170.69 112.91 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 72.13 110.894 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.6 m-90 -155.04 113.05 3.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 72.35 110.923 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 96.1 m -88.48 135.34 33.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 51.24 111.151 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 10' ' ' ALA . 15.8 t -64.75 114.94 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 73.4 111.14 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.62 -2.34 3.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 61.12 110.894 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.773 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -113.51 -174.89 19.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 74.33 112.48 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.493 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.49 156.73 35.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 75.04 110.896 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.67 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.64 167.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 61.33 111.128 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -127.46 129.44 47.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 52.2 110.889 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -78.69 48.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 74.01 110.844 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 65.14 111.091 179.947 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.857 0.361 . . . . 54.23 110.901 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -143.99 67.29 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.31 110.931 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.54 139.57 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.583 0.706 . . . . 74.22 111.067 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 165.07 32.22 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.664 2.243 . . . . 64.52 112.35 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 134.79 28.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.635 2.223 . . . . 72.03 112.375 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -80.34 135.0 36.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 75.12 111.115 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.7 m -93.95 77.7 4.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 64.51 111.105 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 8' ' ' LEU . 2.3 mp -85.84 111.45 20.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 63.52 110.898 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.543 ' O ' HD11 ' A' ' 16' ' ' LEU . 2.5 mm-40 -84.58 -155.14 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.131 -0.486 . . . . 75.52 110.906 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -143.62 80.44 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 63.43 111.065 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 17' ' ' ARG . 2.6 mm -69.51 172.27 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 61.22 111.123 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.692 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.18 172.74 0.23 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.627 0.727 . . . . 60.25 110.834 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.1 Cg_endo -69.77 19.82 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.239 . . . . 65.12 112.36 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.0 OUTLIER -124.54 21.72 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 64.21 110.923 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.55 -177.47 31.07 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 61.11 112.434 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.726 HD13 HD11 ' A' ' 67' ' ' LEU . 36.0 tp -149.47 162.05 40.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 73.13 110.92 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.756 ' HB2' HD11 ' A' ' 11' ' ' ILE . 37.3 ttt180 -123.16 138.3 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 63.11 110.886 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.1 t -148.61 110.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 70.22 111.092 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.407 ' HB2' HG23 ' A' ' 59' ' ' ILE . 8.5 t -123.31 156.12 35.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 54.34 110.828 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 6' ' ' ALA . 23.9 m -141.45 151.66 61.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.649 0.738 . . . . 75.44 111.125 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 126.26 13.1 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.709 2.273 . . . . 64.02 112.31 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 34.3 t0 -97.21 86.23 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.32 110.871 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -20.57 63.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 74.32 110.895 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 160.84 30.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 73.52 112.523 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 83.4 m-85 -81.36 167.75 19.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 75.23 110.866 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 t -127.22 -10.48 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.845 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.006 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -151.96 141.44 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 75.3 110.949 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.006 ' N ' HD22 ' A' ' 27' ' ' LEU . 14.5 t80 -137.34 140.89 41.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 70.51 110.924 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.17 144.66 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 74.11 111.092 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.442 ' CE1' ' CZ ' ' A' ' 75' ' ' PHE . 1.6 t80 -130.78 109.7 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 73.4 110.852 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 1.155 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -135.84 93.69 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 73.24 110.841 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 75' ' ' PHE . . . -142.28 -177.26 17.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.679 -0.772 . . . . 54.22 112.467 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -131.3 -164.27 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 75.41 110.882 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.713 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -133.9 129.07 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 72.34 110.903 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.495 ' OD1' HD12 ' A' ' 34' ' ' LEU . 21.1 m120 60.29 17.11 6.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.897 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -153.23 142.01 21.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 52.23 110.888 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HB3' ' CB ' ' A' ' 74' ' ' TYR . 4.3 pt-20 -117.59 154.41 31.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 62.11 110.914 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 7.2 ptt? -109.83 178.88 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 71.14 110.919 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.07 173.49 10.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 71.01 110.866 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 46.41 39.48 10.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 60.33 112.521 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.3 OUTLIER 32.49 76.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.753 0.311 . . . . 74.3 110.912 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -113.66 -164.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 70.31 110.892 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.155 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -97.9 101.23 12.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 71.03 111.111 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . -57.85 -114.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.732 -0.747 . . . . 53.34 112.477 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.31 -71.42 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.319 . . . . 53.13 110.871 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.713 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.9 m-90 -58.09 155.41 11.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.2 110.931 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 87.3 p -153.15 108.2 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 61.31 110.833 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.79 160.76 39.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 65.55 110.861 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.729 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -144.96 108.41 4.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.876 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 28' ' ' PHE . 4.6 mm -85.85 101.0 9.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.444 . . . . 72.24 111.111 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 p -87.81 26.48 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 65.43 111.154 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' H ' HG22 ' A' ' 50' ' ' ILE . 2.8 mttt 178.84 135.38 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 72.55 110.889 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 168.12 22.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.684 2.256 . . . . 61.42 112.329 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.617 ' HD2' HD12 ' A' ' 59' ' ' ILE . 17.2 ttmt -105.77 -60.35 1.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 74.23 110.933 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -132.11 53.94 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 65.41 110.863 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.91 -20.01 48.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 42.15 112.472 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -133.84 162.4 32.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 74.34 110.922 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.516 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 15.8 m95 -85.07 91.85 8.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 75.12 110.956 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.617 HD12 ' HD2' ' A' ' 54' ' ' LYS . 17.3 mt -100.38 146.08 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 64.24 111.123 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -142.69 155.06 44.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.03 110.902 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.0 119.95 11.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 72.13 110.875 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD2' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -93.24 -178.24 4.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 74.2 110.855 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -145.25 10.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 70.51 110.878 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.486 ' ND2' ' OD2' ' A' ' 62' ' ' ASP . 15.1 p30 -124.08 -1.39 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 52.14 110.883 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.492 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -84.41 98.93 10.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 62.12 111.082 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -100.19 78.98 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 73.4 111.124 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.86 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -127.75 170.24 12.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 72.32 110.924 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.86 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.31 151.99 23.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 64.45 110.865 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.603 HG12 ' CE2' ' A' ' 98' ' ' PHE . 2.8 mm -27.45 122.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.116 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.03 -25.46 7.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 53.24 112.513 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.11 -168.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 74.22 110.841 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.9 mttt -151.18 171.96 16.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 71.3 110.908 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.58 HG12 HD22 ' A' ' 34' ' ' LEU . 83.9 mt -147.96 149.23 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 75.42 111.09 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.1 m-85 -152.76 115.3 4.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 65.52 110.935 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.598 ' CE2' HG23 ' A' ' 77' ' ' THR . 8.3 p90 -171.55 -159.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.529 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -151.79 133.29 14.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 75.25 110.935 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.598 HG23 ' CE2' ' A' ' 75' ' ' PHE . 1.7 p -93.78 166.84 12.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 63.31 111.182 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.58 132.22 28.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 65.33 110.857 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.414 ' C ' HG13 ' A' ' 80' ' ' ILE . 2.1 m -135.6 177.12 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 71.21 111.103 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.8 HG13 HD12 ' A' ' 27' ' ' LEU . 79.0 mt -150.13 99.65 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 60.32 111.155 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -115.92 140.86 48.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.22 110.907 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.87 33.13 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 62.31 110.848 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.94 36.96 83.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 54.34 112.5 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.43 -52.22 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.906 0.384 . . . . 54.5 110.908 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.02 102.9 0.73 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 74.1 112.486 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -122.88 179.19 4.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 74.34 110.948 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.456 ' CG ' ' O ' ' A' ' 77' ' ' THR . 1.7 tmm_? -177.38 136.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 75.44 110.899 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -75.28 160.87 29.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 73.23 110.942 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -139.34 -167.77 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 72.01 110.88 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.7 OUTLIER 82.47 -40.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 65.31 110.822 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.09 79.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 25.22 112.502 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -167.49 109.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 73.4 110.888 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 -149.17 111.29 4.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 74.02 110.899 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 84.8 m -91.98 135.17 34.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 64.43 111.156 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.715 HG13 ' HB2' ' A' ' 10' ' ' ALA . 9.9 t -60.45 156.03 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 72.11 111.154 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 69' ' ' ILE . 13.7 mt-10 -163.05 -33.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.916 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.729 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -103.02 -170.91 26.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 74.25 112.486 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.603 ' CE2' HG12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -150.3 168.5 23.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.924 0.392 . . . . 61.05 110.879 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.63 ' HB ' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.52 175.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 71.31 111.138 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -137.73 142.26 40.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.888 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -88.48 51.29 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 70.33 110.836 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 51.22 111.085 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 9.6 t80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.817 0.341 . . . . 72.21 110.962 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.96 76.74 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 64.32 110.89 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.38 143.33 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.6 0.714 . . . . 71.21 111.114 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 167.79 23.45 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.7 2.267 . . . . 62.42 112.37 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 133.13 24.84 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 72.22 112.34 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.955 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -85.3 142.52 29.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 71.21 111.098 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m -99.01 77.36 2.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 65.12 111.174 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.593 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.8 mp -76.05 105.72 7.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 72.25 110.929 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.761 ' O ' HD11 ' A' ' 16' ' ' LEU . 5.1 mm-40 -78.53 -170.88 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 75.02 110.863 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.86 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -133.78 80.27 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 42.12 111.098 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.718 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.1 mm -71.94 172.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 71.24 111.135 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.704 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.25 172.09 0.25 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.596 0.712 . . . . 73.03 110.855 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.82 20.06 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 53.41 112.301 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 12' ' ' HIS . 2.7 pttt -125.95 21.87 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 72.32 110.918 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 62' ' ' ASP . . . 155.58 -178.49 32.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 61.43 112.485 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.808 HD13 HD11 ' A' ' 67' ' ' LEU . 19.9 tp -149.83 168.23 24.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 75.23 110.931 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HB2' HD11 ' A' ' 11' ' ' ILE . 13.9 ttm180 -135.56 134.91 39.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 64.32 110.87 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 8' ' ' LEU . 78.6 t -144.62 106.65 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 75.42 111.114 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.418 ' HB2' HG23 ' A' ' 59' ' ' ILE . 20.1 t -116.08 156.47 26.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 75.51 110.822 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.978 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 33.0 m -141.25 152.66 64.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.672 0.749 . . . . 62.04 111.088 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 120.91 7.61 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.628 2.218 . . . . 63.52 112.312 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.48 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 3.6 t70 -75.9 99.71 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 70.52 110.855 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -88.98 35.44 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 52.54 110.873 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.12 25.01 25.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 60.12 112.485 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.488 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 98.8 m-85 -73.05 168.1 19.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.913 0.387 . . . . 72.24 110.857 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.2 t -129.34 -8.15 4.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 53.24 110.839 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.014 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -159.62 142.06 13.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 73.42 110.95 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.014 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -137.19 150.97 48.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 64.14 110.876 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.17 143.81 40.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 64.54 111.133 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -126.52 119.76 27.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 63.22 110.884 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 5.8 m-70 -152.08 92.32 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.504 . . . . 63.3 110.846 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 75' ' ' PHE . . . -146.22 178.55 23.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 71.14 112.498 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.459 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -133.18 -164.81 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 44.11 110.907 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 36' ' ' GLU . 1.4 tp -132.56 152.33 51.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 65.31 110.921 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.5 m120 41.27 25.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 43.11 110.916 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -164.01 136.86 5.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 71.04 110.915 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.42 163.81 12.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 73.25 110.839 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.579 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -112.42 -177.47 3.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 64.32 110.867 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -146.53 146.24 30.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 73.32 110.907 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.42 26.86 74.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 75.44 112.499 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.47 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 1.6 mt 47.46 84.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.313 . . . . 73.2 110.88 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.32 170.69 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 72.22 110.886 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.512 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -87.35 100.83 13.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 71.33 111.078 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.459 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . -66.93 -107.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 71.3 112.523 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.03 -71.82 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 70.24 110.907 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -53.73 148.35 10.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.975 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.543 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 52.4 p -155.45 119.74 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 52.11 110.889 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.57 160.97 11.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 64.33 110.89 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.02 114.7 9.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.3 110.87 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' PHE . 10.2 mm -94.57 97.51 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 64.1 111.124 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.561 HG22 HD23 ' A' ' 27' ' ' LEU . 46.2 p -95.38 29.7 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 73.25 111.158 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.92 133.06 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 74.41 110.902 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -178.14 2.18 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.675 2.25 . . . . 64.44 112.387 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -135.73 -34.39 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 74.24 110.924 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -138.77 49.2 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 72.33 110.909 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.87 -26.12 4.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 72.52 112.415 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.64 168.22 14.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.775 0.322 . . . . 70.34 110.897 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.488 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 13.9 m95 -90.25 87.96 7.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 72.41 110.908 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.418 HG23 ' HB2' ' A' ' 19' ' ' SER . 44.9 mt -91.91 141.52 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.5 111.075 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.524 ' CE2' ' OD1' ' A' ' 62' ' ' ASP . 18.8 t80 -138.24 147.06 43.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 64.12 110.869 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 139.38 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 62.15 110.928 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -120.29 140.59 51.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 70.14 110.867 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.03 31.03 6.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 70.32 110.877 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.36 19.89 2.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 73.34 110.867 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.4 112.4 23.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 62.22 111.091 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -108.39 83.72 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 51.13 111.107 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -135.61 171.22 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.12 110.884 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.661 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.85 158.46 36.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.24 110.9 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.684 HD11 ' O ' ' A' ' 97' ' ' GLY . 26.9 mm -32.16 115.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 64.24 111.136 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.24 -26.66 4.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.709 -0.757 . . . . 71.13 112.474 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.37 -172.5 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.914 0.388 . . . . 52.1 110.834 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -143.17 168.23 20.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.917 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.7 mt -145.24 143.18 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 71.45 111.145 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -147.43 108.69 4.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 73.11 110.948 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.422 ' CB ' ' HA3' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -164.07 -163.87 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 75.02 110.833 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.579 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -149.13 144.1 26.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 74.12 110.925 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.1 p -113.15 149.62 33.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 70.11 111.17 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.59 142.96 46.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.873 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -141.8 170.83 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 74.42 111.14 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.721 HG13 HD12 ' A' ' 27' ' ' LEU . 80.1 mt -147.63 96.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 70.44 111.138 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 9.2 tttt -112.68 140.74 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.32 110.921 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 40.97 38.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 33.35 110.893 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.01 40.86 51.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 63.04 112.501 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 mt -105.09 -48.24 3.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 74.3 110.946 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.21 105.27 1.08 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.704 -0.76 . . . . 73.41 112.499 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -123.97 168.96 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.38 . . . . 64.33 110.9 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 77' ' ' THR . 3.7 ttp-105 -175.05 140.03 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 63.41 110.848 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.435 ' N ' ' HG2' ' A' ' 87' ' ' ARG . 15.6 tp60 -84.19 155.47 22.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 74.35 110.869 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -137.97 -169.47 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 70.4 110.884 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 83.78 -33.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 63.32 110.884 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 41.13 83.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.8 -0.714 . . . . 71.42 112.429 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -169.66 112.98 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 75.45 110.9 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -155.32 110.97 3.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 75.23 110.931 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 95.9 m -83.82 139.27 32.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 73.22 111.137 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.676 HG13 ' HB2' ' A' ' 10' ' ' ALA . 39.2 t -69.67 116.67 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 65.21 111.083 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -138.64 10.3 2.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 72.54 110.849 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.86 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -117.88 -178.11 17.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.771 -0.728 . . . . 73.42 112.512 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.585 ' CE2' HG13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -153.41 152.01 30.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 55.3 110.872 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.718 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.61 170.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 73.44 111.166 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.61 129.03 25.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 64.1 110.865 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -87.66 45.94 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 54.32 110.906 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 44.32 111.096 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 13.8 t80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.84 0.353 . . . . 75.23 110.954 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -149.74 87.71 1.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 74.22 110.882 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.716 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . . . 61.0 143.61 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.605 0.717 . . . . 73.25 111.109 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 161.03 47.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.719 2.279 . . . . 71.34 112.323 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 134.58 28.27 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.694 2.263 . . . . 63.32 112.327 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.629 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -89.53 139.06 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 50.02 111.095 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -89.48 77.7 7.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 73.52 111.145 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.516 HD23 ' CG2' ' A' ' 18' ' ' VAL . 1.9 mp -79.63 111.47 15.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 44.22 110.919 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.495 ' O ' HD11 ' A' ' 16' ' ' LEU . 2.0 mm-40 -86.18 -155.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 61.34 110.848 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -144.21 80.96 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 41.11 111.074 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 17' ' ' ARG . 4.0 mm -69.62 172.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 61.51 111.134 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.7 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.69 172.41 0.23 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.597 0.713 . . . . 62.23 110.861 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.2 Cg_endo -69.75 20.38 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.671 2.247 . . . . 74.21 112.356 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 1.2 ptmt -128.33 26.44 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.23 110.933 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.34 -178.81 29.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.749 . . . . 63.33 112.454 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.074 HD13 HD21 ' A' ' 67' ' ' LEU . 35.1 tp -150.78 167.07 28.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 71.21 110.896 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.716 ' HB2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -129.33 141.1 51.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 62.13 110.871 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.516 ' CG2' HD23 ' A' ' 8' ' ' LEU . 62.4 t -153.17 105.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 31.43 111.1 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 t -116.31 164.28 14.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.23 110.874 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 6' ' ' ALA . 22.7 m -143.15 151.65 56.02 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.668 0.747 . . . . 43.24 111.117 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 122.12 8.81 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 44.51 112.344 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -81.84 94.89 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 72.25 110.898 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -91.88 24.97 2.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 71.24 110.871 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.98 28.15 4.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.729 -0.748 . . . . 63.43 112.534 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 77.7 m-85 -78.41 165.83 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 72.01 110.839 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.0 t -128.79 -8.25 5.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 65.13 110.844 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.008 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -161.19 140.63 10.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 72.34 110.926 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.008 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.6 t80 -134.57 145.68 48.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 70.02 110.846 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.64 164.6 23.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 65.14 111.088 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.2 t80 -150.16 113.75 4.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 72.53 110.877 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.79 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 1.5 t-80 -149.23 95.17 2.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 43.54 110.864 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.556 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -146.19 -175.36 19.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 74.44 112.474 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.428 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 mtpp -131.84 -165.12 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.324 . . . . 64.23 110.882 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.64 148.14 40.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.901 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 49.29 22.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.43 110.844 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.7 143.17 2.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 64.4 110.879 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -108.82 154.17 22.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 41.3 110.902 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -177.88 4.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.907 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -96.12 133.2 40.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 54.5 110.91 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.88 -92.49 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.735 . . . . 73.44 112.475 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -157.25 83.83 0.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 75.11 110.897 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 43' ' ' ALA . 7.9 pt-20 -124.31 -168.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 74.21 110.893 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.79 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -94.01 106.6 18.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 54.51 111.095 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . -72.9 -109.15 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 71.45 112.485 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.88 -69.17 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 63.32 110.845 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -54.98 170.96 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 75.14 110.931 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.9 p -176.13 127.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 74.41 110.927 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.06 155.58 3.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 52.32 110.875 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.26 99.98 3.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.855 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.96 122.53 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.117 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.5 p -110.14 37.92 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 65.22 111.134 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 174.35 116.91 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.594 0.711 . . . . 70.13 110.871 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.541 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 54.0 Cg_endo -69.74 159.35 53.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.24 . . . . 73.43 112.375 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -142.12 131.88 24.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 71.33 110.909 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 1.9 t30 78.45 16.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 54.22 110.869 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.33 -23.87 33.74 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 54.51 112.454 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.52 171.79 13.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 71.31 110.856 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.541 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 9.4 m95 -86.87 101.06 13.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 75.54 110.919 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 mt -101.06 137.04 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 74.41 111.144 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -132.23 145.11 51.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.12 110.895 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.36 134.01 31.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.42 110.914 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.94 179.32 4.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 61.35 110.906 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 19.84 2.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.2 110.883 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -137.84 30.28 2.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 71.51 110.908 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.425 ' O ' HD23 ' A' ' 67' ' ' LEU . . . -118.71 83.35 2.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 54.42 111.074 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -80.09 86.06 5.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 43.32 111.057 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.074 HD21 HD13 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -125.71 171.68 10.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 74.43 110.925 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -160.28 140.57 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 65.44 110.91 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 97' ' ' GLY . 11.5 mm -24.26 118.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 72.22 111.093 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.27 -18.68 7.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.775 -0.726 . . . . 73.32 112.468 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.12 -176.76 4.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.339 . . . . 55.04 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -143.99 161.81 37.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 70.43 110.857 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.8 mt -138.93 145.66 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 71.42 111.108 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -146.15 103.01 3.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 71.54 110.89 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -162.14 -157.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 70.33 110.889 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.423 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.1 p-90 -150.93 173.74 13.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 74.2 110.932 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 p -143.05 158.74 43.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 54.11 111.172 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.16 144.48 45.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 73.41 110.829 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -143.69 169.52 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 62.43 111.111 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.736 HG13 HD12 ' A' ' 27' ' ' LEU . 66.9 mt -147.71 96.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.172 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -114.63 140.64 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.03 110.942 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 50.63 27.12 2.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 75.32 110.845 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.37 29.13 68.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 42.3 112.5 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.45 HD13 ' OH ' ' A' ' 86' ' ' TYR . 2.4 mt -98.98 -49.53 4.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 74.23 110.908 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.6 131.48 4.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 74.1 112.496 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.65 ' HB2' HG23 ' A' ' 79' ' ' VAL . 76.5 m-85 -145.17 -179.24 6.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 74.41 110.935 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -172.24 133.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 75.34 110.897 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.716 ' OE1' ' HB3' ' A' ' 3' ' ' ALA . 4.3 tp60 -78.74 155.15 29.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 75.32 110.92 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.509 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -141.6 -163.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 75.12 110.87 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.509 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.7 t-20 83.05 -36.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 75.14 110.893 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.19 78.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 41.1 112.471 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -170.47 109.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.358 . . . . 74.42 110.925 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -151.14 112.89 4.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 74.53 110.928 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.9 m -86.85 130.92 34.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.43 111.066 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.69 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 21.2 t -62.85 116.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 63.23 111.128 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.0 15.2 3.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 62.11 110.895 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -130.44 -177.82 15.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 62.41 112.507 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.448 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -153.86 155.52 35.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.372 . . . . 64.43 110.872 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.604 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -166.71 168.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 65.12 111.151 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.34 133.92 39.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 54.55 110.876 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.17 39.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 73.33 110.851 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 62.22 111.099 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.814 0.34 . . . . 75.04 110.936 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -126.18 71.64 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 71.31 110.855 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.12 143.54 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.612 0.72 . . . . 64.14 111.062 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.483 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.8 Cg_endo -69.74 166.95 25.83 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.653 2.235 . . . . 72.24 112.365 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 132.65 23.77 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.683 2.255 . . . . 72.52 112.379 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.811 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -83.12 138.24 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 45.13 111.103 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.5 m -95.59 78.03 3.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 72.31 111.138 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.559 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.4 mp -79.32 109.31 13.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 52.34 110.969 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.846 ' O ' HD11 ' A' ' 16' ' ' LEU . 6.7 mm-40 -79.99 -171.79 3.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 53.1 110.924 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -130.46 81.26 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 52.24 111.119 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.731 HD13 ' CG2' ' A' ' 99' ' ' VAL . 2.9 mm -72.66 172.52 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 73.45 111.12 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.706 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.34 172.01 0.26 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.605 0.717 . . . . 61.41 110.849 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.73 19.86 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 74.03 112.373 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 12' ' ' HIS . 11.1 ptmt -124.66 19.94 8.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.887 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.21 -177.44 33.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.796 -0.716 . . . . 60.33 112.486 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.846 HD11 ' O ' ' A' ' 9' ' ' GLU . 19.8 tp -150.89 168.98 22.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 72.54 110.888 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HB2' HD11 ' A' ' 11' ' ' ILE . 3.2 ttt180 -132.92 139.44 47.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 73.04 110.86 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -147.83 108.28 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 73.42 111.137 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 59' ' ' ILE . 12.8 t -119.5 157.41 28.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 60.03 110.859 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 6' ' ' ALA . 21.6 m -141.6 151.58 60.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.644 0.735 . . . . 63.44 111.138 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 122.21 8.89 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.713 2.275 . . . . 65.44 112.326 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 28.4 t0 -84.55 86.12 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 75.04 110.86 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -73.08 2.52 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.852 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.33 24.24 0.86 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.737 . . . . 74.31 112.511 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 81.4 m-85 -70.45 168.34 16.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 74.05 110.866 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t -125.39 -16.03 6.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 54.32 110.893 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.026 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -158.34 140.14 13.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 64.24 110.944 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.026 ' N ' HD22 ' A' ' 27' ' ' LEU . 8.3 t80 -132.77 151.5 51.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 72.32 110.883 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.74 155.39 48.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 71.34 111.082 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.645 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.4 m-85 -128.88 131.28 47.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 64.41 110.849 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.642 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 14.0 m-70 -157.63 84.97 0.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 71.43 110.868 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -144.55 177.47 23.08 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 70.21 112.491 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -136.21 -166.23 1.84 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 75.24 110.905 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 72' ' ' LYS . 13.7 tp -127.38 148.12 50.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 73.2 110.889 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 m120 43.14 23.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.12 110.886 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 34' ' ' LEU . 2.0 tp10 -157.67 145.54 18.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 74.1 110.907 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.462 ' CB ' ' HB2' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -125.09 150.42 46.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 61.23 110.849 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.467 ' HE3' ' O ' ' A' ' 31' ' ' HIS . 2.3 ptt? -102.73 -172.53 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 54.14 110.88 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.95 172.52 12.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 62.2 110.892 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 48.25 37.03 17.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 51.32 112.483 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.539 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.2 OUTLIER 35.05 83.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 62.35 110.864 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -124.79 -164.34 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 63.23 110.882 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.642 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -102.61 99.98 10.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 51.13 111.083 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 43' ' ' ALA . . . -56.74 -114.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.759 . . . . 74.42 112.522 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.55 -65.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 72.23 110.857 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -60.01 154.83 18.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 72.55 110.941 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.432 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 99.3 p -158.01 109.22 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 61.43 110.836 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.845 ' NH1' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.73 162.92 40.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 74.2 110.871 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.509 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -143.65 113.73 7.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 74.35 110.893 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.845 HD13 ' NH1' ' A' ' 48' ' ' ARG . 11.2 mm -99.85 103.9 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 64.42 111.177 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.47 HG22 HD23 ' A' ' 27' ' ' LEU . 76.6 p -96.06 30.47 2.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.169 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 175.46 132.8 0.15 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 74.41 110.945 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 178.68 4.35 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.634 2.222 . . . . 64.24 112.363 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -129.53 -30.41 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 53.01 110.878 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -146.27 47.66 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 54.54 110.863 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.13 -26.26 7.04 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 40.42 112.459 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.88 164.42 21.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.827 0.346 . . . . 62.15 110.845 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 5.9 m95 -87.16 96.2 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 75.31 110.946 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.503 HD12 ' HD2' ' A' ' 54' ' ' LYS . 43.0 mt -102.75 142.04 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 62.34 111.155 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -134.98 154.28 51.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 74.43 110.91 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.76 135.4 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 71.33 110.869 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD2' ' ND2' ' A' ' 64' ' ' ASN . 6.0 t70 -112.22 174.97 5.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 72.54 110.839 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -139.42 15.46 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 63.34 110.844 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.492 ' ND2' ' OD2' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -129.44 4.94 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.888 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.16 98.13 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 73.21 111.102 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -96.45 87.53 4.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 71.41 111.086 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.798 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -138.79 171.17 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 61.22 110.911 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.699 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.73 156.57 31.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 72.23 110.943 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.4 mm -32.01 118.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 75.42 111.189 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.26 -23.56 6.43 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 62.11 112.516 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.9 -170.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 73.05 110.88 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.514 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -147.91 162.05 40.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 60.42 110.924 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.87 145.9 29.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 61.15 111.114 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -148.4 111.42 4.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.959 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.6 p90 -171.98 -163.45 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 74.22 110.913 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.539 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -152.18 145.6 24.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 61.35 110.895 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.484 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 11.2 p -113.45 161.11 17.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 74.2 111.153 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.551 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -119.17 144.77 46.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 71.31 110.884 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.642 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -139.24 166.14 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.35 111.178 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.643 HG13 HD12 ' A' ' 27' ' ' LEU . 90.7 mt -143.26 96.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 64.51 111.15 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.461 ' HG2' ' N ' ' A' ' 82' ' ' ASP . 4.9 tttt -118.66 146.36 44.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 72.14 110.918 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 52.15 22.26 1.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.44 110.858 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.15 27.67 71.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.754 . . . . 61.32 112.499 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mt -100.05 -65.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 73.25 110.917 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.39 124.85 4.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.688 -0.768 . . . . 31.32 112.464 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.642 ' HB2' HG23 ' A' ' 79' ' ' VAL . 8.2 m-85 -136.71 178.0 7.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.394 . . . . 74.0 110.89 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.551 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -164.2 123.97 2.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 72.22 110.886 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.579 HE22 ' N ' ' A' ' 6' ' ' ALA . 1.9 tt0 -52.85 -173.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 62.1 110.897 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -170.49 -166.25 0.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 62.3 110.885 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER 83.53 -32.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 73.21 110.873 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 33.9 61.76 0.48 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.71 -0.757 . . . . 43.43 112.495 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -167.88 106.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 74.01 110.91 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 25.7 m-90 -145.42 115.51 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 61.12 110.889 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 60.5 m -87.31 133.16 33.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 65.54 111.149 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 10' ' ' ALA . 21.6 t -63.38 107.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 51.22 111.143 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.75 5.21 7.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 60.32 110.892 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.8 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -117.53 179.76 17.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 75.1 112.464 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -152.96 155.52 37.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.904 0.383 . . . . 74.42 110.872 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.731 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.51 -176.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 72.43 111.14 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -141.88 129.6 21.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 63.5 110.893 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -80.23 58.71 3.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.33 110.897 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 74.4 111.109 179.927 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.563 ' CD1' ' C ' ' A' ' 1' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.819 0.343 . . . . 75.05 110.91 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 1' ' ' TYR . 39.6 mt-10 -162.53 68.68 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 73.15 110.9 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 86' ' ' TYR . . . -33.22 142.07 0.2 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.576 0.703 . . . . 53.02 111.125 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.501 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.6 Cg_endo -69.74 154.62 67.62 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.71 2.273 . . . . 74.53 112.315 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 134.47 28.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.672 2.248 . . . . 52.52 112.336 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.888 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -86.24 137.92 32.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 64.12 111.11 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 m -93.18 77.19 4.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 74.22 111.122 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.535 HD21 ' CE1' ' A' ' 75' ' ' PHE . 1.9 mp -77.94 110.87 13.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 72.54 110.911 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.795 ' O ' HD11 ' A' ' 16' ' ' LEU . 20.4 mm-40 -87.26 -167.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 75.52 110.858 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.867 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -134.32 80.51 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 62.24 111.131 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 17' ' ' ARG . 4.5 mm -69.38 172.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 71.2 111.122 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.7 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -53.85 172.03 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 73.25 110.817 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.9 Cg_endo -69.77 21.43 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 54.51 112.347 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 12' ' ' HIS . 7.5 pttt -128.82 25.07 5.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 72.14 110.884 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.29 -177.9 30.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 51.11 112.488 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.934 HD13 HD21 ' A' ' 67' ' ' LEU . 24.6 tp -150.71 157.97 43.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.347 . . . . 61.54 110.919 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.771 ' HB2' HD11 ' A' ' 11' ' ' ILE . 74.8 ttt180 -122.75 135.25 54.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 65.4 110.889 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 8' ' ' LEU . 53.7 t -147.06 108.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 74.33 111.095 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.702 ' HB2' HG23 ' A' ' 59' ' ' ILE . 46.4 t -120.56 162.2 20.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.897 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.888 HG12 ' HA ' ' A' ' 6' ' ' ALA . 30.4 m -141.04 152.03 63.87 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.646 0.736 . . . . 73.42 111.102 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 123.98 10.65 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.646 2.231 . . . . 72.34 112.364 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 17.0 t0 -87.82 107.05 18.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 63.43 110.889 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -96.09 6.81 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 44.13 110.893 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.48 8.97 2.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 73.24 112.462 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 63.5 m-85 -60.27 168.5 1.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.328 . . . . 71.41 110.887 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -128.95 -7.39 4.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.33 110.854 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.994 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -156.32 143.06 18.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 62.51 110.915 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.994 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.3 t80 -139.73 139.32 36.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 75.5 110.882 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.44 158.86 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 73.24 111.141 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.484 ' HE2' HG11 ' A' ' 18' ' ' VAL . 4.1 t80 -145.75 114.65 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 65.51 110.891 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.722 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -147.35 94.87 2.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 73.35 110.846 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.62 177.61 23.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 53.34 112.456 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.55 -164.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 75.21 110.905 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.688 HD12 ' O ' ' A' ' 72' ' ' LYS . 15.0 tp -136.31 148.53 47.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 70.34 110.954 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 48.96 19.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 71.42 110.894 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -161.24 142.7 11.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 73.02 110.888 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.03 156.69 22.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 73.43 110.897 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.599 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -100.75 -178.98 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 64.35 110.821 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.26 136.51 51.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 71.52 110.87 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.21 -91.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 33.44 112.498 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.742 HD22 ' NH1' ' A' ' 87' ' ' ARG . 0.8 OUTLIER -164.56 91.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.751 0.31 . . . . 60.32 110.916 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -129.28 173.88 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 75.53 110.843 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.722 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -85.66 101.67 12.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 71.42 111.069 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.23 -119.58 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 71.43 112.483 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -103.41 -51.75 3.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 75.01 110.877 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.567 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 8.3 m0 -70.19 165.42 22.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.922 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.557 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 96.0 p -164.65 124.25 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 72.0 110.847 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HG2' ' CD1' ' A' ' 60' ' ' PHE . 17.0 tpp180 -165.44 144.26 6.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 73.21 110.872 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.572 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -139.39 99.31 3.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.868 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mm -87.87 115.42 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 64.41 111.115 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.415 HG22 HD23 ' A' ' 27' ' ' LEU . 63.8 p -103.78 33.47 3.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 53.14 111.134 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.6 OUTLIER 167.84 127.38 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.605 0.717 . . . . 72.01 110.903 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 171.17 15.01 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.687 2.258 . . . . 73.1 112.32 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.82 19.45 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 44.42 110.907 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -177.56 38.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.14 110.917 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.47 -13.62 15.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 75.33 112.452 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.05 160.54 40.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.805 0.336 . . . . 75.21 110.873 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.474 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 3.9 m95 -85.79 101.39 12.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 75.22 110.949 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.702 HG23 ' HB2' ' A' ' 19' ' ' SER . 7.7 mt -104.32 143.78 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 62.4 111.121 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.494 ' CD1' ' HG2' ' A' ' 48' ' ' ARG . 13.1 t80 -132.27 147.89 52.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 73.53 110.939 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.439 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -140.93 127.45 20.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 74.01 110.886 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.567 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 2.5 t0 -104.47 -179.53 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 65.42 110.853 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -148.95 28.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 75.44 110.865 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -144.88 13.58 1.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 63.44 110.876 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.03 100.09 9.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 73.2 111.142 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -95.54 86.55 4.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 62.45 111.094 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.934 HD21 HD13 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -125.62 171.55 10.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 74.15 110.895 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.501 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -152.79 140.49 19.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 63.53 110.931 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.54 HG12 ' CD1' ' A' ' 98' ' ' PHE . 17.1 mm -28.23 118.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 60.53 111.096 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.67 -22.04 5.56 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.749 -0.739 . . . . 71.1 112.474 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.84 -166.87 0.32 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 65.24 110.898 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.688 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.1 mttt -147.33 172.16 14.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 73.33 110.871 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.2 mt -144.72 144.69 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 75.11 111.129 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.3 100.75 3.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 74.3 110.87 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.535 ' CE1' HD21 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -159.5 -156.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 72.41 110.826 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.599 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -152.46 156.68 39.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.51 110.918 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 p -118.82 175.38 5.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 74.45 111.176 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -146.95 130.46 16.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 70.24 110.905 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 86' ' ' TYR . 3.3 m -134.13 -179.03 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 64.43 111.138 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.737 HG13 HD12 ' A' ' 27' ' ' LEU . 83.1 mt -153.37 97.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 74.1 111.108 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.531 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 16.1 tttm -113.1 135.19 54.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 62.22 110.9 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.3 t0 50.51 25.1 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.25 110.851 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.98 30.04 73.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 54.21 112.511 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.733 HD13 ' OH ' ' A' ' 86' ' ' TYR . 2.0 mt -92.53 -66.87 0.89 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.359 . . . . 75.4 110.915 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.59 116.09 4.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.755 . . . . 60.13 112.495 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.733 ' OH ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -127.33 166.46 17.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.879 0.371 . . . . 70.11 110.902 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.742 ' NH1' HD22 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -160.33 110.67 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 74.52 110.904 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -60.74 157.9 13.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 74.45 110.924 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -146.72 -169.11 3.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.3 110.849 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.6 m120 83.93 -28.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 71.04 110.862 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 34.41 78.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 31.54 112.492 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -165.96 104.14 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 75.41 110.887 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.406 ' CG ' HD13 ' A' ' 8' ' ' LEU . 19.4 m-90 -145.95 113.28 6.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 73.1 110.939 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 93.1 m -82.07 140.07 34.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 75.1 111.138 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.867 HG13 ' HB2' ' A' ' 10' ' ' ALA . 21.2 t -78.64 111.61 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 53.51 111.133 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -138.66 16.32 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 74.53 110.861 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -139.38 121.7 2.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.78 -0.724 . . . . 61.3 112.527 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -91.02 170.08 10.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.91 0.386 . . . . 73.03 110.895 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.643 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -168.03 155.16 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 71.32 111.127 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -115.18 127.35 55.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 65.12 110.864 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -89.81 39.5 0.96 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 54.42 110.924 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 73.02 111.132 179.927 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.864 0.364 . . . . 73.33 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.538 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 43.0 mt-10 -142.57 73.13 1.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 71.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 2' ' ' GLU . . . 69.71 145.03 0.11 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 71.4 111.075 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.66 168.3 21.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.267 . . . . 73.33 112.358 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 132.72 23.96 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 64.22 112.356 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.784 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.01 134.92 35.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 51.25 111.085 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -93.12 77.16 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 75.55 111.117 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.666 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.1 mp -79.34 107.18 11.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 63.35 110.928 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.903 ' O ' HD11 ' A' ' 16' ' ' LEU . 6.6 mm-40 -79.92 -173.58 3.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 74.34 110.909 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.68 79.65 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 64.42 111.047 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 17' ' ' ARG . 3.2 mm -70.6 172.61 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 73.24 111.139 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.694 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -53.05 171.54 0.22 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 64.03 110.839 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.5 Cg_endo -69.79 19.77 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.686 2.257 . . . . 72.13 112.307 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' HIS . 25.5 pttt -127.91 25.43 5.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 72.42 110.921 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.55 -179.98 30.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.754 -0.736 . . . . 71.55 112.498 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.019 HD13 HD21 ' A' ' 67' ' ' LEU . 20.5 tp -149.97 158.3 44.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 71.01 110.902 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.717 ' HB2' HD11 ' A' ' 11' ' ' ILE . 11.4 ttt180 -126.37 132.55 51.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.02 110.88 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.666 HG22 ' HA ' ' A' ' 8' ' ' LEU . 54.2 t -141.29 114.03 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 71.1 111.129 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.529 ' HB2' HG23 ' A' ' 59' ' ' ILE . 7.8 t -119.96 156.56 30.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 63.3 110.85 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.784 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.4 m -139.01 152.67 70.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.589 0.709 . . . . 74.25 111.168 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 121.36 8.05 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.727 2.285 . . . . 72.01 112.313 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.598 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.1 t70 -55.69 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 65.03 110.881 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' A' ' 22' ' ' ASP . 0.9 OUTLIER 83.46 -13.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 75.44 110.874 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.83 6.47 2.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 71.23 112.516 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CD2' ' O ' ' A' ' 22' ' ' ASP . 36.1 m-85 -53.8 166.74 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 74.12 110.865 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 80' ' ' ILE . 11.4 t -133.08 -2.25 3.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 73.41 110.822 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.043 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -171.45 139.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 75.31 110.892 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.043 ' N ' HD22 ' A' ' 27' ' ' LEU . 13.3 t80 -133.77 152.5 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 64.13 110.871 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.79 158.87 43.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 75.53 111.113 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.522 ' HE2' HG11 ' A' ' 18' ' ' VAL . 1.5 t80 -139.2 127.27 22.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 71.13 110.871 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -152.89 88.04 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.2 110.859 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.523 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.27 -176.67 20.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 33.55 112.47 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -134.8 -164.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 74.11 110.863 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.1 tp -131.94 147.02 52.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 73.14 110.875 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.0 m120 39.92 30.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 74.42 110.859 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.03 127.6 4.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.45 110.893 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -99.96 146.81 26.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 71.34 110.864 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.0 ptp -101.98 -174.92 2.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 64.05 110.881 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.37 154.65 42.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 75.22 110.909 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 56.52 36.29 70.09 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 32.34 112.508 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 40' ' ' GLY . 4.1 mt 35.72 84.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 60.14 110.937 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -124.61 178.41 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 72.42 110.877 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.83 98.26 10.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 71.22 111.137 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.96 -116.35 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.694 -0.765 . . . . 74.1 112.503 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.74 -58.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.752 0.31 . . . . 63.44 110.837 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -69.66 146.96 51.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 74.54 110.936 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -155.12 120.18 4.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 64.24 110.812 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.14 158.85 25.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 63.34 110.92 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.743 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -143.56 116.19 8.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 71.14 110.835 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mm -98.76 108.17 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 54.45 111.144 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -98.23 31.84 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 72.22 111.106 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.23 115.59 0.27 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.656 0.741 . . . . 74.44 110.858 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 53.7 Cg_endo -69.71 178.16 4.82 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.66 2.24 . . . . 74.13 112.377 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.693 ' HD3' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -169.88 133.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 62.33 110.902 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 7.1 t-20 81.62 8.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 52.02 110.92 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.88 -16.84 42.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 74.21 112.542 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.1 176.01 9.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 72.14 110.911 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.55 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 6.9 m95 -93.41 107.91 19.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 71.54 110.893 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.693 HD12 ' HD3' ' A' ' 54' ' ' LYS . 11.1 mt -106.21 146.62 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 72.24 111.111 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -136.38 144.53 44.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 73.51 110.85 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.51 133.43 40.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 73.13 110.859 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.78 155.1 31.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 70.31 110.864 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -123.31 41.9 3.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 54.35 110.862 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -153.87 24.02 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 64.24 110.854 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.3 93.1 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.45 111.129 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -89.38 81.1 6.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.42 111.11 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.019 HD21 HD13 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -121.91 171.52 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 70.51 110.948 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.569 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -157.74 138.45 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.935 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.569 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.8 mm -22.65 118.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 75.41 111.181 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.94 -18.12 7.09 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 24.2 112.472 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.97 -169.19 1.47 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.866 0.365 . . . . 72.33 110.908 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.9 mttt -150.34 161.67 42.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 71.44 110.937 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.3 mt -135.63 146.65 29.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 74.15 111.145 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.9 m-85 -147.59 107.01 3.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 75.21 110.903 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.4 p90 -167.67 -167.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 70.12 110.883 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.9 p-90 -135.97 163.11 31.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 73.01 110.943 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 p -131.35 164.4 25.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 55.33 111.133 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.67 141.64 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 75.31 110.912 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.598 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -141.03 167.3 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.25 111.137 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.589 ' CD1' HD12 ' A' ' 27' ' ' LEU . 94.1 mt -149.89 95.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 65.12 111.094 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -109.84 137.49 47.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 71.43 110.891 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 43.4 34.95 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 64.5 110.909 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.69 37.73 92.77 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 64.35 112.461 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.81 -55.11 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 64.32 110.94 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.11 113.22 1.13 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 73.22 112.482 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.598 ' HB2' HG23 ' A' ' 79' ' ' VAL . 96.7 m-85 -132.23 -178.72 5.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 75.44 110.918 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -174.09 135.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 70.14 110.849 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.538 ' NE2' ' O ' ' A' ' 2' ' ' GLU . 0.5 OUTLIER -86.1 153.19 22.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 74.11 110.881 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -135.19 -163.91 1.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 65.12 110.884 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.4 t-20 83.73 -37.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 73.2 110.896 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.51 79.12 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.77 -0.728 . . . . 75.24 112.479 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -170.14 110.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 62.11 110.886 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -151.52 115.4 4.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.33 110.921 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.5 m -87.06 131.18 34.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 61.45 111.185 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.688 HG21 HD12 ' A' ' 67' ' ' LEU . 28.8 t -63.21 116.33 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 73.45 111.123 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.04 6.1 3.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 75.41 110.875 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.812 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -115.82 -178.55 18.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 71.1 112.461 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.515 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.7 155.7 33.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 63.33 110.89 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.711 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.76 178.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 64.54 111.119 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.38 133.61 27.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 70.52 110.905 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -85.24 44.89 1.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 75.12 110.882 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.4 111.074 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.865 0.364 . . . . 70.12 110.928 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -145.95 86.32 1.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 62.41 110.889 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.93 148.5 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 75.55 111.126 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 169.11 19.6 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.281 . . . . 54.13 112.369 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 133.37 25.28 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 51.41 112.35 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.727 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -83.68 140.54 32.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 64.31 111.063 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m -100.77 78.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 63.34 111.175 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.529 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.7 mp -78.27 110.18 13.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 74.11 110.925 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.635 ' O ' HD11 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -78.19 -160.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 75.2 110.891 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.796 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -139.92 80.34 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 71.21 111.118 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.755 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.3 mm -72.19 172.69 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 73.43 111.179 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.709 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.18 172.09 0.25 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.712 . . . . 71.23 110.858 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.598 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.2 Cg_endo -69.82 20.07 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.665 2.243 . . . . 74.5 112.3 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 12' ' ' HIS . 3.0 pttt -125.1 19.8 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 53.3 110.902 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.78 -177.3 33.77 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 71.33 112.492 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.987 HD13 HD21 ' A' ' 67' ' ' LEU . 27.8 tp -150.98 167.93 26.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.804 0.335 . . . . 75.3 110.922 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.575 ' HB2' HD11 ' A' ' 11' ' ' ILE . 5.2 ttm180 -130.78 141.08 50.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 74.21 110.879 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -149.59 107.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 72.43 111.121 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.553 ' HB2' HG23 ' A' ' 59' ' ' ILE . 11.7 t -120.18 156.3 31.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 65.03 110.871 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 6' ' ' ALA . 3.1 m -145.08 151.76 49.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 73.04 111.139 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 121.2 7.9 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.677 2.251 . . . . 74.13 112.339 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 1.2 t70 -75.7 130.84 39.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 74.13 110.872 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.7 23.93 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 73.41 110.836 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 112.8 5.91 23.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.736 . . . . 74.52 112.468 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 66.7 m-85 -55.62 162.54 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 53.13 110.897 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.3 t -129.84 -8.9 4.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 61.31 110.879 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.009 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -158.64 141.85 14.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 71.42 110.936 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 1.009 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -135.65 150.39 49.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 70.22 110.841 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.718 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . . . -141.0 136.75 32.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 74.45 111.083 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.62 118.28 30.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 75.14 110.84 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.727 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -146.0 90.58 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 71.51 110.881 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 75' ' ' PHE . . . -146.24 -178.31 21.56 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 73.41 112.494 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -132.76 -164.3 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 72.24 110.909 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.44 ' HG ' ' CG ' ' A' ' 35' ' ' ASN . 14.0 tp -133.18 147.94 52.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 62.33 110.965 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.44 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 6.9 m-20 43.39 24.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 74.02 110.881 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -166.49 143.09 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 70.52 110.938 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -105.51 -170.55 1.76 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 72.32 110.907 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.508 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 2.1 ptt? -137.96 178.84 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 63.01 110.866 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' A' ' 40' ' ' GLY . 1.4 mt-10 -45.16 171.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 64.5 110.895 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.5 ' C ' ' O ' ' A' ' 39' ' ' GLU . . . -30.04 -49.21 0.15 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.754 -0.736 . . . . 63.24 112.442 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.472 ' HA ' ' NE1' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -170.03 84.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.778 0.323 . . . . 44.31 110.944 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 43' ' ' ALA . 3.9 pt-20 -127.9 -152.95 0.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 70.14 110.937 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -104.62 107.15 17.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 73.54 111.11 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.508 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . -61.09 -121.6 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 73.1 112.483 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.43 -69.87 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 54.12 110.897 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.446 ' O ' ' ND1' ' A' ' 31' ' ' HIS . 6.1 m-90 -47.47 164.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 70.41 110.915 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.488 ' CB ' ' NE2' ' A' ' 31' ' ' HIS . 97.0 p -166.31 117.39 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 74.21 110.878 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.56 162.43 21.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 62.24 110.874 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.718 ' OD1' ' HB2' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -139.44 108.38 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 55.31 110.915 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 28' ' ' PHE . 3.4 mm -82.94 104.2 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 60.31 111.095 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.1 p -91.94 28.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 51.4 111.136 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.34 140.78 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.555 0.693 . . . . 72.34 110.885 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 178.25 4.74 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.739 2.293 . . . . 53.34 112.298 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.706 ' HD2' HD12 ' A' ' 59' ' ' ILE . 12.3 ttmt -109.9 -55.53 2.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 71.2 110.926 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -147.02 75.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 73.3 110.906 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.61 -22.22 6.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 74.43 112.481 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -137.98 171.89 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 73.14 110.906 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.585 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 18.9 m95 -93.58 98.44 11.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 74.54 110.922 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.706 HD12 ' HD2' ' A' ' 54' ' ' LYS . 27.9 mt -99.97 150.67 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 73.24 111.132 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -146.1 147.41 31.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 55.41 110.935 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.29 127.46 22.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 71.12 110.869 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -98.6 -179.55 4.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 73.21 110.871 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.59 16.17 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 72.21 110.879 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -133.43 6.93 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 75.43 110.871 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.68 103.28 15.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 73.42 111.09 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -98.61 83.01 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 75.12 111.057 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.987 HD21 HD13 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -122.38 171.6 8.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 73.22 110.917 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -158.45 141.62 14.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 71.2 110.888 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.576 HD11 ' O ' ' A' ' 97' ' ' GLY . 5.2 mm -26.0 117.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 62.25 111.168 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.31 -17.15 10.54 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.803 -0.713 . . . . 63.04 112.507 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.83 -167.98 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 73.43 110.892 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 16.4 mttt -151.52 165.56 33.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.34 110.918 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.8 mt -141.26 151.12 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 53.34 111.143 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -150.28 101.1 2.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.25 110.87 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.488 ' CB ' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -160.1 -166.35 1.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.872 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.472 ' NE1' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.4 148.64 32.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 74.13 110.902 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 p -115.07 155.61 26.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.431 . . . . 75.42 111.173 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.02 142.97 49.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 71.55 110.877 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.451 ' CG1' ' CD2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -142.68 170.72 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 72.53 111.098 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.675 HG13 HD12 ' A' ' 27' ' ' LEU . 77.5 mt -146.5 96.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 71.33 111.151 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.443 ' HG3' ' C ' ' A' ' 24' ' ' GLY . 1.6 tttt -114.15 141.58 47.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.41 110.947 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 49.14 32.44 4.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 72.15 110.852 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.08 30.11 60.27 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 74.31 112.476 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.535 HD13 ' OH ' ' A' ' 86' ' ' TYR . 1.5 mt -96.85 -63.6 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 65.05 110.923 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.09 106.11 3.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 72.22 112.452 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.535 ' OH ' HD13 ' A' ' 84' ' ' LEU . 80.2 m-85 -119.47 171.72 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 74.44 110.875 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 6.8 ttp-105 -171.33 131.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 71.43 110.895 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -74.08 158.93 33.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 72.13 110.923 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.4 OUTLIER -140.83 -164.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 64.14 110.869 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.2 t-20 83.75 -42.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.23 110.907 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.52 70.48 0.75 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 31.4 112.473 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -170.02 117.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 62.13 110.895 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -155.23 118.65 4.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 73.42 110.942 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.8 m -87.6 132.04 34.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 64.44 111.147 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.71 HG21 HD12 ' A' ' 67' ' ' LEU . 32.8 t -67.29 112.3 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.15 111.159 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -129.42 10.92 5.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.52 110.897 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.796 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -122.65 -177.0 15.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 61.3 112.473 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.507 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -154.04 155.76 36.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.372 . . . . 71.34 110.861 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.755 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.48 -176.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 72.23 111.153 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -151.95 132.57 13.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 60.53 110.829 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -102.93 46.14 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 63.42 110.897 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 63.3 111.078 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 121.62 0.724 . . . . 54.43 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.26 24.92 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 73.099999999999994 112.333 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.422 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 53.6 Cg_endo -69.79 134.19 27.32 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.686 2.257 . . . . 74.450000000000003 112.342 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.921 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.55 136.02 35.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 71.219999999999999 111.112 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.4 m -95.6 77.57 3.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 74.010000000000005 111.107 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -79.42 110.17 14.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 71.219999999999999 110.912 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.789 ' O ' HD11 ' A' ' 16' ' ' LEU . 12.9 mm-40 -79.8 -165.61 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 64.420000000000002 110.903 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.823 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -134.95 80.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 60.299999999999997 111.103 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.702 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.6 mm -70.81 172.5 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 74.150000000000006 111.127 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.702 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.79 172.37 0.23 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.573 0.702 . . . . 60.119999999999997 110.853 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.79 20.02 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.614 2.209 . . . . 63.030000000000001 112.378 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 12' ' ' HIS . 3.8 ptpt -126.78 24.04 6.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 70.019999999999996 110.885 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.91 -178.48 30.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 42.409999999999997 112.498 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.789 HD11 ' O ' ' A' ' 9' ' ' GLU . 29.1 tp -150.52 164.11 36.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.857 0.361 . . . . 64.310000000000002 110.892 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.618 ' HB2' HD11 ' A' ' 11' ' ' ILE . 49.6 ttt180 -127.61 137.61 52.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 71.129999999999995 110.863 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.8 t -145.6 108.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 72.420000000000002 111.11 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.5 t -122.3 156.45 33.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 73.340000000000003 110.919 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 6' ' ' ALA . 10.4 m -141.36 150.86 59.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.633 0.73 . . . . 72.349999999999994 111.117 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 122.27 8.95 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.725 2.283 . . . . 71.140000000000001 112.348 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 15.0 t70 -83.81 128.74 34.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.099999999999994 110.844 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -117.97 2.21 12.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 51.009999999999998 110.916 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.27 31.08 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 62.530000000000001 112.452 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.518 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 63.3 m-85 -82.27 160.9 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 53.210000000000001 110.897 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.7 t -126.48 -13.52 6.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 53.420000000000002 110.856 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.035 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -153.64 140.17 18.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 70.109999999999999 110.959 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.035 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -133.75 143.72 48.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 64.030000000000001 110.861 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.03 129.35 43.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 74.510000000000005 111.171 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -115.24 120.62 40.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.140000000000001 110.941 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.487 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 11.4 m-70 -151.58 91.07 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 55.049999999999997 110.864 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -145.96 -177.6 20.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.777 -0.725 . . . . 62.030000000000001 112.484 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -135.3 -166.44 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 73.25 110.847 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' ASN . 9.5 tp -128.07 147.35 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 62.299999999999997 110.886 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 34' ' ' LEU . 1.7 m-80 36.47 34.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 65.299999999999997 110.929 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 34' ' ' LEU . 1.2 tp10 -163.43 129.16 3.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 65.129999999999995 110.922 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -102.74 150.21 23.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 64.299999999999997 110.87 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 64.349999999999994 110.898 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.435 -0.266 . . . . 74.209999999999994 112.435 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -103.27 -53.32 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 74.209999999999994 110.861 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.9 m-90 -73.25 147.47 44.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.219 -0.446 . . . . 70.120000000000005 110.881 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.487 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 87.2 p -151.27 119.01 6.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 60.219999999999999 110.88 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.92 163.12 4.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 71.340000000000003 110.889 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -142.82 119.37 11.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 45.43 110.88 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 28' ' ' PHE . 5.5 mm -86.17 109.98 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 63.530000000000001 111.138 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 p -94.79 28.01 2.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 71.120000000000005 111.174 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt 171.22 135.66 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.562 0.696 . . . . 62.350000000000001 110.908 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -175.57 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.679 2.253 . . . . 74.340000000000003 112.399 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.619 ' HD2' HD12 ' A' ' 59' ' ' ILE . 1.2 ttmm -157.16 109.57 2.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 60.340000000000003 110.867 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 3.6 t-20 82.68 15.14 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 54.229999999999997 110.855 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.67 -17.5 49.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 62.210000000000001 112.444 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.86 160.4 37.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 71.310000000000002 110.865 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.539 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 20.1 m95 -84.69 94.17 8.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 73.049999999999997 110.946 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.619 HD12 ' HD2' ' A' ' 54' ' ' LYS . 21.7 mt -97.72 143.12 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 71.230000000000004 111.102 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -138.55 153.52 48.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 62.009999999999998 110.864 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.99 137.41 26.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 73.299999999999997 110.873 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.433 ' OD2' ' CG ' ' A' ' 64' ' ' ASN . 1.1 t70 -112.19 -177.67 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.219999999999999 110.894 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -143.49 10.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 73.430000000000007 110.85 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.433 ' CG ' ' OD2' ' A' ' 62' ' ' ASP . 22.1 p30 -127.28 9.87 6.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 73.219999999999999 110.844 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.24 101.06 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.349999999999994 111.085 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -100.85 88.74 3.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 64.540000000000006 111.162 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.743 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -136.33 171.22 14.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 63.240000000000002 110.951 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.669 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.29 154.48 32.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 63.229999999999997 110.906 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.616 ' CG1' ' CE2' ' A' ' 98' ' ' PHE . 16.2 mm -32.14 115.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 75.200000000000003 111.106 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.8 -20.53 6.4 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.686 -0.769 . . . . 55.32 112.455 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.69 -173.75 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.881 0.372 . . . . 75.319999999999993 110.849 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.5 mttt -149.56 159.68 44.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.450000000000003 110.894 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 33' ' ' LYS . 10.4 mt -134.26 148.1 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.113 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -147.75 105.55 3.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 64.530000000000001 110.938 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 2.3 p90 -163.68 -159.44 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 74.230000000000004 110.855 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.431 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.9 p-90 -145.44 168.58 20.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 70.420000000000002 110.92 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.403 HG23 ' CE2' ' A' ' 75' ' ' PHE . 1.7 p -139.92 147.59 40.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 73.319999999999993 111.152 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -112.92 141.01 47.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 75.530000000000001 110.884 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.405 ' C ' HG13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -139.69 171.2 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.140000000000001 111.112 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.624 HG13 HD12 ' A' ' 27' ' ' LEU . 97.4 mt -150.24 96.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 61.43 111.111 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.51 135.85 53.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 72.239999999999995 110.89 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 48.43 33.37 3.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 64.349999999999994 110.897 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.69 31.0 63.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 71.420000000000002 112.524 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.536 HD13 ' OH ' ' A' ' 86' ' ' TYR . 29.7 mt -95.19 -56.54 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.882 0.372 . . . . 64.109999999999999 110.921 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.14 113.93 2.92 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 52.200000000000003 112.462 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.536 ' OH ' HD13 ' A' ' 84' ' ' LEU . 97.4 m-85 -133.4 170.67 15.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 75.030000000000001 110.9 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -170.86 137.82 1.29 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 72.409999999999997 110.919 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.422 ' NE2' ' HA ' ' A' ' 5' ' ' PRO . 1.5 tp60 -85.75 152.22 23.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 72.340000000000003 110.898 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -134.35 -166.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.420000000000002 110.828 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 82.92 -36.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.239999999999995 110.86 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 43.47 80.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 65.299999999999997 112.469 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -168.74 113.43 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 74.099999999999994 110.91 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -151.09 121.56 7.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.187 -0.46 . . . . 71.540000000000006 110.9 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.4 m -92.96 134.56 34.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 64.420000000000002 111.143 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.823 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 21.4 t -63.61 121.24 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 63.340000000000003 111.145 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.1 34.05 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 63.420000000000002 110.891 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -162.9 125.52 1.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.7 -0.762 . . . . 50.539999999999999 112.509 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.616 ' CE2' ' CG1' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -94.92 163.89 13.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 75.120000000000005 110.886 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.649 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.48 167.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 74.129999999999995 111.13 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.34 130.31 50.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 62.009999999999998 110.876 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.36 57.07 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.510000000000005 110.862 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 71.439999999999998 111.121 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 121.541 0.686 . . . . 63.399999999999999 111.156 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.443 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.7 Cg_endo -69.75 166.01 29.03 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.65 2.233 . . . . 44.240000000000002 112.37 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 134.25 27.39 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.667 2.245 . . . . 75.0 112.327 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.752 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.01 140.41 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 61.539999999999999 111.086 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -97.1 78.7 2.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 75.519999999999996 111.146 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.5 HD21 ' CE1' ' A' ' 75' ' ' PHE . 1.7 mp -76.15 110.79 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 73.140000000000001 110.938 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.708 ' O ' HD11 ' A' ' 16' ' ' LEU . 4.8 mm-40 -84.5 -168.54 2.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 75.319999999999993 110.848 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -134.57 80.54 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 71.540000000000006 111.05 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.689 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -72.16 172.2 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 65.040000000000006 111.136 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.689 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.07 172.53 0.23 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 75.019999999999996 110.825 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.604 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.3 Cg_endo -69.8 19.91 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.705 2.27 . . . . 55.25 112.335 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 12' ' ' HIS . 8.1 pttt -127.18 25.14 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 72.239999999999995 110.862 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.58 -179.23 30.06 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.775 -0.726 . . . . 61.549999999999997 112.482 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.975 HD13 HD11 ' A' ' 67' ' ' LEU . 17.7 tp -150.35 164.49 35.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 71.219999999999999 110.931 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.626 ' HB2' HD11 ' A' ' 11' ' ' ILE . 25.1 ttt-85 -126.19 141.89 51.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 73.019999999999996 110.9 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -152.11 102.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 63.240000000000002 111.113 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -115.22 157.08 24.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 73.219999999999999 110.83 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 6' ' ' ALA . 20.5 m -139.94 151.64 65.86 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 71.310000000000002 111.148 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.429 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 53.9 Cg_endo -69.74 125.26 11.95 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.719 2.279 . . . . 74.040000000000006 112.366 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 20.1 t0 -87.33 83.72 7.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 31.23 110.868 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -70.96 -0.27 8.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 110.899 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.5 28.7 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 75.120000000000005 112.489 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -77.18 166.87 22.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.868 0.365 . . . . 74.230000000000004 110.906 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.5 t -124.64 -15.26 6.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 73.329999999999998 110.836 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.05 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -157.0 136.9 12.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 75.400000000000006 110.965 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.05 ' N ' HD22 ' A' ' 27' ' ' LEU . 7.6 t80 -131.06 148.09 52.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 74.0 110.881 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.25 157.7 45.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 64.409999999999997 111.091 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.629 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.5 m-85 -130.96 127.28 38.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 73.140000000000001 110.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -153.27 85.76 1.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 71.439999999999998 110.877 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.533 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.15 173.84 26.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 61.509999999999998 112.488 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.32 -164.57 1.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 73.109999999999999 110.942 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 tp -134.01 145.3 49.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 72.319999999999993 110.916 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 47.57 28.88 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 53.420000000000002 110.914 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -168.32 134.64 1.94 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.310000000000002 110.922 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -108.49 160.18 16.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 63.140000000000001 110.852 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 61.219999999999999 110.843 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.505 -0.238 . . . . 64.409999999999997 112.505 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.68 -65.27 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.742 0.305 . . . . 64.0 110.861 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -60.64 139.37 57.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 71.200000000000003 110.954 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.5 p -139.64 115.55 10.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 43.219999999999999 110.811 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.76 154.75 31.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.487 . . . . 65.150000000000006 110.87 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.668 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -144.34 109.63 5.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.010000000000005 110.859 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 52' ' ' LYS . 12.8 mm -92.64 125.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 60.329999999999998 111.094 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 55.6 p -111.06 33.85 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 43.149999999999999 111.141 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.506 ' H ' HG22 ' A' ' 50' ' ' ILE . 3.2 tttt 163.45 131.78 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 60.130000000000003 110.906 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -176.0 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.698 2.266 . . . . 63.310000000000002 112.363 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.409 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -139.04 -35.98 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 72.219999999999999 110.881 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' NH1' ' A' ' 57' ' ' ARG . 1.9 m120 -128.0 38.24 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.899 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.42 -27.86 8.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.685 -0.769 . . . . 74.420000000000002 112.548 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -125.2 173.51 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.348 . . . . 74.209999999999994 110.877 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.412 ' HB2' HG22 ' A' ' 20' ' ' VAL . 12.6 m95 -92.28 94.46 9.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 72.510000000000005 110.898 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.409 HD12 ' HD2' ' A' ' 54' ' ' LYS . 56.2 mt -98.24 141.31 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 63.439999999999998 111.141 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 19.6 t80 -136.52 153.08 51.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 62.25 110.895 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.406 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -143.96 137.28 27.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 74.329999999999998 110.883 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.17 178.41 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 64.430000000000007 110.9 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.89 10.83 2.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 61.229999999999997 110.83 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -125.47 7.38 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 62.420000000000002 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -94.82 103.03 14.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 54.149999999999999 111.097 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -102.42 85.21 2.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 70.219999999999999 111.105 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.975 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -138.56 170.96 15.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 110.904 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.663 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.84 164.56 37.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.885 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.537 HD11 ' O ' ' A' ' 97' ' ' GLY . 26.4 mm -33.01 122.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.310000000000002 111.11 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.4 -29.41 6.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.719 -0.753 . . . . 63.240000000000002 112.509 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.36 -176.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.903 0.382 . . . . 72.230000000000004 110.86 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -143.6 169.36 17.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 110.91 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.3 mt -147.84 145.22 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 64.400000000000006 111.092 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.2 m-85 -148.38 105.25 3.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 110.938 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 2.4 p90 -164.6 -160.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 72.400000000000006 110.905 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.486 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -149.05 155.58 40.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 110.937 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.455 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 5.6 p -124.0 147.37 47.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 61.229999999999997 111.163 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.99 151.07 25.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 60.420000000000002 110.879 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.596 HG13 ' HD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -145.48 169.41 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 71.450000000000003 111.125 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.715 HG13 HD12 ' A' ' 27' ' ' LEU . 69.9 mt -150.26 95.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 111.151 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -112.15 136.6 51.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 71.209999999999994 110.899 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.35 38.79 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 72.150000000000006 110.871 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.9 35.74 59.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 63.409999999999997 112.459 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 mt -97.72 -59.19 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 64.420000000000002 110.951 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.53 105.87 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 54.219999999999999 112.526 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.517 ' HB2' HG23 ' A' ' 79' ' ' VAL . 94.5 m-85 -124.21 178.35 5.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.824 0.345 . . . . 75.030000000000001 110.957 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 tmm_? -178.42 130.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 64.310000000000002 110.903 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -65.29 -171.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.92 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.0 t70 -170.37 -169.8 0.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 62.520000000000003 110.841 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.3 t-20 83.01 -36.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 64.120000000000005 110.864 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.33 75.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 34.539999999999999 112.513 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -168.18 117.49 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.889 0.375 . . . . 73.420000000000002 110.9 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -157.06 118.53 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 71.400000000000006 110.93 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 36.5 m -90.82 142.12 28.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 54.439999999999998 111.153 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.687 HG13 ' HB2' ' A' ' 10' ' ' ALA . 28.2 t -76.35 112.47 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 71.400000000000006 111.154 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -131.52 4.7 4.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.239999999999995 110.923 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.813 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -116.6 -176.53 17.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.777 -0.725 . . . . 43.240000000000002 112.492 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.5 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -156.66 159.89 38.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.371 . . . . 74.439999999999998 110.896 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.64 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.79 -174.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.329999999999998 111.101 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.05 137.68 22.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 43.240000000000002 110.877 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.27 46.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 74.349999999999994 110.892 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 50.130000000000003 111.072 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.541 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 121.597 0.713 . . . . 74.019999999999996 111.06 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.09 25.41 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.666 2.244 . . . . 74.010000000000005 112.33 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 133.47 25.69 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.235 . . . . 65.120000000000005 112.34 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.867 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -82.03 136.6 35.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 70.329999999999998 111.122 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -92.95 77.72 4.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 64.310000000000002 111.141 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.436 HD21 ' CE1' ' A' ' 75' ' ' PHE . 2.0 mp -78.48 108.68 12.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 54.409999999999997 110.927 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.845 ' O ' HD11 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -82.55 -173.47 4.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 71.450000000000003 110.928 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.49 80.75 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 111.096 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 12' ' ' HIS . 2.5 mm -71.72 172.68 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 72.430000000000007 111.134 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.71 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.92 171.63 0.26 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 74.219999999999999 110.823 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.585 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.2 Cg_endo -69.79 19.7 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.628 2.219 . . . . 63.439999999999998 112.361 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 12' ' ' HIS . 12.6 pttt -125.82 22.1 7.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 73.329999999999998 110.861 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 155.67 -178.98 31.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.757 -0.735 . . . . 34.030000000000001 112.506 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.845 HD11 ' O ' ' A' ' 9' ' ' GLU . 19.4 tp -150.46 164.42 35.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 72.109999999999999 110.938 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HB2' HD11 ' A' ' 11' ' ' ILE . 8.5 ttm180 -128.95 136.77 50.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 55.509999999999998 110.839 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -146.34 106.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 72.349999999999994 111.157 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.531 ' HB2' HG23 ' A' ' 59' ' ' ILE . 13.0 t -119.68 157.84 27.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 63.130000000000003 110.83 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.867 HG12 ' HA ' ' A' ' 6' ' ' ALA . 20.6 m -140.86 151.53 63.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.735 . . . . 73.129999999999995 111.125 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 122.16 8.84 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 32.109999999999999 112.325 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -80.51 97.91 7.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.409999999999997 110.838 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.32 12.42 10.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 110.931 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.26 15.68 3.7 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.703 -0.761 . . . . 63.109999999999999 112.46 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 87.5 m-85 -66.49 165.56 14.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 74.310000000000002 110.865 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 t -125.03 -17.24 5.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 71.030000000000001 110.839 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.046 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -153.45 139.67 18.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 73.340000000000003 110.903 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.046 ' N ' HD22 ' A' ' 27' ' ' LEU . 8.0 t80 -132.0 148.63 52.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 63.020000000000003 110.873 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.53 155.12 50.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 65.430000000000007 111.152 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.644 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.6 m-85 -127.94 125.51 39.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 72.109999999999999 110.871 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -149.03 83.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 73.120000000000005 110.83 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.14 173.61 26.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 70.109999999999999 112.496 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.6 -164.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 73.439999999999998 110.925 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 36' ' ' GLU . 21.9 tp -126.49 147.61 49.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 64.310000000000002 110.962 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 34' ' ' LEU . 1.6 m-80 37.04 32.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 110.86 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 34' ' ' LEU . 64.5 tt0 -161.96 134.36 5.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.925 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -106.51 160.43 15.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.200000000000003 110.88 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.411 ' HE1' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 62.140000000000001 110.888 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.482 -0.247 . . . . 55.399999999999999 112.482 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.67 -68.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.322 . . . . 74.239999999999995 110.827 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.594 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 6.0 m0 -58.02 97.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 72.150000000000006 110.925 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.8 p -109.17 105.09 14.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 62.420000000000002 110.874 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.89 162.8 37.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.868 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -144.6 117.22 8.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 110.833 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 52' ' ' LYS . 18.4 mm -97.42 113.04 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 72.420000000000002 111.163 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.6 p -95.9 30.46 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 111.17 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.552 ' H ' HG22 ' A' ' 50' ' ' ILE . 2.8 tttt 173.99 138.62 0.15 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.721 . . . . 61.5 110.937 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -175.47 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.707 2.271 . . . . 73.430000000000007 112.323 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.719 ' HD2' HD12 ' A' ' 59' ' ' ILE . 21.7 ttmm -118.47 -71.56 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 72.140000000000001 110.872 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.07 46.57 2.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 60.310000000000002 110.87 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.67 -35.05 4.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 30.02 112.497 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.78 177.2 6.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 72.340000000000003 110.879 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -93.32 98.65 11.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 75.319999999999993 110.879 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.719 HD12 ' HD2' ' A' ' 54' ' ' LYS . 20.9 mt -103.09 141.0 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 73.420000000000002 111.147 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -135.64 147.1 48.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.914 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 126.83 29.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 110.872 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.594 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -104.06 169.81 8.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 61.130000000000003 110.916 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.2 mtt180 -136.93 20.3 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.0 110.837 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -133.19 14.55 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 74.510000000000005 110.887 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.54 101.86 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 64.129999999999995 111.109 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -98.96 84.23 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 54.149999999999999 111.11 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.764 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -135.89 171.17 14.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 75.519999999999996 110.879 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.757 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.71 158.07 34.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 43.439999999999998 110.959 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.6 mm -31.44 116.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 73.010000000000005 111.11 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.24 -26.1 5.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 74.209999999999994 112.512 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -72.79 -175.62 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 62.25 110.856 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.0 mptt -144.88 163.02 35.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 70.030000000000001 110.902 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 37.3 mt -138.63 143.59 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 62.340000000000003 111.169 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -145.48 105.27 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 110.931 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.546 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 3.9 p90 -165.44 -161.38 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 74.129999999999995 110.853 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.86 174.06 11.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 73.150000000000006 110.877 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 p -141.5 156.45 45.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 72.109999999999999 111.137 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.2 137.79 52.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 70.430000000000007 110.903 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -134.19 166.62 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 73.340000000000003 111.149 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.66 HG13 HD12 ' A' ' 27' ' ' LEU . 91.7 mt -142.44 95.9 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 63.229999999999997 111.138 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -116.44 147.51 41.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 71.329999999999998 110.919 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.05 27.8 1.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 62.100000000000001 110.884 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.77 30.94 70.27 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.734 -0.746 . . . . 53.409999999999997 112.464 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.17 -73.14 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.803 0.335 . . . . 61.219999999999999 110.93 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.94 117.21 2.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 73.120000000000005 112.505 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.656 ' HB2' HG23 ' A' ' 79' ' ' VAL . 76.7 m-85 -128.08 170.76 12.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.95 0.405 . . . . 72.430000000000007 110.911 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -159.05 139.0 11.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 71.299999999999997 110.884 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.541 ' OE1' ' HB3' ' A' ' 3' ' ' ALA . 2.9 tp60 -80.78 160.93 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 75.329999999999998 110.908 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 6.1 m-20 -145.49 -173.45 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 110.876 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 85.11 -32.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 63.149999999999999 110.894 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 33.47 81.91 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 72.319999999999993 112.512 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -172.48 110.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 72.239999999999995 110.909 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -153.22 105.89 2.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 110.943 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.3 m -76.3 136.39 39.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 74.329999999999998 111.122 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.757 HG13 ' HB2' ' A' ' 10' ' ' ALA . 45.6 t -64.82 109.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 75.329999999999998 111.128 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -128.6 5.2 5.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.219999999999999 110.89 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.825 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -115.64 -178.64 18.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 74.019999999999996 112.498 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.497 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.96 155.87 33.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 75.310000000000002 110.881 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.684 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.58 -177.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 72.25 111.142 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -139.45 132.0 28.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 70.099999999999994 110.865 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -76.06 54.98 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 63.310000000000002 110.913 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 70.129999999999995 111.083 179.928 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 79' ' ' VAL . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.596 0.713 . . . . 65.209999999999994 111.063 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 169.68 18.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 72.200000000000003 112.354 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.444 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 53.7 Cg_endo -69.78 134.79 28.79 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.256 . . . . 72.219999999999999 112.362 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.883 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -83.32 137.46 33.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 74.019999999999996 111.148 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -96.5 77.43 2.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 74.099999999999994 111.141 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.568 HD21 ' CE1' ' A' ' 75' ' ' PHE . 1.9 mp -76.81 110.13 11.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.437 . . . . 75.010000000000005 110.953 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.846 ' O ' HD11 ' A' ' 16' ' ' LEU . 28.9 mp0 -83.01 -173.24 4.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.230000000000004 110.857 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.664 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -131.12 80.29 1.93 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 71.010000000000005 111.115 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.753 HD13 ' CG2' ' A' ' 99' ' ' VAL . 2.9 mm -70.23 172.42 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 73.239999999999995 111.126 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.698 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.92 172.04 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.581 0.705 . . . . 75.010000000000005 110.841 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.5 Cg_endo -69.77 20.12 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.674 2.249 . . . . 64.310000000000002 112.368 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' HIS . 39.9 pttt -125.76 21.71 7.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 44.219999999999999 110.895 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.4 -178.11 32.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.784 -0.722 . . . . 74.120000000000005 112.518 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.846 HD11 ' O ' ' A' ' 9' ' ' GLU . 23.1 tp -150.08 164.57 35.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 71.299999999999997 110.862 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.664 ' HB2' HD11 ' A' ' 11' ' ' ILE . 51.7 ttt180 -130.2 140.59 50.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 70.120000000000005 110.901 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 8' ' ' LEU . 45.0 t -148.58 111.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 52.530000000000001 111.084 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 t -122.57 156.17 34.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.85 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.883 HG12 ' HA ' ' A' ' 6' ' ' ALA . 29.9 m -140.06 152.17 66.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.671 0.748 . . . . 65.439999999999998 111.102 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 121.39 8.08 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.672 2.248 . . . . 74.219999999999999 112.355 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -76.3 105.89 7.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 61.340000000000003 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.47 34.67 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 62.530000000000001 110.855 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.66 1.48 52.87 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.731 -0.747 . . . . 55.039999999999999 112.494 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.491 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 74.3 m-85 -54.05 164.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 75.120000000000005 110.881 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 t -127.08 -11.8 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 110.885 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.05 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -158.73 138.49 11.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 73.230000000000004 110.914 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.05 ' N ' HD22 ' A' ' 27' ' ' LEU . 7.3 t80 -130.89 146.01 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 63.039999999999999 110.88 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.445 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . . . -129.53 158.39 39.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 72.109999999999999 111.071 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.668 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 1.8 m-85 -132.81 127.85 35.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 71.030000000000001 110.902 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -157.35 86.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 73.140000000000001 110.854 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -144.8 175.02 24.69 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 53.409999999999997 112.523 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.29 -166.68 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 61.520000000000003 110.919 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.708 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -129.93 124.64 33.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 70.310000000000002 110.912 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.595 ' ND2' HD12 ' A' ' 34' ' ' LEU . 67.9 m-80 62.05 23.54 13.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 64.239999999999995 110.875 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -155.93 144.13 19.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 71.140000000000001 110.893 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -112.73 169.05 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 63.509999999999998 110.853 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.551 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 74.230000000000004 110.853 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.514 -0.234 . . . . 15.109999999999999 112.514 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.49 -63.09 1.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.343 . . . . 72.5 110.836 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.708 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.4 m-90 -61.15 155.33 20.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 71.310000000000002 110.9 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.2 p -158.45 109.53 2.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 75.540000000000006 110.867 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.37 160.3 38.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 61.340000000000003 110.861 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.531 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -144.09 107.22 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 72.319999999999993 110.913 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.1 mm -86.75 106.66 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 74.010000000000005 111.137 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.0 p -96.01 29.93 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 74.439999999999998 111.145 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -176.85 113.66 0.25 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.628 0.727 . . . . 73.219999999999999 110.871 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.514 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 53.9 Cg_endo -69.76 -178.23 2.24 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.677 2.252 . . . . 73.239999999999995 112.321 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -174.33 136.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.019999999999996 110.893 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 2.6 t30 82.48 7.88 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 71.310000000000002 110.937 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' CD ' ' A' ' 57' ' ' ARG . . . 100.0 -6.73 58.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 74.010000000000005 112.51 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.418 ' CD ' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -153.27 174.2 14.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 73.120000000000005 110.883 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.514 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 14.6 m95 -90.35 106.24 18.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.219999999999999 110.935 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.5 146.63 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 74.319999999999993 111.13 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -143.43 149.06 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 65.519999999999996 110.913 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 133.1 28.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 110.883 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.72 -178.49 3.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 64.040000000000006 110.855 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.56 20.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.867 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -134.89 14.56 3.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 74.319999999999993 110.908 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.36 107.25 18.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 51.520000000000003 111.112 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -103.47 79.7 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 111.069 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.734 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -126.65 171.6 11.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 110.944 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.707 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.09 154.43 27.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 71.239999999999995 110.893 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.501 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.7 mm -29.61 123.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 73.530000000000001 111.096 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.54 7.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 61.43 112.499 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.73 -176.89 1.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.927 0.394 . . . . 63.140000000000001 110.808 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -142.2 166.6 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 75.400000000000006 110.919 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.501 HG12 HD22 ' A' ' 34' ' ' LEU . 87.4 mt -142.96 145.27 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 63.140000000000001 111.125 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -147.5 103.32 3.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 110.937 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.568 ' CE1' HD21 ' A' ' 8' ' ' LEU . 1.4 p90 -162.29 -162.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 74.150000000000006 110.927 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.551 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -150.64 149.77 30.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 110.896 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.537 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 7.0 p -119.76 145.87 46.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 62.32 111.132 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -103.84 150.5 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 75.420000000000002 110.896 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -143.28 166.92 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 65.040000000000006 111.112 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.629 HG13 HD12 ' A' ' 27' ' ' LEU . 85.7 mt -145.61 96.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 50.340000000000003 111.143 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -115.14 137.31 52.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 63.149999999999999 110.854 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 42.92 41.16 2.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 65.329999999999998 110.897 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.08 37.27 36.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.746 -0.74 . . . . 74.140000000000001 112.535 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 mt -98.18 -55.79 2.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 53.210000000000001 110.913 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.79 105.23 1.63 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 60.310000000000002 112.447 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.538 ' HB2' HG23 ' A' ' 79' ' ' VAL . 99.0 m-85 -130.1 176.16 8.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 75.150000000000006 110.929 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.451 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -176.77 136.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 64.049999999999997 110.907 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' A' ' 5' ' ' PRO . 1.4 tp60 -73.42 163.53 27.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 71.519999999999996 110.878 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -145.94 -169.92 3.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.519999999999996 110.849 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.6 t-20 83.46 -33.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 73.150000000000006 110.884 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.73 84.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 73.540000000000006 112.468 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -170.13 116.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.822 0.344 . . . . 53.340000000000003 110.888 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.8 m-90 -157.84 109.57 2.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.194 -0.457 . . . . 75.420000000000002 110.938 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.6 m -81.59 138.91 35.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 65.340000000000003 111.138 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.664 HG13 ' HB2' ' A' ' 10' ' ' ALA . 22.4 t -70.11 110.58 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.430000000000007 111.083 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -131.76 4.32 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 63.219999999999999 110.887 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -113.95 -176.39 19.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 60.420000000000002 112.51 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.473 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -158.36 155.2 28.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.888 0.375 . . . . 73.329999999999998 110.895 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.753 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.51 175.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 53.409999999999997 111.136 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -139.1 127.64 23.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 75.120000000000005 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -80.22 54.6 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 73.439999999999998 110.898 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 74.510000000000005 111.081 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.082 0 CA-C-O 121.571 0.7 . . . . 61.329999999999998 111.069 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 167.61 23.97 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.644 2.229 . . . . 73.219999999999999 112.315 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 136.35 32.78 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.685 2.256 . . . . 61.109999999999999 112.32 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.889 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -89.65 137.27 32.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 63.200000000000003 111.132 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m -95.94 77.07 3.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 42.009999999999998 111.153 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.506 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.5 mp -75.71 108.39 8.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 61.210000000000001 110.913 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.842 ' O ' HD11 ' A' ' 16' ' ' LEU . 10.3 mm-40 -79.93 -172.54 3.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 62.340000000000003 110.835 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.63 80.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.030000000000001 111.104 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 17' ' ' ARG . 3.2 mm -71.01 172.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 65.510000000000005 111.152 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.687 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -54.2 172.32 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.574 0.702 . . . . 62.240000000000002 110.898 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.74 20.39 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.664 2.243 . . . . 75.25 112.347 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' HIS . 1.8 pttt -125.58 22.26 7.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 72.420000000000002 110.864 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.49 -177.42 31.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.697 -0.763 . . . . 44.020000000000003 112.464 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.842 HD11 ' O ' ' A' ' 9' ' ' GLU . 20.7 tp -149.47 161.73 41.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 74.439999999999998 110.93 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.76 ' HB2' HD11 ' A' ' 11' ' ' ILE . 18.0 ttm180 -125.51 137.8 53.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 110.862 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 8' ' ' LEU . 77.0 t -147.69 110.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 61.340000000000003 111.122 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 59' ' ' ILE . 11.0 t -120.32 154.28 35.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 71.430000000000007 110.882 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.899 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 34.1 m -141.64 152.65 63.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.639 0.733 . . . . 74.319999999999993 111.116 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 122.09 8.77 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.664 2.243 . . . . 65.239999999999995 112.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 1.1 t70 -76.99 107.56 9.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 72.310000000000002 110.874 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.451 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -95.21 30.01 2.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 73.530000000000001 110.9 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.6 20.9 27.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 75.409999999999997 112.495 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 94.9 m-85 -68.13 167.56 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 74.140000000000001 110.888 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.8 t -128.95 -8.5 4.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.349999999999994 110.851 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.998 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -156.02 143.07 19.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 65.109999999999999 110.967 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.998 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -139.68 148.4 42.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 55.049999999999997 110.878 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.0 136.64 35.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.340000000000003 111.102 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -118.52 120.54 37.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.907 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -148.85 92.05 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 73.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.466 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.11 172.06 26.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 73.340000000000003 112.46 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.34 -164.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 70.109999999999999 110.885 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.632 HD21 ' OD2' ' A' ' 71' ' ' ASP . 7.9 tp -136.21 142.49 44.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 73.010000000000005 110.925 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 54.22 25.38 5.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 73.319999999999993 110.866 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -167.53 141.22 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.932 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -113.63 160.52 18.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 63.119999999999997 110.887 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.573 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 64.230000000000004 110.901 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.487 -0.245 . . . . 34.119999999999997 112.487 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.32 -63.31 1.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 64.430000000000007 110.873 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.7 m0 -66.51 146.95 53.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 74.319999999999993 110.904 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.3 p -146.51 112.27 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 73.129999999999995 110.862 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.14 162.14 41.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.230000000000004 110.877 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.48 117.35 8.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.239999999999995 110.889 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -98.97 107.12 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 65.310000000000002 111.127 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 60.7 p -101.01 32.4 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 53.109999999999999 111.136 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 51' ' ' THR . 14.6 mttt 164.32 135.83 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 73.230000000000004 110.919 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -175.65 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.732 2.288 . . . . 42.020000000000003 112.34 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.06 14.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.140000000000001 110.896 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -179.35 33.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 75.140000000000001 110.895 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 57' ' ' ARG . . . 87.94 -17.13 48.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 70.239999999999995 112.468 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -136.57 167.62 21.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 74.140000000000001 110.893 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.515 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 11.2 m95 -92.61 92.82 8.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 71.219999999999999 110.856 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.585 HG23 ' HB2' ' A' ' 19' ' ' SER . 12.0 mt -95.76 138.48 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 75.540000000000006 111.14 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -126.77 148.68 49.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.881 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 135.07 27.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 72.239999999999995 110.873 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -113.76 177.22 4.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 63.140000000000001 110.853 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.84 12.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 110.835 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.62 5.73 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 71.200000000000003 110.936 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.81 101.95 14.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 54.399999999999999 111.1 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -99.96 86.67 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 63.210000000000001 111.124 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.858 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -137.42 170.79 15.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 64.120000000000005 110.912 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.858 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -154.82 158.35 39.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 65.409999999999997 110.852 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.577 HD11 ' O ' ' A' ' 97' ' ' GLY . 10.3 mm -30.93 124.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 64.25 111.137 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.14 -30.04 6.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.744 -0.741 . . . . 53.200000000000003 112.515 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.632 ' OD2' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -63.29 -171.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 52.450000000000003 110.87 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.8 mptt -150.03 159.27 44.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.030000000000001 110.926 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 97.5 mt -133.15 147.39 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 70.329999999999998 111.133 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -148.98 103.09 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 75.450000000000003 110.905 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 1.1 p90 -162.35 -161.46 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.497 . . . . 74.319999999999993 110.874 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.573 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -150.72 144.89 25.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 75.129999999999995 110.926 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.498 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 3.3 p -112.83 151.85 29.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 71.450000000000003 111.14 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.12 144.89 46.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 60.32 110.897 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.507 ' CG1' ' CD2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -144.52 172.68 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 33.149999999999999 111.133 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.754 HG13 HD12 ' A' ' 27' ' ' LEU . 84.1 mt -148.14 96.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 45.25 111.14 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.585 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -113.44 138.33 50.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 72.329999999999998 110.86 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 43.01 38.9 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.906 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.91 37.88 45.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.723 -0.751 . . . . 52.329999999999998 112.463 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.64 -53.13 3.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 61.509999999999998 110.942 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 104.68 1.68 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 70.340000000000003 112.494 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -124.8 166.03 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.382 . . . . 75.319999999999993 110.926 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.498 ' CG ' ' O ' ' A' ' 77' ' ' THR . 7.1 ttp180 -174.15 136.56 0.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 72.230000000000004 110.85 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -75.65 168.78 19.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 73.420000000000002 110.906 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.7 t0 -152.94 -176.3 5.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 73.430000000000007 110.896 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 83.82 -26.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.340000000000003 110.886 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 34.74 87.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 71.430000000000007 112.493 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -172.01 110.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.845 0.355 . . . . 63.140000000000001 110.91 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -150.63 115.91 5.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 71.319999999999993 110.896 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 92.6 m -87.04 136.19 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 64.439999999999998 111.138 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.826 HG13 ' HB2' ' A' ' 10' ' ' ALA . 45.4 t -67.58 118.36 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 73.200000000000003 111.099 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -134.16 0.89 3.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 73.340000000000003 110.884 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.832 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -117.75 -177.74 17.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 71.109999999999999 112.468 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.52 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -154.78 155.69 34.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 65.510000000000005 110.891 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.714 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.79 169.81 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 72.450000000000003 111.155 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -132.42 139.77 48.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 60.310000000000002 110.889 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.53 45.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 63.420000000000002 110.907 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.486 ' N ' ' OD1' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 44.439999999999998 111.111 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.566 0.698 . . . . 73.540000000000006 111.097 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 164.36 34.81 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.743 2.295 . . . . 73.239999999999995 112.314 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 134.34 27.62 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.674 2.249 . . . . 71.150000000000006 112.313 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.669 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -84.38 139.6 32.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 71.019999999999996 111.105 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.6 m -92.72 77.44 4.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 75.409999999999997 111.165 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.456 HD23 HG21 ' A' ' 18' ' ' VAL . 1.5 mp -78.34 111.76 14.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 62.240000000000002 110.92 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.475 ' CB ' HG21 ' A' ' 99' ' ' VAL . 4.3 mm-40 -86.7 -158.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.230000000000004 110.903 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.838 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -143.08 81.2 1.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 61.450000000000003 111.096 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 12' ' ' HIS . 6.6 mm -71.0 172.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 63.149999999999999 111.143 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.71 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.08 172.2 0.24 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.595 0.712 . . . . 64.340000000000003 110.832 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.4 Cg_endo -69.76 20.31 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.681 2.254 . . . . 73.329999999999998 112.339 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 42.3 pttt -130.08 27.8 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 64.409999999999997 110.908 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.66 -178.84 30.4 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 73.400000000000006 112.442 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.824 HD13 HD11 ' A' ' 67' ' ' LEU . 19.3 tp -152.83 166.22 32.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 74.439999999999998 110.896 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.696 ' HB2' HD11 ' A' ' 11' ' ' ILE . 35.1 ttt180 -130.31 141.39 50.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.875 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.456 HG21 HD23 ' A' ' 8' ' ' LEU . 77.3 t -153.12 103.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 111.138 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.4 t -114.93 159.82 20.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.099999999999994 110.858 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 6' ' ' ALA . 26.7 m -139.55 151.63 66.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.604 0.716 . . . . 53.32 111.17 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 121.99 8.69 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.671 2.247 . . . . 72.150000000000006 112.338 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -80.19 101.33 8.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 62.329999999999998 110.871 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -96.01 28.13 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 65.299999999999997 110.864 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.27 16.51 13.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.762 -0.732 . . . . 73.230000000000004 112.533 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 92.1 m-85 -67.08 164.82 17.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 63.32 110.929 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.6 t -127.98 -9.55 5.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 73.040000000000006 110.87 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.028 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -158.97 139.97 12.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 110.894 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.028 ' N ' HD22 ' A' ' 27' ' ' LEU . 19.3 t80 -134.16 152.49 51.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.319999999999993 110.881 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.35 163.29 30.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 74.219999999999999 111.104 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.5 t80 -148.22 113.28 5.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 55.350000000000001 110.856 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.59 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -147.28 95.15 2.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 73.540000000000006 110.859 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.09 -174.14 17.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.729 -0.748 . . . . 63.100000000000001 112.509 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.408 ' O ' ' CZ3' ' A' ' 46' ' ' TRP . 3.0 mtpp -134.74 -164.27 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 73.219999999999999 110.911 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.523 HD11 ' OD2' ' A' ' 71' ' ' ASP . 1.7 tp -140.24 140.18 35.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 72.310000000000002 110.889 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.505 ' ND2' ' HG ' ' A' ' 34' ' ' LEU . 3.1 m120 51.26 21.59 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.209999999999994 110.848 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -156.39 123.51 5.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 74.230000000000004 110.877 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -94.86 140.66 29.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 73.230000000000004 110.884 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.2 ptp . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 75.340000000000003 110.879 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 N-CA-C 112.493 -0.243 . . . . 70.239999999999995 112.493 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -104.24 -62.72 1.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.733 0.302 . . . . 71.209999999999994 110.885 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.514 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 9.1 m0 -60.87 155.09 20.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 73.239999999999995 110.926 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.59 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 53.1 p -160.99 114.43 2.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 74.409999999999997 110.879 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -156.76 149.24 23.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 63.509999999999998 110.842 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -139.5 102.32 4.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 74.120000000000005 110.887 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 52' ' ' LYS . 8.7 mm -90.26 117.77 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 62.350000000000001 111.098 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.415 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 17.2 p -103.34 34.34 2.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 74.420000000000002 111.163 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 50' ' ' ILE . 3.3 mtpt 167.07 137.46 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.55 0.691 . . . . 72.010000000000005 110.865 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -175.6 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.66 2.24 . . . . 73.0 112.358 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HG3' ' N ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -139.39 -35.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 110.859 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.429 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 1.4 t30 -137.25 51.76 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.430000000000007 110.906 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.18 -29.43 4.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 52.420000000000002 112.513 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.92 171.23 11.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 74.230000000000004 110.846 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.442 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 6.0 m95 -90.12 89.73 7.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 75.430000000000007 110.957 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.3 mt -92.47 138.14 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 64.049999999999997 111.117 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -132.35 146.61 52.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.409999999999997 110.892 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.84 127.55 23.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 110.903 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -99.78 -178.46 3.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.92 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.38 26.4 1.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 74.010000000000005 110.9 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -149.44 28.24 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 72.230000000000004 110.865 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . . . -113.52 84.92 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 43.25 111.137 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -82.09 93.76 7.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 63.100000000000001 111.092 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.892 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -148.33 169.33 20.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.030000000000001 110.948 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.892 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.04 164.55 38.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 75.310000000000002 110.939 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 98' ' ' PHE . 9.4 mm -34.78 118.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.019999999999996 111.147 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.22 -28.92 5.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.769 -0.729 . . . . 61.409999999999997 112.485 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.523 ' OD2' HD11 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -67.96 -178.16 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 73.010000000000005 110.865 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.2 mttt -141.22 167.66 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.200000000000003 110.885 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.3 mt -144.85 149.37 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 54.340000000000003 111.116 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -151.96 108.54 3.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 74.310000000000002 110.902 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.48 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -165.72 -168.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 75.340000000000003 110.88 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.6 p-90 -135.28 162.75 31.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 71.040000000000006 110.94 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.6 p -134.89 146.4 49.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 64.450000000000003 111.126 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.46 149.01 28.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.319999999999993 110.872 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.55 HG13 ' HD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -148.94 165.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 74.310000000000002 111.157 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.715 HG13 HD12 ' A' ' 27' ' ' LEU . 41.1 mt -148.38 96.24 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.151 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 23.5 tttt -113.18 138.43 49.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 71.230000000000004 110.857 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.82 28.89 3.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 75.329999999999998 110.866 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.71 27.5 66.53 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 64.409999999999997 112.491 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.65 -50.97 4.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 63.450000000000003 110.906 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.56 125.85 3.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 72.140000000000001 112.492 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -143.07 -179.67 6.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 75.319999999999993 110.923 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 77' ' ' THR . 1.2 ttp180 -177.46 136.48 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 70.439999999999998 110.911 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -78.21 166.02 23.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 74.030000000000001 110.925 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.1 t0 -147.22 -165.86 2.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 65.040000000000006 110.852 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 2.5 t-20 83.59 -33.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 44.399999999999999 110.895 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 39.04 74.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.746 . . . . 41.530000000000001 112.484 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -167.7 112.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 54.149999999999999 110.867 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -152.33 122.57 7.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 73.010000000000005 110.945 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.1 m -94.08 145.23 24.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 74.439999999999998 111.16 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.838 HG13 ' HB2' ' A' ' 10' ' ' ALA . 62.7 t -75.24 129.7 36.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 63.350000000000001 111.124 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -154.79 23.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.049999999999997 110.888 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -155.62 111.28 0.48 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.786 -0.721 . . . . 54.240000000000002 112.499 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.578 ' CD2' HG12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -82.34 170.39 15.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 72.409999999999997 110.871 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.556 HG22 ' C ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -167.34 -178.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.329999999999998 111.137 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.26 139.1 37.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.472 . . . . 74.409999999999997 110.857 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -87.2 44.71 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 53.340000000000003 110.845 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.430000000000007 111.089 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.153 0 CA-C-O 121.574 0.702 . . . . 72.150000000000006 111.109 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 161.01 47.58 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.733 2.288 . . . . 74.200000000000003 112.313 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 134.84 28.95 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.709 2.273 . . . . 63.32 112.342 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.937 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -90.52 139.68 30.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 61.240000000000002 111.061 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.5 m -93.16 77.3 4.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 52.109999999999999 111.113 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.11 107.38 10.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 64.150000000000006 110.913 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.527 ' O ' HD11 ' A' ' 16' ' ' LEU . 1.2 mm-40 -80.92 -156.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 71.150000000000006 110.935 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.814 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -143.1 80.21 1.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 53.119999999999997 111.082 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.703 HG22 ' H ' ' A' ' 12' ' ' HIS . 4.1 mm -70.64 172.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 111.079 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.703 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -54.19 172.0 0.25 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 73.400000000000006 110.835 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.9 Cg_endo -69.77 21.05 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.661 2.241 . . . . 52.119999999999997 112.336 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 12' ' ' HIS . 10.6 ptmt -126.79 20.71 7.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.907 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.64 -176.81 33.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 75.340000000000003 112.514 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.787 HD13 HD11 ' A' ' 67' ' ' LEU . 22.2 tp -151.13 163.57 38.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 74.239999999999995 110.924 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.656 ' HB2' HD11 ' A' ' 11' ' ' ILE . 69.0 ttt180 -126.77 137.32 53.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 110.861 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.44 HG12 ' HE2' ' A' ' 30' ' ' PHE . 69.7 t -148.26 102.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 70.329999999999998 111.091 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.547 ' HB2' HG23 ' A' ' 59' ' ' ILE . 19.6 t -114.49 157.07 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 73.109999999999999 110.902 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 6' ' ' ALA . 17.8 m -140.81 151.51 63.11 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.616 0.722 . . . . 75.239999999999995 111.077 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 123.37 10.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.639 2.226 . . . . 73.5 112.327 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 4.7 t70 -79.94 133.38 36.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 64.010000000000005 110.885 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -123.88 12.86 9.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 73.319999999999993 110.838 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.68 4.94 8.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 74.439999999999998 112.42 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 68.5 m-85 -54.28 163.02 0.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 65.109999999999999 110.878 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.9 t -130.01 -7.67 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.869 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.994 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -157.3 143.71 18.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 54.409999999999997 110.966 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.994 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -139.59 143.65 37.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 54.049999999999997 110.889 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.91 123.03 22.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 61.119999999999997 111.12 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.44 ' HE2' HG12 ' A' ' 18' ' ' VAL . 3.0 m-85 -109.84 113.98 27.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 74.019999999999996 110.863 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 47' ' ' SER . 0.2 OUTLIER -142.27 95.29 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 110.879 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -146.31 -178.55 21.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 73.120000000000005 112.477 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.0 -168.27 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.341 . . . . 62.409999999999997 110.881 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' CG ' ' A' ' 35' ' ' ASN . 4.4 tp -134.85 146.73 49.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 55.350000000000001 110.906 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.451 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 2.4 m120 42.73 27.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.883 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -159.46 130.39 5.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 54.43 110.857 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -97.23 144.13 27.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 64.510000000000005 110.886 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.1 ptp . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 63.340000000000003 110.918 179.934 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.498 -0.241 . . . . 30.300000000000001 112.498 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.38 -60.95 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 74.230000000000004 110.86 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.462 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 7.4 m0 -60.28 165.91 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 110.91 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 6.9 t -164.38 122.34 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 72.540000000000006 110.863 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 49' ' ' ASP . 3.2 tpm_? -159.67 145.02 15.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 64.209999999999994 110.877 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.464 ' N ' ' HG3' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -130.75 82.41 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 71.340000000000003 110.831 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 28' ' ' PHE . 2.7 mm -71.92 110.72 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 64.0 111.162 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.458 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 82.4 p -104.69 34.05 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 71.209999999999994 111.136 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 51' ' ' THR . 37.7 tttt 163.97 137.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.546 0.688 . . . . 41.329999999999998 110.925 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -175.87 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.715 2.277 . . . . 64.239999999999995 112.324 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.727 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -134.25 -34.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 60.210000000000001 110.9 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -139.85 51.66 1.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 54.149999999999999 110.895 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.07 -27.78 4.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.75 -0.738 . . . . 53.020000000000003 112.482 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 169.27 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.331 . . . . 75.140000000000001 110.867 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 10.7 m95 -92.09 90.79 7.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.919 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.727 HD12 ' HD2' ' A' ' 54' ' ' LYS . 27.0 mt -96.17 138.2 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 75.150000000000006 111.178 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -130.34 151.98 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 72.530000000000001 110.873 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.27 135.44 28.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.549999999999997 110.891 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.6 OUTLIER -108.53 -179.41 3.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 63.399999999999999 110.895 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -145.26 11.67 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 42.119999999999997 110.866 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -129.84 12.31 5.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 62.329999999999998 110.874 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.32 94.84 6.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 111.072 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -94.35 75.33 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 64.340000000000003 111.089 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.787 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -123.81 171.36 9.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 61.32 110.91 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.693 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.16 156.7 31.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 64.129999999999995 110.873 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.72 HD13 HG12 ' A' ' 95' ' ' VAL . 18.0 mm -30.34 121.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 64.010000000000005 111.135 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.33 -29.46 6.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 22.129999999999999 112.48 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.41 -179.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 74.310000000000002 110.856 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 1.1 mtmt -144.85 153.71 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 75.519999999999996 110.923 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.1 mt -128.43 141.25 47.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 72.109999999999999 111.145 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -140.96 99.08 3.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 74.510000000000005 110.968 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.519 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -159.85 -160.07 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 74.099999999999994 110.822 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -148.29 177.7 9.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 71.0 110.911 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -144.45 153.95 42.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 64.510000000000005 111.149 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -118.23 136.44 53.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 54.439999999999998 110.899 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.77 167.58 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 73.319999999999993 111.101 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.641 HG13 HD12 ' A' ' 27' ' ' LEU . 78.4 mt -146.01 96.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 74.329999999999998 111.116 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 18.6 tttt -114.27 141.43 47.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 55.530000000000001 110.898 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.441 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 2.5 m-20 44.91 38.23 2.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 73.239999999999995 110.874 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.52 35.35 44.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 74.209999999999994 112.481 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.44 HD13 ' OH ' ' A' ' 86' ' ' TYR . 14.9 mt -100.51 -71.25 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.876 0.369 . . . . 74.319999999999993 110.947 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.49 106.41 2.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 74.319999999999993 112.487 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.44 ' OH ' HD13 ' A' ' 84' ' ' LEU . 44.7 m-85 -120.57 171.84 8.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 75.230000000000004 110.909 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -174.38 138.47 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 73.150000000000006 110.86 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -85.98 153.71 21.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 74.299999999999997 110.885 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -136.82 -163.18 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 65.340000000000003 110.903 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.2 t-20 82.23 -39.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 74.310000000000002 110.89 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.57 76.44 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 52.200000000000003 112.454 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -172.8 113.22 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 74.400000000000006 110.862 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -152.43 110.88 3.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.103 -0.499 . . . . 64.230000000000004 110.922 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 97.1 m -82.37 136.16 35.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 54.310000000000002 111.149 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.793 HG13 ' HB2' ' A' ' 10' ' ' ALA . 39.3 t -67.27 110.32 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 70.129999999999995 111.135 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -128.94 17.82 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.040000000000006 110.911 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.814 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -133.92 -178.26 15.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 71.340000000000003 112.475 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.429 ' C ' HG22 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -152.8 157.57 40.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.362 . . . . 73.540000000000006 110.894 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.69 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.81 164.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 73.540000000000006 111.143 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -129.81 131.08 46.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 61.100000000000001 110.858 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -85.68 51.43 2.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 74.319999999999993 110.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 43.200000000000003 111.116 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.576 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.589 0.709 . . . . 63.229999999999997 111.085 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 167.39 24.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.715 2.277 . . . . 73.120000000000005 112.312 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 133.99 27.02 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.645 2.23 . . . . 62.009999999999998 112.361 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.737 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -86.51 137.83 32.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 74.030000000000001 111.105 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -93.99 77.15 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 63.140000000000001 111.159 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.401 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.8 mp -77.4 107.98 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 65.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.845 ' O ' HD11 ' A' ' 16' ' ' LEU . 43.9 mm-40 -80.34 -173.28 3.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 63.329999999999998 110.892 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.859 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.76 81.49 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 65.439999999999998 111.094 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.753 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.2 mm -72.01 172.49 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 62.229999999999997 111.146 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.697 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.16 172.03 0.25 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.584 0.707 . . . . 74.200000000000003 110.897 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.3 Cg_endo -69.72 20.15 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.639 2.226 . . . . 61.329999999999998 112.35 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.0 OUTLIER -125.92 21.71 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 60.539999999999999 110.943 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 155.38 -178.02 32.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 71.430000000000007 112.481 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.899 HD13 HD11 ' A' ' 67' ' ' LEU . 21.9 tp -150.24 167.74 26.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 60.020000000000003 110.961 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.593 ' HB2' HD11 ' A' ' 11' ' ' ILE . 2.1 ttt180 -132.83 139.24 47.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.299999999999997 110.857 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.413 HG21 ' HE2' ' A' ' 30' ' ' PHE . 70.4 t -148.52 108.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 54.100000000000001 111.125 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -119.85 157.94 27.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 63.119999999999997 110.857 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.737 HG12 ' HA ' ' A' ' 6' ' ' ALA . 17.2 m -139.99 149.35 58.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 71.140000000000001 111.149 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 122.19 8.87 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.707 2.271 . . . . 72.230000000000004 112.354 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 22.8 t70 -88.45 97.26 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 72.340000000000003 110.86 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.75 0.21 40.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 54.130000000000003 110.879 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 138.41 30.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 61.520000000000003 112.47 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 82.2 m-85 -82.28 167.96 18.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.804 0.335 . . . . 75.409999999999997 110.936 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.5 t -127.19 -10.89 5.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 65.430000000000007 110.846 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.999 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -153.32 142.72 21.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 72.439999999999998 110.916 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.999 ' N ' HD22 ' A' ' 27' ' ' LEU . 18.3 t80 -139.13 144.32 38.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 75.510000000000005 110.93 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.69 163.68 23.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 72.540000000000006 111.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.451 ' C ' ' CD1' ' A' ' 30' ' ' PHE . 4.4 t80 -151.04 114.42 4.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.89 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.4 OUTLIER -147.57 95.26 2.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 73.430000000000007 110.859 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.07 -174.27 18.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 65.319999999999993 112.466 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.464 ' CE ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -135.92 -165.45 1.71 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.792 0.33 . . . . 70.230000000000004 110.863 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.754 HD12 ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -132.36 127.24 35.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 74.510000000000005 110.935 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.754 ' ND2' HD12 ' A' ' 34' ' ' LEU . 67.2 m-80 56.45 34.13 23.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.866 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG2' ' CE ' ' A' ' 33' ' ' LYS . 5.6 tp10 -155.56 131.52 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 73.239999999999995 110.903 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -98.59 140.65 32.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 73.019999999999996 110.856 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 1.3 mtt . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 74.25 110.873 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.454 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.501 -0.24 . . . . 50.549999999999997 112.501 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.9 -55.3 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.831 0.348 . . . . 71.530000000000001 110.89 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.706 ' HH2' HD23 ' A' ' 34' ' ' LEU . 6.5 m0 -68.4 173.16 5.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 110.91 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.543 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 95.3 p -176.84 118.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 73.540000000000006 110.851 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.39 162.2 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.230000000000004 110.848 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.682 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -144.46 106.55 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 75.409999999999997 110.883 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.482 ' N ' ' O ' ' A' ' 28' ' ' PHE . 36.5 mm -90.27 105.13 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 71.239999999999995 111.121 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.754 HG22 HD23 ' A' ' 27' ' ' LEU . 32.3 p -102.42 34.42 2.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 45.299999999999997 111.156 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.5 124.53 0.11 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.593 0.711 . . . . 74.209999999999994 110.857 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 165.6 30.46 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.267 . . . . 75.439999999999998 112.346 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.93 -17.7 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.882 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -149.75 43.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 73.420000000000002 110.903 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.42 -16.64 12.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.712 -0.756 . . . . 61.509999999999998 112.555 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -133.57 164.66 26.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.826 0.346 . . . . 75.049999999999997 110.88 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.481 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 12.2 m95 -88.18 96.16 10.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 75.099999999999994 110.931 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.415 HG22 ' HD2' ' A' ' 61' ' ' ARG . 16.0 mt -99.47 142.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 72.230000000000004 111.121 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -133.56 144.91 49.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 70.409999999999997 110.926 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HD2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -136.59 127.74 27.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 74.450000000000003 110.847 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.42 -178.62 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 110.891 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -148.85 17.42 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 74.519999999999996 110.889 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -135.89 14.44 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.430000000000007 110.886 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.62 109.54 21.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 71.219999999999999 111.136 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -105.94 87.91 2.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 62.32 111.069 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.899 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -139.87 170.95 14.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 53.299999999999997 110.904 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.67 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.55 161.79 38.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 70.549999999999997 110.871 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.592 HG13 ' CE2' ' A' ' 98' ' ' PHE . 11.8 mm -33.28 120.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 73.109999999999999 111.138 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.84 -29.89 5.46 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.734 -0.746 . . . . 63.229999999999997 112.464 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.98 177.96 2.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 74.439999999999998 110.86 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -138.55 162.02 35.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 71.329999999999998 110.907 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.744 HG12 HD22 ' A' ' 34' ' ' LEU . 62.6 mt -137.96 152.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 54.210000000000001 111.116 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -151.15 107.56 3.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.450000000000003 110.861 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.445 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -165.32 -163.66 0.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 73.230000000000004 110.883 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.48 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.2 p-90 -145.14 166.06 26.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 73.049999999999997 110.887 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.478 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 5.0 p -136.52 162.37 33.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 64.400000000000006 111.151 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.95 142.94 51.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 65.25 110.837 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.45 176.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.517 . . . . 75.010000000000005 111.133 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.786 HG13 HD12 ' A' ' 27' ' ' LEU . 68.7 mt -150.91 98.67 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 73.329999999999998 111.149 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -117.8 141.32 48.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 64.230000000000004 110.904 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.453 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 46.07 36.74 3.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 64.209999999999994 110.885 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.23 33.85 39.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 52.329999999999998 112.441 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.413 HD13 ' OH ' ' A' ' 86' ' ' TYR . 2.3 mt -100.33 -54.84 2.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.865 0.364 . . . . 74.099999999999994 110.934 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.22 116.49 1.76 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.726 -0.75 . . . . 75.510000000000005 112.45 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.413 ' OH ' HD13 ' A' ' 84' ' ' LEU . 98.8 m-85 -132.72 -175.09 3.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 74.329999999999998 110.955 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.478 ' CG ' ' O ' ' A' ' 77' ' ' THR . 7.5 ttp180 -177.61 138.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 110.874 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.576 ' OE1' ' HB3' ' A' ' 3' ' ' ALA . 2.7 tp60 -81.94 155.17 25.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 110.857 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -140.0 -166.86 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 65.040000000000006 110.899 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.8 OUTLIER 83.06 -38.88 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.400000000000006 110.918 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.47 81.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 70.230000000000004 112.514 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -171.77 114.4 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 75.219999999999999 110.887 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -154.87 112.97 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 71.329999999999998 110.942 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.2 m -85.11 132.96 34.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 71.129999999999995 111.104 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.744 HG21 HD23 ' A' ' 67' ' ' LEU . 37.6 t -63.76 117.72 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.340000000000003 111.112 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -136.39 14.37 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.120000000000005 110.927 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.859 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -124.95 -178.02 15.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 62.039999999999999 112.492 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -154.69 151.49 28.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 73.310000000000002 110.863 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.753 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.12 -178.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 61.200000000000003 111.119 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -146.51 129.86 16.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 72.109999999999999 110.843 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.13 40.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 71.540000000000006 110.909 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 111.11 179.918 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.577 0.703 . . . . 73.120000000000005 111.111 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.99 22.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.657 2.238 . . . . 73.109999999999999 112.366 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 133.39 25.57 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.684 2.256 . . . . 72.209999999999994 112.356 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.772 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -80.19 139.55 36.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 72.109999999999999 111.1 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 m -99.76 77.6 2.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 51.25 111.166 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.592 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.8 mp -77.65 109.69 11.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 74.200000000000003 110.936 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.761 ' O ' HD11 ' A' ' 16' ' ' LEU . 3.0 mm-40 -80.08 -168.56 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 64.340000000000003 110.866 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.831 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -133.81 81.58 1.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 111.139 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 12' ' ' HIS . 7.6 mm -71.66 172.84 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.340000000000003 111.125 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.718 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -54.17 172.37 0.24 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.583 0.706 . . . . 64.120000000000005 110.825 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.78 20.2 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.613 2.209 . . . . 74.310000000000002 112.326 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -129.1 26.28 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 74.540000000000006 110.86 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.25 -177.71 31.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 34.340000000000003 112.467 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.039 HD13 HD21 ' A' ' 67' ' ' LEU . 22.2 tp -152.29 166.98 30.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.812 0.339 . . . . 73.319999999999993 110.89 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HB2' HD11 ' A' ' 11' ' ' ILE . 61.7 ttt180 -132.59 136.57 46.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 110.833 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 8' ' ' LEU . 51.1 t -145.0 109.36 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 54.409999999999997 111.152 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.79 ' HB2' HG23 ' A' ' 59' ' ' ILE . 11.2 t -121.53 159.54 26.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 110.843 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.883 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 10.2 m -142.73 151.61 57.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 74.109999999999999 111.109 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 121.69 8.38 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.628 2.219 . . . . 74.109999999999999 112.32 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.16 140.19 52.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 61.119999999999997 110.863 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -132.51 18.88 4.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 74.530000000000001 110.883 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.72 8.17 30.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.733 -0.746 . . . . 62.200000000000003 112.45 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.546 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 39.5 m-85 -58.41 164.63 2.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 64.25 110.908 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -126.37 -13.01 6.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 75.450000000000003 110.886 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.027 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -153.82 140.68 19.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 55.539999999999999 110.935 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.027 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -134.61 145.77 48.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 110.924 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.79 142.69 49.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 111.117 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.28 120.95 31.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 53.240000000000002 110.855 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.465 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -152.67 93.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 75.129999999999995 110.88 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.463 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.9 176.73 24.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 74.239999999999995 112.5 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.66 -164.94 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 65.439999999999998 110.839 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 tp -134.23 145.79 49.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.934 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.498 ' ND2' ' OD1' ' A' ' 71' ' ' ASP . 22.0 m-80 49.15 24.04 0.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 74.439999999999998 110.858 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -163.43 139.34 6.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.340000000000003 110.861 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -110.1 164.94 12.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 74.430000000000007 110.892 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.65 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.439999999999998 110.855 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 N-CA-C 112.485 -0.246 . . . . 71.549999999999997 112.485 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -102.44 -68.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 72.400000000000006 110.881 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.489 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 5.2 m-90 -62.37 154.19 28.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 73.150000000000006 110.863 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.465 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 95.1 p -158.39 123.84 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 54.210000000000001 110.887 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.66 160.73 10.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 73.420000000000002 110.861 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.708 ' OD1' HD21 ' A' ' 27' ' ' LEU . 14.4 t0 -138.9 103.14 4.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 71.329999999999998 110.853 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' PHE . 5.6 mm -77.98 108.9 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 111.165 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 81.1 p -96.37 30.58 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 70.420000000000002 111.133 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.9 OUTLIER 163.29 138.82 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.569 0.7 . . . . 70.349999999999994 110.903 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.406 ' N ' ' HG3' ' A' ' 52' ' ' LYS . 53.9 Cg_endo -69.74 176.2 7.07 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.705 2.27 . . . . 71.319999999999993 112.349 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HD2' HD12 ' A' ' 59' ' ' ILE . 4.4 ttmt -109.19 -77.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 70.420000000000002 110.91 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -113.24 60.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 71.340000000000003 110.929 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.17 -19.2 32.23 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.713 -0.756 . . . . 61.009999999999998 112.485 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.45 164.91 25.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 73.019999999999996 110.861 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.546 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 16.3 m95 -89.83 94.15 9.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.79 HG23 ' HB2' ' A' ' 19' ' ' SER . 6.4 mt -102.3 149.7 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 75.040000000000006 111.156 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.455 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 42.1 t80 -144.31 159.87 41.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 55.32 110.874 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -147.68 140.01 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 110.853 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -114.39 -178.16 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 74.310000000000002 110.887 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.29 17.99 1.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 75.099999999999994 110.879 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -137.07 20.42 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . . . -107.39 95.76 5.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.430000000000007 111.106 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -94.11 84.55 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 54.299999999999997 111.073 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.039 HD21 HD13 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -120.03 171.61 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 63.229999999999997 110.881 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -153.24 134.29 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.439999999999998 110.889 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.552 ' C ' ' O ' ' A' ' 68' ' ' LYS . 9.2 mm -23.6 118.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.450000000000003 111.098 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.6 -19.09 9.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.787 -0.72 . . . . 64.540000000000006 112.495 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.498 ' OD1' ' ND2' ' A' ' 35' ' ' ASN . 0.4 OUTLIER -67.23 -166.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 55.530000000000001 110.837 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 1.5 mtmt -152.45 165.15 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.519999999999996 110.873 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 99.2 mt -142.53 149.15 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 54.340000000000003 111.194 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -149.62 104.1 3.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 73.540000000000006 110.885 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.495 ' CE2' HG23 ' A' ' 77' ' ' THR . 1.0 OUTLIER -160.3 -164.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 73.510000000000005 110.903 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.65 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -146.98 142.73 27.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 110.893 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.495 HG23 ' CE2' ' A' ' 75' ' ' PHE . 4.4 p -112.37 147.75 35.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 73.319999999999993 111.113 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.401 ' CD1' ' HG3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -112.68 143.51 43.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 72.209999999999994 110.855 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.01 168.69 13.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 74.400000000000006 111.118 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.671 HG13 HD12 ' A' ' 27' ' ' LEU . 95.4 mt -146.69 96.17 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 75.329999999999998 111.121 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 7.4 tttt -114.51 143.73 44.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 72.25 110.961 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.405 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER 53.03 20.71 1.8 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 62.210000000000001 110.892 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.09 27.54 73.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 50.020000000000003 112.481 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 84' ' ' LEU . 8.0 mt -97.86 -72.31 0.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 61.439999999999998 110.907 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.48 109.86 2.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 70.439999999999998 112.484 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -122.31 161.68 22.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 74.540000000000006 110.921 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.401 ' HG3' ' CD1' ' A' ' 78' ' ' PHE . 6.2 ttp180 -163.45 129.13 3.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 72.329999999999998 110.866 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -80.64 150.35 29.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.120000000000005 110.917 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -132.02 -159.92 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 110.866 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 82.86 -37.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 64.230000000000004 110.923 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.51 78.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.783 -0.722 . . . . 64.439999999999998 112.481 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -171.41 111.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 64.420000000000002 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -148.98 119.42 7.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 52.130000000000003 110.898 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.6 m -89.84 141.15 28.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 52.450000000000003 111.152 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.86 HG21 HD12 ' A' ' 67' ' ' LEU . 40.2 t -75.81 124.92 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 63.310000000000002 111.093 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -147.19 21.97 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 61.450000000000003 110.936 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -154.67 114.35 0.61 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 74.439999999999998 112.482 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.542 ' C ' HG22 ' A' ' 99' ' ' VAL . 0.6 OUTLIER -87.81 172.16 9.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 71.140000000000001 110.882 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.702 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -167.53 156.64 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 75.519999999999996 111.109 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.55 130.25 56.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -100.11 38.59 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 72.540000000000006 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 111.082 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.1 0 CA-C-O 121.6 0.714 . . . . 73.120000000000005 111.061 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.82 33.09 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.254 . . . . 63.299999999999997 112.385 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 134.37 27.89 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.735 2.29 . . . . 72.310000000000002 112.371 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -82.43 140.71 33.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 60.210000000000001 111.121 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 m -97.19 79.14 2.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 74.400000000000006 111.145 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.3 mp -83.1 113.06 20.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 73.340000000000003 110.884 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.584 ' O ' HD11 ' A' ' 16' ' ' LEU . 2.6 mm-40 -83.94 -158.34 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.147 -0.478 . . . . 73.030000000000001 110.893 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.88 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -141.12 80.37 1.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.102 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.722 HD13 ' CG2' ' A' ' 99' ' ' VAL . 2.7 mm -71.3 172.55 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 65.430000000000007 111.131 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.707 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -54.22 172.16 0.25 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.561 0.695 . . . . 54.039999999999999 110.842 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.8 Cg_endo -69.76 19.47 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.66 2.24 . . . . 73.319999999999993 112.384 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -124.58 19.79 8.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 73.420000000000002 110.868 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.24 -177.93 33.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 63.340000000000003 112.521 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.689 HD13 HD11 ' A' ' 67' ' ' LEU . 26.3 tp -151.27 166.38 31.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 75.409999999999997 110.94 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.529 ' HB2' HD11 ' A' ' 11' ' ' ILE . 50.6 ttt180 -128.23 139.13 52.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.867 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.3 t -151.26 105.26 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 61.119999999999997 111.131 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' A' ' 59' ' ' ILE . 18.7 t -122.46 162.25 22.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.549999999999997 110.876 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 6' ' ' ALA . 5.4 m -140.4 151.17 63.38 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.664 0.745 . . . . 73.420000000000002 111.084 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 122.2 8.87 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.673 2.249 . . . . 74.439999999999998 112.327 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 14.9 t70 -83.44 140.0 32.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 72.140000000000001 110.913 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -137.2 12.61 3.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 74.540000000000006 110.91 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.01 2.93 2.64 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.748 . . . . 51.229999999999997 112.491 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 91.5 m-85 -58.33 160.18 5.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 64.510000000000005 110.899 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -129.72 -7.04 4.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 73.019999999999996 110.859 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.992 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -157.75 140.75 15.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 72.530000000000001 110.898 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.992 ' N ' HD22 ' A' ' 27' ' ' LEU . 19.8 t80 -137.61 146.2 43.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.841 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.98 163.06 28.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 74.200000000000003 111.134 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.435 ' C ' ' CD1' ' A' ' 30' ' ' PHE . 4.4 t80 -147.59 111.7 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 74.140000000000001 110.876 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.588 ' CE1' ' HB3' ' A' ' 47' ' ' SER . 0.2 OUTLIER -144.29 92.58 2.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 73.530000000000001 110.836 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -145.99 -179.48 22.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 71.540000000000006 112.484 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.69 -164.15 1.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 75.049999999999997 110.929 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.473 ' HG ' ' ND2' ' A' ' 35' ' ' ASN . 1.1 tp -143.48 144.91 32.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 70.120000000000005 110.931 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.473 ' ND2' ' HG ' ' A' ' 34' ' ' LEU . 2.3 m120 57.73 12.02 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 73.040000000000006 110.867 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -156.77 130.58 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.400000000000006 110.877 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -102.4 143.92 31.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 42.549999999999997 110.905 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.43 ' HE1' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 54.32 110.92 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.539 -0.224 . . . . 73.140000000000001 112.539 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.46 -65.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.771 0.32 . . . . 74.329999999999998 110.89 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.418 ' O ' ' ND1' ' A' ' 31' ' ' HIS . 8.2 m0 -58.03 161.43 4.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.194 -0.457 . . . . 73.049999999999997 110.851 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.588 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 97.0 p -167.39 122.51 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 60.200000000000003 110.887 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.77 155.36 8.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 61.420000000000002 110.872 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.24 103.2 4.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 72.450000000000003 110.873 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 52' ' ' LYS . 28.0 mm -80.84 117.14 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.340000000000003 111.121 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.5 p -99.36 32.24 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 73.109999999999999 111.17 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.539 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER 172.99 135.67 0.11 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.61 0.719 . . . . 73.409999999999997 110.909 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 168.18 22.22 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.26 . . . . 54.229999999999997 112.322 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -141.95 112.78 7.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.040000000000006 110.905 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER 78.27 27.72 0.51 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 72.129999999999995 110.883 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.81 -25.88 19.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 73.530000000000001 112.507 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 161.76 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 75.510000000000005 110.825 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 13.2 m95 -82.15 101.19 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 110.953 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.484 HD12 ' HD2' ' A' ' 54' ' ' LYS . 28.0 mt -105.65 139.13 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 61.210000000000001 111.119 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -135.32 141.91 45.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.120000000000005 110.852 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.454 ' HD2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -134.04 130.44 37.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 110.859 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.57 -178.9 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 43.520000000000003 110.864 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -144.82 15.56 1.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 75.409999999999997 110.887 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -131.45 3.58 4.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 74.239999999999995 110.874 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.2 101.01 13.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 55.130000000000003 111.093 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -99.58 84.53 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 64.140000000000001 111.061 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.737 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -129.38 171.29 12.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 51.409999999999997 110.899 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.737 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -152.8 147.47 26.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 75.430000000000007 110.894 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.499 HG12 ' CE1' ' A' ' 98' ' ' PHE . 2.5 mm -30.89 115.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 111.145 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.44 -19.37 7.15 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 70.25 112.505 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.16 -162.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 74.099999999999994 110.865 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.1 mttt -155.0 167.24 31.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 73.530000000000001 110.901 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 80.0 mt -146.4 146.35 19.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 65.310000000000002 111.138 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -148.9 102.19 3.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.340000000000003 110.956 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.535 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 0.8 OUTLIER -160.68 -161.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 70.340000000000003 110.896 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.543 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.5 OUTLIER -145.97 161.34 40.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 74.140000000000001 110.908 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 p -131.05 159.69 36.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 63.219999999999999 111.151 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.62 146.06 48.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 75.239999999999995 110.859 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -146.08 170.87 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 62.539999999999999 111.16 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.696 HG13 HD12 ' A' ' 27' ' ' LEU . 81.1 mt -149.36 96.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 62.219999999999999 111.171 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 1.7 tttt -113.05 137.72 51.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 65.510000000000005 110.916 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 47.31 33.11 2.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 71.099999999999994 110.853 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.33 33.39 61.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.738 . . . . 70.420000000000002 112.478 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.412 HD13 ' OH ' ' A' ' 86' ' ' TYR . 1.7 mt -97.47 -54.25 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 52.350000000000001 110.878 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 119.32 2.83 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.784 -0.722 . . . . 54.43 112.492 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB2' HG23 ' A' ' 79' ' ' VAL . 96.0 m-85 -143.47 156.81 44.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 73.540000000000006 110.916 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -152.56 133.68 14.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 71.310000000000002 110.854 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -80.11 154.98 27.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 54.130000000000003 110.894 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.542 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -138.52 -160.79 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 65.450000000000003 110.854 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.542 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 3.1 t-20 82.7 -38.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 65.400000000000006 110.861 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.03 78.87 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 25.23 112.536 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -171.74 110.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.35 . . . . 73.420000000000002 110.895 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 17.1 m-90 -151.72 120.09 6.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.134 -0.485 . . . . 73.219999999999999 110.963 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.4 m -91.24 130.43 37.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.010000000000005 111.186 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.88 HG13 ' HB2' ' A' ' 10' ' ' ALA . 48.3 t -61.41 110.5 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 71.049999999999997 111.117 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.0 7.5 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 55.340000000000003 110.895 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.814 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -120.23 179.13 16.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 62.310000000000002 112.476 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -151.75 153.2 33.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 64.109999999999999 110.895 -179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.722 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -159.96 177.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 64.530000000000001 111.109 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -146.03 126.87 14.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 60.299999999999997 110.843 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -80.43 55.31 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 74.230000000000004 110.87 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 52.509999999999998 111.093 179.919 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 121.543 0.687 . . . . 75.239999999999995 111.097 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 165.46 30.88 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 74.409999999999997 112.34 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 133.6 25.92 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 75.239999999999995 112.301 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.778 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.64 144.15 31.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 32.229999999999997 111.111 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.5 m -99.83 77.13 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 73.319999999999993 111.138 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.465 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.7 mp -73.04 109.89 6.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 72.340000000000003 110.961 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.834 ' O ' HD11 ' A' ' 16' ' ' LEU . 7.9 mm-40 -85.99 -172.92 4.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 110.863 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -130.56 80.25 1.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 71.120000000000005 111.084 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.682 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.2 mm -70.27 172.34 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 62.130000000000003 111.159 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.682 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.07 171.83 0.26 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.622 0.725 . . . . 74.450000000000003 110.818 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.1 Cg_endo -69.72 20.54 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 64.099999999999994 112.37 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 12' ' ' HIS . 20.7 pttt -126.64 23.06 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 62.439999999999998 110.884 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.1 -178.13 31.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 45.439999999999998 112.501 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.834 HD11 ' O ' ' A' ' 9' ' ' GLU . 20.0 tp -149.65 160.83 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 73.439999999999998 110.924 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.661 ' HB2' HD11 ' A' ' 11' ' ' ILE . 1.3 ttt85 -125.95 138.95 53.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 61.310000000000002 110.888 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 8' ' ' LEU . 54.2 t -148.79 103.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 72.299999999999997 111.098 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.529 ' HB2' HG23 ' A' ' 59' ' ' ILE . 41.3 t -114.21 160.69 18.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 64.230000000000004 110.89 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 6' ' ' ALA . 24.3 m -141.51 151.73 61.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 64.239999999999995 111.146 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 122.14 8.82 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.719 2.279 . . . . 75.230000000000004 112.343 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 17.1 t0 -89.12 107.91 19.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 65.140000000000001 110.868 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -95.79 -3.55 45.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 63.409999999999997 110.894 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.94 31.02 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 53.229999999999997 112.513 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.464 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 81.4 m-85 -80.14 165.1 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 74.310000000000002 110.87 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -126.05 -11.55 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 110.878 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.012 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -155.66 141.13 17.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 73.400000000000006 110.898 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.012 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.9 t80 -133.38 146.42 51.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.329999999999998 110.909 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.67 155.8 49.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.040000000000006 111.119 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.511 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 3.2 t80 -141.0 123.78 16.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 75.329999999999998 110.895 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.511 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 8.4 m-70 -153.47 93.31 1.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 72.310000000000002 110.884 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -145.94 -177.1 20.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.75 . . . . 55.43 112.506 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 45' ' ' HIS . 2.6 mtpp -135.73 -169.64 2.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 62.240000000000002 110.912 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.415 ' CD2' HD22 ' A' ' 35' ' ' ASN . 2.3 tp -131.77 143.78 50.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 75.019999999999996 110.897 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.415 HD22 ' CD2' ' A' ' 34' ' ' LEU . 67.2 m-80 37.48 37.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 72.109999999999999 110.901 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -159.17 139.84 12.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.109999999999999 110.913 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -90.36 145.28 25.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 110.913 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.5 ptp . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 64.310000000000002 110.904 179.966 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.44 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.504 -0.239 . . . . 51.32 112.504 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.453 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -106.25 -62.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.75 0.31 . . . . 30.210000000000001 110.825 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -65.41 150.93 47.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 55.229999999999997 110.91 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.461 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 58.5 p -158.33 119.02 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 63.210000000000001 110.822 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.22 158.56 21.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 73.340000000000003 110.897 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -144.34 115.26 7.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.866 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 mm -96.27 120.49 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 72.420000000000002 111.148 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 81.4 p -107.89 36.92 2.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.219999999999999 111.126 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.8 OUTLIER 163.08 130.81 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.616 0.722 . . . . 74.439999999999998 110.901 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -176.33 1.46 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.682 2.255 . . . . 61.009999999999998 112.318 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.14 19.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 62.509999999999998 110.842 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 178.85 34.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 73.230000000000004 110.858 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.42 -19.53 13.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 63.509999999999998 112.445 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.04 164.32 27.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.806 0.336 . . . . 64.540000000000006 110.861 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.552 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 18.3 m95 -87.5 93.27 9.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 74.120000000000005 110.918 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 ' HB2' ' A' ' 19' ' ' SER . 8.1 mt -96.47 136.37 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 53.140000000000001 111.146 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -129.95 150.63 51.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.010000000000005 110.883 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.89 138.68 28.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 61.539999999999999 110.878 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.5 -176.53 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 74.109999999999999 110.826 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.45 17.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 70.230000000000004 110.842 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -131.77 12.09 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.329999999999998 110.879 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.22 103.82 13.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 70.409999999999997 111.077 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -101.57 73.8 1.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 60.32 111.111 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.843 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -117.52 171.41 8.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 73.5 110.932 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.843 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.53 151.05 27.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 71.420000000000002 110.914 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.2 mm -28.04 116.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 63.310000000000002 111.13 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.31 -24.72 6.85 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 75.420000000000002 112.515 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.93 -175.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 74.200000000000003 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 2.4 mttt -141.75 166.73 23.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 64.239999999999995 110.898 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.6 mt -144.52 143.21 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.230000000000004 111.142 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.4 OUTLIER -145.38 103.88 3.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.129999999999995 110.954 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.518 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -168.71 -162.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 110.908 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.7 p-90 -146.91 174.61 11.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 71.099999999999994 110.927 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 p -139.23 159.05 43.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 74.549999999999997 111.11 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.54 150.21 42.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 72.140000000000001 110.882 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -147.81 174.55 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.483 . . . . 63.109999999999999 111.171 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.776 HG13 HD12 ' A' ' 27' ' ' LEU . 78.4 mt -150.48 96.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 60.530000000000001 111.148 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 17.1 tttm -113.01 121.55 44.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 72.439999999999998 110.907 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.79 32.41 18.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.439999999999998 110.895 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.75 33.33 72.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 34.5 112.471 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -99.67 -55.95 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 64.030000000000001 110.921 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.05 112.19 2.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 72.230000000000004 112.499 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.677 ' HB2' HG23 ' A' ' 79' ' ' VAL . 29.0 m-85 -126.27 164.77 20.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.889 0.376 . . . . 75.519999999999996 110.902 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -152.88 137.63 17.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 73.25 110.862 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.73 141.86 28.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 70.540000000000006 110.91 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.403 ' O ' ' ND2' ' A' ' 90' ' ' ASN . 2.9 p30 -132.39 143.44 49.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 110.854 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER 167.53 -37.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 63.240000000000002 110.873 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 40.55 44.53 3.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.726 -0.75 . . . . 34.119999999999997 112.533 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -168.08 105.4 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.348 . . . . 70.5 110.854 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -146.48 106.3 3.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 110.929 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.4 m -80.87 131.12 35.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 74.140000000000001 111.18 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.678 HG13 ' HB2' ' A' ' 10' ' ' ALA . 69.0 t -63.41 121.35 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.520000000000003 111.142 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -137.9 8.51 2.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 71.340000000000003 110.881 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.743 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -119.54 -175.54 15.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 55.310000000000002 112.466 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.485 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -157.17 153.55 27.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.96 0.409 . . . . 75.120000000000005 110.875 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.667 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.67 172.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 61.049999999999997 111.132 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -141.54 132.86 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 62.020000000000003 110.867 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.93 45.62 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 72.299999999999997 110.882 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 45.25 111.121 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.096 0 CA-C-O 121.569 0.7 . . . . 73.209999999999994 111.115 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 167.66 23.87 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.642 2.228 . . . . 65.219999999999999 112.331 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 134.98 29.31 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 64.019999999999996 112.339 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.83 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -85.54 136.85 33.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 53.409999999999997 111.098 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 m -94.66 77.27 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 64.439999999999998 111.169 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.663 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.0 mp -80.08 106.25 11.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 71.319999999999993 110.934 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.806 ' O ' HD11 ' A' ' 16' ' ' LEU . 3.6 mm-40 -78.38 -165.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 74.329999999999998 110.847 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.853 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -135.88 79.45 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 71.200000000000003 111.07 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.726 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.6 mm -68.6 172.42 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.409999999999997 111.098 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.684 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.34 172.05 0.22 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.581 0.705 . . . . 65.129999999999995 110.841 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.591 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.72 21.48 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 73.540000000000006 112.34 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 12' ' ' HIS . 6.9 ptpt -129.06 26.14 5.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 55.530000000000001 110.953 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.99 -178.63 29.14 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 54.130000000000003 112.486 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.035 HD13 HD21 ' A' ' 67' ' ' LEU . 35.6 tp -149.87 163.67 37.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 64.450000000000003 110.901 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.646 ' HB2' HD11 ' A' ' 11' ' ' ILE . 6.2 ttt180 -131.24 135.23 47.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 62.229999999999997 110.863 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.663 HG22 ' HA ' ' A' ' 8' ' ' LEU . 41.9 t -143.26 110.6 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 51.130000000000003 111.113 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 59' ' ' ILE . 10.8 t -118.2 157.41 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 71.219999999999999 110.888 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.83 HG12 ' HA ' ' A' ' 6' ' ' ALA . 25.4 m -139.94 151.94 66.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.654 0.74 . . . . 74.230000000000004 111.123 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 121.36 8.04 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.655 2.237 . . . . 75.540000000000006 112.335 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.426 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 22.8 t0 -82.81 93.6 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.530000000000001 110.862 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.7 30.59 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 73.310000000000002 110.933 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.414 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 105.14 23.46 7.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 73.319999999999993 112.464 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 64.3 m-85 -72.24 166.23 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 73.209999999999994 110.871 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 t -129.86 -6.49 4.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 72.349999999999994 110.854 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.029 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -163.05 140.56 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 72.420000000000002 110.912 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.029 ' N ' HD22 ' A' ' 27' ' ' LEU . 14.0 t80 -135.59 149.97 49.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.299999999999997 110.898 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.62 152.73 42.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 63.130000000000003 111.139 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' HE2' HG11 ' A' ' 18' ' ' VAL . 1.9 t80 -132.68 132.47 42.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 72.519999999999996 110.922 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 16.3 m-70 -157.79 89.05 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 72.530000000000001 110.875 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.547 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.12 -175.32 19.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 62.210000000000001 112.481 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -135.48 -164.17 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 72.239999999999995 110.928 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.717 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -130.27 138.83 50.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 64.109999999999999 110.897 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.646 ' ND2' HD12 ' A' ' 34' ' ' LEU . 68.4 m-80 46.52 26.69 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.310000000000002 110.905 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -154.11 144.22 22.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 63.229999999999997 110.914 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.32 152.77 29.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 73.230000000000004 110.855 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 63.009999999999998 110.899 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.456 -0.257 . . . . 51.020000000000003 112.456 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.44 -54.28 2.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.82 0.343 . . . . 74.299999999999997 110.854 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.717 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.4 m-90 -71.39 171.11 11.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.109999999999999 110.9 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -173.31 115.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 63.109999999999999 110.854 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.46 158.24 20.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.340000000000003 110.884 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.46 122.88 13.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.861 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.449 HG22 ' H ' ' A' ' 52' ' ' LYS . 19.2 mm -103.66 118.35 50.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 63.409999999999997 111.115 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 51.7 p -104.6 35.07 2.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 55.43 111.152 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.449 ' H ' HG22 ' A' ' 50' ' ' ILE . 16.7 mttt 164.93 137.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.571 0.701 . . . . 73.530000000000001 110.91 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 174.77 9.04 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 2.263 . . . . 73.010000000000005 112.318 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -136.94 11.57 3.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.919 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.77 44.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 73.430000000000007 110.917 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.78 -24.62 5.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.807 -0.711 . . . . 72.430000000000007 112.477 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.23 163.36 27.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 75.329999999999998 110.909 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.426 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 8.1 m95 -85.1 96.2 9.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 73.200000000000003 110.918 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 19' ' ' SER . 28.2 mt -102.41 140.83 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 111.127 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 41.9 t80 -134.64 158.01 45.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 73.340000000000003 110.865 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -148.37 139.0 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 75.099999999999994 110.843 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.68 -179.38 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 65.319999999999993 110.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.75 28.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 71.040000000000006 110.895 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -144.47 18.59 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 63.229999999999997 110.945 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.41 102.71 11.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 72.219999999999999 111.128 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -98.59 83.11 2.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 63.549999999999997 111.066 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.035 HD21 HD13 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -121.66 171.63 8.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 110.91 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -155.51 141.75 18.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 72.230000000000004 110.873 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.707 HD11 ' O ' ' A' ' 97' ' ' GLY . 25.6 mm -25.41 119.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 63.130000000000003 111.153 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.56 -18.08 8.78 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.743 -0.742 . . . . 60.549999999999997 112.469 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.29 -176.58 2.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 74.040000000000006 110.85 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 6.7 mttt -143.32 160.58 40.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 71.430000000000007 110.86 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.479 HG12 ' CD2' ' A' ' 34' ' ' LEU . 49.1 mt -137.82 146.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 111.126 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.9 m-85 -146.98 104.97 3.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.951 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.547 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.9 p90 -165.96 -168.26 1.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 110.906 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.3 p-90 -135.61 171.59 14.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.474 . . . . 64.099999999999994 110.908 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.2 p -142.11 149.01 39.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 71.439999999999998 111.182 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.07 144.17 39.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.030000000000001 110.868 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.54 HG13 ' HD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -143.72 167.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 72.109999999999999 111.152 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.66 HG13 HD12 ' A' ' 27' ' ' LEU . 88.9 mt -149.0 96.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 72.219999999999999 111.116 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.548 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 1.3 tttt -112.28 133.66 54.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 110.884 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 48.88 37.85 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 74.209999999999994 110.882 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.65 29.71 49.52 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 64.299999999999997 112.472 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 mt -93.0 -58.33 2.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.858 0.361 . . . . 63.340000000000003 110.924 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.21 120.66 3.79 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.776 -0.726 . . . . 73.420000000000002 112.497 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.41 ' HB2' HG23 ' A' ' 79' ' ' VAL . 98.2 m-85 -143.59 163.74 32.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.947 0.403 . . . . 64.219999999999999 110.9 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -159.04 134.7 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 74.019999999999996 110.874 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -80.77 154.8 27.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.496 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -138.84 -164.73 1.7 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.895 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.496 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.2 t-20 82.08 -40.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.891 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.16 84.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.671 -0.776 . . . . 74.549999999999997 112.493 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -172.26 110.68 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.823 0.344 . . . . 71.430000000000007 110.89 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -149.75 114.77 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 74.420000000000002 110.915 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.5 m -87.98 136.04 33.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 64.310000000000002 111.111 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.853 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 35.5 t -71.85 115.09 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 111.134 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -133.21 12.46 4.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.904 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.844 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -130.78 177.7 18.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 72.109999999999999 112.44 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -145.02 160.41 41.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 71.420000000000002 110.902 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.726 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.13 167.57 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 111.133 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.43 137.28 50.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 74.25 110.896 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -89.49 42.22 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 63.450000000000003 110.876 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 63.229999999999997 111.096 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 121.564 0.697 . . . . 21.02 111.118 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 167.05 25.61 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 2.238 . . . . 63.350000000000001 112.318 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 135.76 31.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.64 2.226 . . . . 73.340000000000003 112.392 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.627 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -89.65 141.43 28.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 64.140000000000001 111.078 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.2 m -100.47 76.83 1.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 70.209999999999994 111.156 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.505 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.9 mp -73.81 106.73 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 65.219999999999999 110.943 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.797 ' O ' HD11 ' A' ' 16' ' ' LEU . 7.3 mm-40 -78.41 -170.28 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 71.519999999999996 110.881 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -133.59 80.83 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 64.540000000000006 111.125 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.697 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -72.14 172.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 75.530000000000001 111.174 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.697 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.0 171.82 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.603 0.715 . . . . 72.140000000000001 110.854 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.2 Cg_endo -69.71 20.85 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.693 2.262 . . . . 54.25 112.356 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 9.5 pttt -125.67 19.76 7.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 62.119999999999997 110.901 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 156.21 -177.39 33.27 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.782 -0.723 . . . . 73.150000000000006 112.508 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.797 HD11 ' O ' ' A' ' 9' ' ' GLU . 24.0 tp -149.8 166.71 28.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 50.210000000000001 110.902 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.584 ' HB2' HD11 ' A' ' 11' ' ' ILE . 65.6 ttt180 -133.25 138.93 46.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 74.450000000000003 110.86 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 8' ' ' LEU . 73.0 t -147.19 107.49 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 74.239999999999995 111.151 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.48 ' HB2' HG23 ' A' ' 59' ' ' ILE . 12.4 t -112.24 156.45 22.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 63.119999999999997 110.872 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 6' ' ' ALA . 30.3 m -141.73 151.84 61.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.653 0.74 . . . . 75.439999999999998 111.132 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 122.44 9.11 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.733 2.289 . . . . 74.230000000000004 112.311 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.512 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 12.1 t0 -83.64 92.77 7.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 72.219999999999999 110.853 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.35 40.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 110.897 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.405 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 92.0 24.5 24.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 52.520000000000003 112.511 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.592 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 95.7 m-85 -74.71 165.02 25.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.866 0.365 . . . . 72.219999999999999 110.854 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.1 t -129.41 -7.61 4.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 53.229999999999997 110.861 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.008 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -155.02 142.1 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 71.049999999999997 110.951 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.008 ' N ' HD22 ' A' ' 27' ' ' LEU . 17.9 t80 -137.55 147.9 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 110.903 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.7 156.76 46.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.349999999999994 111.098 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.448 ' HE2' HG11 ' A' ' 18' ' ' VAL . 1.8 t80 -139.4 125.42 19.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 73.319999999999993 110.901 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.445 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 25.8 m-70 -152.58 92.58 1.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 73.420000000000002 110.869 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.486 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -144.67 -174.47 16.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 61.229999999999997 112.448 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -163.98 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 72.430000000000007 110.918 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.756 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -131.86 123.46 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 53.240000000000002 110.899 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.405 ' ND2' HD12 ' A' ' 34' ' ' LEU . 68.0 m-80 61.4 27.23 16.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 110.878 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -156.89 146.68 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.915 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -113.92 159.33 20.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 61.350000000000001 110.893 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.562 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 73.010000000000005 110.887 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.459 -0.256 . . . . 30.440000000000001 112.459 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 -56.33 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 74.430000000000007 110.837 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.756 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.3 m-90 -69.85 177.07 3.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 70.439999999999998 110.931 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.445 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 66.0 p -179.92 109.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 70.140000000000001 110.837 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.06 156.7 24.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 73.219999999999999 110.863 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -140.22 120.02 13.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 63.229999999999997 110.859 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 52' ' ' LYS . 8.6 mm -95.18 117.16 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 74.430000000000007 111.154 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.403 HG23 ' OD1' ' A' ' 49' ' ' ASP . 30.6 p -98.96 32.55 2.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 72.400000000000006 111.149 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.582 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.8 OUTLIER 170.24 139.83 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.555 0.693 . . . . 63.32 110.923 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -178.95 2.58 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.66 2.24 . . . . 70.420000000000002 112.363 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HD2' HD12 ' A' ' 59' ' ' ILE . 15.8 ttmt -119.63 -61.7 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 74.129999999999995 110.89 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -131.43 58.47 1.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 64.340000000000003 110.891 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.38 -28.74 6.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 40.439999999999998 112.461 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.5 160.7 29.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.322 . . . . 64.409999999999997 110.887 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.512 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 44.1 m95 -82.59 89.1 6.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 75.129999999999995 110.949 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.48 HG23 ' HB2' ' A' ' 19' ' ' SER . 25.8 mt -94.46 135.91 27.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 75.25 111.159 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.478 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 56.1 t80 -135.56 162.37 32.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 71.310000000000002 110.847 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.478 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -158.24 152.71 24.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 75.430000000000007 110.892 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.39 -176.41 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 65.400000000000006 110.855 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.1 mtt180 -142.76 16.47 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 72.150000000000006 110.877 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -132.8 8.72 4.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 54.25 110.892 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.85 95.96 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 53.130000000000003 111.108 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -93.67 77.46 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 60.109999999999999 111.104 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.82 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -125.07 171.47 10.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 71.230000000000004 110.9 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.82 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.71 154.88 28.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 55.32 110.913 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.7 mm -29.98 121.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 73.409999999999997 111.118 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.52 -28.45 5.98 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.729 -0.748 . . . . 74.400000000000006 112.452 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.469 ' OD2' HD11 ' A' ' 34' ' ' LEU . 1.4 m-20 -66.53 -171.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 71.430000000000007 110.861 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.7 mttt -148.78 168.71 22.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 72.5 110.898 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.454 HG12 HD22 ' A' ' 34' ' ' LEU . 78.6 mt -146.67 145.28 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 63.140000000000001 111.153 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -148.36 103.29 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 72.109999999999999 110.914 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.486 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.3 p90 -160.97 -168.99 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 75.140000000000001 110.903 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.562 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -139.99 146.12 38.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.912 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.402 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 1.9 p -111.63 161.76 15.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 73.329999999999998 111.142 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 138.1 51.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.893 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.577 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 2.3 m -141.86 177.2 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 74.340000000000003 111.141 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.772 HG13 HD12 ' A' ' 27' ' ' LEU . 68.3 mt -152.95 98.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 70.049999999999997 111.122 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -112.7 141.02 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 72.150000000000006 110.866 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.427 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER 44.92 32.51 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 110.879 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.38 36.98 91.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 54.210000000000001 112.472 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.7 -50.59 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.836 0.35 . . . . 52.509999999999998 110.899 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.48 105.01 0.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.758 . . . . 63.310000000000002 112.501 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -123.72 -175.02 3.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 74.319999999999993 110.906 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.449 ' NH1' ' HB3' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -178.44 135.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 64.409999999999997 110.854 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -79.1 153.28 30.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.918 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.482 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -136.28 -165.5 1.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 71.099999999999994 110.841 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.482 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 81.34 -40.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 73.200000000000003 110.861 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.27 83.05 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 54.229999999999997 112.504 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -170.69 112.91 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 72.129999999999995 110.894 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.6 m-90 -155.04 113.05 3.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 72.349999999999994 110.923 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 96.1 m -88.48 135.34 33.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 51.240000000000002 111.151 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 10' ' ' ALA . 15.8 t -64.75 114.94 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 73.400000000000006 111.14 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.62 -2.34 3.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 61.119999999999997 110.894 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.773 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -113.51 -174.89 19.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 74.329999999999998 112.48 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.493 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.49 156.73 35.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 75.040000000000006 110.896 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.67 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.64 167.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 61.329999999999998 111.128 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -127.46 129.44 47.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 52.200000000000003 110.889 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -78.69 48.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 74.010000000000005 110.844 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 65.140000000000001 111.091 179.947 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.094 0 CA-C-O 121.583 0.706 . . . . 74.219999999999999 111.067 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 165.07 32.22 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.664 2.243 . . . . 64.519999999999996 112.35 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 134.79 28.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.635 2.223 . . . . 72.030000000000001 112.375 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -80.34 135.0 36.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 75.120000000000005 111.115 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.7 m -93.95 77.7 4.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 64.510000000000005 111.105 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 8' ' ' LEU . 2.3 mp -85.84 111.45 20.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 63.520000000000003 110.898 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.543 ' O ' HD11 ' A' ' 16' ' ' LEU . 2.5 mm-40 -84.58 -155.14 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.131 -0.486 . . . . 75.519999999999996 110.906 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -143.62 80.44 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 63.43 111.065 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 17' ' ' ARG . 2.6 mm -69.51 172.27 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 61.219999999999999 111.123 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.692 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -54.18 172.74 0.23 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.627 0.727 . . . . 60.25 110.834 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.1 Cg_endo -69.77 19.82 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.239 . . . . 65.120000000000005 112.36 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.0 OUTLIER -124.54 21.72 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 64.209999999999994 110.923 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.55 -177.47 31.07 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 61.109999999999999 112.434 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.726 HD13 HD11 ' A' ' 67' ' ' LEU . 36.0 tp -149.47 162.05 40.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 73.129999999999995 110.92 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.756 ' HB2' HD11 ' A' ' 11' ' ' ILE . 37.3 ttt180 -123.16 138.3 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 63.109999999999999 110.886 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.1 t -148.61 110.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 70.219999999999999 111.092 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.407 ' HB2' HG23 ' A' ' 59' ' ' ILE . 8.5 t -123.31 156.12 35.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 54.340000000000003 110.828 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 6' ' ' ALA . 23.9 m -141.45 151.66 61.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.649 0.738 . . . . 75.439999999999998 111.125 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 126.26 13.1 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.709 2.273 . . . . 64.019999999999996 112.31 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 34.3 t0 -97.21 86.23 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.319999999999993 110.871 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -20.57 63.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 110.895 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.417 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 160.84 30.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 73.519999999999996 112.523 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 83.4 m-85 -81.36 167.75 19.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 75.230000000000004 110.866 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 t -127.22 -10.48 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 73.239999999999995 110.845 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.006 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -151.96 141.44 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 75.299999999999997 110.949 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.006 ' N ' HD22 ' A' ' 27' ' ' LEU . 14.5 t80 -137.34 140.89 41.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 70.510000000000005 110.924 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.17 144.66 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 74.109999999999999 111.092 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.442 ' CE1' ' CZ ' ' A' ' 75' ' ' PHE . 1.6 t80 -130.78 109.7 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 73.400000000000006 110.852 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.1 OUTLIER -135.84 93.69 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 73.239999999999995 110.841 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 75' ' ' PHE . . . -142.28 -177.26 17.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.679 -0.772 . . . . 54.219999999999999 112.467 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -131.3 -164.27 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 75.409999999999997 110.882 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.713 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -133.9 129.07 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 72.340000000000003 110.903 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.645 ' ND2' HD12 ' A' ' 34' ' ' LEU . 61.0 m-80 60.29 17.11 6.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.409999999999997 110.897 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -153.23 142.01 21.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 52.229999999999997 110.888 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HB3' ' CB ' ' A' ' 74' ' ' TYR . 4.3 pt-20 -117.59 154.41 31.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 62.109999999999999 110.914 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 7.2 ptt? . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 71.140000000000001 110.919 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.477 -0.249 . . . . 53.340000000000003 112.477 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.31 -71.42 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.319 . . . . 53.130000000000003 110.871 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.713 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.9 m-90 -58.09 155.41 11.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 110.931 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.511 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 87.3 p -153.15 108.2 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 61.310000000000002 110.833 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.79 160.76 39.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 65.549999999999997 110.861 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.729 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -144.96 108.41 4.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 110.876 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 28' ' ' PHE . 4.6 mm -85.85 101.0 9.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.444 . . . . 72.239999999999995 111.111 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 p -87.81 26.48 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 65.430000000000007 111.154 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' H ' HG22 ' A' ' 50' ' ' ILE . 2.8 mttt 178.84 135.38 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 72.549999999999997 110.889 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 168.12 22.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.684 2.256 . . . . 61.420000000000002 112.329 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.617 ' HD2' HD12 ' A' ' 59' ' ' ILE . 17.2 ttmt -105.77 -60.35 1.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 110.933 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -132.11 53.94 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 65.409999999999997 110.863 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.91 -20.01 48.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 42.149999999999999 112.472 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -133.84 162.4 32.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 74.340000000000003 110.922 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.516 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 15.8 m95 -85.07 91.85 8.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 75.120000000000005 110.956 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.617 HD12 ' HD2' ' A' ' 54' ' ' LYS . 17.3 mt -100.38 146.08 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 64.239999999999995 111.123 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -142.69 155.06 44.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.030000000000001 110.902 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.0 119.95 11.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 72.129999999999995 110.875 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD2' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -93.24 -178.24 4.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 74.200000000000003 110.855 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -145.25 10.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 70.510000000000005 110.878 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.486 ' ND2' ' OD2' ' A' ' 62' ' ' ASP . 15.1 p30 -124.08 -1.39 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 52.140000000000001 110.883 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.492 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -84.41 98.93 10.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 62.119999999999997 111.082 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -100.19 78.98 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 73.400000000000006 111.124 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.86 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -127.75 170.24 12.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 110.924 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.86 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.31 151.99 23.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 64.450000000000003 110.865 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.603 HG12 ' CE2' ' A' ' 98' ' ' PHE . 2.8 mm -27.45 122.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 72.310000000000002 111.116 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.03 -25.46 7.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 53.240000000000002 112.513 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.11 -168.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 74.219999999999999 110.841 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.9 mttt -151.18 171.96 16.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 71.299999999999997 110.908 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.58 HG12 HD22 ' A' ' 34' ' ' LEU . 83.9 mt -147.96 149.23 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 75.420000000000002 111.09 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.1 m-85 -152.76 115.3 4.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 65.519999999999996 110.935 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.598 ' CE2' HG23 ' A' ' 77' ' ' THR . 8.3 p90 -171.55 -159.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.428 ' CZ2' ' HG3' ' A' ' 38' ' ' MET . 0.0 OUTLIER -151.79 133.29 14.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 75.25 110.935 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.598 HG23 ' CE2' ' A' ' 75' ' ' PHE . 1.7 p -93.78 166.84 12.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 63.310000000000002 111.182 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.58 132.22 28.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 65.329999999999998 110.857 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.414 ' C ' HG13 ' A' ' 80' ' ' ILE . 2.1 m -135.6 177.12 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 71.209999999999994 111.103 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.8 HG13 HD12 ' A' ' 27' ' ' LEU . 79.0 mt -150.13 99.65 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 60.32 111.155 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -115.92 140.86 48.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.219999999999999 110.907 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.87 33.13 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 62.310000000000002 110.848 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.94 36.96 83.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 54.340000000000003 112.5 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.43 -52.22 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.906 0.384 . . . . 54.5 110.908 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.02 102.9 0.73 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 74.099999999999994 112.486 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -122.88 179.19 4.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 74.340000000000003 110.948 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.456 ' CG ' ' O ' ' A' ' 77' ' ' THR . 1.7 tmm_? -177.38 136.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 75.439999999999998 110.899 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -75.28 160.87 29.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 73.230000000000004 110.942 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -139.34 -167.77 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 72.010000000000005 110.88 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.7 OUTLIER 82.47 -40.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 65.310000000000002 110.822 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.09 79.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 25.219999999999999 112.502 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -167.49 109.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 73.400000000000006 110.888 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 -149.17 111.29 4.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 74.019999999999996 110.899 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 84.8 m -91.98 135.17 34.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 111.156 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.715 HG13 ' HB2' ' A' ' 10' ' ' ALA . 9.9 t -60.45 156.03 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 72.109999999999999 111.154 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 69' ' ' ILE . 13.7 mt-10 -163.05 -33.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 110.916 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.729 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -103.02 -170.91 26.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 74.25 112.486 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.603 ' CE2' HG12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -150.3 168.5 23.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.924 0.392 . . . . 61.049999999999997 110.879 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.63 ' HB ' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.52 175.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 71.310000000000002 111.138 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -137.73 142.26 40.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 110.888 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -88.48 51.29 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 70.329999999999998 110.836 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 51.219999999999999 111.085 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.6 0.714 . . . . 71.209999999999994 111.114 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.427 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.8 Cg_endo -69.79 167.79 23.45 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.7 2.267 . . . . 62.420000000000002 112.37 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 133.13 24.84 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 72.219999999999999 112.34 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.955 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -85.3 142.52 29.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 71.209999999999994 111.098 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m -99.01 77.36 2.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 65.120000000000005 111.174 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.593 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.8 mp -76.05 105.72 7.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 72.25 110.929 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.761 ' O ' HD11 ' A' ' 16' ' ' LEU . 5.1 mm-40 -78.53 -170.88 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 75.019999999999996 110.863 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.86 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -133.78 80.27 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 42.119999999999997 111.098 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.718 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.1 mm -71.94 172.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 71.239999999999995 111.135 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.704 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.25 172.09 0.25 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.596 0.712 . . . . 73.030000000000001 110.855 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.82 20.06 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 53.409999999999997 112.301 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 12' ' ' HIS . 2.7 pttt -125.95 21.87 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 72.319999999999993 110.918 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 62' ' ' ASP . . . 155.58 -178.49 32.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 61.43 112.485 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.808 HD13 HD11 ' A' ' 67' ' ' LEU . 19.9 tp -149.83 168.23 24.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 75.230000000000004 110.931 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HB2' HD11 ' A' ' 11' ' ' ILE . 13.9 ttm180 -135.56 134.91 39.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 64.319999999999993 110.87 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 8' ' ' LEU . 78.6 t -144.62 106.65 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 111.114 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.418 ' HB2' HG23 ' A' ' 59' ' ' ILE . 20.1 t -116.08 156.47 26.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 75.510000000000005 110.822 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.978 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 33.0 m -141.25 152.66 64.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.672 0.749 . . . . 62.039999999999999 111.088 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 120.91 7.61 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.628 2.218 . . . . 63.520000000000003 112.312 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.48 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 3.6 t70 -75.9 99.71 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 70.519999999999996 110.855 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -88.98 35.44 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 52.539999999999999 110.873 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.12 25.01 25.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 60.119999999999997 112.485 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.488 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 98.8 m-85 -73.05 168.1 19.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.913 0.387 . . . . 72.239999999999995 110.857 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.2 t -129.34 -8.15 4.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 53.240000000000002 110.839 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.014 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -159.62 142.06 13.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.95 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.014 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -137.19 150.97 48.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 64.140000000000001 110.876 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.17 143.81 40.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 64.540000000000006 111.133 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -126.52 119.76 27.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 63.219999999999999 110.884 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 5.8 m-70 -152.08 92.32 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.504 . . . . 63.299999999999997 110.846 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 75' ' ' PHE . . . -146.22 178.55 23.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 71.140000000000001 112.498 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.459 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -133.18 -164.81 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 44.109999999999999 110.907 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.451 HD23 HD22 ' A' ' 35' ' ' ASN . 1.4 tp -132.56 152.33 51.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 65.310000000000002 110.921 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.451 HD22 HD23 ' A' ' 34' ' ' LEU . 13.3 m-80 41.27 25.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 43.109999999999999 110.916 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -164.01 136.86 5.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 71.040000000000006 110.915 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.42 163.81 12.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 73.25 110.839 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.579 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 64.319999999999993 110.867 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.459 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.523 -0.231 . . . . 71.299999999999997 112.523 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.03 -71.82 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 70.239999999999995 110.907 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -53.73 148.35 10.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 73.450000000000003 110.975 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.543 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 52.4 p -155.45 119.74 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 52.109999999999999 110.889 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.57 160.97 11.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 64.329999999999998 110.89 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.02 114.7 9.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.299999999999997 110.87 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' PHE . 10.2 mm -94.57 97.51 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 64.099999999999994 111.124 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.561 HG22 HD23 ' A' ' 27' ' ' LEU . 46.2 p -95.38 29.7 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 73.25 111.158 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.92 133.06 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 74.409999999999997 110.902 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -178.14 2.18 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.675 2.25 . . . . 64.439999999999998 112.387 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -135.73 -34.39 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 74.239999999999995 110.924 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -138.77 49.2 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 72.329999999999998 110.909 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.87 -26.12 4.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 72.519999999999996 112.415 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.64 168.22 14.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.775 0.322 . . . . 70.340000000000003 110.897 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.488 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 13.9 m95 -90.25 87.96 7.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 72.409999999999997 110.908 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.418 HG23 ' HB2' ' A' ' 19' ' ' SER . 44.9 mt -91.91 141.52 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.5 111.075 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.524 ' CE2' ' OD1' ' A' ' 62' ' ' ASP . 18.8 t80 -138.24 147.06 43.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 64.120000000000005 110.869 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 139.38 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 62.149999999999999 110.928 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -120.29 140.59 51.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 70.140000000000001 110.867 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.03 31.03 6.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 70.319999999999993 110.877 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.36 19.89 2.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.867 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.4 112.4 23.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 62.219999999999999 111.091 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -108.39 83.72 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 51.130000000000003 111.107 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -135.61 171.22 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 110.884 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.661 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.85 158.46 36.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.239999999999995 110.9 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.684 HD11 ' O ' ' A' ' 97' ' ' GLY . 26.9 mm -32.16 115.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 64.239999999999995 111.136 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.24 -26.66 4.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.709 -0.757 . . . . 71.129999999999995 112.474 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.37 -172.5 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.914 0.388 . . . . 52.100000000000001 110.834 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -143.17 168.23 20.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 110.917 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.7 mt -145.24 143.18 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 71.450000000000003 111.145 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -147.43 108.69 4.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 73.109999999999999 110.948 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.422 ' CB ' ' HA3' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -164.07 -163.87 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 75.019999999999996 110.833 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.579 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -149.13 144.1 26.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 74.120000000000005 110.925 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.1 p -113.15 149.62 33.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 70.109999999999999 111.17 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.59 142.96 46.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 110.873 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -141.8 170.83 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 111.14 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.721 HG13 HD12 ' A' ' 27' ' ' LEU . 80.1 mt -147.63 96.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 70.439999999999998 111.138 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 9.2 tttt -112.68 140.74 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.319999999999993 110.921 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 40.97 38.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 33.350000000000001 110.893 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.01 40.86 51.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 63.039999999999999 112.501 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 mt -105.09 -48.24 3.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 74.299999999999997 110.946 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.21 105.27 1.08 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.704 -0.76 . . . . 73.409999999999997 112.499 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -123.97 168.96 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.38 . . . . 64.329999999999998 110.9 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 77' ' ' THR . 3.7 ttp-105 -175.05 140.03 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 63.409999999999997 110.848 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.435 ' N ' ' HG2' ' A' ' 87' ' ' ARG . 3.2 tp-100 -84.19 155.47 22.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 74.349999999999994 110.869 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -137.97 -169.47 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 70.400000000000006 110.884 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 83.78 -33.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 63.32 110.884 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 41.13 83.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.8 -0.714 . . . . 71.420000000000002 112.429 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -169.66 112.98 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 75.450000000000003 110.9 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -155.32 110.97 3.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 75.230000000000004 110.931 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 95.9 m -83.82 139.27 32.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 73.219999999999999 111.137 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.676 HG13 ' HB2' ' A' ' 10' ' ' ALA . 39.2 t -69.67 116.67 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 65.209999999999994 111.083 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -138.64 10.3 2.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 72.540000000000006 110.849 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.86 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -117.88 -178.11 17.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.771 -0.728 . . . . 73.420000000000002 112.512 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.585 ' CE2' HG13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -153.41 152.01 30.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 55.299999999999997 110.872 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.718 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.61 170.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 111.166 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.61 129.03 25.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 64.099999999999994 110.865 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -87.66 45.94 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 54.32 110.906 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 44.32 111.096 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.716 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.605 0.717 . . . . 73.25 111.109 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 161.03 47.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.719 2.279 . . . . 71.340000000000003 112.323 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 134.58 28.27 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.694 2.263 . . . . 63.32 112.327 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.629 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -89.53 139.06 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 50.020000000000003 111.095 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -89.48 77.7 7.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 73.519999999999996 111.145 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.516 HD23 ' CG2' ' A' ' 18' ' ' VAL . 1.9 mp -79.63 111.47 15.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 44.219999999999999 110.919 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.495 ' O ' HD11 ' A' ' 16' ' ' LEU . 2.0 mm-40 -86.18 -155.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 61.340000000000003 110.848 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -144.21 80.96 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 41.109999999999999 111.074 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 17' ' ' ARG . 4.0 mm -69.62 172.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 61.509999999999998 111.134 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.7 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.69 172.41 0.23 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.597 0.713 . . . . 62.229999999999997 110.861 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.2 Cg_endo -69.75 20.38 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.671 2.247 . . . . 74.209999999999994 112.356 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 1.2 ptmt -128.33 26.44 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 110.933 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.34 -178.81 29.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.749 . . . . 63.329999999999998 112.454 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.074 HD13 HD21 ' A' ' 67' ' ' LEU . 35.1 tp -150.78 167.07 28.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 71.209999999999994 110.896 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.716 ' HB2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -129.33 141.1 51.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 62.130000000000003 110.871 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.516 ' CG2' HD23 ' A' ' 8' ' ' LEU . 62.4 t -153.17 105.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 31.43 111.1 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 t -116.31 164.28 14.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.230000000000004 110.874 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 6' ' ' ALA . 22.7 m -143.15 151.65 56.02 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.668 0.747 . . . . 43.240000000000002 111.117 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 122.12 8.81 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 44.509999999999998 112.344 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -81.84 94.89 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 72.25 110.898 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -91.88 24.97 2.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 71.239999999999995 110.871 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.98 28.15 4.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.729 -0.748 . . . . 63.43 112.534 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 77.7 m-85 -78.41 165.83 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 72.010000000000005 110.839 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.0 t -128.79 -8.25 5.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 65.129999999999995 110.844 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.008 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -161.19 140.63 10.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 72.340000000000003 110.926 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.008 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.6 t80 -134.57 145.68 48.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 70.019999999999996 110.846 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.64 164.6 23.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 65.140000000000001 111.088 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.424 ' C ' ' CD1' ' A' ' 30' ' ' PHE . 4.2 t80 -150.16 113.75 4.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 72.530000000000001 110.877 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CD2' ' O ' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -149.23 95.17 2.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 43.539999999999999 110.864 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.556 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -146.19 -175.36 19.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 74.439999999999998 112.474 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 mtpp -131.84 -165.12 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.324 . . . . 64.230000000000004 110.882 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.64 148.14 40.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 75.239999999999995 110.901 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.415 ' N ' HD22 ' A' ' 35' ' ' ASN . 1.0 OUTLIER 49.29 22.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 110.844 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.7 143.17 2.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 64.400000000000006 110.879 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -108.82 154.17 22.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 41.299999999999997 110.902 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.907 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.485 -0.246 . . . . 71.450000000000003 112.485 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.88 -69.17 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 63.32 110.845 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.543 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 8.0 m0 -54.98 170.96 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 75.140000000000001 110.931 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.418 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 59.9 p -176.13 127.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 74.409999999999997 110.927 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.06 155.58 3.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 52.32 110.875 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.26 99.98 3.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 71.340000000000003 110.855 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.96 122.53 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 74.409999999999997 111.117 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.5 p -110.14 37.92 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 65.219999999999999 111.134 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 174.35 116.91 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.594 0.711 . . . . 70.129999999999995 110.871 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.541 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 54.0 Cg_endo -69.74 159.35 53.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.24 . . . . 73.430000000000007 112.375 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -142.12 131.88 24.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.909 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 1.9 t30 78.45 16.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 54.219999999999999 110.869 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.33 -23.87 33.74 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 54.509999999999998 112.454 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.52 171.79 13.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 71.310000000000002 110.856 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.541 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 9.4 m95 -86.87 101.06 13.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 75.540000000000006 110.919 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 mt -101.06 137.04 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 74.409999999999997 111.144 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -132.23 145.11 51.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.120000000000005 110.895 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.36 134.01 31.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.420000000000002 110.914 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.94 179.32 4.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 61.350000000000001 110.906 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 19.84 2.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.200000000000003 110.883 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -137.84 30.28 2.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 71.510000000000005 110.908 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.425 ' O ' HD23 ' A' ' 67' ' ' LEU . . . -118.71 83.35 2.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 54.420000000000002 111.074 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -80.09 86.06 5.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 43.32 111.057 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.074 HD21 HD13 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -125.71 171.68 10.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 74.430000000000007 110.925 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -160.28 140.57 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 65.439999999999998 110.91 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 97' ' ' GLY . 11.5 mm -24.26 118.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 72.219999999999999 111.093 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.27 -18.68 7.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.775 -0.726 . . . . 73.319999999999993 112.468 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.12 -176.76 4.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.339 . . . . 55.039999999999999 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -143.99 161.81 37.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 70.430000000000007 110.857 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.8 mt -138.93 145.66 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 111.108 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -146.15 103.01 3.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 71.540000000000006 110.89 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -162.14 -157.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 70.329999999999998 110.889 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.423 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.1 p-90 -150.93 173.74 13.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 74.200000000000003 110.932 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 p -143.05 158.74 43.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 54.109999999999999 111.172 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.16 144.48 45.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 73.409999999999997 110.829 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -143.69 169.52 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 62.43 111.111 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.736 HG13 HD12 ' A' ' 27' ' ' LEU . 66.9 mt -147.71 96.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.172 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -114.63 140.64 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.030000000000001 110.942 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 50.63 27.12 2.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 75.319999999999993 110.845 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.37 29.13 68.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 42.299999999999997 112.5 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.45 HD13 ' OH ' ' A' ' 86' ' ' TYR . 2.4 mt -98.98 -49.53 4.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 74.230000000000004 110.908 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.6 131.48 4.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 74.099999999999994 112.496 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.65 ' HB2' HG23 ' A' ' 79' ' ' VAL . 76.5 m-85 -145.17 -179.24 6.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 74.409999999999997 110.935 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -172.24 133.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 75.340000000000003 110.897 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.716 ' OE1' ' HB3' ' A' ' 3' ' ' ALA . 4.3 tp60 -78.74 155.15 29.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 75.319999999999993 110.92 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.509 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -141.6 -163.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 75.120000000000005 110.87 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.509 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.7 t-20 83.05 -36.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 75.140000000000001 110.893 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.19 78.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 41.100000000000001 112.471 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -170.47 109.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.358 . . . . 74.420000000000002 110.925 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -151.14 112.89 4.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 74.530000000000001 110.928 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.9 m -86.85 130.92 34.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.430000000000007 111.066 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.69 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 21.2 t -62.85 116.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 63.229999999999997 111.128 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.0 15.2 3.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 62.109999999999999 110.895 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -130.44 -177.82 15.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 62.409999999999997 112.507 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.448 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -153.86 155.52 35.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.372 . . . . 64.430000000000007 110.872 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.604 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -166.71 168.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 65.120000000000005 111.151 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.34 133.92 39.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 54.549999999999997 110.876 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.17 39.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 73.329999999999998 110.851 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.099 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.612 0.72 . . . . 64.140000000000001 111.062 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.483 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.8 Cg_endo -69.74 166.95 25.83 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.653 2.235 . . . . 72.239999999999995 112.365 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 132.65 23.77 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.683 2.255 . . . . 72.519999999999996 112.379 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.811 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -83.12 138.24 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 45.130000000000003 111.103 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.5 m -95.59 78.03 3.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 72.310000000000002 111.138 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.559 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.4 mp -79.32 109.31 13.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 52.340000000000003 110.969 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.846 ' O ' HD11 ' A' ' 16' ' ' LEU . 6.7 mm-40 -79.99 -171.79 3.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 53.100000000000001 110.924 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -130.46 81.26 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 52.240000000000002 111.119 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.731 HD13 ' CG2' ' A' ' 99' ' ' VAL . 2.9 mm -72.66 172.52 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 111.12 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.706 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.34 172.01 0.26 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.605 0.717 . . . . 61.409999999999997 110.849 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.73 19.86 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 74.030000000000001 112.373 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 12' ' ' HIS . 11.1 ptmt -124.66 19.94 8.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 72.540000000000006 110.887 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.21 -177.44 33.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.796 -0.716 . . . . 60.329999999999998 112.486 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.846 HD11 ' O ' ' A' ' 9' ' ' GLU . 19.8 tp -150.89 168.98 22.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 72.540000000000006 110.888 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HB2' HD11 ' A' ' 11' ' ' ILE . 3.2 ttt180 -132.92 139.44 47.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 73.040000000000006 110.86 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -147.83 108.28 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 111.137 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 59' ' ' ILE . 12.8 t -119.5 157.41 28.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 60.030000000000001 110.859 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 6' ' ' ALA . 21.6 m -141.6 151.58 60.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.644 0.735 . . . . 63.439999999999998 111.138 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 122.21 8.89 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.713 2.275 . . . . 65.439999999999998 112.326 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 28.4 t0 -84.55 86.12 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 75.040000000000006 110.86 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -73.08 2.52 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 74.450000000000003 110.852 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.33 24.24 0.86 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.737 . . . . 74.310000000000002 112.511 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 81.4 m-85 -70.45 168.34 16.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 74.049999999999997 110.866 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t -125.39 -16.03 6.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 54.32 110.893 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.026 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -158.34 140.14 13.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 64.239999999999995 110.944 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.026 ' N ' HD22 ' A' ' 27' ' ' LEU . 8.3 t80 -132.77 151.5 51.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 72.319999999999993 110.883 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.74 155.39 48.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 71.340000000000003 111.082 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.645 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.4 m-85 -128.88 131.28 47.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 64.409999999999997 110.849 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.436 ' O ' ' CE ' ' A' ' 38' ' ' MET . 14.0 m-70 -157.63 84.97 0.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 71.430000000000007 110.868 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -144.55 177.47 23.08 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 70.209999999999994 112.491 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -136.21 -166.23 1.84 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 75.239999999999995 110.905 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 72' ' ' LYS . 13.7 tp -127.38 148.12 50.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 73.200000000000003 110.889 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 43.14 23.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.120000000000005 110.886 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 34' ' ' LEU . 2.0 tp10 -157.67 145.54 18.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 74.099999999999994 110.907 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.462 ' CB ' ' HB2' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -125.09 150.42 46.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 61.229999999999997 110.849 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.436 ' CE ' ' O ' ' A' ' 31' ' ' HIS . 2.3 ptt? . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 54.140000000000001 110.88 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.522 -0.231 . . . . 74.420000000000002 112.522 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.55 -65.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 72.230000000000004 110.857 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -60.01 154.83 18.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 72.549999999999997 110.941 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.432 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 99.3 p -158.01 109.22 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 61.43 110.836 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.845 ' NH1' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.73 162.92 40.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 74.200000000000003 110.871 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.509 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -143.65 113.73 7.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 74.349999999999994 110.893 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.845 HD13 ' NH1' ' A' ' 48' ' ' ARG . 11.2 mm -99.85 103.9 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 64.420000000000002 111.177 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.47 HG22 HD23 ' A' ' 27' ' ' LEU . 76.6 p -96.06 30.47 2.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 111.169 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 175.46 132.8 0.15 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 74.409999999999997 110.945 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 178.68 4.35 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.634 2.222 . . . . 64.239999999999995 112.363 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -129.53 -30.41 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 53.009999999999998 110.878 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -146.27 47.66 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 54.539999999999999 110.863 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.13 -26.26 7.04 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 40.420000000000002 112.459 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.88 164.42 21.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.827 0.346 . . . . 62.149999999999999 110.845 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 5.9 m95 -87.16 96.2 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 75.310000000000002 110.946 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.503 HD12 ' HD2' ' A' ' 54' ' ' LYS . 43.0 mt -102.75 142.04 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 62.340000000000003 111.155 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -134.98 154.28 51.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 74.430000000000007 110.91 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.76 135.4 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 71.329999999999998 110.869 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD2' ' ND2' ' A' ' 64' ' ' ASN . 6.0 t70 -112.22 174.97 5.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 72.540000000000006 110.839 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -139.42 15.46 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 63.340000000000003 110.844 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.492 ' ND2' ' OD2' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -129.44 4.94 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 72.219999999999999 110.888 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.16 98.13 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 73.209999999999994 111.102 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -96.45 87.53 4.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 111.086 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.798 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -138.79 171.17 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 61.219999999999999 110.911 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.699 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.73 156.57 31.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 72.230000000000004 110.943 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.4 mm -32.01 118.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 75.420000000000002 111.189 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.26 -23.56 6.43 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 62.109999999999999 112.516 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.9 -170.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 73.049999999999997 110.88 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.514 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -147.91 162.05 40.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 60.420000000000002 110.924 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.87 145.9 29.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 61.149999999999999 111.114 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -148.4 111.42 4.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.959 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.6 p90 -171.98 -163.45 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.913 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.18 145.6 24.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 61.350000000000001 110.895 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.484 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 11.2 p -113.45 161.11 17.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 111.153 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.551 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -119.17 144.77 46.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 71.310000000000002 110.884 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.642 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -139.24 166.14 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.349999999999994 111.178 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.643 HG13 HD12 ' A' ' 27' ' ' LEU . 90.7 mt -143.26 96.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 64.510000000000005 111.15 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.461 ' HG2' ' N ' ' A' ' 82' ' ' ASP . 4.9 tttt -118.66 146.36 44.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 72.140000000000001 110.918 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 52.15 22.26 1.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.439999999999998 110.858 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.15 27.67 71.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.754 . . . . 61.32 112.499 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mt -100.05 -65.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 73.25 110.917 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.39 124.85 4.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.688 -0.768 . . . . 31.32 112.464 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.642 ' HB2' HG23 ' A' ' 79' ' ' VAL . 8.2 m-85 -136.71 178.0 7.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.394 . . . . 74.0 110.89 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.551 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -164.2 123.97 2.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 72.219999999999999 110.886 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.579 HE22 ' N ' ' A' ' 6' ' ' ALA . 1.9 tt0 -52.85 -173.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 62.100000000000001 110.897 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -170.49 -166.25 0.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 62.299999999999997 110.885 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER 83.53 -32.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 73.209999999999994 110.873 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 33.9 61.76 0.48 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.71 -0.757 . . . . 43.43 112.495 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -167.88 106.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 74.010000000000005 110.91 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 25.7 m-90 -145.42 115.51 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 61.119999999999997 110.889 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 60.5 m -87.31 133.16 33.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 65.540000000000006 111.149 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 10' ' ' ALA . 21.6 t -63.38 107.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 51.219999999999999 111.143 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.75 5.21 7.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 60.32 110.892 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.8 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -117.53 179.76 17.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 75.099999999999994 112.464 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -152.96 155.52 37.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.904 0.383 . . . . 74.420000000000002 110.872 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.731 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.51 -176.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 72.430000000000007 111.14 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -141.88 129.6 21.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 63.5 110.893 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -80.23 58.71 3.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.329999999999998 110.897 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 74.400000000000006 111.109 179.927 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 86' ' ' TYR . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.576 0.703 . . . . 53.020000000000003 111.125 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 154.62 67.62 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.71 2.273 . . . . 74.530000000000001 112.315 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 134.47 28.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.672 2.248 . . . . 52.520000000000003 112.336 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.888 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -86.24 137.92 32.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 64.120000000000005 111.11 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 m -93.18 77.19 4.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 74.219999999999999 111.122 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.535 HD21 ' CE1' ' A' ' 75' ' ' PHE . 1.9 mp -77.94 110.87 13.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 72.540000000000006 110.911 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.795 ' O ' HD11 ' A' ' 16' ' ' LEU . 20.4 mm-40 -87.26 -167.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 75.519999999999996 110.858 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.867 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -134.32 80.51 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 62.240000000000002 111.131 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 17' ' ' ARG . 4.5 mm -69.38 172.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 71.200000000000003 111.122 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.7 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -53.85 172.03 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 73.25 110.817 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.9 Cg_endo -69.77 21.43 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 54.509999999999998 112.347 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 12' ' ' HIS . 7.5 pttt -128.82 25.07 5.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 72.140000000000001 110.884 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.29 -177.9 30.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 51.109999999999999 112.488 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.934 HD13 HD21 ' A' ' 67' ' ' LEU . 24.6 tp -150.71 157.97 43.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.347 . . . . 61.539999999999999 110.919 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.771 ' HB2' HD11 ' A' ' 11' ' ' ILE . 74.8 ttt180 -122.75 135.25 54.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 65.400000000000006 110.889 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 8' ' ' LEU . 53.7 t -147.06 108.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 74.329999999999998 111.095 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.702 ' HB2' HG23 ' A' ' 59' ' ' ILE . 46.4 t -120.56 162.2 20.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 75.120000000000005 110.897 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.888 HG12 ' HA ' ' A' ' 6' ' ' ALA . 30.4 m -141.04 152.03 63.87 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.646 0.736 . . . . 73.420000000000002 111.102 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 123.98 10.65 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.646 2.231 . . . . 72.340000000000003 112.364 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 17.0 t0 -87.82 107.05 18.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 63.43 110.889 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -96.09 6.81 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 44.130000000000003 110.893 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.48 8.97 2.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 73.239999999999995 112.462 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 63.5 m-85 -60.27 168.5 1.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.328 . . . . 71.409999999999997 110.887 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -128.95 -7.39 4.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.854 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.994 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -156.32 143.06 18.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 62.509999999999998 110.915 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.994 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.3 t80 -139.73 139.32 36.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 75.5 110.882 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.44 158.86 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 73.239999999999995 111.141 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.484 ' HE2' HG11 ' A' ' 18' ' ' VAL . 4.1 t80 -145.75 114.65 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 65.510000000000005 110.891 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.557 ' CD2' ' HA ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -147.35 94.87 2.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 73.349999999999994 110.846 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.62 177.61 23.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 53.340000000000003 112.456 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.55 -164.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 75.209999999999994 110.905 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.688 HD12 ' O ' ' A' ' 72' ' ' LYS . 15.0 tp -136.31 148.53 47.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 70.340000000000003 110.954 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 48.96 19.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 71.420000000000002 110.894 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -161.24 142.7 11.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 73.019999999999996 110.888 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.03 156.69 22.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 73.430000000000007 110.897 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.599 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 64.349999999999994 110.821 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 N-CA-C 112.483 -0.247 . . . . 71.430000000000007 112.483 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -103.41 -51.75 3.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 75.010000000000005 110.877 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.567 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 8.3 m0 -70.19 165.42 22.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.922 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.557 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 96.0 p -164.65 124.25 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 72.0 110.847 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HG2' ' CD1' ' A' ' 60' ' ' PHE . 17.0 tpp180 -165.44 144.26 6.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 73.209999999999994 110.872 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.572 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -139.39 99.31 3.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.868 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mm -87.87 115.42 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 64.409999999999997 111.115 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.415 HG22 HD23 ' A' ' 27' ' ' LEU . 63.8 p -103.78 33.47 3.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 53.140000000000001 111.134 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.6 OUTLIER 167.84 127.38 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.605 0.717 . . . . 72.010000000000005 110.903 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 171.17 15.01 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.687 2.258 . . . . 73.099999999999994 112.32 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.82 19.45 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 44.420000000000002 110.907 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -177.56 38.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.140000000000001 110.917 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.47 -13.62 15.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 75.329999999999998 112.452 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.05 160.54 40.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.805 0.336 . . . . 75.209999999999994 110.873 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.474 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 3.9 m95 -85.79 101.39 12.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 75.219999999999999 110.949 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.702 HG23 ' HB2' ' A' ' 19' ' ' SER . 7.7 mt -104.32 143.78 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 62.399999999999999 111.121 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.494 ' CD1' ' HG2' ' A' ' 48' ' ' ARG . 13.1 t80 -132.27 147.89 52.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 73.530000000000001 110.939 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.439 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -140.93 127.45 20.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 74.010000000000005 110.886 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.567 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 2.5 t0 -104.47 -179.53 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 65.420000000000002 110.853 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -148.95 28.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 75.439999999999998 110.865 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -144.88 13.58 1.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 63.439999999999998 110.876 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.03 100.09 9.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 73.200000000000003 111.142 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -95.54 86.55 4.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 62.450000000000003 111.094 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.934 HD21 HD13 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -125.62 171.55 10.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 74.150000000000006 110.895 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.501 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -152.79 140.49 19.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 63.530000000000001 110.931 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.54 HG12 ' CD1' ' A' ' 98' ' ' PHE . 17.1 mm -28.23 118.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 60.530000000000001 111.096 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.67 -22.04 5.56 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.749 -0.739 . . . . 71.099999999999994 112.474 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.84 -166.87 0.32 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 65.239999999999995 110.898 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.688 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.1 mttt -147.33 172.16 14.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 110.871 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.2 mt -144.72 144.69 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 75.109999999999999 111.129 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.3 100.75 3.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 74.299999999999997 110.87 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.535 ' CE1' HD21 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -159.5 -156.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 72.409999999999997 110.826 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.599 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -152.46 156.68 39.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.510000000000005 110.918 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 p -118.82 175.38 5.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 74.450000000000003 111.176 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -146.95 130.46 16.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 70.239999999999995 110.905 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 86' ' ' TYR . 3.3 m -134.13 -179.03 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 64.430000000000007 111.138 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.737 HG13 HD12 ' A' ' 27' ' ' LEU . 83.1 mt -153.37 97.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 74.099999999999994 111.108 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.531 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 16.1 tttm -113.1 135.19 54.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 62.219999999999999 110.9 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.3 t0 50.51 25.1 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.25 110.851 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.98 30.04 73.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 54.210000000000001 112.511 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.733 HD13 ' OH ' ' A' ' 86' ' ' TYR . 2.0 mt -92.53 -66.87 0.89 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.359 . . . . 75.400000000000006 110.915 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.59 116.09 4.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.755 . . . . 60.130000000000003 112.495 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.733 ' OH ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -127.33 166.46 17.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.879 0.371 . . . . 70.109999999999999 110.902 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.434 ' HB2' ' CE2' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -160.33 110.67 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 74.519999999999996 110.904 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.74 157.9 13.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 74.450000000000003 110.924 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -146.72 -169.11 3.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.299999999999997 110.849 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.6 m120 83.93 -28.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 71.040000000000006 110.862 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 34.41 78.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 31.539999999999999 112.492 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -165.96 104.14 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 75.409999999999997 110.887 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.406 ' CG ' HD13 ' A' ' 8' ' ' LEU . 19.4 m-90 -145.95 113.28 6.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 110.939 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 93.1 m -82.07 140.07 34.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 75.099999999999994 111.138 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.867 HG13 ' HB2' ' A' ' 10' ' ' ALA . 21.2 t -78.64 111.61 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 53.509999999999998 111.133 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -138.66 16.32 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 74.530000000000001 110.861 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -139.38 121.7 2.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.78 -0.724 . . . . 61.299999999999997 112.527 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -91.02 170.08 10.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.91 0.386 . . . . 73.030000000000001 110.895 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.643 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -168.03 155.16 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 71.319999999999993 111.127 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -115.18 127.35 55.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 65.120000000000005 110.864 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -89.81 39.5 0.96 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 54.420000000000002 110.924 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 73.019999999999996 111.132 179.927 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.58 0.705 . . . . 71.400000000000006 111.075 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.472 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 54.2 Cg_endo -69.66 168.3 21.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.267 . . . . 73.329999999999998 112.358 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 132.72 23.96 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 64.219999999999999 112.356 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.784 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.01 134.92 35.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 51.25 111.085 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -93.12 77.16 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 75.549999999999997 111.117 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.666 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.1 mp -79.34 107.18 11.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 63.350000000000001 110.928 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.903 ' O ' HD11 ' A' ' 16' ' ' LEU . 6.6 mm-40 -79.92 -173.58 3.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.909 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.68 79.65 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 64.420000000000002 111.047 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 17' ' ' ARG . 3.2 mm -70.6 172.61 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 73.239999999999995 111.139 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.694 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -53.05 171.54 0.22 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 64.030000000000001 110.839 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.5 Cg_endo -69.79 19.77 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.686 2.257 . . . . 72.129999999999995 112.307 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' HIS . 25.5 pttt -127.91 25.43 5.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 72.420000000000002 110.921 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.55 -179.98 30.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.754 -0.736 . . . . 71.549999999999997 112.498 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.019 HD13 HD21 ' A' ' 67' ' ' LEU . 20.5 tp -149.97 158.3 44.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 71.010000000000005 110.902 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.717 ' HB2' HD11 ' A' ' 11' ' ' ILE . 11.4 ttt180 -126.37 132.55 51.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.019999999999996 110.88 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.666 HG22 ' HA ' ' A' ' 8' ' ' LEU . 54.2 t -141.29 114.03 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 71.099999999999994 111.129 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.529 ' HB2' HG23 ' A' ' 59' ' ' ILE . 7.8 t -119.96 156.56 30.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 63.299999999999997 110.85 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.784 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.4 m -139.01 152.67 70.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.589 0.709 . . . . 74.25 111.168 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 121.36 8.05 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.727 2.285 . . . . 72.010000000000005 112.313 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.598 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.1 t70 -55.69 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 65.030000000000001 110.881 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' A' ' 22' ' ' ASP . 0.9 OUTLIER 83.46 -13.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 75.439999999999998 110.874 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.83 6.47 2.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 71.230000000000004 112.516 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CD2' ' O ' ' A' ' 22' ' ' ASP . 36.1 m-85 -53.8 166.74 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 74.120000000000005 110.865 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 80' ' ' ILE . 11.4 t -133.08 -2.25 3.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 73.409999999999997 110.822 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.043 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -171.45 139.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.892 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.043 ' N ' HD22 ' A' ' 27' ' ' LEU . 13.3 t80 -133.77 152.5 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 64.129999999999995 110.871 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.79 158.87 43.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 75.530000000000001 111.113 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.522 ' HE2' HG11 ' A' ' 18' ' ' VAL . 1.5 t80 -139.2 127.27 22.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 71.129999999999995 110.871 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.529 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 7.3 m-70 -152.89 88.04 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.200000000000003 110.859 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.523 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.27 -176.67 20.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 33.549999999999997 112.47 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -134.8 -164.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 74.109999999999999 110.863 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.1 tp -131.94 147.02 52.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 73.140000000000001 110.875 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 39.92 30.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 74.420000000000002 110.859 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.03 127.6 4.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.450000000000003 110.893 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -99.96 146.81 26.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 71.340000000000003 110.864 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.0 ptp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 64.049999999999997 110.881 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.503 -0.239 . . . . 74.099999999999994 112.503 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.74 -58.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.752 0.31 . . . . 63.439999999999998 110.837 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -69.66 146.96 51.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 74.540000000000006 110.936 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.529 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 77.7 p -155.12 120.18 4.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 64.239999999999995 110.812 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.14 158.85 25.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 63.340000000000003 110.92 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.743 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -143.56 116.19 8.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 71.140000000000001 110.835 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mm -98.76 108.17 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 54.450000000000003 111.144 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -98.23 31.84 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 72.219999999999999 111.106 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.23 115.59 0.27 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.656 0.741 . . . . 74.439999999999998 110.858 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 53.7 Cg_endo -69.71 178.16 4.82 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.66 2.24 . . . . 74.129999999999995 112.377 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.693 ' HD3' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -169.88 133.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 62.329999999999998 110.902 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 7.1 t-20 81.62 8.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 52.020000000000003 110.92 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.88 -16.84 42.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 74.209999999999994 112.542 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.1 176.01 9.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 72.140000000000001 110.911 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.55 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 6.9 m95 -93.41 107.91 19.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 71.540000000000006 110.893 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.693 HD12 ' HD3' ' A' ' 54' ' ' LYS . 11.1 mt -106.21 146.62 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 72.239999999999995 111.111 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -136.38 144.53 44.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 73.510000000000005 110.85 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.51 133.43 40.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.859 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.78 155.1 31.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 70.310000000000002 110.864 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -123.31 41.9 3.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 54.350000000000001 110.862 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.87 24.02 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 64.239999999999995 110.854 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.3 93.1 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 111.129 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -89.38 81.1 6.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.420000000000002 111.11 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.019 HD21 HD13 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -121.91 171.52 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 70.510000000000005 110.948 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.569 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -157.74 138.45 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 73.409999999999997 110.935 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.569 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.8 mm -22.65 118.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 75.409999999999997 111.181 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.94 -18.12 7.09 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 24.199999999999999 112.472 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.97 -169.19 1.47 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.866 0.365 . . . . 72.329999999999998 110.908 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.9 mttt -150.34 161.67 42.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 71.439999999999998 110.937 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.3 mt -135.63 146.65 29.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 74.150000000000006 111.145 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.9 m-85 -147.59 107.01 3.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 75.209999999999994 110.903 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.4 p90 -167.67 -167.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 70.120000000000005 110.883 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.9 p-90 -135.97 163.11 31.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 73.010000000000005 110.943 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 p -131.35 164.4 25.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 55.329999999999998 111.133 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.67 141.64 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 75.310000000000002 110.912 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.598 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -141.03 167.3 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.25 111.137 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.589 ' CD1' HD12 ' A' ' 27' ' ' LEU . 94.1 mt -149.89 95.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 65.120000000000005 111.094 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -109.84 137.49 47.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 71.430000000000007 110.891 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 43.4 34.95 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 64.5 110.909 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.69 37.73 92.77 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 64.349999999999994 112.461 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.81 -55.11 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 64.319999999999993 110.94 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.11 113.22 1.13 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 73.219999999999999 112.482 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.598 ' HB2' HG23 ' A' ' 79' ' ' VAL . 96.7 m-85 -132.23 -178.72 5.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 75.439999999999998 110.918 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -174.09 135.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 70.140000000000001 110.849 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 4' ' ' PRO . 1.4 tp-100 -86.1 153.19 22.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 74.109999999999999 110.881 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -135.19 -163.91 1.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 65.120000000000005 110.884 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.4 t-20 83.73 -37.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 73.200000000000003 110.896 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.51 79.12 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.77 -0.728 . . . . 75.239999999999995 112.479 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -170.14 110.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 62.109999999999999 110.886 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -151.52 115.4 4.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.329999999999998 110.921 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.5 m -87.06 131.18 34.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 61.450000000000003 111.185 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.688 HG21 HD12 ' A' ' 67' ' ' LEU . 28.8 t -63.21 116.33 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 73.450000000000003 111.123 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.04 6.1 3.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 75.409999999999997 110.875 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.812 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -115.82 -178.55 18.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 71.099999999999994 112.461 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.515 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.7 155.7 33.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 63.329999999999998 110.89 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.711 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.76 178.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 64.540000000000006 111.119 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.38 133.61 27.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 70.519999999999996 110.905 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -85.24 44.89 1.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 75.120000000000005 110.882 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.400000000000006 111.074 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.563 0.697 . . . . 75.549999999999997 111.126 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 169.11 19.6 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.281 . . . . 54.130000000000003 112.369 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 133.37 25.28 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 51.409999999999997 112.35 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.727 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -83.68 140.54 32.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 64.310000000000002 111.063 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m -100.77 78.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 63.340000000000003 111.175 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.529 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.7 mp -78.27 110.18 13.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 74.109999999999999 110.925 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.635 ' O ' HD11 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -78.19 -160.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 75.200000000000003 110.891 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.796 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -139.92 80.34 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 71.209999999999994 111.118 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.755 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.3 mm -72.19 172.69 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 73.430000000000007 111.179 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.709 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.18 172.09 0.25 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.712 . . . . 71.230000000000004 110.858 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.598 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.2 Cg_endo -69.82 20.07 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.665 2.243 . . . . 74.5 112.3 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 12' ' ' HIS . 3.0 pttt -125.1 19.8 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 53.299999999999997 110.902 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.78 -177.3 33.77 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 71.329999999999998 112.492 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.987 HD13 HD21 ' A' ' 67' ' ' LEU . 27.8 tp -150.98 167.93 26.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.804 0.335 . . . . 75.299999999999997 110.922 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.575 ' HB2' HD11 ' A' ' 11' ' ' ILE . 5.2 ttm180 -130.78 141.08 50.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 74.209999999999994 110.879 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -149.59 107.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 111.121 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.553 ' HB2' HG23 ' A' ' 59' ' ' ILE . 11.7 t -120.18 156.3 31.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 65.030000000000001 110.871 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 6' ' ' ALA . 3.1 m -145.08 151.76 49.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 73.040000000000006 111.139 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 121.2 7.9 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.677 2.251 . . . . 74.129999999999995 112.339 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 1.2 t70 -75.7 130.84 39.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 74.129999999999995 110.872 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.7 23.93 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 73.409999999999997 110.836 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 112.8 5.91 23.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.736 . . . . 74.519999999999996 112.468 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 66.7 m-85 -55.62 162.54 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 53.130000000000003 110.897 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.3 t -129.84 -8.9 4.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 61.310000000000002 110.879 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.009 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -158.64 141.85 14.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 71.420000000000002 110.936 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 1.009 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -135.65 150.39 49.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 70.219999999999999 110.841 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.718 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . . . -141.0 136.75 32.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 74.450000000000003 111.083 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.62 118.28 30.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 75.140000000000001 110.84 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.488 ' NE2' ' CB ' ' A' ' 47' ' ' SER . 0.2 OUTLIER -146.0 90.58 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 71.510000000000005 110.881 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 75' ' ' PHE . . . -146.24 -178.31 21.56 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 73.409999999999997 112.494 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -132.76 -164.3 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 72.239999999999995 110.909 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' HG ' ' ND2' ' A' ' 35' ' ' ASN . 14.0 tp -133.18 147.94 52.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 62.329999999999998 110.965 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.466 ' ND2' ' HG ' ' A' ' 34' ' ' LEU . 2.2 m120 43.39 24.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 74.019999999999996 110.881 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -166.49 143.09 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 70.519999999999996 110.938 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -105.51 -170.55 1.76 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.907 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.508 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 2.1 ptt? . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 63.009999999999998 110.866 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.508 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.483 -0.247 . . . . 73.099999999999994 112.483 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.43 -69.87 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 54.119999999999997 110.897 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.446 ' O ' ' ND1' ' A' ' 31' ' ' HIS . 6.1 m-90 -47.47 164.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 70.409999999999997 110.915 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.488 ' CB ' ' NE2' ' A' ' 31' ' ' HIS . 97.0 p -166.31 117.39 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 74.209999999999994 110.878 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.56 162.43 21.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 62.240000000000002 110.874 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.718 ' OD1' ' HB2' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -139.44 108.38 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 55.310000000000002 110.915 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 28' ' ' PHE . 3.4 mm -82.94 104.2 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 60.310000000000002 111.095 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.1 p -91.94 28.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 51.399999999999999 111.136 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.34 140.78 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.555 0.693 . . . . 72.340000000000003 110.885 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 178.25 4.74 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.739 2.293 . . . . 53.340000000000003 112.298 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.706 ' HD2' HD12 ' A' ' 59' ' ' ILE . 12.3 ttmt -109.9 -55.53 2.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 71.200000000000003 110.926 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.02 75.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 73.299999999999997 110.906 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.61 -22.22 6.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 74.430000000000007 112.481 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -137.98 171.89 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 73.140000000000001 110.906 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.585 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 18.9 m95 -93.58 98.44 11.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 110.922 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.706 HD12 ' HD2' ' A' ' 54' ' ' LYS . 27.9 mt -99.97 150.67 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 73.239999999999995 111.132 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -146.1 147.41 31.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 55.409999999999997 110.935 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.29 127.46 22.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 71.120000000000005 110.869 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -98.6 -179.55 4.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 73.209999999999994 110.871 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.59 16.17 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 72.209999999999994 110.879 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -133.43 6.93 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 75.430000000000007 110.871 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.68 103.28 15.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 73.420000000000002 111.09 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -98.61 83.01 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 75.120000000000005 111.057 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.987 HD21 HD13 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -122.38 171.6 8.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 73.219999999999999 110.917 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -158.45 141.62 14.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.888 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.576 HD11 ' O ' ' A' ' 97' ' ' GLY . 5.2 mm -26.0 117.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 62.25 111.168 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.31 -17.15 10.54 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.803 -0.713 . . . . 63.039999999999999 112.507 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.83 -167.98 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 73.430000000000007 110.892 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 16.4 mttt -151.52 165.56 33.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.340000000000003 110.918 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.8 mt -141.26 151.12 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 53.340000000000003 111.143 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -150.28 101.1 2.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.25 110.87 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.488 ' CB ' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -160.1 -166.35 1.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 74.109999999999999 110.872 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.4 148.64 32.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 74.129999999999995 110.902 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 p -115.07 155.61 26.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.431 . . . . 75.420000000000002 111.173 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.02 142.97 49.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 71.549999999999997 110.877 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.451 ' CG1' ' CD2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -142.68 170.72 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 72.530000000000001 111.098 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.675 HG13 HD12 ' A' ' 27' ' ' LEU . 77.5 mt -146.5 96.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 71.329999999999998 111.151 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.443 ' HG3' ' C ' ' A' ' 24' ' ' GLY . 1.6 tttt -114.15 141.58 47.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.409999999999997 110.947 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 49.14 32.44 4.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 72.150000000000006 110.852 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.08 30.11 60.27 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 74.310000000000002 112.476 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.535 HD13 ' OH ' ' A' ' 86' ' ' TYR . 1.5 mt -96.85 -63.6 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 65.049999999999997 110.923 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.09 106.11 3.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 72.219999999999999 112.452 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.535 ' OH ' HD13 ' A' ' 84' ' ' LEU . 80.2 m-85 -119.47 171.72 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 74.439999999999998 110.875 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 6.8 ttp-105 -171.33 131.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 71.430000000000007 110.895 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -74.08 158.93 33.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 72.129999999999995 110.923 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.4 OUTLIER -140.83 -164.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 64.140000000000001 110.869 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.2 t-20 83.75 -42.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.230000000000004 110.907 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.52 70.48 0.75 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 31.399999999999999 112.473 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -170.02 117.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 62.130000000000003 110.895 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -155.23 118.65 4.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 110.942 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.8 m -87.6 132.04 34.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 64.439999999999998 111.147 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.71 HG21 HD12 ' A' ' 67' ' ' LEU . 32.8 t -67.29 112.3 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.150000000000006 111.159 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -129.42 10.92 5.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.519999999999996 110.897 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.796 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -122.65 -177.0 15.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 61.299999999999997 112.473 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.507 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -154.04 155.76 36.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.372 . . . . 71.340000000000003 110.861 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.755 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.48 -176.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 72.230000000000004 111.153 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -151.95 132.57 13.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 60.530000000000001 110.829 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -102.93 46.14 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 63.420000000000002 110.897 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 63.299999999999997 111.078 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.879 0.371 . . . . 71.329999999999998 110.902 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -141.78 85.86 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.081 -0.509 . . . . 74.219999999999999 110.898 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 66.67 141.06 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.62 0.724 . . . . 54.43 111.07 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 167.26 24.92 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.697 2.265 . . . . 73.099999999999994 112.333 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.422 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 53.6 Cg_endo -69.79 134.19 27.32 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.686 2.257 . . . . 74.450000000000003 112.342 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.921 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.55 136.02 35.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 71.219999999999999 111.112 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.4 m -95.6 77.57 3.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 74.010000000000005 111.107 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.494 ' H ' HD12 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -79.42 110.17 14.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 71.219999999999999 110.912 179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.789 ' O ' HD11 ' A' ' 16' ' ' LEU . 12.9 mm-40 -79.8 -165.61 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 64.420000000000002 110.903 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.823 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -134.95 80.33 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 60.299999999999997 111.103 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.702 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.6 mm -70.81 172.5 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 74.150000000000006 111.127 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.702 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.79 172.37 0.23 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.573 0.702 . . . . 60.119999999999997 110.853 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.79 20.02 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.614 2.209 . . . . 63.030000000000001 112.378 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 12' ' ' HIS . 3.8 ptpt -126.78 24.04 6.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 70.019999999999996 110.885 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.91 -178.48 30.8 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 42.409999999999997 112.498 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.789 HD11 ' O ' ' A' ' 9' ' ' GLU . 29.1 tp -150.52 164.11 36.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.857 0.361 . . . . 64.310000000000002 110.892 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.618 ' HB2' HD11 ' A' ' 11' ' ' ILE . 49.6 ttt180 -127.61 137.61 52.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 71.129999999999995 110.863 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 78.8 t -145.6 108.25 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 72.420000000000002 111.11 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.5 t -122.3 156.45 33.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.464 . . . . 73.340000000000003 110.919 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.921 HG12 ' HA ' ' A' ' 6' ' ' ALA . 10.4 m -141.36 150.86 59.49 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.633 0.73 . . . . 72.349999999999994 111.117 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 122.27 8.95 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.725 2.283 . . . . 71.140000000000001 112.348 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 15.0 t70 -83.81 128.74 34.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 73.099999999999994 110.844 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -117.97 2.21 12.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 51.009999999999998 110.916 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.27 31.08 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.726 -0.75 . . . . 62.530000000000001 112.452 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.518 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 63.3 m-85 -82.27 160.9 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.826 0.346 . . . . 53.210000000000001 110.897 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 30.7 t -126.48 -13.52 6.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 53.420000000000002 110.856 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.035 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -153.64 140.17 18.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.125 -0.489 . . . . 70.109999999999999 110.959 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.035 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -133.75 143.72 48.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 64.030000000000001 110.861 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.03 129.35 43.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.093 -0.503 . . . . 74.510000000000005 111.171 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -115.24 120.62 40.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 75.140000000000001 110.941 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.487 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 11.4 m-70 -151.58 91.07 1.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 55.049999999999997 110.864 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.501 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -145.96 -177.6 20.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.777 -0.725 . . . . 62.030000000000001 112.484 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' O ' HG23 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -135.3 -166.44 1.84 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.886 0.374 . . . . 73.25 110.847 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' O ' ' C ' ' A' ' 35' ' ' ASN . 9.5 tp -128.07 147.35 50.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 62.299999999999997 110.886 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.411 ' C ' ' O ' ' A' ' 34' ' ' LEU . 1.7 m-80 36.47 34.88 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.137 -0.483 . . . . 65.299999999999997 110.929 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 34' ' ' LEU . 1.2 tp10 -163.43 129.16 3.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 65.129999999999995 110.922 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -102.74 150.21 23.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 64.299999999999997 110.87 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.35 -174.47 2.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 64.349999999999994 110.898 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -146.04 146.65 31.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 64.519999999999996 110.88 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 65.14 36.48 92.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.753 -0.736 . . . . 44.140000000000001 112.476 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 40' ' ' GLY . 5.6 mt 36.88 81.04 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.77 0.319 . . . . 72.299999999999997 110.958 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -123.32 171.68 9.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 64.109999999999999 110.818 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -79.31 98.63 6.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.481 . . . . 70.239999999999995 111.127 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.83 -115.16 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.721 -0.752 . . . . 74.209999999999994 112.435 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -103.27 -53.32 2.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 74.209999999999994 110.861 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.415 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.9 m-90 -73.25 147.47 44.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.219 -0.446 . . . . 70.120000000000005 110.881 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.487 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 87.2 p -151.27 119.01 6.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 60.219999999999999 110.88 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.92 163.12 4.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 71.340000000000003 110.889 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -142.82 119.37 11.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.187 -0.461 . . . . 45.43 110.88 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 28' ' ' PHE . 5.5 mm -86.17 109.98 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 63.530000000000001 111.138 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.9 p -94.79 28.01 2.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.179 -0.464 . . . . 71.120000000000005 111.174 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt 171.22 135.66 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.562 0.696 . . . . 62.350000000000001 110.908 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -175.57 1.19 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.679 2.253 . . . . 74.340000000000003 112.399 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.619 ' HD2' HD12 ' A' ' 59' ' ' ILE . 1.2 ttmm -157.16 109.57 2.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 60.340000000000003 110.867 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.483 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 3.6 t-20 82.68 15.14 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 54.229999999999997 110.855 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.67 -17.5 49.71 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 62.210000000000001 112.444 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.86 160.4 37.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 71.310000000000002 110.865 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.539 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 20.1 m95 -84.69 94.17 8.59 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 73.049999999999997 110.946 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.619 HD12 ' HD2' ' A' ' 54' ' ' LYS . 21.7 mt -97.72 143.12 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.444 . . . . 71.230000000000004 111.102 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -138.55 153.52 48.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 62.009999999999998 110.864 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.99 137.41 26.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 73.299999999999997 110.873 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.433 ' OD2' ' CG ' ' A' ' 64' ' ' ASN . 1.1 t70 -112.19 -177.67 3.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 73.219999999999999 110.894 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -143.49 10.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 73.430000000000007 110.85 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.433 ' CG ' ' OD2' ' A' ' 62' ' ' ASP . 22.1 p30 -127.28 9.87 6.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 73.219999999999999 110.844 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -97.24 101.06 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 72.349999999999994 111.085 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -100.85 88.74 3.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 64.540000000000006 111.162 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.743 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -136.33 171.22 14.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.451 . . . . 63.240000000000002 110.951 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.669 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.29 154.48 32.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 63.229999999999997 110.906 179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.616 ' CG1' ' CE2' ' A' ' 98' ' ' PHE . 16.2 mm -32.14 115.87 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 75.200000000000003 111.106 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 125.8 -20.53 6.4 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.686 -0.769 . . . . 55.32 112.455 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.69 -173.75 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.881 0.372 . . . . 75.319999999999993 110.849 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.5 mttt -149.56 159.68 44.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.446 . . . . 74.450000000000003 110.894 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 33' ' ' LYS . 10.4 mt -134.26 148.1 30.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 74.400000000000006 111.113 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -147.75 105.55 3.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 64.530000000000001 110.938 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 2.3 p90 -163.68 -159.44 0.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 74.230000000000004 110.855 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.431 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.9 p-90 -145.44 168.58 20.2 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 70.420000000000002 110.92 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.403 HG23 ' CE2' ' A' ' 75' ' ' PHE . 1.7 p -139.92 147.59 40.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 73.319999999999993 111.152 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -112.92 141.01 47.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 75.530000000000001 110.884 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.405 ' C ' HG13 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -139.69 171.2 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 73.140000000000001 111.112 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.624 HG13 HD12 ' A' ' 27' ' ' LEU . 97.4 mt -150.24 96.23 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 61.43 111.111 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.51 135.85 53.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 72.239999999999995 110.89 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 t70 48.43 33.37 3.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 64.349999999999994 110.897 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.69 31.0 63.28 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.75 . . . . 71.420000000000002 112.524 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.536 HD13 ' OH ' ' A' ' 86' ' ' TYR . 29.7 mt -95.19 -56.54 2.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.882 0.372 . . . . 64.109999999999999 110.921 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.14 113.93 2.92 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.769 -0.729 . . . . 52.200000000000003 112.462 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.536 ' OH ' HD13 ' A' ' 84' ' ' LEU . 97.4 m-85 -133.4 170.67 15.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 75.030000000000001 110.9 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.405 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -170.86 137.82 1.29 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 72.409999999999997 110.919 -179.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.422 ' NE2' ' HA ' ' A' ' 5' ' ' PRO . 1.5 tp60 -85.75 152.22 23.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.244 -0.435 . . . . 72.340000000000003 110.898 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -134.35 -166.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 73.420000000000002 110.828 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 82.92 -36.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.239999999999995 110.86 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 43.47 80.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.765 -0.731 . . . . 65.299999999999997 112.469 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -168.74 113.43 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 74.099999999999994 110.91 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.3 m-90 -151.09 121.56 7.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.187 -0.46 . . . . 71.540000000000006 110.9 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.4 m -92.96 134.56 34.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 64.420000000000002 111.143 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.823 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 21.4 t -63.61 121.24 12.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.464 . . . . 63.340000000000003 111.145 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.1 34.05 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.15 -0.477 . . . . 63.420000000000002 110.891 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -162.9 125.52 1.42 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.7 -0.762 . . . . 50.539999999999999 112.509 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.616 ' CE2' ' CG1' ' A' ' 69' ' ' ILE . 0.7 OUTLIER -94.92 163.89 13.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.872 0.368 . . . . 75.120000000000005 110.886 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.649 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.48 167.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 74.129999999999995 111.13 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.34 130.31 50.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 62.009999999999998 110.876 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -76.36 57.07 1.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 73.510000000000005 110.862 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 71.439999999999998 111.121 179.908 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.851 0.358 . . . . 73.109999999999999 110.921 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -143.01 76.51 1.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 71.439999999999998 110.899 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.06 147.25 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.541 0.686 . . . . 63.399999999999999 111.156 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.7 Cg_endo -69.75 166.01 29.03 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.65 2.233 . . . . 44.240000000000002 112.37 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 134.25 27.39 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.667 2.245 . . . . 75.0 112.327 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.752 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.01 140.41 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 61.539999999999999 111.086 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -97.1 78.7 2.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 75.519999999999996 111.146 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.5 HD21 ' CE1' ' A' ' 75' ' ' PHE . 1.7 mp -76.15 110.79 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 73.140000000000001 110.938 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.708 ' O ' HD11 ' A' ' 16' ' ' LEU . 4.8 mm-40 -84.5 -168.54 2.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 75.319999999999993 110.848 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.813 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -134.57 80.54 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.087 -0.506 . . . . 71.540000000000006 111.05 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.689 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -72.16 172.2 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 65.040000000000006 111.136 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.689 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.07 172.53 0.23 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.602 0.715 . . . . 75.019999999999996 110.825 179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.604 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.3 Cg_endo -69.8 19.91 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.705 2.27 . . . . 55.25 112.335 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 12' ' ' HIS . 8.1 pttt -127.18 25.14 6.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 72.239999999999995 110.862 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.58 -179.23 30.06 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.775 -0.726 . . . . 61.549999999999997 112.482 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.975 HD13 HD11 ' A' ' 67' ' ' LEU . 17.7 tp -150.35 164.49 35.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.802 0.334 . . . . 71.219999999999999 110.931 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.626 ' HB2' HD11 ' A' ' 11' ' ' ILE . 25.1 ttt-85 -126.19 141.89 51.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 73.019999999999996 110.9 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.8 t -152.11 102.47 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 63.240000000000002 111.113 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -115.22 157.08 24.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 73.219999999999999 110.83 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.752 HG12 ' HA ' ' A' ' 6' ' ' ALA . 20.5 m -139.94 151.64 65.86 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 71.310000000000002 111.148 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.429 ' HG2' ' CG ' ' A' ' 4' ' ' PRO . 53.9 Cg_endo -69.74 125.26 11.95 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.719 2.279 . . . . 74.040000000000006 112.366 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 20.1 t0 -87.33 83.72 7.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.236 -0.438 . . . . 31.23 110.868 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -70.96 -0.27 8.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 73.409999999999997 110.899 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.5 28.7 0.46 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 75.120000000000005 112.489 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -77.18 166.87 22.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.868 0.365 . . . . 74.230000000000004 110.906 -179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.5 t -124.64 -15.26 6.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.145 -0.479 . . . . 73.329999999999998 110.836 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.05 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -157.0 136.9 12.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.157 -0.474 . . . . 75.400000000000006 110.965 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.05 ' N ' HD22 ' A' ' 27' ' ' LEU . 7.6 t80 -131.06 148.09 52.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 74.0 110.881 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.25 157.7 45.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 64.409999999999997 111.091 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.629 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.5 m-85 -130.96 127.28 38.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 73.140000000000001 110.895 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.571 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 1.7 m-70 -153.27 85.76 1.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.152 -0.476 . . . . 71.439999999999998 110.877 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.533 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.15 173.84 26.29 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 61.509999999999998 112.488 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.32 -164.57 1.5 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 73.109999999999999 110.942 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.5 tp -134.01 145.3 49.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.249 -0.432 . . . . 72.319999999999993 110.916 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 47.57 28.88 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 53.420000000000002 110.914 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -168.32 134.64 1.94 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.310000000000002 110.922 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -108.49 160.18 16.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 63.140000000000001 110.852 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -103.03 -173.77 2.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 61.219999999999999 110.843 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -146.11 145.87 30.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 65.519999999999996 110.925 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.39 21.9 74.5 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.728 -0.748 . . . . 73.319999999999993 112.487 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.549 HD13 ' NH2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER 50.81 86.5 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.794 0.33 . . . . 64.450000000000003 110.958 -179.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -129.37 -171.47 2.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.019999999999996 110.867 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.571 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -92.31 105.19 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.132 -0.485 . . . . 70.319999999999993 111.096 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.19 -121.11 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.702 -0.761 . . . . 64.409999999999997 112.505 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.68 -65.27 0.98 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.742 0.305 . . . . 64.0 110.861 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -60.64 139.37 57.86 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 71.200000000000003 110.954 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.5 p -139.64 115.55 10.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 43.219999999999999 110.811 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.76 154.75 31.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.487 . . . . 65.150000000000006 110.87 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.668 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -144.34 109.63 5.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 75.010000000000005 110.859 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 52' ' ' LYS . 12.8 mm -92.64 125.78 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 60.329999999999998 111.094 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 55.6 p -111.06 33.85 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 43.149999999999999 111.141 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.506 ' H ' HG22 ' A' ' 50' ' ' ILE . 3.2 tttt 163.45 131.78 0.02 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.617 0.722 . . . . 60.130000000000003 110.906 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 -176.0 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.698 2.266 . . . . 63.310000000000002 112.363 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.409 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -139.04 -35.98 0.55 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 72.219999999999999 110.881 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' NH1' ' A' ' 57' ' ' ARG . 1.9 m120 -128.0 38.24 4.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.899 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.42 -27.86 8.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.685 -0.769 . . . . 74.420000000000002 112.548 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -125.2 173.51 8.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.832 0.348 . . . . 74.209999999999994 110.877 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.412 ' HB2' HG22 ' A' ' 20' ' ' VAL . 12.6 m95 -92.28 94.46 9.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 72.510000000000005 110.898 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.409 HD12 ' HD2' ' A' ' 54' ' ' LYS . 56.2 mt -98.24 141.31 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 63.439999999999998 111.141 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 61' ' ' ARG . 19.6 t80 -136.52 153.08 51.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 62.25 110.895 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.406 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -143.96 137.28 27.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 74.329999999999998 110.883 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.17 178.41 4.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 64.430000000000007 110.9 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.89 10.83 2.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 61.229999999999997 110.83 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -125.47 7.38 7.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 62.420000000000002 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.432 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -94.82 103.03 14.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 54.149999999999999 111.097 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -102.42 85.21 2.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 70.219999999999999 111.105 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.975 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -138.56 170.96 15.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 110.904 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.663 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.84 164.56 37.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.885 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.537 HD11 ' O ' ' A' ' 97' ' ' GLY . 26.4 mm -33.01 122.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 73.310000000000002 111.11 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.4 -29.41 6.71 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.719 -0.753 . . . . 63.240000000000002 112.509 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -63.36 -176.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.903 0.382 . . . . 72.230000000000004 110.86 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -143.6 169.36 17.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 72.140000000000001 110.91 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 92.3 mt -147.84 145.22 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 64.400000000000006 111.092 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.468 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.2 m-85 -148.38 105.25 3.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 110.938 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 2.4 p90 -164.6 -160.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 72.400000000000006 110.905 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.486 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -149.05 155.58 40.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 75.109999999999999 110.937 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.455 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 5.6 p -124.0 147.37 47.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 61.229999999999997 111.163 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -105.99 151.07 25.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 60.420000000000002 110.879 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.596 HG13 ' HD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -145.48 169.41 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 71.450000000000003 111.125 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.715 HG13 HD12 ' A' ' 27' ' ' LEU . 69.9 mt -150.26 95.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 111.151 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -112.15 136.6 51.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 71.209999999999994 110.899 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 44.35 38.79 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.225 -0.443 . . . . 72.150000000000006 110.871 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.9 35.74 59.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 63.409999999999997 112.459 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 mt -97.72 -59.19 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 64.420000000000002 110.951 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.53 105.87 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 54.219999999999999 112.526 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.517 ' HB2' HG23 ' A' ' 79' ' ' VAL . 94.5 m-85 -124.21 178.35 5.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.824 0.345 . . . . 75.030000000000001 110.957 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.549 ' NH2' HD13 ' A' ' 41' ' ' LEU . 4.1 tmm_? -178.42 130.35 0.13 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 64.310000000000002 110.903 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.443 ' NE2' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -65.29 -171.19 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.92 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.502 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.0 t70 -170.37 -169.8 0.87 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.193 -0.458 . . . . 62.520000000000003 110.841 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.3 t-20 83.01 -36.64 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 64.120000000000005 110.864 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.33 75.98 0.15 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.758 -0.734 . . . . 34.539999999999999 112.513 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -168.18 117.49 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.889 0.375 . . . . 73.420000000000002 110.9 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -157.06 118.53 3.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 71.400000000000006 110.93 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 36.5 m -90.82 142.12 28.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.426 . . . . 54.439999999999998 111.153 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.687 HG13 ' HB2' ' A' ' 10' ' ' ALA . 28.2 t -76.35 112.47 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 71.400000000000006 111.154 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -131.52 4.7 4.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 72.239999999999995 110.923 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.813 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -116.6 -176.53 17.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.777 -0.725 . . . . 43.240000000000002 112.492 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.5 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 0.1 OUTLIER -156.66 159.89 38.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.371 . . . . 74.439999999999998 110.896 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.64 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.79 -174.42 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 71.329999999999998 111.101 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -148.05 137.68 22.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 43.240000000000002 110.877 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -79.27 46.79 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 74.349999999999994 110.892 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 50.130000000000003 111.072 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.878 0.37 . . . . 74.010000000000005 110.893 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -135.86 72.9 1.45 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 71.140000000000001 110.913 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.541 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . . . 59.38 147.32 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.597 0.713 . . . . 74.019999999999996 111.06 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.73 167.09 25.41 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.666 2.244 . . . . 74.010000000000005 112.33 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 133.47 25.69 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.652 2.235 . . . . 65.120000000000005 112.34 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.867 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -82.03 136.6 35.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 70.329999999999998 111.122 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.2 m -92.95 77.72 4.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 64.310000000000002 111.141 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.436 HD21 ' CE1' ' A' ' 75' ' ' PHE . 2.0 mp -78.48 108.68 12.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 54.409999999999997 110.927 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.845 ' O ' HD11 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -82.55 -173.47 4.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 71.450000000000003 110.928 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.49 80.75 1.98 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 111.096 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 12' ' ' HIS . 2.5 mm -71.72 172.68 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 72.430000000000007 111.134 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.71 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.92 171.63 0.26 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 74.219999999999999 110.823 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.585 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.2 Cg_endo -69.79 19.7 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.628 2.219 . . . . 63.439999999999998 112.361 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.482 ' H ' ' C ' ' A' ' 12' ' ' HIS . 12.6 pttt -125.82 22.1 7.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 73.329999999999998 110.861 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 155.67 -178.98 31.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.757 -0.735 . . . . 34.030000000000001 112.506 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.845 HD11 ' O ' ' A' ' 9' ' ' GLU . 19.4 tp -150.46 164.42 35.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 72.109999999999999 110.938 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HB2' HD11 ' A' ' 11' ' ' ILE . 8.5 ttm180 -128.95 136.77 50.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 55.509999999999998 110.839 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.3 t -146.34 106.8 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.451 . . . . 72.349999999999994 111.157 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.531 ' HB2' HG23 ' A' ' 59' ' ' ILE . 13.0 t -119.68 157.84 27.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 63.130000000000003 110.83 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.867 HG12 ' HA ' ' A' ' 6' ' ' ALA . 20.6 m -140.86 151.53 63.02 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.645 0.735 . . . . 73.129999999999995 111.125 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 122.16 8.84 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.651 2.234 . . . . 32.109999999999999 112.325 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -80.51 97.91 7.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 75.409999999999997 110.838 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -86.32 12.42 10.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 110.931 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 123.26 15.68 3.7 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.703 -0.761 . . . . 63.109999999999999 112.46 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 87.5 m-85 -66.49 165.56 14.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 74.310000000000002 110.865 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.8 t -125.03 -17.24 5.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 71.030000000000001 110.839 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.046 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -153.45 139.67 18.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 73.340000000000003 110.903 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.046 ' N ' HD22 ' A' ' 27' ' ' LEU . 8.0 t80 -132.0 148.63 52.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 63.020000000000003 110.873 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.53 155.12 50.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 65.430000000000007 111.152 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.644 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.6 m-85 -127.94 125.51 39.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 72.109999999999999 110.871 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.973 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 4.1 m-70 -149.03 83.52 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.485 . . . . 73.120000000000005 110.83 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.14 173.61 26.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.739 -0.743 . . . . 70.109999999999999 112.496 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -131.6 -164.11 1.41 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 73.439999999999998 110.925 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.432 ' O ' ' N ' ' A' ' 36' ' ' GLU . 21.9 tp -126.49 147.61 49.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 64.310000000000002 110.962 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 34' ' ' LEU . 1.6 m-80 37.04 32.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 110.86 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 34' ' ' LEU . 64.5 tt0 -161.96 134.36 5.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 74.140000000000001 110.925 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -106.51 160.43 15.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.200000000000003 110.88 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.439 ' HE1' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -111.43 178.45 4.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 62.140000000000001 110.888 179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.46 153.94 48.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.265 -0.425 . . . . 64.030000000000001 110.933 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.45 27.06 68.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 73.129999999999995 112.502 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.647 HD13 ' NH1' ' A' ' 87' ' ' ARG . 2.0 mt 45.58 78.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.842 0.354 . . . . 71.140000000000001 110.91 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -119.0 174.16 6.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 64.439999999999998 110.87 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.973 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -84.09 103.9 13.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 65.030000000000001 111.097 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.45 -121.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.747 -0.74 . . . . 55.399999999999999 112.482 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -100.67 -68.74 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.322 . . . . 74.239999999999995 110.827 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.594 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 6.0 m0 -58.02 97.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 72.150000000000006 110.925 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 93.8 p -109.17 105.09 14.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 62.420000000000002 110.874 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.89 162.8 37.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.868 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -144.6 117.22 8.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 110.833 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 52' ' ' LYS . 18.4 mm -97.42 113.04 30.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 72.420000000000002 111.163 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 79.6 p -95.9 30.46 2.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 111.17 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.552 ' H ' HG22 ' A' ' 50' ' ' ILE . 2.8 tttt 173.99 138.62 0.15 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.721 . . . . 61.5 110.937 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -175.47 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.707 2.271 . . . . 73.430000000000007 112.323 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.719 ' HD2' HD12 ' A' ' 59' ' ' ILE . 21.7 ttmm -118.47 -71.56 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 72.140000000000001 110.872 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -123.07 46.57 2.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 60.310000000000002 110.87 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.67 -35.05 4.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 30.02 112.497 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.78 177.2 6.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.759 0.314 . . . . 72.340000000000003 110.879 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -93.32 98.65 11.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.201 -0.454 . . . . 75.319999999999993 110.879 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.719 HD12 ' HD2' ' A' ' 54' ' ' LYS . 20.9 mt -103.09 141.0 19.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 73.420000000000002 111.147 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -135.64 147.1 48.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.914 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.96 126.83 29.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 110.872 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.594 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.4 OUTLIER -104.06 169.81 8.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 61.130000000000003 110.916 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.2 mtt180 -136.93 20.3 3.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 75.0 110.837 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -133.19 14.55 4.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 74.510000000000005 110.887 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -104.54 101.86 11.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.219 -0.446 . . . . 64.129999999999995 111.109 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -98.96 84.23 3.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 54.149999999999999 111.11 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.764 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -135.89 171.17 14.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 75.519999999999996 110.879 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.757 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.71 158.07 34.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 43.439999999999998 110.959 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.6 mm -31.44 116.95 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 73.010000000000005 111.11 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.24 -26.1 5.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.678 -0.772 . . . . 74.209999999999994 112.512 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -72.79 -175.62 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 62.25 110.856 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.0 mptt -144.88 163.02 35.38 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.171 -0.468 . . . . 70.030000000000001 110.902 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 37.3 mt -138.63 143.59 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 62.340000000000003 111.169 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -145.48 105.27 4.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 73.209999999999994 110.931 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.546 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 3.9 p90 -165.44 -161.38 0.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 74.129999999999995 110.853 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.494 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -145.86 174.06 11.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 73.150000000000006 110.877 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 p -141.5 156.45 45.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 72.109999999999999 111.137 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.2 137.79 52.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.453 . . . . 70.430000000000007 110.903 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -134.19 166.62 28.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 73.340000000000003 111.149 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.66 HG13 HD12 ' A' ' 27' ' ' LEU . 91.7 mt -142.44 95.9 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 63.229999999999997 111.138 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 tttp -116.44 147.51 41.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 71.329999999999998 110.919 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 49.05 27.8 1.83 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.441 . . . . 62.100000000000001 110.884 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.77 30.94 70.27 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.734 -0.746 . . . . 53.409999999999997 112.464 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.17 -73.14 0.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.803 0.335 . . . . 61.219999999999999 110.93 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.94 117.21 2.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.732 -0.747 . . . . 73.120000000000005 112.505 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.656 ' HB2' HG23 ' A' ' 79' ' ' VAL . 76.7 m-85 -128.08 170.76 12.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.95 0.405 . . . . 72.430000000000007 110.911 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.647 ' NH1' HD13 ' A' ' 41' ' ' LEU . 43.0 ttp180 -159.05 139.0 11.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 71.299999999999997 110.884 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.541 ' OE1' ' HB3' ' A' ' 3' ' ' ALA . 2.9 tp60 -80.78 160.93 24.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 75.329999999999998 110.908 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 6.1 m-20 -145.49 -173.45 4.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 75.230000000000004 110.876 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 85.11 -32.87 0.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 63.149999999999999 110.894 -179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.441 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 33.47 81.91 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.769 -0.729 . . . . 72.319999999999993 112.512 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -172.48 110.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.838 0.351 . . . . 72.239999999999995 110.909 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.7 m-90 -153.22 105.89 2.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 110.943 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.3 m -76.3 136.39 39.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 74.329999999999998 111.122 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.757 HG13 ' HB2' ' A' ' 10' ' ' ALA . 45.6 t -64.82 109.72 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 75.329999999999998 111.128 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -128.6 5.2 5.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.219999999999999 110.89 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.825 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -115.64 -178.64 18.46 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.797 -0.716 . . . . 74.019999999999996 112.498 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.497 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.96 155.87 33.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.944 0.402 . . . . 75.310000000000002 110.881 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.684 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.58 -177.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 72.25 111.142 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -139.45 132.0 28.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 70.099999999999994 110.865 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -76.06 54.98 0.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 63.310000000000002 110.913 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 70.129999999999995 111.083 179.928 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.846 0.355 . . . . 74.219999999999999 110.924 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -142.57 73.84 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 71.129999999999995 110.884 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 79' ' ' VAL . . . 62.05 148.43 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.596 0.713 . . . . 65.209999999999994 111.063 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 169.68 18.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.651 2.234 . . . . 72.200000000000003 112.354 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.444 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 53.7 Cg_endo -69.78 134.79 28.79 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.683 2.256 . . . . 72.219999999999999 112.362 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.883 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -83.32 137.46 33.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 74.019999999999996 111.148 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -96.5 77.43 2.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.442 . . . . 74.099999999999994 111.141 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.568 HD21 ' CE1' ' A' ' 75' ' ' PHE . 1.9 mp -76.81 110.13 11.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.24 -0.437 . . . . 75.010000000000005 110.953 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.846 ' O ' HD11 ' A' ' 16' ' ' LEU . 28.9 mp0 -83.01 -173.24 4.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.230000000000004 110.857 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.664 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -131.12 80.29 1.93 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.157 -0.474 . . . . 71.010000000000005 111.115 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.753 HD13 ' CG2' ' A' ' 99' ' ' VAL . 2.9 mm -70.23 172.42 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 73.239999999999995 111.126 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.698 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.92 172.04 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.581 0.705 . . . . 75.010000000000005 110.841 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.5 Cg_endo -69.77 20.12 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.674 2.249 . . . . 64.310000000000002 112.368 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' HIS . 39.9 pttt -125.76 21.71 7.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 44.219999999999999 110.895 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 155.4 -178.11 32.21 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.784 -0.722 . . . . 74.120000000000005 112.518 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.846 HD11 ' O ' ' A' ' 9' ' ' GLU . 23.1 tp -150.08 164.57 35.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.863 0.363 . . . . 71.299999999999997 110.862 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.664 ' HB2' HD11 ' A' ' 11' ' ' ILE . 51.7 ttt180 -130.2 140.59 50.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 70.120000000000005 110.901 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.45 HG22 ' HA ' ' A' ' 8' ' ' LEU . 45.0 t -148.58 111.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 52.530000000000001 111.084 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.7 t -122.57 156.17 34.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 72.25 110.85 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.883 HG12 ' HA ' ' A' ' 6' ' ' ALA . 29.9 m -140.06 152.17 66.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.671 0.748 . . . . 65.439999999999998 111.102 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 121.39 8.08 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.672 2.248 . . . . 74.219999999999999 112.355 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -76.3 105.89 7.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.24 -0.436 . . . . 61.340000000000003 110.878 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.47 34.67 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 62.530000000000001 110.855 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.66 1.48 52.87 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.731 -0.747 . . . . 55.039999999999999 112.494 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.491 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 74.3 m-85 -54.05 164.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.891 0.377 . . . . 75.120000000000005 110.881 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 42.0 t -127.08 -11.8 5.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 73.329999999999998 110.885 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.05 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -158.73 138.49 11.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.123 -0.489 . . . . 73.230000000000004 110.914 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.05 ' N ' HD22 ' A' ' 27' ' ' LEU . 7.3 t80 -130.89 146.01 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 63.039999999999999 110.88 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.445 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . . . -129.53 158.39 39.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 72.109999999999999 111.071 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.668 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 1.8 m-85 -132.81 127.85 35.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 71.030000000000001 110.902 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.624 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 22.2 m-70 -157.35 86.74 0.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 73.140000000000001 110.854 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -144.8 175.02 24.69 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.796 -0.716 . . . . 53.409999999999997 112.523 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.29 -166.68 1.66 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.812 0.339 . . . . 61.520000000000003 110.919 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.708 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -129.93 124.64 33.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 70.310000000000002 110.912 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.595 ' ND2' HD12 ' A' ' 34' ' ' LEU . 67.9 m-80 62.05 23.54 13.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.46 . . . . 64.239999999999995 110.875 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -155.93 144.13 19.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 71.140000000000001 110.893 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -112.73 169.05 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.12 -0.491 . . . . 63.509999999999998 110.853 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.551 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -116.68 -174.4 2.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 74.230000000000004 110.853 -179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -144.1 147.0 33.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 71.230000000000004 110.905 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.53 31.69 81.73 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.751 -0.738 . . . . 41.100000000000001 112.502 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 1.9 mt 42.93 86.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.764 0.316 . . . . 74.319999999999993 110.901 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -131.47 175.07 9.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.204 -0.453 . . . . 62.100000000000001 110.852 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.624 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -84.46 104.28 14.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 72.010000000000005 111.125 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.6 -120.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.757 -0.735 . . . . 15.109999999999999 112.514 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.49 -63.09 1.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.819 0.343 . . . . 72.5 110.836 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.708 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.4 m-90 -61.15 155.33 20.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 71.310000000000002 110.9 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 99.2 p -158.45 109.53 2.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 75.540000000000006 110.867 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.37 160.3 38.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 61.340000000000003 110.861 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.531 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -144.09 107.22 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 72.319999999999993 110.913 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.1 mm -86.75 106.66 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 74.010000000000005 111.137 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.0 p -96.01 29.93 2.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 74.439999999999998 111.145 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 0.4 OUTLIER -176.85 113.66 0.25 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.628 0.727 . . . . 73.219999999999999 110.871 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.514 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 53.9 Cg_endo -69.76 -178.23 2.24 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.677 2.252 . . . . 73.239999999999995 112.321 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -174.33 136.26 0.47 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 75.019999999999996 110.893 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 2.6 t30 82.48 7.88 0.85 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 71.310000000000002 110.937 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.418 ' C ' ' CD ' ' A' ' 57' ' ' ARG . . . 100.0 -6.73 58.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.759 -0.734 . . . . 74.010000000000005 112.51 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.418 ' CD ' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -153.27 174.2 14.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 73.120000000000005 110.883 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.514 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 14.6 m95 -90.35 106.24 18.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 75.219999999999999 110.935 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.9 mt -107.5 146.63 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 74.319999999999993 111.13 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -143.43 149.06 37.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.166 -0.47 . . . . 65.519999999999996 110.913 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.45 133.1 28.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 110.883 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.72 -178.49 3.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 64.040000000000006 110.855 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -147.56 20.51 1.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 73.109999999999999 110.867 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -134.89 14.56 3.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 74.319999999999993 110.908 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.36 107.25 18.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 51.520000000000003 111.112 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -103.47 79.7 1.73 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 75.230000000000004 111.069 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.734 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -126.65 171.6 11.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.235 -0.439 . . . . 74.439999999999998 110.944 -179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.707 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.09 154.43 27.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 71.239999999999995 110.893 179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.501 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.7 mm -29.61 123.13 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 73.530000000000001 111.096 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.59 -25.54 7.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.755 -0.736 . . . . 61.43 112.499 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -70.73 -176.89 1.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.927 0.394 . . . . 63.140000000000001 110.808 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.3 OUTLIER -142.2 166.6 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 75.400000000000006 110.919 179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.501 HG12 HD22 ' A' ' 34' ' ' LEU . 87.4 mt -142.96 145.27 23.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.242 -0.435 . . . . 63.140000000000001 111.125 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -147.5 103.32 3.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 110.937 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.568 ' CE1' HD21 ' A' ' 8' ' ' LEU . 1.4 p90 -162.29 -162.09 0.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 74.150000000000006 110.927 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.551 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -150.64 149.77 30.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 110.896 -179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.537 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 7.0 p -119.76 145.87 46.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 62.32 111.132 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -103.84 150.5 24.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 75.420000000000002 110.896 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -143.28 166.92 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.098 -0.501 . . . . 65.040000000000006 111.112 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.629 HG13 HD12 ' A' ' 27' ' ' LEU . 85.7 mt -145.61 96.24 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 50.340000000000003 111.143 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.457 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -115.14 137.31 52.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 63.149999999999999 110.854 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 42.92 41.16 2.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 65.329999999999998 110.897 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.08 37.27 36.76 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.746 -0.74 . . . . 74.140000000000001 112.535 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.1 mt -98.18 -55.79 2.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.915 0.388 . . . . 53.210000000000001 110.913 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.79 105.23 1.63 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 60.310000000000002 112.447 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.538 ' HB2' HG23 ' A' ' 79' ' ' VAL . 99.0 m-85 -130.1 176.16 8.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.917 0.389 . . . . 75.150000000000006 110.929 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.451 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 0.4 OUTLIER -176.77 136.29 0.23 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 64.049999999999997 110.907 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.444 ' NE2' ' HA ' ' A' ' 5' ' ' PRO . 1.4 tp60 -73.42 163.53 27.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 71.519999999999996 110.878 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -145.94 -169.92 3.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.519999999999996 110.849 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.497 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.6 t-20 83.46 -33.79 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 73.150000000000006 110.884 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.73 84.66 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.797 -0.716 . . . . 73.540000000000006 112.468 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -170.13 116.28 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.822 0.344 . . . . 53.340000000000003 110.888 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.8 m-90 -157.84 109.57 2.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.194 -0.457 . . . . 75.420000000000002 110.938 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.6 m -81.59 138.91 35.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.253 -0.43 . . . . 65.340000000000003 111.138 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.664 HG13 ' HB2' ' A' ' 10' ' ' ALA . 22.4 t -70.11 110.58 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 73.430000000000007 111.083 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -131.76 4.32 4.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 63.219999999999999 110.887 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.66 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -113.95 -176.39 19.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 60.420000000000002 112.51 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.473 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -158.36 155.2 28.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.888 0.375 . . . . 73.329999999999998 110.895 -179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.753 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.51 175.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 53.409999999999997 111.136 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -139.1 127.64 23.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 75.120000000000005 110.891 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -80.22 54.6 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 73.439999999999998 110.898 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 74.510000000000005 111.081 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 4.8 t80 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.859 0.362 . . . . 73.420000000000002 110.897 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 6.5 mt-10 -140.94 72.57 1.39 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 64.030000000000001 110.899 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.501 ' HB3' ' O ' ' A' ' 2' ' ' GLU . . . 71.86 144.88 0.11 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.571 0.7 . . . . 61.329999999999998 111.069 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 167.61 23.97 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.644 2.229 . . . . 73.219999999999999 112.315 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 136.35 32.78 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.685 2.256 . . . . 61.109999999999999 112.32 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.889 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -89.65 137.27 32.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 63.200000000000003 111.132 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m -95.94 77.07 3.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.445 . . . . 42.009999999999998 111.153 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.506 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.5 mp -75.71 108.39 8.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.237 -0.438 . . . . 61.210000000000001 110.913 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.842 ' O ' HD11 ' A' ' 16' ' ' LEU . 10.3 mm-40 -79.93 -172.54 3.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 62.340000000000003 110.835 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.832 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.63 80.58 1.97 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.030000000000001 111.104 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.76 HD11 ' HB2' ' A' ' 17' ' ' ARG . 3.2 mm -71.01 172.13 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 65.510000000000005 111.152 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.687 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -54.2 172.32 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.574 0.702 . . . . 62.240000000000002 110.898 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.74 20.39 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.664 2.243 . . . . 75.25 112.347 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' HIS . 1.8 pttt -125.58 22.26 7.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 72.420000000000002 110.864 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.49 -177.42 31.05 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.697 -0.763 . . . . 44.020000000000003 112.464 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.842 HD11 ' O ' ' A' ' 9' ' ' GLU . 20.7 tp -149.47 161.73 41.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.845 0.355 . . . . 74.439999999999998 110.93 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.76 ' HB2' HD11 ' A' ' 11' ' ' ILE . 18.0 ttm180 -125.51 137.8 53.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 110.862 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.443 HG22 ' HA ' ' A' ' 8' ' ' LEU . 77.0 t -147.69 110.85 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 61.340000000000003 111.122 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.585 ' HB2' HG23 ' A' ' 59' ' ' ILE . 11.0 t -120.32 154.28 35.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 71.430000000000007 110.882 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.899 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 34.1 m -141.64 152.65 63.64 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.639 0.733 . . . . 74.319999999999993 111.116 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 122.09 8.77 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.664 2.243 . . . . 65.239999999999995 112.341 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 1.1 t70 -76.99 107.56 9.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 72.310000000000002 110.874 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.451 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -95.21 30.01 2.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 73.530000000000001 110.9 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 94.6 20.9 27.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 75.409999999999997 112.495 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 94.9 m-85 -68.13 167.56 13.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.84 0.352 . . . . 74.140000000000001 110.888 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.8 t -128.95 -8.5 4.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 73.349999999999994 110.851 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.998 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -156.02 143.07 19.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.177 -0.465 . . . . 65.109999999999999 110.967 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.998 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -139.68 148.4 42.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 55.049999999999997 110.878 179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.0 136.64 35.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.340000000000003 111.102 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -118.52 120.54 37.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.907 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -148.85 92.05 1.94 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 73.0 110.859 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.11 172.06 26.03 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 73.340000000000003 112.46 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.34 -164.6 1.42 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 70.109999999999999 110.885 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.632 HD21 ' OD2' ' A' ' 71' ' ' ASP . 7.9 tp -136.21 142.49 44.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 73.010000000000005 110.925 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 54.22 25.38 5.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 73.319999999999993 110.866 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -167.53 141.22 3.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.25 110.932 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -113.63 160.52 18.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 63.119999999999997 110.887 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.573 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -108.2 -173.87 2.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 64.230000000000004 110.901 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -116.79 146.2 43.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 73.109999999999999 110.878 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.511 ' O ' ' CH2' ' A' ' 76' ' ' TRP . . . 51.65 -96.96 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 64.209999999999994 112.482 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.7 OUTLIER -161.9 88.88 0.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.346 . . . . 73.420000000000002 110.887 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -126.15 174.3 8.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.166 -0.47 . . . . 75.120000000000005 110.909 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -86.95 103.44 15.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 63.439999999999998 111.101 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.74 -111.65 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 34.119999999999997 112.487 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -101.32 -63.31 1.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.761 0.315 . . . . 64.430000000000007 110.873 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.466 ' CE3' ' O ' ' A' ' 32' ' ' GLY . 5.7 m0 -66.51 146.95 53.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.217 -0.447 . . . . 74.319999999999993 110.904 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 78.3 p -146.51 112.27 5.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 73.129999999999995 110.862 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.14 162.14 41.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 75.230000000000004 110.877 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -144.48 117.35 8.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 72.239999999999995 110.889 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -98.97 107.12 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 65.310000000000002 111.127 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 60.7 p -101.01 32.4 3.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 53.109999999999999 111.136 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.452 ' CB ' ' O ' ' A' ' 51' ' ' THR . 14.6 mttt 164.32 135.83 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.56 0.695 . . . . 73.230000000000004 110.919 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -175.65 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.732 2.288 . . . . 42.020000000000003 112.34 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.06 14.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 73.140000000000001 110.896 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -179.35 33.73 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 75.140000000000001 110.895 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.409 ' C ' ' HG3' ' A' ' 57' ' ' ARG . . . 87.94 -17.13 48.02 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.738 -0.744 . . . . 70.239999999999995 112.468 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HG3' ' C ' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -136.57 167.62 21.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 74.140000000000001 110.893 -179.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.515 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 11.2 m95 -92.61 92.82 8.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.459 . . . . 71.219999999999999 110.856 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.585 HG23 ' HB2' ' A' ' 19' ' ' SER . 12.0 mt -95.76 138.48 21.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 75.540000000000006 111.14 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -126.77 148.68 49.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 110.881 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.51 135.07 27.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 72.239999999999995 110.873 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -113.76 177.22 4.71 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 63.140000000000001 110.853 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.84 12.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 110.835 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.62 5.73 6.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 71.200000000000003 110.936 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -93.81 101.95 14.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 54.399999999999999 111.1 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -99.96 86.67 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 63.210000000000001 111.124 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.858 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -137.42 170.79 15.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.232 -0.44 . . . . 64.120000000000005 110.912 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.858 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -154.82 158.35 39.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 65.409999999999997 110.852 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.577 HD11 ' O ' ' A' ' 97' ' ' GLY . 10.3 mm -30.93 124.43 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 64.25 111.137 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.14 -30.04 6.48 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.744 -0.741 . . . . 53.200000000000003 112.515 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.632 ' OD2' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -63.29 -171.7 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.889 0.376 . . . . 52.450000000000003 110.87 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.8 mptt -150.03 159.27 44.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 74.030000000000001 110.926 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 97.5 mt -133.15 147.39 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.446 . . . . 70.329999999999998 111.133 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -148.98 103.09 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 75.450000000000003 110.905 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' CB ' ' HA2' ' A' ' 32' ' ' GLY . 1.1 p90 -162.35 -161.46 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.108 -0.497 . . . . 74.319999999999993 110.874 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.573 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -150.72 144.89 25.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 75.129999999999995 110.926 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.498 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 3.3 p -112.83 151.85 29.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.201 -0.454 . . . . 71.450000000000003 111.14 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.12 144.89 46.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 60.32 110.897 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.507 ' CG1' ' CD2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -144.52 172.68 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 33.149999999999999 111.133 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.754 HG13 HD12 ' A' ' 27' ' ' LEU . 84.1 mt -148.14 96.19 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 45.25 111.14 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.585 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -113.44 138.33 50.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 72.329999999999998 110.86 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 43.01 38.9 1.59 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 72.120000000000005 110.906 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.91 37.88 45.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.723 -0.751 . . . . 52.329999999999998 112.463 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.64 -53.13 3.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.884 0.373 . . . . 61.509999999999998 110.942 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 104.68 1.68 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.771 -0.728 . . . . 70.340000000000003 112.494 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -124.8 166.03 16.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.903 0.382 . . . . 75.319999999999993 110.926 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.498 ' CG ' ' O ' ' A' ' 77' ' ' THR . 7.1 ttp180 -174.15 136.56 0.51 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.093 -0.503 . . . . 72.230000000000004 110.85 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -75.65 168.78 19.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 73.420000000000002 110.906 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 3.7 t0 -152.94 -176.3 5.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 73.430000000000007 110.896 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 83.82 -26.95 0.11 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 74.340000000000003 110.886 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 34.74 87.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.737 -0.744 . . . . 71.430000000000007 112.493 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -172.01 110.04 0.26 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.845 0.355 . . . . 63.140000000000001 110.91 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -150.63 115.91 5.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.128 -0.487 . . . . 71.319999999999993 110.896 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 92.6 m -87.04 136.19 33.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 64.439999999999998 111.138 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.826 HG13 ' HB2' ' A' ' 10' ' ' ALA . 45.4 t -67.58 118.36 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 73.200000000000003 111.099 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -134.16 0.89 3.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 73.340000000000003 110.884 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.832 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -117.75 -177.74 17.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.698 -0.763 . . . . 71.109999999999999 112.468 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.52 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -154.78 155.69 34.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.852 0.358 . . . . 65.510000000000005 110.891 -179.875 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.714 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.79 169.81 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 72.450000000000003 111.155 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -132.42 139.77 48.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 60.310000000000002 110.889 179.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.53 45.47 1.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 63.420000000000002 110.907 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.486 ' N ' ' OD1' ' A' ' 100' ' ' ASP . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 44.439999999999998 111.111 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.835 0.35 . . . . 74.239999999999995 110.956 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -140.54 91.75 2.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 45.549999999999997 110.883 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.7 145.63 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.566 0.698 . . . . 73.540000000000006 111.097 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 164.36 34.81 Favored 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 122.743 2.295 . . . . 73.239999999999995 112.314 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 134.34 27.62 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.674 2.249 . . . . 71.150000000000006 112.313 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.669 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -84.38 139.6 32.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 71.019999999999996 111.105 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.6 m -92.72 77.44 4.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 75.409999999999997 111.165 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.456 HD23 HG21 ' A' ' 18' ' ' VAL . 1.5 mp -78.34 111.76 14.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.244 -0.435 . . . . 62.240000000000002 110.92 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.475 ' CB ' HG21 ' A' ' 99' ' ' VAL . 4.3 mm-40 -86.7 -158.03 0.4 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 72.230000000000004 110.903 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.838 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -143.08 81.2 1.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 61.450000000000003 111.096 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 12' ' ' HIS . 6.6 mm -71.0 172.75 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 63.149999999999999 111.143 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.71 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.08 172.2 0.24 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.595 0.712 . . . . 64.340000000000003 110.832 179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.4 Cg_endo -69.76 20.31 0.18 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.681 2.254 . . . . 73.329999999999998 112.339 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 42.3 pttt -130.08 27.8 5.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 64.409999999999997 110.908 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.66 -178.84 30.4 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 73.400000000000006 112.442 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.824 HD13 HD11 ' A' ' 67' ' ' LEU . 19.3 tp -152.83 166.22 32.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.816 0.341 . . . . 74.439999999999998 110.896 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.696 ' HB2' HD11 ' A' ' 11' ' ' ILE . 35.1 ttt180 -130.31 141.39 50.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.875 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.456 HG21 HD23 ' A' ' 8' ' ' LEU . 77.3 t -153.12 103.99 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 111.138 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 45.4 t -114.93 159.82 20.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.099999999999994 110.858 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.669 HG12 ' HA ' ' A' ' 6' ' ' ALA . 26.7 m -139.55 151.63 66.96 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.604 0.716 . . . . 53.32 111.17 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 121.99 8.69 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.671 2.247 . . . . 72.150000000000006 112.338 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -80.19 101.33 8.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 62.329999999999998 110.871 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -96.01 28.13 3.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 65.299999999999997 110.864 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.27 16.51 13.21 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.762 -0.732 . . . . 73.230000000000004 112.533 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 92.1 m-85 -67.08 164.82 17.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 63.32 110.929 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.6 t -127.98 -9.55 5.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 73.040000000000006 110.87 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.028 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -158.97 139.97 12.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 73.430000000000007 110.894 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.028 ' N ' HD22 ' A' ' 27' ' ' LEU . 19.3 t80 -134.16 152.49 51.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 72.319999999999993 110.881 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -136.35 163.29 30.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 74.219999999999999 111.104 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.416 ' CD1' ' C ' ' A' ' 30' ' ' PHE . 4.5 t80 -148.22 113.28 5.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 55.350000000000001 110.856 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.697 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -147.28 95.15 2.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 73.540000000000006 110.859 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.09 -174.14 17.97 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.729 -0.748 . . . . 63.100000000000001 112.509 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.408 ' O ' ' CZ3' ' A' ' 46' ' ' TRP . 3.0 mtpp -134.74 -164.27 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 73.219999999999999 110.911 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.523 HD11 ' OD2' ' A' ' 71' ' ' ASP . 1.7 tp -140.24 140.18 35.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 72.310000000000002 110.889 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.505 ' ND2' ' HG ' ' A' ' 34' ' ' LEU . 3.1 m120 51.26 21.59 1.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 74.209999999999994 110.848 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -156.39 123.51 5.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 74.230000000000004 110.877 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -94.86 140.66 29.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 73.230000000000004 110.884 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 2.2 ptp -96.46 -174.49 3.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 75.340000000000003 110.879 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -149.67 157.33 43.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.150000000000006 110.848 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 57.23 35.91 72.91 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.716 . . . . 42.119999999999997 112.518 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 40' ' ' GLY . 4.0 mt 35.85 83.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.762 0.315 . . . . 61.25 110.889 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -124.92 169.69 11.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 63.530000000000001 110.861 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.697 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -79.1 98.23 6.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 54.350000000000001 111.082 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.95 -115.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.776 -0.726 . . . . 70.239999999999995 112.493 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -104.24 -62.72 1.28 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.733 0.302 . . . . 71.209999999999994 110.885 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.514 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 9.1 m0 -60.87 155.09 20.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.227 -0.442 . . . . 73.239999999999995 110.926 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.59 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 53.1 p -160.99 114.43 2.0 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.448 . . . . 74.409999999999997 110.879 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -156.76 149.24 23.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 63.509999999999998 110.842 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -139.5 102.32 4.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.162 -0.472 . . . . 74.120000000000005 110.887 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.482 HG22 ' H ' ' A' ' 52' ' ' LYS . 8.7 mm -90.26 117.77 34.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 62.350000000000001 111.098 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.415 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 17.2 p -103.34 34.34 2.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 74.420000000000002 111.163 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.482 ' H ' HG22 ' A' ' 50' ' ' ILE . 3.3 mtpt 167.07 137.46 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.55 0.691 . . . . 72.010000000000005 110.865 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -175.6 1.21 Allowed 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.66 2.24 . . . . 73.0 112.358 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HG3' ' N ' ' A' ' 55' ' ' ASN . 0.2 OUTLIER -139.39 -35.83 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 72.120000000000005 110.859 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.429 ' N ' ' HG3' ' A' ' 54' ' ' LYS . 1.4 t30 -137.25 51.76 1.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.241 -0.436 . . . . 75.430000000000007 110.906 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.18 -29.43 4.3 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.753 -0.737 . . . . 52.420000000000002 112.513 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.92 171.23 11.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.852 0.358 . . . . 74.230000000000004 110.846 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.442 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 6.0 m95 -90.12 89.73 7.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.152 -0.476 . . . . 75.430000000000007 110.957 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.3 mt -92.47 138.14 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.268 -0.424 . . . . 64.049999999999997 111.117 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -132.35 146.61 52.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.409999999999997 110.892 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.84 127.55 23.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 75.219999999999999 110.903 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.5 OUTLIER -99.78 -178.46 3.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 73.25 110.92 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.38 26.4 1.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 74.010000000000005 110.9 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -149.44 28.24 0.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 72.230000000000004 110.865 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . . . -113.52 84.92 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 43.25 111.137 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -82.09 93.76 7.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.25 -0.432 . . . . 63.100000000000001 111.092 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.892 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -148.33 169.33 20.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 73.030000000000001 110.948 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.892 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.04 164.55 38.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 75.310000000000002 110.939 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.578 HG12 ' CD2' ' A' ' 98' ' ' PHE . 9.4 mm -34.78 118.93 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 74.019999999999996 111.147 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.22 -28.92 5.45 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.769 -0.729 . . . . 61.409999999999997 112.485 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.523 ' OD2' HD11 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -67.96 -178.16 0.95 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 73.010000000000005 110.865 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.2 mttt -141.22 167.66 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 73.200000000000003 110.885 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.3 mt -144.85 149.37 17.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 54.340000000000003 111.116 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -151.96 108.54 3.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 74.310000000000002 110.902 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.48 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.0 OUTLIER -165.72 -168.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 75.340000000000003 110.88 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.453 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.6 p-90 -135.28 162.75 31.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.125 -0.489 . . . . 71.040000000000006 110.94 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.439 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.6 p -134.89 146.4 49.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 64.450000000000003 111.126 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -107.46 149.01 28.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.319999999999993 110.872 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.55 HG13 ' HD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -148.94 165.7 3.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.131 -0.486 . . . . 74.310000000000002 111.157 179.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.715 HG13 HD12 ' A' ' 27' ' ' LEU . 41.1 mt -148.38 96.24 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 111.151 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.524 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 23.5 tttt -113.18 138.43 49.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.187 -0.46 . . . . 71.230000000000004 110.857 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.82 28.89 3.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 75.329999999999998 110.866 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.71 27.5 66.53 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.732 -0.747 . . . . 64.409999999999997 112.491 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.8 mt -96.65 -50.97 4.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.841 0.353 . . . . 63.450000000000003 110.906 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.56 125.85 3.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 72.140000000000001 112.492 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -143.07 -179.67 6.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.821 0.343 . . . . 75.319999999999993 110.923 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 77' ' ' THR . 1.2 ttp180 -177.46 136.48 0.2 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 70.439999999999998 110.911 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -78.21 166.02 23.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.172 -0.467 . . . . 74.030000000000001 110.925 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 1.1 t0 -147.22 -165.86 2.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 65.040000000000006 110.852 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 2.5 t-20 83.59 -33.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 44.399999999999999 110.895 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 39.04 74.99 0.11 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.732 -0.746 . . . . 41.530000000000001 112.484 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -167.7 112.35 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.833 0.349 . . . . 54.149999999999999 110.867 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 -152.33 122.57 7.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 73.010000000000005 110.945 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.1 m -94.08 145.23 24.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 74.439999999999998 111.16 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.838 HG13 ' HB2' ' A' ' 10' ' ' ALA . 62.7 t -75.24 129.7 36.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 63.350000000000001 111.124 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -154.79 23.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.049999999999997 110.888 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.507 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -155.62 111.28 0.48 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.786 -0.721 . . . . 54.240000000000002 112.499 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.578 ' CD2' HG12 ' A' ' 69' ' ' ILE . 0.5 OUTLIER -82.34 170.39 15.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.913 0.387 . . . . 72.409999999999997 110.871 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.556 HG22 ' C ' ' A' ' 98' ' ' PHE . 0.1 OUTLIER -167.34 -178.59 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 71.329999999999998 111.137 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -139.26 139.1 37.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.472 . . . . 74.409999999999997 110.857 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -87.2 44.71 1.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 53.340000000000003 110.845 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 75.430000000000007 111.089 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 18.7 t80 . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.817 0.341 . . . . 63.5 110.955 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -158.9 85.2 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 74.409999999999997 110.903 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.66 142.42 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.574 0.702 . . . . 72.150000000000006 111.109 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 161.01 47.58 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.733 2.288 . . . . 74.200000000000003 112.313 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 134.84 28.95 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.709 2.273 . . . . 63.32 112.342 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.937 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -90.52 139.68 30.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 61.240000000000002 111.061 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.5 m -93.16 77.3 4.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 52.109999999999999 111.113 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mp -78.11 107.38 10.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 64.150000000000006 110.913 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.527 ' O ' HD11 ' A' ' 16' ' ' LEU . 1.2 mm-40 -80.92 -156.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 71.150000000000006 110.935 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.814 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -143.1 80.21 1.67 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 53.119999999999997 111.082 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.703 HG22 ' H ' ' A' ' 12' ' ' HIS . 4.1 mm -70.64 172.6 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 74.319999999999993 111.079 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.703 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -54.19 172.0 0.25 Allowed Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.599 0.714 . . . . 73.400000000000006 110.835 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.9 Cg_endo -69.77 21.05 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.661 2.241 . . . . 52.119999999999997 112.336 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 12' ' ' HIS . 10.6 ptmt -126.79 20.71 7.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 73.109999999999999 110.907 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.64 -176.81 33.87 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 75.340000000000003 112.514 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.787 HD13 HD11 ' A' ' 67' ' ' LEU . 22.2 tp -151.13 163.57 38.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.816 0.341 . . . . 74.239999999999995 110.924 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.656 ' HB2' HD11 ' A' ' 11' ' ' ILE . 69.0 ttt180 -126.77 137.32 53.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 110.861 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.44 HG12 ' HE2' ' A' ' 30' ' ' PHE . 69.7 t -148.26 102.01 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 70.329999999999998 111.091 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.547 ' HB2' HG23 ' A' ' 59' ' ' ILE . 19.6 t -114.49 157.07 23.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 73.109999999999999 110.902 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.937 HG12 ' HA ' ' A' ' 6' ' ' ALA . 17.8 m -140.81 151.51 63.11 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.616 0.722 . . . . 75.239999999999995 111.077 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 123.37 10.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.639 2.226 . . . . 73.5 112.327 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 4.7 t70 -79.94 133.38 36.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 64.010000000000005 110.885 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -123.88 12.86 9.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.164 -0.471 . . . . 73.319999999999993 110.838 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 122.68 4.94 8.61 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.757 -0.735 . . . . 74.439999999999998 112.42 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 68.5 m-85 -54.28 163.02 0.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 65.109999999999999 110.878 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.9 t -130.01 -7.67 4.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.869 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.994 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -157.3 143.71 18.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 54.409999999999997 110.966 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.994 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -139.59 143.65 37.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 54.049999999999997 110.889 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.91 123.03 22.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.474 . . . . 61.119999999999997 111.12 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.44 ' HE2' HG12 ' A' ' 18' ' ' VAL . 3.0 m-85 -109.84 113.98 27.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 74.019999999999996 110.863 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.789 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -142.27 95.29 2.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 74.329999999999998 110.879 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -146.31 -178.55 21.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.757 -0.735 . . . . 73.120000000000005 112.477 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -134.0 -168.27 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.817 0.341 . . . . 62.409999999999997 110.881 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' CG ' ' A' ' 35' ' ' ASN . 4.4 tp -134.85 146.73 49.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 55.350000000000001 110.906 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.451 ' CG ' ' HG ' ' A' ' 34' ' ' LEU . 2.4 m120 42.73 27.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.883 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -159.46 130.39 5.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 54.43 110.857 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -97.23 144.13 27.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.495 . . . . 64.510000000000005 110.886 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 5.1 ptp -94.24 -174.89 3.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 63.340000000000003 110.918 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.472 ' O ' ' N ' ' A' ' 41' ' ' LEU . 1.2 tt0 -98.32 126.69 43.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 73.409999999999997 110.91 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.05 -91.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 75.409999999999997 112.546 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.472 ' N ' ' O ' ' A' ' 39' ' ' GLU . 0.8 OUTLIER -154.84 89.68 1.25 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.779 0.323 . . . . 54.409999999999997 110.94 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -130.32 -175.73 3.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 74.349999999999994 110.852 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.789 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -85.83 100.45 12.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 72.319999999999993 111.112 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.85 -118.18 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 30.300000000000001 112.498 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.38 -60.95 1.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 74.230000000000004 110.86 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.462 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 7.4 m0 -60.28 165.91 3.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 110.91 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 31' ' ' HIS . 6.9 t -164.38 122.34 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 72.540000000000006 110.863 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 49' ' ' ASP . 3.2 tpm_? -159.67 145.02 15.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 64.209999999999994 110.877 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' N ' ' HG3' ' A' ' 48' ' ' ARG . 0.1 OUTLIER -130.75 82.41 2.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 71.340000000000003 110.831 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 28' ' ' PHE . 2.7 mm -71.92 110.72 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 64.0 111.162 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.458 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 82.4 p -104.69 34.05 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 71.209999999999994 111.136 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 51' ' ' THR . 37.7 tttt 163.97 137.96 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.546 0.688 . . . . 41.329999999999998 110.925 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -175.87 1.3 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.715 2.277 . . . . 64.239999999999995 112.324 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.727 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -134.25 -34.85 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 60.210000000000001 110.9 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -139.85 51.66 1.71 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 54.149999999999999 110.895 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.07 -27.78 4.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.75 -0.738 . . . . 53.020000000000003 112.482 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.56 169.27 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.794 0.331 . . . . 75.140000000000001 110.867 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.576 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 10.7 m95 -92.09 90.79 7.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.919 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.727 HD12 ' HD2' ' A' ' 54' ' ' LYS . 27.0 mt -96.17 138.2 22.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 75.150000000000006 111.178 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -130.34 151.98 50.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 72.530000000000001 110.873 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.27 135.44 28.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 74.549999999999997 110.891 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.6 OUTLIER -108.53 -179.41 3.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 63.399999999999999 110.895 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -145.26 11.67 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 42.119999999999997 110.866 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -129.84 12.31 5.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 62.329999999999998 110.874 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.32 94.84 6.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 74.230000000000004 111.072 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -94.35 75.33 3.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 64.340000000000003 111.089 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.787 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -123.81 171.36 9.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 61.32 110.91 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.693 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.16 156.7 31.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 64.129999999999995 110.873 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.72 HD13 HG12 ' A' ' 95' ' ' VAL . 18.0 mm -30.34 121.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 64.010000000000005 111.135 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.33 -29.46 6.15 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 22.129999999999999 112.48 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.41 -179.19 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 74.310000000000002 110.856 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 1.1 mtmt -144.85 153.71 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 75.519999999999996 110.923 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.1 mt -128.43 141.25 47.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.435 . . . . 72.109999999999999 111.145 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -140.96 99.08 3.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 74.510000000000005 110.968 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.519 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -159.85 -160.07 0.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.492 . . . . 74.099999999999994 110.822 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 31.3 p-90 -148.29 177.7 9.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 71.0 110.911 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -144.45 153.95 42.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.277 -0.42 . . . . 64.510000000000005 111.149 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -118.23 136.44 53.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 54.439999999999998 110.899 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.77 167.58 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 73.319999999999993 111.101 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.641 HG13 HD12 ' A' ' 27' ' ' LEU . 78.4 mt -146.01 96.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 74.329999999999998 111.116 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.588 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 18.6 tttt -114.27 141.43 47.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 55.530000000000001 110.898 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.441 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 2.5 m-20 44.91 38.23 2.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 73.239999999999995 110.874 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.52 35.35 44.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.717 -0.754 . . . . 74.209999999999994 112.481 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.44 HD13 ' OH ' ' A' ' 86' ' ' TYR . 14.9 mt -100.51 -71.25 0.71 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.876 0.369 . . . . 74.319999999999993 110.947 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 114.49 106.41 2.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 74.319999999999993 112.487 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.44 ' OH ' HD13 ' A' ' 84' ' ' LEU . 44.7 m-85 -120.57 171.84 8.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 75.230000000000004 110.909 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.5 ttm180 -174.38 138.47 0.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.13 -0.486 . . . . 73.150000000000006 110.86 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -85.98 153.71 21.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 74.299999999999997 110.885 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -136.82 -163.18 1.38 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 65.340000000000003 110.903 179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.2 t-20 82.23 -39.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.187 -0.461 . . . . 74.310000000000002 110.89 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.57 76.44 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 52.200000000000003 112.454 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -172.8 113.22 0.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 74.400000000000006 110.862 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -152.43 110.88 3.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.103 -0.499 . . . . 64.230000000000004 110.922 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 97.1 m -82.37 136.16 35.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.258 -0.428 . . . . 54.310000000000002 111.149 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.793 HG13 ' HB2' ' A' ' 10' ' ' ALA . 39.3 t -67.27 110.32 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 70.129999999999995 111.135 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -128.94 17.82 6.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 75.040000000000006 110.911 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.814 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -133.92 -178.26 15.49 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 71.340000000000003 112.475 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.429 ' C ' HG22 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -152.8 157.57 40.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.861 0.362 . . . . 73.540000000000006 110.894 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.69 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.81 164.5 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 73.540000000000006 111.143 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -129.81 131.08 46.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 61.100000000000001 110.858 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -85.68 51.43 2.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 74.319999999999993 110.892 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 43.200000000000003 111.116 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.885 0.374 . . . . 74.549999999999997 110.907 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -128.96 76.61 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 72.129999999999995 110.84 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.576 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . . . 60.2 140.53 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.589 0.709 . . . . 63.229999999999997 111.085 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 167.39 24.63 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.715 2.277 . . . . 73.120000000000005 112.312 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 133.99 27.02 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.645 2.23 . . . . 62.009999999999998 112.361 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.737 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -86.51 137.83 32.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 74.030000000000001 111.105 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 m -93.99 77.15 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.277 -0.42 . . . . 63.140000000000001 111.159 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.8 mp -77.4 107.98 10.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 65.0 110.906 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.845 ' O ' HD11 ' A' ' 16' ' ' LEU . 43.9 mm-40 -80.34 -173.28 3.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 63.329999999999998 110.892 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.859 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.76 81.49 2.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 65.439999999999998 111.094 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.753 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.2 mm -72.01 172.49 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 62.229999999999997 111.146 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.697 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.16 172.03 0.25 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.584 0.707 . . . . 74.200000000000003 110.897 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.3 Cg_endo -69.72 20.15 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.639 2.226 . . . . 61.329999999999998 112.35 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.486 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.0 OUTLIER -125.92 21.71 7.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.281 -0.418 . . . . 60.539999999999999 110.943 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 155.38 -178.02 32.24 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.742 . . . . 71.430000000000007 112.481 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.899 HD13 HD11 ' A' ' 67' ' ' LEU . 21.9 tp -150.24 167.74 26.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.329 . . . . 60.020000000000003 110.961 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.593 ' HB2' HD11 ' A' ' 11' ' ' ILE . 2.1 ttt180 -132.83 139.24 47.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.299999999999997 110.857 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.413 HG21 ' HE2' ' A' ' 30' ' ' PHE . 70.4 t -148.52 108.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 54.100000000000001 111.125 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -119.85 157.94 27.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 63.119999999999997 110.857 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.737 HG12 ' HA ' ' A' ' 6' ' ' ALA . 17.2 m -139.99 149.35 58.45 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.597 0.713 . . . . 71.140000000000001 111.149 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 122.19 8.87 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.707 2.271 . . . . 72.230000000000004 112.354 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 22.8 t70 -88.45 97.26 10.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 72.340000000000003 110.86 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -81.75 0.21 40.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 54.130000000000003 110.879 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 138.41 30.9 0.22 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 61.520000000000003 112.47 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.586 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 82.2 m-85 -82.28 167.96 18.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.804 0.335 . . . . 75.409999999999997 110.936 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.5 t -127.19 -10.89 5.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 65.430000000000007 110.846 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.999 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -153.32 142.72 21.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 72.439999999999998 110.916 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.999 ' N ' HD22 ' A' ' 27' ' ' LEU . 18.3 t80 -139.13 144.32 38.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 75.510000000000005 110.93 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -127.69 163.68 23.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 72.540000000000006 111.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.451 ' C ' ' CD1' ' A' ' 30' ' ' PHE . 4.4 t80 -151.04 114.42 4.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 110.89 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.721 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -147.57 95.26 2.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 73.430000000000007 110.859 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.445 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.07 -174.27 18.07 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.726 -0.75 . . . . 65.319999999999993 112.466 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.464 ' CE ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -135.92 -165.45 1.71 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.792 0.33 . . . . 70.230000000000004 110.863 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.754 HD12 ' ND2' ' A' ' 35' ' ' ASN . 0.2 OUTLIER -132.36 127.24 35.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 74.510000000000005 110.935 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.754 ' ND2' HD12 ' A' ' 34' ' ' LEU . 67.2 m-80 56.45 34.13 23.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 73.0 110.866 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.464 ' HG2' ' CE ' ' A' ' 33' ' ' LYS . 5.6 tp10 -155.56 131.52 10.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 73.239999999999995 110.903 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -98.59 140.65 32.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 73.019999999999996 110.856 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 1.3 mtt -83.49 -178.4 7.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 74.25 110.873 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.2 124.51 13.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 71.340000000000003 110.854 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 65.32 40.63 96.64 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.765 -0.731 . . . . 74.239999999999995 112.498 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.2 mt 41.38 88.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.782 0.325 . . . . 75.450000000000003 110.918 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -128.7 -177.84 4.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.452 . . . . 70.219999999999999 110.887 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.721 ' HB1' ' NE2' ' A' ' 31' ' ' HIS . . . -87.2 102.14 14.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 71.239999999999995 111.112 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.454 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . -60.4 -120.19 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.7 -0.762 . . . . 50.549999999999997 112.501 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.9 -55.3 2.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.831 0.348 . . . . 71.530000000000001 110.89 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.706 ' HH2' HD23 ' A' ' 34' ' ' LEU . 6.5 m0 -68.4 173.16 5.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 110.91 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.543 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 95.3 p -176.84 118.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 73.540000000000006 110.851 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.39 162.2 22.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.471 . . . . 74.230000000000004 110.848 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.682 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -144.46 106.55 4.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 75.409999999999997 110.883 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.482 ' N ' ' O ' ' A' ' 28' ' ' PHE . 36.5 mm -90.27 105.13 15.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 71.239999999999995 111.121 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.754 HG22 HD23 ' A' ' 27' ' ' LEU . 32.3 p -102.42 34.42 2.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 45.299999999999997 111.156 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.5 124.53 0.11 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.593 0.711 . . . . 74.209999999999994 110.857 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 165.6 30.46 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.701 2.267 . . . . 75.439999999999998 112.346 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -124.93 -17.7 5.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.882 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -149.75 43.99 0.91 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 73.420000000000002 110.903 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 80.42 -16.64 12.81 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.712 -0.756 . . . . 61.509999999999998 112.555 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.1 mtt180 -133.57 164.66 26.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.826 0.346 . . . . 75.049999999999997 110.88 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.481 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 12.2 m95 -88.18 96.16 10.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 75.099999999999994 110.931 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.415 HG22 ' HD2' ' A' ' 61' ' ' ARG . 16.0 mt -99.47 142.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.271 -0.422 . . . . 72.230000000000004 111.121 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -133.56 144.91 49.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 70.409999999999997 110.926 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HD2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -136.59 127.74 27.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 74.450000000000003 110.847 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -102.42 -178.62 3.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 74.510000000000005 110.891 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.5 mtt180 -148.85 17.42 0.99 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 74.519999999999996 110.889 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -135.89 14.44 3.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.430000000000007 110.886 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.62 109.54 21.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 71.219999999999999 111.136 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -105.94 87.91 2.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 62.32 111.069 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.899 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -139.87 170.95 14.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 53.299999999999997 110.904 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.67 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.55 161.79 38.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.148 -0.478 . . . . 70.549999999999997 110.871 179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.592 HG13 ' CE2' ' A' ' 98' ' ' PHE . 11.8 mm -33.28 120.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 73.109999999999999 111.138 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.84 -29.89 5.46 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.734 -0.746 . . . . 63.229999999999997 112.464 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.98 177.96 2.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.896 0.379 . . . . 74.439999999999998 110.86 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.5 OUTLIER -138.55 162.02 35.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 71.329999999999998 110.907 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.744 HG12 HD22 ' A' ' 34' ' ' LEU . 62.6 mt -137.96 152.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 54.210000000000001 111.116 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -151.15 107.56 3.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 74.450000000000003 110.861 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.445 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -165.32 -163.66 0.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.123 -0.489 . . . . 73.230000000000004 110.883 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.48 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 1.2 p-90 -145.14 166.06 26.51 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.461 . . . . 73.049999999999997 110.887 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.478 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 5.0 p -136.52 162.37 33.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 64.400000000000006 111.151 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.95 142.94 51.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 65.25 110.837 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.5 m -142.45 176.54 3.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.064 -0.517 . . . . 75.010000000000005 111.133 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.786 HG13 HD12 ' A' ' 27' ' ' LEU . 68.7 mt -150.91 98.67 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.474 . . . . 73.329999999999998 111.149 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 0.1 OUTLIER -117.8 141.32 48.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 64.230000000000004 110.904 179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.453 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 46.07 36.74 3.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 64.209999999999994 110.885 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.23 33.85 39.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 52.329999999999998 112.441 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.413 HD13 ' OH ' ' A' ' 86' ' ' TYR . 2.3 mt -100.33 -54.84 2.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.865 0.364 . . . . 74.099999999999994 110.934 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.22 116.49 1.76 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.726 -0.75 . . . . 75.510000000000005 112.45 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.413 ' OH ' HD13 ' A' ' 84' ' ' LEU . 98.8 m-85 -132.72 -175.09 3.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.852 0.358 . . . . 74.329999999999998 110.955 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.478 ' CG ' ' O ' ' A' ' 77' ' ' THR . 7.5 ttp180 -177.61 138.05 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 110.874 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.576 ' OE1' ' HB3' ' A' ' 3' ' ' ALA . 2.7 tp60 -81.94 155.17 25.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 73.140000000000001 110.857 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.501 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -140.0 -166.86 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 65.040000000000006 110.899 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.8 OUTLIER 83.06 -38.88 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 72.400000000000006 110.918 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.47 81.07 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.736 -0.745 . . . . 70.230000000000004 112.514 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -171.77 114.4 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.805 0.336 . . . . 75.219999999999999 110.887 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -154.87 112.97 3.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 71.329999999999998 110.942 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 37.2 m -85.11 132.96 34.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 71.129999999999995 111.104 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.744 HG21 HD23 ' A' ' 67' ' ' LEU . 37.6 t -63.76 117.72 4.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 71.340000000000003 111.112 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -136.39 14.37 3.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.120000000000005 110.927 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.859 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -124.95 -178.02 15.14 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 62.039999999999999 112.492 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -154.69 151.49 28.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 73.310000000000002 110.863 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.753 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.12 -178.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.476 . . . . 61.200000000000003 111.119 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -146.51 129.86 16.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 72.109999999999999 110.843 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -83.13 40.99 0.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 71.540000000000006 110.909 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 111.11 179.918 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.858 0.361 . . . . 73.450000000000003 110.925 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 5.1 mt-10 -140.93 75.91 1.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.132 -0.486 . . . . 61.0 110.875 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 2' ' ' GLU . . . 66.63 142.5 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.577 0.703 . . . . 73.120000000000005 111.111 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 167.99 22.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.657 2.238 . . . . 73.109999999999999 112.366 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 133.39 25.57 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.684 2.256 . . . . 72.209999999999994 112.356 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.772 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -80.19 139.55 36.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 72.109999999999999 111.1 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.9 m -99.76 77.6 2.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.251 -0.431 . . . . 51.25 111.166 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.592 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.8 mp -77.65 109.69 11.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 74.200000000000003 110.936 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.761 ' O ' HD11 ' A' ' 16' ' ' LEU . 3.0 mm-40 -80.08 -168.56 1.69 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 64.340000000000003 110.866 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.831 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -133.81 81.58 1.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 72.299999999999997 111.139 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.718 HG22 ' H ' ' A' ' 12' ' ' HIS . 7.6 mm -71.66 172.84 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 71.340000000000003 111.125 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.718 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -54.17 172.37 0.24 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.583 0.706 . . . . 64.120000000000005 110.825 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.78 20.2 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.613 2.209 . . . . 74.310000000000002 112.326 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -129.1 26.28 5.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.444 . . . . 74.540000000000006 110.86 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.25 -177.71 31.5 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 34.340000000000003 112.467 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.039 HD13 HD21 ' A' ' 67' ' ' LEU . 22.2 tp -152.29 166.98 30.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.812 0.339 . . . . 73.319999999999993 110.89 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HB2' HD11 ' A' ' 11' ' ' ILE . 61.7 ttt180 -132.59 136.57 46.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 110.833 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 8' ' ' LEU . 51.1 t -145.0 109.36 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 54.409999999999997 111.152 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.79 ' HB2' HG23 ' A' ' 59' ' ' ILE . 11.2 t -121.53 159.54 26.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 73.409999999999997 110.843 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.883 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 10.2 m -142.73 151.61 57.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.647 0.737 . . . . 74.109999999999999 111.109 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 121.69 8.38 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.628 2.219 . . . . 74.109999999999999 112.32 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -70.16 140.19 52.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 61.119999999999997 110.863 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -132.51 18.88 4.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 74.530000000000001 110.883 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.72 8.17 30.61 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.733 -0.746 . . . . 62.200000000000003 112.45 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.546 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 39.5 m-85 -58.41 164.63 2.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.861 0.362 . . . . 64.25 110.908 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 29.9 t -126.37 -13.01 6.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 75.450000000000003 110.886 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.027 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -153.82 140.68 19.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.144 -0.48 . . . . 55.539999999999999 110.935 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.027 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -134.61 145.77 48.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 110.924 179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -132.79 142.69 49.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 111.117 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -126.28 120.95 31.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 53.240000000000002 110.855 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.842 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -152.67 93.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 75.129999999999995 110.88 179.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.9 176.73 24.71 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.691 -0.766 . . . . 74.239999999999995 112.5 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.66 -164.94 1.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.868 0.366 . . . . 65.439999999999998 110.839 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.2 tp -134.23 145.79 49.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 73.219999999999999 110.934 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.498 ' ND2' ' OD1' ' A' ' 71' ' ' ASP . 22.0 m-80 49.15 24.04 0.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 74.439999999999998 110.858 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -163.43 139.34 6.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.21 -0.45 . . . . 71.340000000000003 110.861 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -110.1 164.94 12.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 74.430000000000007 110.892 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.65 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -111.42 178.19 4.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.439999999999998 110.855 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -141.18 130.56 23.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.209 -0.45 . . . . 63.530000000000001 110.862 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.468 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 76.95 42.99 18.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.709 -0.758 . . . . 61.340000000000003 112.445 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.507 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.3 OUTLIER 32.9 80.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.764 0.316 . . . . 65.510000000000005 110.926 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -119.54 -169.74 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 72.140000000000001 110.855 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -98.83 103.4 15.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 62.229999999999997 111.122 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -70.75 -111.54 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.76 . . . . 71.549999999999997 112.485 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -102.44 -68.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.823 0.344 . . . . 72.400000000000006 110.881 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.489 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 5.2 m-90 -62.37 154.19 28.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 73.150000000000006 110.863 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.465 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 95.1 p -158.39 123.84 4.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 54.210000000000001 110.887 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.66 160.73 10.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.489 . . . . 73.420000000000002 110.861 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.708 ' OD1' HD21 ' A' ' 27' ' ' LEU . 14.4 t0 -138.9 103.14 4.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.181 -0.463 . . . . 71.329999999999998 110.853 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.446 ' N ' ' O ' ' A' ' 28' ' ' PHE . 5.6 mm -77.98 108.9 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 75.230000000000004 111.165 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.46 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 81.1 p -96.37 30.58 2.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 70.420000000000002 111.133 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.9 OUTLIER 163.29 138.82 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.569 0.7 . . . . 70.349999999999994 110.903 179.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' N ' ' HG3' ' A' ' 52' ' ' LYS . 53.9 Cg_endo -69.74 176.2 7.07 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.705 2.27 . . . . 71.319999999999993 112.349 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.609 ' HD2' HD12 ' A' ' 59' ' ' ILE . 4.4 ttmt -109.19 -77.76 0.6 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 70.420000000000002 110.91 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -113.24 60.68 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 71.340000000000003 110.929 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.17 -19.2 32.23 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.713 -0.756 . . . . 61.009999999999998 112.485 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.45 164.91 25.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 73.019999999999996 110.861 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.546 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 16.3 m95 -89.83 94.15 9.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.45 . . . . 73.319999999999993 110.898 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.79 HG23 ' HB2' ' A' ' 19' ' ' SER . 6.4 mt -102.3 149.7 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 75.040000000000006 111.156 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.455 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 42.1 t80 -144.31 159.87 41.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 55.32 110.874 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.455 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -147.68 140.01 24.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 74.439999999999998 110.853 -179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 0.9 OUTLIER -114.39 -178.16 3.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.457 . . . . 74.310000000000002 110.887 179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -143.29 17.99 1.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 75.099999999999994 110.879 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -137.07 20.42 3.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.902 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.439 ' HB3' ' HB2' ' A' ' 16' ' ' LEU . . . -107.39 95.76 5.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 74.430000000000007 111.106 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -94.11 84.55 4.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 54.299999999999997 111.073 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.039 HD21 HD13 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -120.03 171.61 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 63.229999999999997 110.881 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -153.24 134.29 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 74.439999999999998 110.889 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.552 ' C ' ' O ' ' A' ' 68' ' ' LYS . 9.2 mm -23.6 118.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 71.450000000000003 111.098 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.6 -19.09 9.86 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.787 -0.72 . . . . 64.540000000000006 112.495 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.498 ' OD1' ' ND2' ' A' ' 35' ' ' ASN . 0.4 OUTLIER -67.23 -166.22 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.887 0.375 . . . . 55.530000000000001 110.837 -179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 1.5 mtmt -152.45 165.15 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 74.519999999999996 110.873 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 99.2 mt -142.53 149.15 19.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 54.340000000000003 111.194 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -149.62 104.1 3.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.211 -0.45 . . . . 73.540000000000006 110.885 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.495 ' CE2' HG23 ' A' ' 77' ' ' THR . 1.0 OUTLIER -160.3 -164.25 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 73.510000000000005 110.903 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.65 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -146.98 142.73 27.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 110.893 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.495 HG23 ' CE2' ' A' ' 75' ' ' PHE . 4.4 p -112.37 147.75 35.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.24 -0.436 . . . . 73.319999999999993 111.113 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.401 ' CD1' ' HG3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -112.68 143.51 43.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 72.209999999999994 110.855 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -143.01 168.69 13.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 74.400000000000006 111.118 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.671 HG13 HD12 ' A' ' 27' ' ' LEU . 95.4 mt -146.69 96.17 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 75.329999999999998 111.121 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.424 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 7.4 tttt -114.51 143.73 44.49 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 72.25 110.961 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.405 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER 53.03 20.71 1.8 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.276 -0.42 . . . . 62.210000000000001 110.892 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.09 27.54 73.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 50.020000000000003 112.481 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' A' ' 84' ' ' LEU . 8.0 mt -97.86 -72.31 0.65 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 61.439999999999998 110.907 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 120.48 109.86 2.22 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.754 -0.736 . . . . 70.439999999999998 112.484 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -122.31 161.68 22.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.85 0.357 . . . . 74.540000000000006 110.921 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.401 ' HG3' ' CD1' ' A' ' 78' ' ' PHE . 6.2 ttp180 -163.45 129.13 3.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.104 -0.498 . . . . 72.329999999999998 110.866 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -80.64 150.35 29.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.120000000000005 110.917 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.53 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.2 OUTLIER -132.02 -159.92 1.0 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 110.866 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER 82.86 -37.08 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 64.230000000000004 110.923 -179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.51 78.57 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.783 -0.722 . . . . 64.439999999999998 112.481 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -171.41 111.24 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.822 0.344 . . . . 64.420000000000002 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -148.98 119.42 7.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 52.130000000000003 110.898 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 25.6 m -89.84 141.15 28.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.231 -0.44 . . . . 52.450000000000003 111.152 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.86 HG21 HD12 ' A' ' 67' ' ' LEU . 40.2 t -75.81 124.92 34.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 63.310000000000002 111.093 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -147.19 21.97 1.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 61.450000000000003 110.936 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.506 ' O ' ' N ' ' A' ' 10' ' ' ALA . . . -154.67 114.35 0.61 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.734 -0.746 . . . . 74.439999999999998 112.482 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.542 ' C ' HG22 ' A' ' 99' ' ' VAL . 0.6 OUTLIER -87.81 172.16 9.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.885 0.374 . . . . 71.140000000000001 110.882 -179.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.702 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -167.53 156.64 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 75.519999999999996 111.109 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -113.55 130.25 56.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 73.0 110.874 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -100.11 38.59 1.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 72.540000000000006 110.916 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.340000000000003 111.082 179.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.816 0.341 . . . . 74.129999999999995 110.933 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 90.3 mt-10 -143.9 70.13 1.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 73.510000000000005 110.868 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 2' ' ' GLU . . . 69.42 145.49 0.11 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.6 0.714 . . . . 73.120000000000005 111.061 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 164.82 33.09 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.68 2.254 . . . . 63.299999999999997 112.385 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 134.37 27.89 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.735 2.29 . . . . 72.310000000000002 112.371 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -82.43 140.71 33.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.435 . . . . 60.210000000000001 111.121 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.6 m -97.19 79.14 2.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 74.400000000000006 111.145 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.586 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.3 mp -83.1 113.06 20.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 73.340000000000003 110.884 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.584 ' O ' HD11 ' A' ' 16' ' ' LEU . 2.6 mm-40 -83.94 -158.34 0.31 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.147 -0.478 . . . . 73.030000000000001 110.893 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.88 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -141.12 80.37 1.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.102 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.722 HD13 ' CG2' ' A' ' 99' ' ' VAL . 2.7 mm -71.3 172.55 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.445 . . . . 65.430000000000007 111.131 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.707 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -54.22 172.16 0.25 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.561 0.695 . . . . 54.039999999999999 110.842 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.8 Cg_endo -69.76 19.47 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.66 2.24 . . . . 73.319999999999993 112.384 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.48 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.1 OUTLIER -124.58 19.79 8.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 73.420000000000002 110.868 179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 157.24 -177.93 33.85 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.764 -0.731 . . . . 63.340000000000003 112.521 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.689 HD13 HD11 ' A' ' 67' ' ' LEU . 26.3 tp -151.27 166.38 31.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.781 0.324 . . . . 75.409999999999997 110.94 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.529 ' HB2' HD11 ' A' ' 11' ' ' ILE . 50.6 ttt180 -128.23 139.13 52.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 110.867 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.3 t -151.26 105.26 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 61.119999999999997 111.131 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.428 ' CB ' ' HA ' ' A' ' 59' ' ' ILE . 18.7 t -122.46 162.25 22.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 72.549999999999997 110.876 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 6' ' ' ALA . 5.4 m -140.4 151.17 63.38 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.664 0.745 . . . . 73.420000000000002 111.084 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 122.2 8.87 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.673 2.249 . . . . 74.439999999999998 112.327 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.405 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 14.9 t70 -83.44 140.0 32.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 72.140000000000001 110.913 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -137.2 12.61 3.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.447 . . . . 74.540000000000006 110.91 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 136.01 2.93 2.64 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.748 . . . . 51.229999999999997 112.491 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 91.5 m-85 -58.33 160.18 5.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.855 0.359 . . . . 64.510000000000005 110.899 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.3 t -129.72 -7.04 4.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.484 . . . . 73.019999999999996 110.859 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.992 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -157.75 140.75 15.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 72.530000000000001 110.898 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.992 ' N ' HD22 ' A' ' 27' ' ' LEU . 19.8 t80 -137.61 146.2 43.69 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.841 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -130.98 163.06 28.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 74.200000000000003 111.134 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.435 ' C ' ' CD1' ' A' ' 30' ' ' PHE . 4.4 t80 -147.59 111.7 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 74.140000000000001 110.876 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.722 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -144.29 92.58 2.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 73.530000000000001 110.836 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -145.99 -179.48 22.23 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.793 -0.718 . . . . 71.540000000000006 112.484 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.69 -164.15 1.47 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.816 0.341 . . . . 75.049999999999997 110.929 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.473 ' HG ' ' ND2' ' A' ' 35' ' ' ASN . 1.1 tp -143.48 144.91 32.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 70.120000000000005 110.931 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.473 ' ND2' ' HG ' ' A' ' 34' ' ' LEU . 2.3 m120 57.73 12.02 1.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 73.040000000000006 110.867 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -156.77 130.58 8.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.400000000000006 110.877 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -102.4 143.92 31.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 42.549999999999997 110.905 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.43 ' HE1' ' HA2' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -93.07 172.7 8.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.472 . . . . 54.32 110.92 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -130.85 157.83 41.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.284 -0.416 . . . . 61.149999999999999 110.912 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 52.56 35.32 44.84 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 72.150000000000006 112.475 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.477 ' C ' ' CZ2' ' A' ' 76' ' ' TRP . 1.1 mt 39.24 84.83 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.763 0.316 . . . . 72.340000000000003 110.914 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -126.22 174.19 8.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 75.219999999999999 110.908 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.722 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -79.41 98.9 6.95 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 74.340000000000003 111.107 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.84 -116.05 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.738 -0.744 . . . . 73.140000000000001 112.539 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -103.46 -65.12 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.771 0.32 . . . . 74.329999999999998 110.89 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.418 ' O ' ' ND1' ' A' ' 31' ' ' HIS . 8.2 m0 -58.03 161.43 4.05 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.194 -0.457 . . . . 73.049999999999997 110.851 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.588 ' HB3' ' CE1' ' A' ' 31' ' ' HIS . 97.0 p -167.39 122.51 1.05 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 60.200000000000003 110.887 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.77 155.36 8.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 61.420000000000002 110.872 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -141.24 103.2 4.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 72.450000000000003 110.873 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 52' ' ' LYS . 28.0 mm -80.84 117.14 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.340000000000003 111.121 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.5 p -99.36 32.24 2.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.458 . . . . 73.109999999999999 111.17 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.539 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.2 OUTLIER 172.99 135.67 0.11 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.61 0.719 . . . . 73.409999999999997 110.909 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 168.18 22.22 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.691 2.26 . . . . 54.229999999999997 112.322 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.484 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.3 OUTLIER -141.95 112.78 7.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 71.040000000000006 110.905 179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 0.7 OUTLIER 78.27 27.72 0.51 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.229 -0.441 . . . . 72.129999999999995 110.883 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.81 -25.88 19.28 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.759 -0.734 . . . . 73.530000000000001 112.507 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.38 161.76 28.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 75.510000000000005 110.825 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 13.2 m95 -82.15 101.19 10.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 110.953 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.484 HD12 ' HD2' ' A' ' 54' ' ' LYS . 28.0 mt -105.65 139.13 27.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 61.210000000000001 111.119 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 45.5 t80 -135.32 141.91 45.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 74.120000000000005 110.852 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.454 ' HD2' HG22 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -134.04 130.44 37.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 110.859 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.57 -178.9 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 43.520000000000003 110.864 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -144.82 15.56 1.57 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 75.409999999999997 110.887 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -131.45 3.58 4.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 74.239999999999995 110.874 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -89.2 101.01 13.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 55.130000000000003 111.093 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -99.58 84.53 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 64.140000000000001 111.061 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.737 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -129.38 171.29 12.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 51.409999999999997 110.899 -179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.737 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -152.8 147.47 26.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 75.430000000000007 110.894 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.499 HG12 ' CE1' ' A' ' 98' ' ' PHE . 2.5 mm -30.89 115.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 73.310000000000002 111.145 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.44 -19.37 7.15 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.695 -0.764 . . . . 70.25 112.505 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.16 -162.87 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 74.099999999999994 110.865 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 3.1 mttt -155.0 167.24 31.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 73.530000000000001 110.901 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 80.0 mt -146.4 146.35 19.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 65.310000000000002 111.138 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -148.9 102.19 3.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 73.340000000000003 110.956 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.535 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 0.8 OUTLIER -160.68 -161.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 70.340000000000003 110.896 -179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.543 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 0.5 OUTLIER -145.97 161.34 40.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 74.140000000000001 110.908 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.4 p -131.05 159.69 36.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 63.219999999999999 111.151 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -123.62 146.06 48.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.43 . . . . 75.239999999999995 110.859 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -146.08 170.87 4.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 62.539999999999999 111.16 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.696 HG13 HD12 ' A' ' 27' ' ' LEU . 81.1 mt -149.36 96.12 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 62.219999999999999 111.171 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.516 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 1.7 tttt -113.05 137.72 51.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.146 -0.479 . . . . 65.510000000000005 110.916 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.2 OUTLIER 47.31 33.11 2.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 71.099999999999994 110.853 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.33 33.39 61.66 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.738 . . . . 70.420000000000002 112.478 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.412 HD13 ' OH ' ' A' ' 86' ' ' TYR . 1.7 mt -97.47 -54.25 3.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 52.350000000000001 110.878 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.3 119.32 2.83 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.784 -0.722 . . . . 54.43 112.492 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.414 ' HB2' HG23 ' A' ' 79' ' ' VAL . 96.0 m-85 -143.47 156.81 44.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.919 0.39 . . . . 73.540000000000006 110.916 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -152.56 133.68 14.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.083 -0.508 . . . . 71.310000000000002 110.854 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -80.11 154.98 27.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 54.130000000000003 110.894 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.542 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -138.52 -160.79 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 65.450000000000003 110.854 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.542 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 3.1 t-20 82.7 -38.19 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 65.400000000000006 110.861 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.03 78.87 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.752 -0.737 . . . . 25.23 112.536 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -171.74 110.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.834 0.35 . . . . 73.420000000000002 110.895 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 17.1 m-90 -151.72 120.09 6.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.134 -0.485 . . . . 73.219999999999999 110.963 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.4 m -91.24 130.43 37.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.217 -0.447 . . . . 74.010000000000005 111.186 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.88 HG13 ' HB2' ' A' ' 10' ' ' ALA . 48.3 t -61.41 110.5 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 71.049999999999997 111.117 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -128.0 7.5 6.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 55.340000000000003 110.895 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.814 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -120.23 179.13 16.52 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.747 -0.74 . . . . 62.310000000000002 112.476 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.499 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -151.75 153.2 33.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.862 0.363 . . . . 64.109999999999999 110.895 -179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.722 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -159.96 177.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 64.530000000000001 111.109 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 40.1 m-20 -146.03 126.87 14.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 60.299999999999997 110.843 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -80.43 55.31 2.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 74.230000000000004 110.87 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 52.509999999999998 111.093 179.919 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 17.2 t80 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.847 0.356 . . . . 71.019999999999996 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -141.53 76.45 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 55.200000000000003 110.921 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.03 141.78 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.543 0.687 . . . . 75.239999999999995 111.097 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 165.46 30.88 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.701 2.267 . . . . 74.409999999999997 112.34 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 133.6 25.92 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.689 2.26 . . . . 75.239999999999995 112.301 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.778 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.64 144.15 31.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 32.229999999999997 111.111 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.5 m -99.83 77.13 2.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 73.319999999999993 111.138 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.465 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.7 mp -73.04 109.89 6.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 72.340000000000003 110.961 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.834 ' O ' HD11 ' A' ' 16' ' ' LEU . 7.9 mm-40 -85.99 -172.92 4.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 110.863 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -130.56 80.25 1.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 71.120000000000005 111.084 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.682 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.2 mm -70.27 172.34 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 62.130000000000003 111.159 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.682 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.07 171.83 0.26 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.622 0.725 . . . . 74.450000000000003 110.818 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.1 Cg_endo -69.72 20.54 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.668 2.245 . . . . 64.099999999999994 112.37 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 12' ' ' HIS . 20.7 pttt -126.64 23.06 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 62.439999999999998 110.884 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.1 -178.13 31.14 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 45.439999999999998 112.501 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.834 HD11 ' O ' ' A' ' 9' ' ' GLU . 20.0 tp -149.65 160.83 43.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.834 0.35 . . . . 73.439999999999998 110.924 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.661 ' HB2' HD11 ' A' ' 11' ' ' ILE . 1.3 ttt85 -125.95 138.95 53.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.199 -0.455 . . . . 61.310000000000002 110.888 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 8' ' ' LEU . 54.2 t -148.79 103.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 72.299999999999997 111.098 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.529 ' HB2' HG23 ' A' ' 59' ' ' ILE . 41.3 t -114.21 160.69 18.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 64.230000000000004 110.89 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 6' ' ' ALA . 24.3 m -141.51 151.73 61.54 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.639 0.733 . . . . 64.239999999999995 111.146 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 122.14 8.82 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.719 2.279 . . . . 75.230000000000004 112.343 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 17.1 t0 -89.12 107.91 19.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.229 -0.442 . . . . 65.140000000000001 110.868 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -95.79 -3.55 45.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 63.409999999999997 110.894 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 142.94 31.02 0.11 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.765 -0.731 . . . . 53.229999999999997 112.513 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.464 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 81.4 m-85 -80.14 165.1 22.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.857 0.36 . . . . 74.310000000000002 110.87 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.2 t -126.05 -11.55 6.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 74.340000000000003 110.878 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.012 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -155.66 141.13 17.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 73.400000000000006 110.898 -179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.012 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.9 t80 -133.38 146.42 51.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 75.329999999999998 110.909 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -133.67 155.8 49.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 74.040000000000006 111.119 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.511 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 3.2 t80 -141.0 123.78 16.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 75.329999999999998 110.895 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.511 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 8.4 m-70 -153.47 93.31 1.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 72.310000000000002 110.884 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -145.94 -177.1 20.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.75 . . . . 55.43 112.506 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 45' ' ' HIS . 2.6 mtpp -135.73 -169.64 2.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.804 0.335 . . . . 62.240000000000002 110.912 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.415 ' CD2' HD22 ' A' ' 35' ' ' ASN . 2.3 tp -131.77 143.78 50.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 75.019999999999996 110.897 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.415 HD22 ' CD2' ' A' ' 34' ' ' LEU . 67.2 m-80 37.48 37.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 72.109999999999999 110.901 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -159.17 139.84 12.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.109999999999999 110.913 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -90.36 145.28 25.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 75.129999999999995 110.913 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 8.5 ptp -104.03 177.78 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 64.310000000000002 110.904 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' O ' ' N ' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -83.31 169.92 15.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 74.010000000000005 110.911 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -46.12 90.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.743 -0.741 . . . . 72.239999999999995 112.455 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 39' ' ' GLU . 1.0 OUTLIER 49.95 83.33 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.803 0.335 . . . . 55.140000000000001 110.899 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -143.83 -176.98 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.177 -0.465 . . . . 73.349999999999994 110.878 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.5 99.85 12.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 74.030000000000001 111.038 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.44 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . -68.3 -106.52 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.77 -0.728 . . . . 51.32 112.504 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.453 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 0.1 OUTLIER -106.25 -62.39 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.75 0.31 . . . . 30.210000000000001 110.825 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.8 m0 -65.41 150.93 47.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 55.229999999999997 110.91 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.461 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 58.5 p -158.33 119.02 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 63.210000000000001 110.822 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.22 158.56 21.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 73.340000000000003 110.897 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -144.34 115.26 7.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 110.866 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 mm -96.27 120.49 45.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 72.420000000000002 111.148 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 81.4 p -107.89 36.92 2.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 71.219999999999999 111.126 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.8 OUTLIER 163.08 130.81 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.616 0.722 . . . . 74.439999999999998 110.901 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 -176.33 1.46 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.682 2.255 . . . . 61.009999999999998 112.318 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.14 19.5 0.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 62.509999999999998 110.842 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 178.85 34.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 73.230000000000004 110.858 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.42 -19.53 13.85 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 63.509999999999998 112.445 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.04 164.32 27.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.806 0.336 . . . . 64.540000000000006 110.861 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.552 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 18.3 m95 -87.5 93.27 9.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.147 -0.479 . . . . 74.120000000000005 110.918 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.529 HG23 ' HB2' ' A' ' 19' ' ' SER . 8.1 mt -96.47 136.37 27.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 53.140000000000001 111.146 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -129.95 150.63 51.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 74.010000000000005 110.883 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.89 138.68 28.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 61.539999999999999 110.878 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -112.5 -176.53 2.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 74.109999999999999 110.826 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.45 17.52 1.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 70.230000000000004 110.842 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -131.77 12.09 4.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 74.329999999999998 110.879 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -103.22 103.82 13.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 70.409999999999997 111.077 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -101.57 73.8 1.48 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 60.32 111.111 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.843 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -117.52 171.41 8.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 73.5 110.932 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.843 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -155.53 151.05 27.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 71.420000000000002 110.914 179.852 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.2 mm -28.04 116.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 63.310000000000002 111.13 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 122.31 -24.72 6.85 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 75.420000000000002 112.515 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.93 -175.1 0.17 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.879 0.371 . . . . 74.200000000000003 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 2.4 mttt -141.75 166.73 23.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 64.239999999999995 110.898 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 77.6 mt -144.52 143.21 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.22 -0.445 . . . . 72.230000000000004 111.142 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.4 OUTLIER -145.38 103.88 3.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 74.129999999999995 110.954 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -168.71 -162.79 0.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 110.908 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.477 ' NE1' ' HA ' ' A' ' 41' ' ' LEU . 2.7 p-90 -146.91 174.61 11.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.156 -0.474 . . . . 71.099999999999994 110.927 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.1 p -139.23 159.05 43.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 74.549999999999997 111.11 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -122.54 150.21 42.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 72.140000000000001 110.882 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.677 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -147.81 174.55 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.483 . . . . 63.109999999999999 111.171 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.776 HG13 HD12 ' A' ' 27' ' ' LEU . 78.4 mt -150.48 96.14 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 60.530000000000001 111.148 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.44 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 17.1 tttm -113.01 121.55 44.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 72.439999999999998 110.907 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.79 32.41 18.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.439999999999998 110.895 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.75 33.33 72.42 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.716 -0.754 . . . . 34.5 112.471 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.3 mt -99.67 -55.95 2.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 64.030000000000001 110.921 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.05 112.19 2.54 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.766 -0.731 . . . . 72.230000000000004 112.499 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.677 ' HB2' HG23 ' A' ' 79' ' ' VAL . 29.0 m-85 -126.27 164.77 20.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.889 0.376 . . . . 75.519999999999996 110.902 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.5 tmm_? -152.88 137.63 17.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 73.25 110.862 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -89.73 141.86 28.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 70.540000000000006 110.91 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.403 ' O ' ' ND2' ' A' ' 90' ' ' ASN . 2.9 p30 -132.39 143.44 49.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 72.439999999999998 110.854 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 89' ' ' ASP . 0.3 OUTLIER 167.53 -37.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 63.240000000000002 110.873 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 40.55 44.53 3.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.726 -0.75 . . . . 34.119999999999997 112.533 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -168.08 105.4 0.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.83 0.348 . . . . 70.5 110.854 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -146.48 106.3 3.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 110.929 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 30.4 m -80.87 131.12 35.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.244 -0.434 . . . . 74.140000000000001 111.18 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.678 HG13 ' HB2' ' A' ' 10' ' ' ALA . 69.0 t -63.41 121.35 12.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.520000000000003 111.142 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -137.9 8.51 2.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 71.340000000000003 110.881 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.743 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -119.54 -175.54 15.92 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.73 -0.748 . . . . 55.310000000000002 112.466 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.485 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -157.17 153.55 27.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.96 0.409 . . . . 75.120000000000005 110.875 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.667 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.67 172.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 61.049999999999997 111.132 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -141.54 132.86 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 62.020000000000003 110.867 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.93 45.62 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 72.299999999999997 110.882 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 45.25 111.121 179.959 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 3.0 t80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.84 0.352 . . . . 64.239999999999995 110.943 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -140.95 67.47 1.35 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 72.120000000000005 110.921 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.86 143.85 0.07 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.569 0.7 . . . . 73.209999999999994 111.115 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 167.66 23.87 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.642 2.228 . . . . 65.219999999999999 112.331 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 134.98 29.31 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.726 2.284 . . . . 64.019999999999996 112.339 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.83 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -85.54 136.85 33.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 53.409999999999997 111.098 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.4 m -94.66 77.27 3.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 64.439999999999998 111.169 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.663 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.0 mp -80.08 106.25 11.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 71.319999999999993 110.934 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.806 ' O ' HD11 ' A' ' 16' ' ' LEU . 3.6 mm-40 -78.38 -165.82 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 74.329999999999998 110.847 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.853 ' HB2' ' CG1' ' A' ' 95' ' ' VAL . . . -135.88 79.45 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 71.200000000000003 111.07 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.726 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.6 mm -68.6 172.42 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 73.409999999999997 111.098 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.684 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.34 172.05 0.22 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.581 0.705 . . . . 65.129999999999995 110.841 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.591 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.72 21.48 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.686 2.257 . . . . 73.540000000000006 112.34 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.492 ' H ' ' C ' ' A' ' 12' ' ' HIS . 6.9 ptpt -129.06 26.14 5.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 55.530000000000001 110.953 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 151.99 -178.63 29.14 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.767 -0.73 . . . . 54.130000000000003 112.486 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.035 HD13 HD21 ' A' ' 67' ' ' LEU . 35.6 tp -149.87 163.67 37.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 64.450000000000003 110.901 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.646 ' HB2' HD11 ' A' ' 11' ' ' ILE . 6.2 ttt180 -131.24 135.23 47.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 62.229999999999997 110.863 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.663 HG22 ' HA ' ' A' ' 8' ' ' LEU . 41.9 t -143.26 110.6 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 51.130000000000003 111.113 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.443 ' HB2' HG23 ' A' ' 59' ' ' ILE . 10.8 t -118.2 157.41 27.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 71.219999999999999 110.888 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.83 HG12 ' HA ' ' A' ' 6' ' ' ALA . 25.4 m -139.94 151.94 66.61 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.654 0.74 . . . . 74.230000000000004 111.123 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 121.36 8.04 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.655 2.237 . . . . 75.540000000000006 112.335 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.426 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 22.8 t0 -82.81 93.6 7.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.194 -0.457 . . . . 74.530000000000001 110.862 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.7 30.59 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.469 . . . . 73.310000000000002 110.933 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.414 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 105.14 23.46 7.68 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.727 -0.749 . . . . 73.319999999999993 112.464 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.548 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 64.3 m-85 -72.24 166.23 22.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 73.209999999999994 110.871 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.8 t -129.86 -6.49 4.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 72.349999999999994 110.854 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.029 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -163.05 140.56 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 72.420000000000002 110.912 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.029 ' N ' HD22 ' A' ' 27' ' ' LEU . 14.0 t80 -135.59 149.97 49.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 73.299999999999997 110.898 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.62 152.73 42.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 63.130000000000003 111.139 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' HE2' HG11 ' A' ' 18' ' ' VAL . 1.9 t80 -132.68 132.47 42.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 72.519999999999996 110.922 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.551 ' CD2' ' O ' ' A' ' 30' ' ' PHE . 16.3 m-70 -157.79 89.05 1.0 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 72.530000000000001 110.875 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.547 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.12 -175.32 19.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.719 -0.753 . . . . 62.210000000000001 112.481 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -135.48 -164.17 1.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.817 0.341 . . . . 72.239999999999995 110.928 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.717 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -130.27 138.83 50.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 64.109999999999999 110.897 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.646 ' ND2' HD12 ' A' ' 34' ' ' LEU . 68.4 m-80 46.52 26.69 0.53 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 73.310000000000002 110.905 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -154.11 144.22 22.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 63.229999999999997 110.914 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -113.32 152.77 29.49 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 73.230000000000004 110.855 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.77 178.54 4.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 63.009999999999998 110.899 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.28 145.0 50.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 54.119999999999997 110.923 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 57.9 40.0 92.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.761 -0.733 . . . . 62.310000000000002 112.506 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.471 ' HB3' ' CE2' ' A' ' 76' ' ' TRP . 7.5 mt 35.38 84.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.765 0.317 . . . . 71.430000000000007 110.921 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -124.3 -179.76 4.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 43.520000000000003 110.899 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.58 99.69 8.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 64.439999999999998 111.134 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.91 -118.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.781 -0.723 . . . . 51.020000000000003 112.456 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -100.44 -54.28 2.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.82 0.343 . . . . 74.299999999999997 110.854 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.717 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.4 m-90 -71.39 171.11 11.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.109999999999999 110.9 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 89.2 p -173.31 115.85 0.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 63.109999999999999 110.854 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.46 158.24 20.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 74.340000000000003 110.884 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -142.46 122.88 13.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 72.219999999999999 110.861 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.449 HG22 ' H ' ' A' ' 52' ' ' LYS . 19.2 mm -103.66 118.35 50.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 63.409999999999997 111.115 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.439 ' O ' ' CB ' ' A' ' 52' ' ' LYS . 51.7 p -104.6 35.07 2.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 55.43 111.152 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.449 ' H ' HG22 ' A' ' 50' ' ' ILE . 16.7 mttt 164.93 137.71 0.03 OUTLIER Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.571 0.701 . . . . 73.530000000000001 110.91 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 174.77 9.04 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.695 2.263 . . . . 73.010000000000005 112.318 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -136.94 11.57 3.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 74.109999999999999 110.919 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 175.77 44.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.426 . . . . 73.430000000000007 110.917 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.78 -24.62 5.76 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.807 -0.711 . . . . 72.430000000000007 112.477 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.23 163.36 27.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 75.329999999999998 110.909 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.426 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 8.1 m95 -85.1 96.2 9.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 73.200000000000003 110.918 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 19' ' ' SER . 28.2 mt -102.41 140.83 19.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 111.127 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.404 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 41.9 t80 -134.64 158.01 45.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 73.340000000000003 110.865 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.404 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -148.37 139.0 22.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 75.099999999999994 110.843 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.68 -179.38 3.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 65.319999999999993 110.85 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.75 28.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 71.040000000000006 110.895 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -144.47 18.59 1.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 63.229999999999997 110.945 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.41 102.71 11.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 72.219999999999999 111.128 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -98.59 83.11 2.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 63.549999999999997 111.066 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.035 HD21 HD13 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -121.66 171.63 8.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 110.91 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -155.51 141.75 18.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 72.230000000000004 110.873 179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.707 HD11 ' O ' ' A' ' 97' ' ' GLY . 25.6 mm -25.41 119.52 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 63.130000000000003 111.153 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.56 -18.08 8.78 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.743 -0.742 . . . . 60.549999999999997 112.469 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -73.29 -176.58 2.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.912 0.387 . . . . 74.040000000000006 110.85 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 6.7 mttt -143.32 160.58 40.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 71.430000000000007 110.86 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.479 HG12 ' CD2' ' A' ' 34' ' ' LEU . 49.1 mt -137.82 146.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 111.126 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.9 m-85 -146.98 104.97 3.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.168 -0.469 . . . . 73.310000000000002 110.951 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.547 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.9 p90 -165.96 -168.26 1.24 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 110.906 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.471 ' CE2' ' HB3' ' A' ' 41' ' ' LEU . 1.3 p-90 -135.61 171.59 14.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.158 -0.474 . . . . 64.099999999999994 110.908 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.2 p -142.11 149.01 39.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 71.439999999999998 111.182 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.07 144.17 39.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.030000000000001 110.868 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.54 HG13 ' HD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -143.72 167.83 12.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 72.109999999999999 111.152 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.66 HG13 HD12 ' A' ' 27' ' ' LEU . 88.9 mt -149.0 96.05 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 72.219999999999999 111.116 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.548 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 1.3 tttt -112.28 133.66 54.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 74.230000000000004 110.884 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 48.88 37.85 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.225 -0.443 . . . . 74.209999999999994 110.882 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.65 29.71 49.52 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 64.299999999999997 112.472 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.7 mt -93.0 -58.33 2.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.858 0.361 . . . . 63.340000000000003 110.924 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.21 120.66 3.79 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.776 -0.726 . . . . 73.420000000000002 112.497 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.41 ' HB2' HG23 ' A' ' 79' ' ' VAL . 98.2 m-85 -143.59 163.74 32.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.947 0.403 . . . . 64.219999999999999 110.9 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -159.04 134.7 8.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 74.019999999999996 110.874 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -80.77 154.8 27.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 110.899 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.496 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -138.84 -164.73 1.7 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.895 179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.496 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.2 t-20 82.08 -40.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.891 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.16 84.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.671 -0.776 . . . . 74.549999999999997 112.493 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -172.26 110.68 0.25 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.823 0.344 . . . . 71.430000000000007 110.89 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 14.8 m-90 -149.75 114.77 5.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.135 -0.484 . . . . 74.420000000000002 110.915 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 17.5 m -87.98 136.04 33.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 64.310000000000002 111.111 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.853 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 35.5 t -71.85 115.09 11.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 111.134 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -133.21 12.46 4.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.904 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.844 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -130.78 177.7 18.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.716 -0.754 . . . . 72.109999999999999 112.44 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.452 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -145.02 160.41 41.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.846 0.355 . . . . 71.420000000000002 110.902 -179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.726 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.13 167.57 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 71.319999999999993 111.133 179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.43 137.28 50.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 74.25 110.896 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -89.49 42.22 1.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 63.450000000000003 110.876 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 63.229999999999997 111.096 179.941 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 3.4 t80 . . . . . 0 C--O 1.23 0.048 0 CA-C-O 120.806 0.336 . . . . 75.239999999999995 110.924 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -140.5 77.36 1.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.083 -0.508 . . . . 74.439999999999998 110.867 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.6 142.92 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.564 0.697 . . . . 21.02 111.118 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 167.05 25.61 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.658 2.238 . . . . 63.350000000000001 112.318 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 135.76 31.35 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.64 2.226 . . . . 73.340000000000003 112.392 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.627 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -89.65 141.43 28.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 64.140000000000001 111.078 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.2 m -100.47 76.83 1.88 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 70.209999999999994 111.156 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.505 ' HA ' HG22 ' A' ' 18' ' ' VAL . 1.9 mp -73.81 106.73 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 65.219999999999999 110.943 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.797 ' O ' HD11 ' A' ' 16' ' ' LEU . 7.3 mm-40 -78.41 -170.28 1.98 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 71.519999999999996 110.881 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.773 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -133.59 80.83 1.89 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 64.540000000000006 111.125 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.697 HG22 ' H ' ' A' ' 12' ' ' HIS . 3.1 mm -72.14 172.39 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.444 . . . . 75.530000000000001 111.174 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.697 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.0 171.82 0.25 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.603 0.715 . . . . 72.140000000000001 110.854 179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.2 Cg_endo -69.71 20.85 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.693 2.262 . . . . 54.25 112.356 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 9.5 pttt -125.67 19.76 7.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 62.119999999999997 110.901 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 156.21 -177.39 33.27 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.782 -0.723 . . . . 73.150000000000006 112.508 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.797 HD11 ' O ' ' A' ' 9' ' ' GLU . 24.0 tp -149.8 166.71 28.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 50.210000000000001 110.902 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.584 ' HB2' HD11 ' A' ' 11' ' ' ILE . 65.6 ttt180 -133.25 138.93 46.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 74.450000000000003 110.86 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 8' ' ' LEU . 73.0 t -147.19 107.49 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 74.239999999999995 111.151 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.48 ' HB2' HG23 ' A' ' 59' ' ' ILE . 12.4 t -112.24 156.45 22.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.105 -0.498 . . . . 63.119999999999997 110.872 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 6' ' ' ALA . 30.3 m -141.73 151.84 61.14 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.653 0.74 . . . . 75.439999999999998 111.132 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 122.44 9.11 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.733 2.289 . . . . 74.230000000000004 112.311 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.512 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 12.1 t0 -83.64 92.77 7.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 72.219999999999999 110.853 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.35 40.89 0.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 110.897 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.405 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 92.0 24.5 24.81 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.752 -0.737 . . . . 52.520000000000003 112.511 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.592 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 95.7 m-85 -74.71 165.02 25.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.866 0.365 . . . . 72.219999999999999 110.854 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 37.1 t -129.41 -7.61 4.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 53.229999999999997 110.861 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.008 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -155.02 142.1 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 71.049999999999997 110.951 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.008 ' N ' HD22 ' A' ' 27' ' ' LEU . 17.9 t80 -137.55 147.9 45.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 72.439999999999998 110.903 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.7 156.76 46.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 74.349999999999994 111.098 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.448 ' HE2' HG11 ' A' ' 18' ' ' VAL . 1.8 t80 -139.4 125.42 19.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 73.319999999999993 110.901 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.445 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 25.8 m-70 -152.58 92.58 1.68 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 73.420000000000002 110.869 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.486 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -144.67 -174.47 16.95 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 61.229999999999997 112.448 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -134.14 -163.98 1.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.783 0.325 . . . . 72.430000000000007 110.918 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.756 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -131.86 123.46 27.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 53.240000000000002 110.899 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.405 ' ND2' HD12 ' A' ' 34' ' ' LEU . 68.0 m-80 61.4 27.23 16.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 110.878 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -156.89 146.68 20.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.915 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -113.92 159.33 20.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 61.350000000000001 110.893 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.562 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -110.89 -174.52 2.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 73.010000000000005 110.887 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -152.15 138.32 18.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 72.140000000000001 110.879 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 75.28 31.09 57.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 73.400000000000006 112.513 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.461 ' HA ' ' NE1' ' A' ' 76' ' ' TRP . 5.1 mt 43.96 83.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.794 0.331 . . . . 51.210000000000001 110.926 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -129.25 169.07 15.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 74.200000000000003 110.91 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.31 101.5 9.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.164 -0.471 . . . . 75.430000000000007 111.078 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -59.54 -111.88 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 30.440000000000001 112.459 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.11 -56.33 2.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.804 0.335 . . . . 74.430000000000007 110.837 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.756 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.3 m-90 -69.85 177.07 3.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 70.439999999999998 110.931 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.445 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 66.0 p -179.92 109.4 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 70.140000000000001 110.837 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.06 156.7 24.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.091 -0.504 . . . . 73.219999999999999 110.863 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -140.22 120.02 13.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 63.229999999999997 110.859 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.582 HG22 ' H ' ' A' ' 52' ' ' LYS . 8.6 mm -95.18 117.16 38.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 74.430000000000007 111.154 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.403 HG23 ' OD1' ' A' ' 49' ' ' ASP . 30.6 p -98.96 32.55 2.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 72.400000000000006 111.149 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.582 ' H ' HG22 ' A' ' 50' ' ' ILE . 0.8 OUTLIER 170.24 139.83 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.555 0.693 . . . . 63.32 110.923 179.933 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -178.95 2.58 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.66 2.24 . . . . 70.420000000000002 112.363 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HD2' HD12 ' A' ' 59' ' ' ILE . 15.8 ttmt -119.63 -61.7 1.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 74.129999999999995 110.89 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -131.43 58.47 1.72 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 64.340000000000003 110.891 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 89.38 -28.74 6.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 40.439999999999998 112.461 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.5 160.7 29.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.775 0.322 . . . . 64.409999999999997 110.887 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.512 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 44.1 m95 -82.59 89.1 6.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 75.129999999999995 110.949 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.48 HG23 ' HB2' ' A' ' 19' ' ' SER . 25.8 mt -94.46 135.91 27.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 75.25 111.159 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.478 ' CG ' ' N ' ' A' ' 61' ' ' ARG . 56.1 t80 -135.56 162.37 32.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 71.310000000000002 110.847 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.478 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -158.24 152.71 24.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 75.430000000000007 110.892 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -119.39 -176.41 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 65.400000000000006 110.855 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 16.1 mtt180 -142.76 16.47 1.97 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 72.150000000000006 110.877 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -132.8 8.72 4.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 54.25 110.892 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.85 95.96 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 53.130000000000003 111.108 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -93.67 77.46 4.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 60.109999999999999 111.104 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.82 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -125.07 171.47 10.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.244 -0.435 . . . . 71.230000000000004 110.9 -179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.82 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.71 154.88 28.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 55.32 110.913 179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.494 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.7 mm -29.98 121.32 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 73.409999999999997 111.118 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.52 -28.45 5.98 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.729 -0.748 . . . . 74.400000000000006 112.452 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.469 ' OD2' HD11 ' A' ' 34' ' ' LEU . 1.4 m-20 -66.53 -171.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 71.430000000000007 110.861 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.504 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.7 mttt -148.78 168.71 22.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 72.5 110.898 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.454 HG12 HD22 ' A' ' 34' ' ' LEU . 78.6 mt -146.67 145.28 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 63.140000000000001 111.153 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.504 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -148.36 103.29 3.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 72.109999999999999 110.914 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.486 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.3 p90 -160.97 -168.99 2.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 75.140000000000001 110.903 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.562 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -139.99 146.12 38.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.185 -0.461 . . . . 74.430000000000007 110.912 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.402 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 1.9 p -111.63 161.76 15.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 73.329999999999998 111.142 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.78 138.1 51.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.893 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.577 ' HB ' ' CD1' ' A' ' 25' ' ' PHE . 2.3 m -141.86 177.2 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.479 . . . . 74.340000000000003 111.141 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.772 HG13 HD12 ' A' ' 27' ' ' LEU . 68.3 mt -152.95 98.41 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 70.049999999999997 111.122 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -112.7 141.02 46.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 72.150000000000006 110.866 179.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.427 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER 44.92 32.51 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 110.879 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.38 36.98 91.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.729 -0.748 . . . . 54.210000000000001 112.472 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -100.7 -50.59 3.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.836 0.35 . . . . 52.509999999999998 110.899 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 83.48 105.01 0.52 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.707 -0.758 . . . . 63.310000000000002 112.501 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -123.72 -175.02 3.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.921 0.391 . . . . 74.319999999999993 110.906 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.449 ' NH1' ' HB3' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -178.44 135.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.105 -0.498 . . . . 64.409999999999997 110.854 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -79.1 153.28 30.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.918 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.482 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -136.28 -165.5 1.73 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 71.099999999999994 110.841 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.482 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 81.34 -40.97 0.15 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 73.200000000000003 110.861 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 47.27 83.05 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.732 -0.747 . . . . 54.229999999999997 112.504 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -170.69 112.91 0.41 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 72.129999999999995 110.894 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.6 m-90 -155.04 113.05 3.45 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.137 -0.483 . . . . 72.349999999999994 110.923 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 96.1 m -88.48 135.34 33.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.247 -0.433 . . . . 51.240000000000002 111.151 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.689 HG13 ' HB2' ' A' ' 10' ' ' ALA . 15.8 t -64.75 114.94 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 73.400000000000006 111.14 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -131.62 -2.34 3.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 61.119999999999997 110.894 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.773 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -113.51 -174.89 19.05 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 74.329999999999998 112.48 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.493 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.49 156.73 35.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 75.040000000000006 110.896 -179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.67 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.64 167.34 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.151 -0.477 . . . . 61.329999999999998 111.128 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -127.46 129.44 47.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 52.200000000000003 110.889 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -78.69 48.51 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 74.010000000000005 110.844 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 65.140000000000001 111.091 179.947 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 2.3 t80 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.857 0.361 . . . . 54.229999999999997 110.901 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -143.99 67.29 1.27 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.310000000000002 110.931 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.54 139.57 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.583 0.706 . . . . 74.219999999999999 111.067 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 165.07 32.22 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.664 2.243 . . . . 64.519999999999996 112.35 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 134.79 28.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.635 2.223 . . . . 72.030000000000001 112.375 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.835 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -80.34 135.0 36.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.275 -0.42 . . . . 75.120000000000005 111.115 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.7 m -93.95 77.7 4.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 64.510000000000005 111.105 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 8' ' ' LEU . 2.3 mp -85.84 111.45 20.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 63.520000000000003 110.898 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.543 ' O ' HD11 ' A' ' 16' ' ' LEU . 2.5 mm-40 -84.58 -155.14 0.19 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.131 -0.486 . . . . 75.519999999999996 110.906 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -143.62 80.44 1.66 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 63.43 111.065 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 17' ' ' ARG . 2.6 mm -69.51 172.27 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 61.219999999999999 111.123 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.692 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -54.18 172.74 0.23 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.627 0.727 . . . . 60.25 110.834 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.1 Cg_endo -69.77 19.82 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.659 2.239 . . . . 65.120000000000005 112.36 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 12' ' ' HIS . 0.0 OUTLIER -124.54 21.72 8.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 64.209999999999994 110.923 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.55 -177.47 31.07 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 61.109999999999999 112.434 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.726 HD13 HD11 ' A' ' 67' ' ' LEU . 36.0 tp -149.47 162.05 40.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.853 0.359 . . . . 73.129999999999995 110.92 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.756 ' HB2' HD11 ' A' ' 11' ' ' ILE . 37.3 ttt180 -123.16 138.3 54.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 63.109999999999999 110.886 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.1 t -148.61 110.01 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 70.219999999999999 111.092 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.407 ' HB2' HG23 ' A' ' 59' ' ' ILE . 8.5 t -123.31 156.12 35.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 54.340000000000003 110.828 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' A' ' 6' ' ' ALA . 23.9 m -141.45 151.66 61.54 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.649 0.738 . . . . 75.439999999999998 111.125 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 126.26 13.1 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.709 2.273 . . . . 64.019999999999996 112.31 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 34.3 t0 -97.21 86.23 3.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 71.319999999999993 110.871 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -20.57 63.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 110.895 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 160.84 30.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 73.519999999999996 112.523 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 83.4 m-85 -81.36 167.75 19.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.864 0.364 . . . . 75.230000000000004 110.866 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.1 t -127.22 -10.48 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 73.239999999999995 110.845 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.006 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -151.96 141.44 21.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 75.299999999999997 110.949 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.006 ' N ' HD22 ' A' ' 27' ' ' LEU . 14.5 t80 -137.34 140.89 41.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 70.510000000000005 110.924 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.17 144.66 48.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 74.109999999999999 111.092 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.442 ' CE1' ' CZ ' ' A' ' 75' ' ' PHE . 1.6 t80 -130.78 109.7 10.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 73.400000000000006 110.852 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.955 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -135.84 93.69 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 73.239999999999995 110.841 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' HA2' ' CB ' ' A' ' 75' ' ' PHE . . . -142.28 -177.26 17.18 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.679 -0.772 . . . . 54.219999999999999 112.467 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -131.3 -164.27 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 75.409999999999997 110.882 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.713 HD23 ' HH2' ' A' ' 46' ' ' TRP . 0.2 OUTLIER -133.9 129.07 35.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 72.340000000000003 110.903 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.645 ' ND2' HD12 ' A' ' 34' ' ' LEU . 61.0 m-80 60.29 17.11 6.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 74.409999999999997 110.897 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -153.23 142.01 21.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 52.229999999999997 110.888 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HB3' ' CB ' ' A' ' 74' ' ' TYR . 4.3 pt-20 -117.59 154.41 31.59 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 62.109999999999999 110.914 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.486 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 7.2 ptt? -109.83 178.88 4.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 71.140000000000001 110.919 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.07 173.49 10.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.285 -0.416 . . . . 71.010000000000005 110.866 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.469 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 46.41 39.48 10.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.738 -0.744 . . . . 60.329999999999998 112.521 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.3 OUTLIER 32.49 76.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.753 0.311 . . . . 74.299999999999997 110.912 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -113.66 -164.02 0.9 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 70.310000000000002 110.892 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.955 ' HB1' ' NE2' ' A' ' 31' ' ' HIS . . . -97.9 101.23 12.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 71.030000000000001 111.111 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . -57.85 -114.39 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.732 -0.747 . . . . 53.340000000000003 112.477 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -102.31 -71.42 0.72 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.769 0.319 . . . . 53.130000000000003 110.871 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.713 ' HH2' HD23 ' A' ' 34' ' ' LEU . 5.9 m-90 -58.09 155.41 11.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 75.200000000000003 110.931 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.511 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 87.3 p -153.15 108.2 3.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 61.310000000000002 110.833 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.79 160.76 39.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.48 . . . . 65.549999999999997 110.861 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.729 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -144.96 108.41 4.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 110.876 179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 28' ' ' PHE . 4.6 mm -85.85 101.0 9.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.222 -0.444 . . . . 72.239999999999995 111.111 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 p -87.81 26.48 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.479 . . . . 65.430000000000007 111.154 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' H ' HG22 ' A' ' 50' ' ' ILE . 2.8 mttt 178.84 135.38 0.24 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.578 0.704 . . . . 72.549999999999997 110.889 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.86 168.12 22.61 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.684 2.256 . . . . 61.420000000000002 112.329 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.617 ' HD2' HD12 ' A' ' 59' ' ' ILE . 17.2 ttmt -105.77 -60.35 1.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 110.933 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -132.11 53.94 1.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 65.409999999999997 110.863 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 92.91 -20.01 48.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.746 -0.74 . . . . 42.149999999999999 112.472 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -133.84 162.4 32.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 74.340000000000003 110.922 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.516 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 15.8 m95 -85.07 91.85 8.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 75.120000000000005 110.956 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.617 HD12 ' HD2' ' A' ' 54' ' ' LYS . 17.3 mt -100.38 146.08 9.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.284 -0.416 . . . . 64.239999999999995 111.123 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -142.69 155.06 44.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 74.030000000000001 110.902 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.0 119.95 11.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 72.129999999999995 110.875 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD2' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -93.24 -178.24 4.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 74.200000000000003 110.855 179.961 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.5 ptt180 -145.25 10.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 70.510000000000005 110.878 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.486 ' ND2' ' OD2' ' A' ' 62' ' ' ASP . 15.1 p30 -124.08 -1.39 8.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 52.140000000000001 110.883 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.492 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . . . -84.41 98.93 10.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 62.119999999999997 111.082 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -100.19 78.98 2.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 73.400000000000006 111.124 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.86 HD22 ' N ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -127.75 170.24 12.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 72.319999999999993 110.924 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.86 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -158.31 151.99 23.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 64.450000000000003 110.865 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.603 HG12 ' CE2' ' A' ' 98' ' ' PHE . 2.8 mm -27.45 122.58 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 72.310000000000002 111.116 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.03 -25.46 7.87 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.747 -0.74 . . . . 53.240000000000002 112.513 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -71.11 -168.22 0.28 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.911 0.386 . . . . 74.219999999999999 110.841 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.487 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.9 mttt -151.18 171.96 16.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 71.299999999999997 110.908 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.58 HG12 HD22 ' A' ' 34' ' ' LEU . 83.9 mt -147.96 149.23 15.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 75.420000000000002 111.09 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.1 m-85 -152.76 115.3 4.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 65.519999999999996 110.935 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.598 ' CE2' HG23 ' A' ' 77' ' ' THR . 8.3 p90 -171.55 -159.37 0.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.0 110.915 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.529 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -151.79 133.29 14.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 75.25 110.935 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.598 HG23 ' CE2' ' A' ' 75' ' ' PHE . 1.7 p -93.78 166.84 12.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.208 -0.451 . . . . 63.310000000000002 111.182 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.58 132.22 28.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 65.329999999999998 110.857 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.414 ' C ' HG13 ' A' ' 80' ' ' ILE . 2.1 m -135.6 177.12 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.501 . . . . 71.209999999999994 111.103 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.8 HG13 HD12 ' A' ' 27' ' ' LEU . 79.0 mt -150.13 99.65 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 60.32 111.155 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -115.92 140.86 48.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 72.219999999999999 110.907 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 44.87 33.13 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 62.310000000000002 110.848 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.94 36.96 83.1 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.727 -0.749 . . . . 54.340000000000003 112.5 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.1 mt -100.43 -52.22 3.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.906 0.384 . . . . 54.5 110.908 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.02 102.9 0.73 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.743 -0.742 . . . . 74.099999999999994 112.486 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -122.88 179.19 4.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 74.340000000000003 110.948 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.456 ' CG ' ' O ' ' A' ' 77' ' ' THR . 1.7 tmm_? -177.38 136.39 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 75.439999999999998 110.899 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -75.28 160.87 29.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 73.230000000000004 110.942 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.489 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -139.34 -167.77 2.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 72.010000000000005 110.88 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.489 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.7 OUTLIER 82.47 -40.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 65.310000000000002 110.822 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 46.09 79.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.767 -0.73 . . . . 25.219999999999999 112.502 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -167.49 109.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.362 . . . . 73.400000000000006 110.888 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.9 m-90 -149.17 111.29 4.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.113 -0.494 . . . . 74.019999999999996 110.899 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 84.8 m -91.98 135.17 34.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 64.430000000000007 111.156 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.715 HG13 ' HB2' ' A' ' 10' ' ' ALA . 9.9 t -60.45 156.03 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 72.109999999999999 111.154 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.502 ' O ' ' CD1' ' A' ' 69' ' ' ILE . 13.7 mt-10 -163.05 -33.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 110.916 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.729 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -103.02 -170.91 26.22 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.75 -0.738 . . . . 74.25 112.486 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.603 ' CE2' HG12 ' A' ' 69' ' ' ILE . 0.2 OUTLIER -150.3 168.5 23.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.924 0.392 . . . . 61.049999999999997 110.879 -179.897 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.63 ' HB ' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.52 175.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 71.310000000000002 111.138 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -137.73 142.26 40.99 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 110.888 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -88.48 51.29 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 70.329999999999998 110.836 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 51.219999999999999 111.085 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 9.6 t80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.817 0.341 . . . . 72.209999999999994 110.962 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.96 76.74 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 64.319999999999993 110.89 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.38 143.33 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.6 0.714 . . . . 71.209999999999994 111.114 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.8 Cg_endo -69.79 167.79 23.45 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.7 2.267 . . . . 62.420000000000002 112.37 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 133.13 24.84 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.714 2.276 . . . . 72.219999999999999 112.34 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.955 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -85.3 142.52 29.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 71.209999999999994 111.098 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m -99.01 77.36 2.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 65.120000000000005 111.174 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.593 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.8 mp -76.05 105.72 7.24 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.464 . . . . 72.25 110.929 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.761 ' O ' HD11 ' A' ' 16' ' ' LEU . 5.1 mm-40 -78.53 -170.88 2.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 75.019999999999996 110.863 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.86 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -133.78 80.27 1.86 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 42.119999999999997 111.098 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.718 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.1 mm -71.94 172.59 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 71.239999999999995 111.135 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.704 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.25 172.09 0.25 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.596 0.712 . . . . 73.030000000000001 110.855 179.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.593 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.82 20.06 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.668 2.245 . . . . 53.409999999999997 112.301 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' H ' ' C ' ' A' ' 12' ' ' HIS . 2.7 pttt -125.95 21.87 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 72.319999999999993 110.918 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.498 ' CA ' ' O ' ' A' ' 62' ' ' ASP . . . 155.58 -178.49 32.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.731 -0.747 . . . . 61.43 112.485 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.808 HD13 HD11 ' A' ' 67' ' ' LEU . 19.9 tp -149.83 168.23 24.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.818 0.342 . . . . 75.230000000000004 110.931 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HB2' HD11 ' A' ' 11' ' ' ILE . 13.9 ttm180 -135.56 134.91 39.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 64.319999999999993 110.87 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 8' ' ' LEU . 78.6 t -144.62 106.65 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 111.114 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.418 ' HB2' HG23 ' A' ' 59' ' ' ILE . 20.1 t -116.08 156.47 26.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 75.510000000000005 110.822 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.978 HG21 ' CZ ' ' A' ' 28' ' ' PHE . 33.0 m -141.25 152.66 64.97 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.672 0.749 . . . . 62.039999999999999 111.088 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 120.91 7.61 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.628 2.218 . . . . 63.520000000000003 112.312 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.48 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 3.6 t70 -75.9 99.71 4.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 70.519999999999996 110.855 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -88.98 35.44 0.79 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 52.539999999999999 110.873 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.12 25.01 25.46 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 60.119999999999997 112.485 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.488 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 98.8 m-85 -73.05 168.1 19.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.913 0.387 . . . . 72.239999999999995 110.857 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.2 t -129.34 -8.15 4.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 53.240000000000002 110.839 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.014 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -159.62 142.06 13.64 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.95 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.014 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -137.19 150.97 48.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 64.140000000000001 110.876 179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.17 143.81 40.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.123 -0.489 . . . . 64.540000000000006 111.133 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -126.52 119.76 27.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.416 . . . . 63.219999999999999 110.884 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.543 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 5.8 m-70 -152.08 92.32 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.504 . . . . 63.299999999999997 110.846 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.422 ' HA3' ' CB ' ' A' ' 75' ' ' PHE . . . -146.22 178.55 23.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.715 -0.755 . . . . 71.140000000000001 112.498 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.459 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 0.1 OUTLIER -133.18 -164.81 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 44.109999999999999 110.907 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.451 HD23 HD22 ' A' ' 35' ' ' ASN . 1.4 tp -132.56 152.33 51.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 65.310000000000002 110.921 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.451 HD22 HD23 ' A' ' 34' ' ' LEU . 13.3 m-80 41.27 25.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 43.109999999999999 110.916 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 34' ' ' LEU . 0.4 OUTLIER -164.01 136.86 5.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 71.040000000000006 110.915 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -107.42 163.81 12.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 73.25 110.839 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.579 ' HG2' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -112.42 -177.47 3.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 64.319999999999993 110.867 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -146.53 146.24 30.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 73.319999999999993 110.907 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.42 26.86 74.08 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 75.439999999999998 112.499 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.47 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 1.6 mt 47.46 84.32 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.756 0.313 . . . . 73.200000000000003 110.88 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.32 170.69 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 72.219999999999999 110.886 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.512 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -87.35 100.83 13.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 71.329999999999998 111.078 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.459 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . -66.93 -107.13 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.752 -0.737 . . . . 71.299999999999997 112.523 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.03 -71.82 0.69 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.802 0.334 . . . . 70.239999999999995 110.907 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -53.73 148.35 10.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 73.450000000000003 110.975 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.543 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 52.4 p -155.45 119.74 4.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.282 -0.417 . . . . 52.109999999999999 110.889 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.57 160.97 11.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 64.329999999999998 110.89 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -139.02 114.7 9.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.299999999999997 110.87 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' PHE . 10.2 mm -94.57 97.51 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 64.099999999999994 111.124 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.561 HG22 HD23 ' A' ' 27' ' ' LEU . 46.2 p -95.38 29.7 2.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.158 -0.474 . . . . 73.25 111.158 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.92 133.06 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.572 0.701 . . . . 74.409999999999997 110.902 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 -178.14 2.18 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.675 2.25 . . . . 64.439999999999998 112.387 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -135.73 -34.39 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 74.239999999999995 110.924 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -138.77 49.2 1.89 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 72.329999999999998 110.909 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.87 -26.12 4.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.766 -0.73 . . . . 72.519999999999996 112.415 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -125.64 168.22 14.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.775 0.322 . . . . 70.340000000000003 110.897 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.488 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 13.9 m95 -90.25 87.96 7.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 72.409999999999997 110.908 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.418 HG23 ' HB2' ' A' ' 19' ' ' SER . 44.9 mt -91.91 141.52 14.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 75.5 111.075 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.524 ' CE2' ' OD1' ' A' ' 62' ' ' ASP . 18.8 t80 -138.24 147.06 43.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.127 -0.488 . . . . 64.120000000000005 110.869 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.17 139.38 39.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 62.149999999999999 110.928 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.524 ' OD1' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -120.29 140.59 51.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 70.140000000000001 110.867 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.03 31.03 6.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 70.319999999999993 110.877 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -140.36 19.89 2.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.867 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -112.4 112.4 23.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 62.219999999999999 111.091 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -108.39 83.72 1.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 51.130000000000003 111.107 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.808 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -135.61 171.22 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.120000000000005 110.884 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.661 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -156.85 158.46 36.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.239999999999995 110.9 179.798 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.684 HD11 ' O ' ' A' ' 97' ' ' GLY . 26.9 mm -32.16 115.09 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 64.239999999999995 111.136 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 129.24 -26.66 4.38 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.709 -0.757 . . . . 71.129999999999995 112.474 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -72.37 -172.5 0.94 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.914 0.388 . . . . 52.100000000000001 110.834 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.527 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.1 OUTLIER -143.17 168.23 20.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 110.917 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.7 mt -145.24 143.18 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 71.450000000000003 111.145 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.527 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.0 OUTLIER -147.43 108.69 4.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 73.109999999999999 110.948 -179.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.422 ' CB ' ' HA3' ' A' ' 32' ' ' GLY . 0.2 OUTLIER -164.07 -163.87 0.82 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 75.019999999999996 110.833 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.579 ' CZ2' ' HG2' ' A' ' 38' ' ' MET . 0.0 OUTLIER -149.13 144.1 26.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.156 -0.474 . . . . 74.120000000000005 110.925 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.48 ' O ' ' CG ' ' A' ' 87' ' ' ARG . 6.1 p -113.15 149.62 33.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 70.109999999999999 111.17 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.59 142.96 46.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 73.140000000000001 110.873 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -141.8 170.83 12.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 111.14 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.721 HG13 HD12 ' A' ' 27' ' ' LEU . 80.1 mt -147.63 96.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 70.439999999999998 111.138 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.42 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 9.2 tttt -112.68 140.74 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 71.319999999999993 110.921 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 40.97 38.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 33.350000000000001 110.893 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.01 40.86 51.61 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 63.039999999999999 112.501 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.6 mt -105.09 -48.24 3.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.834 0.35 . . . . 74.299999999999997 110.946 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 89.21 105.27 1.08 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.704 -0.76 . . . . 73.409999999999997 112.499 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -123.97 168.96 12.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.897 0.38 . . . . 64.329999999999998 110.9 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.48 ' CG ' ' O ' ' A' ' 77' ' ' THR . 3.7 ttp-105 -175.05 140.03 0.51 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 63.409999999999997 110.848 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.435 ' N ' ' HG2' ' A' ' 87' ' ' ARG . 3.2 tp-100 -84.19 155.47 22.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 74.349999999999994 110.869 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -137.97 -169.47 2.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 70.400000000000006 110.884 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.1 OUTLIER 83.78 -33.43 0.07 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 63.32 110.884 -179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 41.13 83.37 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.8 -0.714 . . . . 71.420000000000002 112.429 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -169.66 112.98 0.5 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.831 0.348 . . . . 75.450000000000003 110.9 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.7 m-90 -155.32 110.97 3.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 75.230000000000004 110.931 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 95.9 m -83.82 139.27 32.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.263 -0.426 . . . . 73.219999999999999 111.137 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.676 HG13 ' HB2' ' A' ' 10' ' ' ALA . 39.2 t -69.67 116.67 11.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 65.209999999999994 111.083 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -138.64 10.3 2.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 72.540000000000006 110.849 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.86 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -117.88 -178.11 17.3 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.771 -0.728 . . . . 73.420000000000002 112.512 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.585 ' CE2' HG13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -153.41 152.01 30.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.896 0.379 . . . . 55.299999999999997 110.872 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.718 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -165.61 170.48 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 111.166 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -138.61 129.03 25.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.445 . . . . 64.099999999999994 110.865 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -87.66 45.94 1.33 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.18 -0.464 . . . . 54.32 110.906 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 44.32 111.096 179.934 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 13.8 t80 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.84 0.353 . . . . 75.230000000000004 110.954 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -149.74 87.71 1.51 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 74.219999999999999 110.882 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.716 ' HB3' ' OE1' ' A' ' 88' ' ' GLN . . . 61.0 143.61 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.605 0.717 . . . . 73.25 111.109 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 161.03 47.52 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.719 2.279 . . . . 71.340000000000003 112.323 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 134.58 28.27 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.694 2.263 . . . . 63.32 112.327 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.629 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -89.53 139.06 30.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 50.020000000000003 111.095 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -89.48 77.7 7.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 73.519999999999996 111.145 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.516 HD23 ' CG2' ' A' ' 18' ' ' VAL . 1.9 mp -79.63 111.47 15.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 44.219999999999999 110.919 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.495 ' O ' HD11 ' A' ' 16' ' ' LEU . 2.0 mm-40 -86.18 -155.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 61.340000000000003 110.848 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -144.21 80.96 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 41.109999999999999 111.074 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 17' ' ' ARG . 4.0 mm -69.62 172.52 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 61.509999999999998 111.134 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.7 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -53.69 172.41 0.23 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.597 0.713 . . . . 62.229999999999997 110.861 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.602 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 54.2 Cg_endo -69.75 20.38 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.671 2.247 . . . . 74.209999999999994 112.356 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 12' ' ' HIS . 1.2 ptmt -128.33 26.44 5.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.230000000000004 110.933 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 152.34 -178.81 29.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.749 . . . . 63.329999999999998 112.454 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.074 HD13 HD21 ' A' ' 67' ' ' LEU . 35.1 tp -150.78 167.07 28.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.825 0.345 . . . . 71.209999999999994 110.896 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.716 ' HB2' HD11 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -129.33 141.1 51.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 62.130000000000003 110.871 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.516 ' CG2' HD23 ' A' ' 8' ' ' LEU . 62.4 t -153.17 105.1 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 31.43 111.1 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 t -116.31 164.28 14.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 74.230000000000004 110.874 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG12 ' HA ' ' A' ' 6' ' ' ALA . 22.7 m -143.15 151.65 56.02 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.668 0.747 . . . . 43.240000000000002 111.117 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 122.12 8.81 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.711 2.274 . . . . 44.509999999999998 112.344 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -81.84 94.89 7.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 72.25 110.898 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -91.88 24.97 2.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 71.239999999999995 110.871 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.98 28.15 4.0 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.729 -0.748 . . . . 63.43 112.534 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CD1' ' HB2' ' A' ' 81' ' ' LYS . 77.7 m-85 -78.41 165.83 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.85 0.357 . . . . 72.010000000000005 110.839 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 43.0 t -128.79 -8.25 5.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 65.129999999999995 110.844 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.008 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -161.19 140.63 10.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 72.340000000000003 110.926 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.008 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.6 t80 -134.57 145.68 48.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 70.019999999999996 110.846 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -129.64 164.6 23.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.09 -0.504 . . . . 65.140000000000001 111.088 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.424 ' C ' ' CD1' ' A' ' 30' ' ' PHE . 4.2 t80 -150.16 113.75 4.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 72.530000000000001 110.877 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.603 ' NE2' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -149.23 95.17 2.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 43.539999999999999 110.864 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.556 ' HA3' ' CD2' ' A' ' 75' ' ' PHE . . . -146.19 -175.36 19.14 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.711 -0.757 . . . . 74.439999999999998 112.474 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.428 ' CG ' ' HA3' ' A' ' 44' ' ' GLY . 1.9 mtpp -131.84 -165.12 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.779 0.324 . . . . 64.230000000000004 110.882 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.64 148.14 40.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 75.239999999999995 110.901 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.415 ' N ' HD22 ' A' ' 35' ' ' ASN . 1.0 OUTLIER 49.29 22.84 0.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 74.430000000000007 110.844 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.7 143.17 2.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.464 . . . . 64.400000000000006 110.879 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -108.82 154.17 22.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.125 -0.489 . . . . 41.299999999999997 110.902 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.34 -177.88 4.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.907 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -96.12 133.2 40.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 54.5 110.91 -179.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 45.88 -92.49 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.735 . . . . 73.439999999999998 112.475 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -157.25 83.83 0.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.767 0.318 . . . . 75.109999999999999 110.897 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 43' ' ' ALA . 7.9 pt-20 -124.31 -168.09 1.75 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 74.209999999999994 110.893 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.603 ' HB1' ' NE2' ' A' ' 31' ' ' HIS . . . -94.01 106.6 18.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 54.509999999999998 111.095 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA3' ' CG ' ' A' ' 33' ' ' LYS . . . -72.9 -109.15 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.689 -0.767 . . . . 71.450000000000003 112.485 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -107.88 -69.17 0.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.83 0.348 . . . . 63.32 110.845 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.543 ' O ' ' CD2' ' A' ' 31' ' ' HIS . 8.0 m0 -54.98 170.96 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 75.140000000000001 110.931 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.418 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 59.9 p -176.13 127.92 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.265 -0.425 . . . . 74.409999999999997 110.927 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.06 155.58 3.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 52.32 110.875 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.26 99.98 3.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 71.340000000000003 110.855 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.0 mm -82.96 122.53 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 74.409999999999997 111.117 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.5 p -110.14 37.92 2.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 65.219999999999999 111.134 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 174.35 116.91 0.1 OUTLIER Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.594 0.711 . . . . 70.129999999999995 110.871 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.541 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 54.0 Cg_endo -69.74 159.35 53.74 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.661 2.24 . . . . 73.430000000000007 112.375 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 55' ' ' ASN . 0.0 OUTLIER -142.12 131.88 24.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.909 179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.414 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 1.9 t30 78.45 16.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 54.219999999999999 110.869 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.33 -23.87 33.74 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 54.509999999999998 112.454 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.52 171.79 13.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.793 0.33 . . . . 71.310000000000002 110.856 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.541 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 9.4 m95 -86.87 101.06 13.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 75.540000000000006 110.919 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.6 mt -101.06 137.04 29.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 74.409999999999997 111.144 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -132.23 145.11 51.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 73.120000000000005 110.895 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.36 134.01 31.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 75.420000000000002 110.914 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -110.94 179.32 4.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.227 -0.442 . . . . 61.350000000000001 110.906 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.16 19.84 2.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 75.200000000000003 110.883 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -137.84 30.28 2.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 71.510000000000005 110.908 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.425 ' O ' HD23 ' A' ' 67' ' ' LEU . . . -118.71 83.35 2.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 54.420000000000002 111.074 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -80.09 86.06 5.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.453 . . . . 43.32 111.057 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.074 HD21 HD13 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -125.71 171.68 10.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 74.430000000000007 110.925 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -160.28 140.57 11.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 65.439999999999998 110.91 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.611 HD11 ' O ' ' A' ' 97' ' ' GLY . 11.5 mm -24.26 118.07 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.251 -0.431 . . . . 72.219999999999999 111.093 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 123.27 -18.68 7.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.775 -0.726 . . . . 73.319999999999993 112.468 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.12 -176.76 4.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.813 0.339 . . . . 55.039999999999999 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 0.0 OUTLIER -143.99 161.81 37.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 70.430000000000007 110.857 179.967 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.8 mt -138.93 145.66 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 111.108 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -146.15 103.01 3.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 71.540000000000006 110.89 179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' CD2' ' HA3' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -162.14 -157.78 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.089 -0.505 . . . . 70.329999999999998 110.889 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.423 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.1 p-90 -150.93 173.74 13.93 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.196 -0.456 . . . . 74.200000000000003 110.932 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 10.1 p -143.05 158.74 43.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 54.109999999999999 111.172 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.16 144.48 45.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 73.409999999999997 110.829 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -143.69 169.52 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.108 -0.496 . . . . 62.43 111.111 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.736 HG13 HD12 ' A' ' 27' ' ' LEU . 66.9 mt -147.71 96.09 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 74.25 111.172 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.581 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -114.63 140.64 48.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 73.030000000000001 110.942 179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 50.63 27.12 2.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.25 -0.432 . . . . 75.319999999999993 110.845 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.37 29.13 68.35 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.723 -0.751 . . . . 42.299999999999997 112.5 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.45 HD13 ' OH ' ' A' ' 86' ' ' TYR . 2.4 mt -98.98 -49.53 4.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 74.230000000000004 110.908 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.6 131.48 4.83 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.744 -0.741 . . . . 74.099999999999994 112.496 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.65 ' HB2' HG23 ' A' ' 79' ' ' VAL . 76.5 m-85 -145.17 -179.24 6.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.895 0.379 . . . . 74.409999999999997 110.935 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.5 tmm_? -172.24 133.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 75.340000000000003 110.897 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.716 ' OE1' ' HB3' ' A' ' 3' ' ' ALA . 4.3 tp60 -78.74 155.15 29.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 75.319999999999993 110.92 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.509 ' CG ' ' N ' ' A' ' 90' ' ' ASN . 0.0 OUTLIER -141.6 -163.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 75.120000000000005 110.87 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.509 ' N ' ' CG ' ' A' ' 89' ' ' ASP . 1.7 t-20 83.05 -36.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 75.140000000000001 110.893 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.19 78.2 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.758 -0.734 . . . . 41.100000000000001 112.471 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -170.47 109.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.853 0.358 . . . . 74.420000000000002 110.925 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 16.1 m-90 -151.14 112.89 4.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 74.530000000000001 110.928 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 28.9 m -86.85 130.92 34.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 73.430000000000007 111.066 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.69 ' CG1' ' HB2' ' A' ' 10' ' ' ALA . 21.2 t -62.85 116.08 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 63.229999999999997 111.128 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.0 15.2 3.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 62.109999999999999 110.895 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -130.44 -177.82 15.09 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.721 -0.752 . . . . 62.409999999999997 112.507 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.448 ' CE1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -153.86 155.52 35.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.88 0.372 . . . . 64.430000000000007 110.872 -179.838 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.604 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -166.71 168.37 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 65.120000000000005 111.151 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.34 133.92 39.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 54.549999999999997 110.876 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -85.17 39.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 73.329999999999998 110.851 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 62.219999999999999 111.099 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.814 0.34 . . . . 75.040000000000006 110.936 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -126.18 71.64 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 71.310000000000002 110.855 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 60.12 143.54 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.612 0.72 . . . . 64.140000000000001 111.062 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.483 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 53.8 Cg_endo -69.74 166.95 25.83 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.653 2.235 . . . . 72.239999999999995 112.365 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 132.65 23.77 Favored 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.683 2.255 . . . . 72.519999999999996 112.379 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.811 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -83.12 138.24 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 45.130000000000003 111.103 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.5 m -95.59 78.03 3.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 72.310000000000002 111.138 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.559 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.4 mp -79.32 109.31 13.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 52.340000000000003 110.969 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.846 ' O ' HD11 ' A' ' 16' ' ' LEU . 6.7 mm-40 -79.99 -171.79 3.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 53.100000000000001 110.924 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.8 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -130.46 81.26 1.99 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.2 -0.454 . . . . 52.240000000000002 111.119 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.731 HD13 ' CG2' ' A' ' 99' ' ' VAL . 2.9 mm -72.66 172.52 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 73.450000000000003 111.12 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.706 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.34 172.01 0.26 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.605 0.717 . . . . 61.409999999999997 110.849 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.6 Cg_endo -69.73 19.86 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 74.030000000000001 112.373 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 12' ' ' HIS . 11.1 ptmt -124.66 19.94 8.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.238 -0.437 . . . . 72.540000000000006 110.887 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.21 -177.44 33.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.796 -0.716 . . . . 60.329999999999998 112.486 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.846 HD11 ' O ' ' A' ' 9' ' ' GLU . 19.8 tp -150.89 168.98 22.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.843 0.354 . . . . 72.540000000000006 110.888 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.466 ' HB2' HD11 ' A' ' 11' ' ' ILE . 3.2 ttt180 -132.92 139.44 47.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 73.040000000000006 110.86 179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -147.83 108.28 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 73.420000000000002 111.137 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 59' ' ' ILE . 12.8 t -119.5 157.41 28.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 60.030000000000001 110.859 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 6' ' ' ALA . 21.6 m -141.6 151.58 60.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.644 0.735 . . . . 63.439999999999998 111.138 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 122.21 8.89 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.713 2.275 . . . . 65.439999999999998 112.326 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 28.4 t0 -84.55 86.12 7.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 75.040000000000006 110.86 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -73.08 2.52 6.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 74.450000000000003 110.852 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.33 24.24 0.86 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.751 -0.737 . . . . 74.310000000000002 112.511 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CD1' ' HB ' ' A' ' 79' ' ' VAL . 81.4 m-85 -70.45 168.34 16.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.858 0.361 . . . . 74.049999999999997 110.866 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.5 t -125.39 -16.03 6.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 54.32 110.893 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.026 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -158.34 140.14 13.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.067 -0.515 . . . . 64.239999999999995 110.944 179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.026 ' N ' HD22 ' A' ' 27' ' ' LEU . 8.3 t80 -132.77 151.5 51.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 72.319999999999993 110.883 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -138.74 155.39 48.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 71.340000000000003 111.082 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.645 ' CZ ' ' CE2' ' A' ' 28' ' ' PHE . 1.4 m-85 -128.88 131.28 47.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 64.409999999999997 110.849 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.642 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 14.0 m-70 -157.63 84.97 0.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 71.430000000000007 110.868 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -144.55 177.47 23.08 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.726 -0.75 . . . . 70.209999999999994 112.491 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.4 OUTLIER -136.21 -166.23 1.84 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.805 0.336 . . . . 75.239999999999995 110.905 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 72' ' ' LYS . 13.7 tp -127.38 148.12 50.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.25 -0.432 . . . . 73.200000000000003 110.889 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 43.14 23.03 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.120000000000005 110.886 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' N ' ' O ' ' A' ' 34' ' ' LEU . 2.0 tp10 -157.67 145.54 18.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 74.099999999999994 110.907 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.462 ' CB ' ' HB2' ' A' ' 74' ' ' TYR . 0.2 OUTLIER -125.09 150.42 46.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 61.229999999999997 110.849 -179.908 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.467 ' HE3' ' O ' ' A' ' 31' ' ' HIS . 2.3 ptt? -102.73 -172.53 2.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 54.140000000000001 110.88 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.95 172.52 12.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 62.200000000000003 110.892 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 48.25 37.03 17.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.696 -0.764 . . . . 51.32 112.483 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.539 ' HA ' ' CE2' ' A' ' 76' ' ' TRP . 0.2 OUTLIER 35.05 83.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 62.350000000000001 110.864 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -124.79 -164.34 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 63.229999999999997 110.882 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.642 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -102.61 99.98 10.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 51.130000000000003 111.083 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 43' ' ' ALA . . . -56.74 -114.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.707 -0.759 . . . . 74.420000000000002 112.522 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -98.55 -65.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.782 0.325 . . . . 72.230000000000004 110.857 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -60.01 154.83 18.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 72.549999999999997 110.941 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.432 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 99.3 p -158.01 109.22 2.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 61.43 110.836 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.845 ' NH1' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -152.73 162.92 40.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.072 -0.513 . . . . 74.200000000000003 110.871 -179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.509 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -143.65 113.73 7.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 74.349999999999994 110.893 179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.845 HD13 ' NH1' ' A' ' 48' ' ' ARG . 11.2 mm -99.85 103.9 15.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 64.420000000000002 111.177 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.47 HG22 HD23 ' A' ' 27' ' ' LEU . 76.6 p -96.06 30.47 2.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 111.169 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 175.46 132.8 0.15 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.532 0.682 . . . . 74.409999999999997 110.945 179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 178.68 4.35 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.634 2.222 . . . . 64.239999999999995 112.363 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HD2' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -129.53 -30.41 2.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 53.009999999999998 110.878 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 m-20 -146.27 47.66 1.21 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.235 -0.439 . . . . 54.539999999999999 110.863 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 87.13 -26.26 7.04 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.754 -0.736 . . . . 40.420000000000002 112.459 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.88 164.42 21.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.827 0.346 . . . . 62.149999999999999 110.845 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 5.9 m95 -87.16 96.2 10.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 75.310000000000002 110.946 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.503 HD12 ' HD2' ' A' ' 54' ' ' LYS . 43.0 mt -102.75 142.04 17.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 62.340000000000003 111.155 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -134.98 154.28 51.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.438 . . . . 74.430000000000007 110.91 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.76 135.4 26.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 71.329999999999998 110.869 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.492 ' OD2' ' ND2' ' A' ' 64' ' ' ASN . 6.0 t70 -112.22 174.97 5.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 72.540000000000006 110.839 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -139.42 15.46 2.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 63.340000000000003 110.844 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.492 ' ND2' ' OD2' ' A' ' 62' ' ' ASP . 0.1 OUTLIER -129.44 4.94 5.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 72.219999999999999 110.888 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -92.16 98.13 11.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 73.209999999999994 111.102 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -96.45 87.53 4.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 111.086 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.798 HD11 HD13 ' A' ' 16' ' ' LEU . 0.0 OUTLIER -138.79 171.17 14.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 61.219999999999999 110.911 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.699 ' N ' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -157.73 156.57 31.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 72.230000000000004 110.943 179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.464 ' C ' ' O ' ' A' ' 68' ' ' LYS . 3.4 mm -32.01 118.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 75.420000000000002 111.189 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.26 -23.56 6.43 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.741 -0.742 . . . . 62.109999999999999 112.516 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -73.9 -170.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.867 0.365 . . . . 73.049999999999997 110.88 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.514 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -147.91 162.05 40.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 60.420000000000002 110.924 -179.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.4 mt -136.87 145.9 29.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 61.149999999999999 111.114 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -148.4 111.42 4.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.17 -0.468 . . . . 74.25 110.959 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.529 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.6 p90 -171.98 -163.45 0.25 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.913 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.539 ' CE2' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -152.18 145.6 24.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 61.350000000000001 110.895 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.484 ' HB ' ' CE1' ' A' ' 28' ' ' PHE . 11.2 p -113.45 161.11 17.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 74.200000000000003 111.153 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.551 ' CD1' ' HB2' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -119.17 144.77 46.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.196 -0.456 . . . . 71.310000000000002 110.884 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.642 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -139.24 166.14 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.349999999999994 111.178 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.643 HG13 HD12 ' A' ' 27' ' ' LEU . 90.7 mt -143.26 96.65 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 64.510000000000005 111.15 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.461 ' HG2' ' N ' ' A' ' 82' ' ' ASP . 4.9 tttt -118.66 146.36 44.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 72.140000000000001 110.918 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.461 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 0.1 OUTLIER 52.15 22.26 1.87 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 63.439999999999998 110.858 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.15 27.67 71.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.754 . . . . 61.32 112.499 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 mt -100.05 -65.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 73.25 110.917 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.39 124.85 4.96 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.688 -0.768 . . . . 31.32 112.464 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.642 ' HB2' HG23 ' A' ' 79' ' ' VAL . 8.2 m-85 -136.71 178.0 7.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.928 0.394 . . . . 74.0 110.89 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.551 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -164.2 123.97 2.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.102 -0.499 . . . . 72.219999999999999 110.886 -179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.579 HE22 ' N ' ' A' ' 6' ' ' ALA . 1.9 tt0 -52.85 -173.3 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 62.100000000000001 110.897 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.499 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -170.49 -166.25 0.51 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 62.299999999999997 110.885 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER 83.53 -32.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 73.209999999999994 110.873 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 33.9 61.76 0.48 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.71 -0.757 . . . . 43.43 112.495 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -167.88 106.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.877 0.37 . . . . 74.010000000000005 110.91 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 25.7 m-90 -145.42 115.51 7.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 61.119999999999997 110.889 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 60.5 m -87.31 133.16 33.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 65.540000000000006 111.149 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.733 HG13 ' HB2' ' A' ' 10' ' ' ALA . 21.6 t -63.38 107.66 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 51.219999999999999 111.143 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.75 5.21 7.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 60.32 110.892 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.8 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -117.53 179.76 17.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.756 . . . . 75.099999999999994 112.464 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.43 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.1 OUTLIER -152.96 155.52 37.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.904 0.383 . . . . 74.420000000000002 110.872 -179.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.731 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -164.51 -176.41 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 72.430000000000007 111.14 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -141.88 129.6 21.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 63.5 110.893 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -80.23 58.71 3.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.48 . . . . 73.329999999999998 110.897 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 74.400000000000006 111.109 179.927 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.563 ' C ' ' CD1' ' A' ' 1' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.819 0.343 . . . . 75.049999999999997 110.91 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.509 ' CG ' ' O ' ' A' ' 1' ' ' TYR . 39.6 mt-10 -162.53 68.68 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 73.150000000000006 110.9 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' A' ' 86' ' ' TYR . . . -33.22 142.07 0.2 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.576 0.703 . . . . 53.020000000000003 111.125 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 154.62 67.62 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.71 2.273 . . . . 74.530000000000001 112.315 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 134.47 28.0 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.672 2.248 . . . . 52.520000000000003 112.336 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.888 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -86.24 137.92 32.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 64.120000000000005 111.11 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.1 m -93.18 77.19 4.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 74.219999999999999 111.122 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.535 HD21 ' CE1' ' A' ' 75' ' ' PHE . 1.9 mp -77.94 110.87 13.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 72.540000000000006 110.911 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.795 ' O ' HD11 ' A' ' 16' ' ' LEU . 20.4 mm-40 -87.26 -167.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 75.519999999999996 110.858 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.867 ' HB2' HG13 ' A' ' 95' ' ' VAL . . . -134.32 80.51 1.86 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 62.240000000000002 111.131 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.771 HD11 ' HB2' ' A' ' 17' ' ' ARG . 4.5 mm -69.38 172.52 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 71.200000000000003 111.122 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.7 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -53.85 172.03 0.24 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.641 0.734 . . . . 73.25 110.817 179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.9 Cg_endo -69.77 21.43 0.17 Allowed 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 54.509999999999998 112.347 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 12' ' ' HIS . 7.5 pttt -128.82 25.07 5.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 72.140000000000001 110.884 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 153.29 -177.9 30.63 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.76 -0.733 . . . . 51.109999999999999 112.488 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.934 HD13 HD21 ' A' ' 67' ' ' LEU . 24.6 tp -150.71 157.97 43.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.828 0.347 . . . . 61.539999999999999 110.919 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.771 ' HB2' HD11 ' A' ' 11' ' ' ILE . 74.8 ttt180 -122.75 135.25 54.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 65.400000000000006 110.889 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 8' ' ' LEU . 53.7 t -147.06 108.05 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 74.329999999999998 111.095 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.702 ' HB2' HG23 ' A' ' 59' ' ' ILE . 46.4 t -120.56 162.2 20.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 75.120000000000005 110.897 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.888 HG12 ' HA ' ' A' ' 6' ' ' ALA . 30.4 m -141.04 152.03 63.87 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.646 0.736 . . . . 73.420000000000002 111.102 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 123.98 10.65 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.646 2.231 . . . . 72.340000000000003 112.364 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 17.0 t0 -87.82 107.05 18.48 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 63.43 110.889 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -96.09 6.81 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.449 . . . . 44.130000000000003 110.893 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 131.48 8.97 2.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.734 -0.746 . . . . 73.239999999999995 112.462 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.531 ' CD2' ' HB2' ' A' ' 81' ' ' LYS . 63.5 m-85 -60.27 168.5 1.99 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.328 . . . . 71.409999999999997 110.887 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 22.9 t -128.95 -7.39 4.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.854 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.994 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -156.32 143.06 18.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.125 -0.489 . . . . 62.509999999999998 110.915 179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.994 ' N ' HD22 ' A' ' 27' ' ' LEU . 16.3 t80 -139.73 139.32 36.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 75.5 110.882 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -125.44 158.86 33.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 73.239999999999995 111.141 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.484 ' HE2' HG11 ' A' ' 18' ' ' VAL . 4.1 t80 -145.75 114.65 6.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 65.510000000000005 110.891 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.722 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -147.35 94.87 2.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 73.349999999999994 110.846 -179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.487 ' O ' ' CE3' ' A' ' 46' ' ' TRP . . . -145.62 177.61 23.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.766 -0.731 . . . . 53.340000000000003 112.456 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -129.55 -164.67 1.43 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.826 0.346 . . . . 75.209999999999994 110.905 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.688 HD12 ' O ' ' A' ' 72' ' ' LYS . 15.0 tp -136.31 148.53 47.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 70.340000000000003 110.954 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 48.96 19.89 0.31 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 71.420000000000002 110.894 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -161.24 142.7 11.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 73.019999999999996 110.888 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -113.03 156.69 22.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 73.430000000000007 110.897 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.599 ' CG ' ' CZ2' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -100.75 -178.98 3.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.489 . . . . 64.349999999999994 110.821 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -112.26 136.51 51.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 71.519999999999996 110.87 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 56.21 -91.93 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.74 -0.743 . . . . 33.439999999999998 112.498 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.742 HD22 ' NH1' ' A' ' 87' ' ' ARG . 0.8 OUTLIER -164.56 91.38 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.751 0.31 . . . . 60.32 110.916 -179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -129.28 173.88 10.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 75.530000000000001 110.843 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.722 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -85.66 101.67 12.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 71.420000000000002 111.069 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -61.23 -119.58 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 71.430000000000007 112.483 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -103.41 -51.75 3.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.78 0.324 . . . . 75.010000000000005 110.877 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.567 ' CD1' ' OD2' ' A' ' 62' ' ' ASP . 8.3 m0 -70.19 165.42 22.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.922 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.557 ' HA ' ' CD2' ' A' ' 31' ' ' HIS . 96.0 p -164.65 124.25 1.91 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.251 -0.431 . . . . 72.0 110.847 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HG2' ' CD1' ' A' ' 60' ' ' PHE . 17.0 tpp180 -165.44 144.26 6.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.128 -0.487 . . . . 73.209999999999994 110.872 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.572 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -139.39 99.31 3.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.868 179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.3 mm -87.87 115.42 28.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 64.409999999999997 111.115 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.415 HG22 HD23 ' A' ' 27' ' ' LEU . 63.8 p -103.78 33.47 3.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 53.140000000000001 111.134 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 51' ' ' THR . 0.6 OUTLIER 167.84 127.38 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.605 0.717 . . . . 72.010000000000005 110.903 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 171.17 15.01 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.687 2.258 . . . . 73.099999999999994 112.32 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.82 19.45 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 44.420000000000002 110.907 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -177.56 38.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.140000000000001 110.917 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.47 -13.62 15.82 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.741 . . . . 75.329999999999998 112.452 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.05 160.54 40.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.805 0.336 . . . . 75.209999999999994 110.873 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.474 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 3.9 m95 -85.79 101.39 12.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 75.219999999999999 110.949 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.702 HG23 ' HB2' ' A' ' 19' ' ' SER . 7.7 mt -104.32 143.78 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 62.399999999999999 111.121 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.494 ' CD1' ' HG2' ' A' ' 48' ' ' ARG . 13.1 t80 -132.27 147.89 52.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 73.530000000000001 110.939 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.439 ' N ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -140.93 127.45 20.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 74.010000000000005 110.886 -179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.567 ' OD2' ' CD1' ' A' ' 46' ' ' TRP . 2.5 t0 -104.47 -179.53 3.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.24 -0.436 . . . . 65.420000000000002 110.853 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 -148.95 28.34 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 75.439999999999998 110.865 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -144.88 13.58 1.49 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 63.439999999999998 110.876 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.03 100.09 9.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 73.200000000000003 111.142 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -95.54 86.55 4.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 62.450000000000003 111.094 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.934 HD21 HD13 ' A' ' 16' ' ' LEU . 0.6 OUTLIER -125.62 171.55 10.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.428 . . . . 74.150000000000006 110.895 -179.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.501 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -152.79 140.49 19.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.46 . . . . 63.530000000000001 110.931 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.54 HG12 ' CD1' ' A' ' 98' ' ' PHE . 17.1 mm -28.23 118.08 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.238 -0.437 . . . . 60.530000000000001 111.096 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 127.67 -22.04 5.56 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.749 -0.739 . . . . 71.099999999999994 112.474 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.84 -166.87 0.32 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.869 0.366 . . . . 65.239999999999995 110.898 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.688 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.1 mttt -147.33 172.16 14.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 73.329999999999998 110.871 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 96.2 mt -144.72 144.69 21.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.211 -0.45 . . . . 75.109999999999999 111.129 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -148.3 100.75 3.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 74.299999999999997 110.87 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.535 ' CE1' HD21 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -159.5 -156.59 0.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.106 -0.497 . . . . 72.409999999999997 110.826 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.599 ' CZ2' ' CG ' ' A' ' 38' ' ' MET . 0.0 OUTLIER -152.46 156.68 39.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 75.510000000000005 110.918 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.6 p -118.82 175.38 5.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 74.450000000000003 111.176 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.434 ' CE2' ' HB2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -146.95 130.46 16.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 70.239999999999995 110.905 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 86' ' ' TYR . 3.3 m -134.13 -179.03 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 64.430000000000007 111.138 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.737 HG13 HD12 ' A' ' 27' ' ' LEU . 83.1 mt -153.37 97.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 74.099999999999994 111.108 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.531 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . 16.1 tttm -113.1 135.19 54.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 62.219999999999999 110.9 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.3 t0 50.51 25.1 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 75.25 110.851 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.98 30.04 73.9 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.741 . . . . 54.210000000000001 112.511 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.733 HD13 ' OH ' ' A' ' 86' ' ' TYR . 2.0 mt -92.53 -66.87 0.89 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.853 0.359 . . . . 75.400000000000006 110.915 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.59 116.09 4.12 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.713 -0.755 . . . . 60.130000000000003 112.495 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.733 ' OH ' HD13 ' A' ' 84' ' ' LEU . 0.5 OUTLIER -127.33 166.46 17.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.879 0.371 . . . . 70.109999999999999 110.902 -179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.742 ' NH1' HD22 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -160.33 110.67 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 74.519999999999996 110.904 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.74 157.9 13.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 74.450000000000003 110.924 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.3 OUTLIER -146.72 -169.11 3.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 63.299999999999997 110.849 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.6 m120 83.93 -28.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 71.040000000000006 110.862 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 90' ' ' ASN . . . 34.41 78.54 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.762 -0.733 . . . . 31.539999999999999 112.492 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -165.96 104.14 0.67 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.803 0.335 . . . . 75.409999999999997 110.887 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.406 ' CG ' HD13 ' A' ' 8' ' ' LEU . 19.4 m-90 -145.95 113.28 6.24 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 110.939 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 93.1 m -82.07 140.07 34.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 75.099999999999994 111.138 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.867 HG13 ' HB2' ' A' ' 10' ' ' ALA . 21.2 t -78.64 111.61 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 53.509999999999998 111.133 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -138.66 16.32 2.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 74.530000000000001 110.861 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.662 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -139.38 121.7 2.13 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.78 -0.724 . . . . 61.299999999999997 112.527 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.54 ' CD1' HG12 ' A' ' 69' ' ' ILE . 0.0 OUTLIER -91.02 170.08 10.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.91 0.386 . . . . 73.030000000000001 110.895 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.643 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -168.03 155.16 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 71.319999999999993 111.127 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 32.9 p-10 -115.18 127.35 55.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.479 . . . . 65.120000000000005 110.864 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -89.81 39.5 0.96 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 54.420000000000002 110.924 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 73.019999999999996 111.132 179.927 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.7 t80 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.864 0.364 . . . . 73.329999999999998 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 43.0 mt-10 -142.57 73.13 1.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 71.0 110.911 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 2' ' ' GLU . . . 69.71 145.03 0.11 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.58 0.705 . . . . 71.400000000000006 111.075 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.472 ' O ' ' NE2' ' A' ' 88' ' ' GLN . 54.2 Cg_endo -69.66 168.3 21.82 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.701 2.267 . . . . 73.329999999999998 112.358 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.73 132.72 23.96 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.682 2.255 . . . . 64.219999999999999 112.356 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.784 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -81.01 134.92 35.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 51.25 111.085 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.1 m -93.12 77.16 4.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.168 -0.469 . . . . 75.549999999999997 111.117 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.666 ' HA ' HG22 ' A' ' 18' ' ' VAL . 2.1 mp -79.34 107.18 11.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 63.350000000000001 110.928 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.903 ' O ' HD11 ' A' ' 16' ' ' LEU . 6.6 mm-40 -79.92 -173.58 3.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 74.340000000000003 110.909 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -129.68 79.65 1.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 64.420000000000002 111.047 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.717 HD11 ' HB2' ' A' ' 17' ' ' ARG . 3.2 mm -70.6 172.61 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 73.239999999999995 111.139 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.694 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -53.05 171.54 0.22 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 64.030000000000001 110.839 179.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.5 Cg_endo -69.79 19.77 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.686 2.257 . . . . 72.129999999999995 112.307 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.483 ' H ' ' C ' ' A' ' 12' ' ' HIS . 25.5 pttt -127.91 25.43 5.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 72.420000000000002 110.921 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 154.55 -179.98 30.25 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.754 -0.736 . . . . 71.549999999999997 112.498 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.019 HD13 HD21 ' A' ' 67' ' ' LEU . 20.5 tp -149.97 158.3 44.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.83 0.348 . . . . 71.010000000000005 110.902 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.717 ' HB2' HD11 ' A' ' 11' ' ' ILE . 11.4 ttt180 -126.37 132.55 51.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 72.019999999999996 110.88 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.666 HG22 ' HA ' ' A' ' 8' ' ' LEU . 54.2 t -141.29 114.03 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 71.099999999999994 111.129 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.529 ' HB2' HG23 ' A' ' 59' ' ' ILE . 7.8 t -119.96 156.56 30.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 63.299999999999997 110.85 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.784 HG12 ' HA ' ' A' ' 6' ' ' ALA . 33.4 m -139.01 152.67 70.59 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.589 0.709 . . . . 74.25 111.168 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 121.36 8.05 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.727 2.285 . . . . 72.010000000000005 112.313 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.598 ' O ' ' CD2' ' A' ' 25' ' ' PHE . 7.1 t70 -55.69 -81.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.22 -0.445 . . . . 65.030000000000001 110.881 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.501 ' CB ' ' O ' ' A' ' 22' ' ' ASP . 0.9 OUTLIER 83.46 -13.8 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.261 -0.427 . . . . 75.439999999999998 110.874 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.83 6.47 2.26 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.779 -0.724 . . . . 71.230000000000004 112.516 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.598 ' CD2' ' O ' ' A' ' 22' ' ' ASP . 36.1 m-85 -53.8 166.74 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 74.120000000000005 110.865 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.462 ' N ' ' O ' ' A' ' 80' ' ' ILE . 11.4 t -133.08 -2.25 3.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 73.409999999999997 110.822 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.043 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -171.45 139.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 75.310000000000002 110.892 -179.966 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.043 ' N ' HD22 ' A' ' 27' ' ' LEU . 13.3 t80 -133.77 152.5 51.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 64.129999999999995 110.871 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.79 158.87 43.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 75.530000000000001 111.113 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.522 ' HE2' HG11 ' A' ' 18' ' ' VAL . 1.5 t80 -139.2 127.27 22.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 71.129999999999995 110.871 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.529 ' CE1' ' CB ' ' A' ' 47' ' ' SER . 7.3 m-70 -152.89 88.04 1.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.200000000000003 110.859 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.523 ' HA3' ' CG ' ' A' ' 75' ' ' PHE . . . -146.27 -176.67 20.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.768 -0.73 . . . . 33.549999999999997 112.47 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.411 ' HG3' ' C ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -134.8 -164.29 1.5 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.832 0.349 . . . . 74.109999999999999 110.863 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 13.1 tp -131.94 147.02 52.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 73.140000000000001 110.875 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 39.92 30.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 74.420000000000002 110.859 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.03 127.6 4.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.450000000000003 110.893 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -99.96 146.81 26.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 71.340000000000003 110.864 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 10.0 ptp -101.98 -174.92 2.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 64.049999999999997 110.881 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -145.37 154.65 42.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 75.219999999999999 110.909 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' O ' ' C ' ' A' ' 41' ' ' LEU . . . 56.52 36.29 70.09 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 32.340000000000003 112.508 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' A' ' 40' ' ' GLY . 4.1 mt 35.72 84.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 60.140000000000001 110.937 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -124.61 178.41 5.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 72.420000000000002 110.877 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.83 98.26 10.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 111.137 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.96 -116.35 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.694 -0.765 . . . . 74.099999999999994 112.503 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.74 -58.42 1.89 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.752 0.31 . . . . 63.439999999999998 110.837 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 8.0 m0 -69.66 146.96 51.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.241 -0.436 . . . . 74.540000000000006 110.936 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.529 ' CB ' ' CE1' ' A' ' 31' ' ' HIS . 77.7 p -155.12 120.18 4.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 64.239999999999995 110.812 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.14 158.85 25.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 63.340000000000003 110.92 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.743 ' OD1' HD21 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -143.56 116.19 8.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.228 -0.442 . . . . 71.140000000000001 110.835 -179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.5 mm -98.76 108.17 21.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.179 -0.464 . . . . 54.450000000000003 111.144 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.1 p -98.23 31.84 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 72.219999999999999 111.106 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.23 115.59 0.27 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.656 0.741 . . . . 74.439999999999998 110.858 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.55 ' HD3' ' CH2' ' A' ' 58' ' ' TRP . 53.7 Cg_endo -69.71 178.16 4.82 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.66 2.24 . . . . 74.129999999999995 112.377 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.693 ' HD3' HD12 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -169.88 133.2 1.19 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 62.329999999999998 110.902 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 54' ' ' LYS . 7.1 t-20 81.62 8.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.23 -0.441 . . . . 52.020000000000003 110.92 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.88 -16.84 42.77 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.741 . . . . 74.209999999999994 112.542 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.1 176.01 9.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.783 0.325 . . . . 72.140000000000001 110.911 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.55 ' CH2' ' HD3' ' A' ' 53' ' ' PRO . 6.9 m95 -93.41 107.91 19.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 71.540000000000006 110.893 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.693 HD12 ' HD3' ' A' ' 54' ' ' LYS . 11.1 mt -106.21 146.62 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 72.239999999999995 111.111 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -136.38 144.53 44.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 73.510000000000005 110.85 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.51 133.43 40.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 73.129999999999995 110.859 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -118.78 155.1 31.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.456 . . . . 70.310000000000002 110.864 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.1 mtt180 -123.31 41.9 3.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 54.350000000000001 110.862 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.87 24.02 0.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 64.239999999999995 110.854 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -116.3 93.1 4.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 75.450000000000003 111.129 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -89.38 81.1 6.67 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.420000000000002 111.11 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.019 HD21 HD13 ' A' ' 16' ' ' LEU . 0.7 OUTLIER -121.91 171.52 8.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 70.510000000000005 110.948 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.569 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -157.74 138.45 13.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 73.409999999999997 110.935 179.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.569 ' C ' ' O ' ' A' ' 68' ' ' LYS . 2.8 mm -22.65 118.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 75.409999999999997 111.181 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.94 -18.12 7.09 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 24.199999999999999 112.472 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.97 -169.19 1.47 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.866 0.365 . . . . 72.329999999999998 110.908 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 4.9 mttt -150.34 161.67 42.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 71.439999999999998 110.937 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 82.3 mt -135.63 146.65 29.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 74.150000000000006 111.145 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 1.9 m-85 -147.59 107.01 3.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 75.209999999999994 110.903 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CG ' ' HA3' ' A' ' 32' ' ' GLY . 1.4 p90 -167.67 -167.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 70.120000000000005 110.883 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 76' ' ' TRP . 2.9 p-90 -135.97 163.11 31.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.153 -0.476 . . . . 73.010000000000005 110.943 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 p -131.35 164.4 25.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 55.329999999999998 111.133 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -127.67 141.64 51.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 75.310000000000002 110.912 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.598 HG23 ' HB2' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -141.03 167.3 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.25 111.137 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.589 ' CD1' HD12 ' A' ' 27' ' ' LEU . 94.1 mt -149.89 95.69 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 65.120000000000005 111.094 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -109.84 137.49 47.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.449 . . . . 71.430000000000007 110.891 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 43.4 34.95 0.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 64.5 110.909 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 59.69 37.73 92.77 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 64.349999999999994 112.461 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -98.81 -55.11 2.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.89 0.376 . . . . 64.319999999999993 110.94 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.11 113.22 1.13 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 73.219999999999999 112.482 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.598 ' HB2' HG23 ' A' ' 79' ' ' VAL . 96.7 m-85 -132.23 -178.72 5.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.845 0.355 . . . . 75.439999999999998 110.918 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -174.09 135.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 70.140000000000001 110.849 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.472 ' NE2' ' O ' ' A' ' 4' ' ' PRO . 1.4 tp-100 -86.1 153.19 22.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 74.109999999999999 110.881 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.511 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -135.19 -163.91 1.45 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 65.120000000000005 110.884 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.4 t-20 83.73 -37.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 73.200000000000003 110.896 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 42.51 79.12 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.77 -0.728 . . . . 75.239999999999995 112.479 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -170.14 110.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.824 0.345 . . . . 62.109999999999999 110.886 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -151.52 115.4 4.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 74.329999999999998 110.921 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 41.5 m -87.06 131.18 34.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 61.450000000000003 111.185 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.688 HG21 HD12 ' A' ' 67' ' ' LEU . 28.8 t -63.21 116.33 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 73.450000000000003 111.123 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -134.04 6.1 3.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 75.409999999999997 110.875 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.812 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -115.82 -178.55 18.37 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.733 -0.746 . . . . 71.099999999999994 112.461 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.515 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -155.7 155.7 33.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.912 0.387 . . . . 63.329999999999998 110.89 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.711 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.76 178.67 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 64.540000000000006 111.119 179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -141.38 133.61 27.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 70.519999999999996 110.905 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -85.24 44.89 1.12 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 75.120000000000005 110.882 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 73.400000000000006 111.074 179.917 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.865 0.364 . . . . 70.120000000000005 110.928 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -145.95 86.32 1.71 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 62.409999999999997 110.889 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.93 148.5 0.1 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.563 0.697 . . . . 75.549999999999997 111.126 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.7 169.11 19.6 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.722 2.281 . . . . 54.130000000000003 112.369 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 133.37 25.28 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.696 2.264 . . . . 51.409999999999997 112.35 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.727 ' HA ' HG12 ' A' ' 20' ' ' VAL . . . -83.68 140.54 32.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 64.310000000000002 111.063 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.5 m -100.77 78.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 63.340000000000003 111.175 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.529 ' H ' HD12 ' A' ' 8' ' ' LEU . 1.7 mp -78.27 110.18 13.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 74.109999999999999 110.925 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.635 ' O ' HD11 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -78.19 -160.64 0.21 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 75.200000000000003 110.891 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.796 ' HB3' ' O ' ' A' ' 97' ' ' GLY . . . -139.92 80.34 1.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 71.209999999999994 111.118 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.755 HD13 ' CG2' ' A' ' 99' ' ' VAL . 3.3 mm -72.19 172.69 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 73.430000000000007 111.179 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.709 ' H ' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -54.18 172.09 0.25 Allowed Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.594 0.712 . . . . 71.230000000000004 110.858 179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.598 ' HD2' ' CG ' ' A' ' 12' ' ' HIS . 53.2 Cg_endo -69.82 20.07 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.665 2.243 . . . . 74.5 112.3 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.485 ' H ' ' C ' ' A' ' 12' ' ' HIS . 3.0 pttt -125.1 19.8 8.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 53.299999999999997 110.902 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 156.78 -177.3 33.77 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.758 -0.734 . . . . 71.329999999999998 112.492 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.987 HD13 HD21 ' A' ' 67' ' ' LEU . 27.8 tp -150.98 167.93 26.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.804 0.335 . . . . 75.299999999999997 110.922 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.575 ' HB2' HD11 ' A' ' 11' ' ' ILE . 5.2 ttm180 -130.78 141.08 50.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 74.209999999999994 110.879 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.4 t -149.59 107.15 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 111.121 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.553 ' HB2' HG23 ' A' ' 59' ' ' ILE . 11.7 t -120.18 156.3 31.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 65.030000000000001 110.871 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 6' ' ' ALA . 3.1 m -145.08 151.76 49.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 73.040000000000006 111.139 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 121.2 7.9 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.677 2.251 . . . . 74.129999999999995 112.339 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HB2' ' CD1' ' A' ' 58' ' ' TRP . 1.2 t70 -75.7 130.84 39.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 74.129999999999995 110.872 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.7 23.93 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 73.409999999999997 110.836 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' C ' ' HG3' ' A' ' 81' ' ' LYS . . . 112.8 5.91 23.45 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.753 -0.736 . . . . 74.519999999999996 112.468 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' HB2' ' CZ2' ' A' ' 58' ' ' TRP . 66.7 m-85 -55.62 162.54 1.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.869 0.366 . . . . 53.130000000000003 110.897 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.3 t -129.84 -8.9 4.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 61.310000000000002 110.879 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.009 HD22 ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -158.64 141.85 14.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 71.420000000000002 110.936 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 1.009 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -135.65 150.39 49.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 70.219999999999999 110.841 179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.718 ' HB2' ' OD1' ' A' ' 49' ' ' ASP . . . -141.0 136.75 32.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 74.450000000000003 111.083 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -119.62 118.28 30.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 75.140000000000001 110.84 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.727 ' CE1' ' HB1' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -146.0 90.58 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.146 -0.479 . . . . 71.510000000000005 110.881 179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 75' ' ' PHE . . . -146.24 -178.31 21.56 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 73.409999999999997 112.494 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -132.76 -164.3 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.808 0.337 . . . . 72.239999999999995 110.909 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' HG ' ' ND2' ' A' ' 35' ' ' ASN . 14.0 tp -133.18 147.94 52.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 62.329999999999998 110.965 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.466 ' ND2' ' HG ' ' A' ' 34' ' ' LEU . 2.2 m120 43.39 24.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 74.019999999999996 110.881 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -166.49 143.09 4.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 70.519999999999996 110.938 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -105.51 -170.55 1.76 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 72.319999999999993 110.907 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.508 ' SD ' ' N ' ' A' ' 44' ' ' GLY . 2.1 ptt? -137.96 178.84 6.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 63.009999999999998 110.866 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' A' ' 40' ' ' GLY . 1.4 mt-10 -45.16 171.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 64.5 110.895 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.5 ' C ' ' O ' ' A' ' 39' ' ' GLU . . . -30.04 -49.21 0.15 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.754 -0.736 . . . . 63.240000000000002 112.442 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.472 ' HA ' ' NE1' ' A' ' 76' ' ' TRP . 0.6 OUTLIER -170.03 84.42 0.12 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.778 0.323 . . . . 44.310000000000002 110.944 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 43' ' ' ALA . 3.9 pt-20 -127.9 -152.95 0.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 70.140000000000001 110.937 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB1' ' CE1' ' A' ' 31' ' ' HIS . . . -104.62 107.15 17.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 73.540000000000006 111.11 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.508 ' N ' ' SD ' ' A' ' 38' ' ' MET . . . -61.09 -121.6 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 73.099999999999994 112.483 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.43 -69.87 0.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.816 0.341 . . . . 54.119999999999997 110.897 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.446 ' O ' ' ND1' ' A' ' 31' ' ' HIS . 6.1 m-90 -47.47 164.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 70.409999999999997 110.915 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.488 ' CB ' ' NE2' ' A' ' 31' ' ' HIS . 97.0 p -166.31 117.39 0.99 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 74.209999999999994 110.878 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.56 162.43 21.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 62.240000000000002 110.874 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.718 ' OD1' ' HB2' ' A' ' 29' ' ' ALA . 0.3 OUTLIER -139.44 108.38 6.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 55.310000000000002 110.915 179.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.45 ' N ' ' O ' ' A' ' 28' ' ' PHE . 3.4 mm -82.94 104.2 11.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 60.310000000000002 111.095 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 80.1 p -91.94 28.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.163 -0.471 . . . . 51.399999999999999 111.136 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 169.34 140.78 0.06 OUTLIER Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.555 0.693 . . . . 72.340000000000003 110.885 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 178.25 4.74 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.739 2.293 . . . . 53.340000000000003 112.298 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.706 ' HD2' HD12 ' A' ' 59' ' ' ILE . 12.3 ttmt -109.9 -55.53 2.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 71.200000000000003 110.926 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -147.02 75.51 1.38 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 73.299999999999997 110.906 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.61 -22.22 6.72 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 74.430000000000007 112.481 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -137.98 171.89 13.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.802 0.334 . . . . 73.140000000000001 110.906 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.585 ' CZ2' ' HB2' ' A' ' 25' ' ' PHE . 18.9 m95 -93.58 98.44 11.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.205 -0.452 . . . . 74.540000000000006 110.922 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.706 HD12 ' HD2' ' A' ' 54' ' ' LYS . 27.9 mt -99.97 150.67 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 73.239999999999995 111.132 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -146.1 147.41 31.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 55.409999999999997 110.935 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.29 127.46 22.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 71.120000000000005 110.869 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -98.6 -179.55 4.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 73.209999999999994 110.871 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.59 16.17 1.45 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 72.209999999999994 110.879 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -133.43 6.93 3.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 75.430000000000007 110.871 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -94.68 103.28 15.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 73.420000000000002 111.09 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 13' ' ' PRO . . . -98.61 83.01 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 75.120000000000005 111.057 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.987 HD21 HD13 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -122.38 171.6 8.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 73.219999999999999 110.917 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.537 ' O ' ' C ' ' A' ' 69' ' ' ILE . 0.0 OUTLIER -158.45 141.62 14.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 110.888 179.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.576 HD11 ' O ' ' A' ' 97' ' ' GLY . 5.2 mm -26.0 117.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 62.25 111.168 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 119.31 -17.15 10.54 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.803 -0.713 . . . . 63.039999999999999 112.507 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -74.83 -167.98 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.846 0.355 . . . . 73.430000000000007 110.892 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 74' ' ' TYR . 16.4 mttt -151.52 165.56 33.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.340000000000003 110.918 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 68.8 mt -141.26 151.12 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 53.340000000000003 111.143 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.416 ' CZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -150.28 101.1 2.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.462 . . . . 74.25 110.87 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.488 ' CB ' ' HA3' ' A' ' 32' ' ' GLY . 0.5 OUTLIER -160.1 -166.35 1.68 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 74.109999999999999 110.872 179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.472 ' NE1' ' HA ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -146.4 148.64 32.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 74.129999999999995 110.902 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 p -115.07 155.61 26.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.253 -0.431 . . . . 75.420000000000002 111.173 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.02 142.97 49.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 71.549999999999997 110.877 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.451 ' CG1' ' CD2' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -142.68 170.72 11.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 72.530000000000001 111.098 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.675 HG13 HD12 ' A' ' 27' ' ' LEU . 77.5 mt -146.5 96.2 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 71.329999999999998 111.151 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.443 ' HG3' ' C ' ' A' ' 24' ' ' GLY . 1.6 tttt -114.15 141.58 47.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 75.409999999999997 110.947 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 49.14 32.44 4.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 72.150000000000006 110.852 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 57.08 30.11 60.27 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.741 -0.742 . . . . 74.310000000000002 112.476 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.535 HD13 ' OH ' ' A' ' 86' ' ' TYR . 1.5 mt -96.85 -63.6 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 65.049999999999997 110.923 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.09 106.11 3.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.755 -0.736 . . . . 72.219999999999999 112.452 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.535 ' OH ' HD13 ' A' ' 84' ' ' LEU . 80.2 m-85 -119.47 171.72 8.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.91 0.386 . . . . 74.439999999999998 110.875 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.487 ' CZ ' ' HB3' ' A' ' 87' ' ' ARG . 6.8 ttp-105 -171.33 131.25 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.063 -0.517 . . . . 71.430000000000007 110.895 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -74.08 158.93 33.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.247 -0.433 . . . . 72.129999999999995 110.923 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.512 ' O ' ' CB ' ' A' ' 90' ' ' ASN . 0.4 OUTLIER -140.83 -164.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 64.140000000000001 110.869 -179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.512 ' CB ' ' O ' ' A' ' 89' ' ' ASP . 1.2 t-20 83.75 -42.92 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 71.230000000000004 110.907 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.52 70.48 0.75 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.763 -0.732 . . . . 31.399999999999999 112.473 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -170.02 117.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.877 0.37 . . . . 62.130000000000003 110.895 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 23.6 m-90 -155.23 118.65 4.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 110.942 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 18.8 m -87.6 132.04 34.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 64.439999999999998 111.147 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.71 HG21 HD12 ' A' ' 67' ' ' LEU . 32.8 t -67.29 112.3 2.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 71.150000000000006 111.159 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -129.42 10.92 5.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 72.519999999999996 110.897 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.796 ' O ' ' HB3' ' A' ' 10' ' ' ALA . . . -122.65 -177.0 15.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.744 -0.741 . . . . 61.299999999999997 112.473 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.507 ' O ' HG13 ' A' ' 99' ' ' VAL . 0.1 OUTLIER -154.04 155.76 36.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.88 0.372 . . . . 71.340000000000003 110.861 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.755 ' CG2' HD13 ' A' ' 11' ' ' ILE . 0.0 OUTLIER -167.48 -176.36 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.463 . . . . 72.230000000000004 111.153 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -151.95 132.57 13.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 60.530000000000001 110.829 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -102.93 46.14 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 63.420000000000002 110.897 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 63.299999999999997 111.078 179.914 . . . . . . . . 0 0 . 1 stop_ save_